(((SDEV:0.06278,SDOW:0.06856):0.01333,(SEQU:0.01549,(SLUT:0.01641,SINF:0.01336):0.01611):0.02143):0.00768,SRAT:0.07753,(SSAL:0.01853,SVES:0.03610):0.06842):0.00000;
(((SINF:0.02227,SEQU:0.01679):0.15215,(SSUI:0.08660,(SRAT:0.06968,SDEV:0.06836):0.01844):0.08537):0.01441,((((SANG:0.11433,SCON:0.08776):0.02886,((SMIT:0.01757,SPSE:0.01792):0.08791,SINT:0.10728):0.02553):0.33493,(SPLU:0.20409,SENT:0.22091):0.05167):0.02771,(SCAN:0.10593,SDYS:0.11082):0.14009):0.03891,SSAL:0.18682):0.00000;
(SENT:0.19456,SINF:0.19456):0.00000;
(SENT:0.29307,SINF:0.29307):0.00000;
(SSAL:0.24768,SINF:0.24768):0.00000;
((((SPSE:0.03153,(SMIT:0.02791,SPNE:0.01584):0.00761):0.12604,(SANG:0.07885,(SCON:0.04261,SINT:0.06144):0.01809):0.07050):0.05660,((((((SCAN:0.10409,SDYS:0.09758):0.12803,((SPLU:0.17950,SDEV:0.18422):0.00830,((SLUT:0.06898,SINF:0.06378):0.02880,SEQU:0.08160):0.09988):0.01070):0.01971,SRAT:0.23984):0.03001,SENT:0.25840):0.03953,((LLAC:0.09655,LCRE:0.09113):0.14346,((SANG:0.07632,(SINT:0.01295,SCON:0.01839):0.05565):0.15458,(((SMIT:0.05188,SPSE:0.06966):0.00577,SPNE:0.05475):0.13996,SSUI:0.22222):0.00396):0.05582):0.02056):0.19914,(LLAC:0.07357,LCRE:0.07451):0.17476):0.02818):0.01348,((SPYO:0.08579,(SDYS:0.04688,SCAN:0.03584):0.03033):0.12230,(((SINF:0.05369,SLUT:0.01999):0.01894,SEQU:0.03685):0.07859,(SRAT:0.06729,SDEV:0.05161):0.08223):0.02926):0.01379,(((STHE:0.01599,SVES:0.02093):0.02851,SSAL:0.03162):0.15071,SDOW:0.20458):0.00850):0.00000;
(SINF:0.03016,SEQU:0.06833,SLUT:0.02652):0.00000;
((SEQU:0.08967,((SINF:0.03750,SLUT:0.05592):0.11721,SEQU:0.19733):0.42898):0.07857,SINF:0.02392,SLUT:0.02141):0.00000;
(SINF:0.27248,SCON:0.40960,SENT:0.27507):0.00000;
(SINF:0.02536,(SLUT:0.01361,SEQU:0.01482):0.00860,SRAT:0.57600):0.00000;
(SINF:0.00000,SEQU:0.05588,SLUT:0.00875):0.00000;
(((SSUI:0.07386,(((SLUT:0.05305,SEQU:0.03561):0.02431,SINF:0.04188):0.05656,(SDEV:0.06539,SRAT:0.04532):0.01880):0.00863):0.01404,SDOW:0.12202):0.00316,((SDEV:0.33943,(SMIT:0.01617,(SPSE:0.00000,SPNE:0.00000):0.01008):0.08539):0.01370,(SPYO:0.08281,(SENT:0.12260,(SCAN:0.02838,SDYS:0.01816):0.03466):0.01287):0.01990):0.00703,(STHE:0.01260,(SSAL:0.00811,SVES:0.00486):0.00039):0.06133):0.00000;
(SPSE:0.17542,SINF:0.17542):0.00000;
(SLUT:0.07551,SINF:0.07551):0.00000;
((SSUI:0.20791,(((SDYS:0.04464,SCAN:0.05116):0.15220,(SINF:0.03914,(SLUT:0.00529,SEQU:0.00591):0.04785):0.09714):0.03189,SPLU:0.18734):0.05941):0.00913,((((LLAC:0.00902,LCRE:0.01102):0.29452,(((SMIT:0.00834,SPNE:0.00672):0.06103,((SANG:0.00877,SINT:0.00676):0.01028,SCON:0.02033):0.05858):0.24210,((SDYS:0.04639,SCAN:0.04641):0.14972,(SEQU:0.06124,(SLUT:0.01255,SINF:0.00858):0.03750):0.14253):0.15795):0.00931):0.00790,(SRAT:0.02869,SDEV:0.03649):0.30522):0.04535,(SLUT:0.02892,SINF:0.02422):0.32643):0.04145,(((SDEV:0.02717,SRAT:0.03199):0.12169,(((SINF:0.00552,SLUT:0.00876):0.04400,SEQU:0.04829):0.10490,((SDYS:0.04044,SCAN:0.04209):0.01320,SPYO:0.06577):0.09631):0.01347):0.02416,(SDOW:0.22217,SENT:0.15791):0.01838):0.02801):0.00000;
(LCRE:0.34719,SMIT:0.39290,SINF:0.32185):0.00000;
(SEQU:0.10804,SINF:0.10804):0.00000;
(SLUT:0.04359,SINF:0.04359):0.00000;
(SINF:0.01603,SEQU:0.06797,SLUT:0.00003):0.00000;
(SLUT:0.00000,SINF:0.00000):0.00000;
(SLUT:0.03438,SINF:0.03438):0.00000;
((SPLU:0.13780,SENT:0.23747):0.02931,((((SMIT:0.01694,(SPSE:0.00225,SPNE:0.00272):0.01074):0.10028,(SANG:0.01095,(SINT:0.00677,SCON:0.00682):0.00765):0.09199):0.02231,SSUI:0.16586):0.05220,(SDOW:0.14457,(((SEQU:0.04276,(SLUT:0.01068,SINF:0.00776):0.02925):0.05859,(SCAN:0.01671,(SPYO:0.01665,SDYS:0.00796):0.00724):0.09763):0.01153,(SDEV:0.01773,SRAT:0.03016):0.12265):0.01347):0.00860):0.00333,(STHE:0.02944,(SSAL:0.00327,SVES:0.00672):0.01997):0.10975):0.00000;
(SSUI:0.36559,SENT:0.36559):0.00000;
(SENT:0.61280,SSUI:0.08160,SPLU:0.07742):0.00000;
(SENT:0.20502,(((SPLU:0.37436,(LCRE:0.09917,LLAC:0.09551):0.21359):0.02330,(SINF:0.11145,(SLUT:0.07297,SEQU:0.04406):0.07588):0.10960):0.02058,(SDYS:0.10441,SCAN:0.11734):0.10967):0.02038,SPLU:0.17496):0.00000;
((SPSE:0.02042,(SENT:0.13188,(SPLU:0.05405,SRAT:0.07991):0.05094):0.14527):0.00458,SPNE:0.03054,SMIT:0.01888):0.00000;
((STHE:0.02339,(SSAL:0.01187,SVES:0.01173):0.00380):0.08125,(((SINF:0.01573,SLUT:0.01183):0.00402,SEQU:0.01825):0.05623,SDOW:0.10943):0.01556,((SSUI:0.13124,((SPLU:0.10572,(SPYO:0.05557,(SCAN:0.03470,SDYS:0.02528):0.01830):0.06907):0.00708,(SENT:0.14290,(SENT:0.11746,(((STHE:0.01264,(SSAL:0.00327,SVES:0.00426):0.00545):0.02884,(SLUT:0.02334,(SINF:0.01276,SEQU:0.01365):0.00991):0.01884):0.09291,((SMIT:0.00579,SPSE:0.00470):0.09552,SSUI:0.10865):0.01485):0.02662):0.22629):0.03113):0.00762):0.00999,((((SMIT:0.00467,SPSE:0.00724):0.00302,SPNE:0.01010):0.06247,((SANG:0.02948,SINT:0.04538):0.00983,SCON:0.02954):0.03320):0.04060,(SDEV:0.02343,SRAT:0.02152):0.08038):0.00875):0.00535):0.00000;
((((STHE:0.01162,(SSAL:0.00244,SVES:0.00293):0.00085):0.01922,(SCAN:0.00397,(SPYO:0.00139,SDYS:0.00254):0.00111):0.01696):0.00171,(SPLU:0.03395,(SENT:0.03860,(((LCRE:0.00411,LLAC:0.00335):0.18465,(((SMIT:0.00079,(SPSE:0.00128,SPNE:0.00196):0.00115):0.02109,(SINT:0.01119,(SANG:0.00385,SCON:0.00203):0.00491):0.01702):0.00599,SSUI:0.04381):0.00420):0.00711,(SDEV:0.00565,SRAT:0.00484):0.02676):0.00084):0.00212):0.00252):0.00050,SDOW:0.02854,((SINF:0.00048,SLUT:0.00229):0.00260,SEQU:0.00303):0.01757):0.00000;
(SENT:0.32094,(SPLU:0.24737,((SDEV:0.01864,SRAT:0.02347):0.18824,((SEQU:0.02656,(SLUT:0.00258,SINF:0.00246):0.02620):0.15189,(SPYO:0.07891,(SDYS:0.03909,SCAN:0.04257):0.03271):0.12635):0.04112):0.03593):0.01273,(((SANG:0.05744,(SINT:0.00817,SCON:0.01207):0.04016):0.12116,((SPNE:0.00827,SPSE:0.00702):0.07847,SMIT:0.08986):0.12999):0.04460,SSUI:0.28327):0.06600):0.00000;
(SENT:0.19545,(SRAT:0.08679,SDEV:0.05842):0.24661,SPLU:0.26942):0.00000;
((((((SRAT:0.03429,SDEV:0.03558):0.13436,SENT:0.16462):0.02732,SPLU:0.22145):0.25234,SENT:0.20789):0.02324,((SANG:0.04417,(SINT:0.00000,SCON:0.00000):0.04384):0.07268,((SPYO:0.02344,SDYS:0.02540):0.00322,SCAN:0.02259):0.12654):0.02457):0.00954,((SPSE:0.01256,SPNE:0.00984):0.00959,SMIT:0.01991):0.14512,((SPSE:0.00568,SPNE:0.01270):0.04198,SMIT:0.03920):0.14332):0.00000;
((SLUT:0.14060,SENT:0.55518):0.09203,SEQU:0.05124,SINF:0.05796):0.00000;
((SDOW:0.06511,((((SMIT:0.00260,SPSE:0.00297):0.00169,SPNE:0.00833):0.04597,(SANG:0.03672,SCON:0.04238):0.01635):0.01013,((SCAN:0.01665,(SPYO:0.01565,SDYS:0.00700):0.00110):0.06811,((SSUI:0.00645,SPLU:0.01217):0.06679,((LCRE:0.00739,LLAC:0.00562):0.11199,SENT:0.22284):0.01820):0.01519):0.01270):0.01975):0.00734,((SLUT:0.00441,(SINF:0.00174,SEQU:0.00272):0.00005):0.02788,(SRAT:0.00463,SDEV:0.00866):0.03269):0.00574,(STHE:0.01041,SSAL:0.00784):0.02579):0.00000;
(((((SPSE:0.01292,(SMIT:0.00820,SPNE:0.01127):0.00516):0.15752,((SANG:0.01841,SCON:0.01487):0.03721,SINT:0.05496):0.12362):0.08381,SSUI:0.20060):0.02521,((SSAL:0.03349,(STHE:0.02898,SVES:0.01007):0.01490):0.20482,SENT:0.23639):0.02641):0.00600,(SDOW:0.24508,(((SINF:0.00000,SLUT:0.00000):0.04256,SEQU:0.03025):0.11617,(((SDYS:0.04766,SCAN:0.05049):0.04810,SPYO:0.09371):0.09895,(SDEV:0.01135,SRAT:0.02183):0.13162):0.01064):0.01446):0.00775,SPLU:0.24387):0.00000;
(SENT:0.40135,SCAN:0.16988,SDYS:0.19180):0.00000;
(((SENT:0.24923,((SPYO:0.06507,(SCAN:0.03452,SDYS:0.03863):0.00937):0.14920,((SSAL:0.01948,(STHE:0.02622,SVES:0.01834):0.01187):0.12462,(SDEV:0.02422,SRAT:0.02582):0.13227):0.02058):0.01303):0.01376,SPLU:0.21406):0.02299,(SSUI:0.27225,(((SANG:0.02639,SCON:0.03064):0.07687,(SPNE:0.01715,(SPSE:0.00991,SMIT:0.01386):0.01372):0.07504):0.11323,((SANG:0.10200,(SPNE:0.01589,(SPSE:0.00429,SMIT:0.00502):0.00446):0.07064):0.15852,(SSUI:0.19849,(SEQU:0.04385,(SLUT:0.02353,SINF:0.02810):0.01855):0.11763):0.05589):0.03865):0.02032):0.00362,((LLAC:0.02765,LCRE:0.02919):0.29521,SINT:0.32980):0.07850):0.00000;
(LLAC:0.17474,SENT:0.17474):0.00000;
(SENT:0.13380,SENT:0.20959,SANG:0.17116):0.00000;
(SANG:0.25403,SENT:0.25403):0.00000;
(SENT:0.46325,SDYS:0.06482,SPLU:0.04435):0.00000;
(SPYO:0.27474,SENT:0.27474):0.00000;
(SPYO:0.27411,SENT:0.27411):0.00000;
(SPYO:0.25124,SENT:0.25124):0.00000;
(SCAN:0.26678,SENT:0.26678):0.00000;
(((SSUI:0.31395,((SPYO:0.07519,(SDYS:0.05522,SCAN:0.05070):0.02746):0.27769,SENT:0.27525):0.01027):0.02621,(((SPSE:0.01391,SPNE:0.01642):0.00938,SMIT:0.02261):0.23168,(SANG:0.07170,(SINT:0.01387,SCON:0.00815):0.06074):0.15628):0.05021):0.00770,(SDOW:0.23998,((SMIT:0.17294,(SANG:0.17587,SINT:0.16248):0.01386):0.03909,(SDEV:0.08060,SRAT:0.08133):0.12435):0.01788):0.03890,((SSAL:0.02282,SVES:0.02829):0.03160,STHE:0.06795):0.25993):0.00000;
(SENT:0.22518,((SMIT:0.02910,(SPNE:0.01488,SPSE:0.02150):0.00887):0.37118,(SDYS:0.03685,(SPYO:0.02830,SCAN:0.02782):0.01075):0.16462):0.00767,((SMIT:0.07664,(SPSE:0.02614,SPNE:0.02321):0.03968):0.13634,(SANG:0.08608,(SINT:0.00562,SCON:0.00430):0.09697):0.07138):0.01023):0.00000;
((SPNE:0.02684,SENT:0.34679):0.00841,SMIT:0.00852,SPSE:0.01734):0.00000;
(SDEV:0.11553,SENT:0.11553):0.00000;
((SENT:0.29598,(SINT:0.30077,SRAT:0.25072):0.06424):0.00822,SEQU:0.38486,SMIT:0.31586):0.00000;
(((SINF:0.00000,SLUT:0.00000):0.01285,SEQU:0.00859):0.01192,((SPLU:0.06427,SENT:0.06752):0.01209,((((LCRE:0.01750,LLAC:0.01254):0.30788,(STHE:0.04266,(SSAL:0.02800,SVES:0.01522):0.00270):0.07409):0.01979,(((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.08124,((SANG:0.00493,SINT:0.00092):0.01022,SCON:0.00923):0.02651):0.01449,SSUI:0.07283):0.01782):0.02280,((SPYO:0.01123,(SCAN:0.00479,SDYS:0.00698):0.00642):0.02718,(SDEV:0.01280,SRAT:0.02604):0.02999):0.00302):0.01770):0.00335,SDOW:0.04948):0.00000;
((SPLU:0.13027,SENT:0.15061):0.02679,(((SSAL:0.01628,(STHE:0.01629,SVES:0.01133):0.01175):0.11362,SDOW:0.15031):0.00951,((((SINF:0.00287,SLUT:0.00358):0.01310,SEQU:0.01747):0.06167,(SPYO:0.02978,(SCAN:0.01357,SDYS:0.01051):0.01679):0.06182):0.01734,(SDEV:0.01799,SRAT:0.01473):0.09391):0.03774):0.00583,((LLAC:0.02723,LCRE:0.01911):0.28015,(SSUI:0.13267,((SMIT:0.03642,(SPSE:0.00266,SPNE:0.00371):0.03009):0.05810,((SANG:0.00903,SINT:0.01328):0.00393,SCON:0.01046):0.07558):0.07498):0.02282):0.02792):0.00000;
((SPSE:0.05625,SENT:0.17537):0.03186,(SVES:0.02331,SSAL:0.02492):0.01661,STHE:0.05703):0.00000;
(((((SMIT:0.02215,(SPSE:0.01564,SPNE:0.02586):0.01429):0.06231,(SINT:0.04131,(SANG:0.02357,SCON:0.02475):0.00704):0.10038):0.02178,(((LLAC:0.02697,LCRE:0.02706):0.22048,SSUI:0.15799):0.01683,SPLU:0.14078):0.00426):0.01177,((STHE:0.08337,(SSAL:0.02818,SVES:0.02631):0.05106):0.03280,(SDOW:0.12633,SENT:0.14027):0.01324):0.01039):0.00288,(((SINF:0.02046,SLUT:0.01746):0.03181,SEQU:0.04454):0.05433,(SPYO:0.09641,(SDYS:0.04925,SCAN:0.05416):0.03269):0.06063):0.01007,(SDEV:0.03041,SRAT:0.04414):0.10918):0.00000;
(SPNE:0.10370,SENT:0.10370):0.00000;
(SENT:0.21008,SCAN:0.25503,SPLU:0.45360):0.00000;
(SCAN:0.09457,SENT:0.09457):0.00000;
(SCAN:0.05565,SENT:0.05565):0.00000;
(SPYO:0.32271,SENT:0.32271):0.00000;
(SCAN:0.04666,SENT:0.04666):0.00000;
(((SCAN:0.02219,(SANG:0.06179,(((SMIT:0.00978,SPNE:0.01623):0.00328,SVES:0.00847):0.12552,(SENT:0.10425,SENT:0.34987):0.01453):0.05568):0.03990):0.00442,(SPLU:0.00237,SDYS:0.00700):0.00228):0.00070,SSUI:0.01307,SSUI:0.00947):0.00000;
(SCAN:0.16608,SENT:0.16608):0.00000;
(SCAN:0.13997,SENT:0.13997):0.00000;
((SENT:0.06151,((SENT:0.12451,SCAN:0.16495):0.25966,(LCRE:0.00878,LLAC:0.00555):0.10903):0.05121):0.00370,((SPYO:0.01519,(SCAN:0.01839,SDYS:0.01335):0.00442):0.04424,(SSUI:0.04787,(((STHE:0.01053,SSAL:0.00292):0.00138,SVES:0.01282):0.02713,((((SMIT:0.00784,(SPSE:0.00380,SPNE:0.00617):0.00264):0.02416,(SINT:0.02485,(SANG:0.01291,SCON:0.01907):0.00445):0.01293):0.00707,((SINF:0.00156,SLUT:0.00093):0.00112,SEQU:0.00609):0.02710):0.00112,(SDEV:0.02771,SRAT:0.03158):0.01624):0.00597):0.00245):0.00280):0.00210,(SPLU:0.05364,SDOW:0.05036):0.00317):0.00000;
(SCAN:0.21841,SENT:0.21841):0.00000;
(SCAN:0.17935,SENT:0.17935):0.00000;
(((((SENT:0.06576,((SPLU:0.03023,SDYS:0.02449):0.00997,SPSE:0.02406):0.01419):0.17530,(SSUI:0.16024,(SDEV:0.13708,((SENT:0.07287,SENT:0.04852):0.01964,SENT:0.05246):0.06548):0.00733):0.04206):0.06892,SDYS:0.21634):0.00974,(SENT:0.20311,SMIT:0.17889):0.01327):0.00492,(SSAL:0.04116,SVES:0.03561):0.13180,SMIT:0.25135):0.00000;
(SDYS:0.06424,SENT:0.06424):0.00000;
(SDYS:0.09277,SENT:0.09277):0.00000;
(SENT:0.14933,SDYS:0.14688,SENT:0.44553):0.00000;
(LCRE:0.07557,LLAC:0.07557):0.00000;
(((SPLU:0.13601,((SSAL:0.02360,(STHE:0.01671,SVES:0.01519):0.00406):0.09995,((SINF:0.00740,(SLUT:0.00169,SEQU:0.00078):0.01052):0.08895,(SPYO:0.03055,(SCAN:0.01236,SDYS:0.01686):0.01043):0.05739):0.01071):0.00341):0.02286,((((SPNE:0.20596,(SDEV:0.15800,SINT:0.14103):0.03890):0.05524,(SPSE:0.18299,SSUI:0.17382):0.06873):0.12293,(SSUI:0.41393,((LLAC:0.02754,LCRE:0.03017):0.14235,(((SCAN:0.02674,SDYS:0.02858):0.02340,SPYO:0.04776):0.09818,(SMIT:0.02840,SPSE:0.01884):0.11933):0.03384):0.22961):0.02641):0.04382,(SLUT:0.21567,LLAC:0.22582):0.07355):0.14896):0.00629,(SSUI:0.13128,(((SPSE:0.00670,(SMIT:0.00820,SPNE:0.00790):0.00012):0.04298,(SANG:0.02501,(SINT:0.00743,SCON:0.00616):0.02289):0.03516):0.05997,(SDEV:0.02756,SRAT:0.03022):0.09665):0.00396):0.01867,(SENT:0.12887,SDOW:0.13722):0.00262):0.00000;
(LCRE:0.02155,LLAC:0.02155):0.00000;
(LCRE:0.20524,LLAC:0.20524):0.00000;
(LCRE:0.01392,LLAC:0.01392):0.00000;
(((((SPNE:0.28931,(LCRE:0.26581,(SEQU:0.03849,(SLUT:0.02150,SINF:0.01514):0.01237):0.20563):0.08502):0.01810,LLAC:0.41425):0.22793,(SDEV:0.07118,((SLUT:0.00359,SEQU:0.00523):0.02946,SINF:0.03911):0.04278):0.01752):0.06120,SCON:0.03280):0.00221,SINT:0.03308,SANG:0.02556):0.00000;
(LLAC:0.56051,LCRE:0.01016,LLAC:0.01129):0.00000;
(SPLU:0.19166,LLAC:0.19166):0.00000;
(LCRE:0.08362,LLAC:0.08362):0.00000;
(LCRE:0.08818,LLAC:0.08818):0.00000;
(LLAC:0.47748,SINF:0.11665,SEQU:0.08448):0.00000;
((((SCAN:0.02077,SPYO:0.01382):0.00510,SDYS:0.01898):0.04645,((((((SMIT:0.01064,(SPSE:0.00267,SPNE:0.00437):0.00734):0.07073,((SANG:0.02862,SINT:0.02715):0.00453,SCON:0.05437):0.03761):0.01898,SSUI:0.09473):0.01465,SENT:0.08454):0.01091,((STHE:0.01243,(SSAL:0.00944,SVES:0.00833):0.00190):0.05941,(SPLU:0.12422,(LCRE:0.02398,LLAC:0.02078):0.20280):0.00708):0.00913):0.02027,(SDEV:0.00727,SRAT:0.00739):0.06545):0.00897):0.00070,SDOW:0.06213,((SINF:0.00935,SLUT:0.00910):0.01122,SEQU:0.01538):0.03137):0.00000;
((((SSUI:0.03061,SPLU:0.02653):0.03525,SENT:0.07563):0.01980,((((SSAL:0.01205,(STHE:0.01575,SVES:0.00948):0.00453):0.03218,(SPSE:0.01173,(SMIT:0.00472,SPNE:0.01448):0.00153):0.03561):0.00575,(SANG:0.01890,(SINT:0.00759,SCON:0.00715):0.01306):0.02643):0.04523,(LLAC:0.01087,LCRE:0.01088):0.22699):0.01392):0.00631,((SDEV:0.01912,SRAT:0.01743):0.05444,((SLUT:0.01247,(SINF:0.00845,SEQU:0.00460):0.00651):0.04179,(SCAN:0.01150,(SPYO:0.00962,SDYS:0.00794):0.00339):0.06354):0.00507):0.00162,SDOW:0.09257):0.00000;
(LCRE:0.14881,LLAC:0.14881):0.00000;
(SPLU:0.02214,SSUI:0.02924,LLAC:0.52720):0.00000;
(((LLAC:0.57546,(SCON:0.00000,(SSUI:0.00000,(SENT:0.00000,SCAN:0.00000):0.00000):0.00000):0.00000):0.00000,SANG:0.00000):0.00000,SPNE:0.00000,SPSE:0.00000):0.00000;
((SDOW:0.07614,((SDEV:0.05778,(((SENT:0.14106,((LLAC:0.01954,LCRE:0.01463):0.17084,LLAC:0.27416):0.03435):0.01847,(((SMIT:0.00037,SPSE:0.00734):0.00223,SPNE:0.00356):0.04140,(SANG:0.00842,(SINT:0.00323,SCON:0.00315):0.01137):0.02906):0.06288):0.01259,(SDYS:0.04027,(SCAN:0.05196,SPYO:0.04078):0.01105):0.08940):0.02275):0.00352,((SSUI:0.02438,SPLU:0.02287):0.04192,(STHE:0.01467,(SSAL:0.00640,SVES:0.00640):0.00485):0.05005):0.01605):0.00234):0.00123,SRAT:0.06235,(SINF:0.00765,(SLUT:0.01434,SEQU:0.00193):0.00084):0.05021):0.00000;
(((LCRE:0.01608,LLAC:0.01700):0.19679,((SCON:0.05950,(SINT:0.05396,SANG:0.04975):0.01854):0.13019,LLAC:0.22094):0.09312):0.08720,(SCAN:0.05841,(SPYO:0.00793,SDYS:0.00663):0.05915):0.11813,(SSUI:0.16399,SRAT:0.17154):0.01849):0.00000;
(LCRE:0.06569,LLAC:0.06569):0.00000;
(((((SMIT:0.01081,(SPSE:0.00860,SPNE:0.00781):0.00275):0.07676,(SANG:0.03693,(SINT:0.00499,SCON:0.00822):0.02654):0.05652):0.01715,SSUI:0.10393):0.02110,(LCRE:0.01550,LLAC:0.02675):0.19908):0.00399,(((SENT:0.12440,((STHE:0.04077,(SSAL:0.00728,SVES:0.01081):0.01597):0.06049,(SPLU:0.08689,(SINF:0.02146,(SLUT:0.01060,SEQU:0.00505):0.01139):0.06938):0.00715):0.00977):0.00199,SDOW:0.11792):0.00884,(SDEV:0.02662,SRAT:0.02761):0.10182):0.00148,(SPYO:0.04177,(SCAN:0.03299,SDYS:0.04796):0.01369):0.06355):0.00000;
(LCRE:0.10253,LLAC:0.10253):0.00000;
(LCRE:0.27659,LLAC:0.27659):0.00000;
(LCRE:0.14294,LLAC:0.14294):0.00000;
(SPLU:0.20412,LLAC:0.20412):0.00000;
((LCRE:0.02286,LLAC:0.03071):0.13922,(SDOW:0.08435,((((STHE:0.02410,(SSAL:0.01277,SVES:0.00786):0.00849):0.02418,((SMIT:0.00244,SPSE:0.00363):0.00155,SPNE:0.00270):0.03720):0.01398,(SINT:0.00241,SCON:0.00324):0.04570):0.01078,(SDEV:0.04858,SRAT:0.02725):0.02431):0.01224):0.00165,(SENT:0.09440,((SSUI:0.02218,SPLU:0.02594):0.03254,(SPYO:0.05894,((SANG:0.01416,((SINF:0.00293,SLUT:0.00692):0.00326,SEQU:0.00619):0.01055):0.03199,(SCAN:0.02678,SDYS:0.03796):0.02499):0.00487):0.01788):0.00309):0.00714):0.00000;
(LLAC:0.08109,LLAC:0.08109):0.00000;
(LLAC:0.03079,LCRE:0.04632,SDOW:0.56461):0.00000;
(LCRE:0.16561,LLAC:0.16561):0.00000;
(((SDEV:0.03816,SRAT:0.03138):0.09570,(SPLU:0.12853,((((SPSE:0.00846,(SMIT:0.00519,SPNE:0.01238):0.00297):0.08357,(SANG:0.02655,(SINT:0.00455,SCON:0.01123):0.02433):0.06421):0.03403,SSUI:0.16228):0.01058,((SDEV:0.45077,(LLAC:0.04318,LCRE:0.05301):0.22267):0.09917,SENT:0.30640):0.02059):0.00650):0.00520):0.00190,(((SINF:0.00000,SLUT:0.00000):0.02019,SEQU:0.02061):0.06273,((SCAN:0.03663,SPYO:0.05832):0.00864,SDYS:0.04312):0.04863):0.02804,(((SSAL:0.01460,SVES:0.01185):0.02114,STHE:0.03694):0.08573,SDOW:0.12119):0.00980):0.00000;
(LCRE:0.12389,LLAC:0.12389):0.00000;
(LCRE:0.05465,LLAC:0.05465):0.00000;
(LCRE:0.11753,LLAC:0.11753):0.00000;
(LCRE:0.02269,LLAC:0.02269):0.00000;
(LCRE:0.18010,LLAC:0.18010):0.00000;
(LLAC:0.04675,LCRE:0.05287,SSUI:0.65253):0.00000;
(LCRE:0.06045,LLAC:0.06045):0.00000;
(LCRE:0.15478,LLAC:0.15478):0.00000;
(((SSUI:0.06287,(((SMIT:0.00894,SPNE:0.00010):0.03232,(SANG:0.00870,(SINT:0.00357,SCON:0.00541):0.00136):0.03968):0.02024,(LCRE:0.00293,LLAC:0.00249):0.13152):0.02164):0.00658,(SDEV:0.01068,SRAT:0.01397):0.04163):0.00527,(((SSAL:0.00147,(STHE:0.00653,SVES:0.00057):0.00031):0.07850,SPLU:0.04936):0.00687,SDOW:0.05564):0.00985,((SLUT:0.02985,(SINF:0.00963,SEQU:0.01447):0.02463):0.04956,(SCAN:0.00743,(SPYO:0.00979,SDYS:0.00586):0.00712):0.04257):0.00161):0.00000;
((LLAC:0.06324,LCRE:0.06680):0.48447,LCRE:0.08060,LLAC:0.10191):0.00000;
((SENT:0.11520,(((SSAL:0.02094,STHE:0.04791):0.02504,SVES:0.04261):0.12515,(((((SANG:0.03436,(SINT:0.04678,SCON:0.01816):0.02061):0.05510,SSUI:0.09444):0.01847,((SMIT:0.03922,(SPSE:0.02425,SPNE:0.02938):0.01161):0.14435,SDOW:0.09418):0.01978):0.02128,(LLAC:0.02863,LCRE:0.02639):0.23223):0.00277,(SDEV:0.02299,SRAT:0.01882):0.09349):0.00944):0.00639):0.00160,((SCAN:0.04697,SPYO:0.05255):0.02148,SDYS:0.06005):0.05639,(SPLU:0.10077,(SEQU:0.01997,(SINF:0.01477,SLUT:0.00311):0.02163):0.09879):0.01516):0.00000;
(((LLAC:0.01582,LCRE:0.01892):0.25404,LLAC:0.27906):0.02603,(SSAL:0.21472,SVES:0.20073):0.22681,SEQU:0.32225):0.00000;
((SPLU:0.18125,(SLUT:0.53496,(LLAC:0.04411,LCRE:0.04970):0.13875):0.01790):0.00646,(SENT:0.17228,((SEQU:0.04273,(SINF:0.01146,SLUT:0.01001):0.03407):0.08967,((SDOW:0.14776,(SDEV:0.04174,SRAT:0.04639):0.10352):0.02916,((SCAN:0.04169,SPYO:0.04767):0.04050,SDYS:0.07743):0.07410):0.00883):0.01756):0.00786,((STHE:0.12294,((SSAL:0.01160,SVES:0.01054):0.10824,(SANG:0.06934,(SCON:0.01632,SINT:0.02371):0.04924):0.04551):0.00343):0.03076,SSUI:0.15842):0.02350):0.00000;
(LCRE:0.32680,LLAC:0.32680):0.00000;
(SDOW:0.23402,((((SMIT:0.02097,SPSE:0.01431):0.01150,SPNE:0.03564):0.14531,SENT:0.19061):0.05136,SPLU:0.25321):0.00868,(((SANG:0.11973,(SINT:0.01051,SCON:0.01667):0.16261):0.20420,(LLAC:0.14792,LCRE:0.11583):0.21741):0.04367,((SDYS:0.12958,(SPYO:0.03546,SCAN:0.02002):0.12016):0.11462,SSUI:0.26888):0.01366):0.00972):0.00000;
((SMIT:0.40310,LLAC:0.37392):0.10431,((((SDEV:0.04863,SRAT:0.05737):0.06323,SANG:0.11497):0.17710,SENT:0.33083):0.01208,SDOW:0.28147):0.00959,(SMIT:0.08549,(SVES:0.03183,SSAL:0.03655):0.05662):0.25003):0.00000;
(LCRE:0.09931,LLAC:0.09931):0.00000;
((((SSUI:0.01069,SPLU:0.01108):0.02345,SENT:0.03513):0.00447,((((SMIT:0.00035,SPSE:0.00204):0.00089,SPNE:0.00477):0.01932,(SINT:0.01083,(SANG:0.00975,SCON:0.00661):0.00524):0.01468):0.01621,(LCRE:0.00752,LLAC:0.00691):0.07854):0.00678):0.00494,(SDOW:0.03434,(SDEV:0.01291,SRAT:0.02123):0.01853):0.00313,(((SSAL:0.00386,(STHE:0.00817,SVES:0.00336):0.00176):0.03349,((SINF:0.01070,SLUT:0.00739):0.00552,SEQU:0.01120):0.01462):0.01194,(SPYO:0.04811,(SCAN:0.01561,SDYS:0.01334):0.00504):0.02745):0.00375):0.00000;
(LCRE:0.07158,LLAC:0.07158):0.00000;
(LCRE:0.13263,LLAC:0.13263):0.00000;
(LCRE:0.06180,LLAC:0.06180):0.00000;
((SSAL:0.00129,SVES:0.00292):0.14196,((LLAC:0.41446,((SCAN:0.05042,SDYS:0.07613):0.07367,((SSUI:0.09236,SPYO:0.10004):0.01801,SRAT:0.09578):0.00463):0.00920):0.00656,SDOW:0.14058):0.00389,SENT:0.11958):0.00000;
((LLAC:0.32284,(SRAT:0.04011,SDEV:0.04805):0.25807):0.07395,(SDEV:0.21946,((SINF:0.04964,SLUT:0.07768):0.06881,SEQU:0.08882):0.08361):0.05173,SPLU:0.27121):0.00000;
((SMIT:0.05599,((SPSE:0.01798,SSAL:0.01980):0.40021,LLAC:0.15122):0.10338):0.01545,(SVES:0.05966,(SANG:0.00962,SINT:0.00601):0.01915):0.00864,SSAL:0.03198):0.00000;
(LCRE:0.04136,LLAC:0.04136):0.00000;
(LCRE:0.04534,LLAC:0.04534):0.00000;
(LCRE:0.21586,LLAC:0.21586):0.00000;
((((SDEV:0.01644,SRAT:0.01609):0.05677,((SPYO:0.01926,(SCAN:0.01489,SDYS:0.01510):0.00556):0.04572,(SEQU:0.01014,(SINF:0.00722,SLUT:0.00546):0.00652):0.04596):0.01316):0.00682,((SPLU:0.07919,SENT:0.07990):0.02201,(((SPSE:0.00592,(SMIT:0.00084,SPNE:0.00104):0.00395):0.04745,(SANG:0.01499,(SINT:0.00034,SCON:0.00107):0.01636):0.03387):0.03208,(SSUI:0.10038,((LLAC:0.01088,LCRE:0.01158):0.13380,(((SRAT:0.22646,((SVES:0.00824,SSAL:0.00869):0.11877,SPNE:0.13142):0.09160):0.01021,SPLU:0.24544):0.02862,(LCRE:0.34370,LLAC:0.28875):0.01276):0.17777):0.03375):0.00675):0.00603):0.00591):0.00333,SDOW:0.09103,(STHE:0.00975,(SSAL:0.00410,SVES:0.00720):0.00305):0.07110):0.00000;
(LLAC:0.03019,SLUT:0.04990,LCRE:0.12759):0.00000;
(LCRE:0.05877,LLAC:0.05877):0.00000;
(LLAC:0.24648,LLAC:0.24648):0.00000;
(LCRE:0.04066,LLAC:0.04066):0.00000;
(((SSUI:0.14176,((SMIT:0.01850,(SPSE:0.00185,SPNE:0.00374):0.00850):0.09048,(SANG:0.03876,(SCON:0.01873,SINT:0.02142):0.02620):0.07579):0.06543):0.02040,(LLAC:0.07700,LCRE:0.06155):0.22070):0.02531,((SDOW:0.15887,(SDEV:0.05625,SRAT:0.07827):0.11127):0.01008,(SPYO:0.15924,(SDYS:0.07232,SCAN:0.07820):0.04338):0.08311):0.00420,(SENT:0.15007,((((STHE:0.01178,SSAL:0.00626):0.00532,SVES:0.02415):0.10621,SPLU:0.12667):0.01618,((SINF:0.01464,SLUT:0.02426):0.02147,SEQU:0.03647):0.07423):0.00637):0.01178):0.00000;
(LCRE:0.25734,LLAC:0.25734):0.00000;
(((LLAC:0.02905,LCRE:0.02513):0.30857,(((SSUI:0.01716,SPLU:0.01685):0.07631,SENT:0.09618):0.02711,(((SMIT:0.01782,SPSE:0.01597):0.00446,SPNE:0.02971):0.08504,((((STHE:0.02784,(SSAL:0.00962,SVES:0.01530):0.00986):0.05211,((SINF:0.00816,SLUT:0.01020):0.00211,SEQU:0.00781):0.07408):0.01296,(SCAN:0.04073,(SPYO:0.02514,SDYS:0.02155):0.01187):0.06514):0.00894,SDOW:0.10763):0.01115):0.01029):0.00678):0.00625,(SDEV:0.02111,SRAT:0.02576):0.10934,(SANG:0.02506,(SINT:0.00860,SCON:0.00698):0.01833):0.10754):0.00000;
(LCRE:0.10383,LLAC:0.10383):0.00000;
(LCRE:0.12619,LLAC:0.12619):0.00000;
((SINF:0.02578,(SLUT:0.01330,SEQU:0.00697):0.02765):0.08222,(SPLU:0.13761,(SENT:0.16970,(((SCAN:0.05928,SPYO:0.05385):0.00766,SDYS:0.06683):0.11880,(((SINF:0.34662,((((SSUI:0.18948,(SPNE:0.01493,SPSE:0.01983):0.15654):0.08293,(SDEV:0.21835,SINT:0.21668):0.07218):0.04386,SLUT:0.32830):0.02146,(SLUT:0.22152,LLAC:0.21946):0.06549):0.03808):0.08079,(SRAT:0.05287,SDEV:0.04853):0.26995):0.14932,((SDEV:0.01989,SRAT:0.01986):0.11461,(SSUI:0.14072,((SPSE:0.01378,(SMIT:0.01481,SPNE:0.01680):0.00315):0.08149,(SANG:0.06577,(SINT:0.01765,SCON:0.01648):0.06116):0.03737):0.03299):0.01077):0.03967):0.02255):0.01231):0.01118):0.00628,(SDOW:0.12001,(STHE:0.03376,(SSAL:0.01572,SVES:0.01187):0.01003):0.06877):0.00765):0.00000;
(SINF:0.36250,LLAC:0.36250):0.00000;
(LLAC:0.24608,SPSE:0.10314,SCAN:0.06857):0.00000;
(LCRE:0.06430,LLAC:0.06430):0.00000;
(LCRE:0.03321,LLAC:0.03321):0.00000;
((SPLU:0.08470,(SENT:0.10580,((STHE:0.03426,(SSAL:0.00679,SVES:0.01261):0.01768):0.10029,(((((SMIT:0.00665,SPSE:0.00652):0.00139,SPNE:0.00663):0.04559,(SANG:0.02536,(SINT:0.01313,SCON:0.01496):0.01620):0.02878):0.04560,SSUI:0.10859):0.01073,(LLAC:0.00923,LCRE:0.01042):0.24599):0.01018):0.00620):0.00895):0.00925,((SDEV:0.01519,SRAT:0.01596):0.05930,SDOW:0.08016):0.00484,((SINF:0.01466,(SLUT:0.01398,SEQU:0.00765):0.00518):0.04703,(SCAN:0.01301,(SPYO:0.00896,SDYS:0.00824):0.00301):0.05838):0.00505):0.00000;
(LCRE:0.02339,LLAC:0.02339):0.00000;
((SINT:0.08185,(((LLAC:0.03601,LCRE:0.04221):0.12899,((SPYO:0.01124,SDYS:0.00396):0.01900,SCAN:0.03204):0.14968):0.06359,SSUI:0.14108):0.06782):0.06856,(SPSE:0.01137,SPNE:0.00870):0.00723,SMIT:0.01156):0.00000;
(((SCAN:0.07753,SPYO:0.07936):0.00428,((((SSUI:0.00992,SPLU:0.01435):0.05896,SENT:0.06740):0.01431,(SANG:0.07067,(SDYS:0.08274,(LLAC:0.06327,LCRE:0.07719):0.26024):0.00991):0.00225):0.00351,((((SSAL:0.00469,(STHE:0.00868,SVES:0.01259):0.00179):0.03153,(SMIT:0.02478,(SPSE:0.02052,SPNE:0.02703):0.00638):0.01257):0.01017,SDEV:0.04837):0.00391,((SINT:0.02155,SCON:0.01711):0.01641,SRAT:0.02865):0.02331):0.00113):0.00339):0.00085,SDOW:0.04925,(SINF:0.02131,(SLUT:0.02600,SEQU:0.00701):0.00684):0.04947):0.00000;
(LCRE:0.01258,LLAC:0.01258):0.00000;
(LCRE:0.16795,LLAC:0.16795):0.00000;
(LCRE:0.08319,LLAC:0.08319):0.00000;
(LLAC:0.22440,LLAC:0.22440):0.00000;
((((SMIT:0.00707,(SPSE:0.00761,SPNE:0.00577):0.00074):0.04633,(SANG:0.02264,(SINT:0.02028,SCON:0.01265):0.00807):0.02508):0.01779,((LCRE:0.01271,LLAC:0.01074):0.08549,LLAC:0.39681):0.05705):0.00797,((SPLU:0.07546,(SSUI:0.04702,SENT:0.05554):0.01315):0.01159,(SDEV:0.01726,SRAT:0.02457):0.04004):0.00664,((SINF:0.01611,(SLUT:0.00838,SEQU:0.00442):0.00524):0.05911,((STHE:0.02008,(SSAL:0.00660,SVES:0.00952):0.00159):0.05175,(((SCAN:0.02032,SPYO:0.02137):0.00563,SDYS:0.03130):0.02750,SDOW:0.04809):0.01116):0.00632):0.00560):0.00000;
(LLAC:0.34513,LLAC:0.34513):0.00000;
(LCRE:0.19039,LLAC:0.19039):0.00000;
(LCRE:0.04918,LLAC:0.04918):0.00000;
(LCRE:0.22473,LLAC:0.22473):0.00000;
(LCRE:0.06796,LLAC:0.06796):0.00000;
(LCRE:0.06047,LLAC:0.06047):0.00000;
(LCRE:0.10734,LLAC:0.10734):0.00000;
(LCRE:0.09218,LLAC:0.09218):0.00000;
(LLAC:0.28101,LLAC:0.28101):0.00000;
(SANG:0.27904,LLAC:0.27904):0.00000;
(LLAC:0.06075,LLAC:0.06075):0.00000;
(LCRE:0.08450,LLAC:0.08450):0.00000;
(LCRE:0.10122,LLAC:0.10122):0.00000;
(LCRE:0.04939,LLAC:0.04939):0.00000;
(LLAC:0.36540,SDYS:0.31296,STHE:0.28484):0.00000;
(LCRE:0.11565,LLAC:0.11565):0.00000;
(((LLAC:0.01505,LCRE:0.02185):0.12798,(LLAC:0.03572,LCRE:0.03465):0.13307):0.24342,(SINT:0.05540,(SANG:0.03517,SCON:0.03739):0.00711):0.06668,((SSAL:0.01433,SVES:0.01851):0.09121,((SCAN:0.02027,(SPYO:0.00714,SDYS:0.00131):0.01335):0.08954,((SLUT:0.02352,(SINF:0.00658,SEQU:0.00507):0.01007):0.05508,(SDEV:0.05329,SRAT:0.06694):0.02660):0.01338):0.00995):0.00627):0.00000;
(LLAC:0.05439,LLAC:0.05439):0.00000;
(LLAC:0.30776,(LCRE:0.26701,LLAC:0.26180):0.06363,LLAC:0.32784):0.00000;
(LLAC:0.10826,LLAC:0.09549,LCRE:0.05714):0.00000;
(LLAC:0.05899,(LCRE:0.03959,LLAC:0.02627):0.08807,LCRE:0.04755):0.00000;
(LCRE:0.03110,LLAC:0.03110):0.00000;
(SINF:0.00221,SEQU:0.23448,SLUT:0.01850):0.00000;
(SINF:0.02795,SEQU:0.12846,SLUT:0.02250):0.00000;
((SDOW:0.28771,(SEQU:0.16524,(SINF:0.01429,SLUT:0.02372):0.11697):0.09771):0.02294,((SDYS:0.17646,SPYO:0.19659):0.23631,(SRAT:0.06456,SDEV:0.07474):0.18393):0.00414,((LLAC:0.12239,LCRE:0.12739):0.21377,(((SSAL:0.11872,(SVES:0.02498,STHE:0.02648):0.10112):0.18190,SSUI:0.26324):0.00930,((SMIT:0.04889,(SPSE:0.01273,SPNE:0.02552):0.03349):0.16181,(SANG:0.08876,(SCON:0.06778,SINT:0.07545):0.03835):0.10188):0.07429):0.01107):0.01808):0.00000;
(((((SRAT:0.03281,SDEV:0.03742):0.11355,((LLAC:0.02611,LCRE:0.02233):0.18210,(SMIT:0.01416,(SPSE:0.00710,SPNE:0.00371):0.00868):0.16886):0.04030):0.05133,SDOW:0.11571):0.03729,(SINF:0.05480,SEQU:0.05106):0.03746):0.07346,(SSAL:0.00630,SVES:0.00818):0.00518,STHE:0.02106):0.00000;
(((((SPNE:0.03518,(SPSE:0.03009,SMIT:0.02669):0.00890):0.19419,((SANG:0.07048,SCON:0.04684):0.04231,SINT:0.08987):0.11363):0.06336,(((STHE:0.04104,(SSAL:0.02418,SVES:0.02158):0.01364):0.18392,SPLU:0.22191):0.03032,(SDOW:0.28557,((SLUT:0.05719,SINF:0.05973):0.04092,SEQU:0.11812):0.11419):0.02373):0.03076):0.00495,(SDEV:0.10291,SRAT:0.10108):0.15718):0.00312,SSUI:0.28416,(SDYS:0.12368,SCAN:0.16157):0.19453):0.00000;
(SLUT:0.01705,SINF:0.01705):0.00000;
(SINF:0.01625,SPLU:0.01608,((SCON:0.03394,SPNE:0.03736):0.25638,SPLU:0.14927):0.17691):0.00000;
((SDOW:0.13442,SINF:0.19490):0.01762,(((SCAN:0.01745,SDYS:0.00881):0.00913,SPYO:0.02713):0.10874,(SRAT:0.04359,SDEV:0.05045):0.07793):0.03368,(LLAC:0.02324,LCRE:0.01890):0.20750):0.00000;
(SINF:0.56744,SPYO:0.03256,SDYS:0.02101):0.00000;
(SPSE:0.35475,SINF:0.35475):0.00000;
(SPSE:0.28030,SINF:0.28030):0.00000;
((SINF:0.25889,SPLU:0.19057):0.32222,SPSE:0.02942,SPNE:0.03457):0.00000;
(SINF:0.21287,(SENT:0.30011,SPYO:0.20406):0.04601,SPSE:0.27804):0.00000;
(SINF:0.25332,SPNE:0.21151,SENT:0.39014):0.00000;
((SINF:0.21984,SANG:0.20200):0.00063,(SPSE:0.20887,SPNE:0.09752):0.07233,SENT:0.21202):0.00000;
(SPYO:0.33654,SINF:0.33654):0.00000;
(SINF:0.00022,SEQU:0.14264,SLUT:0.04203):0.00000;
(SINF:0.04147,SEQU:0.08401,SLUT:0.02511):0.00000;
(SINF:0.02231,SEQU:0.09294,SLUT:0.03281):0.00000;
(SLUT:0.04302,SINF:0.04302):0.00000;
(((SCAN:0.01575,(SPYO:0.01381,SDYS:0.01903):0.00912):0.07224,((SLUT:0.01799,SEQU:0.01084):0.02171,SINF:0.04316):0.05285):0.01243,(SDEV:0.06614,SRAT:0.06680):0.03596,((SPLU:0.10955,((SPSE:0.00657,(SMIT:0.00408,SPNE:0.00185):0.00381):0.07271,((SINT:0.00828,SCON:0.01534):0.03420,SANG:0.03937):0.02488):0.05593):0.01715,((LLAC:0.01365,LCRE:0.00866):0.33811,SENT:0.14163):0.03602):0.04515):0.00000;
(((SMIT:0.12192,(SSAL:0.06620,SVES:0.06586):0.05836):0.13910,SINF:0.19712):0.00982,SDOW:0.16550,SRAT:0.19278):0.00000;
(SINF:0.00806,(SEQU:0.01426,((LLAC:0.02241,LCRE:0.02078):0.21391,SRAT:0.08398):0.05627):0.00695,SLUT:0.00775):0.00000;
(SINF:0.01451,SEQU:0.03408,SLUT:0.02953):0.00000;
(SANG:0.31054,SINF:0.31054):0.00000;
((SPYO:0.08902,(SRAT:0.10380,((LCRE:0.01774,LLAC:0.01953):0.08672,((SDOW:0.29024,LCRE:0.25641):0.02127,((((LLAC:0.02564,LCRE:0.02380):0.24080,LLAC:0.26633):0.07753,SINF:0.34558):0.10866,(SDOW:0.35068,(SPYO:0.32388,((SCAN:0.01324,(SPYO:0.00922,SDYS:0.00644):0.00913):0.04385,((SPNE:0.03006,(SINT:0.00000,SCON:0.00000):0.03051):0.02585,(SSUI:0.03610,SPLU:0.04978):0.01506):0.00753):0.31479):0.02974):0.00971):0.05734):0.18223):0.00475):0.02883):0.00172,SDEV:0.06301,(((SSAL:0.00680,SVES:0.01343):0.01415,SMIT:0.02034):0.03514,((SINF:0.00677,SLUT:0.00717):0.00921,SEQU:0.02332):0.05207):0.01618):0.00000;
((SINF:0.15081,SPYO:0.14096):0.08797,SPSE:0.27628,SPSE:0.50779):0.00000;
(((SINF:0.05159,SLUT:0.05367):0.06197,(SANG:0.01487,SINT:0.01444):0.07527):0.02491,LLAC:0.25929,SVES:0.14650):0.00000;
(SPSE:0.36581,SINF:0.36581):0.00000;
(SINF:0.00872,SINF:0.00872):0.00000;
(SINF:0.26240,SDOW:0.24202,STHE:0.40847):0.00000;
((SENT:0.02136,SSUI:0.03269):0.04721,SPNE:0.00157,SPSE:0.00000):0.00000;
((SENT:0.00000,SPLU:0.00000):0.03189,SANG:0.24439,SVES:0.07019):0.00000;
(SRAT:0.16037,SENT:0.16037):0.00000;
((SSUI:0.02318,(SCAN:0.02567,(SENT:0.27214,SANG:0.10883):0.07153):0.00214):0.00421,(SPLU:0.01587,SDYS:0.01342):0.00198,SSUI:0.01869):0.00000;
((SSUI:0.01794,(SENT:0.35088,(SANG:0.23480,(SMIT:0.02466,(SPNE:0.03875,SVES:0.01226):0.00916):0.28422):0.02620):0.23956):0.00666,(SDYS:0.01965,SPLU:0.00650):0.00461,(SSUI:0.00935,SCAN:0.00905):0.00532):0.00000;
(SDOW:0.29122,SENT:0.29122):0.00000;
(((((SMIT:0.00231,SPSE:0.00242):0.00031,SPNE:0.00514):0.01863,(SANG:0.00641,(SINT:0.00392,SCON:0.00769):0.01555):0.01416):0.00680,((SSUI:0.02285,SENT:0.03292):0.00607,((LCRE:0.00597,LLAC:0.00937):0.10038,((LLAC:0.00710,LCRE:0.00578):0.16708,(((SANG:0.03300,((SPNE:0.00892,(SMIT:0.00437,SPSE:0.00359):0.00567):0.01377,(SINT:0.00659,SCON:0.00476):0.01383):0.00684):0.01026,(SSUI:0.02154,SENT:0.02275):0.02145):0.01118,(((STHE:0.00657,(SSAL:0.00241,SVES:0.00102):0.00295):0.02837,SPLU:0.03103):0.01117,(((SEQU:0.00491,SINF:0.00685):0.00204,SLUT:0.00611):0.03861,(SPYO:0.04316,(SCAN:0.01391,SDYS:0.01408):0.02104):0.01292):0.00341):0.00388):0.13569):0.43642):0.07709):0.00308):0.00456,(SDOW:0.02962,(SDEV:0.00910,SRAT:0.01345):0.01758):0.00121,((SINF:0.00016,(SLUT:0.00000,SEQU:0.00000):0.00020):0.02072,((SSAL:0.00220,(STHE:0.00480,SVES:0.00140):0.00326):0.01975,(SPLU:0.02203,(SCAN:0.00771,(SPYO:0.00260,SDYS:0.00361):0.00397):0.01926):0.00438):0.00908):0.00169):0.00000;
((SENT:0.10001,(SSUI:0.01729,SPLU:0.01727):0.09212):0.06253,((SCON:0.02610,SANG:0.02333):0.10475,SINT:0.14988):0.04351,(SPNE:0.01320,SMIT:0.01404):0.25776):0.00000;
(((LLAC:0.10030,LCRE:0.08992):0.37352,SENT:0.24304):0.01518,((SDYS:0.22563,SPLU:0.19721):0.00717,((SCON:0.07268,SANG:0.06592):0.12449,((SINF:0.02385,SLUT:0.02837):0.03187,SEQU:0.06439):0.13867):0.02004):0.00404,(SRAT:0.07255,SDEV:0.08901):0.12553):0.00000;
(SSUI:0.17640,SENT:0.17640):0.00000;
(SSUI:0.31140,SENT:0.31140):0.00000;
((SENT:0.25050,SENT:0.29692):0.02449,((SSUI:0.30323,SPLU:0.29706):0.02244,SDYS:0.28535):0.01387,((SSUI:0.21120,SANG:0.22863):0.01867,SPLU:0.24077):0.02914):0.00000;
(((SENT:0.32030,SPLU:0.29739):0.17217,SPLU:0.29487):0.00441,SSUI:0.30070,SANG:0.31136):0.00000;
((((LLAC:0.01093,LCRE:0.01099):0.20537,((SCON:0.04725,SANG:0.05208):0.07758,(((SMIT:0.00116,SPSE:0.00884):0.00703,SPNE:0.01785):0.09678,((SANG:0.03461,SCON:0.04576):0.01092,SINT:0.05963):0.04053):0.02408):0.02037):0.03698,((SPLU:0.19309,SDOW:0.15081):0.00547,(SENT:0.20157,SSUI:0.21751):0.01087):0.00583):0.00530,((SVES:0.01417,SSAL:0.01933):0.11553,((SPYO:0.03534,(SCAN:0.01454,SDYS:0.01141):0.00566):0.10913,(SDEV:0.01679,SRAT:0.01974):0.11846):0.01783):0.01128,(SEQU:0.03735,(SLUT:0.01236,SINF:0.00494):0.02630):0.09262):0.00000;
(SENT:0.23616,(SEQU:0.01728,SINF:0.02929):0.20957,SPLU:0.23039):0.00000;
((SPNE:0.09894,SENT:0.44045):0.08340,(SINT:0.00093,SCON:0.00246):0.00499,SANG:0.00989):0.00000;
(SENT:0.48280,SPYO:0.04017,SDYS:0.05872):0.00000;
(SSUI:0.22490,SENT:0.22490):0.00000;
(SDOW:0.20833,(SPLU:0.16985,SENT:0.20915):0.01583,(((SINF:0.04439,(SLUT:0.01581,SEQU:0.00908):0.02991):0.10360,(SCAN:0.00311,(SPYO:0.00000,SDYS:0.00000):0.00755):0.15022):0.05422,((STHE:0.05022,(SSAL:0.02194,SVES:0.02488):0.01660):0.18472,((SMIT:0.04001,(SPSE:0.02135,SPNE:0.01589):0.02168):0.17613,(SSUI:0.18474,((SANG:0.01292,SINT:0.02418):0.01176,SCON:0.03169):0.13601):0.04956):0.12472):0.01281):0.00444):0.00000;
((SSUI:0.24399,(SENT:0.23771,SPLU:0.23576):0.02426):0.02190,(SINT:0.12947,(SANG:0.04091,SCON:0.05003):0.08827):0.17624,(SPNE:0.03161,(SPSE:0.02467,SMIT:0.01890):0.00258):0.19645):0.00000;
(((SPLU:0.15932,((((((LLAC:0.02003,LCRE:0.02238):0.16372,LLAC:0.21181):0.19837,SSUI:0.26772):0.01354,((SMIT:0.07142,(SPNE:0.00756,SPSE:0.00664):0.05314):0.09008,((SANG:0.02708,SCON:0.02741):0.01230,SINT:0.03551):0.08447):0.06160):0.03088,((SSAL:0.04109,(SVES:0.03848,STHE:0.02860):0.01465):0.18163,SDOW:0.20576):0.00793):0.01558,SENT:0.22081):0.01091):0.01746,((SCAN:0.05480,SDYS:0.05442):0.01804,SPYO:0.07415):0.07366):0.00980,(SDEV:0.03525,SRAT:0.02957):0.15086,((SINF:0.00402,SLUT:0.00062):0.07213,SEQU:0.06067):0.06019):0.00000;
((SPLU:0.27327,SENT:0.23219):0.01365,(((SVES:0.03214,SSAL:0.04189):0.25079,SDOW:0.28952):0.04620,(SRAT:0.06155,SDEV:0.06683):0.23935):0.00644,(SPYO:0.17053,(SCAN:0.12076,SDYS:0.12005):0.04431):0.14282):0.00000;
(((((SSUI:0.01019,SENT:0.01340):0.12201,SPLU:0.12430):0.08947,SDOW:0.20445):0.22407,((SINT:0.09243,(SCON:0.03890,SANG:0.03158):0.06863):0.09922,((SSAL:0.03524,(STHE:0.03899,SVES:0.02294):0.00922):0.10894,(SPSE:0.01643,(SMIT:0.01575,SPNE:0.01624):0.00606):0.11509):0.07883):0.02237):0.01964,(SRAT:0.08312,SDEV:0.08615):0.15376,(((SINF:0.02009,SLUT:0.02149):0.02407,SEQU:0.03790):0.13305,((SPYO:0.05086,SDYS:0.05065):0.00569,SCAN:0.06467):0.12201):0.03724):0.00000;
((SSUI:0.21893,SENT:0.23501):0.00859,((((STHE:0.04517,(SSAL:0.01613,SVES:0.01841):0.02368):0.19520,(SDOW:0.19902,(SEQU:0.08428,(SLUT:0.01510,SINF:0.01278):0.07085):0.10754):0.00676):0.00689,(SPYO:0.13543,(SDYS:0.10888,SCAN:0.10560):0.01338):0.13619):0.00900,(SRAT:0.08522,SDEV:0.07793):0.20142):0.00376,((LLAC:0.03579,LCRE:0.03368):0.28443,((SMIT:0.02089,(SPSE:0.01977,SPNE:0.02076):0.00486):0.18901,(SANG:0.04330,(SINT:0.02708,SCON:0.02737):0.02201):0.11924):0.03887):0.00482):0.00000;
(SENT:0.20686,(SSUI:0.17468,SINF:0.20684):0.03324,(SPNE:0.02728,SMIT:0.00996):0.39136):0.00000;
(((((LLAC:0.02273,LCRE:0.03066):0.27547,(((SPSE:0.03221,(SPNE:0.03291,SMIT:0.03324):0.00335):0.17175,(SINT:0.07419,(SCON:0.05487,SANG:0.05393):0.00884):0.11807):0.04545,SSUI:0.22768):0.01530):0.03494,(SRAT:0.04124,SDEV:0.03971):0.21052):0.00559,(((SEQU:0.08437,(SLUT:0.02585,SINF:0.02122):0.05886):0.16554,(SPYO:0.12289,(SCAN:0.07845,SDYS:0.07242):0.03832):0.13639):0.00605,SENT:0.30111):0.00812):0.00695,(SPLU:0.25078,SDOW:0.27237):0.00419,((SSAL:0.04416,SVES:0.03796):0.01341,STHE:0.05234):0.25956):0.00000;
((SPLU:0.37301,SENT:0.35251):0.00406,(((SLUT:0.00513,SINF:0.00476):0.10526,SEQU:0.10113):0.19151,((SDYS:0.08501,SCAN:0.07683):0.04113,SPYO:0.12733):0.17516):0.01024,(SSUI:0.30150,((SMIT:0.06065,(SPSE:0.01816,SPNE:0.01666):0.04750):0.14097,((SANG:0.04291,SCON:0.03950):0.01601,SINT:0.05831):0.11881):0.08328):0.09939):0.00000;
(SENT:0.24052,((((SRAT:0.07563,SDEV:0.07135):0.14213,(SSUI:0.21934,SDOW:0.25141):0.01875):0.15922,(((SVES:0.07053,(SSAL:0.04831,STHE:0.04998):0.02038):0.18131,((SPSE:0.02578,SPNE:0.02468):0.00679,SMIT:0.03071):0.21992):0.02273,(SANG:0.07473,(SCON:0.07026,SINT:0.06875):0.00913):0.17120):0.01635):0.01748,SDYS:0.25170):0.01629,(SEQU:0.05169,(SLUT:0.00784,SINF:0.00668):0.06049):0.18322):0.00000;
((SPLU:0.20543,SENT:0.19756):0.02845,(SRAT:0.05076,SDEV:0.04751):0.43080,(SDEV:0.03111,SRAT:0.03429):0.18187):0.00000;
(((SINT:0.01157,(SANG:0.00214,SCON:0.00222):0.00760):0.06308,((SPLU:0.09339,(SPYO:0.00714,SDYS:0.00681):0.07088):0.01800,SENT:0.12951):0.02365):0.05289,(SPSE:0.00738,SPNE:0.00387):0.00850,SMIT:0.01466):0.00000;
((((SENT:0.31388,(SINF:0.24771,(SDYS:0.06289,SCAN:0.06499):0.19880):0.05337):0.13059,SSUI:0.27890):0.21020,SANG:0.03141):0.02330,SCON:0.01619,SINT:0.01920):0.00000;
(SANG:0.28775,SENT:0.28775):0.00000;
(((SMIT:0.24389,SANG:0.22214):0.01558,(SSAL:0.11221,(((SMIT:0.00620,SINT:0.00770):0.02299,(SPLU:0.01176,SCAN:0.01338):0.02471):0.06677,SENT:0.10972):0.02117):0.05349):0.02307,(SDEV:0.10536,((SSAL:0.01004,SDOW:0.00645):0.03414,SRAT:0.01945):0.04714):0.00463,SPSE:0.14482):0.00000;
(SPLU:0.09753,SENT:0.09753):0.00000;
(((SPYO:0.00877,SDYS:0.01835):0.02401,SCAN:0.03540):0.07316,SPLU:0.13617,(((((SMIT:0.01058,(SPSE:0.00000,SPNE:0.00000):0.00903):0.06230,(SANG:0.01299,(SINT:0.01493,SCON:0.00951):0.00642):0.06724):0.02885,SSUI:0.09805):0.01760,SENT:0.09188):0.01046,((LLAC:0.08107,LCRE:0.09028):0.06527,(SPNE:0.23321,((SMIT:0.00766,SPNE:0.01348):0.10030,SCAN:0.11778):0.07213):0.00119):0.05456):0.00715):0.00000;
(SENT:0.15113,(SPLU:0.14105,(((((SINF:0.00695,SLUT:0.00636):0.00774,SEQU:0.01557):0.08194,((SCAN:0.02473,SPYO:0.03148):0.00939,SDYS:0.03509):0.06029):0.01723,((SSAL:0.02316,(STHE:0.01864,SVES:0.01996):0.00466):0.08767,SDOW:0.11088):0.00897):0.01317,(SDEV:0.01380,SRAT:0.01147):0.09026):0.01468):0.00674,(SSUI:0.12908,((SINT:0.02163,(SANG:0.01074,SCON:0.01234):0.00888):0.09695,(LCRE:0.04136,LLAC:0.03306):0.16215):0.01312):0.03783):0.00000;
((((((((((((STHE:0.00152,((SANG:0.00000,(SINT:0.00000,SCON:0.00000):0.00000):0.02833,((SPSE:0.02462,(SMIT:0.00000,SPNE:0.00000):0.00241):0.01865,(((LCRE:0.00000,LLAC:0.00000):0.21035,SSUI:0.03519):0.01866,SENT:0.03268):0.01142):0.02053):0.02621):0.00986,SRAT:0.01544):0.00242,SDOW:0.00000):0.00000,SDEV:0.00000):0.00000,SDYS:0.00000):0.00000,SPYO:0.00000):0.00000,SCAN:0.00000):0.00000,SEQU:0.00000):0.00000,SLUT:0.00000):0.00000,SINF:0.00000):0.00000,SPLU:0.00000):0.00000,SVES:0.00000,SSAL:0.00000):0.00000;
(SENT:0.27871,SEQU:0.19328,SEQU:0.47841):0.00000;
(SPLU:0.27139,SENT:0.27139):0.00000;
(((SSUI:0.14701,((SANG:0.04069,(SCON:0.02344,SINT:0.01861):0.02702):0.13890,((LCRE:0.01922,LLAC:0.02062):0.27712,(((SPLU:0.19437,(SDYS:0.04084,SCAN:0.04878):0.13685):0.01288,(((SANG:0.03040,(SINT:0.00442,SCON:0.00426):0.02716):0.14938,SENT:0.17724):0.00771,SSUI:0.18528):0.01572):0.14692,((((SDYS:0.09321,SPYO:0.10686):0.13513,(SSUI:0.18051,(((SMIT:0.01520,SPSE:0.02403):0.00233,SPNE:0.02464):0.15276,(SPLU:0.16589,((((SINF:0.01389,SLUT:0.01638):0.01972,SEQU:0.03188):0.10287,(SRAT:0.03040,SDEV:0.03512):0.10450):0.01106,((SDOW:0.13598,(STHE:0.04212,(SSAL:0.02233,SVES:0.02236):0.00935):0.11173):0.00447,(SINT:0.04529,(SANG:0.02305,SCON:0.02460):0.01708):0.10267):0.01119):0.00820):0.01015):0.01102):0.02182):0.03356,SENT:0.27666):0.09522,(((SDEV:0.11843,(SSAL:0.00961,SVES:0.01378):0.11207):0.10813,((SINF:0.01668,SLUT:0.01568):0.00340,SEQU:0.01376):0.21144):0.10123,((LCRE:0.03354,LLAC:0.03355):0.25811,((SSUI:0.12214,(SDYS:0.11533,(((SPLU:0.09392,SDOW:0.10095):0.00899,(((SINF:0.01095,SLUT:0.01180):0.03503,SEQU:0.04478):0.04328,(SDEV:0.02536,SRAT:0.02489):0.06256):0.01105):0.00515,((SANG:0.02140,(SINT:0.00374,SCON:0.00372):0.01686):0.05349,(SSAL:0.01715,(STHE:0.01383,SVES:0.01232):0.00519):0.06066):0.03032):0.00851):0.00155):0.01223,SENT:0.13098):0.14990):0.03090):0.01187):0.05914):0.03332):0.10178):0.04016):0.00783,SDOW:0.11634):0.01199,((SCAN:0.04185,SDYS:0.02797):0.06686,((SINF:0.04215,SEQU:0.04093):0.04861,(SDEV:0.01735,SRAT:0.01770):0.07607):0.01264):0.00410,((SPLU:0.10613,(((STHE:0.01158,SSAL:0.00807):0.00128,SVES:0.01648):0.05082,(SPSE:0.02281,(SMIT:0.00981,SPNE:0.01203):0.00218):0.06384):0.01804):0.01389,SENT:0.12179):0.00136):0.00000;
((SSUI:0.07078,((LLAC:0.07499,LCRE:0.07261):0.12123,(SENT:0.10152,((SRAT:0.02955,(SDOW:0.02792,SDEV:0.02570):0.00996):0.06197,((SINF:0.01412,SLUT:0.01532):0.02012,SEQU:0.04381):0.05242):0.01642):0.25777):0.11711):0.03781,(SANG:0.03946,SINT:0.04178):0.00365,((STHE:0.01803,(SSAL:0.00570,SVES:0.00437):0.00589):0.01971,(SMIT:0.00494,(SPSE:0.00522,SPNE:0.00667):0.00335):0.01822):0.00892):0.00000;
(((SSAL:0.09697,SENT:0.38508):0.02334,((SLUT:0.05367,SEQU:0.04117):0.04165,(SDEV:0.06549,SRAT:0.05039):0.05030):0.01189):0.00950,SDOW:0.11407,(SANG:0.07087,SCON:0.13626):0.02009):0.00000;
(((SRAT:0.03093,SDEV:0.02629):0.09771,((SSAL:0.01483,(STHE:0.01400,SVES:0.01318):0.00711):0.13069,((SPLU:0.15182,(SPYO:0.05488,(SCAN:0.03235,SDYS:0.03737):0.00636):0.10569):0.00660,(((SMIT:0.01442,(SPSE:0.00512,SPNE:0.00470):0.01014):0.09117,(SANG:0.01799,(SINT:0.01199,SCON:0.01407):0.01185):0.07517):0.04865,((LLAC:0.01106,LCRE:0.01160):0.24799,SENT:0.20933):0.01344):0.01042):0.00167):0.00743):0.00166,SDOW:0.12518,((SINF:0.00867,SLUT:0.00530):0.00943,SEQU:0.01556):0.09169):0.00000;
(SSUI:0.27174,((SPYO:0.12941,(SCAN:0.03547,SDYS:0.01817):0.08821):0.17060,SPLU:0.18297):0.03770,SENT:0.18105):0.00000;
((((SMIT:0.12090,(SPSE:0.00637,SPNE:0.01274):0.10333):0.14349,((SANG:0.04030,SCON:0.04508):0.02253,SINT:0.06404):0.14812):0.04336,(((((SEQU:0.05219,(SINF:0.01997,SLUT:0.02347):0.03965):0.15108,(SPYO:0.11381,(SDYS:0.08752,SCAN:0.09093):0.01370):0.10978):0.00715,(SPLU:0.22884,SENT:0.23715):0.01855):0.01305,(SDEV:0.06324,SRAT:0.07547):0.17528):0.01601,((SSAL:0.07134,(STHE:0.03273,SVES:0.03313):0.05046):0.20935,SDOW:0.23872):0.03253):0.00795):0.00236,SSUI:0.29387,(LLAC:0.06787,LCRE:0.06023):0.20956):0.00000;
(SPLU:0.25365,((((SSUI:0.29125,((SANG:0.05340,(SCON:0.00825,SINT:0.01426):0.03759):0.16458,(SMIT:0.08561,(SPSE:0.02144,SPNE:0.02129):0.06110):0.12050):0.10401):0.03496,SENT:0.29758):0.01744,SDOW:0.27186):0.01159,((SRAT:0.03492,SDEV:0.02856):0.18510,(SSAL:0.05749,(STHE:0.02794,SVES:0.02142):0.04667):0.21883):0.02954):0.00968,(((SINF:0.01471,SLUT:0.01598):0.06196,SEQU:0.07513):0.12770,(SPYO:0.17571,(SDYS:0.07537,SCAN:0.07396):0.07381):0.10441):0.01091):0.00000;
((SSUI:0.23846,(((LLAC:0.01878,LCRE:0.02283):0.33212,((SINT:0.03796,(SCON:0.02993,SANG:0.03018):0.00569):0.13794,(SPSE:0.01810,(SMIT:0.01492,SPNE:0.01038):0.00285):0.19661):0.04343):0.00969,SENT:0.26626):0.00145):0.02276,(SPLU:0.21131,(SDOW:0.17622,((((SINF:0.01374,SLUT:0.01589):0.01603,SEQU:0.03105):0.12198,(SDEV:0.03949,SRAT:0.04596):0.10925):0.00412,((SCAN:0.05293,SDYS:0.05249):0.01288,SPYO:0.07161):0.09835):0.01359):0.01895):0.00049,(STHE:0.04544,(SSAL:0.02203,SVES:0.02370):0.02235):0.15994):0.00000;
((SENT:0.42387,(SCON:0.06573,SANG:0.04897):0.23389):0.02895,(SMIT:0.22287,(SENT:0.14363,SPLU:0.13139):0.08902):0.03682,SSUI:0.26415):0.00000;
((SDOW:0.06565,((STHE:0.02433,(SSAL:0.00663,SVES:0.00730):0.00894):0.06802,(SSUI:0.10344,(((SMIT:0.00252,(SPSE:0.00234,SPNE:0.00531):0.00067):0.09460,((SANG:0.00795,SINT:0.01629):0.00316,SCON:0.01848):0.05243):0.06539,(((LCRE:0.01005,LLAC:0.01384):0.15916,SENT:0.29968):0.01486,(SDYS:0.04640,(SCAN:0.01320,SPYO:0.02477):0.03221):0.07288):0.00861):0.03003):0.01210):0.01274):0.00903,(SDEV:0.02841,SRAT:0.02092):0.03517,((SINF:0.00753,SLUT:0.00835):0.00883,SEQU:0.01536):0.05483):0.00000;
(((((SINF:0.00332,SLUT:0.00237):0.00398,SEQU:0.00454):0.04192,(SSUI:0.08301,(((SPYO:0.05918,(SCAN:0.05282,SDYS:0.04756):0.00606):0.02493,(((LCRE:0.02093,LLAC:0.01378):0.08897,SENT:0.41375):0.04091,((SANG:0.01603,(SINT:0.02306,SCON:0.01376):0.00666):0.04213,(SMIT:0.01861,(SPSE:0.00971,SPNE:0.01468):0.00243):0.05117):0.01439):0.01346):0.01352,(SDEV:0.01437,SRAT:0.01496):0.03095):0.00401):0.00440):0.01143,SDOW:0.02877):0.00572,(SSAL:0.00196,SVES:0.00469):0.00059,STHE:0.01223):0.00000;
(((LLAC:0.00953,LCRE:0.00790):0.13675,((SINT:0.03942,(SANG:0.01794,SCON:0.03020):0.00917):0.12560,(SSUI:0.11249,SENT:0.37665):0.03514):0.01160):0.00930,(SDOW:0.08162,((STHE:0.01503,(SSAL:0.00903,SVES:0.02380):0.00185):0.05701,(SMIT:0.01707,(SPSE:0.01754,SPNE:0.00769):0.00732):0.08263):0.00698):0.00362,((((SCAN:0.06831,SPYO:0.07160):0.00947,SDYS:0.06977):0.06246,SDEV:0.08035):0.01461,(((SINF:0.00706,SLUT:0.02209):0.01362,SEQU:0.02328):0.06707,SRAT:0.06644):0.00297):0.00918):0.00000;
(((SENT:0.09117,(SSUI:0.11880,(SDEV:0.03505,SRAT:0.02590):0.03294):0.02383):0.01522,SDOW:0.08979):0.01118,(SPLU:0.05499,(SCAN:0.02820,SDYS:0.02564):0.03629):0.01361,((STHE:0.01631,SSAL:0.01121):0.00429,SVES:0.01356):0.05175):0.00000;
((((SEQU:0.08377,(SINF:0.01990,SLUT:0.03131):0.05279):0.06018,((LLAC:0.35956,SENT:0.25000):0.03069,((SCAN:0.02927,SDYS:0.02588):0.15702,((SRAT:0.02531,SDEV:0.02502):0.13506,SDOW:0.15983):0.02148):0.01819):0.04956):0.01150,(SINT:0.02911,(SANG:0.01224,SCON:0.01430):0.00610):0.09370):0.00539,(SPSE:0.01671,(SPNE:0.01982,SMIT:0.02069):0.00153):0.10221,(SSAL:0.02797,(STHE:0.02337,SVES:0.02027):0.01266):0.09102):0.00000;
(((SMIT:0.00759,SPNE:0.00576):0.01127,SPSE:0.01574):0.15034,((SSUI:0.22731,(SENT:0.29156,(SDOW:0.14849,(SANG:0.01999,(SINT:0.00907,SCON:0.00752):0.01384):0.13494):0.08672):0.14625):0.02505,(SSAL:0.05562,(SVES:0.02877,STHE:0.03786):0.02322):0.13135):0.00084,((SCAN:0.03781,(SPYO:0.03356,SDYS:0.02607):0.00671):0.08505,(SDEV:0.12530,(SLUT:0.08450,(SINF:0.05168,SEQU:0.05681):0.02948):0.04279):0.01295):0.06209):0.00000;
(SENT:0.16440,SDOW:0.15883,STHE:0.16548):0.00000;
(SENT:0.03891,SDEV:0.10056,SPNE:0.05516):0.00000;
(SEQU:0.06210,SENT:0.06210):0.00000;
(SEQU:0.22482,SENT:0.22482):0.00000;
(SENT:0.45872,SSAL:0.03528,SVES:0.02273):0.00000;
(SSUI:0.33420,SENT:0.33420):0.00000;
((((SMIT:0.02405,(SPSE:0.00000,SPNE:0.00000):0.02445):0.08472,(((SPLU:0.17560,SENT:0.17540):0.01585,SSUI:0.15902):0.03733,(SDYS:0.06987,SCAN:0.08628):0.29488):0.13535):0.07273,SCON:0.02460):0.00639,SINT:0.02321,SANG:0.00897):0.00000;
(((SANG:0.13069,(SENT:0.19202,(SPNE:0.14249,STHE:0.14295):0.07971):0.41461):0.08800,(SPLU:0.02528,SDYS:0.02715):0.02673):0.02608,(SPLU:0.01942,SCAN:0.02034):0.00193,SSUI:0.02286):0.00000;
((((SCAN:0.01363,SPYO:0.02652):0.00026,SDYS:0.02196):0.06533,(SENT:0.08822,SPLU:0.06212):0.02413):0.00355,((SPSE:0.01213,(SMIT:0.00382,SPNE:0.01089):0.00070):0.06116,(SSUI:0.06215,((SANG:0.02235,(SINT:0.01605,SCON:0.01934):0.00971):0.03042,((SINF:0.01355,(SLUT:0.00160,SEQU:0.00099):0.00770):0.02115,(SRAT:0.03684,SDEV:0.03327):0.00299):0.01704):0.00495):0.01202):0.00293,(SDOW:0.06536,(STHE:0.01772,(SSAL:0.00636,SVES:0.00824):0.00392):0.04246):0.02663):0.00000;
((((SSUI:0.05626,((SDEV:0.00275,SRAT:0.00821):0.08502,(SPNE:0.03887,(SCON:0.00411,SINT:0.00483):0.02761):0.02171):0.00746):0.04754,SPLU:0.03742):0.03500,SDYS:0.00301):0.00281,SPYO:0.00526,SCAN:0.00513):0.00000;
(((SPSE:0.03551,(SPNE:0.03049,SMIT:0.02821):0.00216):0.20531,SPLU:0.23329):0.02048,LLAC:0.24203,(((SPNE:0.02275,(SPSE:0.00914,SMIT:0.00566):0.00609):0.17369,(SINT:0.02676,(SANG:0.01816,SCON:0.01371):0.00964):0.14645):0.10912,SENT:0.28018):0.01808):0.00000;
((((SANG:0.04261,(SINT:0.00000,SCON:0.00000):0.06004):0.13051,((SMIT:0.03493,(SPSE:0.01173,SPNE:0.01675):0.01058):0.18879,SSUI:0.24929):0.00838):0.04287,SPLU:0.18260):0.01363,((((SCAN:0.03679,SDYS:0.04503):0.03523,SPYO:0.11273):0.10569,(SEQU:0.04568,(SINF:0.04671,SLUT:0.02607):0.02394):0.08212):0.01177,(SDOW:0.14756,(SDEV:0.05653,SRAT:0.03798):0.11512):0.04378):0.02886,((SSAL:0.00335,SVES:0.00947):0.05118,STHE:0.05139):0.19422):0.00000;
(((SPLU:0.15656,((SSAL:0.01225,(STHE:0.01797,SVES:0.00526):0.00291):0.09931,(SDEV:0.07258,SRAT:0.08260):0.03464):0.03330):0.01310,(SDYS:0.19829,(SINF:0.05653,SEQU:0.04347):0.10324):0.00285):0.02343,SSUI:0.16653,(((SMIT:0.02517,SPSE:0.02015):0.01280,SPNE:0.02955):0.09805,(SINT:0.08327,(SANG:0.02627,SCON:0.02883):0.02637):0.07780):0.00410):0.00000;
((SENT:0.29715,((((SANG:0.30831,(SMIT:0.04462,(SPSE:0.02913,SPNE:0.02358):0.01629):0.25387):0.11709,LCRE:0.38223):0.06432,SPLU:0.31835):0.01471,((SSAL:0.05363,(STHE:0.03033,SVES:0.01889):0.03120):0.26875,(((SEQU:0.09830,(SINF:0.05136,SLUT:0.05074):0.04834):0.13201,(SCAN:0.07867,(SPYO:0.00954,SDYS:0.00673):0.07163):0.14600):0.02632,SDOW:0.28257):0.02424):0.02594):0.02275):0.00787,(SRAT:0.06064,SDEV:0.05613):0.19036,SSUI:0.28474):0.00000;
(((SPLU:0.16115,SDOW:0.11970):0.05072,(((((SPSE:0.00142,(SMIT:0.00000,SPNE:0.00000):0.00071):0.13660,(SANG:0.00837,(SCON:0.01277,SINT:0.01088):0.00419):0.08897):0.07353,SENT:0.20337):0.04383,(STHE:0.04210,(SSAL:0.00627,SVES:0.00477):0.02752):0.20273):0.02451,((SCAN:0.02324,SPYO:0.01308):0.00220,SDYS:0.01576):0.11000):0.03163):0.00398,(SRAT:0.05936,SDEV:0.04350):0.13096,((SLUT:0.00480,SEQU:0.00915):0.01377,SINF:0.02408):0.10468):0.00000;
(((LCRE:0.34500,((SVES:0.03389,SSAL:0.02488):0.22128,SPNE:0.22999):0.09616):0.02253,SPLU:0.23576):0.01834,SRAT:0.24900,(STHE:0.02091,(SSAL:0.00436,SVES:0.00430):0.00853):0.20262):0.00000;
((((SINF:0.00742,SLUT:0.00669):0.03179,SEQU:0.03124):0.09692,(SENT:0.13826,SPLU:0.12241):0.04386):0.01615,(SCAN:0.04868,(SPYO:0.02027,SDYS:0.02289):0.02285):0.11645,((LLAC:0.03210,LCRE:0.03153):0.19139,(SSUI:0.24340,(SSAL:0.22967,(((SPSE:0.01870,SPNE:0.01872):0.00080,SMIT:0.03107):0.16462,(SANG:0.08197,(SCON:0.01814,SINT:0.03483):0.06330):0.07912):0.03232):0.04326):0.07588):0.04074):0.00000;
(SPLU:0.48008,SANG:0.03266,SCON:0.01955):0.00000;
(((((SPSE:0.01338,(SMIT:0.00926,SPNE:0.02174):0.00148):0.07178,(SINT:0.04151,(SANG:0.02182,SCON:0.02763):0.00529):0.05136):0.01306,SSUI:0.11860):0.00764,((((LCRE:0.02728,LLAC:0.03389):0.20081,SENT:0.16609):0.00787,((SCAN:0.03251,SPYO:0.05357):0.02430,SDYS:0.05723):0.05752):0.00726,SPLU:0.11002):0.00668):0.00697,(((SINF:0.00783,SLUT:0.01105):0.01360,SEQU:0.01234):0.05610,(SDEV:0.03876,SRAT:0.04516):0.05028):0.00836,((SSAL:0.01965,(STHE:0.01255,SVES:0.01694):0.01096):0.05207,SDOW:0.08226):0.00092):0.00000;
(((SPYO:0.03807,SDYS:0.02843):0.11336,SPLU:0.17531):0.01171,(SDEV:0.03962,SRAT:0.04224):0.08621,(SSUI:0.15318,SENT:0.15128):0.01676):0.00000;
(SENT:0.12466,SPLU:0.12466):0.00000;
(((SCON:0.11132,(SVES:0.01685,SSAL:0.01655):0.08273):0.09022,(SPLU:0.09841,SSUI:0.11247):0.07889):0.00962,(LLAC:0.31973,SENT:0.17918):0.00548,SCAN:0.23195):0.00000;
(SCON:0.16779,(SPLU:0.31201,SSUI:0.29080):0.08101,(SVES:0.02944,SSAL:0.02333):0.17528):0.00000;
(SPLU:0.34303,LCRE:0.03006,LLAC:0.04275):0.00000;
(((((((SANG:0.04687,SINT:0.06143):0.00435,SCON:0.04971):0.12837,(SMIT:0.01251,(SPSE:0.00724,SPNE:0.00520):0.00702):0.12553):0.01178,SSUI:0.16219):0.02912,(SCAN:0.08208,SDYS:0.08414):0.11249):0.00865,(((LLAC:0.10874,LCRE:0.11078):0.19534,(SSAL:0.04053,(STHE:0.01486,SVES:0.01523):0.04170):0.10365):0.03166,(SENT:0.15699,SPLU:0.19755):0.00821):0.00699):0.01479,(SDOW:0.16581,((SDEV:0.06827,SRAT:0.05740):0.07772,SPYO:0.15924):0.00697):0.00340,((SINF:0.01361,SLUT:0.01910):0.03073,SEQU:0.03874):0.12451):0.00000;
(((((LLAC:0.07476,LCRE:0.06820):0.28855,SDOW:0.24004):0.00930,SPLU:0.22535):0.01030,(((SINF:0.00538,SLUT:0.01012):0.05466,SEQU:0.05626):0.10959,(SRAT:0.13963,SDEV:0.11977):0.03882):0.03542):0.00287,(SPYO:0.04580,(SDYS:0.04687,SCAN:0.05025):0.00784):0.19051,(((SSAL:0.01698,SVES:0.01979):0.06804,STHE:0.09377):0.19006,((SMIT:0.02742,SPSE:0.03799):0.13163,(SINT:0.09398,(SCON:0.08235,SANG:0.06225):0.00899):0.08902):0.04130):0.01948):0.00000;
((((SENT:0.19865,(SINT:0.07904,(SANG:0.03064,SCON:0.04979):0.04298):0.11488):0.00198,(((SPYO:0.11738,(SCAN:0.06269,SDYS:0.05932):0.05712):0.10907,(((STHE:0.02027,(SSAL:0.00886,SVES:0.01141):0.00286):0.15881,(SLUT:0.09063,(SINF:0.06647,SEQU:0.06153):0.02970):0.11372):0.01164,SPLU:0.20507):0.00344):0.01162,(SRAT:0.12676,SDEV:0.14803):0.05284):0.01341):0.01490,SDOW:0.20662):0.00237,(((SMIT:0.01425,SPSE:0.00953):0.01274,SPNE:0.03483):0.14802,SSUI:0.17491):0.03685,(LCRE:0.01190,LLAC:0.00932):0.27148):0.00000;
(((SENT:0.18914,SPLU:0.16474):0.01205,(((SSUI:0.20989,(((SMIT:0.00604,SPSE:0.00533):0.00807,SPNE:0.01013):0.11797,(SINT:0.03031,(SANG:0.01405,SCON:0.01624):0.00737):0.08042):0.06592):0.02108,((LCRE:0.02398,LLAC:0.01577):0.27123,(STHE:0.03410,(SVES:0.00185,SSAL:0.01833):0.00696):0.16174):0.00848):0.01273,SDOW:0.20163):0.01307):0.00405,(SEQU:0.05948,(SINF:0.01327,SLUT:0.01541):0.03184):0.11939,((SPYO:0.06711,(SCAN:0.04090,SDYS:0.03752):0.02960):0.07923,(SRAT:0.06712,SDEV:0.06851):0.06274):0.01176):0.00000;
(((SMIT:0.12111,(SPSE:0.02224,SPNE:0.01285):0.06258):0.08622,(SANG:0.02205,(SCON:0.02646,SINT:0.02534):0.00328):0.15117):0.08380,((((SDEV:0.02425,SRAT:0.02656):0.15456,(((SCAN:0.04164,SPYO:0.06568):0.00974,SDYS:0.06979):0.06009,((SINF:0.02722,SLUT:0.02051):0.02160,SEQU:0.04913):0.09030):0.05598):0.04327,(SPLU:0.22432,(STHE:0.05674,(SSAL:0.04318,SVES:0.03920):0.01099):0.19460):0.03809):0.02274,SENT:0.22665):0.02101,SSUI:0.27407):0.00000;
(((SPLU:0.19244,SSUI:0.19765):0.14170,(SDYS:0.00282,SPYO:0.00281):0.24746):0.15519,(SINT:0.02959,SCON:0.01374):0.03624,SANG:0.03727):0.00000;
((((STHE:0.02216,(SSAL:0.00000,SVES:0.00000):0.01394):0.11903,(SDEV:0.03234,SRAT:0.03699):0.07684):0.00829,SPLU:0.14183):0.00355,(((LCRE:0.06832,LLAC:0.07060):0.24990,((SINF:0.02184,SLUT:0.02595):0.03387,SEQU:0.06532):0.07003):0.00754,(((SANG:0.02225,(SINT:0.00937,SCON:0.00693):0.02665):0.09187,SSUI:0.13368):0.01511,(SMIT:0.01144,(SPSE:0.00558,SPNE:0.01161):0.00956):0.12951):0.00504):0.00518,SDOW:0.11778):0.00000;
(((SDOW:0.08066,SEQU:0.08281):0.03157,(((LCRE:0.01868,LLAC:0.01933):0.34766,((((SDEV:0.03880,SRAT:0.04594):0.30002,((SPYO:0.03405,SCAN:0.03578):0.13894,(SSUI:0.11179,(SCON:0.02112,(SPNE:0.00687,SPSE:0.00686):0.02141):0.07402):0.06932):0.12331):0.00700,(LLAC:0.17274,SEQU:0.16243):0.14070):0.02433,((LCRE:0.11569,LLAC:0.10619):0.15396,(((SENT:0.14496,(SVES:0.01159,SSAL:0.00985):0.13301):0.00637,SEQU:0.14649):0.05082,(SANG:0.12633,(SINF:0.10702,(SDEV:0.06205,SRAT:0.05966):0.04408):0.02230):0.05977):0.06440):0.07163):0.01875):0.02988,((((SINT:0.09519,(SLUT:0.00743,SEQU:0.00578):0.08918):0.01214,SPLU:0.10578):0.04645,(SRAT:0.06884,SDOW:0.06500):0.10121):0.12785,((SENT:0.10859,(SSUI:0.10106,(SPNE:0.02688,(SMIT:0.01251,SPSE:0.01451):0.01102):0.08231):0.00588):0.04111,(((SPYO:0.02480,SDYS:0.02314):0.01198,SCAN:0.03706):0.11997,((STHE:0.01440,(SSAL:0.00195,SVES:0.00119):0.01098):0.09422,(SANG:0.08635,(SINF:0.08634,SDEV:0.08510):0.00671):0.01497):0.04230):0.00609):0.14924):0.03269):0.22905):0.00667,(((SSUI:0.08879,SENT:0.10652):0.01192,SPLU:0.08827):0.01514,((SRAT:0.04021,SDEV:0.03786):0.04772,(SDYS:0.00611,SPYO:0.00962):0.10562):0.01082):0.00096,((SPNE:0.00749,SPSE:0.00571):0.10490,(SINT:0.01616,SCON:0.01248):0.07082):0.01325):0.00000;
((SPLU:0.25743,(SPYO:0.03628,(SCAN:0.02171,SDYS:0.02559):0.00715):0.20089):0.02112,(SEQU:0.07032,(SINF:0.02371,SLUT:0.01889):0.04878):0.22839,((LLAC:0.02113,LCRE:0.02349):0.37945,((SSAL:0.01962,SVES:0.01721):0.00587,STHE:0.02573):0.26287):0.01067):0.00000;
((((SCON:0.00978,SANG:0.00583):0.25246,SPLU:0.27453):0.01942,SEQU:0.32000):0.03670,SENT:0.36223,(SDEV:0.41185,SDOW:0.31423):0.01360):0.00000;
((SMIT:0.31211,(SCON:0.32851,SPLU:0.28577):0.01022):0.00510,((SCON:0.14427,(SANG:0.09775,SINT:0.08724):0.04388):0.07973,SENT:0.24809):0.02017,(SCON:0.23544,(SPSE:0.07381,(SMIT:0.04605,(SPSE:0.02821,SPNE:0.03296):0.01361):0.02576):0.16916):0.04388):0.00000;
((SENT:0.24475,SPLU:0.23025):0.00984,((LLAC:0.03867,LCRE:0.02885):0.38908,(STHE:0.05188,(SSAL:0.00945,SVES:0.01543):0.02707):0.19406):0.00368,(SDOW:0.27007,((SDEV:0.01742,SRAT:0.01586):0.16298,((SCAN:0.02704,(SPYO:0.00961,SDYS:0.01552):0.01451):0.12074,(SINF:0.02694,(SEQU:0.00579,SLUT:0.00646):0.02071):0.08761):0.03653):0.01269):0.02099):0.00000;
(SSUI:0.12814,SPLU:0.12814):0.00000;
(((SENT:0.27423,(SCAN:0.06366,SSUI:0.05703):0.16430):0.01948,(((SRAT:0.09477,SPLU:0.10566):0.13486,((SSUI:0.19657,(SPNE:0.01027,SPSE:0.02617):0.14350):0.02374,SSAL:0.18174):0.02704):0.02073,SPLU:0.22190):0.02453):0.01220,((SSUI:0.05426,SPLU:0.07262):0.04679,SDOW:0.08356):0.11948,SPLU:0.39385):0.00000;
(SDYS:0.13898,(SRAT:0.06678,SDEV:0.06070):0.11272,SPLU:0.17296):0.00000;
((SPLU:0.05562,(SPYO:0.00256,SDYS:0.00052):0.05119):0.02879,SDEV:0.01114,SRAT:0.01105):0.00000;
(SPLU:0.27173,(SDEV:0.06625,SRAT:0.08734):0.15339,(SDYS:0.06637,SPYO:0.08959):0.20491):0.00000;
(SPLU:0.29418,SENT:0.18849,SSUI:0.18227):0.00000;
(SPLU:0.02020,SPLU:0.02020):0.00000;
(SEQU:0.24292,SPLU:0.24292):0.00000;
(SPNE:0.30564,SPLU:0.30564):0.00000;
(SPLU:0.23952,(((SPNE:0.01703,SMIT:0.02176):0.32295,SENT:0.43602):0.05053,SSUI:0.33283):0.02746,(SPSE:0.04179,SMIT:0.03543):0.21217):0.00000;
(SENT:0.31910,SPLU:0.31910):0.00000;
(SPLU:0.32380,(SENT:0.31436,(SDYS:0.05578,SPYO:0.06203):0.26103):0.02692,((SMIT:0.02416,(SPSE:0.01555,SPNE:0.00519):0.02773):0.18801,(SINT:0.03429,(SCON:0.01047,SANG:0.01371):0.02897):0.16232):0.10199):0.00000;
((SDOW:0.11579,((SCAN:0.09872,SSUI:0.09535):0.22188,(SPLU:0.07389,SRAT:0.06056):0.32245):0.17395):0.09580,SSUI:0.02139,SPLU:0.01095):0.00000;
(((((LCRE:0.00746,LLAC:0.00734):0.16968,(SSUI:0.06479,(((SPSE:0.01459,SMIT:0.00274):0.00432,SPNE:0.02305):0.03396,(SANG:0.01875,(SINT:0.01229,SCON:0.00844):0.01331):0.02131):0.01073):0.02555):0.01133,((STHE:0.03165,(SSAL:0.00000,SVES:0.00000):0.00707):0.04483,(SDEV:0.01300,SRAT:0.01818):0.03437):0.00989):0.00362,((SPYO:0.02416,(SCAN:0.01328,SDYS:0.00997):0.00958):0.03563,(SENT:0.10389,SPLU:0.06071):0.00908):0.00445):0.00278,((SINF:0.01029,SLUT:0.01276):0.00225,SEQU:0.01197):0.05130,SDOW:0.06439):0.00000;
((((SRAT:0.20890,(SINT:0.01378,SMIT:0.01390):0.18903):0.10028,SPLU:0.33090):0.02450,(SPLU:0.16282,SPLU:0.15039):0.15126):0.03944,(SPLU:0.29488,SENT:0.25633):0.00799,(((SPLU:0.07202,SPLU:0.08241):0.12442,SDEV:0.18767):0.07760,(SANG:0.16870,SVES:0.16085):0.07290):0.05360):0.00000;
((SMIT:0.03370,((SSUI:0.00658,SPLU:0.01080):0.06416,(SENT:0.15108,SDEV:0.13573):0.03414):0.06020):0.01023,SINT:0.04695,SVES:0.02677):0.00000;
(SENT:0.12589,SPLU:0.12589):0.00000;
(SPLU:0.19003,SDOW:0.21979,((((SCON:0.03319,(SINT:0.02133,SANG:0.01997):0.01700):0.12243,((SPSE:0.01227,SPNE:0.00768):0.09055,SMIT:0.08659):0.07473):0.03176,SSUI:0.20376):0.14887,(SENT:0.18533,((STHE:0.03932,(SSAL:0.01397,SVES:0.02178):0.02210):0.13492,((SINF:0.04199,(SEQU:0.00344,SLUT:0.00626):0.03515):0.10001,(SPYO:0.02399,(SCAN:0.02255,SDYS:0.02114):0.00424):0.12192):0.02130):0.02355):0.01357):0.00853):0.00000;
(SSUI:0.08385,(SCAN:0.03902,SDYS:0.01900):0.15018,SPLU:0.12712):0.00000;
(SENT:0.12188,SSUI:0.12188):0.00000;
((((SDEV:0.01816,SRAT:0.01668):0.03667,((SCAN:0.01858,(SPYO:0.00595,SDYS:0.01234):0.00483):0.04437,SDOW:0.06105):0.01097):0.00853,(((SPSE:0.00357,(SMIT:0.00000,SPNE:0.00000):0.00055):0.07681,(SANG:0.02367,(SINT:0.01142,SCON:0.01957):0.00429):0.07311):0.01209,SSUI:0.12253):0.02739):0.00501,(SENT:0.08500,(LCRE:0.01618,LLAC:0.00613):0.26121):0.00931,((SEQU:0.02114,(SLUT:0.01933,SINF:0.01741):0.00339):0.03851,((STHE:0.00000,(SSAL:0.00000,SVES:0.00000):0.00000):0.05803,SPLU:0.11305):0.02033):0.01810):0.00000;
((SSUI:0.27270,(SDEV:0.15628,SRAT:0.16834):0.14896):0.00469,(SEQU:0.22665,SDOW:0.22808):0.05459,SENT:0.32081):0.00000;
(((LCRE:0.00864,LLAC:0.00462):0.23255,(SSUI:0.14391,((SINT:0.04635,(SANG:0.02931,SCON:0.03417):0.00581):0.09057,(SMIT:0.02027,(SPSE:0.01515,SPNE:0.01716):0.00561):0.13921):0.02450):0.00325):0.01997,((SDEV:0.03608,SRAT:0.04003):0.08266,((((SINF:0.00694,SLUT:0.01209):0.01610,SEQU:0.02372):0.06949,(SCAN:0.04111,(SPYO:0.01130,SDYS:0.00910):0.02751):0.07855):0.00922,((STHE:0.02482,(SSAL:0.01147,SVES:0.01638):0.00718):0.10283,(SPLU:0.10423,SDOW:0.13370):0.00859):0.00560):0.00812):0.00366,SENT:0.14432):0.00000;
((((SPYO:0.13324,(SDYS:0.07493,SCAN:0.04976):0.04746):0.11321,((SSAL:0.04843,(SVES:0.01292,STHE:0.03519):0.04904):0.17617,(((SPSE:0.03286,(SMIT:0.00902,SPNE:0.01237):0.01259):0.10062,(SCON:0.08538,(SANG:0.05663,SINT:0.06427):0.04993):0.07304):0.09165,(SSUI:0.08417,SPLU:0.08656):0.18978):0.05081):0.02192):0.03497,((SLUT:0.02555,SEQU:0.03256):0.01245,SINF:0.02407):0.16218):0.00772,(SDEV:0.06700,SRAT:0.09544):0.15924,SDOW:0.18029):0.00000;
(SSUI:0.01989,SSUI:0.02055,(SDYS:0.00361,SDYS:0.00438):0.65995):0.00000;
(SLUT:0.18207,SSUI:0.18207):0.00000;
(SLUT:0.05773,SSUI:0.05773):0.00000;
((STHE:0.04668,(SSAL:0.01363,SVES:0.01057):0.02233):0.10722,(SEQU:0.02287,(SINF:0.00892,SLUT:0.01005):0.02972):0.09134,((SRAT:0.05108,SDEV:0.05221):0.10280,((SCAN:0.07713,SDYS:0.07883):0.11376,((SPNE:0.00601,(SPSE:0.00419,SMIT:0.00078):0.00112):0.17408,SSUI:0.53039):0.01481):0.02225):0.00641):0.00000;
(((SPYO:0.13542,(SCAN:0.05652,SDYS:0.05845):0.07593):0.03659,(SENT:0.19207,((LCRE:0.04300,LLAC:0.03431):0.26371,(SDOW:0.18529,(((SSAL:0.02677,(STHE:0.01921,SVES:0.02364):0.00572):0.13979,SPLU:0.17747):0.03119,(((SANG:0.04830,(SINT:0.04742,SCON:0.04021):0.00470):0.10077,(SMIT:0.04444,(SPNE:0.03506,SPSE:0.03078):0.00928):0.09414):0.04211,SSUI:0.18220):0.02657):0.00899):0.00535):0.01238):0.01248):0.00477,(SEQU:0.05166,(SINF:0.03770,SLUT:0.04357):0.00674):0.10782,(SDEV:0.06152,SRAT:0.06712):0.11750):0.00000;
(SPLU:0.17541,SSUI:0.17541):0.00000;
(SPLU:0.18821,SSUI:0.18821):0.00000;
(((((SMIT:0.01831,(SPSE:0.00000,SPNE:0.00000):0.02064):0.09896,(SANG:0.04262,(SINT:0.03607,SCON:0.04706):0.00516):0.05271):0.02961,SSUI:0.14408):0.06791,SENT:0.14933):0.00779,((SANG:0.05987,(SINT:0.01909,SCON:0.01518):0.03640):0.06555,(SCAN:0.01672,(SPYO:0.00199,SDYS:0.00314):0.01562):0.12014):0.01309,((STHE:0.04679,SSAL:0.03576):0.07801,(SMIT:0.02097,(SPSE:0.00790,SPNE:0.01099):0.00713):0.09960):0.02559):0.00000;
(((SSUI:0.07102,(((SPNE:0.00529,SMIT:0.00498):0.59211,(LCRE:0.01223,LLAC:0.02173):0.16498):0.07532,((SSAL:0.00316,SVES:0.00719):0.05459,(SPYO:0.01118,(SCAN:0.00410,SDYS:0.00741):0.00263):0.03282):0.03986):0.03437):0.02304,SINT:0.03143):0.02890,(SPSE:0.01539,SPNE:0.00308):0.00196,SMIT:0.00179):0.00000;
((((LCRE:0.02423,LLAC:0.02032):0.16811,(SENT:0.14162,(((SMIT:0.03239,SPSE:0.03299):0.01641,SPNE:0.05708):0.10086,((SANG:0.02012,(SINT:0.02081,SCON:0.01595):0.00855):0.07156,(SPLU:0.05233,SSUI:0.06836):0.03656):0.01484):0.01130):0.01169):0.00835,(SDEV:0.05029,SRAT:0.04949):0.05339):0.00560,((SINF:0.02787,(SLUT:0.00897,SEQU:0.01272):0.01768):0.05920,((SPYO:0.10417,(SCAN:0.06106,SDYS:0.04487):0.02656):0.04164,SDOW:0.10443):0.00940):0.01356,(STHE:0.02484,(SSAL:0.00440,SVES:0.00433):0.02056):0.11202):0.00000;
(SPLU:0.04903,SSUI:0.04903):0.00000;
(((SSUI:0.01486,SPLU:0.02997):0.31539,SVES:0.05770):0.01435,SINT:0.06741,SMIT:0.05768):0.00000;
(SSUI:0.03220,SPLU:0.01914,SENT:0.51862):0.00000;
((SMIT:0.01461,((SSUI:0.21157,((SPLU:0.16338,SENT:0.14010):0.02222,(SDYS:0.07335,(SCAN:0.03720,SPYO:0.04500):0.04282):0.13166):0.09546):0.11173,(SANG:0.03673,(SINT:0.00501,SCON:0.00726):0.02874):0.07023):0.08581):0.01753,SPNE:0.00587,SPSE:0.00181):0.00000;
(SSUI:0.43386,(SCON:0.08293,SANG:0.07968):0.01867,SINT:0.09853):0.00000;
((SSUI:0.16261,SPLU:0.14602):0.31019,(SDYS:0.11229,SCAN:0.07315):0.03447,SPYO:0.14243):0.00000;
(SPLU:0.05774,SSUI:0.05774):0.00000;
((((SINF:0.06435,(SLUT:0.00972,SEQU:0.00577):0.05387):0.06521,(SPLU:0.13984,SENT:0.11250):0.01225):0.00882,(SDOW:0.16178,SSUI:0.13870):0.00878):0.00789,(((((LLAC:0.04701,LCRE:0.04471):0.27554,((SSUI:0.12606,(SINF:0.06147,SEQU:0.04682):0.07417):0.04993,(SPNE:0.01892,(SPSE:0.00705,SMIT:0.00628):0.00331):0.17853):0.08077):0.19082,(LLAC:0.07782,LCRE:0.07151):0.16197):0.09081,((SDYS:0.07282,SCAN:0.07664):0.04045,SPYO:0.19159):0.03921):0.01427,((SMIT:0.01772,(SPSE:0.00983,SPNE:0.01159):0.00561):0.15828,(SRAT:0.06280,SDEV:0.07663):0.07284):0.00933):0.00586,((STHE:0.06111,(SSAL:0.00687,SVES:0.00867):0.04422):0.10273,(SANG:0.04603,(SINT:0.04416,SCON:0.04950):0.00422):0.06182):0.02258):0.00000;
((((SRAT:0.10868,SDEV:0.10436):0.17842,SDOW:0.26041):0.00962,SSUI:0.32153):0.00494,((((SPYO:0.02983,SDYS:0.02962):0.05800,SCAN:0.09686):0.13999,SPLU:0.23785):0.02393,(SRAT:0.07716,SDEV:0.07504):0.15082):0.02539,(SSAL:0.06393,(SVES:0.02086,STHE:0.02669):0.03296):0.20143):0.00000;
(SSUI:0.09593,SCAN:0.12878,SPSE:0.21318):0.00000;
(((((SPYO:0.02274,(SCAN:0.00966,SDYS:0.00616):0.01657):0.07924,SSUI:0.12424):0.01309,SDEV:0.11654):0.02752,(SINT:0.01950,(SANG:0.00508,SCON:0.00093):0.02916):0.04737):0.01190,SPNE:0.08030,SSAL:0.07212):0.00000;
(SSUI:0.32287,((SDOW:0.18548,(SDEV:0.02395,SRAT:0.02695):0.11771):0.02225,((SPLU:0.16518,((SCAN:0.01805,SPYO:0.02447):0.11958,SDYS:0.15014):0.06234):0.03163,(SMIT:0.00750,SPNE:0.01689):0.19535):0.02304):0.00991,(SSAL:0.02333,(STHE:0.00817,SVES:0.01494):0.01673):0.13521):0.00000;
(((SENT:0.30914,SDOW:0.28570):0.01912,(SSUI:0.35207,(SEQU:0.22965,(SVES:0.00762,SSAL:0.01153):0.20640):0.02421):0.01075):0.01026,((SPNE:0.01512,(SPSE:0.01246,SMIT:0.00655):0.00280):0.27332,(SRAT:0.05336,SDEV:0.04739):0.21857):0.02689,(SPLU:0.29261,(SDYS:0.05016,(SPYO:0.02512,SCAN:0.02513):0.02200):0.22454):0.03382):0.00000;
(SSUI:0.05516,SDYS:0.03749,SPLU:0.08760):0.00000;
((SDOW:0.10281,SSUI:0.10400):0.01591,((LLAC:0.06234,LCRE:0.06415):0.18003,(SDEV:0.04272,SRAT:0.04581):0.07564):0.00333,(SANG:0.11158,((SSAL:0.01588,(STHE:0.01384,SVES:0.01614):0.00371):0.08233,((SINF:0.01067,SLUT:0.01561):0.00687,SEQU:0.01471):0.08624):0.00999):0.01077):0.00000;
(((SEQU:0.05680,(SINF:0.00363,SLUT:0.00132):0.07182):0.09266,(((STHE:0.02019,(SSAL:0.01753,SVES:0.02201):0.00091):0.10830,SDOW:0.17313):0.01061,((SANG:0.02658,(SINT:0.01559,SCON:0.03537):0.00929):0.13177,((SPSE:0.01805,(SMIT:0.01874,SPNE:0.02709):0.00650):0.12341,SSUI:0.15310):0.03859):0.01511):0.01120):0.00616,((SDEV:0.03808,SRAT:0.02780):0.11502,(((LCRE:0.04261,LLAC:0.01468):0.27531,SENT:0.23888):0.02222,SPLU:0.19549):0.01611):0.00274,(SPYO:0.07250,(SCAN:0.05304,SDYS:0.05345):0.01901):0.10244):0.00000;
((((LCRE:0.01231,LLAC:0.00281):0.16559,SENT:0.07378):0.00467,((SINT:0.00711,(SANG:0.00755,SCON:0.00429):0.00230):0.05015,SSUI:0.06148):0.00926):0.01264,(SDOW:0.04029,(SDEV:0.00972,SRAT:0.00692):0.02891):0.02118,(((SSAL:0.00566,SVES:0.00463):0.03742,(SMIT:0.00208,(SPSE:0.00127,SPNE:0.00083):0.00071):0.04219):0.00928,(SPLU:0.04565,((SINF:0.02815,SEQU:0.02076):0.01881,(SCAN:0.01141,(SPYO:0.00425,SDYS:0.00338):0.01011):0.02777):0.00716):0.00308):0.00278):0.00000;
(SPLU:0.10456,SSUI:0.10456):0.00000;
(SSUI:0.40485,SPNE:0.03564,SPSE:0.03951):0.00000;
(SSUI:0.56232,(SINT:0.01774,SANG:0.02397):0.02396,SCON:0.03371):0.00000;
(((((SMIT:0.01733,SPSE:0.01138):0.01522,SPNE:0.03765):0.11255,(SANG:0.06557,(SINT:0.07989,SCON:0.05670):0.00998):0.05568):0.19849,SSUI:0.26804):0.02556,(SENT:0.24487,(SPYO:0.20607,(SDYS:0.08212,SCAN:0.09135):0.08410):0.09764):0.00371,(((SSAL:0.08917,(SVES:0.02194,STHE:0.02138):0.06863):0.10389,SPLU:0.22134):0.04073,((SDOW:0.18070,(SRAT:0.07798,SDEV:0.07411):0.11955):0.02889,((SLUT:0.15074,SEQU:0.12870):0.01897,SINF:0.15114):0.06562):0.01143):0.02315):0.00000;
(((STHE:0.33423,(((STHE:0.19921,(SINT:0.16448,(STHE:0.03240,SSAL:0.03490):0.11126):0.01897):0.09595,SSUI:0.28747):0.08446,(SPLU:0.32631,((SPSE:0.03154,(SPNE:0.03068,SMIT:0.02984):0.00337):0.26987,SDYS:0.29632):0.01192):0.07985):0.01903):0.13619,(SDYS:0.07171,(SPYO:0.04586,SCAN:0.04316):0.02556):0.14830):0.01138,SPSE:0.21369,(SINF:0.17048,((STHE:0.05703,(SCAN:0.04473,SPYO:0.05031):0.01033):0.06476,SMIT:0.12264):0.05559):0.03845):0.00000;
(SMIT:0.30665,SSUI:0.30665):0.00000;
(((SCAN:0.08384,(SDYS:0.06060,SPYO:0.07765):0.00732):0.14697,SSUI:0.18250):0.02829,(((SSAL:0.03469,(STHE:0.03278,SVES:0.02484):0.01926):0.12594,SPLU:0.15939):0.01187,(SENT:0.20329,(SDEV:0.06245,SRAT:0.07001):0.10153):0.00616):0.00487,((SDOW:0.19803,((SANG:0.04825,(SINT:0.02648,SCON:0.02861):0.02961):0.09710,(SMIT:0.03491,(SPSE:0.01500,SPNE:0.01259):0.00647):0.14033):0.01109):0.01267,((LLAC:0.08179,LCRE:0.08315):0.24212,((SINF:0.01086,SLUT:0.01736):0.03688,SEQU:0.05982):0.10729):0.01980):0.00186):0.00000;
(((SVES:0.06414,SSAL:0.06093):0.21171,(SCAN:0.10985,(SDYS:0.01617,SPYO:0.00895):0.07696):0.19842):0.01515,((SSUI:0.11847,SPLU:0.11370):0.17916,((SEQU:0.06725,SINF:0.05909):0.14552,(SENT:0.31386,(SDEV:0.10554,SRAT:0.09618):0.11146):0.01247):0.01111):0.00406,SDOW:0.22088):0.00000;
(((((SPSE:0.00822,(SMIT:0.01990,SPNE:0.00918):0.00316):0.10868,(SANG:0.06216,SCON:0.07376):0.06405):0.05885,SSUI:0.17056):0.07365,(SDEV:0.02969,SRAT:0.02151):0.14414):0.00327,((STHE:0.00940,(SSAL:0.00536,SVES:0.01227):0.00252):0.21179,(SENT:0.16743,SDOW:0.17238):0.01059):0.01992,(((SINF:0.00000,SLUT:0.00000):0.02584,SEQU:0.02302):0.08291,(SPLU:0.11706,(SPYO:0.03784,(SCAN:0.00732,SDYS:0.01204):0.02599):0.08289):0.01185):0.04012):0.00000;
(SENT:0.21254,SSUI:0.21254):0.00000;
(SSUI:0.26261,SSUI:0.37536,SSUI:0.22139):0.00000;
(SSUI:0.18008,(SDOW:0.13505,(SEQU:0.05767,(SLUT:0.01050,SINF:0.00898):0.05689):0.06275):0.02401,((SDEV:0.01547,SRAT:0.02392):0.13480,(SPYO:0.05722,(SCAN:0.03789,SDYS:0.03537):0.01743):0.12430):0.15512):0.00000;
(((SENT:0.11008,(((SMIT:0.00767,(SPSE:0.00503,SPNE:0.00324):0.00508):0.10599,((SANG:0.01522,SINT:0.01972):0.00418,SCON:0.01836):0.11123):0.02413,((SDEV:0.02478,SRAT:0.02638):0.12054,SSUI:0.15694):0.04157):0.00948):0.00463,(SDOW:0.14433,(((SINF:0.00605,SLUT:0.01138):0.00853,SEQU:0.01271):0.03917,((STHE:0.00237,SSAL:0.00667):0.00643,SVES:0.00412):0.06225):0.01025):0.01497):0.00205,(SCAN:0.02629,(SPYO:0.00336,SDYS:0.00587):0.02259):0.08331,SPLU:0.11352):0.00000;
(SPLU:0.20650,SSUI:0.20650):0.00000;
((SEQU:0.08646,((SVES:0.02794,SSAL:0.03351):0.29421,SSUI:0.29103):0.31754):0.04179,SINF:0.03405,SLUT:0.04430):0.00000;
((SENT:0.26216,SSUI:0.22926):0.01261,((SRAT:0.05601,SDEV:0.04485):0.17436,(SPLU:0.26001,((((SINF:0.06352,SLUT:0.06657):0.02894,SEQU:0.08688):0.10950,(SCAN:0.11271,SDYS:0.12751):0.10680):0.01572,SDOW:0.21217):0.01204):0.00873):0.00630,((SSUI:0.27251,(((SANG:0.05649,SINT:0.06919):0.03927,SCON:0.10097):0.11430,((SPNE:0.01857,(SPSE:0.00978,SMIT:0.00863):0.01177):0.18332,((STHE:0.04900,SSAL:0.03868):0.02148,SVES:0.06469):0.12244):0.01852):0.05271):0.15844,(LLAC:0.04320,LCRE:0.05066):0.21696):0.07067):0.00000;
(((SPSE:0.00546,(SMIT:0.00009,SPNE:0.00165):0.00147):0.06976,(SSUI:0.17272,(((LLAC:0.02001,LCRE:0.02606):0.19668,(SENT:0.22408,((((SRAT:0.02238,SDEV:0.01629):0.12273,SSUI:0.11933):0.01414,((SCAN:0.04244,SDYS:0.04265):0.11350,(((SINF:0.00956,SLUT:0.01099):0.00964,SEQU:0.01768):0.07063,SDOW:0.12601):0.02754):0.00866):0.02128,SPLU:0.15551):0.02926):0.05525):0.04381,SDOW:0.32616):0.10678):0.11009):0.00500,((SANG:0.01038,SINT:0.02133):0.00644,SCON:0.01927):0.04321,((STHE:0.00789,SSAL:0.00334):0.00855,SVES:0.02259):0.03688):0.00000;
((SSUI:0.06022,SPLU:0.08524):0.05825,(SPSE:0.00498,SPNE:0.00498):0.08635,SSAL:0.15231):0.00000;
(((SENT:0.23473,SENT:0.21803):0.03863,(SSUI:0.05131,SPLU:0.04646):0.18012):0.00885,((SPLU:0.24917,SDOW:0.22586):0.01696,((LCRE:0.05914,LLAC:0.05758):0.31075,(SDEV:0.15040,SRAT:0.15197):0.10670):0.02317):0.00549,((SCAN:0.05087,SDYS:0.04580):0.16044,(SEQU:0.12849,(SLUT:0.11198,SINF:0.09161):0.03012):0.08489):0.01105):0.00000;
(SPLU:0.06769,SSUI:0.06769):0.00000;
(SPLU:0.07103,SSUI:0.07103):0.00000;
((SDOW:0.12761,(SSUI:0.13245,((LCRE:0.05471,LLAC:0.05640):0.18839,((SPSE:0.01307,SMIT:0.00817):0.12929,((SCON:0.01299,SANG:0.01426):0.00442,SINT:0.01153):0.06623):0.06812):0.00438):0.01027):0.00391,(((STHE:0.02294,(SSAL:0.01611,SVES:0.01227):0.00990):0.10582,((SINF:0.02156,SLUT:0.02107):0.02221,SEQU:0.04536):0.05593):0.00718,((SPLU:0.11038,SENT:0.09638):0.01433,(SDEV:0.05226,SRAT:0.04891):0.05340):0.00423):0.00679,(SCAN:0.05404,(SPYO:0.01642,SDYS:0.02213):0.03180):0.10794):0.00000;
((SSUI:0.18191,(SRAT:0.18177,(SINF:0.13210,SDOW:0.13541):0.15972):0.07394):0.01512,SVES:0.26260,((SRAT:0.12022,(SDOW:0.07041,SDEV:0.07858):0.02514):0.21464,SDOW:0.32468):0.09784):0.00000;
((SSUI:0.35920,SSUI:0.29970):0.04748,((SPLU:0.06451,SVES:0.05489):0.24373,SCAN:0.26586):0.05612,SSUI:0.35977):0.00000;
((SPSE:0.00767,((SSUI:0.24750,((SPYO:0.00756,SDYS:0.00848):0.10245,SCAN:0.10862):0.24351):0.02738,SINT:0.23521):0.19189):0.00178,SPNE:0.00252,SPSE:0.00159):0.00000;
(SSUI:0.31956,SCON:0.04797,SANG:0.03883):0.00000;
(((SPLU:0.15779,(SDOW:0.11998,(SDYS:0.03053,(SCAN:0.02502,SPYO:0.02685):0.00647):0.07698):0.01665):0.01153,(((STHE:0.03156,(SSAL:0.02188,SVES:0.02079):0.00942):0.15548,(((SINF:0.00949,SLUT:0.01043):0.02813,SEQU:0.03663):0.10359,(SRAT:0.05598,SDEV:0.04512):0.06744):0.02881):0.01029,((LLAC:0.00807,LCRE:0.00840):0.19333,(SPLU:0.53384,SSUI:0.22159):0.03178):0.02365):0.01001):0.00282,SENT:0.15081,(((SMIT:0.01418,SPSE:0.00802):0.00468,SPNE:0.00963):0.05353,(SINT:0.01139,(SANG:0.00474,SCON:0.00608):0.01129):0.03906):0.08834):0.00000;
(SENT:0.31884,SSUI:0.31884):0.00000;
(SSUI:0.05033,((SSUI:0.29456,(SEQU:0.12308,SPLU:0.11047):0.23476):0.18007,SDYS:0.07553):0.02282,SPLU:0.05106):0.00000;
(SSUI:0.25339,SSUI:0.25339):0.00000;
(SMIT:0.29665,SSUI:0.29665):0.00000;
(SENT:0.30981,SSUI:0.30981):0.00000;
((SSUI:0.10901,SPLU:0.12971):0.14414,SMIT:0.00869,SPSE:0.01156):0.00000;
(((SSUI:0.41195,(SRAT:0.09526,SSAL:0.08618):0.17995):0.07333,((SPLU:0.06277,SSUI:0.08190):0.08752,SENT:0.17484):0.03272):0.16991,(SPYO:0.02658,SDYS:0.01526):0.00353,SCAN:0.01902):0.00000;
(((SANG:0.16657,SSUI:0.17451):0.01384,SENT:0.17207):0.02950,((SRAT:0.06564,SDEV:0.06573):0.14937,SSAL:0.19135):0.00676,SDOW:0.24533):0.00000;
(SPLU:0.26667,SSUI:0.26667):0.00000;
(SSUI:0.13137,SSUI:0.13137):0.00000;
(SSUI:0.00298,SSUI:0.00298):0.00000;
(SCAN:0.29998,SSUI:0.29998):0.00000;
((SPSE:0.01907,((SDYS:0.23019,(SSUI:0.34434,(SPSE:0.24666,(SMIT:0.25447,(SCON:0.03221,SANG:0.02626):0.23524):0.00872):0.06272):0.09079):0.17766,SPSE:0.05133):0.00933):0.00416,SPNE:0.01369,SMIT:0.00748):0.00000;
(((STHE:0.01805,(SSAL:0.00528,SVES:0.01015):0.00548):0.23382,((((SMIT:0.00000,SPSE:0.00000):0.01137,SPNE:0.01310):0.21373,(SINT:0.03767,(SANG:0.01901,SCON:0.02180):0.01051):0.13041):0.09700,SSUI:0.28618):0.09800):0.01313,((SPYO:0.04254,(SCAN:0.03302,SDYS:0.02244):0.00939):0.11855,((SINF:0.01069,SLUT:0.01882):0.02378,SEQU:0.03410):0.10526):0.02168,(SDOW:0.19677,((SDEV:0.02166,SRAT:0.03292):0.14601,(SENT:0.16828,SPLU:0.20563):0.00962):0.00995):0.00297):0.00000;
(SSUI:0.47232,SSAL:0.00392,SVES:0.00392):0.00000;
((SSUI:0.27218,SDOW:0.20656):0.00261,SENT:0.33450,SDEV:0.38935):0.00000;
(((((SCAN:0.02519,SPYO:0.01992):0.01929,SDYS:0.03882):0.07684,(((SINF:0.00712,SLUT:0.00924):0.01240,SEQU:0.02212):0.08618,SDOW:0.10751):0.00274):0.00357,((SSUI:0.12072,SENT:0.18186):0.00848,((LCRE:0.01192,LLAC:0.00955):0.21917,((SPSE:0.00696,(SMIT:0.00455,SPNE:0.01094):0.00126):0.05358,((SANG:0.02682,SINT:0.02931):0.00313,SCON:0.02750):0.05021):0.03327):0.01628):0.01274):0.00300,(SPLU:0.07941,(SDEV:0.03166,SRAT:0.03576):0.03944):0.00954,(STHE:0.01175,(SSAL:0.00431,SVES:0.00559):0.00710):0.07352):0.00000;
((SCAN:0.08071,(SSUI:0.26669,((SCON:0.02268,SINT:0.01399):0.10113,SPNE:0.14059):0.09309):0.20115):0.06230,SDYS:0.01552,SPYO:0.02183):0.00000;
(SCON:0.00779,SINT:0.04795,SANG:0.06691):0.00000;
((SMIT:0.00531,SPNE:0.00696):0.08812,(SPLU:0.15324,(SANG:0.02634,(SINT:0.00152,SCON:0.00211):0.02479):0.06913):0.01200,((SCAN:0.01965,SPYO:0.02726):0.04106,(SDEV:0.00972,SRAT:0.01295):0.04967):0.00988):0.00000;
(SCON:0.00335,SINT:0.10116,SANG:0.00654):0.00000;
((SANG:0.06997,SCON:0.05354):0.16289,(SRAT:0.07987,SDEV:0.07368):0.18175,SPLU:0.34511):0.00000;
(SCON:0.00782,SINT:0.01172,SANG:0.16773):0.00000;
(SCON:0.03216,SINT:0.07719,SANG:0.11879):0.00000;
(((SDOW:0.18378,(SVES:0.03332,SSAL:0.03718):0.12773):0.07819,(((SCON:0.03508,SINT:0.03459):0.01313,SANG:0.04704):0.12218,(SMIT:0.08910,(SPSE:0.01189,SPNE:0.01344):0.07306):0.11916):0.06624):0.03207,(SDEV:0.16237,((SCAN:0.03745,SDYS:0.03522):0.12113,SENT:0.15328):0.01480):0.00554,SPLU:0.16289):0.00000;
((SENT:0.14523,((LLAC:0.02162,LCRE:0.02890):0.14284,(SSUI:0.11211,((SCON:0.03548,(SANG:0.03213,SINT:0.04121):0.00478):0.05891,(SMIT:0.01249,(SPSE:0.00793,SPNE:0.01258):0.00971):0.08903):0.00784):0.00453):0.00815):0.00514,((SPLU:0.08421,(STHE:0.01908,(SSAL:0.00648,SVES:0.00856):0.00450):0.05732):0.02404,(SCAN:0.02140,(SDYS:0.00980,SPYO:0.00930):0.01366):0.08203):0.00672,(SDOW:0.10760,(((SINF:0.00542,SLUT:0.00649):0.00410,SEQU:0.00825):0.07805,(SDEV:0.02399,SRAT:0.02073):0.07116):0.00999):0.00602):0.00000;
(SCON:0.07355,(SCAN:0.02148,SDYS:0.01922):0.08461,SPLU:0.17368):0.00000;
(((SVES:0.01080,SSAL:0.01434):0.07712,(((SMIT:0.00649,SPSE:0.00605):0.00589,SPNE:0.01461):0.06281,(SANG:0.00917,(SINT:0.01073,SCON:0.00657):0.00556):0.05278):0.00601):0.08500,(((SPLU:0.02650,(SSUI:0.00288,SENT:0.00696):0.02968):0.08163,(SCAN:0.04672,(SPYO:0.03737,SDYS:0.02832):0.01371):0.08802):0.00228,(((SINF:0.00821,SLUT:0.00807):0.00848,SEQU:0.01411):0.07532,(SDEV:0.02759,SRAT:0.02849):0.06000):0.01583):0.00151,SDOW:0.15191):0.00000;
((((LLAC:0.00784,LCRE:0.00810):0.39881,(SDOW:0.15347,((SSAL:0.00881,SVES:0.01088):0.01264,STHE:0.03361):0.12130):0.01459):0.01089,(((SMIT:0.01370,SPSE:0.01159):0.12612,(SINT:0.01761,(SANG:0.01450,SCON:0.01721):0.00175):0.08214):0.03333,SSUI:0.14060):0.02516):0.00507,((SENT:0.17331,(SDEV:0.01259,SRAT:0.01093):0.11464):0.01095,(((SINF:0.00410,SLUT:0.00598):0.01960,SEQU:0.03407):0.07620,(SPYO:0.03494,(SDYS:0.02136,SCAN:0.02341):0.01465):0.09991):0.00863):0.00883,SPLU:0.17736):0.00000;
(((SENT:0.20908,(SSUI:0.29649,((((LLAC:0.04602,LCRE:0.04455):0.22238,((SPNE:0.03001,(SPSE:0.02477,SMIT:0.02349):0.00752):0.20973,((SCON:0.09185,SINT:0.09886):0.01697,SANG:0.10867):0.12296):0.08819):0.02922,((((SPSE:0.02597,SPNE:0.02194):0.01699,SMIT:0.03856):0.14324,(SINT:0.08957,(SANG:0.03051,SCON:0.02937):0.05409):0.13191):0.06038,SSUI:0.25379):0.06921):0.07335,((((STHE:0.07101,(SSAL:0.04338,SVES:0.03808):0.02848):0.19156,(SPYO:0.07745,SDYS:0.08558):0.15730):0.00749,SDOW:0.25333):0.00558,((SRAT:0.07695,SDEV:0.06578):0.12485,((SINF:0.04078,SLUT:0.03643):0.08250,SEQU:0.10003):0.09521):0.00853):0.03075):0.01618):0.03283):0.01451,(((STHE:0.05142,(SSAL:0.01597,SVES:0.02047):0.03119):0.11439,SPLU:0.18566):0.00841,(SDEV:0.05821,SRAT:0.06120):0.12198):0.00926):0.00822,((SDYS:0.09192,(SPYO:0.06491,SCAN:0.05445):0.02592):0.13569,SDOW:0.18992):0.01021,(SEQU:0.07113,(SLUT:0.02821,SINF:0.02288):0.04579):0.11178):0.00000;
((SPSE:0.26291,SCON:0.43996):0.04395,SDEV:0.21260,SVES:0.19333):0.00000;
((((((LCRE:0.00331,LLAC:0.00108):0.11448,((SMIT:0.00613,(SPSE:0.00305,SPNE:0.00226):0.00180):0.02841,(SSUI:0.04320,(SANG:0.01236,SCON:0.01258):0.02766):0.00353):0.01394):0.00657,(SENT:0.03693,(SDEV:0.03252,(SINT:0.01372,SRAT:0.01702):0.01254):0.00770):0.01084):0.00833,SDOW:0.05429):0.00730,(SCAN:0.01658,(SPYO:0.00937,SDYS:0.01042):0.00192):0.02959):0.00626,(SPLU:0.02270,(SINF:0.00732,(SLUT:0.00769,SEQU:0.00816):0.00258):0.01311):0.00374,(STHE:0.00729,(SSAL:0.00006,SVES:0.00126):0.00197):0.02192):0.00000;
((SCON:0.00403,(SCON:0.00668,((SCON:0.00109,SCON:0.00116):0.00208,(SCON:0.00317,(SCON:0.00107,(SCON:0.00002,SCON:0.00148):0.00118):0.00322):0.00238):0.00094):0.00089):0.00075,SDOW:0.17289,SCON:0.00664):0.00000;
(SEQU:0.23234,SINT:0.23234):0.00000;
(SDYS:0.38354,(SINT:0.11471,SPNE:0.13305):0.02708,SCON:0.15372):0.00000;
(SPSE:0.10268,SINT:0.10268):0.00000;
((SINT:0.23199,SCON:0.22983):0.24130,LCRE:0.07736,LLAC:0.05704):0.00000;
(SCON:0.05312,SINT:0.05312):0.00000;
(SSAL:0.21356,SINT:0.21356):0.00000;
(SCON:0.05425,SINT:0.05425):0.00000;
((SINT:0.00902,SCON:0.01017):0.08998,SANG:0.11165,(SENT:0.28511,SSUI:0.37955):0.11047):0.00000;
(SANG:0.05141,SINT:0.05141):0.00000;
(SINT:0.43502,SSUI:0.14901,SENT:0.12848):0.00000;
(SSAL:0.31581,SINT:0.31581):0.00000;
(SEQU:0.33269,(SINT:0.15330,SINT:0.24577):0.00270,SINT:0.14427):0.00000;
(SINT:0.59698,LCRE:0.11559,LLAC:0.10159):0.00000;
((LCRE:0.24638,(SINT:0.21578,SEQU:0.16250):0.03154):0.01826,LCRE:0.20360,(SPLU:0.14645,SPLU:0.14963):0.30015):0.00000;
((SINT:0.04498,SANG:0.04161):0.19090,SPNE:0.01029,SPSE:0.01585):0.00000;
(SINT:0.28678,SPLU:0.29928,(SEQU:0.11328,LCRE:0.09757):0.26190):0.00000;
(SSUI:0.09966,SINT:0.09966):0.00000;
((((((SINT:0.08001,(SANG:0.03403,SCON:0.03614):0.04348):0.05985,(SDYS:0.05696,SCAN:0.06138):0.08576):0.32410,((LLAC:0.06105,LCRE:0.06380):0.17707,SINT:0.18230):0.04665):0.00678,(SENT:0.22792,(SPLU:0.03592,SSUI:0.04874):0.15643):0.03939):0.09166,((SPNE:0.03595,(SPSE:0.02344,SMIT:0.02608):0.00760):0.19398,SSUI:0.16756):0.01964):0.02278,(SPLU:0.19570,SENT:0.20480):0.03123,(SDOW:0.18313,((SINT:0.02392,(SCON:0.00750,SANG:0.00604):0.01367):0.11905,((((SVES:0.03488,STHE:0.02915):0.00665,SSAL:0.04027):0.04339,((SINF:0.02379,SLUT:0.03082):0.01798,SEQU:0.02757):0.03489):0.05769,(SDEV:0.06039,SRAT:0.04922):0.06027):0.01262):0.04056):0.01497):0.00000;
(SCON:0.00000,SINT:0.00000):0.00000;
(SINT:0.25040,SDOW:0.26003,SINT:0.26129):0.00000;
(SDOW:0.30783,SINT:0.30783):0.00000;
(((((LLAC:0.06748,LCRE:0.07354):0.28663,(((LLAC:0.02323,LCRE:0.01717):0.19715,((SANG:0.01097,SINT:0.01407):0.04513,SCON:0.05023):0.16615):0.02392,((SINF:0.02348,SLUT:0.02376):0.22841,SDOW:0.27257):0.00554):0.06692):0.14634,(SSUI:0.10208,(STHE:0.02268,(SSAL:0.01140,SVES:0.01338):0.00365):0.10216):0.07875):0.05733,(SINT:0.04118,(SANG:0.01104,SCON:0.01092):0.02822):0.07687):0.10393,(SPSE:0.01041,SPNE:0.00953):0.00374,SMIT:0.01117):0.00000;
((SDYS:0.19385,SINF:0.10615):0.04848,SDOW:0.16442,(SINT:0.20779,(SANG:0.26242,SVES:0.20099):0.20837):0.17610):0.00000;
(SINT:0.26905,SDOW:0.23720,(SCON:0.06900,SANG:0.05463):0.13226):0.00000;
(SANG:0.01263,SENT:0.19364,SCON:0.00792):0.00000;
(SANG:0.06262,SCON:0.05115,SENT:0.56345):0.00000;
(((SDOW:0.35859,SANG:0.28654):0.19840,SSUI:0.22445):0.11344,SEQU:0.14030,SPYO:0.11011):0.00000;
(((SPLU:0.15941,((((SINF:0.06692,SLUT:0.07123):0.02885,SEQU:0.10782):0.07629,(SPSE:0.03036,(SMIT:0.01267,SPNE:0.01256):0.01213):0.19271):0.00696,((SINT:0.00000,SANG:0.00000):0.00472,SCON:0.00002):0.19338):0.02112):0.00984,(SSUI:0.24052,(SDOW:0.19616,((LLAC:0.06636,LCRE:0.07617):0.26024,((SPYO:0.05438,SDYS:0.04499):0.09480,SCAN:0.15862):0.14795):0.02990):0.01560):0.01731):0.00868,(SDEV:0.06907,SRAT:0.06284):0.13434,(SVES:0.04530,(SSAL:0.03558,STHE:0.03018):0.01191):0.17359):0.00000;
(SDEV:0.04991,(SDOW:0.06035,((STHE:0.00703,SSAL:0.00270):0.03253,((SINF:0.00519,(SLUT:0.01212,SEQU:0.00340):0.00344):0.00177,SRAT:0.01031):0.02560):0.00220):0.00138,(SPLU:0.06370,(SCAN:0.07881,((LLAC:0.02028,LCRE:0.01593):0.15201,((((SANG:0.03629,SCON:0.04415):0.00774,SINT:0.04437):0.04434,SMIT:0.07529):0.24520,((((STHE:0.00763,SSAL:0.00427):0.00754,SVES:0.02334):0.16720,(SPSE:0.08119,SSUI:0.06093):0.11673):0.02724,((SRAT:0.04714,SDEV:0.04258):0.12282,((SENT:0.12151,(SCAN:0.04497,SDYS:0.04226):0.08049):0.01135,((SPSE:0.01458,(SMIT:0.00495,SPNE:0.00406):0.00430):0.06270,(SANG:0.01538,(SINT:0.01346,SCON:0.01188):0.00401):0.06408):0.05553):0.01661):0.05650):0.09511):0.09361):0.11649):0.00405):0.01336):0.00000;
(SANG:0.04168,SCON:0.04074,SINT:0.08290):0.00000;
(SANG:0.01358,SCON:0.06072,SINT:0.13268):0.00000;
(SANG:0.07222,SCON:0.09097,SINT:0.09856):0.00000;
((SSUI:0.32758,((SANG:0.01049,SINT:0.00772):0.06200,SCON:0.06949):0.18157):0.04757,(((SMIT:0.01846,SPSE:0.01620):0.00199,SPNE:0.01946):0.17994,(SANG:0.03010,(SINT:0.00761,SCON:0.01032):0.02175):0.17551):0.01744,((SSAL:0.03393,SVES:0.04472):0.02438,STHE:0.06915):0.16447):0.00000;
(SANG:0.05938,SCON:0.00643,SINT:0.00592):0.00000;
(SCON:0.00198,SANG:0.00198):0.00000;
(SCON:0.00414,SANG:0.00414):0.00000;
((((SMIT:0.03076,(SPSE:0.03141,SPNE:0.02560):0.01111):0.13429,(SANG:0.01741,SCON:0.01490):0.14485):0.02326,((((STHE:0.03163,SVES:0.03043):0.01184,SSAL:0.04546):0.12541,SDOW:0.15518):0.01653,((SENT:0.22372,SPLU:0.20561):0.00885,(SRAT:0.07711,SDEV:0.07528):0.11952):0.00477):0.00880):0.00171,(SCAN:0.07199,(SPYO:0.01808,SDYS:0.02626):0.05044):0.13553,((LLAC:0.08115,LCRE:0.07896):0.26282,SSUI:0.29610):0.08793):0.00000;
(SCON:0.03800,SANG:0.03800):0.00000;
(SCON:0.00232,SANG:0.00232):0.00000;
((SPSE:0.04117,(((SANG:0.00083,SCON:0.03392):0.13369,(SINF:0.03351,(SEQU:0.00767,SLUT:0.00382):0.01899):0.14864):0.01898,((SDEV:0.02036,SRAT:0.01766):0.01270,(SEQU:0.00571,SLUT:0.00568):0.01478):0.18777):0.05563):0.00628,(SANG:0.00000,SINT:0.00000):0.03701,(SSAL:0.00000,SVES:0.00000):0.01909):0.00000;
((SANG:0.03853,SCON:0.04401):0.36901,SDEV:0.02293,SRAT:0.02735):0.00000;
((SANG:0.03324,SCON:0.02281):0.62882,SDEV:0.03906,SRAT:0.03711):0.00000;
(SINT:0.01254,SANG:0.01254):0.00000;
((SANG:0.01178,SCON:0.01849):0.26908,SVES:0.25929,SSAL:0.34170):0.00000;
(SINT:0.08393,SANG:0.08393):0.00000;
(SCON:0.09006,SANG:0.09006):0.00000;
(SANG:0.02543,SDOW:0.31288,SINT:0.04365):0.00000;
(SANG:0.05561,SCON:0.03626,SINT:0.06873):0.00000;
(SANG:0.08972,(STHE:0.04261,SVES:0.08197):0.01869,(LCRE:0.29260,SPLU:0.30707):0.27875):0.00000;
(SANG:0.06310,SCON:0.29599,SINT:0.12382):0.00000;
(SANG:0.14662,SCON:0.04273,SINT:0.02883):0.00000;
((SSUI:0.07632,((LCRE:0.00835,LLAC:0.00925):0.10426,((SINT:0.19780,SCAN:0.21073):0.13336,(((((SINF:0.04976,(SLUT:0.00462,SEQU:0.00554):0.04221):0.01769,(((STHE:0.02264,(SSAL:0.00419,SVES:0.00175):0.02331):0.02025,(SPSE:0.01969,(SMIT:0.00994,SPNE:0.01186):0.00793):0.03067):0.01881,((SINT:0.00537,SCON:0.00443):0.01213,SANG:0.01865):0.05275):0.00692):0.00543,(SDEV:0.03056,SRAT:0.02755):0.04354):0.01931,(SSUI:0.08586,SDOW:0.07886):0.00364):0.01508,(SPYO:0.07290,SDYS:0.07008):0.02650):0.18306):0.13869):0.03082):0.00442,(((SMIT:0.00603,(SPSE:0.00961,SPNE:0.00910):0.00423):0.04565,(SINT:0.01399,(SANG:0.01078,SCON:0.01132):0.00362):0.03652):0.02135,((SPYO:0.03602,(SCAN:0.02218,SDYS:0.01960):0.00716):0.04642,(SENT:0.08126,((SDEV:0.01158,SRAT:0.01044):0.05505,(((STHE:0.01905,(SSAL:0.00693,SVES:0.00832):0.00706):0.04308,SPLU:0.06717):0.00738,SDOW:0.06878):0.00222):0.00433):0.00460):0.00470):0.00123,((SINF:0.01156,SLUT:0.00894):0.01274,SEQU:0.01900):0.04781):0.00000;
((((SSAL:0.00219,(STHE:0.00608,SVES:0.00329):0.00125):0.05195,((SINF:0.00526,SLUT:0.01271):0.01079,SEQU:0.01493):0.03413):0.00280,(((SSUI:0.04791,SENT:0.04044):0.01039,(SPLU:0.04253,(SPYO:0.03834,(SCAN:0.00735,SDYS:0.00693):0.01916):0.03602):0.00537):0.00629,(((LLAC:0.12268,LCRE:0.10417):0.24007,(SDYS:0.29440,((SCON:0.04812,SANG:0.04120):0.06068,SENT:0.09538):0.11729):0.01382):0.19075,((SMIT:0.01112,(SPSE:0.00521,SPNE:0.01019):0.00738):0.03780,((SANG:0.00396,SINT:0.01083):0.00216,SCON:0.00770):0.03730):0.05911):0.03093):0.01087):0.00233,(SDEV:0.01215,SRAT:0.01039):0.02946,SDOW:0.03968):0.00000;
(SANG:0.02939,SCON:0.03084,SINT:0.10258):0.00000;
((((SINT:0.03400,SANG:0.03357):0.10371,SCON:0.12496):0.10710,LLAC:0.25434):0.08947,(SLUT:0.01779,SINF:0.03156):0.29823,SANG:0.36507):0.00000;
((((SPLU:0.29396,(SENT:0.19852,(SDEV:0.06469,SRAT:0.06615):0.13150):0.01533):0.01777,(((SINT:0.06366,SANG:0.06017):0.01947,SCON:0.07326):0.09758,((SPNE:0.03287,SPSE:0.01180):0.10020,SMIT:0.10769):0.05201):0.08056):0.00677,(SDOW:0.24819,((LLAC:0.02870,LCRE:0.03266):0.42088,((STHE:0.03050,SVES:0.03626):0.00863,SSAL:0.04202):0.15588):0.04084):0.00715):0.00217,((SINF:0.01115,SLUT:0.01916):0.04396,SEQU:0.06163):0.11540,SSUI:0.22935):0.00000;
((SANG:0.05656,SCON:0.04245):0.20558,SENT:0.30587,(SCON:0.01204,SANG:0.01043):0.43769):0.00000;
(SCON:0.04732,SANG:0.04732):0.00000;
(SVES:0.36316,SANG:0.36316):0.00000;
(((SSUI:0.03581,(SCAN:0.00686,SPYO:0.00468):0.02937):0.02781,((SDOW:0.04607,(SDEV:0.00979,SRAT:0.01500):0.02307):0.04266,((SPLU:0.00580,SSUI:0.00268):0.08409,(SINT:0.12123,(SPNE:0.31826,(SANG:0.08009,SEQU:0.07710):0.09237):0.12243):0.01346):0.01272):0.01358):0.01261,((SINF:0.00579,SLUT:0.00531):0.02072,SANG:0.02163):0.03751,((SPNE:0.00282,SMIT:0.00457):0.00440,SPSE:0.00968):0.07064):0.00000;
(SPSE:0.15596,SANG:0.15596):0.00000;
(SPSE:0.18322,SANG:0.18322):0.00000;
(SPSE:0.21856,SANG:0.21856):0.00000;
(LLAC:0.57169,SANG:0.19934,SPSE:0.23066):0.00000;
(SPSE:0.17491,SANG:0.17491):0.00000;
(LLAC:0.31759,SANG:0.31759):0.00000;
((SANG:0.13487,LLAC:0.14888):0.26808,SDYS:0.35376,SENT:0.36872):0.00000;
((SANG:0.24052,SDYS:0.19074):0.10700,SENT:0.32479,LLAC:0.37734):0.00000;
((SMIT:0.36887,((SDYS:0.33938,SANG:0.23559):0.03049,(SPNE:0.29132,SPLU:0.26062):0.18663):0.02773):0.02359,SPLU:0.22974,SANG:0.24709):0.00000;
(SENT:0.23971,SANG:0.23971):0.00000;
(SENT:0.09203,SANG:0.09203):0.00000;
(SENT:0.18922,SANG:0.18922):0.00000;
((SANG:0.14087,(((SSAL:0.03949,(STHE:0.02025,SVES:0.01463):0.02454):0.06008,((SINF:0.01725,SLUT:0.01951):0.01016,SEQU:0.02662):0.07426):0.00843,(SDEV:0.04783,SRAT:0.05262):0.05588):0.01949):0.00843,(SSUI:0.12326,SDOW:0.12313):0.01875,(LLAC:0.08247,LCRE:0.08995):0.14569):0.00000;
(((((SDYS:0.07417,SINF:0.08556):0.06462,SANG:0.19991):0.03171,SDYS:0.17058):0.06589,(SSUI:0.00984,SSUI:0.01516):0.01580):0.01137,SCAN:0.06696,SPLU:0.03194):0.00000;
(SANG:0.08859,SCON:0.04359,SINT:0.01078):0.00000;
(SPYO:0.27492,SANG:0.27492):0.00000;
(SPLU:0.22864,SANG:0.22864):0.00000;
(((SINF:0.00589,SLUT:0.00627):0.00477,SEQU:0.00437):0.01910,(SDOW:0.03459,SRAT:0.03655):0.01036,((((STHE:0.00484,SSAL:0.00021):0.00098,SVES:0.00761):0.02474,SDEV:0.03948):0.00268,(((SCAN:0.00757,SPYO:0.03320):0.00198,SDYS:0.01465):0.01721,(((SMIT:0.00242,(SPSE:0.00205,SPNE:0.00299):0.00061):0.02329,((SSUI:0.00223,SPLU:0.00382):0.02555,SENT:0.04136):0.00565):0.00407,((LCRE:0.00600,LLAC:0.01151):0.11435,((SINT:0.01077,SCON:0.01299):0.02074,SANG:0.02958):0.01658):0.00655):0.00428):0.00515):0.00090):0.00000;
(((SLUT:0.15923,(SRAT:0.00252,SRAT:0.00035):0.13939):0.05251,(SPNE:0.00077,SENT:0.00109):0.51894):0.01099,(SLUT:0.11311,SPNE:0.09607):0.08834,SSUI:0.22132):0.00000;
(((SSUI:0.07848,SENT:0.08633):0.03181,((((SMIT:0.00198,SPSE:0.00054):0.00824,SPNE:0.00182):0.08253,(SANG:0.01826,(SINT:0.00238,SCON:0.00406):0.03415):0.07208):0.01994,SPNE:0.56379):0.04366):0.02912,(SCAN:0.01890,SDYS:0.01875):0.09017,SPLU:0.06992):0.00000;
(SCAN:0.25069,SPNE:0.25069):0.00000;
(((SPYO:0.02338,(SCAN:0.01133,SDYS:0.00728):0.00817):0.01936,((STHE:0.01141,(SSAL:0.00488,SVES:0.00381):0.00103):0.02687,(SMIT:0.00760,(SPSE:0.00529,SPNE:0.00732):0.00223):0.01954):0.01022):0.00260,(((SINT:0.01298,(SANG:0.01246,SCON:0.02498):0.00595):0.02024,((SINF:0.00145,SLUT:0.00523):0.00199,SEQU:0.00351):0.02368):0.00658,(SDOW:0.04077,(SDEV:0.04132,SRAT:0.02629):0.02181):0.00379):0.00434,((SSUI:0.01620,SPLU:0.03439):0.03011,((LCRE:0.00809,LLAC:0.00964):0.14822,SENT:0.09937):0.00734):0.00312):0.00000;
(SPSE:0.00602,SPNE:0.00602):0.00000;
(((((SINF:0.01399,SLUT:0.01576):0.02955,SEQU:0.03723):0.02099,(SDOW:0.10350,((SSUI:0.08348,(SDEV:0.01710,SRAT:0.01949):0.03477):0.04584,((SPNE:0.03623,(SANG:0.02497,SCON:0.02282):0.01192):0.14918,(SRAT:0.00553,SDEV:0.00407):0.36678):0.07767):0.04245):0.02288):0.02440,(STHE:0.01365,(SSAL:0.00340,SVES:0.00191):0.00407):0.04309):0.00383,(SCAN:0.00376,(SPYO:0.00175,SDYS:0.00357):0.00067):0.02880,(SPLU:0.02642,SENT:0.04974):0.00705):0.00000;
(SPSE:0.13277,SPNE:0.13277):0.00000;
(SEQU:0.17968,(SPYO:0.20445,((SANG:0.19683,SENT:0.22229):0.08319,SPNE:0.25733):0.14571):0.03715,SPLU:0.15068):0.00000;
(SPNE:0.00000,(SPSE:0.00148,((SSAL:0.00538,SVES:0.01255):0.04110,(SINF:0.03297,SEQU:0.02915):0.09894):0.03678):0.00128,SMIT:0.00000):0.00000;
(((SSUI:0.23848,(((SPNE:0.00000,SPSE:0.00000):0.07652,SMIT:0.05034):0.12255,(SANG:0.03233,(SINT:0.00949,SCON:0.01372):0.00968):0.14309):0.00842):0.03255,((SENT:0.23084,((SCAN:0.01510,SPYO:0.01092):0.02566,SDYS:0.02825):0.14125):0.02812,(((SINF:0.00708,SLUT:0.00399):0.01971,SEQU:0.03575):0.08917,(SDEV:0.03628,SRAT:0.03540):0.09661):0.02685):0.01636):0.00602,((SSAL:0.03230,(SVES:0.04079,STHE:0.03389):0.00902):0.14324,SDOW:0.17654):0.01059,((LLAC:0.01413,LCRE:0.00408):0.36701,SPLU:0.24456):0.01427):0.00000;
((((SSAL:0.02161,(STHE:0.02937,SVES:0.01915):0.00199):0.14188,((SENT:0.22575,(SDEV:0.06297,SRAT:0.06428):0.10236):0.02055,((LLAC:0.05677,LCRE:0.05380):0.20468,(SSUI:0.15315,(((SINT:0.00973,SCON:0.01527):0.01977,SANG:0.02609):0.07556,(SPNE:0.01671,(SMIT:0.01515,SPSE:0.01192):0.00599):0.09744):0.05413):0.01254):0.01999):0.00664):0.00679,(SPLU:0.15014,SDOW:0.14516):0.02573):0.00562,(SPYO:0.11035,(SDYS:0.06295,SCAN:0.06615):0.01656):0.10032,((SINF:0.01176,SLUT:0.01489):0.03332,SEQU:0.03729):0.08517):0.00000;
(((SDOW:0.08294,((((SPLU:0.03160,SSUI:0.01491):0.12536,((SMIT:0.00325,(SPSE:0.00000,SPNE:0.00000):0.00409):0.03424,(SANG:0.03617,SINT:0.04366):0.04341):0.11913):0.04031,(SPYO:0.06663,(SDYS:0.01346,SCAN:0.02385):0.01515):0.15145):0.00894,SENT:0.12987):0.06120):0.02107,(STHE:0.02683,(SSAL:0.00000,SVES:0.00000):0.02146):0.03434):0.01057,SRAT:0.04830,SDEV:0.07939):0.00000;
((SPSE:0.00909,SPNE:0.01420):0.01562,SDOW:0.28636,SMIT:0.02951):0.00000;
(SPNE:0.00000,SMIT:0.00000,SVES:0.01887):0.00000;
(SPNE:0.01238,SCAN:0.13873,SMIT:0.00848):0.00000;
(((SINF:0.16780,(((SMIT:0.02756,SPSE:0.03156):0.01234,SPNE:0.04589):0.25394,SSUI:0.20722):0.08045):0.12674,SCAN:0.05056):0.01659,SDYS:0.02282,SPYO:0.03089):0.00000;
(SPYO:0.02352,SPNE:0.02352):0.00000;
((SRAT:0.32966,SPNE:0.29686):0.02541,(SVES:0.02261,SSAL:0.02649):0.25313,LCRE:0.41829):0.00000;
(SPNE:0.00001,SPSE:0.01436,SPSE:0.01147):0.00000;
((((SINF:0.07095,SEQU:0.06957):0.05467,(((SPNE:0.00000,SPSE:0.00000):0.01708,SMIT:0.01025):0.12288,(STHE:0.00434,(SVES:0.00403,SSAL:0.00203):0.00122):0.09026):0.02300):0.01033,(SDEV:0.05642,SRAT:0.05615):0.09659):0.00432,SDOW:0.13446,(((LLAC:0.05379,LCRE:0.04308):0.14768,(((SDOW:0.14766,((SSAL:0.08551,((SINF:0.01010,SLUT:0.01847):0.05000,SEQU:0.05582):0.02713):0.01193,(SDEV:0.09241,SRAT:0.08096):0.01796):0.03333):0.11677,(LLAC:0.05226,LCRE:0.06323):0.22463):0.25430,(LCRE:0.12171,LLAC:0.10852):0.20406):0.06604):0.01836,(SPYO:0.03456,(SCAN:0.02360,SDYS:0.02691):0.00594):0.17387):0.03245):0.00000;
((((SINT:0.03522,(SANG:0.02074,SCON:0.05388):0.04874):0.03938,SSUI:0.08668):0.01084,(((SPSE:0.00808,(SMIT:0.00045,SPNE:0.00143):0.00881):0.05397,SANG:0.07549):0.02326,(SDOW:0.04759,((((STHE:0.01589,(SSAL:0.00264,SVES:0.00685):0.00304):0.03345,(SPLU:0.02974,SENT:0.03276):0.01626):0.01232,((SINF:0.00165,(SLUT:0.00000,SEQU:0.00000):0.00394):0.03747,(SCAN:0.01833,SDYS:0.03754):0.01331):0.00943):0.00570,(SDEV:0.03213,SRAT:0.03142):0.02153):0.00850):0.00956):0.01029):0.00233,((LCRE:0.00000,LLAC:0.00000):0.10468,(((((((STHE:0.03010,(SSAL:0.01541,SVES:0.02291):0.00892):0.07852,SPLU:0.14114):0.04777,(SDOW:0.12886,((SDEV:0.06347,SRAT:0.06629):0.02610,((SINF:0.00831,SEQU:0.00600):0.02798,SLUT:0.03201):0.04913):0.02207):0.02719):0.00365,(SCAN:0.07787,(SDYS:0.03073,SPYO:0.03594):0.07112):0.06216):0.03942,(((SANG:0.06051,SINT:0.07724):0.01038,SCON:0.06409):0.07231,(SMIT:0.01254,(SPSE:0.00086,SPNE:0.00642):0.01110):0.15297):0.04692):0.00619,SENT:0.21571):0.02749,((LCRE:0.01425,LLAC:0.01288):0.20375,SSUI:0.24710):0.00587):0.40000):0.03177,SPYO:0.06936):0.00000;
(SPNE:0.00446,SPSE:0.00136,SMIT:0.03661):0.00000;
((SPNE:0.01011,SDEV:0.25678):0.00822,SPSE:0.01208,SMIT:0.00375):0.00000;
((((SPNE:0.03297,SPSE:0.02811):0.00971,SMIT:0.04661):0.21476,(((SVES:0.03709,STHE:0.03879):0.06986,SSAL:0.11069):0.17480,(SENT:0.25476,(SPYO:0.18058,SCAN:0.16550):0.12810):0.00442):0.00796):0.00599,(SEQU:0.17360,(SLUT:0.05675,SINF:0.05350):0.10518):0.09904,(((SINT:0.07635,(SANG:0.06593,SCON:0.07436):0.00850):0.17971,(SDOW:0.20896,(SDEV:0.06781,SRAT:0.06240):0.12697):0.03517):0.00522,(SSUI:0.22461,SPLU:0.20887):0.01034):0.01919):0.00000;
(SPNE:0.05134,SPSE:0.04790,SMIT:0.06862):0.00000;
(SPNE:0.01122,(SPSE:0.00869,SENT:0.11243):0.00202,SMIT:0.00614):0.00000;
((LCRE:0.00458,LLAC:0.00860):0.55638,(SINT:0.01559,SCON:0.00848):0.00758,SANG:0.02318):0.00000;
((((LCRE:0.05729,LLAC:0.06141):0.31569,(((((SPSE:0.02604,(SMIT:0.01038,SPNE:0.00805):0.00367):0.06177,(SANG:0.05321,(SINT:0.01428,SCON:0.01192):0.03892):0.02052):0.01262,SSUI:0.08226):0.01835,((SLUT:0.00670,(SINF:0.00285,SEQU:0.00010):0.00213):0.05876,SRAT:0.05069):0.01377):0.01002,((SCAN:0.02133,SDYS:0.01674):0.02553,SPYO:0.04695):0.06949):0.00666):0.00723,SDOW:0.10140):0.00494,((SSAL:0.01859,(STHE:0.02221,SVES:0.02185):0.00869):0.05480,(SPLU:0.04800,SDEV:0.06228):0.01290):0.01154,SENT:0.08531):0.00000;
(LLAC:0.14317,LCRE:0.14317):0.00000;
(LLAC:0.09200,LCRE:0.09200):0.00000;
((STHE:0.03309,(SSAL:0.00324,SVES:0.00175):0.01774):0.06904,(SPLU:0.09641,(SENT:0.13318,(LCRE:0.00479,LLAC:0.00469):0.30701):0.01679):0.00464,((SSUI:0.10316,(((SPSE:0.00755,SPNE:0.00431):0.00486,SMIT:0.00594):0.08939,(SINT:0.03270,(SANG:0.02540,SCON:0.02045):0.00297):0.04480):0.05066):0.01014,(SDOW:0.08726,((SPYO:0.02321,(SDYS:0.01826,SCAN:0.03213):0.00144):0.05976,(((SINF:0.00314,SLUT:0.00593):0.01359,SEQU:0.02417):0.03701,(SRAT:0.02925,SDEV:0.03138):0.04923):0.00693):0.00834):0.00500):0.00278):0.00000;
(LLAC:0.04289,LCRE:0.04289):0.00000;
(LLAC:0.00628,LCRE:0.00628):0.00000;
((SDOW:0.25529,(((SPNE:0.02379,(SPSE:0.02324,SMIT:0.01946):0.00342):0.17960,(SANG:0.05240,(SCON:0.02825,SINT:0.03392):0.02695):0.12292):0.04053,(LCRE:0.03869,LLAC:0.03366):0.31419):0.00527):0.00559,(SSUI:0.21680,(((SPYO:0.12615,(SCAN:0.08656,SDYS:0.08125):0.02424):0.09568,(((SINF:0.01634,SLUT:0.02122):0.04029,SEQU:0.05989):0.05643,(SDEV:0.04572,SRAT:0.04072):0.07721):0.04674):0.03764,((STHE:0.02978,(SSAL:0.01155,SVES:0.01745):0.01492):0.16846,SPLU:0.21324):0.01559):0.01093):0.00517,SENT:0.23390):0.00000;
(LCRE:0.03112,LLAC:0.03403,SDOW:0.61694):0.00000;
(LLAC:0.02486,LCRE:0.02486):0.00000;
(LLAC:0.09041,LCRE:0.09041):0.00000;
((((SPLU:0.14665,(SENT:0.12430,((SINF:0.32442,((LCRE:0.00957,LLAC:0.01084):0.12898,(SSUI:0.10748,(((SMIT:0.00258,(SPSE:0.00041,SPNE:0.00163):0.00353):0.06669,(SINT:0.03238,(SANG:0.02362,SCON:0.02466):0.00525):0.03228):0.03135,(SPLU:0.10239,((SENT:0.09474,SDOW:0.08137):0.00756,((SDEV:0.01530,SRAT:0.01867):0.06399,(((SINF:0.00413,SLUT:0.00494):0.01559,SEQU:0.02398):0.02018,(SSAL:0.01126,(STHE:0.00350,SVES:0.00406):0.00816):0.03029):0.03485):0.01052):0.00631):0.00810):0.00418):0.03771):0.22003):0.14578,(LLAC:0.03755,LCRE:0.03155):0.13433):0.03686):0.00682):0.01133,(SDOW:0.07770,(SPYO:0.07134,(SCAN:0.04548,SDYS:0.03548):0.01746):0.06023):0.00744):0.00818,(SSUI:0.06591,(SDEV:0.01514,SRAT:0.02495):0.07326):0.00682):0.00417,((STHE:0.01924,(SSAL:0.00747,SVES:0.00769):0.00578):0.04373,((SINF:0.00334,SLUT:0.00322):0.01943,SEQU:0.01405):0.04178):0.02903,((SMIT:0.06886,(SPSE:0.01271,SPNE:0.01091):0.05139):0.01160,(SINT:0.04957,(SANG:0.01889,SCON:0.02448):0.00484):0.05101):0.02457):0.00000;
(LLAC:0.03923,LCRE:0.03923):0.00000;
(LLAC:0.02477,LCRE:0.02477):0.00000;
(LLAC:0.00849,LCRE:0.00849):0.00000;
(LLAC:0.04207,LCRE:0.04207):0.00000;
(LLAC:0.06816,LCRE:0.06816):0.00000;
(LCRE:0.02156,LLAC:0.02481,SCAN:0.56101):0.00000;
(((LCRE:0.06994,LLAC:0.06675):0.34263,(SRAT:0.11218,SDEV:0.08925):0.12720):0.08841,SEQU:0.15850,(SLUT:0.01129,SINF:0.00936):0.10343):0.00000;
(LLAC:0.15105,LCRE:0.15105):0.00000;
(LCRE:0.02204,LLAC:0.03852,(SEQU:0.48757,SRAT:0.21920):0.13379):0.00000;
(LLAC:0.01841,LCRE:0.01841):0.00000;
(((LCRE:0.00925,LLAC:0.00919):0.19084,(((SPSE:0.00651,SPNE:0.02697):0.04083,SSUI:0.06896):0.00645,(SDEV:0.01117,SRAT:0.01739):0.02722):0.00398):0.00576,(((SINF:0.00129,SLUT:0.00066):0.00106,SEQU:0.00235):0.01635,SDOW:0.03166):0.00241,((STHE:0.00242,SSAL:0.00193):0.00230,SVES:0.00831):0.03690):0.00000;
((SENT:0.14977,(SSUI:0.14650,(((SSAL:0.13197,((SMIT:0.00949,SPNE:0.00946):0.00278,SPSE:0.00763):0.12312):0.01453,(SEQU:0.03786,(SLUT:0.01271,SINF:0.01572):0.03171):0.08876):0.13702,(LCRE:0.01263,LLAC:0.02115):0.20386):0.08132):0.02052):0.01704,SDEV:0.10618,(SPLU:0.10342,SDYS:0.14134):0.01334):0.00000;
(LLAC:0.01014,LCRE:0.01014):0.00000;
(LLAC:0.05627,LCRE:0.05627):0.00000;
(LLAC:0.02947,LCRE:0.02947):0.00000;
(LLAC:0.02930,LCRE:0.02930):0.00000;
(LLAC:0.16963,LCRE:0.16963):0.00000;
(SENT:0.31789,LCRE:0.31789):0.00000;
(LLAC:0.03898,LCRE:0.03898):0.00000;
(LLAC:0.06414,LCRE:0.06414):0.00000;
(LLAC:0.04638,LCRE:0.04638):0.00000;
(((((SSAL:0.00947,SVES:0.00908):0.00433,STHE:0.01634):0.16921,(SENT:0.23150,((((SINT:0.05771,(SCON:0.02659,SANG:0.02786):0.02237):0.09315,(SPNE:0.01442,(SPSE:0.00476,SMIT:0.00454):0.00799):0.17249):0.00916,SSUI:0.18152):0.03869,(LCRE:0.04720,LLAC:0.04402):0.28593):0.01105):0.01756):0.00746,((SDYS:0.05561,(SCAN:0.04233,SPYO:0.05159):0.01708):0.09611,((SINF:0.00740,SLUT:0.01109):0.01464,SEQU:0.02316):0.11643):0.02092):0.00398,((SRAT:0.03214,SDEV:0.02315):0.10027,SDOW:0.14929):0.01977,SPLU:0.15397):0.00000;
(LCRE:0.07225,LLAC:0.08474,LCRE:0.57779):0.00000;
(((SENT:0.19380,(((SMIT:0.04049,(SPSE:0.02765,SPNE:0.03030):0.00432):0.18051,(SINT:0.07348,(SANG:0.06156,SCON:0.06148):0.00960):0.11591):0.01441,((SPYO:0.14354,(SCAN:0.08254,SDYS:0.09023):0.03162):0.06936,(LCRE:0.11169,LLAC:0.11280):0.20714):0.01877):0.00787):0.01386,((SINF:0.04832,SLUT:0.04220):0.03541,SEQU:0.07383):0.09414):0.00512,(((SSAL:0.05078,(STHE:0.02787,SVES:0.01946):0.04494):0.10742,(SPLU:0.13946,SDOW:0.15822):0.01330):0.00870,(SDEV:0.04617,SRAT:0.05409):0.11161):0.00804,SSUI:0.18831):0.00000;
(LLAC:0.16887,LCRE:0.16887):0.00000;
((SPSE:0.02178,((((LCRE:0.07209,LLAC:0.08066):0.23607,(STHE:0.02422,(SSAL:0.01258,SVES:0.01197):0.00747):0.30689):0.20911,(LCRE:0.00918,LLAC:0.01312):0.20308):0.03358,(SANG:0.05503,SINT:0.07123):0.10315):0.10030):0.01054,SPNE:0.01898,SMIT:0.02486):0.00000;
(((LCRE:0.05388,LLAC:0.04569):0.24363,((SDEV:0.06535,SRAT:0.09024):0.14127,(SENT:0.21694,(((SINF:0.00941,SLUT:0.00415):0.06247,SEQU:0.06213):0.07415,(SCAN:0.10593,(SPYO:0.12165,SDYS:0.09228):0.01111):0.06377):0.03404):0.00968):0.00837):0.02746,((((SMIT:0.01870,SPSE:0.02407):0.01852,SPNE:0.04768):0.14062,((SANG:0.04407,SCON:0.05034):0.02632,SINT:0.09950):0.10370):0.01305,((STHE:0.06141,(SSAL:0.04124,SVES:0.04980):0.01145):0.12957,(SPLU:0.11749,SSUI:0.13520):0.04745):0.00769):0.00591,SDOW:0.17782):0.00000;
(LLAC:0.03383,LCRE:0.03383):0.00000;
((((SDEV:0.00314,SRAT:0.00485):0.07469,(SENT:0.11058,((SSUI:0.15106,(((SMIT:0.00041,SPSE:0.00896):0.00081,SPNE:0.00454):0.07738,(SINT:0.02340,(SANG:0.00879,SCON:0.00070):0.01050):0.04386):0.02660):0.01729,(LCRE:0.00381,LLAC:0.01168):0.19728):0.02091):0.00626):0.01823,(SCAN:0.02372,(SDYS:0.00162,SPYO:0.01415):0.02822):0.04284):0.01463,(SPLU:0.05862,SDOW:0.03363):0.00825,((SSAL:0.01601,(STHE:0.00024,SVES:0.00109):0.00388):0.04763,((SINF:0.00237,SLUT:0.00832):0.00300,SEQU:0.00770):0.06968):0.00435):0.00000;
(LLAC:0.01377,LCRE:0.01377):0.00000;
(LLAC:0.09228,LCRE:0.09228):0.00000;
(LLAC:0.02612,LCRE:0.02612):0.00000;
((((SSUI:0.04325,(LCRE:0.00331,LLAC:0.00245):0.18404):0.00429,(SANG:0.00914,(SINT:0.00471,SCON:0.00470):0.00982):0.02649):0.04130,SPNE:0.00377):0.00153,SPSE:0.00000,SMIT:0.00000):0.00000;
((SPLU:0.16885,((SDEV:0.07058,SRAT:0.08816):0.09770,(LCRE:0.07782,LLAC:0.06009):0.17282):0.00895):0.00173,(((SENT:0.15127,(SINF:0.04819,(SLUT:0.02741,SEQU:0.01999):0.02332):0.07961):0.01443,SDOW:0.16957):0.00201,((SCAN:0.05862,(SPYO:0.03360,SDYS:0.03658):0.02200):0.09394,((STHE:0.03124,SVES:0.04028):0.00553,SSAL:0.03152):0.08775):0.01416):0.00439,((((SMIT:0.02425,SPSE:0.01355):0.00415,SPNE:0.02782):0.12224,(SANG:0.05505,(SINT:0.00723,SCON:0.00748):0.06577):0.06939):0.02886,SSUI:0.16357):0.01397):0.00000;
((SENT:0.16920,(SDEV:0.02725,SRAT:0.02661):0.10074):0.00868,((((SINF:0.01498,SLUT:0.02785):0.02054,SEQU:0.04325):0.12236,((SSAL:0.02258,(STHE:0.02881,SVES:0.01749):0.00375):0.13720,((SCAN:0.02449,SPYO:0.02831):0.00174,SDYS:0.01657):0.12471):0.01375):0.00842,(SPLU:0.19334,((LCRE:0.06084,LLAC:0.06243):0.29844,(SSUI:0.22012,(((SMIT:0.01834,SPSE:0.02500):0.00879,SPNE:0.03425):0.09117,(SINT:0.03128,(SANG:0.02908,SCON:0.02795):0.00399):0.12192):0.05524):0.01649):0.01175):0.02334):0.00436,SDOW:0.19653):0.00000;
(LLAC:0.07485,LCRE:0.07485):0.00000;
(LCRE:0.03630,LLAC:0.02425,SSUI:0.39804):0.00000;
(LLAC:0.00622,LCRE:0.00622):0.00000;
(LLAC:0.00844,LCRE:0.00844):0.00000;
(LLAC:0.05097,LCRE:0.05097):0.00000;
(LLAC:0.05768,LCRE:0.05768):0.00000;
((LCRE:0.06793,LLAC:0.06081):0.57433,LCRE:0.02969,LLAC:0.02683):0.00000;
(LLAC:0.08706,LCRE:0.08706):0.00000;
(LLAC:0.08824,LCRE:0.08824):0.00000;
((SDOW:0.08745,(((SSUI:0.02967,SPLU:0.02866):0.03746,SENT:0.09042):0.01288,((((SMIT:0.02286,(SPSE:0.00734,SPNE:0.01296):0.00814):0.05389,(SINT:0.06424,(SANG:0.07552,SCON:0.05687):0.01262):0.04646):0.06196,(LCRE:0.06178,LLAC:0.06296):0.17431):0.03599,(SCAN:0.02896,(SPYO:0.01413,SDYS:0.02046):0.01230):0.07184):0.01462):0.00683):0.00328,(SDEV:0.05391,SRAT:0.04724):0.01821,((SSAL:0.02273,(STHE:0.01198,SVES:0.01665):0.02075):0.03845,((SINF:0.02314,SLUT:0.02916):0.00955,SEQU:0.02686):0.03985):0.00422):0.00000;
(LLAC:0.06761,LCRE:0.06761):0.00000;
(((SSAL:0.02054,(STHE:0.01736,SVES:0.01040):0.00467):0.06678,(SENT:0.09549,((((SMIT:0.00749,(SPSE:0.00361,SPNE:0.00519):0.00184):0.03711,(SINT:0.01949,(SANG:0.00754,SCON:0.00769):0.01200):0.03796):0.03861,SSUI:0.15848):0.03743,((SDOW:0.10051,(SENT:0.09445,((SSAL:0.07965,(SDEV:0.01806,SRAT:0.01952):0.06261):0.00109,(SINT:0.01912,(SANG:0.01419,SCON:0.01929):0.00486):0.06463):0.00862):0.00649):0.11578,(LCRE:0.01496,LLAC:0.01255):0.18335):0.24231):0.07480):0.01830):0.00206,(SDOW:0.07800,(SDEV:0.05045,SRAT:0.03762):0.02765):0.00836,((SPLU:0.02002,(SSUI:0.00202,SENT:0.00494):0.01542):0.04979,(((SINF:0.00793,SLUT:0.00519):0.00298,SEQU:0.00781):0.04787,(SCAN:0.02102,(SPYO:0.00492,SDYS:0.00692):0.01052):0.04147):0.00895):0.00683):0.00000;
(LLAC:0.07251,LCRE:0.07251):0.00000;
((LCRE:0.01276,LLAC:0.01630):0.32977,SCAN:0.00830,SDYS:0.00951):0.00000;
((LCRE:0.02826,LLAC:0.02127):0.46568,SCAN:0.03531,SDYS:0.03983):0.00000;
(LLAC:0.10253,LCRE:0.10253):0.00000;
(LLAC:0.06531,LCRE:0.06531):0.00000;
(LCRE:0.01256,LLAC:0.01901,SDOW:0.41843):0.00000;
(LLAC:0.03689,LCRE:0.03689):0.00000;
(((((SINF:0.02161,SLUT:0.01545):0.01399,SEQU:0.01691):0.04598,(SSAL:0.07662,(((((SDOW:0.09341,((SSAL:0.00625,SVES:0.01550):0.06672,(SRAT:0.05756,SPLU:0.05157):0.01861):0.02573):0.07393,(LCRE:0.03524,LLAC:0.03652):0.13232):0.13252,(((SPLU:0.13039,(SENT:0.10761,(SDEV:0.03283,SRAT:0.04452):0.05959):0.02476):0.06355,(SDEV:0.09313,SENT:0.09609):0.10729):0.05846,SENT:0.25162):0.02661):0.27270,SSUI:0.10856):0.04061,SDOW:0.09534):0.01187):0.01753):0.03021,SRAT:0.02158):0.00673,(SINT:0.01190,SCON:0.01530):0.00915,SANG:0.02710):0.00000;
((SENT:0.15838,(LCRE:0.01273,LLAC:0.01086):0.24951):0.03918,((SDEV:0.07108,SRAT:0.07374):0.01030,(SDOW:0.07568,(SCAN:0.04974,(SPYO:0.01066,SDYS:0.01764):0.01645):0.05100):0.01462):0.00838,(SPLU:0.13256,((SINF:0.02226,SLUT:0.01681):0.01154,SEQU:0.03703):0.05040):0.00930):0.00000;
(LLAC:0.06170,LCRE:0.06170):0.00000;
(LLAC:0.09628,LCRE:0.09628):0.00000;
((SMIT:0.18169,LCRE:0.20596):0.05418,SSUI:0.42616,SDYS:0.25021):0.00000;
(SDYS:0.47459,LCRE:0.26890,SMIT:0.33564):0.00000;
(LLAC:0.04373,LCRE:0.04373):0.00000;
(LLAC:0.05502,LCRE:0.05502):0.00000;
(LLAC:0.10443,LCRE:0.10443):0.00000;
(LLAC:0.05789,LCRE:0.05789):0.00000;
((((SSAL:0.00791,(STHE:0.00947,SVES:0.00782):0.00115):0.10396,SDOW:0.12880):0.01301,(SENT:0.19814,((LCRE:0.02591,LLAC:0.02834):0.20647,((SANG:0.02735,(SINT:0.00813,SCON:0.00826):0.01805):0.10053,(SMIT:0.00670,(SPNE:0.01627,SPSE:0.00718):0.00501):0.12781):0.11223):0.03791):0.01999):0.00151,((SPYO:0.05519,(SCAN:0.01166,SDYS:0.01426):0.02413):0.08947,((SDEV:0.01892,SRAT:0.02884):0.09966,((SINF:0.01600,SLUT:0.01788):0.02363,SEQU:0.03620):0.08810):0.00575):0.00114,SPLU:0.14182):0.00000;
(LLAC:0.08452,LCRE:0.08452):0.00000;
(LLAC:0.07333,LCRE:0.07333):0.00000;
(LLAC:0.03174,LCRE:0.03174):0.00000;
((((SDEV:0.05841,SRAT:0.05535):0.18977,(((SPSE:0.02689,SMIT:0.02607):0.19813,((SCON:0.03472,SINT:0.03670):0.02010,SANG:0.04670):0.19263):0.02976,(LCRE:0.04390,LLAC:0.04422):0.28999):0.02155):0.01773,((STHE:0.03707,(SSAL:0.01168,SVES:0.01025):0.02092):0.18861,SDOW:0.22703):0.01291):0.00584,(((SINF:0.01971,SLUT:0.02448):0.10811,SEQU:0.18284):0.04928,((SDYS:0.04642,SPYO:0.04640):0.02420,SCAN:0.07687):0.15475):0.02703,(SPLU:0.04754,SSUI:0.04804):0.17757):0.00000;
(LLAC:0.02505,LCRE:0.02505):0.00000;
(SPLU:0.19960,((STHE:0.01843,(SSAL:0.01011,SVES:0.01514):0.00798):0.19151,(((((SPSE:0.01062,SPNE:0.01464):0.01259,SMIT:0.02162):0.19065,(SINT:0.04399,(SCON:0.03401,SANG:0.03659):0.00891):0.15678):0.02555,SSUI:0.24226):0.02611,(LCRE:0.00875,LLAC:0.01600):0.40308):0.05441):0.01619,(SENT:0.21502,(SDOW:0.19676,((SDEV:0.01526,SRAT:0.01081):0.13900,((SPYO:0.04648,(SCAN:0.01666,SDYS:0.01597):0.01850):0.10455,((SINF:0.00833,SLUT:0.01357):0.00860,SEQU:0.01867):0.12437):0.03615):0.00662):0.00932):0.00634):0.00000;
(LLAC:0.05007,LCRE:0.05007):0.00000;
(LCRE:0.00826,LLAC:0.00728,SLUT:0.26030):0.00000;
((((SMIT:0.02506,(SPNE:0.00967,SPSE:0.02055):0.02279):0.11888,((LCRE:0.22573,SDOW:0.24670):0.06776,(SENT:0.26058,SPYO:0.29109):0.03271):0.11828):0.08926,SINF:0.07135):0.02180,SVES:0.04632,SSAL:0.03118):0.00000;
(((LCRE:0.27436,LCRE:0.23224):0.20649,(LCRE:0.05994,LCRE:0.05770):0.12379):0.06055,LCRE:0.10803,LCRE:0.09365):0.00000;
(LLAC:0.15819,LCRE:0.15819):0.00000;
(LLAC:0.12617,LCRE:0.12617):0.00000;
(LLAC:0.27570,LCRE:0.27570):0.00000;
(LLAC:0.11686,LCRE:0.11686):0.00000;
(LLAC:0.02972,LCRE:0.02972):0.00000;
(LLAC:0.08239,LCRE:0.08239):0.00000;
(LCRE:0.02256,LLAC:0.02381,SPLU:0.51338):0.00000;
((((((STHE:0.00439,SSAL:0.00533):0.00354,SVES:0.01267):0.07373,SPLU:0.19602):0.01410,(((SINF:0.01940,SLUT:0.01206):0.01644,SEQU:0.03165):0.06477,((SCAN:0.01233,SPYO:0.02504):0.00047,SDYS:0.00814):0.08962):0.01315):0.01103,((LCRE:0.01012,LLAC:0.01040):0.31771,SDOW:0.14960):0.01067):0.00455,(SENT:0.09206,(SDEV:0.02486,SRAT:0.02673):0.06814):0.01036,((SPSE:0.00159,(SMIT:0.00000,SPNE:0.00000):0.00298):0.08666,(SINT:0.03110,(SANG:0.01479,SCON:0.03390):0.00863):0.04735):0.05069):0.00000;
(LLAC:0.02182,LCRE:0.02182):0.00000;
(((SDEV:0.05713,SRAT:0.05877):0.11430,((SPYO:0.12807,(SCAN:0.06515,SDYS:0.05885):0.03795):0.08869,(SENT:0.35020,(LCRE:0.03379,LLAC:0.03325):0.19436):0.03758):0.00806):0.00486,(STHE:0.05376,(SSAL:0.01682,SVES:0.02466):0.00716):0.16147,(((SINF:0.02114,SLUT:0.02056):0.05725,SEQU:0.07619):0.10764,SDOW:0.20172):0.01688):0.00000;
(LLAC:0.05784,LCRE:0.05784):0.00000;
(((SDOW:0.11247,((((LCRE:0.07047,LLAC:0.07578):0.15378,((SEQU:0.06063,(SLUT:0.04140,SINF:0.04308):0.01583):0.09995,(((STHE:0.01228,SSAL:0.01406):0.00158,SVES:0.01154):0.07776,(SDOW:0.08558,SRAT:0.07845):0.00282):0.07173):0.08580):0.10835,SDEV:0.39246):0.22883,(LCRE:0.05680,LLAC:0.05300):0.09182):0.01335):0.01469,((SPLU:0.11303,SENT:0.12861):0.01168,(((STHE:0.01571,(SSAL:0.00528,SVES:0.00582):0.01484):0.04681,((SINF:0.00580,SLUT:0.00592):0.02934,SEQU:0.03279):0.03527):0.00729,(SDEV:0.05207,SRAT:0.04252):0.02165):0.02056):0.00981):0.00740,((SMIT:0.01688,(SPSE:0.00857,SPNE:0.01389):0.00431):0.09261,SSUI:0.12618):0.01188,(SANG:0.02509,SINT:0.05237):0.07573):0.00000;
(LCRE:0.32767,LCRE:0.32767):0.00000;
((SPLU:0.18482,((SSUI:0.29205,((LLAC:0.28972,(LCRE:0.00652,LLAC:0.00507):0.29214):0.17493,((SMIT:0.07618,(SPSE:0.00492,SPNE:0.00572):0.06344):0.04819,((SANG:0.00967,SINT:0.01236):0.00588,SCON:0.01715):0.09900):0.18872):0.01117):0.03376,(SVES:0.02186,SSAL:0.01702):0.23394):0.07780):0.00346,(((STHE:0.03652,(SVES:0.00591,SSAL:0.00568):0.02501):0.13420,SDOW:0.15013):0.01569,((SRAT:0.01545,SDEV:0.01551):0.15576,((SPYO:0.04211,(SCAN:0.03656,SDYS:0.03706):0.00522):0.08543,((SINF:0.01316,SLUT:0.01574):0.02003,SEQU:0.03220):0.08783):0.04925):0.00446):0.00740,SENT:0.18591):0.00000;
(LLAC:0.07685,LCRE:0.07685):0.00000;
(LLAC:0.07063,LCRE:0.07063):0.00000;
(LLAC:0.02270,LCRE:0.02270):0.00000;
(LLAC:0.05534,LCRE:0.05534):0.00000;
(LLAC:0.05556,LCRE:0.05556):0.00000;
(LLAC:0.06488,LCRE:0.06488):0.00000;
((LCRE:0.15738,LLAC:0.15350):0.20510,(SDOW:0.12518,(SANG:0.04135,(SINT:0.00027,SCON:0.00182):0.03920):0.10777):0.00806,SMIT:0.13221):0.00000;
(LCRE:0.43488,SSAL:0.04821,SVES:0.05777):0.00000;
(SCAN:0.35620,LCRE:0.35620):0.00000;
((LLAC:0.01581,LCRE:0.01645):0.31717,LCRE:0.28968,((LLAC:0.10581,LCRE:0.09569):0.30811,LCRE:0.38710):0.03199):0.00000;
((SSAL:0.02463,((LCRE:0.09167,LLAC:0.10139):0.20867,SDOW:0.24873):0.14060):0.00869,STHE:0.02454,SVES:0.02083):0.00000;
(LLAC:0.06941,LCRE:0.06941):0.00000;
(LLAC:0.06371,LCRE:0.06371):0.00000;
(LLAC:0.00575,LCRE:0.00575):0.00000;
((SSUI:0.19881,(LCRE:0.03315,LLAC:0.04289):0.41088):0.14797,SDYS:0.07518,SCAN:0.07007):0.00000;
(((LCRE:0.00827,LLAC:0.01105):0.38110,SSUI:0.17320):0.11786,SCAN:0.03087,SDYS:0.03944):0.00000;
(LLAC:0.17781,LCRE:0.17781):0.00000;
((SPNE:0.02607,((SENT:0.14424,SPLU:0.19887):0.04428,LCRE:0.40585):0.17995):0.00907,SPSE:0.04327,SMIT:0.02023):0.00000;
((LCRE:0.00571,LLAC:0.00427):0.61027,SANG:0.00453,SCON:0.00567):0.00000;
(LLAC:0.03003,LCRE:0.03003):0.00000;
(LLAC:0.02186,LCRE:0.02186):0.00000;
(LCRE:0.63555,LCRE:0.00448,LLAC:0.00448):0.00000;
((SCAN:0.01589,(SPYO:0.00574,SDYS:0.00552):0.00844):0.05020,((SPLU:0.08832,(((SANG:0.01027,(SINT:0.00828,SCON:0.01257):0.00644):0.03805,((SPSE:0.00519,SPNE:0.00669):0.00047,SMIT:0.00671):0.04994):0.07407,((SINF:0.26698,(LCRE:0.01502,LLAC:0.01542):0.26810):0.02124,((LLAC:0.01881,LCRE:0.02309):0.29768,((LLAC:0.05636,LCRE:0.05740):0.27965,(((SVES:0.00329,SSAL:0.00310):0.13213,((SLUT:0.02019,SEQU:0.01509):0.00232,SINF:0.02067):0.10861):0.05530,((SRAT:0.03582,SDEV:0.02739):0.13997,SDOW:0.17160):0.01079):0.19474):0.00929):0.01292):0.16228):0.03105):0.00852,(SSUI:0.05638,SENT:0.05752):0.02680):0.01117,(((STHE:0.02045,(SSAL:0.00984,SVES:0.00876):0.00344):0.05112,(((SINF:0.00757,SLUT:0.00618):0.00737,SEQU:0.01315):0.04216,SDOW:0.07310):0.00181):0.02341,(SDEV:0.01206,SRAT:0.01109):0.06171):0.00236):0.00000;
(LLAC:0.05955,LCRE:0.05955):0.00000;
(LLAC:0.01589,LCRE:0.01589):0.00000;
(LLAC:0.11552,LCRE:0.11552):0.00000;
((LCRE:0.31004,LLAC:0.18832):0.06322,LCRE:0.08470,LLAC:0.08900):0.00000;
(LLAC:0.06901,LCRE:0.06901):0.00000;
(LLAC:0.05036,LCRE:0.05036):0.00000;
(LLAC:0.02863,LCRE:0.02863):0.00000;
(LLAC:0.03820,LCRE:0.03820):0.00000;
(LLAC:0.01840,LCRE:0.01840):0.00000;
(LLAC:0.06667,LCRE:0.06667):0.00000;
(LLAC:0.07458,LCRE:0.07458):0.00000;
(LLAC:0.03302,LCRE:0.03302):0.00000;
(LLAC:0.19647,LCRE:0.19647):0.00000;
(LLAC:0.29093,LCRE:0.29093):0.00000;
(((LCRE:0.04391,LLAC:0.05026):0.37735,SPNE:0.21014):0.22487,SPSE:0.00984,SPNE:0.01308):0.00000;
((((SDYS:0.16980,(LCRE:0.01620,LLAC:0.01317):0.10398):0.01202,(SDOW:0.04241,((SLUT:0.01280,(SINF:0.00696,SEQU:0.00454):0.00366):0.02986,(SDEV:0.00932,SRAT:0.02148):0.02490):0.01022):0.02188):0.02039,((SSUI:0.00256,SPLU:0.00574):0.02469,SENT:0.06466):0.01234):0.00840,(((SMIT:0.00180,SPSE:0.00151):0.00287,SPNE:0.01390):0.01737,(SANG:0.02028,(SINT:0.04452,SCON:0.03721):0.01784):0.01533):0.00272,(STHE:0.00215,(SSAL:0.00363,SVES:0.00187):0.00116):0.02425):0.00000;
(SDEV:0.29973,((SDEV:0.21864,(SDYS:0.09896,(SPLU:0.09586,SSUI:0.10221):0.02418):0.08527):0.12160,(LCRE:0.02366,LLAC:0.02166):0.25476):0.02974,((SPYO:0.07615,(SCAN:0.03246,SDYS:0.02735):0.04271):0.14535,((SPNE:0.09571,(SINT:0.00256,SCON:0.00600):0.07080):0.09138,SSUI:0.18630):0.03333):0.02818):0.00000;
(LLAC:0.05894,LCRE:0.05894):0.00000;
(LLAC:0.00776,LCRE:0.00776):0.00000;
(LLAC:0.03709,LCRE:0.03709):0.00000;
(LLAC:0.01139,LCRE:0.01139):0.00000;
(((SCAN:0.02902,(SPYO:0.03280,SDYS:0.03423):0.00097):0.07460,(((STHE:0.03129,(SSAL:0.00728,SVES:0.01501):0.00541):0.09828,SPLU:0.11343):0.01404,(SENT:0.13391,((LCRE:0.03508,LLAC:0.02846):0.32700,(SSUI:0.13752,((SPSE:0.01222,(SMIT:0.00836,SPNE:0.01204):0.00340):0.07847,(SANG:0.03724,(SINT:0.01579,SCON:0.01784):0.01570):0.06129):0.02051):0.11937):0.08142):0.01119):0.00657):0.00330,(((SINF:0.00979,SLUT:0.00886):0.00609,SEQU:0.01513):0.06733,(SDEV:0.02511,SRAT:0.02296):0.06604):0.01784,SDOW:0.10391):0.00000;
(SENT:0.09487,(SDEV:0.02997,SRAT:0.03690):0.06450,((SPLU:0.09308,(((SINT:0.05306,(SANG:0.02079,SCON:0.01810):0.03338):0.03399,((SMIT:0.00689,(SPSE:0.00560,SPNE:0.00503):0.00424):0.06678,SSUI:0.08220):0.01003):0.02842,(LCRE:0.01203,LLAC:0.01585):0.20860):0.01094):0.00453,((SCAN:0.02641,(SPYO:0.01793,SDYS:0.02691):0.00278):0.04447,(((SSAL:0.01118,(STHE:0.01108,SVES:0.00341):0.00356):0.04896,SDOW:0.06542):0.00785,((SINF:0.00428,SLUT:0.01401):0.01300,SEQU:0.01175):0.03989):0.00840):0.00808):0.00397):0.00000;
(((((SINF:0.02291,SLUT:0.01121):0.00648,SEQU:0.02159):0.08947,(SDOW:0.14737,(SDEV:0.02435,SRAT:0.02850):0.10341):0.00330):0.01246,((SSAL:0.03582,(STHE:0.02396,SVES:0.01992):0.01728):0.10795,(((((SMIT:0.00868,SPSE:0.01053):0.01016,SPNE:0.01547):0.14304,(SANG:0.04994,(SINT:0.05235,SCON:0.04230):0.01011):0.07944):0.05905,SSUI:0.19896):0.01098,((LCRE:0.05212,LLAC:0.05091):0.33186,SENT:0.22141):0.03472):0.02392):0.00418):0.00389,((SCAN:0.03297,SPYO:0.02802):0.01837,SDYS:0.05394):0.10614,SPLU:0.15082):0.00000;
(LLAC:0.01860,LCRE:0.01860):0.00000;
(LLAC:0.03082,LCRE:0.03082):0.00000;
(((LCRE:0.00966,LLAC:0.01349):0.23380,(SPLU:0.23027,(SENT:0.17805,SDYS:0.18344):0.04857):0.16461):0.19847,(SPNE:0.02934,SMIT:0.03402):0.00280,SPNE:0.03769):0.00000;
(LLAC:0.02140,LCRE:0.02140):0.00000;
(LLAC:0.01751,LCRE:0.01751):0.00000;
(LLAC:0.04588,LCRE:0.04588):0.00000;
((((SPSE:0.00590,(SMIT:0.00969,SPNE:0.00966):0.00378):0.09850,SENT:0.13264):0.01258,((SINT:0.03068,(SANG:0.01180,SCON:0.00544):0.03129):0.08220,((((SINF:0.01847,SLUT:0.00565):0.02597,SEQU:0.02779):0.10468,SDOW:0.18262):0.01476,((SCAN:0.03618,(SPYO:0.07045,SDYS:0.03294):0.01364):0.07887,((SRAT:0.02736,SDEV:0.04418):0.15193,((SMIT:0.09454,(SDOW:0.14868,(SVES:0.02898,SSAL:0.02616):0.07110):0.01929):0.25031,((LCRE:0.02134,LLAC:0.00924):0.19370,(LCRE:0.05644,LLAC:0.04506):0.26446):0.08784):0.08370):0.01611):0.01526):0.02845):0.01895):0.01076,SSUI:0.09507,(STHE:0.00567,(SSAL:0.00329,SVES:0.00153):0.00396):0.07777):0.00000;
(SDOW:0.22932,LCRE:0.22932):0.00000;
((((SMIT:0.00438,(SPSE:0.00369,SPNE:0.00571):0.00043):0.04283,(SANG:0.01553,(SINT:0.01574,SCON:0.00961):0.01309):0.03410):0.04305,(LCRE:0.01839,LLAC:0.01760):0.15095):0.01414,((STHE:0.01289,(SSAL:0.00240,SVES:0.00540):0.00461):0.06214,((SLUT:0.00802,(SINF:0.00453,SEQU:0.00219):0.00070):0.03739,(SDEV:0.03268,SRAT:0.02978):0.01487):0.01151):0.00374,((((SSUI:0.05614,SPLU:0.03551):0.01652,SENT:0.07799):0.01327,(SPYO:0.05912,(SCAN:0.02105,SDYS:0.02103):0.04138):0.00430):0.00815,SDOW:0.09395):0.00154):0.00000;
((LCRE:0.11270,LLAC:0.10601):0.33505,LLAC:0.14559,LCRE:0.16148):0.00000;
(LLAC:0.00604,LCRE:0.00604):0.00000;
(LLAC:0.04952,LCRE:0.04952):0.00000;
(((((SPNE:0.02997,(SPSE:0.00981,SMIT:0.00825):0.01503):0.17987,(STHE:0.06564,(SSAL:0.01816,SVES:0.02100):0.03385):0.13081):0.00887,(SPYO:0.07982,SDYS:0.07093):0.15533):0.00599,(SSUI:0.23205,(SPLU:0.18576,(LCRE:0.02446,LLAC:0.02072):0.32160):0.02355):0.02347):0.00557,((SINF:0.06708,(SEQU:0.04277,SLUT:0.05568):0.03417):0.09817,(SDOW:0.21164,(SDEV:0.03928,SRAT:0.03019):0.12681):0.01254):0.00649,(SANG:0.04169,(SINT:0.01971,SCON:0.02342):0.02887):0.16759):0.00000;
(((SPLU:0.10538,((SMIT:0.01407,(SPSE:0.02403,SPNE:0.01269):0.00513):0.10632,((SANG:0.03214,(SINT:0.00256,SCON:0.00925):0.03152):0.09818,(SSUI:0.20954,(LCRE:0.04883,LLAC:0.05788):0.21183):0.02033):0.01286):0.01236):0.01079,(SDEV:0.10821,SRAT:0.08677):0.02650):0.00210,(((SINF:0.02647,SLUT:0.01903):0.03137,SEQU:0.05786):0.05511,SDOW:0.13502):0.00373,(STHE:0.00976,(SSAL:0.00840,SVES:0.00817):0.00761):0.10237):0.00000;
(LLAC:0.03315,LCRE:0.03315):0.00000;
(LLAC:0.11135,LCRE:0.11135):0.00000;
(LLAC:0.04326,LCRE:0.04326):0.00000;
(LLAC:0.03562,LCRE:0.03562):0.00000;
(LLAC:0.03425,LCRE:0.03425):0.00000;
(LLAC:0.13942,LCRE:0.13942):0.00000;
(LLAC:0.21954,LCRE:0.21954):0.00000;
(SEQU:0.31288,LCRE:0.31288):0.00000;
(LCRE:0.26389,LCRE:0.26389):0.00000;
((LCRE:0.38806,SPSE:0.32447):0.09751,SSUI:0.13770,SENT:0.16093):0.00000;
(((((LCRE:0.02310,LLAC:0.02175):0.18466,(((SMIT:0.00434,(SPSE:0.00573,SPNE:0.00794):0.00228):0.04575,((SANG:0.01771,SINT:0.03573):0.00575,SCON:0.03849):0.02671):0.00876,SSUI:0.06213):0.02076):0.01600,((SDEV:0.01951,SRAT:0.03137):0.06504,SDOW:0.06933):0.01009):0.00832,(SCAN:0.02465,(SPYO:0.01281,SDYS:0.01133):0.00761):0.04958):0.00233,((STHE:0.01344,(SSAL:0.00463,SVES:0.00415):0.00565):0.04086,((SINF:0.00737,SLUT:0.00453):0.00555,SEQU:0.01424):0.04724):0.00318,(SPLU:0.04223,SENT:0.06883):0.00694):0.00000;
(((SCAN:0.02229,(SPYO:0.01272,SDYS:0.00531):0.01180):0.05445,(((SINF:0.00413,SLUT:0.00542):0.00707,SEQU:0.00944):0.04118,(SDEV:0.01685,SRAT:0.01815):0.02950):0.01780):0.00305,(((SPSE:0.01306,(SMIT:0.00725,SPNE:0.00827):0.00222):0.04795,(SANG:0.01592,(SINT:0.00676,SCON:0.00717):0.00429):0.04856):0.02600,SDOW:0.08417):0.00391,((STHE:0.02174,(SSAL:0.00901,SVES:0.01574):0.00442):0.06253,(SPLU:0.07192,((LLAC:0.00894,LCRE:0.01237):0.13903,(SSUI:0.08673,SENT:0.08981):0.00427):0.00745):0.00779):0.00657):0.00000;
((SDEV:0.05093,SRAT:0.05185):0.02198,(((((SPSE:0.01556,(SMIT:0.00551,SPNE:0.01229):0.00830):0.04938,(SANG:0.04098,(SINT:0.01635,SCON:0.01014):0.03034):0.02289):0.01241,SSUI:0.09188):0.02096,((SPLU:0.06647,SENT:0.10210):0.01371,(SCAN:0.03144,(SPYO:0.02154,SDYS:0.00728):0.02229):0.06151):0.00610):0.01219,(((STHE:0.01831,SSAL:0.00612):0.00459,SVES:0.01481):0.03970,SDOW:0.05215):0.01627):0.00753,((LCRE:0.01355,LLAC:0.01443):0.07571,((SINF:0.00720,SLUT:0.00919):0.01042,SEQU:0.01198):0.04252):0.00754):0.00000;
((SENT:0.17661,((((STHE:0.03158,(SSAL:0.00460,SVES:0.00877):0.02110):0.07749,SPLU:0.13024):0.02115,(SINF:0.02377,SEQU:0.01955):0.08485):0.03379,(SDEV:0.04197,SRAT:0.04294):0.10896):0.01339):0.01137,((SCAN:0.02956,(SPYO:0.00526,SDYS:0.00377):0.02341):0.08777,SDOW:0.10845):0.04334,((((SMIT:0.00892,SPSE:0.01247):0.00190,SPNE:0.01775):0.10006,(SANG:0.02478,(SINT:0.01070,SCON:0.00834):0.02257):0.07061):0.01978,SSUI:0.17938):0.01132):0.00000;
((SDEV:0.01321,SRAT:0.01527):0.08904,((STHE:0.01712,(SSAL:0.01117,SVES:0.00502):0.00665):0.10441,SDOW:0.09020):0.00458,((((SLUT:0.21893,SRAT:0.18413):0.38643,(LCRE:0.01725,LLAC:0.02113):0.19412):0.01629,((((SMIT:0.01496,SPSE:0.01040):0.00489,SPNE:0.02102):0.04359,((SANG:0.02357,SINT:0.02473):0.00845,SCON:0.02290):0.03010):0.06804,SSUI:0.15182):0.04599):0.06179,(SENT:0.10606,(SPLU:0.08901,((SINF:0.01768,(SLUT:0.00381,SEQU:0.00608):0.00540):0.05292,(SPYO:0.02466,(SCAN:0.02836,SDYS:0.02503):0.00151):0.04078):0.04859):0.01088):0.00778):0.00936):0.00000;
((((SPSE:0.00839,(SMIT:0.00396,SPNE:0.00457):0.00297):0.03228,((SANG:0.00261,SINT:0.00592):0.00565,SCON:0.01286):0.02514):0.00938,(SDEV:0.02062,SRAT:0.01553):0.04843):0.00559,((SSUI:0.05211,SENT:0.07449):0.01783,((SPYO:0.01866,(SCAN:0.01631,SDYS:0.01191):0.00359):0.05690,(SPLU:0.06458,(((SSAL:0.01132,(STHE:0.00967,SVES:0.00165):0.00613):0.04519,((SINF:0.00390,SLUT:0.00273):0.00214,SEQU:0.00590):0.03718):0.00640,SDOW:0.05961):0.00767):0.01380):0.01609):0.00648,(LCRE:0.00243,LLAC:0.00426):0.09895):0.00000;
(((SLUT:0.00771,(SINF:0.01123,SEQU:0.00265):0.00186):0.02426,((SINT:0.00157,(SANG:0.00096,SCON:0.00011):0.00162):0.02213,(SDEV:0.00084,SRAT:0.00445):0.01814):0.01079):0.02064,((STHE:0.00555,(SSAL:0.00284,SVES:0.00141):0.00083):0.02975,((LCRE:0.00309,LLAC:0.00861):0.16083,SDOW:0.03258):0.01038):0.00051,(SENT:0.04898,(SSUI:0.02997,((((SMIT:0.00000,SPSE:0.00000):0.00401,SPNE:0.00130):0.01407,SPLU:0.02485):0.00445,(SCAN:0.00202,(SPYO:0.00127,SDYS:0.00194):0.00439):0.01234):0.00647):0.01317):0.00315):0.00000;
(((SANG:0.00095,(SINT:0.01345,SCON:0.00111):0.01361):0.01039,((SDEV:0.02091,SRAT:0.01215):0.01036,((LLAC:0.01482,LCRE:0.01381):0.16530,SDOW:0.03759):0.00893):0.00954):0.00283,((STHE:0.01225,(SSAL:0.03406,(SVES:0.00982,(((SMIT:0.01453,SPSE:0.00626):0.01582,SSUI:0.02957):0.00518,SPLU:0.03015):0.01361):0.00476):0.00941):0.00456,(SENT:0.03044,(SCAN:0.00238,(SPYO:0.00000,SDYS:0.00000):0.00589):0.01708):0.00486):0.00415,((SINF:0.00000,SLUT:0.00000):0.00786,SEQU:0.00456):0.00348):0.00000;
((SDOW:0.12990,(((LLAC:0.01813,LCRE:0.01597):0.31431,(SSUI:0.12919,((SANG:0.03030,(SCON:0.01577,SINT:0.01420):0.01670):0.06956,(SPNE:0.00766,(SPSE:0.00758,SMIT:0.00685):0.00033):0.10546):0.02736):0.01904):0.01118,(SRAT:0.02910,SDEV:0.03196):0.09482):0.00739):0.00895,((SPLU:0.11898,(SINF:0.00875,(SEQU:0.00663,SLUT:0.01413):0.00112):0.08828):0.00390,(SPYO:0.11634,((SSAL:0.01325,SVES:0.01043):0.00496,STHE:0.01849):0.08442):0.00843):0.00067,((SDYS:0.03700,SCAN:0.04234):0.07548,SENT:0.11631):0.00633):0.00000;
((SSUI:0.15530,((SANG:0.01907,(SINT:0.00026,SCON:0.00175):0.02502):0.07543,(SMIT:0.00046,(SPSE:0.00726,SPNE:0.00074):0.00654):0.11513):0.05590):0.06106,((((SVES:0.00497,STHE:0.00270):0.02402,SSAL:0.02416):0.16412,((SINF:0.00285,SLUT:0.00925):0.02634,SEQU:0.02407):0.08621):0.03102,((SPLU:0.15705,SENT:0.20509):0.01460,(SPYO:0.04553,(SCAN:0.02970,SDYS:0.03379):0.01135):0.11001):0.00702):0.00374,((SDEV:0.00703,SRAT:0.01897):0.11225,SDOW:0.11328):0.03051):0.00000;
((SCAN:0.06543,((SEQU:0.11664,(SINF:0.04144,SLUT:0.03191):0.09188):0.30489,(SRAT:0.12864,SDEV:0.15290):0.15527):0.24220):0.04067,SPYO:0.03495,SDYS:0.03112):0.00000;
((SSUI:0.04815,(SDEV:0.02018,SRAT:0.02084):0.02388):0.01536,((((LCRE:0.00332,LLAC:0.00527):0.08718,SENT:0.08223):0.00993,(SMIT:0.05503,(SDOW:0.05437,(SSAL:0.01025,SVES:0.01557):0.04768):0.06134):0.14069):0.01543,((SCAN:0.00848,(SPYO:0.00907,SDYS:0.00959):0.00236):0.06260,(((STHE:0.02677,(SSAL:0.00147,SVES:0.00631):0.00500):0.04140,((SINF:0.00939,SLUT:0.00560):0.00033,SEQU:0.00837):0.02207):0.00606,SDOW:0.07668):0.00970):0.00713):0.00549,((SPSE:0.00000,SPNE:0.00000):0.04066,(SANG:0.01267,(SINT:0.01295,SCON:0.01305):0.00368):0.02702):0.02123):0.00000;
(((((SPLU:0.25542,((SEQU:0.04633,(SLUT:0.01780,SINF:0.01560):0.03260):0.17234,(SPYO:0.09127,(SDYS:0.06595,SCAN:0.05815):0.02512):0.11740):0.01638):0.00813,(SRAT:0.04261,SDEV:0.04292):0.17662):0.00467,SDOW:0.27497):0.01920,((SSUI:0.29728,(((SMIT:0.01519,SPSE:0.01948):0.00566,SPNE:0.02699):0.17041,(SANG:0.07112,(SINT:0.03646,SCON:0.03512):0.04190):0.12692):0.04681):0.04920,SENT:0.29883):0.00828):0.00314,(SSAL:0.02926,(SVES:0.01256,STHE:0.02499):0.01116):0.26122,(LLAC:0.06555,LCRE:0.05776):0.39213):0.00000;
((((SINF:0.00000,SLUT:0.00000):0.02672,SEQU:0.01245):0.08700,((SSUI:0.50785,((SCAN:0.02153,SPYO:0.01480):0.00229,SDYS:0.01107):0.13504):0.00745,(SDEV:0.02634,SRAT:0.03160):0.08500):0.00751):0.01143,SDOW:0.10760,((((STHE:0.01176,(SSAL:0.00005,SVES:0.00322):0.00454):0.05030,(SPSE:0.00151,(SMIT:0.00000,SPNE:0.00000):0.00066):0.04046):0.01017,(SANG:0.00581,(SINT:0.00516,SCON:0.00134):0.01477):0.05488):0.05576,(SPLU:0.07645,SENT:0.08624):0.01026):0.00434):0.00000;
(((SRAT:0.00770,SDEV:0.00613):0.02263,SEQU:0.03969):0.05120,(SINT:0.00904,SCON:0.00081):0.00209,SANG:0.00702):0.00000;
((SINT:0.01265,((SRAT:0.00295,SDEV:0.00177):0.02487,SEQU:0.05347):0.05558):0.01190,SCON:0.00165,SANG:0.00653):0.00000;
((SINT:0.01246,((SRAT:0.02204,SDEV:0.02161):0.14736,SEQU:0.19892):0.24029):0.00376,SCON:0.00966,SANG:0.00701):0.00000;
((((((SPSE:0.01271,SPNE:0.00265):0.01795,SMIT:0.02330):0.22505,(SINT:0.08378,(SCON:0.04495,SANG:0.02907):0.03577):0.13621):0.02971,(SENT:0.23570,((SRAT:0.05944,SDEV:0.04536):0.13412,SDOW:0.21027):0.01399):0.01203):0.00892,((SPYO:0.19456,(SDYS:0.12222,SCAN:0.12186):0.04144):0.13784,(SEQU:0.13494,(SLUT:0.04121,SINF:0.03839):0.08661):0.10775):0.02333):0.00688,((LCRE:0.16891,LLAC:0.16300):0.23814,SSUI:0.24801):0.00831,(SPLU:0.20301,(STHE:0.04152,(SSAL:0.00599,SVES:0.01687):0.01495):0.22095):0.01909):0.00000;
((((((LCRE:0.03713,LLAC:0.04119):0.21950,SDOW:0.17761):0.00931,(((SSAL:0.00587,SVES:0.00971):0.00787,STHE:0.04223):0.13394,(SEQU:0.02426,(SINF:0.01012,SLUT:0.01058):0.01458):0.11107):0.02144):0.00823,((SPYO:0.04063,(SCAN:0.02563,SDYS:0.02393):0.00875):0.10185,(SRAT:0.02796,SDEV:0.02484):0.10238):0.02039):0.00748,SPLU:0.17142):0.00465,(SSUI:0.20332,(((SPSE:0.00895,SPNE:0.00899):0.07011,SMIT:0.09107):0.10177,(SINT:0.06073,(SANG:0.01599,SCON:0.02006):0.03516):0.07426):0.02834):0.02140,SENT:0.20084):0.00000;
((((((LCRE:0.00000,LLAC:0.00000):0.21938,((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.04173,(SINT:0.01310,(SANG:0.00399,SCON:0.00557):0.00189):0.02056):0.01200):0.00250,SSUI:0.04585):0.00730,SENT:0.09012):0.00915,((STHE:0.01098,(SSAL:0.00002,SVES:0.00189):0.00369):0.01133,(SDEV:0.00258,SRAT:0.00190):0.01991):0.00454):0.00328,(((SINF:0.00316,(SLUT:0.00046,SEQU:0.00273):0.00035):0.01143,(SCAN:0.00567,(SPYO:0.00084,SDYS:0.00172):0.00105):0.01088):0.00638,SDOW:0.03752):0.00743,SPLU:0.03671):0.00000;
((((STHE:0.02409,(SSAL:0.00000,SVES:0.00000):0.00359):0.00776,(((SSUI:0.00403,SPLU:0.01702):0.03383,(SENT:0.08338,((SINT:0.01607,((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.01874,(SANG:0.00031,SCON:0.00320):0.00573):0.00988):0.01555,((SINF:0.00000,(SLUT:0.00000,SEQU:0.00000):0.00000):0.05337,((LCRE:0.00000,LLAC:0.00000):0.14599,(SDEV:0.00930,SRAT:0.00454):0.01639):0.01207):0.02831):0.01929):0.00570):0.00604,SDOW:0.03463):0.02063):0.01123,SDYS:0.01533):0.00203,SPYO:0.00028,SCAN:0.00320):0.00000;
((((STHE:0.00821,(SSAL:0.00000,SVES:0.00000):0.00173):0.02363,((SLUT:0.01474,(SINF:0.00516,SEQU:0.01593):0.00296):0.01431,(SDEV:0.00952,SRAT:0.01482):0.03193):0.00712):0.00820,SDOW:0.05901):0.00613,((LCRE:0.00341,LLAC:0.00673):0.18742,((SPLU:0.02984,SENT:0.06440):0.00750,(SPYO:0.01847,(SCAN:0.00492,SDYS:0.00286):0.00813):0.02333):0.00541):0.01887,((((SMIT:0.00122,SPSE:0.00322):0.00194,SPNE:0.00694):0.01051,(SANG:0.00985,(SINT:0.01523,SCON:0.00678):0.00280):0.03346):0.02743,SSUI:0.07885):0.00858):0.00000;
((((STHE:0.00116,(SSAL:0.00757,SVES:0.00000):0.00036):0.00282,((SPLU:0.01462,(SENT:0.03093,SPYO:0.01590):0.00200):0.00078,(((((SANG:0.01653,SINT:0.01042):0.00055,SCON:0.02268):0.02887,((SPSE:0.00059,(SMIT:0.00018,SPNE:0.00133):0.00092):0.01127,SSUI:0.03234):0.00359):0.00497,((LCRE:0.00000,LLAC:0.00452):0.16407,(SDEV:0.00470,SRAT:0.00137):0.04104):0.01279):0.00393,SDOW:0.04245):0.00391):0.00343):0.00099,(SCAN:0.00695,SDYS:0.00062):0.00648):0.00103,(SINF:0.00000,SEQU:0.00000):0.00018,SLUT:0.01043):0.00000;
(((SSUI:0.03010,(((SDEV:0.00000,SRAT:0.00000):0.01419,((STHE:0.02409,(SSAL:0.00000,(SVES:0.00000,SANG:0.00000):0.00000):0.00001):0.00068,(SCON:0.01956,((LCRE:0.00000,LLAC:0.00000):0.06433,((SINF:0.00000,(SLUT:0.00000,SEQU:0.00000):0.00000):0.00383,SDOW:0.02005):0.01657):0.00267):0.00409):0.00777):0.00057,(SCAN:0.00000,(SPYO:0.00000,SDYS:0.00000):0.00000):0.03852):0.00048):0.00003,SPLU:0.00000):0.00000,SINT:0.00000,SMIT:0.00000):0.00000;
(((((((SINT:0.00273,(SANG:0.00128,SCON:0.00429):0.00117):0.00231,((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.01340,SSUI:0.00776):0.00606):0.00718,(SDEV:0.00400,SRAT:0.00492):0.01283):0.01252,((LCRE:0.00000,LLAC:0.00000):0.07933,SDOW:0.01279):0.00469):0.00287,(SPYO:0.00510,(SCAN:0.00000,SDYS:0.00000):0.00048):0.00981):0.00251,((SINF:0.00000,SLUT:0.00000):0.00941,SEQU:0.00835):0.00480):0.00173,(SPLU:0.01595,SENT:0.03874):0.00511,(STHE:0.00831,(SSAL:0.00000,SVES:0.00000):0.00170):0.01760):0.00000;
(((SDEV:0.00000,SRAT:0.00000):0.00885,SDOW:0.01473):0.01060,((SINF:0.00000,(SLUT:0.00000,SEQU:0.00000):0.00000):0.02520,((STHE:0.00316,(SSAL:0.00000,SVES:0.00000):0.00674):0.01638,(SPYO:0.01001,(SCAN:0.00000,SDYS:0.00000):0.00175):0.01896):0.00787):0.00134,(((LCRE:0.00000,LLAC:0.00000):0.12885,(((SANG:0.00000,SINT:0.00000):0.00184,SCON:0.00012):0.03382,SSUI:0.02880):0.01672):0.00631,(SPLU:0.02112,((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.04776,SENT:0.04083):0.01932):0.01608):0.00093):0.00000;
(((SPLU:0.02416,(((SSUI:0.02826,(((((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.01143,SANG:0.02252):0.01134,(SINT:0.01220,SCON:0.00018):0.00716):0.03448,((LLAC:0.00000,LCRE:0.00000):0.24136,SENT:0.04568):0.00831):0.00962,SPYO:0.03481):0.00399):0.00728,((SINF:0.00935,(SLUT:0.00000,SEQU:0.00000):0.00594):0.00401,(SDEV:0.00000,SRAT:0.00000):0.01426):0.01085):0.01957,SDOW:0.05532):0.01686):0.00456,(SCAN:0.00000,SDYS:0.00000):0.00652):0.00574,(SSAL:0.00000,SVES:0.00000):0.00014,STHE:0.00295):0.00000;
(LCRE:0.25417,SRAT:0.25417):0.00000;
(SPLU:0.24038,SRAT:0.24038):0.00000;
((((SMIT:0.00132,(SPSE:0.00000,SPNE:0.00000):0.00064):0.00675,SSUI:0.01408):0.00220,(((STHE:0.00619,(SSAL:0.00162,SVES:0.00231):0.00290):0.00445,SINF:0.00585):0.00838,((SINT:0.00132,(SANG:0.00000,SCON:0.00000):0.00457):0.00743,((SLUT:0.00512,SEQU:0.00662):0.00771,((SDEV:0.00555,SRAT:0.00426):0.00730,SDOW:0.02091):0.00370):0.00266):0.00602):0.00299):0.00096,((SPLU:0.00832,SENT:0.01183):0.00453,(SCAN:0.00866,(SPYO:0.00000,SDYS:0.00000):0.00459):0.00676):0.00510,(LCRE:0.00000,LLAC:0.00000):0.12510):0.00000;
((SPSE:0.00423,((STHE:0.02548,(SSAL:0.00843,SVES:0.00350):0.00282):0.00536,((SANG:0.04215,(SRAT:0.04939,((SCAN:0.01567,(SPYO:0.01279,SDYS:0.01619):0.00497):0.03876,((SSUI:0.00269,SPLU:0.00432):0.06927,(SENT:0.11152,((LCRE:0.00168,LLAC:0.00460):0.12413,(SDEV:0.03505,SDOW:0.01965):0.09431):0.08600):0.03565):0.01817):0.01203):0.02078):0.00062,((SINT:0.00238,SCON:0.00389):0.01014,(SINF:0.00078,(SLUT:0.01157,SEQU:0.00095):0.00157):0.01079):0.02387):0.02478):0.00901):0.00047,SPNE:0.00307,SMIT:0.00007):0.00000;
((SENT:0.06941,(((STHE:0.01058,(SSAL:0.00000,SVES:0.00000):0.00523):0.03325,SDOW:0.07731):0.01007,((SDEV:0.00985,SRAT:0.01304):0.06960,((SANG:0.02113,SINT:0.03968):0.10330,((LCRE:0.04372,LLAC:0.05110):0.10896,((SDEV:0.30202,SRAT:0.30452):0.02961,(SRAT:0.04434,SDEV:0.03900):0.32622):0.26898):0.00738):0.05549):0.03451):0.01239):0.00672,((SINF:0.00355,SLUT:0.00645):0.00869,SEQU:0.01946):0.04117,((SMIT:0.00238,(SPSE:0.00431,SPNE:0.00691):0.00011):0.04992,(SSUI:0.00956,SPLU:0.01427):0.02909):0.00728):0.00000;
(SDOW:0.20401,SRAT:0.20401):0.00000;
((((SLUT:0.06287,SEQU:0.07087):0.09484,(SDEV:0.03525,SRAT:0.04179):0.11098):0.02086,SDOW:0.16442):0.00836,(SCAN:0.10896,SDYS:0.09120):0.10403,((LCRE:0.00626,LLAC:0.00709):0.39883,(SSAL:0.03158,(STHE:0.03105,SVES:0.01573):0.01826):0.17509):0.02696):0.00000;
((SDEV:0.06456,SRAT:0.04558):0.04484,SDOW:0.11347,SPYO:0.15778):0.00000;
(SRAT:0.19982,((LLAC:0.04798,LCRE:0.04504):0.24018,SSUI:0.26756):0.06343,(SCAN:0.05495,SDYS:0.04897):0.14011):0.00000;
(SRAT:0.17248,SDEV:0.21927,SCON:0.45112):0.00000;
((((SSAL:0.04299,(SPSE:0.00159,SPNE:0.00345):0.06551):0.03585,(((SDEV:0.02176,SRAT:0.01769):0.05451,SDOW:0.07324):0.07041,((LLAC:0.01909,LCRE:0.02396):0.16318,(SRAT:0.03153,SDEV:0.03336):0.10936):0.08485):0.09090):0.00816,SSUI:0.10729):0.01232,SEQU:0.06133,(SPLU:0.08942,SENT:0.07374):0.00670):0.00000;
((STHE:0.00259,((SRAT:0.00703,SDEV:0.01013):0.03565,(SMIT:0.00263,(SPSE:0.00812,SPNE:0.03749):0.00661):0.07412):0.08039):0.00228,SVES:0.00394,SSAL:0.00038):0.00000;
(((SPLU:0.12874,((((STHE:0.00897,(SSAL:0.00582,SVES:0.00495):0.00131):0.06006,((SINF:0.00576,SLUT:0.01245):0.00607,SEQU:0.01096):0.04224):0.01183,(SDEV:0.01800,SRAT:0.01801):0.04912):0.01865,SDOW:0.09348):0.01400):0.00616,((LCRE:0.03249,LLAC:0.04490):0.17037,(SENT:0.14086,SDYS:0.27667):0.01679):0.01749):0.00437,SSUI:0.09335,(((SMIT:0.00570,SPSE:0.00510):0.00110,SPNE:0.01839):0.06519,(SANG:0.03347,(SINT:0.01297,SCON:0.00878):0.03209):0.04228):0.04477):0.00000;
(((((SINF:0.01242,SLUT:0.01640):0.02857,SEQU:0.04534):0.06599,((SCAN:0.02321,SPYO:0.02373):0.02347,SDYS:0.03894):0.07888):0.00772,(SSUI:0.14924,(((SPNE:0.02666,(SPSE:0.02891,SMIT:0.01620):0.01176):0.14723,SENT:0.20591):0.25390,(SDEV:0.03698,SRAT:0.03988):0.08907):0.01215):0.01639):0.00476,SDOW:0.10242,(SSAL:0.02176,(STHE:0.01644,SVES:0.01771):0.01798):0.07923):0.00000;
(((LLAC:0.00516,LCRE:0.00419):0.19710,(((SSAL:0.01505,(STHE:0.01143,SVES:0.01232):0.00492):0.12685,(SDEV:0.01400,SRAT:0.01501):0.09654):0.01074,SDOW:0.12722):0.01000):0.01021,(SSUI:0.14811,((SPLU:0.11366,(SLUT:0.01383,(SINF:0.00440,SEQU:0.00150):0.00174):0.07903):0.01306,(SENT:0.11134,(SPYO:0.05633,(SCAN:0.02248,SDYS:0.02096):0.01202):0.05543):0.01109):0.03327):0.00364,((SPSE:0.01063,(SMIT:0.00561,SPNE:0.00801):0.00129):0.06391,(SANG:0.02189,(SINT:0.00491,SCON:0.00526):0.02476):0.03978):0.05308):0.00000;
(((((((SMIT:0.00226,SPSE:0.00525):0.00124,SPNE:0.00470):0.02312,((SANG:0.00340,SINT:0.00597):0.00138,SCON:0.00331):0.01861):0.02413,SSUI:0.07297):0.01007,((LLAC:0.00144,LCRE:0.00104):0.14001,((LLAC:0.00699,LCRE:0.00971):0.13924,((((SPYO:0.02367,(SCAN:0.01780,SDYS:0.01964):0.00613):0.05700,(((SINF:0.01079,SLUT:0.00842):0.01613,SEQU:0.02261):0.05297,(SENT:0.08097,(SDEV:0.01425,SRAT:0.01391):0.06353):0.00815):0.00387):0.00728,((STHE:0.02356,(SSAL:0.01417,SVES:0.01120):0.00894):0.06705,(SPLU:0.10328,SDOW:0.09761):0.00570):0.00760):0.01802,(((SMIT:0.00512,(SPSE:0.00253,SPNE:0.00494):0.00329):0.04680,(SINT:0.00737,(SANG:0.01034,SCON:0.00648):0.00321):0.04425):0.05559,SSUI:0.11916):0.00575):0.02655):0.20771):0.04787):0.00371,((((STHE:0.01568,(SSAL:0.00561,SVES:0.00745):0.00048):0.02807,SPLU:0.03462):0.00770,SDOW:0.04999):0.00400,(((SCAN:0.00132,SPYO:0.00433):0.00118,SDYS:0.00228):0.00927,((SINF:0.00040,SLUT:0.00209):0.01533,SEQU:0.02659):0.01051):0.02554):0.00727):0.00168,(SDEV:0.00144,SRAT:0.00479):0.06413,SENT:0.05577):0.00000;
(SRAT:0.01456,SDEV:0.02913,((SDYS:0.03569,SPYO:0.00697):0.10091,SPLU:0.17078):0.07193):0.00000;
((SRAT:0.00343,SDEV:0.00806):0.02592,(SPYO:0.00407,SDYS:0.00797):0.02661,((SDEV:0.13074,(SPLU:0.06843,(SPYO:0.00543,SDYS:0.00363):0.05927):0.03899):0.35475,SPLU:0.03603):0.00580):0.00000;
(SDEV:0.09436,SRAT:0.09436):0.00000;
(((((((SCAN:0.01088,(SPYO:0.00708,SDYS:0.00634):0.00394):0.23478,(LCRE:0.02541,LLAC:0.02384):0.11774):0.04070,SENT:0.12239):0.01465,(((SMIT:0.00387,(SPSE:0.00554,SPNE:0.00797):0.00039):0.03693,(SINT:0.01886,(SANG:0.01456,SCON:0.01769):0.00334):0.02635):0.01213,(SDEV:0.03345,SRAT:0.03282):0.03496):0.02422):0.00641,SDOW:0.08972):0.00608,((SCAN:0.01912,SPYO:0.02454):0.01554,SDYS:0.03168):0.04857):0.00558,((SSAL:0.01134,(STHE:0.00372,SVES:0.00405):0.00811):0.02670,(SINF:0.01192,(SLUT:0.00550,SEQU:0.00332):0.00539):0.02529):0.01603,(SSUI:0.02413,SPLU:0.02175):0.04935):0.00000;
((((SRAT:0.07008,SDEV:0.07514):0.18113,(SENT:0.24436,SPLU:0.28332):0.08120):0.04886,SANG:0.25954):0.24955,(SPSE:0.05540,SPNE:0.05411):0.00420,SMIT:0.05889):0.00000;
(((((SINF:0.00848,SLUT:0.00713):0.01086,SEQU:0.01415):0.04801,((SSUI:0.00257,SPLU:0.00862):0.06128,((SCON:0.03824,(SINT:0.01455,SANG:0.01345):0.02318):0.28784,((SSUI:0.01298,SCAN:0.01903):0.03039,SPYO:0.11585):0.01671):0.01366):0.01107):0.01392,((SDEV:0.00835,SRAT:0.02861):0.01753,SDOW:0.06610):0.03336):0.00664,(SCAN:0.00870,(SPYO:0.00492,SDYS:0.00717):0.01385):0.03709,((SMIT:0.00350,(SPSE:0.00927,SPNE:0.00401):0.00315):0.03574,SANG:0.06070):0.01483):0.00000;
(((SDEV:0.02316,SRAT:0.02176):0.07216,(SENT:0.08841,SDOW:0.10867):0.00650):0.00201,(SCAN:0.04759,SDYS:0.04582):0.06295,((((LCRE:0.07017,LLAC:0.05697):0.16717,SSUI:0.36525):0.06181,(((SMIT:0.00875,SPSE:0.01086):0.00302,SPNE:0.01858):0.07612,(SINT:0.01489,(SANG:0.00973,SCON:0.00509):0.01107):0.06184):0.04850):0.02303,((SSAL:0.00670,SVES:0.00748):0.08537,SPLU:0.09217):0.00654):0.00337):0.00000;
((SRAT:0.19663,SDEV:0.19907):0.03051,((STHE:0.01973,(SSAL:0.01995,SVES:0.02210):0.00486):0.20526,((SEQU:0.07592,SINF:0.07406):0.17630,SPLU:0.21669):0.03172):0.00047,((((SPNE:0.05766,(SPSE:0.03596,SMIT:0.04055):0.03079):0.22792,(SINT:0.08868,(SCON:0.01104,SANG:0.00978):0.07632):0.17113):0.04772,SSUI:0.37830):0.05687,SDYS:0.28705):0.00944):0.00000;
((((SDEV:0.04262,SRAT:0.05676):0.13500,SDOW:0.18196):0.01395,(SEQU:0.06767,(SINF:0.03868,SLUT:0.04415):0.03058):0.11485):0.00839,((SPLU:0.26878,((SDYS:0.11392,SCAN:0.08710):0.04847,SPYO:0.18419):0.09446):0.01673,((SSUI:0.27100,SENT:0.29012):0.01500,((LLAC:0.07490,LCRE:0.07732):0.27286,((SANG:0.07036,(SCON:0.04406,SINT:0.03231):0.02329):0.08607,(SMIT:0.01289,(SPSE:0.01522,SPNE:0.01721):0.00126):0.13167):0.05806):0.01061):0.00409):0.00363,(SSAL:0.03688,(SVES:0.02109,STHE:0.02249):0.01193):0.23578):0.00000;
((SDEV:0.07310,SRAT:0.07293):0.13377,SDOW:0.19222,SEQU:0.22393):0.00000;
((SSUI:0.25978,SRAT:0.23303):0.02562,((SANG:0.11166,(SINT:0.00620,SCON:0.00589):0.10976):0.06544,(SMIT:0.13743,(SPSE:0.00579,SPNE:0.00517):0.13915):0.06765):0.08337,(LLAC:0.05092,LCRE:0.05005):0.37488):0.00000;
((SRAT:0.22721,SDOW:0.19427):0.02145,(((LLAC:0.04760,LCRE:0.03694):0.22009,(SENT:0.31067,((SDYS:0.15564,SCAN:0.15557):0.02834,SPYO:0.21419):0.08247):0.00491):0.01410,((SSAL:0.04377,(STHE:0.02320,SVES:0.01062):0.03445):0.21737,((SINF:0.12056,(SLUT:0.02544,SEQU:0.01905):0.10429):0.12872,(SSUI:0.21709,SDEV:0.23554):0.05044):0.01099):0.01657):0.00291,((SPNE:0.03946,(SPSE:0.01777,SMIT:0.01564):0.01907):0.16641,SPLU:0.18863):0.03418):0.00000;
(SRAT:0.01579,SDEV:0.08503,SSAL:0.49961):0.00000;
(SDEV:0.07870,SRAT:0.07870):0.00000;
(SDEV:0.07953,(SRAT:0.09964,SDEV:0.09210):0.39401,SRAT:0.08346):0.00000;
(((SPLU:0.11343,(((SPLU:0.08257,(SRAT:0.01660,SDEV:0.01635):0.07603):0.01424,SENT:0.07783):0.44149,(SANG:0.08315,SSUI:0.13232):0.01631):0.00937):0.01214,((SCAN:0.02096,SDYS:0.01184):0.05423,SDOW:0.05920):0.02364):0.00495,SSAL:0.07477,((SINF:0.00226,SLUT:0.00069):0.02442,SEQU:0.02802):0.05020):0.00000;
((SENT:0.06221,(((STHE:0.02936,(SSAL:0.00000,SVES:0.00000):0.00736):0.03093,(SDEV:0.00000,SRAT:0.00000):0.03279):0.00984,((SPYO:0.01198,(SCAN:0.00000,SDYS:0.00000):0.00087):0.04635,SDOW:0.05108):0.00302):0.00440):0.00257,(SSUI:0.05924,(SPLU:0.04108,((SINF:0.00000,SLUT:0.00000):0.00089,SEQU:0.00989):0.01064):0.01297):0.00075,((SDOW:0.34433,(LCRE:0.00000,LLAC:0.00000):0.18314):0.03401,((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.02693,(SANG:0.00000,(SINT:0.00000,SCON:0.00000):0.00000):0.02547):0.03172):0.01113):0.00000;
((SRAT:0.41928,(LCRE:0.00275,LLAC:0.00403):0.13124):0.12902,LLAC:0.02819,LCRE:0.03073):0.00000;
((((SINT:0.02634,(SCON:0.00437,SANG:0.00238):0.01457):0.19036,SSUI:0.26269):0.08762,SRAT:0.20135):0.19399,(SCAN:0.03623,SDYS:0.02365):0.00783,SPYO:0.02471):0.00000;
((((STHE:0.01736,(SSAL:0.00357,SVES:0.00238):0.00874):0.03943,(SDEV:0.05520,SRAT:0.05662):0.00782):0.00493,(((SINF:0.00077,SLUT:0.00615):0.00578,SEQU:0.00944):0.05082,SDOW:0.06830):0.00426):0.00676,(SCAN:0.02013,(SPYO:0.00680,SDYS:0.01012):0.00754):0.06699,(((SANG:0.02651,(SINT:0.00243,SCON:0.00855):0.03715):0.05462,(((LLAC:0.01902,LCRE:0.01274):0.23585,SENT:0.10640):0.00318,(SSUI:0.08214,(SPSE:0.00578,SMIT:0.00428):0.06095):0.01210):0.00660):0.01486,SPLU:0.08766):0.00131):0.00000;
(SRAT:0.52640,SLUT:0.04199,SEQU:0.03509):0.00000;
(SDEV:0.08433,SRAT:0.08433):0.00000;
(SRAT:0.02248,SDOW:0.32279,SDEV:0.02068):0.00000;
(SRAT:0.00513,SDOW:0.19745,SDEV:0.01157):0.00000;
(((SSUI:0.00343,SENT:0.01595):0.00583,((STHE:0.00564,(SSAL:0.00000,SVES:0.00000):0.00114):0.00965,(SPLU:0.01526,(SDEV:0.00802,SRAT:0.00653):0.00318):0.00453):0.00617):0.00211,(SDYS:0.00489,(SPYO:0.00715,((((SPSE:0.00109,(SMIT:0.00000,SPNE:0.00000):0.00181):0.00427,(SINT:0.00665,(SANG:0.00722,SCON:0.01115):0.00207):0.00395):0.00641,(SINF:0.00322,(SLUT:0.00000,SEQU:0.00000):0.00064):0.01037):0.00788,((LCRE:0.01010,LLAC:0.01013):0.07139,SDOW:0.03367):0.00587):0.00391):0.00418):0.00099,SCAN:0.00751):0.00000;
(SRAT:0.05685,SDOW:0.42256,SDEV:0.05632):0.00000;
((((SINT:0.34187,SINT:0.28706):0.15547,(SRAT:0.00942,SRAT:0.00642):0.06268):0.06010,SINT:0.03131):0.00276,SINT:0.00197,SINT:0.01169):0.00000;
(SDOW:0.26650,SRAT:0.24175,SDEV:0.18819):0.00000;
(SDEV:0.21244,SDOW:0.21244):0.00000;
(SINT:0.13715,SDOW:0.13715):0.00000;
(SDOW:0.44751,SDOW:0.10935,(SDEV:0.01880,SRAT:0.01955):0.05685):0.00000;
((STHE:0.03836,(SSAL:0.01174,SVES:0.00781):0.01550):0.10769,((((SINF:0.00472,SLUT:0.00560):0.01271,SEQU:0.01489):0.05640,SDOW:0.09691):0.04173,(SDEV:0.03236,SRAT:0.02298):0.10815):0.01529,(SMIT:0.12893,(SANG:0.01200,(SINT:0.00166,SCON:0.00384):0.01664):0.07806):0.02739):0.00000;
(SDOW:0.24673,SSUI:0.20886,SDEV:0.41262):0.00000;
(((SRAT:0.22289,SDOW:0.26651):0.19882,SANG:0.02949):0.05947,SCON:0.01471,SINT:0.00010):0.00000;
((SDOW:0.06901,((SPSE:0.01218,(SMIT:0.00740,SPNE:0.00412):0.00387):0.06450,((SINT:0.05523,SCON:0.04048):0.02442,(SDEV:0.02838,SRAT:0.01383):0.04962):0.00644):0.01735):0.00471,((SANG:0.05302,((SINF:0.00301,SLUT:0.00775):0.00399,SEQU:0.01091):0.01976):0.03185,(SPYO:0.10789,(((LCRE:0.02912,LLAC:0.03588):0.18211,((SSUI:0.01251,SPLU:0.02365):0.09753,SENT:0.10136):0.00341):0.02186,(SCAN:0.05490,SDYS:0.07020):0.06209):0.01545):0.00693):0.00487,((STHE:0.00436,SSAL:0.00392):0.00223,SVES:0.00812):0.03951):0.00000;
(SDOW:0.28312,(SDEV:0.13500,SRAT:0.12784):0.12048,(SSAL:0.25590,(SPSE:0.04423,SMIT:0.06257):0.24581):0.16018):0.00000;
((((((LCRE:0.00327,LLAC:0.00091):0.11718,(SSAL:0.00274,(STHE:0.01448,SVES:0.00117):0.00666):0.02500):0.00338,SDOW:0.04078):0.00176,((SINT:0.00429,(SANG:0.00055,SCON:0.00153):0.00370):0.02590,(SDEV:0.00682,SRAT:0.00953):0.02416):0.01403):0.00517,(((SINF:0.00313,SLUT:0.00521):0.00278,SEQU:0.00539):0.01655,(SPYO:0.00852,(SCAN:0.00243,SDYS:0.00138):0.00189):0.03059):0.01076):0.00144,((SSUI:0.02039,SPLU:0.02120):0.01098,SENT:0.04351):0.00395,(SPSE:0.00961,SPNE:0.00806):0.01969):0.00000;
((SDEV:0.22396,((SVES:0.13849,SSAL:0.12000):0.22038,SDOW:0.31223):0.07445):0.07533,SINF:0.13743,(SLUT:0.04292,SEQU:0.04482):0.07268):0.00000;
((LCRE:0.39898,(((((SDOW:0.07320,((SINF:0.00853,(SLUT:0.00096,SEQU:0.00116):0.00307):0.05672,((SPYO:0.01804,(SCAN:0.00357,SDYS:0.00346):0.01222):0.04150,(SDEV:0.04084,SRAT:0.03890):0.01683):0.00880):0.01202):0.02349,(SSAL:0.00202,SVES:0.00147):0.11130):0.08502,(LLAC:0.00145,LCRE:0.00128):0.19845):0.11959,((SPLU:0.08761,SENT:0.07793):0.04303,(SSUI:0.04580,((SPSE:0.01568,(SMIT:0.00428,SPNE:0.00762):0.00918):0.03477,(SINT:0.00233,(SANG:0.00000,SCON:0.00000):0.00327):0.03727):0.00865):0.07954):0.20910):0.04162,LCRE:0.36195):0.02458):0.00180,((((SCAN:0.06340,(SPLU:0.00820,SSUI:0.00743):0.06340):0.27838,(((SPNE:0.04004,SINT:0.04424):0.01380,SDEV:0.05529):0.23935,SLUT:0.31378):0.02486):0.01406,LCRE:0.31289):0.01442,((SPLU:0.31886,(((LCRE:0.00590,LLAC:0.00834):0.14548,((SPYO:0.00672,SDYS:0.00537):0.01299,SCAN:0.01952):0.12894):0.02897,(SSUI:0.12877,(SINT:0.10944,(SMIT:0.01230,(SPSE:0.00363,SPNE:0.00284):0.00971):0.10666):0.01757):0.04372):0.13213):0.03174,(SPNE:0.32892,((LLAC:0.00685,LCRE:0.00406):0.30032,((SDYS:0.17747,(LCRE:0.11162,SMIT:0.11840):0.04623):0.12010,(SPSE:0.07318,SSUI:0.07015):0.20195):0.01650):0.00664):0.03249):0.04668):0.01423,((SPLU:0.05568,SENT:0.05685):0.00172,((SPYO:0.00764,SDYS:0.00511):0.04364,((SINT:0.00503,(SANG:0.00137,SCON:0.00215):0.00414):0.02471,(SMIT:0.00466,(SPSE:0.00247,SPNE:0.00242):0.00162):0.02445):0.02277):0.00415):0.30924):0.00000;
((SDOW:0.31947,SINT:0.31226):0.26534,SSAL:0.04073,SVES:0.05030):0.00000;
(((((SINF:0.02018,SLUT:0.02561):0.00274,SEQU:0.02581):0.12790,((SSAL:0.03259,SVES:0.04025):0.08827,SDOW:0.14246):0.01054):0.01488,(SPYO:0.09003,(SCAN:0.04104,SDYS:0.04219):0.04340):0.07847):0.00953,(SPLU:0.18062,SENT:0.15758):0.01264,((LCRE:0.04352,LLAC:0.04067):0.19841,((SDEV:0.04387,SRAT:0.05356):0.15632,(((SCON:0.02841,SANG:0.02540):0.02112,SINT:0.04555):0.15454,(SMIT:0.04519,(SPSE:0.03642,SPNE:0.04214):0.00630):0.15731):0.01088):0.05798):0.33706):0.00000;
((SANG:0.00594,(((((SMIT:0.00000,SPSE:0.00000):0.00027,SPNE:0.00542):0.01514,SSUI:0.02297):0.01254,((LCRE:0.00417,LLAC:0.00267):0.06941,(SPLU:0.67750,((SPLU:0.03806,(SPYO:0.03662,(SCAN:0.00348,SDYS:0.00435):0.02602):0.01271):0.02999,(SENT:0.04156,(((SSAL:0.00786,(STHE:0.00994,SVES:0.00698):0.00171):0.01335,((SINF:0.00000,SLUT:0.00000):0.00991,SEQU:0.01141):0.00827):0.00799,SDOW:0.03932):0.00948):0.00550):0.00620):0.02248):0.00649):0.01086,(SDEV:0.00831,SRAT:0.00652):0.02994):0.01309):0.00092,SCON:0.00910,SINT:0.00578):0.00000;
((SDOW:0.17748,(SDEV:0.10189,SRAT:0.07881):0.06514):0.00874,((SINF:0.03185,SLUT:0.02500):0.01616,SEQU:0.03801):0.11434,SDOW:0.35917):0.00000;
(((((SINF:0.01452,SLUT:0.01716):0.01549,SEQU:0.02483):0.05487,SDOW:0.12018):0.00548,((((LCRE:0.02344,LLAC:0.02711):0.18650,(((SMIT:0.01257,(SPSE:0.01146,SPNE:0.00756):0.00597):0.10831,(SANG:0.04824,(SINT:0.01587,SCON:0.01326):0.04966):0.04185):0.03789,SSUI:0.13718):0.00363):0.02170,SENT:0.17866):0.00737,(SDEV:0.06272,SRAT:0.04629):0.06990):0.00943):0.00161,(SCAN:0.04286,(SPYO:0.00802,SDYS:0.00854):0.02824):0.07933,(((STHE:0.02884,SSAL:0.01700):0.00275,SVES:0.03303):0.09483,SPLU:0.13334):0.00385):0.00000;
(SRAT:0.15912,SDOW:0.15912):0.00000;
((((LLAC:0.01803,LCRE:0.01149):0.17002,((SPYO:0.04597,(SCAN:0.01328,SDYS:0.01179):0.01903):0.05641,(((STHE:0.01397,SSAL:0.01984):0.00583,SVES:0.01767):0.03653,SDOW:0.07988):0.00607):0.01199):0.00898,(SINT:0.05093,(SDEV:0.01906,SRAT:0.01930):0.04107):0.03370):0.00653,(SENT:0.09032,((SSUI:0.01552,SPLU:0.01118):0.03254,((SINF:0.00580,SLUT:0.02474):0.00458,SEQU:0.00730):0.03246):0.01570):0.00639,((SMIT:0.01763,(SPSE:0.00047,SPNE:0.01148):0.00765):0.04244,(SANG:0.00968,SCON:0.00625):0.06709):0.02551):0.00000;
(SRAT:0.12330,SDOW:0.12330):0.00000;
(SRAT:0.15455,SDOW:0.15455):0.00000;
(((((SINF:0.00280,SLUT:0.00085):0.02879,SEQU:0.03846):0.07334,(SCAN:0.02598,(SPYO:0.02814,SDYS:0.01831):0.00639):0.11448):0.03807,(((SSAL:0.00826,SVES:0.01017):0.02215,STHE:0.02913):0.11438,SDOW:0.18144):0.07241):0.00496,((SPLU:0.16006,SENT:0.18978):0.00504,(SSUI:0.15312,((SANG:0.02059,(SINT:0.02592,SCON:0.01871):0.00686):0.12165,((SMIT:0.00669,SPSE:0.00633):0.00652,SPNE:0.00869):0.19061):0.03284):0.02968):0.00939,((LLAC:0.00570,LCRE:0.00544):0.22593,(SDEV:0.02293,SRAT:0.01443):0.13874):0.01179):0.00000;
((SSAL:0.22255,(SENT:0.29065,(SDOW:0.17863,(SEQU:0.06797,(SLUT:0.03060,SINF:0.01600):0.05070):0.12025):0.06614):0.14736):0.02709,(SDEV:0.03965,SRAT:0.01398):0.17761,(SANG:0.07084,(SINT:0.00000,SCON:0.00000):0.06327):0.12898):0.00000;
(SDOW:0.36084,SRAT:0.12256,SDEV:0.12118):0.00000;
(SDEV:0.26334,SDOW:0.26334):0.00000;
((SPLU:0.17045,SDOW:0.19304):0.02631,((SPYO:0.10101,(SCAN:0.02014,SDYS:0.02737):0.13976):0.08919,((SINF:0.05097,SLUT:0.05442):0.08502,SEQU:0.16986):0.06137):0.00731,(((SSAL:0.03024,SVES:0.03685):0.02153,STHE:0.06833):0.20948,SENT:0.33535):0.02170):0.00000;
(SRAT:0.12784,SDOW:0.12784):0.00000;
((STHE:0.02490,(SSAL:0.00242,SVES:0.00661):0.01594):0.10649,((((SINF:0.00190,SLUT:0.00427):0.02130,SEQU:0.02003):0.07644,((SCAN:0.02440,SPYO:0.02040):0.00814,SDYS:0.03047):0.09663):0.00828,SDOW:0.10248):0.00432,(SPLU:0.13381,(((((LLAC:0.03663,LCRE:0.03697):0.32535,(((SMIT:0.00506,SPSE:0.00788):0.00152,SPNE:0.01165):0.11692,(SANG:0.02749,(SINT:0.01818,SCON:0.01232):0.00926):0.07849):0.06850):0.00808,SSUI:0.13481):0.02461,SENT:0.17072):0.00744,(SDEV:0.01712,SRAT:0.01861):0.12127):0.01225):0.00839):0.00000;
(SDOW:0.53501,SDEV:0.04413,SRAT:0.06800):0.00000;
(SINT:0.33105,SDOW:0.33105):0.00000;
((((((SINF:0.09221,(((STHE:0.00235,STHE:0.00004):0.04522,SPNE:0.05442):0.11940,((((SCON:0.00493,(SCON:0.01134,(SCON:0.00269,(SCON:0.00134,SCON:0.00173):0.00100):0.00213):0.00171):0.13572,(SANG:0.04203,SCON:0.03220):0.12977):0.22418,(SDOW:0.21907,(SPYO:0.03145,((SPYO:0.01904,((SDYS:0.00517,(SDYS:0.00601,SDYS:0.00502):0.00325):0.00381,(SDYS:0.01287,SDYS:0.00278):0.00087):0.00414):0.00497,(SDYS:0.00535,SDYS:0.00328):0.03184):0.00210):0.19414):0.09778):0.19664,((((SDYS:0.00852,SDYS:0.00537):0.00559,SDYS:0.01302):0.00094,((SDYS:0.01456,SDYS:0.00882):0.00237,(SDYS:0.01493,SDYS:0.00765):0.00034):0.00336):0.00054,(SDYS:0.00223,SDYS:0.01408):0.00541):0.14326):0.00336):0.05897):0.00652,SCAN:0.08620):0.05640,(SLUT:0.00130,((SLUT:0.00930,SLUT:0.00209):0.00262,SLUT:0.00216):0.00442):0.01112):0.00205,(SLUT:0.00204,SLUT:0.00336):0.00538):0.00138,(SLUT:0.00130,SLUT:0.00230):0.01461):0.00082,SLUT:0.00103,(SLUT:0.00923,SLUT:0.00035):0.00083):0.00000;
((((((SINF:0.00430,SLUT:0.00719):0.00909,SEQU:0.01006):0.06112,(((STHE:0.00920,(SSAL:0.00467,SVES:0.00715):0.00174):0.04198,SPLU:0.06537):0.01828,(SCAN:0.02358,(SPYO:0.00967,SDYS:0.00840):0.01034):0.05700):0.00564):0.00671,SDOW:0.10868):0.00605,(SENT:0.11428,(SDEV:0.07849,SRAT:0.09841):0.00992):0.00719):0.00394,((SMIT:0.00407,SPSE:0.00781):0.00036,SPNE:0.01013):0.07646,(((SANG:0.01176,(SINT:0.01256,SCON:0.01086):0.00819):0.08706,SSUI:0.10800):0.01298,(LCRE:0.00648,LLAC:0.00465):0.18160):0.02571):0.00000;
((((SANG:0.05114,SCON:0.05965):0.00210,SINT:0.05538):0.27745,(SDOW:0.23704,(SDEV:0.03305,SRAT:0.03217):0.19779):0.04291):0.01172,((SENT:0.25766,SPLU:0.26578):0.03156,(SPYO:0.13565,(SCAN:0.06640,SDYS:0.08171):0.04500):0.11634):0.00951,(((SVES:0.03323,SSAL:0.02471):0.06976,STHE:0.10294):0.14230,(SEQU:0.11510,(SLUT:0.02896,SINF:0.01395):0.10836):0.12655):0.03936):0.00000;
(((STHE:0.02297,(SSAL:0.00849,SVES:0.00758):0.01039):0.09374,(SDOW:0.10341,((((SINF:0.00279,SLUT:0.00362):0.01103,SEQU:0.01371):0.04881,(SPYO:0.01991,(SCAN:0.01312,SDYS:0.01024):0.00951):0.04438):0.01101,(SDEV:0.00852,SRAT:0.01156):0.06390):0.01210):0.00674):0.01225,(SPLU:0.11694,SENT:0.13435):0.00319,((LCRE:0.01486,LLAC:0.01382):0.23141,((((SMIT:0.00906,SPSE:0.01176):0.00739,SPNE:0.01787):0.05364,(SINT:0.01024,(SANG:0.00633,SCON:0.00524):0.00287):0.05102):0.02091,SSUI:0.10729):0.03860):0.00844):0.00000;
(SDOW:0.38594,SINF:0.10911,SDYS:0.14212):0.00000;
(SSAL:0.29763,SDOW:0.29763):0.00000;
((((SPSE:0.00419,SPNE:0.00502):0.14255,((SDOW:0.10988,SPLU:0.09107):0.22778,SENT:0.29652):0.27235):0.00784,((SINF:0.03143,STHE:0.04077):0.08176,SLUT:0.10937):0.02979):0.00214,(SPYO:0.11544,(SCAN:0.04963,SDYS:0.06202):0.04299):0.03311,(SVES:0.01421,SSAL:0.00926):0.11164):0.00000;
(SDOW:0.60836,SANG:0.07638,SINT:0.08147):0.00000;
(SANG:0.18413,SDOW:0.18413):0.00000;
((((SPSE:0.00373,(SMIT:0.00044,SPNE:0.00256):0.00151):0.02071,(SINT:0.00632,SCON:0.00605):0.01703):0.01030,((STHE:0.00435,(SSAL:0.00000,SVES:0.00000):0.00090):0.01810,SDOW:0.02182):0.00555):0.00209,((((SSUI:0.00188,SPLU:0.00225):0.01346,SENT:0.02105):0.01042,(SPYO:0.01513,(SCAN:0.00663,SDYS:0.00352):0.02706):0.01905):0.00330,((LLAC:0.00324,LCRE:0.00344):0.13773,(SDEV:0.01009,SRAT:0.01324):0.01945):0.00501):0.00109,(SANG:0.02894,(SINF:0.00441,(SLUT:0.00115,SEQU:0.00035):0.00683):0.01568):0.00615):0.00000;
(((((SSUI:0.15267,SENT:0.15154):0.02021,((SMIT:0.04305,(SPSE:0.03099,SPNE:0.03051):0.00681):0.10083,SDOW:0.15147):0.00234):0.00633,(((SCAN:0.05715,SDYS:0.06724):0.07705,(SRAT:0.12324,SDEV:0.10864):0.01161):0.00479,((STHE:0.03505,(SSAL:0.02887,SVES:0.01793):0.00476):0.07348,((SINF:0.02099,SEQU:0.02422):0.01291,SLUT:0.03748):0.08151):0.02117):0.01085):0.00920,(SINT:0.07328,(SCON:0.03194,SANG:0.03235):0.03965):0.09666):0.00491,((LLAC:0.05823,LCRE:0.06376):0.18183,SPLU:0.20225):0.00135,SPYO:0.18509):0.00000;
(SDOW:0.27680,(SRAT:0.06859,SDEV:0.07436):0.13883,(SPSE:0.00706,SPNE:0.00707):0.24290):0.00000;
(SSUI:0.28732,SDOW:0.28732):0.00000;
(SDOW:0.11574,((((SPSE:0.04345,(SMIT:0.01276,SPNE:0.01404):0.00132):0.11012,(SANG:0.02616,(SINT:0.01994,SCON:0.01958):0.00521):0.06319):0.03605,(SPLU:0.15217,SENT:0.17807):0.00663):0.00796,((SRAT:0.00922,SDEV:0.01147):0.08399,((SINF:0.00809,SLUT:0.00702):0.01094,SEQU:0.01843):0.06065):0.01172):0.00549,(SSAL:0.01450,(STHE:0.02257,SVES:0.01717):0.00071):0.12141):0.00000;
(SEQU:0.14648,SDOW:0.14648):0.00000;
(SDOW:0.25546,SRAT:0.01895,SDEV:0.02985):0.00000;
((((SSUI:0.01330,SPLU:0.01316):0.05277,SENT:0.08921):0.01269,(((SANG:0.00833,(SINT:0.00165,SCON:0.00579):0.00299):0.10916,(SPYO:0.06281,(SDYS:0.04008,SCAN:0.03573):0.02027):0.04885):0.37172,SDOW:0.07950):0.01423):0.00096,((SPYO:0.05864,(SCAN:0.02928,SDYS:0.01788):0.03912):0.00800,((SSAL:0.00745,(STHE:0.01553,SVES:0.00469):0.00557):0.04150,((SLUT:0.00703,(SINF:0.00888,SEQU:0.00529):0.00054):0.02513,(SDEV:0.02798,SRAT:0.02023):0.01112):0.01295):0.00782):0.00662,(((SMIT:0.00059,SPSE:0.00044):0.00198,SPNE:0.00694):0.04625,(SANG:0.01519,(SINT:0.01136,SCON:0.01023):0.01411):0.02450):0.04157):0.00000;
(((SDOW:0.09164,((SINF:0.02446,SEQU:0.01461):0.06524,(SDEV:0.04063,SRAT:0.02906):0.03025):0.02147):0.01126,(SMIT:0.00907,SPSE:0.01003):0.04382):0.03508,(SSAL:0.00008,SVES:0.00079):0.00467,STHE:0.01289):0.00000;
((((SDOW:0.11703,(SDEV:0.06539,SRAT:0.05601):0.03132):0.02975,(SLUT:0.12344,SEQU:0.08299):0.03271):0.05710,(SMIT:0.00648,SPSE:0.00221):0.04353):0.01382,(SSAL:0.00799,SVES:0.00940):0.01557,STHE:0.05658):0.00000;
(SANG:0.32780,SDOW:0.32780):0.00000;
(SEQU:0.22792,SDOW:0.19433,((SRAT:0.05339,SDEV:0.05162):0.13512,((SVES:0.03638,SSAL:0.03853):0.19800,(LLAC:0.33250,((SVES:0.03216,SSAL:0.02308):0.28310,(SANG:0.23242,((SENT:0.19183,(SRAT:0.05592,SDEV:0.06373):0.11972):0.01580,(SEQU:0.18793,((SVES:0.03236,SSAL:0.02847):0.14183,SDOW:0.21176):0.02351):0.02893):0.03810):0.04911):0.01520):0.04354):0.02571):0.00346):0.00000;
(((((SLUT:0.13276,(SEQU:0.10802,(SINT:0.01641,(SANG:0.01296,SCON:0.01022):0.00835):0.09588):0.01383):0.06587,SINF:0.25982):0.04232,(LLAC:0.05528,LCRE:0.07200):0.35861):0.06751,SDOW:0.25801):0.01107,SDOW:0.29671,SDEV:0.22053):0.00000;
(SRAT:0.07842,SDOW:0.07842):0.00000;
(SDOW:0.25842,(SRAT:0.05649,SDEV:0.05164):0.21158,(SLUT:0.04362,SINF:0.04554):0.27650):0.00000;
((((SINF:0.00807,SLUT:0.01452):0.00404,SEQU:0.01386):0.09019,(((STHE:0.02071,(SSAL:0.01753,SVES:0.02015):0.00523):0.06854,SPLU:0.09594):0.01599,SDOW:0.11603):0.01079):0.00402,(((SCAN:0.03381,SPYO:0.03860):0.03291,SDYS:0.06024):0.11020,(SDEV:0.10217,SRAT:0.10414):0.03780):0.01116,((LCRE:0.01632,LLAC:0.02048):0.19341,(((((SMIT:0.01563,SPSE:0.01798):0.00274,SPNE:0.01933):0.10366,(SINT:0.02484,(SANG:0.00082,SCON:0.00292):0.02435):0.09593):0.02797,SSUI:0.16144):0.01242,SENT:0.25264):0.00932):0.00888):0.00000;
(((SDEV:0.06117,SRAT:0.05886):0.15968,(((SSAL:0.02106,SVES:0.02205):0.00788,STHE:0.03068):0.22821,(SPLU:0.25099,((SENT:0.29903,((LLAC:0.05636,LCRE:0.07464):0.29957,(SSUI:0.29635,((SANG:0.06992,(SINT:0.02248,SCON:0.02457):0.05111):0.15747,((SPSE:0.02010,SPNE:0.01469):0.01576,SMIT:0.03017):0.24135):0.05312):0.04058):0.01352):0.02295,SDOW:0.25322):0.01178):0.01891):0.00378):0.00222,(SPYO:0.09893,(SDYS:0.05719,SCAN:0.07098):0.02079):0.13634,(SEQU:0.08840,(SLUT:0.02410,SINF:0.01008):0.07455):0.15086):0.00000;
((((STHE:0.04430,SVES:0.04352):0.01487,SSAL:0.06298):0.25534,((SENT:0.39821,(SEQU:0.18100,(SLUT:0.02439,SINF:0.03749):0.12667):0.15328):0.02128,(((SINT:0.14576,(SANG:0.05621,SCON:0.03622):0.10933):0.14161,(SPNE:0.03515,(SPSE:0.01790,SMIT:0.02756):0.01863):0.26216):0.08781,(SPLU:0.29435,(SDEV:0.05718,SRAT:0.08687):0.19300):0.04688):0.01735):0.02250):0.01282,SDOW:0.31594,(SPYO:0.21453,(SDYS:0.15910,SCAN:0.17862):0.04600):0.09642):0.00000;
(SRAT:0.02331,SDEV:0.02331):0.00000;
(((SCAN:0.22867,(SDEV:0.25051,SEQU:0.36835):0.16880):0.11873,SMIT:0.06149):0.03940,SPNE:0.05109,SPSE:0.02140):0.00000;
(SSAL:0.22524,SDEV:0.22524):0.00000;
(SRAT:0.13879,SDEV:0.13879):0.00000;
(SRAT:0.04181,SDEV:0.04181):0.00000;
(((((SPNE:0.00742,SMIT:0.01457):0.24134,(SDEV:0.05262,SRAT:0.05445):0.19020):0.02672,(SPYO:0.10750,SCAN:0.13630):0.20331):0.26363,SANG:0.04149):0.02180,SCON:0.02478,SINT:0.01821):0.00000;
(((((SMIT:0.01239,SPSE:0.01182):0.00525,SPNE:0.01778):0.07024,(SINT:0.04803,(SANG:0.02355,SCON:0.03621):0.01069):0.03967):0.02012,((((((SINF:0.01590,SLUT:0.01531):0.01463,SEQU:0.02127):0.04887,((STHE:0.02450,(SSAL:0.00592,SVES:0.01468):0.00595):0.05091,(SDEV:0.06571,SRAT:0.06720):0.01313):0.00370):0.00727,(SPLU:0.07966,SDOW:0.09202):0.00335):0.02031,((SCAN:0.02460,SPYO:0.01820):0.04679,SDYS:0.08193):0.03926):0.00473,SENT:0.19262):0.00532):0.00305,SSUI:0.11385,(LCRE:0.03207,LLAC:0.03099):0.10312):0.00000;
(SRAT:0.03465,SDEV:0.03465):0.00000;
(SRAT:0.04591,SDEV:0.04591):0.00000;
(((SDEV:0.01375,SRAT:0.00686):0.07056,(SDEV:0.01160,SRAT:0.01469):0.45556):0.01277,(SPYO:0.01813,SDYS:0.01264):0.05012,SPLU:0.07455):0.00000;
(SRAT:0.03414,SDEV:0.03414):0.00000;
(SDEV:0.12640,SINT:0.11087,(SRAT:0.19870,SANG:0.11735):0.02832):0.00000;
(SDEV:0.25525,((LLAC:0.24265,SCON:0.23461):0.01401,SENT:0.25154):0.00988,((SCON:0.09101,SVES:0.08854):0.15571,SRAT:0.23399):0.14836):0.00000;
(SDEV:0.05135,(SDOW:0.06139,SRAT:0.05735):0.01030,SPLU:0.14480):0.00000;
((((STHE:0.01963,(SSAL:0.00379,SVES:0.00947):0.00298):0.03090,(SDEV:0.01544,SRAT:0.01966):0.03948):0.00494,((SCAN:0.00823,(SPYO:0.00000,SDYS:0.00000):0.02179):0.04993,SDOW:0.05404):0.01216):0.00352,(((LLAC:0.00000,LCRE:0.00000):0.26435,((SMIT:0.00399,(SPSE:0.00852,SPNE:0.00089):0.00352):0.02258,(SANG:0.03795,(SINT:0.02080,SCON:0.01928):0.01808):0.03602):0.02498):0.02507,(SINF:0.02645,(SLUT:0.03401,SEQU:0.02289):0.01138):0.05114):0.00727,((SSUI:0.02047,SPLU:0.02774):0.03054,SENT:0.06071):0.02721):0.00000;
(SDEV:0.33381,(((LLAC:0.05394,LCRE:0.05348):0.13112,((SLUT:0.01730,SEQU:0.02244):0.02269,SINF:0.03090):0.18024):0.03158,((SDYS:0.05649,SPYO:0.06178):0.18162,SENT:0.24531):0.01661):0.03780,(SMIT:0.36024,(LLAC:0.06548,LCRE:0.06500):0.25122):0.01373):0.00000;
(((((LLAC:0.11130,LCRE:0.11858):0.20055,(((SPSE:0.04816,(SPNE:0.05478,SMIT:0.03809):0.00050):0.19263,(SANG:0.06397,(SINT:0.02687,SCON:0.02195):0.03833):0.14914):0.00814,SSUI:0.24579):0.00881):0.02513,SENT:0.27833):0.02118,((((SLUT:0.04601,SINF:0.04071):0.09288,SEQU:0.13631):0.04879,(SDEV:0.15899,SRAT:0.18466):0.02622):0.00551,SDOW:0.23219):0.01725):0.00428,(SDYS:0.13908,(SPYO:0.05045,SCAN:0.04623):0.07169):0.14293,((SSAL:0.03289,SVES:0.03909):0.03535,STHE:0.08008):0.18048):0.00000;
(((SDEV:0.05505,SRAT:0.05613):0.05227,SDOW:0.17741):0.00486,((((STHE:0.02226,(SSAL:0.00507,SVES:0.00766):0.01101):0.12500,((LCRE:0.06396,LLAC:0.06056):0.10926,(((SMIT:0.00942,(SPSE:0.00361,SPNE:0.00314):0.00969):0.09859,(SANG:0.01706,(SINT:0.00481,SCON:0.00387):0.01785):0.07024):0.03157,SSUI:0.15079):0.00604):0.01172):0.00585,SENT:0.13384):0.00638,(SPLU:0.08292,(SCAN:0.02058,(SPYO:0.01594,SDYS:0.01694):0.00705):0.07074):0.01411):0.00751,((SINF:0.01141,SLUT:0.01616):0.01967,SEQU:0.03406):0.06944):0.00000;
(SDEV:0.05167,SRAT:0.05180,SPLU:0.37472):0.00000;
((SPYO:0.10015,((SDEV:0.06784,SRAT:0.10268):0.16305,(SINT:0.07277,(SCON:0.02488,SANG:0.03221):0.02466):0.28988):0.18996):0.00742,SCAN:0.06973,SDYS:0.07264):0.00000;
(SDEV:0.30944,(SRAT:0.10990,SDOW:0.12820):0.18904,(SDYS:0.05548,SCAN:0.04837):0.20113):0.00000;
(SDEV:0.55372,SSAL:0.03263,SVES:0.02786):0.00000;
((((SSAL:0.02573,SVES:0.03202):0.07707,STHE:0.12548):0.12508,(SDEV:0.07048,SRAT:0.06134):0.16542):0.02044,(SSUI:0.27479,(SPYO:0.16012,(SCAN:0.15946,SDYS:0.17227):0.01431):0.14613):0.01317,(SEQU:0.11716,(SLUT:0.04302,SINF:0.05544):0.06503):0.12341):0.00000;
((SPLU:0.22248,((SDEV:0.05588,SRAT:0.04465):0.08411,SDOW:0.11738):0.07664):0.01761,((SINF:0.02064,SLUT:0.01673):0.14133,((SSUI:0.11516,((STHE:0.03836,SSAL:0.00756):0.00613,SVES:0.01177):0.09747):0.04118,(((SMIT:0.01366,SPSE:0.02765):0.06425,SANG:0.09873):0.04069,SENT:0.29896):0.01396):0.03350):0.02593,(LLAC:0.07530,LCRE:0.07181):0.09811):0.00000;
(SRAT:0.05733,SDEV:0.05733):0.00000;
(SDEV:0.07897,SRAT:0.11539,SDOW:0.26321):0.00000;
((SDEV:0.02226,SRAT:0.03297):0.15229,SPLU:0.20018,LLAC:0.54521):0.00000;
(SRAT:0.08997,SDEV:0.08997):0.00000;
(SRAT:0.02709,SDEV:0.02709):0.00000;
(SDEV:0.02748,SRAT:0.01279,SINT:0.53744):0.00000;
((SDEV:0.07511,SRAT:0.07123):0.25906,SINT:0.27878,SPSE:0.30447):0.00000;
(SRAT:0.13131,SDEV:0.13131):0.00000;
(SRAT:0.04567,SDEV:0.04567):0.00000;
(SRAT:0.07445,SDEV:0.07445):0.00000;
(SRAT:0.01839,SDEV:0.01839):0.00000;
(SRAT:0.08932,SDEV:0.08932):0.00000;
(SRAT:0.04739,SDEV:0.04739):0.00000;
(SRAT:0.05523,SDEV:0.05523):0.00000;
(SRAT:0.05310,SDEV:0.05310):0.00000;
((SDEV:0.02999,SRAT:0.03407):0.26788,(SRAT:0.03061,SDEV:0.04346):0.22792,SINT:0.25117):0.00000;
(SDYS:0.24997,SPYO:0.13035,SCAN:0.10913):0.00000;
((((SPLU:0.08934,SENT:0.08939):0.00752,(SDOW:0.07151,(((STHE:0.00514,SSAL:0.00050):0.00074,SVES:0.00364):0.03868,(SPYO:0.03923,(SCAN:0.01703,SDYS:0.01223):0.01374):0.03966):0.00261):0.01007):0.00335,((((SMIT:0.00529,SPSE:0.00276):0.00332,SPNE:0.00908):0.04036,(SANG:0.02648,(SINT:0.03720,SCON:0.02456):0.01493):0.04329):0.00882,(SDEV:0.02392,SRAT:0.03374):0.07304):0.01058):0.00212,(SINF:0.01409,(SLUT:0.00265,SEQU:0.00043):0.00268):0.04776,((LCRE:0.01856,LLAC:0.00969):0.17839,SSUI:0.06728):0.00636):0.00000;
(SDYS:0.00836,(SCAN:0.00570,SPYO:0.01686):0.00765,SENT:0.22195):0.00000;
((((SINF:0.01051,SLUT:0.02874):0.02255,SEQU:0.05514):0.09814,SDYS:0.19926):0.00858,((SPLU:0.12508,SDOW:0.10940):0.01916,(SDEV:0.00847,SRAT:0.01279):0.15764):0.00997,((SSAL:0.02454,SVES:0.03335):0.17227,(((SMIT:0.01266,(SPSE:0.00254,SPNE:0.00766):0.00545):0.03857,(SANG:0.00776,(SINT:0.01403,SCON:0.00739):0.00616):0.03212):0.06256,SSUI:0.14281):0.04235):0.01020):0.00000;
((((SPNE:0.08330,(SINT:0.00272,SCON:0.00091):0.04998):0.03785,(SSUI:0.02942,SPLU:0.06041):0.04008):0.09925,SDYS:0.00163):0.00203,SPYO:0.00071,SCAN:0.00386):0.00000;
((((SCAN:0.04458,SDYS:0.04722):0.04044,SPYO:0.09863):0.04542,SPYO:0.16039):0.08252,(((SDEV:0.03013,SRAT:0.03217):0.16420,((SSUI:0.18844,((SANG:0.05211,(SINT:0.00167,SCON:0.00157):0.07626):0.08544,(SPNE:0.02286,(SPSE:0.01368,SMIT:0.01761):0.01091):0.16547):0.03128):0.05796,(((LLAC:0.12631,(LLAC:0.02020,LCRE:0.02100):0.09271):0.26344,((STHE:0.02353,(SSAL:0.00854,SVES:0.00970):0.01612):0.23733,SDOW:0.33326):0.01574):0.01763,(SINF:0.04019,(SLUT:0.01551,SEQU:0.01282):0.01800):0.18877):0.02448):0.01209):0.01479,SPLU:0.22955):0.00321,SENT:0.20953):0.00000;
((SDYS:0.05258,SCAN:0.05332):0.07494,(SMIT:0.00767,SPSE:0.00438):0.17279,(LCRE:0.01719,LLAC:0.01316):0.13984):0.00000;
((((SPLU:0.13370,SSUI:0.12694):0.18360,LLAC:0.30302):0.02676,(SENT:0.00368,SENT:0.00330):0.31117):0.00891,((SENT:0.19879,(SMIT:0.01282,(SPSE:0.00176,SPNE:0.00156):0.00955):0.19810):0.15724,((SPNE:0.41935,(((STHE:0.03476,(SSAL:0.00894,SVES:0.00871):0.03380):0.10657,(((SMIT:0.00870,SPSE:0.00860):0.00564,SPNE:0.01815):0.12511,((SPLU:0.10982,SENT:0.12784):0.00956,(((SINT:0.03671,(SANG:0.02174,SCON:0.02198):0.01138):0.06011,SSUI:0.10183):0.02014,((((SINF:0.00832,SLUT:0.01140):0.01610,SEQU:0.02584):0.07809,(SPYO:0.04916,(SCAN:0.02928,SDYS:0.02443):0.02720):0.05802):0.00712,(SDOW:0.08452,(SDEV:0.01789,SRAT:0.01886):0.08199):0.01614):0.00694):0.01074):0.00972):0.00656):0.02963,(LCRE:0.02512,LLAC:0.02419):0.15033):0.20143):0.01473,((SSAL:0.28970,((((SPYO:0.00000,SDYS:0.00000):0.20383,((SSAL:0.01195,SVES:0.00863):0.12519,(((((SMIT:0.00816,(SPSE:0.00518,SPNE:0.00518):0.00351):0.07245,(SANG:0.01159,SCON:0.02087):0.05870):0.01868,SSUI:0.10171):0.01463,SENT:0.11498):0.01202,((SDOW:0.08125,(SDEV:0.01751,SRAT:0.02089):0.07615):0.02628,((SINF:0.03191,(SLUT:0.00467,SEQU:0.00391):0.02984):0.04313,(SPYO:0.06236,(SCAN:0.03236,SDYS:0.03602):0.02205):0.02092):0.02673):0.01794):0.01226):0.07029):0.07893,(SPLU:0.34063,(SDOW:0.28546,SMIT:0.29545):0.00598):0.01269):0.00637,SDOW:0.35095):0.01054):0.02723,(((SENT:0.22539,(SPLU:0.23607,SCON:0.20897):0.02172):0.11290,((SMIT:0.18465,(LLAC:0.18859,((SPNE:0.01154,SPSE:0.00901):0.16937,((SSUI:0.15540,((SMIT:0.00333,SPSE:0.00317):0.00206,SPNE:0.00351):0.16141):0.01285,(SINT:0.13601,(SPLU:0.11827,(SMIT:0.01257,(SMIT:0.00966,SPNE:0.01503):0.00553):0.10276):0.01347):0.02989):0.00929):0.01350):0.00306):0.12497,(SINT:0.22483,SPLU:0.21062):0.09205):0.01562):0.03170,((((SMIT:0.03180,(SPSE:0.01164,SPNE:0.01137):0.02194):0.04818,SANG:0.06590):0.02530,SSUI:0.11398):0.02951,(((STHE:0.01213,(SSAL:0.00334,SVES:0.01083):0.00956):0.07112,SDOW:0.08207):0.02887,((SCAN:0.04269,(SPYO:0.00279,SDYS:0.01150):0.02695):0.06701,(((SPLU:0.06542,SENT:0.07293):0.02137,((SINF:0.00766,SLUT:0.00561):0.01567,SEQU:0.01706):0.06165):0.01160,(SDEV:0.01063,SRAT:0.01686):0.07272):0.00768):0.01518):0.01378):0.16206):0.01153):0.01493):0.01076):0.00798,((((SENT:0.17359,SDOW:0.15868):0.00986,STHE:0.17348):0.07436,(SANG:0.04202,(SINT:0.00441,SCON:0.00653):0.03648):0.19503):0.02459,((((SSAL:0.01048,SVES:0.01009):0.03688,((SMIT:0.00823,SPSE:0.01476):0.00868,SPNE:0.01545):0.02757):0.12663,SSUI:0.19496):0.01319,((SDEV:0.03447,SRAT:0.03957):0.11865,((SDYS:0.00226,SPYO:0.00100):0.02944,SCAN:0.03668):0.13771):0.01733):0.06750):0.06253):0.00000;
(SDYS:0.04344,SPYO:0.13271,SCAN:0.05125):0.00000;
((((SPLU:0.05017,SENT:0.07166):0.00961,(((SCAN:0.02907,SPYO:0.01766):0.01744,SDYS:0.02596):0.02572,(((SINF:0.00754,SLUT:0.00916):0.00597,SEQU:0.00681):0.02294,(SDEV:0.02873,SRAT:0.02225):0.02263):0.01175):0.01310):0.00613,((STHE:0.00247,(SSAL:0.00000,SVES:0.00000):0.00237):0.04249,SDOW:0.06539):0.00881):0.00381,SSUI:0.08364,((LCRE:0.00774,LLAC:0.00697):0.14611,(((SMIT:0.00277,SPSE:0.00812):0.00195,SPNE:0.00350):0.03878,(SANG:0.00859,(SINT:0.00001,SCON:0.00595):0.02321):0.03129):0.01414):0.00801):0.00000;
(SDYS:0.07446,SPYO:0.10347,SCAN:0.13537):0.00000;
((SDOW:0.14762,(((SCAN:0.02485,SDYS:0.03090):0.01654,SPYO:0.04433):0.08726,((SRAT:0.02937,SDEV:0.02060):0.09284,((SINF:0.01096,SLUT:0.01492):0.01676,SEQU:0.02652):0.08741):0.01150):0.01042):0.00255,(SENT:0.15261,SPLU:0.15505):0.01477,((LLAC:0.01238,LCRE:0.01572):0.27174,((((STHE:0.02361,(SSAL:0.01124,SVES:0.01386):0.00742):0.07465,((SANG:0.01318,SINT:0.01671):0.00861,SCON:0.02762):0.04860):0.01797,(SMIT:0.01084,(SPSE:0.00902,SPNE:0.01677):0.00251):0.10115):0.04064,SSUI:0.16325):0.04166):0.03487):0.00000;
(SDYS:0.15419,SDYS:0.15419):0.00000;
(((((SMIT:0.00884,SPSE:0.00803):0.00087,SPNE:0.00725):0.13622,(SINT:0.02114,(SANG:0.01327,SCON:0.01414):0.00804):0.08373):0.03395,(SCAN:0.05164,(SPYO:0.00580,SDYS:0.00340):0.04857):0.04958):0.00770,(SENT:0.09700,(SDEV:0.02161,SRAT:0.02002):0.06220):0.05687,(SSUI:0.06820,SPLU:0.07244):0.04384):0.00000;
(SPSE:0.29206,SDYS:0.29206):0.00000;
((SDYS:0.32156,SDEV:0.44703):0.03980,(SRAT:0.03059,SDEV:0.02787):0.24577,SDEV:0.34457):0.00000;
((((SSUI:0.07323,((SMIT:0.00404,SPSE:0.00499):0.05376,(SCAN:0.01056,SDYS:0.01656):0.06547):0.00524):0.03132,(((LLAC:0.03863,LCRE:0.03612):0.19391,((SCON:0.02938,SANG:0.02614):0.16533,(((SPSE:0.01881,SMIT:0.01749):0.16668,(SDYS:0.03017,SCAN:0.02568):0.13417):0.01363,SSUI:0.16123):0.01442):0.03770):0.22142,(LCRE:0.00602,LLAC:0.00895):0.12473):0.02330):0.01456,(SDEV:0.09675,SDOW:0.06793):0.01107):0.00700,(SANG:0.02790,SCON:0.03498):0.04411,(SSAL:0.01847,SVES:0.01280):0.07220):0.00000;
((SDYS:0.00575,SPYO:0.00905):0.00608,SCAN:0.02238,((SPNE:0.03522,(SINT:0.00173,SCON:0.00243):0.04156):0.07627,(SSUI:0.05702,SPLU:0.06463):0.08613):0.12972):0.00000;
(SDYS:0.00000,SPYO:0.09492,SCAN:0.00000):0.00000;
(SDYS:0.57363,SDYS:0.06067,SPYO:0.06674):0.00000;
(SPSE:0.04308,SPSE:0.04308):0.00000;
(SPSE:0.04034,SPSE:0.04034):0.00000;
(SPSE:0.00710,SENT:0.33270,SPNE:0.00914):0.00000;
(SANG:0.28804,SPSE:0.28804):0.00000;
(SPSE:0.15706,SPYO:0.17969,STHE:0.21909):0.00000;
(SPNE:0.09857,SPSE:0.09857):0.00000;
(SPSE:0.12988,SPSE:0.12988):0.00000;
((SPSE:0.06938,SPSE:0.03760):0.07052,SPSE:0.17115,SPSE:0.10437):0.00000;
((SINT:0.01086,((SMIT:0.01624,SPNE:0.01559):0.34797,(SRAT:0.03206,SDEV:0.01251):0.29208):0.29510):0.01029,SCON:0.00000,SANG:0.00000):0.00000;
((((((SANG:0.06783,SMIT:0.03798):0.04284,SENT:0.09145):0.21673,(LLAC:0.01128,LCRE:0.01249):0.07455):0.02182,((SPSE:0.00962,SPNE:0.00417):0.00725,SMIT:0.00774):0.07942):0.02991,(SDEV:0.01413,SRAT:0.02516):0.03268):0.00332,(((STHE:0.00518,SSAL:0.00064):0.00379,SVES:0.00395):0.03744,SDOW:0.05401):0.00989,(SINF:0.00899,SEQU:0.00367):0.03685):0.00000;
(SMIT:0.00000,(SPNE:0.01792,SINT:0.03801):0.00002,SPSE:0.00000):0.00000;
(((SMIT:0.19860,LLAC:0.25360):0.03346,(SDEV:0.14553,SRAT:0.13956):0.09493):0.01550,(SANG:0.15115,(SCON:0.02166,SINT:0.03531):0.11909):0.04199,(SVES:0.02771,SSAL:0.02005):0.16708):0.00000;
((SMIT:0.11638,SINF:0.08168):0.01457,SENT:0.07539,(LCRE:0.31341,SSAL:0.30882):0.06811):0.00000;
((SDYS:0.12733,SMIT:0.25949):0.01728,SPNE:0.12806,SEQU:0.20954):0.00000;
((SPLU:0.07482,SSUI:0.06739):0.06106,(((SCAN:0.03718,SDYS:0.04787):0.16023,(((LLAC:0.05288,LCRE:0.05372):0.16239,SENT:0.18823):0.10810,((SPYO:0.03024,(SCAN:0.02462,SDYS:0.02630):0.00702):0.14032,(((SINF:0.01086,SLUT:0.00787):0.02549,SEQU:0.03598):0.11484,SDOW:0.15976):0.01995):0.13802):0.15530):0.06013,(SSAL:0.00963,(STHE:0.01199,SVES:0.00755):0.00537):0.14369):0.01064,(((SPSE:0.00120,SMIT:0.00064):0.00396,SPNE:0.00893):0.08515,(SANG:0.03498,(SINT:0.00710,SCON:0.00710):0.03927):0.04607):0.02715):0.00000;
((LLAC:0.02465,LCRE:0.01685):0.31415,((((SPSE:0.01551,SMIT:0.01315):0.00622,SPNE:0.02475):0.13487,SVES:0.14359):0.14648,((((SEQU:0.09823,(SLUT:0.01368,SINF:0.01470):0.09800):0.10233,(SRAT:0.11705,SDEV:0.11628):0.09193):0.03291,(((SSAL:0.02441,SVES:0.02593):0.00473,STHE:0.04289):0.13473,SPLU:0.20016):0.04482):0.01717,(SDOW:0.24996,(SENT:0.24552,((SPYO:0.02141,SDYS:0.02576):0.10794,SCAN:0.11847):0.11870):0.04004):0.00173):0.02657):0.01483,(((((SANG:0.02932,SCON:0.03831):0.01727,SINT:0.05900):0.23850,SSUI:0.27391):0.02721,SENT:0.28455):0.07116,((SINF:0.02530,SPLU:0.01658):0.08074,SINF:0.10962):0.18333):0.00810):0.00000;
(SMIT:0.00400,SPSE:0.01367,SVES:0.57215):0.00000;
((((SRAT:0.02077,SDEV:0.01868):0.15717,(((SINF:0.02145,SLUT:0.01218):0.05024,SEQU:0.06966):0.07908,(SCAN:0.03809,(SPYO:0.00000,SDYS:0.00000):0.03628):0.12302):0.02328):0.02127,((SSUI:0.20436,(SPLU:0.13993,SENT:0.16379):0.02460):0.00786,(((SINT:0.00555,SCON:0.00381):0.02718,SANG:0.03372):0.08607,((SPSE:0.00173,SMIT:0.00107):0.00164,SPNE:0.00397):0.15267):0.05315):0.00990):0.01367,(((SSAL:0.00533,SVES:0.00552):0.03579,STHE:0.04923):0.12633,SDOW:0.16123):0.00859,(LLAC:0.02811,LCRE:0.03204):0.20349):0.00000;
(SSUI:0.12438,(SDOW:0.12424,((SINF:0.01442,SLUT:0.02103):0.01349,SEQU:0.02423):0.08639):0.00627,(((SSAL:0.02329,(STHE:0.02872,SVES:0.02044):0.01152):0.03480,(SDEV:0.05845,SRAT:0.05697):0.01544):0.05960,((((LLAC:0.07791,LCRE:0.06389):0.14375,((SMIT:0.06809,SPSE:0.06431):0.22111,SDYS:0.23221):0.02630):0.00368,SPLU:0.20550):0.04040,(SANG:0.07255,(SINT:0.02389,SCON:0.01422):0.06009):0.09827):0.01553):0.00938):0.00000;
(SMIT:0.00214,SPNE:0.05717,SPSE:0.04304):0.00000;
(SMIT:0.06965,SPNE:0.06066,SPSE:0.02126):0.00000;
((((SDYS:0.07038,SCAN:0.05845):0.15284,(SSAL:0.00402,SVES:0.02170):0.10294):0.02342,(SMIT:0.17082,SSUI:0.13046):0.04175):0.03760,(SDOW:0.11672,(SRAT:0.01818,SDEV:0.02337):0.12606):0.00724,SPLU:0.16923):0.00000;
((SMIT:0.03051,((SSUI:0.01478,SPLU:0.03127):0.04026,SDEV:0.18566):0.03936):0.00898,SINT:0.02493,SVES:0.01969):0.00000;
(SPNE:0.18644,SMIT:0.18644):0.00000;
(SMIT:0.07942,(SMIT:0.12324,SPSE:0.08642):0.02970,SMIT:0.04716):0.00000;
(SMIT:0.01062,SPSE:0.05096,SMIT:0.18246):0.00000;
((SPSE:0.23391,((SPLU:0.25573,((SPSE:0.01277,SMIT:0.00892):0.00749,SPNE:0.02236):0.23861):0.14763,SINF:0.25020):0.05752):0.17013,(SCON:0.00612,SANG:0.00714):0.01661,SINT:0.02605):0.00000;
(SDEV:0.14161,SMIT:0.14161):0.00000;
(SCON:0.33267,SMIT:0.33267):0.00000;
((SPNE:0.09508,SMIT:0.26666):0.07499,(SPNE:0.03385,SMIT:0.02641):0.04929,SPSE:0.07743):0.00000;
(SMIT:0.05772,(SPSE:0.02883,SPNE:0.02261):0.09370,(SDYS:0.03376,SCAN:0.02690):0.37859):0.00000;
(SPNE:0.33979,SMIT:0.33979):0.00000;
(((((SVES:0.04643,SSAL:0.04960):0.24974,(SEQU:0.05964,(SLUT:0.01110,SINF:0.01338):0.05462):0.19547):0.01811,(SSUI:0.30194,((SANG:0.05755,(SINT:0.01142,SCON:0.00923):0.05266):0.18356,((SMIT:0.02812,SPNE:0.03543):0.00591,SPSE:0.04194):0.15832):0.02513):0.11606):0.00709,SDYS:0.27315):0.00531,(SPLU:0.27050,SDOW:0.30392):0.01470,(SENT:0.27014,(SRAT:0.06842,SDEV:0.06121):0.17258):0.03529):0.00000;
(SSAL:0.12656,SMIT:0.12656):0.00000;
(SMIT:0.03297,SPSE:0.00983,SSAL:0.41234):0.00000;
((((SVES:0.06786,(SSAL:0.03110,STHE:0.03333):0.01790):0.24199,SSUI:0.26178):0.02834,((LCRE:0.08999,LLAC:0.10852):0.22501,((SANG:0.08588,(SINT:0.01838,SCON:0.01484):0.09751):0.08961,(SMIT:0.03440,(SPSE:0.00536,SPNE:0.00875):0.02433):0.18463):0.05123):0.01432):0.00632,(SPLU:0.28423,((SEQU:0.10400,(SLUT:0.05473,SINF:0.04617):0.05198):0.13520,(SENT:0.22374,SDOW:0.22494):0.01348):0.00774):0.00953,(SRAT:0.10227,SDEV:0.10541):0.15715):0.00000;
(((SANG:0.02801,SCON:0.02883):0.19823,(SMIT:0.02205,SPSE:0.01187):0.21939):0.03933,(SCAN:0.04565,SDYS:0.03295):0.09624,SSUI:0.20585):0.00000;
(SENT:0.18776,SMIT:0.18776):0.00000;
((SPLU:0.19865,SMIT:0.28406):0.02076,SENT:0.20536,(SSUI:0.17132,(SANG:0.14387,((SVES:0.07537,SSUI:0.06919):0.00225,SCAN:0.07165):0.07617):0.03925):0.00761):0.00000;
(SVES:0.02104,(SSUI:0.03697,SCAN:0.02097):0.00633,((SSUI:0.15884,SENT:0.11820):0.06255,((SANG:0.24978,(SDYS:0.07100,SPLU:0.07024):0.21819):0.08242,SMIT:0.17094):0.03769):0.11620):0.00000;
(((SDEV:0.01404,SRAT:0.02127):0.06217,(SPLU:0.26608,(SMIT:0.02428,SPNE:0.00360):0.17452):0.04521):0.01896,(SCAN:0.04331,SPYO:0.10939):0.06806,(SANG:0.04262,(SINT:0.00895,SCON:0.00974):0.02932):0.09679):0.00000;
(SMIT:0.00708,((SPSE:0.00959,SPNE:0.00812):0.35370,SCAN:0.12256):0.12271,SPNE:0.01310):0.00000;
(((SMIT:0.02761,SPNE:0.02196):0.17422,SCAN:0.19757):0.12627,((((SCON:0.00540,SANG:0.00366):0.06068,SINT:0.05482):0.11045,(SMIT:0.03989,(SPSE:0.00510,SPNE:0.00392):0.03215):0.12210):0.11450,(SPLU:0.20782,(SPYO:0.07437,(SDYS:0.03812,SCAN:0.03711):0.04972):0.15153):0.01571):0.00946,(SSUI:0.19150,SENT:0.18295):0.05322):0.00000;
(SMIT:0.29512,SDOW:0.29657,SSAL:0.45515):0.00000;
(SMIT:0.34176,SMIT:0.34176):0.00000;
(((SDEV:0.04098,SDOW:0.06295):0.00831,((SMIT:0.00766,SPSE:0.00257):0.06349,((STHE:0.01569,SVES:0.00165):0.02921,SPLU:0.04018):0.00933):0.00336):0.00298,SRAT:0.03091,SSUI:0.04941):0.00000;
(SMIT:0.03017,(((SINT:0.06509,SCON:0.05296):0.05519,SANG:0.07966):0.35957,SPNE:0.04024):0.00550,SPSE:0.02886):0.00000;
((SCON:0.48888,SMIT:0.00189):0.00231,SPNE:0.00482,SPSE:0.00189):0.00000;
((SPSE:0.00441,SMIT:0.00545):0.00616,SPNE:0.01212,SCON:0.63703):0.00000;
(SMIT:0.01650,SPNE:0.05344,SPSE:0.00641):0.00000;
(SMIT:0.00804,(SPSE:0.00653,SPNE:0.01207):0.00296,SDEV:0.30894):0.00000;
((SPSE:0.02923,SMIT:0.01214):0.00864,SPNE:0.02293,(SENT:0.43694,(SMIT:0.01563,(SPSE:0.00906,SPNE:0.01405):0.00681):0.37013):0.23902):0.00000;
(SMIT:0.01373,(SPSE:0.00602,SPNE:0.01839):0.00441,SPLU:0.38553):0.00000;
(SPSE:0.00673,SMIT:0.00673):0.00000;
((SPLU:0.33141,((SINT:0.02279,(SCON:0.01633,SANG:0.02173):0.01397):0.23452,((SPSE:0.05731,SMIT:0.04483):0.00747,SPNE:0.05262):0.25785):0.03303):0.01617,SDOW:0.34999,(SSAL:0.03599,SVES:0.03432):0.29390):0.00000;
(((SINT:0.00549,(SANG:0.00000,SCON:0.00000):0.00245):0.15533,(((SPSE:0.01433,SMIT:0.01390):0.01351,SPNE:0.03980):0.14606,(SEQU:0.35124,(SDOW:0.16813,(SDEV:0.07734,SRAT:0.07924):0.08945):0.33643):0.09218):0.01587):0.01098,((SCAN:0.06017,SDYS:0.05826):0.12743,(SPLU:0.13227,SSUI:0.13528):0.01963):0.00758,(SSAL:0.00733,SVES:0.01941):0.15511):0.00000;
(((SMIT:0.03213,(SPSE:0.01556,SPNE:0.01711):0.01580):0.16636,(SPYO:0.08886,(SCAN:0.05901,SDYS:0.05065):0.04338):0.17117):0.00983,SSAL:0.18801,(SANG:0.06902,SINT:0.06513):0.09295):0.00000;
((SMIT:0.17482,SPSE:0.12219):0.27512,SDYS:0.11123,(SCAN:0.08899,SPYO:0.09230):0.01995):0.00000;
(SPSE:0.00742,SMIT:0.00742):0.00000;
((((SDOW:0.15284,(((SSAL:0.03825,(STHE:0.00731,SVES:0.00546):0.02237):0.06120,((SINF:0.01919,SLUT:0.01931):0.01145,SEQU:0.02417):0.06250):0.00766,((SCAN:0.02336,SPYO:0.01938):0.00847,SDYS:0.02860):0.06800):0.00780):0.01643,((LLAC:0.00630,LCRE:0.00970):0.19352,((LLAC:0.04212,LCRE:0.04457):0.19019,((SDOW:0.16638,(SENT:0.17330,(((SPLU:0.12139,((SANG:0.06026,(SINT:0.01066,SCON:0.00603):0.04571):0.06451,SSUI:0.12087):0.01244):0.01074,((SRAT:0.10045,SDEV:0.10364):0.01802,((SSAL:0.01127,(STHE:0.00928,SVES:0.01107):0.00607):0.07461,(SINF:0.02786,(SLUT:0.00917,SEQU:0.00741):0.02024):0.04957):0.03805):0.00346):0.01349,(SCAN:0.03999,(SDYS:0.02891,SPYO:0.03611):0.00878):0.12741):0.01770):0.00883):0.01440,((SPSE:0.00537,SMIT:0.00292):0.00311,SPNE:0.00957):0.18903):0.01774):0.28994):0.08301):0.00467,((SENT:0.10734,SPLU:0.10598):0.00370,(SRAT:0.04884,SDEV:0.05457):0.07065):0.01722):0.00449,SSUI:0.13638,((SMIT:0.00667,(SPSE:0.00117,SPNE:0.00153):0.00626):0.06214,(SANG:0.02681,(SINT:0.03083,SCON:0.02099):0.00475):0.05369):0.04532):0.00000;
(SMIT:0.02024,(SPSE:0.01101,SPNE:0.00767):0.00552,(SINT:0.17444,(((SCAN:0.03959,SPYO:0.05327):0.02245,SDYS:0.06401):0.32289,SSUI:0.33867):0.11891):0.15677):0.00000;
(SMIT:0.05664,SPNE:0.07727,SPSE:0.16004):0.00000;
(SPNE:0.11573,SMIT:0.11573):0.00000;
(SMIT:0.05378,SPNE:0.01930,SPSE:0.06116):0.00000;
(SMIT:0.02193,SPNE:0.03013,SPSE:0.01359):0.00000;
(SMIT:0.04469,(SPSE:0.01326,SPNE:0.01879):0.01665,((SPLU:0.06129,SSUI:0.04941):0.14249,((SSUI:0.18497,SENT:0.19129):0.06628,SDYS:0.28327):0.03020):0.15946):0.00000;
(SMIT:0.01720,SPNE:0.18100,SPSE:0.01495):0.00000;
(SMIT:0.04495,SPNE:0.01866,SPSE:0.01056):0.00000;
(SMIT:0.33077,SMIT:0.33077):0.00000;
(SMIT:0.04668,SPNE:0.02889,SPSE:0.03105):0.00000;
(SMIT:0.05713,SPNE:0.02323,SPSE:0.03214):0.00000;
(((SCAN:0.02144,(SPYO:0.03072,SDYS:0.03542):0.00260):0.04134,((((((SMIT:0.00000,SPSE:0.00000):0.00018,SPNE:0.00300):0.05531,(SINT:0.01696,(SANG:0.02708,SCON:0.02163):0.00452):0.05168):0.00367,SSUI:0.05766):0.00381,((LCRE:0.00775,LLAC:0.00616):0.09542,SENT:0.39637):0.02866):0.01942,(SDEV:0.03475,SRAT:0.02131):0.01905):0.00371):0.00111,SDOW:0.03986,((STHE:0.00943,(SSAL:0.00367,SVES:0.00845):0.00296):0.02669,((SINF:0.00185,SLUT:0.00235):0.01149,SEQU:0.02132):0.01526):0.01005):0.00000;
(((((((SMIT:0.01288,SPSE:0.01778):0.00553,SPNE:0.00801):0.03461,(SINT:0.04150,(SANG:0.03524,SCON:0.03126):0.01069):0.01781):0.02008,SSUI:0.08600):0.03269,(((((SSUI:0.09090,(((SANG:0.03524,(SINT:0.00986,SCON:0.01091):0.02996):0.02928,SDOW:0.06680):0.00492,(((SSAL:0.01762,(STHE:0.00596,SVES:0.00713):0.00345):0.04919,((SINF:0.01134,SLUT:0.00492):0.00329,SEQU:0.01016):0.04137):0.01961,(SDEV:0.05835,SRAT:0.04778):0.01594):0.00650):0.01113):0.01173,(SMIT:0.01217,(SPSE:0.00358,SPNE:0.00585):0.00410):0.08050):0.04722,(LLAC:0.02056,LCRE:0.02723):0.12080):0.46185,(LLAC:0.01754,LCRE:0.01614):0.13641):0.03161,SENT:0.16877):0.04433):0.02311,((SSAL:0.00817,SVES:0.00105):0.00848,STHE:0.01362):0.04909):0.01490,((((SINF:0.01118,SLUT:0.00910):0.01801,SEQU:0.02819):0.03777,SDOW:0.05016):0.00710,(SDEV:0.03895,SRAT:0.03901):0.02300):0.00575,(SCAN:0.04850,(SPYO:0.01102,SDYS:0.00920):0.04375):0.05246):0.00000;
((SDOW:0.23072,(((LLAC:0.00475,LCRE:0.00273):0.32625,SENT:0.25574):0.00847,(SPLU:0.21378,SSUI:0.23932):0.02306):0.01233):0.00990,((((STHE:0.01590,(SSAL:0.00000,SVES:0.00000):0.01390):0.14648,((SINF:0.00723,SLUT:0.00820):0.02120,SEQU:0.02585):0.12136):0.02503,(SDEV:0.02526,SRAT:0.02187):0.13253):0.01232,((SANG:0.02424,(SINT:0.00958,SCON:0.00775):0.02224):0.09315,(SMIT:0.02243,(SPNE:0.02390,SPSE:0.02032):0.00632):0.13084):0.05637):0.00470,(SCAN:0.02482,(SPYO:0.01612,SDYS:0.01620):0.00498):0.15609):0.00000;
((((SVES:0.02171,SMIT:0.02342):0.13720,SENT:0.17277):0.07906,SANG:0.08031):0.05561,(SDYS:0.01538,SPLU:0.02942):0.00572,SSUI:0.02517):0.00000;
(((((SSAL:0.01364,SVES:0.01209):0.01602,STHE:0.02251):0.23358,(SRAT:0.05354,SDEV:0.04882):0.17373):0.05144,SENT:0.34669):0.03257,(SPLU:0.25810,SSUI:0.21169):0.05152,(SCAN:0.06021,(SPYO:0.04830,SDYS:0.04178):0.02800):0.18735):0.00000;
(SPLU:0.00951,SENT:0.00951):0.00000;
((((SDOW:0.20567,(((STHE:0.02446,(SSAL:0.00874,SVES:0.01485):0.00821):0.12428,(SPLU:0.17523,((SINF:0.00393,SLUT:0.00650):0.03066,SEQU:0.03773):0.09608):0.01536):0.01216,((SCAN:0.05543,SDYS:0.04960):0.04720,SPYO:0.12371):0.11654):0.01783):0.02011,(((SPSE:0.00536,SMIT:0.00531):0.22680,(SENT:0.16781,SSUI:0.15746):0.05841):0.02579,(SENT:0.15689,SSUI:0.15770):0.11337):0.16547):0.01875,((SDEV:0.02074,SRAT:0.02391):0.10835,SENT:0.15912):0.02896):0.00529,((SMIT:0.01666,(SPSE:0.01294,SPNE:0.00955):0.01298):0.08027,(SANG:0.03082,(SINT:0.01029,SCON:0.01147):0.02839):0.06992):0.08302,SSUI:0.19156):0.00000;
(SSUI:0.10860,SENT:0.10860):0.00000;
((((SVES:0.08308,(SANG:0.00317,SCON:0.00808):0.06505):0.01399,(SRAT:0.00196,SRAT:0.00000):0.04232):0.01933,SENT:0.03205):0.00179,(SSUI:0.00661,SSUI:0.01257):0.02329,SSUI:0.02271):0.00000;
((SPLU:0.02911,SDYS:0.02956):0.00718,(((SVES:0.00651,(SMIT:0.00000,SPNE:0.00000):0.00651):0.35817,SANG:0.05484):0.02199,SSUI:0.06495):0.03022,SSUI:0.01282):0.00000;
(SEQU:0.06973,SPLU:0.06973):0.00000;
(SEQU:0.27225,SPLU:0.27225):0.00000;
(SPLU:0.04762,SDYS:0.21647,SSUI:0.04378):0.00000;
(LLAC:0.27293,SPLU:0.27293):0.00000;
(SSUI:0.10684,SPLU:0.10684):0.00000;
((((SCAN:0.00537,(SPYO:0.00576,SDYS:0.00260):0.00494):0.04045,SPLU:0.04495):0.00525,((STHE:0.01112,(SSAL:0.00066,SVES:0.00603):0.00673):0.03708,(((SINF:0.00211,SLUT:0.00292):0.00203,SEQU:0.00273):0.02333,SDOW:0.04039):0.00470):0.00584):0.00350,SDEV:0.06068,((((LCRE:0.00331,LLAC:0.00613):0.17130,((SMIT:0.00160,(SPSE:0.00055,SPNE:0.00224):0.00286):0.02380,(SANG:0.01252,(SINT:0.00432,SCON:0.00293):0.00867):0.02133):0.05301):0.00988,SSUI:0.06910):0.00215,SENT:0.06940):0.01720):0.00000;
(SRAT:0.17498,SPLU:0.17498):0.00000;
(LLAC:0.04043,LCRE:0.04043):0.00000;
(LLAC:0.00560,LCRE:0.00560):0.00000;
(LLAC:0.20531,LCRE:0.20531):0.00000;
((((SENT:0.13772,(((SMIT:0.00000,SPSE:0.00000):0.00252,SPNE:0.00759):0.11588,(SINT:0.04781,(SANG:0.01200,SCON:0.02207):0.01018):0.08251):0.02645):0.01178,SSUI:0.16130):0.01547,((STHE:0.02263,(SSAL:0.00587,SVES:0.01246):0.00740):0.10038,(LCRE:0.00290,LLAC:0.00747):0.23287):0.01546):0.00924,((SDEV:0.02588,SRAT:0.06549):0.07245,((SPYO:0.07181,(SCAN:0.03703,SDYS:0.04067):0.01634):0.03257,((SINF:0.01393,SEQU:0.01333):0.00233,SLUT:0.02316):0.07126):0.01689):0.00275,(SPLU:0.11139,SDOW:0.14619):0.00894):0.00000;
(((SPLU:0.11379,(SENT:0.17538,((((SMIT:0.04824,(SPSE:0.00787,SPNE:0.00534):0.04871):0.06358,(SANG:0.01640,(SINT:0.01259,SCON:0.01439):0.00472):0.07283):0.02884,SSUI:0.14599):0.01037,(LCRE:0.01584,LLAC:0.01700):0.27557):0.01785):0.01561):0.01599,SDOW:0.11624):0.00415,(((SINF:0.00455,SLUT:0.00605):0.01194,SEQU:0.01330):0.04143,(SPYO:0.02991,(SCAN:0.01422,SDYS:0.01416):0.00936):0.04139):0.01695,((SDEV:0.00639,SRAT:0.00925):0.06976,(SSAL:0.01433,(STHE:0.01908,SVES:0.01328):0.00545):0.07024):0.01100):0.00000;
(LLAC:0.00831,LCRE:0.00831):0.00000;
(LLAC:0.02623,LCRE:0.02623):0.00000;
(((SSUI:0.04346,((SPNE:0.03761,(SANG:0.00578,(SINT:0.00640,SCON:0.00545):0.00086):0.03791):0.03838,(LCRE:0.00538,LLAC:0.00399):0.47076):0.01493):0.00619,SRAT:0.06560):0.03933,(SPYO:0.00126,SDYS:0.00016):0.00175,SCAN:0.00205):0.00000;
(LLAC:0.04479,LCRE:0.04479):0.00000;
(((SENT:0.02125,(((STHE:0.00000,(SSAL:0.00000,SVES:0.00000):0.00000):0.00361,SPLU:0.03413):0.01776,(((SINF:0.01423,(SLUT:0.00674,SEQU:0.00778):0.00444):0.02642,((LCRE:0.01473,LLAC:0.00001):0.19471,(((SANG:0.00000,SINT:0.00000):0.00032,SCON:0.01618):0.03350,((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.00704,SSUI:0.07629):0.01066):0.01652):0.01844):0.00591,(SDOW:0.03243,(SDEV:0.01730,SRAT:0.00145):0.02147):0.00613):0.00395):0.00885):0.00391,SDYS:0.00000):0.00000,SPYO:0.00000,SCAN:0.00000):0.00000;
(((SENT:0.16378,SDOW:0.20796):0.02090,(((SPSE:0.01123,(SMIT:0.00738,SPNE:0.01041):0.00515):0.10623,(SANG:0.06792,(SINT:0.03220,SCON:0.03174):0.02544):0.07472):0.06178,((LCRE:0.04955,LLAC:0.03437):0.25457,SSUI:0.23746):0.01371):0.02079):0.00151,((SDEV:0.02310,SRAT:0.02019):0.10995,(((STHE:0.03849,SSAL:0.01767):0.01241,SVES:0.04653):0.16459,((SPYO:0.04327,(SCAN:0.01019,SDYS:0.00622):0.01834):0.10400,((SINF:0.02031,SLUT:0.01953):0.02249,SEQU:0.03965):0.10492):0.03613):0.00826):0.01243,SPLU:0.21612):0.00000;
((SPLU:0.10093,((SPYO:0.03640,(SCAN:0.00752,SDYS:0.00796):0.01548):0.08051,(((SINF:0.00753,SLUT:0.01067):0.01021,SEQU:0.01709):0.08162,(((STHE:0.01192,(SSAL:0.00620,SVES:0.00996):0.00306):0.09974,SDOW:0.11146):0.01046,(SENT:0.13729,(LCRE:0.01767,LLAC:0.01719):0.22183):0.03044):0.00634):0.01038):0.00419):0.00378,(SSUI:0.12719,((SANG:0.00994,(SINT:0.01628,SCON:0.01552):0.00326):0.07858,(SPSE:0.00300,(SMIT:0.00000,SPNE:0.00000):0.00155):0.10628):0.01187):0.04333,(SDEV:0.00890,SRAT:0.00651):0.09211):0.00000;
(((SENT:0.29888,((((SMIT:0.00944,SPSE:0.01913):0.00904,SPNE:0.03081):0.06220,(SCON:0.01138,(SANG:0.00761,SINT:0.00688):0.00882):0.07860):0.11209,(LCRE:0.02104,LLAC:0.02492):0.30032):0.01788):0.01609,(SPLU:0.19950,((SRAT:0.07312,SDEV:0.08674):0.13035,((SCAN:0.05404,SDYS:0.04716):0.02565,SPYO:0.06856):0.09026):0.02642):0.01437):0.00760,(SSUI:0.24835,((SINF:0.01618,SLUT:0.00067):0.06770,SEQU:0.07098):0.11004):0.01071,(SSAL:0.02996,(SVES:0.02215,STHE:0.02246):0.01280):0.32869):0.00000;
(LLAC:0.09424,LCRE:0.09424):0.00000;
(LLAC:0.00000,LCRE:0.00000):0.00000;
(((((SEQU:0.11462,(SLUT:0.09198,SINF:0.04405):0.06645):0.08624,(SDYS:0.00845,SCAN:0.00815):0.19268):0.02905,(SRAT:0.01350,SDEV:0.00984):0.19020):0.05851,(LCRE:0.01072,LLAC:0.00398):0.30315):0.01066,SSUI:0.24193,((SPSE:0.00715,(SMIT:0.00451,SPNE:0.00973):0.00710):0.19857,(SANG:0.02509,(SINT:0.01551,SCON:0.00986):0.02206):0.12616):0.03361):0.00000;
((SENT:0.16215,(((SMIT:0.00400,(SPSE:0.00000,SPNE:0.00000):0.00272):0.05065,(SINT:0.00721,(SANG:0.00791,SCON:0.00677):0.00178):0.06277):0.08934,(LCRE:0.00311,LLAC:0.00498):0.27130):0.01276):0.00975,(SPLU:0.13308,(((SLUT:0.00426,(SINF:0.00264,SEQU:0.00381):0.00378):0.05991,(SDEV:0.02473,SRAT:0.01875):0.04602):0.02123,((SPYO:0.03693,(SCAN:0.00622,SDYS:0.01166):0.01643):0.07574,(SSAL:0.01265,(STHE:0.02050,SVES:0.01618):0.00809):0.10056):0.00649):0.02026):0.01771,(SSUI:0.10249,SDOW:0.14298):0.01688):0.00000;
(LLAC:0.00490,LCRE:0.00490):0.00000;
((SSUI:0.07526,((SDEV:0.00025,SRAT:0.00095):0.07070,(SDOW:0.08665,(LCRE:0.01950,LLAC:0.01638):0.39112):0.00875):0.00372):0.00512,(((SANG:0.00129,(SINT:0.00000,SCON:0.00000):0.00373):0.08179,(SCAN:0.01481,(SPYO:0.00469,SDYS:0.00234):0.01785):0.06155):0.01151,(((STHE:0.02781,(SSAL:0.00685,SVES:0.00008):0.01612):0.07186,(SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.08427):0.00700,((SINF:0.00502,SLUT:0.00968):0.02340,SEQU:0.02348):0.06636):0.00653):0.00075,(SPLU:0.07628,SENT:0.11414):0.01812):0.00000;
(LLAC:0.00000,LCRE:0.00000):0.00000;
(LLAC:0.11626,LCRE:0.11626):0.00000;
(LLAC:0.08859,LCRE:0.08859):0.00000;
(LCRE:0.04750,LLAC:0.02432,SDEV:0.60813):0.00000;
(LLAC:0.02704,LCRE:0.02704):0.00000;
(LLAC:0.00302,LCRE:0.00302):0.00000;
(LLAC:0.05697,LCRE:0.05697):0.00000;
(LLAC:0.06314,LCRE:0.06314):0.00000;
(LLAC:0.05442,LCRE:0.05442):0.00000;
(LLAC:0.00046,LCRE:0.00046):0.00000;
((SPLU:0.16179,((LCRE:0.09034,LLAC:0.08294):0.19705,(SPNE:0.02076,SMIT:0.01458):0.23810):0.23635):0.04821,(SENT:0.12289,SSUI:0.11312):0.01759,(SINT:0.00236,SCON:0.00406):0.12908):0.00000;
((LCRE:0.01090,LLAC:0.00898):0.39381,(SPYO:0.00935,SCAN:0.01449):0.20368,SSUI:0.20230):0.00000;
(LLAC:0.05763,LCRE:0.05763):0.00000;
(LLAC:0.07122,LCRE:0.07122):0.00000;
(LLAC:0.03786,LCRE:0.03786):0.00000;
(LLAC:0.22075,LCRE:0.22075):0.00000;
(LLAC:0.12478,LCRE:0.12478):0.00000;
(LLAC:0.28661,LCRE:0.28661):0.00000;
(((((LCRE:0.00734,LLAC:0.01208):0.27048,((((SMIT:0.00127,SPSE:0.00604):0.00944,SPNE:0.00981):0.08151,(SANG:0.02637,(SINT:0.00424,SCON:0.00406):0.03205):0.04861):0.02522,SSUI:0.10722):0.01333):0.02780,(SENT:0.11541,(SDEV:0.05224,SRAT:0.04348):0.07963):0.00614):0.01286,SDOW:0.12221):0.01121,((SINF:0.01540,(SLUT:0.01641,SEQU:0.00883):0.00393):0.07349,(SPLU:0.06725,(SPYO:0.02906,(SCAN:0.02434,SDYS:0.01933):0.00423):0.06733):0.01657):0.00339,(STHE:0.02341,(SSAL:0.00433,SVES:0.01268):0.00629):0.06012):0.00000;
(LCRE:0.07194,LLAC:0.09300,SMIT:0.59139):0.00000;
(LLAC:0.06284,LCRE:0.06284):0.00000;
(((LCRE:0.02570,LLAC:0.02245):0.25588,((SINF:0.11590,SEQU:0.10127):0.12755,SDOW:0.27348):0.20575):0.01809,SANG:0.30465,(LLAC:0.06471,LCRE:0.07503):0.25573):0.00000;
(((LCRE:0.04434,LLAC:0.04974):0.39314,((SDEV:0.04963,SRAT:0.05636):0.07601,SANG:0.14207):0.06220):0.01335,SDOW:0.17462,((SMIT:0.06612,(SVES:0.03785,SSAL:0.03127):0.01888):0.09662,SENT:0.15221):0.01990):0.00000;
(((SCAN:0.06840,SDYS:0.06790):0.13469,(SSUI:0.22245,(((SANG:0.07419,(SINT:0.01446,SCON:0.01992):0.08711):0.11420,(SMIT:0.04672,(SPSE:0.04335,SPNE:0.04713):0.00848):0.14924):0.01230,(LCRE:0.04700,LLAC:0.06321):0.28710):0.01479):0.00884):0.00713,((SSAL:0.07257,(STHE:0.02538,SVES:0.02827):0.03429):0.12537,(SDOW:0.16009,(SRAT:0.13796,SDEV:0.13146):0.02564):0.01902):0.01729,(SEQU:0.07735,(SINF:0.03939,SLUT:0.03637):0.04861):0.09048):0.00000;
(LLAC:0.08686,LCRE:0.08686):0.00000;
((LCRE:0.01652,LLAC:0.01680):0.39483,SDOW:0.15672,SDYS:0.17180):0.00000;
(LLAC:0.09868,LCRE:0.09868):0.00000;
(LLAC:0.03065,LCRE:0.03065):0.00000;
((((SINF:0.00552,SLUT:0.00851):0.00190,SEQU:0.00818):0.01660,(SDOW:0.04015,((SSUI:0.02290,SPLU:0.01297):0.02337,(((SANG:0.04092,SINT:0.04607):0.02293,((SPSE:0.00522,(SMIT:0.00214,SPNE:0.00140):0.00054):0.04258,SENT:0.06870):0.00617):0.01267,(LLAC:0.01534,LCRE:0.02336):0.09942):0.01377):0.00808):0.00777):0.00209,(SDEV:0.01255,SRAT:0.01370):0.01345,(STHE:0.00361,(SSAL:0.00850,SVES:0.00113):0.00252):0.01173):0.00000;
((((SMIT:0.01512,(SPSE:0.00965,SPNE:0.00693):0.00829):0.08950,(SANG:0.02490,(SINT:0.01653,SCON:0.01256):0.01438):0.06650):0.01064,(LCRE:0.00909,LLAC:0.00945):0.18609):0.01292,((SENT:0.13551,(SDEV:0.01924,SRAT:0.02159):0.07281):0.01040,(((SINF:0.00934,SLUT:0.01107):0.02257,SEQU:0.02536):0.06249,(((STHE:0.01473,(SSAL:0.00482,SVES:0.00685):0.00701):0.06654,(SCAN:0.02600,(SPYO:0.02070,SDYS:0.02059):0.00597):0.07682):0.00649,SPLU:0.11627):0.00241):0.00267):0.00180,SDOW:0.11070):0.00000;
(LLAC:0.02870,LCRE:0.02870):0.00000;
(LLAC:0.01984,LCRE:0.01984):0.00000;
(LLAC:0.00336,LCRE:0.00336):0.00000;
((((((SINF:0.03442,(SLUT:0.01389,SEQU:0.00303):0.03790):0.07949,SDEV:0.12520):0.01742,(SVES:0.14216,SDOW:0.13542):0.01737):0.02328,SENT:0.16577):0.01369,(LCRE:0.01902,LLAC:0.02124):0.23066):0.00970,(SSUI:0.10317,SINF:0.09926):0.05253,(((SMIT:0.00311,SPSE:0.00561):0.00523,SPNE:0.01474):0.12538,(SANG:0.01903,(SINT:0.00067,SCON:0.00360):0.03088):0.09474):0.02455):0.00000;
(((STHE:0.03212,(SSAL:0.00358,SVES:0.00597):0.00754):0.07280,((SENT:0.08740,((SINF:0.02258,SLUT:0.01196):0.01178,SEQU:0.03006):0.04819):0.00343,((((SMIT:0.00849,(SPSE:0.00141,SPNE:0.00825):0.00077):0.03208,((SANG:0.00531,SINT:0.01240):0.00435,SCON:0.00976):0.02084):0.02918,SSUI:0.07340):0.01736,(((((SMIT:0.12802,SSAL:0.09926):0.20743,SPLU:0.30241):0.02971,((((SCAN:0.02683,SPYO:0.02407):0.08457,SDYS:0.12208):0.20235,((LLAC:0.25760,SPNE:0.25975):0.02298,((SPYO:0.11016,(SCAN:0.03858,SDYS:0.05040):0.06511):0.04434,((((SINF:0.03839,SLUT:0.03543):0.05343,SEQU:0.09176):0.03371,(SDOW:0.10772,(SDEV:0.01643,SRAT:0.01789):0.09544):0.02876):0.01052,SSUI:0.15171):0.02043):0.10058):0.02271):0.03106,((STHE:0.16412,(((SMIT:0.01348,SPSE:0.02109):0.00541,SPNE:0.01874):0.10942,(SANG:0.05052,(SINT:0.00197,SCON:0.00447):0.04626):0.07678):0.04647):0.16570,(LCRE:0.01183,LLAC:0.01358):0.28543):0.00314):0.00726):0.05029,((SSUI:0.16990,SPLU:0.18235):0.14039,(((LLAC:0.10278,LCRE:0.09506):0.10985,(SDEV:0.19861,(SVES:0.16001,(SSAL:0.15465,((SANG:0.01174,(SINT:0.00938,SCON:0.00461):0.00512):0.10519,((SPSE:0.00497,SPNE:0.00568):0.00120,SMIT:0.00617):0.10702):0.05335):0.01095):0.02385):0.01414):0.00853,(SLUT:0.20719,((SPYO:0.06651,(SCAN:0.03614,SDYS:0.03902):0.02464):0.13261,SENT:0.19320):0.01108):0.01817):0.08962):0.02913):0.26424,(LCRE:0.03062,LLAC:0.02524):0.10284):0.04113):0.01989):0.00449):0.00418,(SDOW:0.05678,(SDEV:0.03655,SRAT:0.03093):0.03878):0.00986,(SPLU:0.06007,(SPYO:0.02594,(SCAN:0.02431,SDYS:0.01581):0.00322):0.04566):0.00291):0.00000;
(LLAC:0.01987,LCRE:0.01987):0.00000;
(LLAC:0.01131,LCRE:0.01131):0.00000;
(LLAC:0.02348,LCRE:0.02348):0.00000;
(((SSAL:0.03084,(SPYO:0.02294,(SCAN:0.00342,SDYS:0.00773):0.02118):0.01256):0.00699,((LCRE:0.01836,LLAC:0.02209):0.15492,(SINT:0.00935,(SANG:0.00278,SCON:0.00227):0.01285):0.06148):0.04860):0.00217,SRAT:0.03251,SINF:0.04675):0.00000;
((((SLUT:0.03418,(SINF:0.02336,SEQU:0.01237):0.01309):0.12144,((SRAT:0.01829,SDEV:0.01669):0.15381,((LLAC:0.02643,LCRE:0.01762):0.27630,((LLAC:0.01402,LCRE:0.01641):0.21609,(LCRE:0.00459,LLAC:0.00458):0.18498):0.03395):0.11640):0.04083):0.00743,(SVES:0.11521,(SCAN:0.01807,SDYS:0.02019):0.08636):0.00915):0.00705,(((SEQU:0.01078,SINF:0.01234):0.00449,SLUT:0.01809):0.06036,((SLUT:0.00599,SINF:0.00358):0.02120,SEQU:0.02572):0.06757):0.02732,SDOW:0.15871):0.00000;
((SDOW:0.05804,(((STHE:0.01396,(SSAL:0.00680,SVES:0.00808):0.00184):0.04098,(SPLU:0.08177,(SPYO:0.00983,(SCAN:0.01894,SDYS:0.00556):0.00223):0.06824):0.00840):0.01752,((SSUI:0.06540,SENT:0.07503):0.00653,((((SMIT:0.00265,SPSE:0.00415):0.00407,SPNE:0.01636):0.03512,(SINT:0.02501,(SANG:0.02748,SCON:0.02016):0.00085):0.03158):0.03269,(LLAC:0.01098,LCRE:0.01334):0.23076):0.00959):0.00671):0.00708):0.00301,(SDEV:0.03573,SRAT:0.02343):0.04060,(SINF:0.03166,(SLUT:0.00946,SEQU:0.00368):0.04015):0.01700):0.00000;
(LLAC:0.00860,LCRE:0.00860):0.00000;
((SINT:0.15368,(((SINF:0.00909,SLUT:0.01914):0.06108,SEQU:0.09640):0.06465,((((SMIT:0.02497,(SPSE:0.01778,SPNE:0.02609):0.01830):0.13439,(SSUI:0.03423,SPLU:0.03090):0.14488):0.00550,(SANG:0.04606,SCON:0.05317):0.11207):0.02618,(LCRE:0.03884,LLAC:0.04740):0.21464):0.00876):0.01381):0.00535,(((SSAL:0.03663,(STHE:0.03369,SVES:0.03283):0.01488):0.07652,(SDEV:0.08896,SRAT:0.07841):0.01424):0.01640,(SENT:0.15916,(SDYS:0.07476,(SCAN:0.04380,SPYO:0.03988):0.03330):0.05771):0.00694):0.00633,SDOW:0.18092):0.00000;
(((STHE:0.00854,SSAL:0.00350):0.01005,SVES:0.01957):0.12382,((SENT:0.16820,((((SPSE:0.01462,(SMIT:0.00398,SPNE:0.01105):0.00363):0.08004,((SANG:0.00538,SINT:0.00456):0.00125,SCON:0.00515):0.10574):0.04451,SSUI:0.10908):0.03474,(LCRE:0.00002,LLAC:0.00070):0.31302):0.03160):0.01030,(((((SINF:0.01476,SLUT:0.01001):0.00173,SEQU:0.00892):0.08749,(SCAN:0.01387,(SPYO:0.00812,SDYS:0.01027):0.00554):0.05651):0.01672,SDOW:0.13606):0.00668,(SDEV:0.01081,SRAT:0.01021):0.07227):0.01038):0.00421,SPLU:0.10800):0.00000;
(LLAC:0.12654,LCRE:0.12654):0.00000;
((LCRE:0.02559,LLAC:0.02151):0.41391,LCRE:0.01484,LLAC:0.01992):0.00000;
((LCRE:0.01173,LLAC:0.01182):0.21371,(SPLU:0.05756,SSUI:0.05430):0.21343,(LLAC:0.04153,LCRE:0.05358):0.34370):0.00000;
(LLAC:0.06104,LCRE:0.06104):0.00000;
((((SSAL:0.00221,(STHE:0.00276,SVES:0.00335):0.00238):0.07850,(((SINF:0.00768,SLUT:0.00749):0.01561,SEQU:0.01097):0.05475,(SCAN:0.01498,(SPYO:0.00604,SDYS:0.00621):0.01798):0.08617):0.00657):0.00957,(((SMIT:0.00887,(SPSE:0.00000,SPNE:0.00000):0.00327):0.08428,(SANG:0.01609,(SCON:0.00658,SINT:0.01457):0.00810):0.05357):0.03623,((LCRE:0.03161,LLAC:0.03099):0.15106,(SPSE:0.30553,(SDYS:0.00000,SCAN:0.00000):0.27664):0.07927):0.06972):0.00615):0.00854,((SENT:0.08783,SDOW:0.09881):0.00873,(SPLU:0.07376,(SDEV:0.02118,SRAT:0.03497):0.05710):0.00534):0.00281,SSUI:0.10670):0.00000;
((SENT:0.24593,((((SMIT:0.02623,(SPSE:0.00544,SPNE:0.00330):0.02306):0.20688,((SINT:0.01805,SCON:0.02483):0.03521,SANG:0.04707):0.12869):0.03824,SSUI:0.22650):0.02083,(LCRE:0.02925,LLAC:0.02017):0.26604):0.01863):0.00896,((SPLU:0.20294,SDOW:0.18580):0.01084,((SCAN:0.06183,(SDYS:0.05069,SPYO:0.06034):0.01118):0.16507,((SDEV:0.04248,SRAT:0.03502):0.11027,((SINF:0.01835,SLUT:0.02686):0.00928,SEQU:0.02586):0.15181):0.02232):0.01405):0.00197,(STHE:0.04964,(SSAL:0.00679,SVES:0.00603):0.02583):0.19133):0.00000;
(LLAC:0.06078,LCRE:0.06078):0.00000;
(LCRE:0.21867,SRAT:0.34588,LCRE:0.28808):0.00000;
(LLAC:0.01707,LCRE:0.01707):0.00000;
(((STHE:0.01703,(SSAL:0.00772,SVES:0.00692):0.00508):0.09571,(((SINF:0.00520,SLUT:0.00670):0.01258,SEQU:0.01595):0.08944,(SPLU:0.10111,(SPYO:0.07233,(SCAN:0.05373,SDYS:0.05475):0.01661):0.06102):0.00872):0.00417):0.00544,((SENT:0.13185,((SSUI:0.12707,((SMIT:0.01840,(SPSE:0.01421,SPNE:0.01994):0.00078):0.07593,(SANG:0.04009,(SINT:0.03531,SCON:0.03623):0.00767):0.05849):0.02282):0.00520,(LCRE:0.03035,LLAC:0.02361):0.19518):0.00603):0.01308,(SDEV:0.02936,SRAT:0.03390):0.07545):0.00393,SDOW:0.11665):0.00000;
(LCRE:0.02530,LLAC:0.02996,SINT:0.36357):0.00000;
(LLAC:0.06051,LCRE:0.06051):0.00000;
(LLAC:0.04676,LCRE:0.04676):0.00000;
(LCRE:0.03485,LLAC:0.03994,(SPLU:0.18785,SPLU:0.17839):0.42224):0.00000;
((((SMIT:0.02339,(SPSE:0.00937,SPNE:0.02000):0.01836):0.13897,(SANG:0.04183,(SINT:0.01302,SCON:0.00675):0.03261):0.08192):0.02470,(LCRE:0.02409,LLAC:0.02909):0.20570):0.02045,(((SENT:0.16319,SPLU:0.13988):0.02708,(SPYO:0.09946,(SCAN:0.06026,SDYS:0.05477):0.01492):0.06991):0.00972,(SDOW:0.14289,((SDEV:0.02907,SRAT:0.02460):0.08298,SSUI:0.17300):0.01996):0.00252):0.00174,(((STHE:0.00990,SSAL:0.01534):0.00529,SVES:0.02194):0.10176,((SINF:0.00715,SLUT:0.00987):0.03501,SEQU:0.03993):0.08683):0.02462):0.00000;
((((SMIT:0.01979,(SPSE:0.01752,SPNE:0.01943):0.00102):0.08104,(SINT:0.05197,(SANG:0.02513,SCON:0.02373):0.01524):0.05739):0.01482,((SDEV:0.04444,SRAT:0.05556):0.07708,(LCRE:0.03280,LLAC:0.03245):0.23536):0.00427):0.01228,(((SPYO:0.09550,(SCAN:0.02541,SDYS:0.02513):0.04130):0.02333,(SPLU:0.07025,((STHE:0.02515,(SSAL:0.00410,SVES:0.02219):0.00543):0.05785,((SINF:0.00772,(SLUT:0.00775,SEQU:0.00230):0.00620):0.04651,SDOW:0.08523):0.00576):0.01264):0.00920):0.00966,SENT:0.13391):0.00455,SSUI:0.09582):0.00000;
(LLAC:0.05518,LCRE:0.05518):0.00000;
(LCRE:0.31277,LCRE:0.31277):0.00000;
(LCRE:0.29428,LCRE:0.29428):0.00000;
((SPLU:0.17054,(SEQU:0.05777,(SINF:0.00682,SLUT:0.01299):0.06014):0.07926):0.00778,((SSUI:0.23468,((SSAL:0.05051,(SVES:0.04867,STHE:0.04545):0.00722):0.15730,(LCRE:0.04638,LLAC:0.04896):0.27014):0.01587):0.01101,(SDOW:0.17229,(SRAT:0.03829,SDEV:0.04193):0.13669):0.02489):0.02374,((SCAN:0.05056,SDYS:0.06478):0.01989,SPYO:0.08396):0.11427):0.00000;
(LLAC:0.07501,LCRE:0.07501):0.00000;
(LLAC:0.11031,LCRE:0.11031):0.00000;
(LLAC:0.05440,LCRE:0.05440):0.00000;
(LLAC:0.07341,LCRE:0.07341):0.00000;
(LCRE:0.05058,LLAC:0.04200,(LLAC:0.04546,LCRE:0.03317):0.55225):0.00000;
(LLAC:0.03026,LCRE:0.03026):0.00000;
(LLAC:0.07068,LCRE:0.07068):0.00000;
(LLAC:0.07114,LCRE:0.07114):0.00000;
(LLAC:0.10322,LCRE:0.10322):0.00000;
((((((SMIT:0.06217,SSUI:0.06786):0.02109,((((STHE:0.00599,SSAL:0.00548):0.00322,SVES:0.00779):0.05310,(SINF:0.01916,SEQU:0.01795):0.05068):0.01375,SDOW:0.08051):0.00697):0.00459,(SDEV:0.01547,SRAT:0.01540):0.08504):0.11017,(LLAC:0.01025,LCRE:0.01198):0.20223):0.14459,((SPYO:0.11444,SINT:0.12431):0.20830,((LLAC:0.01923,LCRE:0.02189):0.15943,STHE:0.19973):0.05427):0.02032):0.17674,(SENT:0.13954,(((SMIT:0.00401,(SPSE:0.00511,SPNE:0.00632):0.00389):0.07343,SANG:0.07764):0.02754,((SSUI:0.07548,(SDEV:0.02188,SRAT:0.02097):0.06420):0.03340,(((SINF:0.01996,SLUT:0.03202):0.01450,SEQU:0.03887):0.04807,((STHE:0.01784,(SSAL:0.00265,SVES:0.00275):0.01405):0.05089,SDOW:0.07608):0.01948):0.01075):0.01664):0.01218):0.00491,(LCRE:0.03268,LLAC:0.03537):0.09890):0.00000;
((SENT:0.28144,((((SPSE:0.03702,SMIT:0.02664):0.24471,((SCON:0.00402,SANG:0.00563):0.04549,SINT:0.08375):0.23405):0.02045,(SSUI:0.27112,(LCRE:0.26993,(SDYS:0.29455,(SENT:0.30544,((SCON:0.01690,SANG:0.01585):0.18923,((SEQU:0.08993,SINF:0.06724):0.12435,(SRAT:0.06551,SDEV:0.07364):0.12072):0.05518):0.04241):0.01283):0.03134):0.00706):0.02204):0.01441,(LLAC:0.11224,LCRE:0.10732):0.16713):0.00902):0.00600,((SEQU:0.12113,(SINF:0.03584,SLUT:0.08169):0.07510):0.08451,(SRAT:0.07364,SDEV:0.04076):0.16507):0.04591,(SDYS:0.19953,SCAN:0.24252):0.07069):0.00000;
((SDYS:0.13438,(((LCRE:0.05482,LLAC:0.05519):0.10515,(SPLU:0.34683,SDYS:0.35282):0.12452):0.02996,(SSUI:0.14376,(SINT:0.01720,(SANG:0.00424,SCON:0.00224):0.01054):0.11222):0.00249):0.02421):0.00265,((SDEV:0.03637,SRAT:0.04139):0.05851,(SINF:0.02305,SEQU:0.02140):0.08032):0.01167,SENT:0.12735):0.00000;
(LLAC:0.09918,LCRE:0.09918):0.00000;
((((STHE:0.04206,(SSAL:0.01781,SVES:0.01726):0.02196):0.06560,(((LCRE:0.07294,LLAC:0.08263):0.22528,SDOW:0.15962):0.04397,(SDEV:0.06179,SRAT:0.04862):0.05542):0.01829):0.07653,SEQU:0.02174):0.00901,SLUT:0.01536,SINF:0.01453):0.00000;
((((STHE:0.01530,(SSAL:0.00943,SVES:0.01332):0.00173):0.05502,((SDOW:0.09668,(LCRE:0.07261,LLAC:0.06859):0.29613):0.02705,(SDEV:0.02528,SRAT:0.03257):0.04212):0.00761):0.04412,SEQU:0.00591):0.00228,SLUT:0.00992,SINF:0.00599):0.00000;
((((SPNE:0.01903,(SANG:0.00171,(SINT:0.00149,SCON:0.00081):0.00116):0.01760):0.01772,SSUI:0.04508):0.00839,(((((((SDOW:0.07455,SRAT:0.08778):0.02526,(LCRE:0.01135,LLAC:0.01075):0.10767):0.35023,SCAN:0.24388):0.04068,((((STHE:0.03309,(SSAL:0.00539,SVES:0.01501):0.01760):0.04585,((SINF:0.00814,SLUT:0.00391):0.03864,SEQU:0.04344):0.03364):0.00932,SDOW:0.11392):0.01225,(SDEV:0.06324,SRAT:0.05899):0.03755):0.09016):0.02609,(LCRE:0.03785,LLAC:0.03299):0.13619):0.05009,(LCRE:0.00352,LLAC:0.00412):0.12832):0.06985,SRAT:0.03244):0.00923):0.01784,(SPYO:0.00416,SDYS:0.00271):0.00302,SCAN:0.00329):0.00000;
((((STHE:0.03816,(SSAL:0.01812,SVES:0.02025):0.01369):0.16937,(((((SMIT:0.01607,SPSE:0.02047):0.00261,SPNE:0.02252):0.13985,(SANG:0.04608,(SINT:0.02967,SCON:0.02845):0.02413):0.10857):0.04152,SSUI:0.18977):0.01093,(LCRE:0.04336,LLAC:0.03951):0.28839):0.00765):0.00831,((SDEV:0.04406,SRAT:0.04249):0.13342,(((SINF:0.01040,SLUT:0.01323):0.03433,SEQU:0.04672):0.11758,(SPYO:0.10756,(SCAN:0.06687,SDYS:0.06315):0.02695):0.10123):0.00691):0.00462):0.00339,(SENT:0.21298,SDOW:0.16790):0.00453,SPLU:0.19313):0.00000;
(LLAC:0.03357,LCRE:0.03357):0.00000;
(LLAC:0.02407,LCRE:0.02407):0.00000;
(LLAC:0.05476,LCRE:0.05476):0.00000;
(LLAC:0.04954,LCRE:0.04954):0.00000;
(LLAC:0.07835,LCRE:0.07835):0.00000;
((LCRE:0.07939,LLAC:0.07860):0.24609,SSUI:0.25035,SPYO:0.41336):0.00000;
(LLAC:0.02127,LCRE:0.02127):0.00000;
(((SDOW:0.13696,(SENT:0.15021,((LCRE:0.06407,LLAC:0.07318):0.30266,(SSUI:0.15830,((SMIT:0.02229,(SPSE:0.01441,SPNE:0.02051):0.00613):0.09618,(SANG:0.04999,(SCON:0.02137,SINT:0.03245):0.04304):0.06113):0.03778):0.01718):0.02705):0.01195):0.01850,(SDEV:0.04327,SRAT:0.05211):0.08396):0.00205,((SSAL:0.03557,(STHE:0.02268,SVES:0.01974):0.01661):0.06222,(((SINF:0.03306,SLUT:0.03117):0.03927,SEQU:0.06654):0.03409,(SPYO:0.12972,(SCAN:0.06047,SDYS:0.06806):0.05216):0.00865):0.00519):0.00855,SPLU:0.15107):0.00000;
(LCRE:0.30910,(((SVES:0.02453,SSAL:0.01756):0.21467,SPNE:0.22243):0.05643,SRAT:0.25857):0.01548,SPLU:0.30118):0.00000;
(SRAT:0.33605,LCRE:0.33605):0.00000;
((LLAC:0.34803,LCRE:0.33957):0.01470,SPLU:0.31217,((SVES:0.02937,SSAL:0.02752):0.19817,SPNE:0.21946):0.10947):0.00000;
((SINF:0.10475,((((SMIT:0.00516,(SPSE:0.00182,SPNE:0.00627):0.00014):0.07935,SPLU:0.10614):0.06562,(LCRE:0.44480,(SVES:0.03960,SSAL:0.03783):0.20460):0.05753):0.01716,((SDOW:0.05893,SRAT:0.07213):0.06807,((SDEV:0.04935,SRAT:0.04359):0.02687,SDOW:0.07975):0.01837):0.03291):0.02038):0.00392,SDOW:0.11001,(STHE:0.10795,(SPSE:0.08299,(SANG:0.02406,(SINT:0.00574,SCON:0.00601):0.01892):0.07070):0.00694):0.01046):0.00000;
(SPSE:0.25744,LCRE:0.25744):0.00000;
(((SDEV:0.02095,SRAT:0.02938):0.08961,((((((SMIT:0.00881,(SPSE:0.01429,SPNE:0.01185):0.00028):0.07459,(SANG:0.02463,(SINT:0.00524,SCON:0.00612):0.03256):0.05906):0.02080,SSUI:0.09954):0.00954,SENT:0.14977):0.01521,(SPLU:0.12467,((SINF:0.00754,SLUT:0.00709):0.02336,SEQU:0.03059):0.06156):0.00592):0.00436,((SCAN:0.05067,(SPYO:0.01054,SDYS:0.01064):0.03150):0.08406,(LCRE:0.03828,LLAC:0.03663):0.23759):0.00921):0.00389):0.00140,(SSAL:0.01962,(STHE:0.01827,SVES:0.01756):0.00353):0.08932,SDOW:0.10916):0.00000;
((SANG:0.24909,((LLAC:0.04358,LCRE:0.05072):0.30265,((LCRE:0.01943,LLAC:0.02373):0.27208,SCAN:0.32823):0.03486):0.19912):0.03311,(SDEV:0.18803,SENT:0.18028):0.01027,SDOW:0.18785):0.00000;
(SSAL:0.11690,(LCRE:0.10690,LLAC:0.09445):0.43109,(SVES:0.06916,STHE:0.04794):0.05515):0.00000;
(LLAC:0.16265,LCRE:0.16265):0.00000;
(LLAC:0.07861,LCRE:0.07861):0.00000;
(((SSUI:0.11544,((LCRE:0.03614,LLAC:0.03928):0.13802,SENT:0.47706):0.08704):0.00936,((SMIT:0.01512,(SPSE:0.01209,SPNE:0.01695):0.00388):0.07531,((SINT:0.02612,SCON:0.02979):0.01600,SANG:0.02445):0.07178):0.00530):0.01369,(((SCAN:0.03282,(SPYO:0.01994,SDYS:0.01864):0.02570):0.06065,(((SINF:0.00734,SLUT:0.00677):0.01520,SEQU:0.01701):0.04279,SDOW:0.07429):0.01722):0.02159,(SDEV:0.04669,SRAT:0.03327):0.04284):0.00238,((STHE:0.00735,SSAL:0.00907):0.00207,SVES:0.01412):0.07676):0.00000;
((((LCRE:0.05228,LLAC:0.07509):0.27842,((((SINF:0.01189,SLUT:0.01375):0.03193,SEQU:0.03195):0.06665,(SRAT:0.03923,SDEV:0.05135):0.07110):0.02746,((SENT:0.12410,SSUI:0.09779):0.04887,((SPSE:0.04335,(SMIT:0.02875,SPNE:0.03942):0.00578):0.09101,(SANG:0.05513,(SINT:0.03299,SCON:0.02704):0.02277):0.07566):0.02267):0.00549):0.01168):0.00518,SDOW:0.13262):0.00418,(SPLU:0.15471,(SPYO:0.06152,(SDYS:0.03813,SCAN:0.04113):0.03297):0.07266):0.00809,(STHE:0.03503,(SSAL:0.02773,SVES:0.02750):0.00439):0.10486):0.00000;
(LLAC:0.14363,LCRE:0.14363):0.00000;
(LCRE:0.03077,LLAC:0.03039,LCRE:0.30830):0.00000;
(((SDEV:0.03785,SRAT:0.04112):0.06368,(SENT:0.14273,(LCRE:0.00521,LLAC:0.00491):0.25126):0.01206):0.00040,(((STHE:0.02304,(SSAL:0.01750,SVES:0.01765):0.00529):0.03419,((SINF:0.00952,SLUT:0.01132):0.01059,SEQU:0.01635):0.05541):0.00325,(SPLU:0.06613,(SCAN:0.04710,(SPYO:0.03703,SDYS:0.03228):0.00903):0.04564):0.00745):0.00998,((((SMIT:0.00464,SPSE:0.00553):0.00330,SPNE:0.00941):0.08456,((SINT:0.05067,(SANG:0.02795,SCON:0.02624):0.01508):0.02627,(SSUI:0.00745,SPLU:0.00484):0.06726):0.00604):0.00962,SDOW:0.08583):0.00932):0.00000;
(LCRE:0.01158,SINT:0.33208,LLAC:0.01184):0.00000;
(LLAC:0.11560,LCRE:0.11560):0.00000;
(LLAC:0.08063,LCRE:0.08063):0.00000;
(((((SSUI:0.12903,SPLU:0.09674):0.01202,SENT:0.16244):0.00992,(SDOW:0.14054,(((STHE:0.04045,(SSAL:0.01279,SVES:0.01524):0.02420):0.12280,(SPYO:0.05153,(SCAN:0.05077,SDYS:0.05346):0.01195):0.12054):0.05018,(LCRE:0.03388,LLAC:0.02987):0.30436):0.04485):0.01233):0.01445,((SLUT:0.05785,(SINF:0.03926,SEQU:0.02721):0.03481):0.06174,SANG:0.11484):0.01523):0.00504,(SDEV:0.04646,SRAT:0.03771):0.08515,((SSAL:0.07310,(SMIT:0.03243,SPNE:0.03585):0.02459):0.08414,(SINT:0.07679,SCON:0.08126):0.04672):0.00956):0.00000;
(LCRE:0.02638,LLAC:0.02584,SSUI:0.34131):0.00000;
(((SENT:0.16908,(SPLU:0.20017,(SSUI:0.20676,(((SMIT:0.10468,(SPSE:0.01043,SPNE:0.00677):0.08211):0.13965,(SINT:0.05720,(SANG:0.01438,SCON:0.01644):0.01421):0.13492):0.02140,(LCRE:0.03190,LLAC:0.02293):0.26067):0.02185):0.01577):0.01785):0.00879,(SEQU:0.06430,(SINF:0.01646,SLUT:0.01986):0.04495):0.10653):0.01589,((SPYO:0.12512,(SCAN:0.05557,SDYS:0.04799):0.04149):0.05144,(SDOW:0.13388,(SDEV:0.04345,SRAT:0.04987):0.09125):0.00618):0.00450,(STHE:0.03671,(SSAL:0.01170,SVES:0.01374):0.01232):0.14435):0.00000;
(LCRE:0.01519,LLAC:0.01653,(SINT:0.17956,SSUI:0.17753):0.29577):0.00000;
(LLAC:0.04892,LCRE:0.04892):0.00000;
(LCRE:0.04616,LLAC:0.05290,LLAC:0.68106):0.00000;
(LLAC:0.06331,LCRE:0.06331):0.00000;
((((SENT:0.08756,SPLU:0.09152):0.01186,((SSUI:0.11995,SDOW:0.09848):0.00977,(((SMIT:0.01219,(SPNE:0.02312,SPSE:0.01440):0.00145):0.05795,(SANG:0.00630,(SINT:0.00205,SCON:0.00462):0.00499):0.07088):0.03929,(LCRE:0.03944,LLAC:0.05073):0.20151):0.01328):0.01256):0.00212,(SRAT:0.05012,SDEV:0.04759):0.05835):0.00183,(((SINF:0.01329,SLUT:0.01449):0.00429,SEQU:0.01270):0.04680,(SCAN:0.02994,(SPYO:0.02702,SDYS:0.02569):0.00851):0.05696):0.01246,(STHE:0.00692,SSAL:0.00832):0.08350):0.00000;
((((SENT:0.26853,(LCRE:0.03468,LLAC:0.03209):0.27558):0.01544,(((SMIT:0.03225,(SPSE:0.03266,SPNE:0.03338):0.00577):0.05407,(SANG:0.04590,(SINT:0.00346,SCON:0.00274):0.04009):0.05441):0.14099,((SPLU:0.29405,SSUI:0.18195):0.03087,(SCAN:0.06061,(SDYS:0.03417,SPYO:0.03973):0.03942):0.16115):0.02343):0.01964):0.02214,(((SINF:0.01146,SLUT:0.01756):0.02326,SEQU:0.03674):0.15483,(SRAT:0.05230,SDEV:0.05235):0.12636):0.01960):0.01057,(STHE:0.02797,(SSAL:0.01935,SVES:0.01876):0.00354):0.17938,SDOW:0.16900):0.00000;
(LLAC:0.03928,LCRE:0.03928):0.00000;
(LLAC:0.07186,LCRE:0.07186):0.00000;
(LCRE:0.12245,LLAC:0.13747,LLAC:0.19294):0.00000;
((LCRE:0.42231,LLAC:0.25363):0.33033,LCRE:0.00186,LLAC:0.00734):0.00000;
(LLAC:0.10520,LCRE:0.10520):0.00000;
(LCRE:0.26914,(SSUI:0.21117,SINT:0.20098):0.27476,SPNE:0.28371):0.00000;
(LLAC:0.02164,LCRE:0.02164):0.00000;
(LLAC:0.10985,LCRE:0.10985):0.00000;
(SRAT:0.27909,LCRE:0.27909):0.00000;
(LLAC:0.03682,LCRE:0.03682):0.00000;
(LLAC:0.04886,LCRE:0.04886):0.00000;
((SDOW:0.12646,((SDEV:0.09071,SRAT:0.07210):0.07111,(SINF:0.37442,(LCRE:0.09063,LLAC:0.11284):0.19290):0.10265):0.02503):0.00712,((SINF:0.01255,SLUT:0.01418):0.04550,SEQU:0.06456):0.06386,SSAL:0.12343):0.00000;
(LLAC:0.21702,LCRE:0.21702):0.00000;
((SDOW:0.07894,(LCRE:0.05082,LLAC:0.08162):0.33889):0.01605,(SDEV:0.01593,SRAT:0.02267):0.04171,(SSAL:0.04016,((SINF:0.00027,SLUT:0.00340):0.01668,SEQU:0.01439):0.03584):0.02060):0.00000;
(LLAC:0.04933,LCRE:0.04933):0.00000;
(LLAC:0.10397,LCRE:0.10397):0.00000;
((((SPSE:0.01982,(SMIT:0.02053,SPNE:0.04262):0.00310):0.06806,SSUI:0.14005):0.01386,(LCRE:0.02984,LLAC:0.04257):0.13551):0.01438,(((((STHE:0.00929,SSAL:0.00518):0.00143,SVES:0.00982):0.03698,(SINF:0.01477,(SLUT:0.01190,SEQU:0.00314):0.00375):0.03598):0.02057,(SDEV:0.05135,SRAT:0.03451):0.03011):0.00391,SDOW:0.08343):0.00269,SPLU:0.10179):0.00000;
(((SDEV:0.02038,SRAT:0.03076):0.02584,(SPLU:0.07136,(SSUI:0.11663,((SSAL:0.02568,((SINF:0.00386,SLUT:0.01443):0.00790,SEQU:0.01028):0.01348):0.07006,(LCRE:0.05676,LLAC:0.05213):0.10873):0.05865):0.01824):0.00307):0.00168,SDOW:0.05830,((STHE:0.01361,SVES:0.00825):0.03198,(SMIT:0.00804,SPSE:0.00343):0.02648):0.02366):0.00000;
((((LCRE:0.01006,LLAC:0.00900):0.25908,((SSAL:0.00410,SVES:0.00642):0.02065,((SINF:0.00761,SLUT:0.00709):0.00184,SEQU:0.00699):0.02462):0.32415):0.20577,((SSUI:0.01241,SPLU:0.01465):0.02616,(SINF:0.02472,(STHE:0.00365,(SSAL:0.00053,SVES:0.00082):0.00124):0.02265):0.01128):0.00953):0.00550,(SDOW:0.03041,(SDEV:0.00627,SRAT:0.00658):0.02827):0.00986,(SMIT:0.00105,(SPSE:0.00039,SPNE:0.00268):0.00203):0.03533):0.00000;
(LLAC:0.02806,LCRE:0.02806):0.00000;
(LLAC:0.09495,LCRE:0.09495):0.00000;
((((SPYO:0.03705,(SCAN:0.01603,SDYS:0.02877):0.00432):0.06176,(LCRE:0.02633,LLAC:0.01828):0.39812):0.05553,(SANG:0.01486,SCON:0.01157):0.01318):0.02682,(SPSE:0.00198,SPNE:0.00260):0.00343,SMIT:0.00318):0.00000;
((LCRE:0.17411,LLAC:0.18876):0.03177,SPLU:0.21815,SDOW:0.44823):0.00000;
(SMIT:0.09480,((SANG:0.01788,(SINT:0.00615,SCON:0.00494):0.01161):0.06793,(SSAL:0.00519,SVES:0.01058):0.06951):0.00942,(LCRE:0.02408,LLAC:0.02763):0.30934):0.00000;
(((SSUI:0.13182,(((SCAN:0.02186,SPYO:0.01882):0.02889,SDYS:0.03794):0.09621,(LCRE:0.04961,LLAC:0.05197):0.39295):0.01602):0.01136,(SDOW:0.07290,((SPSE:0.00899,(SMIT:0.00988,SPNE:0.01873):0.00156):0.03998,((STHE:0.01949,(SSAL:0.00668,SVES:0.01513):0.00574):0.03652,(SANG:0.01764,(SINT:0.00388,SCON:0.00666):0.01630):0.03097):0.00668):0.03261):0.00918):0.00659,(((SINF:0.00326,SLUT:0.00504):0.02078,SEQU:0.03314):0.02925,SRAT:0.08798):0.01635,SPLU:0.08829):0.00000;
(LLAC:0.08669,LCRE:0.08669):0.00000;
((LCRE:0.03016,LLAC:0.02395):0.25131,SPNE:0.18545,((SANG:0.01134,SCON:0.01529):0.11841,(SDEV:0.01595,SRAT:0.01683):0.10198):0.07918):0.00000;
(LCRE:0.48202,LCRE:0.01663,LLAC:0.01194):0.00000;
(LLAC:0.08466,LCRE:0.08466):0.00000;
(LCRE:0.10508,LCRE:0.10508):0.00000;
(LLAC:0.02989,LCRE:0.02989):0.00000;
(LLAC:0.00727,LCRE:0.00727):0.00000;
(LLAC:0.00818,LCRE:0.00818):0.00000;
(LLAC:0.05830,LCRE:0.05830):0.00000;
(LLAC:0.08051,LCRE:0.08051):0.00000;
((LCRE:0.03744,LLAC:0.04988):0.62807,LCRE:0.00976,LLAC:0.01265):0.00000;
(LLAC:0.01729,LCRE:0.01729):0.00000;
(LLAC:0.03593,LCRE:0.03593):0.00000;
(LLAC:0.09701,LCRE:0.09701):0.00000;
((((LLAC:0.03442,LCRE:0.03301):0.31369,(LCRE:0.03915,LLAC:0.02988):0.28158):0.13026,(((SANG:0.04912,(SINT:0.00000,SCON:0.00000):0.03354):0.05890,((SPSE:0.03021,SPNE:0.01213):0.01684,SMIT:0.01434):0.09143):0.03167,(STHE:0.02741,(SSAL:0.01440,SVES:0.01064):0.01016):0.11686):0.01669):0.01560,(SDEV:0.02770,SRAT:0.02276):0.10339,SENT:0.16789):0.00000;
(((LCRE:0.02721,LLAC:0.03576):0.39318,(LLAC:0.00976,LCRE:0.01221):0.25314):0.26598,(SPNE:0.01721,SMIT:0.00848):0.00076,SPSE:0.01044):0.00000;
(((SANG:0.03614,(SINT:0.01006,SCON:0.00864):0.03188):0.07079,((((SSUI:0.15557,((STHE:0.03426,(SVES:0.02043,SSAL:0.01019):0.00658):0.07178,((SMIT:0.02129,SPNE:0.03558):0.00678,SPSE:0.02319):0.06767):0.07697):0.13177,(LCRE:0.01483,LLAC:0.01709):0.40196):0.11419,SENT:0.19261):0.03061,((SPLU:0.10863,(SRAT:0.03080,SDEV:0.02531):0.05874):0.01386,SDOW:0.10196):0.02022):0.03472):0.00210,(SCAN:0.05281,(SPYO:0.00511,SDYS:0.00342):0.05697):0.06932,((SINF:0.02044,SLUT:0.01694):0.01579,SEQU:0.03221):0.07058):0.00000;
(LLAC:0.03207,LCRE:0.03207):0.00000;
(LLAC:0.01098,LCRE:0.01098):0.00000;
(LLAC:0.02740,LCRE:0.02740):0.00000;
(LLAC:0.02142,LCRE:0.02142):0.00000;
(LLAC:0.05516,LCRE:0.05516):0.00000;
(LLAC:0.10087,LCRE:0.10087):0.00000;
(((LCRE:0.01989,LLAC:0.01637):0.56532,SCAN:0.07805):0.02555,SDYS:0.05266,SPYO:0.03449):0.00000;
((LCRE:0.00924,LLAC:0.01079):0.33178,(SRAT:0.02248,SDEV:0.02023):0.07804,SPLU:0.08654):0.00000;
(LCRE:0.02205,LLAC:0.01471,LCRE:0.60056):0.00000;
(LLAC:0.09363,LCRE:0.09363):0.00000;
(LLAC:0.02106,LCRE:0.02106):0.00000;
(((SVES:0.04973,SSAL:0.03392):0.23236,LCRE:0.44648):0.03345,SRAT:0.23543,SDOW:0.23063):0.00000;
(LLAC:0.02944,LCRE:0.02944):0.00000;
(LLAC:0.03641,LCRE:0.03641):0.00000;
(LLAC:0.02612,LCRE:0.02612):0.00000;
((((SCAN:0.09534,SDYS:0.10466):0.01193,(((SSUI:0.02115,SPLU:0.03131):0.05983,SENT:0.11841):0.01812,(LCRE:0.04965,LLAC:0.05703):0.21626):0.01309):0.00727,(((SSAL:0.02162,(STHE:0.01558,SVES:0.02877):0.00425):0.04127,SPYO:0.07133):0.00518,((((SINF:0.01793,SLUT:0.02545):0.00963,SEQU:0.01682):0.02734,(SCON:0.06260,SRAT:0.03582):0.00243):0.01523,(SANG:0.04016,SINT:0.05075):0.02437):0.01011):0.00478):0.00235,(SDEV:0.06195,SDOW:0.08332):0.01272,((SMIT:0.00815,SPSE:0.00774):0.02199,SPNE:0.05403):0.02526):0.00000;
(SDOW:0.28639,LCRE:0.28639):0.00000;
(LLAC:0.01518,LCRE:0.01518):0.00000;
(LLAC:0.03741,LCRE:0.03741):0.00000;
(LLAC:0.01519,LCRE:0.01519):0.00000;
(((SRAT:0.10705,(LCRE:0.02037,LLAC:0.03072):0.11923):0.06773,LLAC:0.12691):0.12327,(SDOW:0.08292,(SLUT:0.03253,SEQU:0.04331):0.03191):0.02483,SDEV:0.06056):0.00000;
(LLAC:0.02269,LCRE:0.02269):0.00000;
((((SDEV:0.06952,SRAT:0.07160):0.12625,(LCRE:0.02863,LLAC:0.02197):0.37257):0.08843,SEQU:0.09570):0.05507,SLUT:0.03582,SINF:0.01791):0.00000;
(LLAC:0.07600,LCRE:0.07600):0.00000;
((SDOW:0.18708,(((LLAC:0.04336,LCRE:0.04576):0.23247,((SANG:0.04347,(SINT:0.01232,SCON:0.01018):0.03254):0.15261,(((SPYO:0.06588,(SCAN:0.04569,SDYS:0.05709):0.01850):0.09939,(SDOW:0.13219,(((STHE:0.02945,(SSAL:0.02551,SVES:0.02938):0.01248):0.06901,(SLUT:0.05401,(SINF:0.02937,SEQU:0.02805):0.01889):0.05940):0.01617,(SDEV:0.06438,SRAT:0.07013):0.06254):0.00353):0.03076):0.06240,SSUI:0.18807):0.00125):0.03079):0.25792,(LCRE:0.02742,LLAC:0.02857):0.23088):0.05296):0.01103,(((SVES:0.03630,SSAL:0.03416):0.17850,((SEQU:0.02454,(SLUT:0.01214,SINF:0.01743):0.02057):0.10959,(SCAN:0.05636,(SDYS:0.04645,SPYO:0.06202):0.00851):0.10230):0.01868):0.00777,(SPLU:0.15932,(SENT:0.16857,((((SMIT:0.01360,SPSE:0.01544):0.01095,SPNE:0.02306):0.11598,((SANG:0.01992,SINT:0.02695):0.00810,SCON:0.03526):0.11272):0.01983,SSUI:0.13717):0.02135):0.00460):0.01488):0.00592,(SRAT:0.08285,SDEV:0.08370):0.08688):0.00000;
(((((((SMIT:0.01802,SPSE:0.01803):0.00394,SPNE:0.02122):0.13634,(SANG:0.04683,(SINT:0.04617,SCON:0.03989):0.01619):0.10796):0.01063,((LCRE:0.08337,LLAC:0.08404):0.25690,SSUI:0.18119):0.03176):0.01167,SENT:0.16155):0.01241,(((SINF:0.00912,SLUT:0.01121):0.01792,SEQU:0.02742):0.10061,(SDEV:0.05646,SRAT:0.04658):0.09379):0.01137):0.00230,(((STHE:0.03569,(SSAL:0.02024,SVES:0.02033):0.00943):0.11702,SPLU:0.16517):0.00905,SDOW:0.15390):0.00978,(SDYS:0.07931,(SPYO:0.09435,SCAN:0.07897):0.01124):0.08558):0.00000;
(((SPYO:0.09131,(SCAN:0.05476,SDYS:0.04211):0.02928):0.06854,((((SMIT:0.00730,(SPSE:0.00713,SPNE:0.00602):0.00256):0.09793,(SANG:0.04574,(SINT:0.03998,SCON:0.04394):0.01565):0.04382):0.04458,(((SINF:0.00959,SLUT:0.01101):0.04024,SEQU:0.05695):0.06331,(SDEV:0.02887,SRAT:0.03160):0.06706):0.04064):0.01286,(SENT:0.16593,(SSUI:0.17218,(LCRE:0.02484,LLAC:0.02862):0.22748):0.05611):0.01686):0.00479):0.00096,SDOW:0.14720,((STHE:0.03134,(SSAL:0.01740,SVES:0.02018):0.00973):0.10272,SPLU:0.12623):0.01713):0.00000;
(((LCRE:0.00979,LLAC:0.00910):0.30812,(LCRE:0.37198,(LLAC:0.02074,LCRE:0.01920):0.27786):0.02650):0.01073,LLAC:0.28913,(LLAC:0.00855,LCRE:0.00464):0.29014):0.00000;
(((SSAL:0.00600,(STHE:0.00219,SVES:0.00174):0.00316):0.05561,((((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.03562,(SANG:0.00531,(SINT:0.00670,SCON:0.00700):0.00318):0.01274):0.04897,(SPLU:0.07507,(SENT:0.11095,(SSUI:0.08971,((LLAC:0.04495,LCRE:0.04676):0.19686,(((SDEV:0.06129,SRAT:0.07127):0.08762,(((SSAL:0.03144,(STHE:0.02273,SVES:0.01336):0.01310):0.10908,SDOW:0.12587):0.01267,(SINF:0.04698,(SLUT:0.01618,SEQU:0.02204):0.03435):0.10229):0.01366):0.16758,(((SENT:0.11839,SPLU:0.10773):0.05345,((((SMIT:0.00519,(SPSE:0.00307,SPNE:0.00537):0.00327):0.05484,(SINT:0.02822,(SANG:0.01679,SCON:0.01124):0.00608):0.04670):0.05966,SSUI:0.15244):0.02242,((SCAN:0.02135,(SPYO:0.01262,SDYS:0.01523):0.00737):0.12533,((((SSAL:0.01086,(STHE:0.01241,SVES:0.00647):0.00611):0.07575,SDOW:0.09656):0.00742,(SDEV:0.01439,SRAT:0.01702):0.07090):0.01275,((SINF:0.01167,SLUT:0.01670):0.01140,SEQU:0.02569):0.07736):0.01287):0.03229):0.00622):0.05782,(LCRE:0.00518,LLAC:0.00331):0.21010):0.13349):0.15427):0.09855):0.00769):0.00584):0.00276):0.01283,((SCAN:0.01765,SPYO:0.02917):0.00382,SDYS:0.02749):0.05542):0.00901):0.00271,(SDOW:0.05644,(SDEV:0.00842,SRAT:0.00853):0.03158):0.00216,((SINF:0.00948,SLUT:0.00489):0.01346,SEQU:0.01341):0.02817):0.00000;
(((SSAL:0.00903,(STHE:0.01828,SVES:0.00398):0.00260):0.05696,SPLU:0.07168):0.00884,(SDOW:0.06173,(((SINF:0.00358,SLUT:0.00716):0.00516,SEQU:0.00510):0.04791,(SDEV:0.03505,SRAT:0.03403):0.01444):0.01368):0.00413,((((SMIT:0.01980,(SPSE:0.00645,SPNE:0.01030):0.00955):0.03418,(SANG:0.01021,(SINT:0.01023,SCON:0.01330):0.00304):0.04891):0.00928,(((LCRE:0.00455,LLAC:0.00128):0.21183,SSUI:0.07756):0.00898,SENT:0.08349):0.01092):0.00581,((SCAN:0.01084,SPYO:0.02115):0.00842,SDYS:0.03095):0.08048):0.00276):0.00000;
(((((SSUI:0.12911,(((SMIT:0.00933,SPSE:0.00819):0.00383,SPNE:0.01422):0.10262,((SINT:0.03391,SCON:0.03516):0.01400,SANG:0.03710):0.07423):0.01652):0.02481,(LLAC:0.02868,LCRE:0.02774):0.21817):0.01321,SENT:0.16068):0.00808,(((STHE:0.03255,(SSAL:0.01095,SVES:0.01678):0.00973):0.08536,SPLU:0.11998):0.00808,(SDYS:0.02920,(SPYO:0.03420,SCAN:0.03016):0.00462):0.12035):0.00965):0.00365,((SDEV:0.05152,SRAT:0.05397):0.07847,(SEQU:0.02426,(SLUT:0.01671,SINF:0.01687):0.01335):0.09353):0.00697,SDOW:0.13558):0.00000;
(SPLU:0.33917,SPLU:0.33917):0.00000;
(SPLU:0.17618,(LLAC:0.02609,LCRE:0.03105):0.17658,(LLAC:0.01643,LCRE:0.02095):0.51311):0.00000;
((SEQU:0.27373,(LLAC:0.29413,(((LLAC:0.07846,LCRE:0.07160):0.14777,SENT:0.22755):0.09648,((LLAC:0.31420,LCRE:0.35132):0.01442,((LLAC:0.04476,LCRE:0.04189):0.22766,(((LLAC:0.01237,LCRE:0.01650):0.20233,(((((SSAL:0.01855,SVES:0.01362):0.00437,STHE:0.01785):0.07090,(SRAT:0.03853,SDEV:0.03348):0.04744):0.04987,(SSUI:0.17446,SENT:0.16454):0.01648):0.06047,((SINF:0.17937,((SMIT:0.05563,(SPSE:0.03208,SPNE:0.03024):0.02059):0.07809,(SANG:0.00224,SCON:0.00312):0.11427):0.04525):0.01111,(SDEV:0.12174,(SDYS:0.07105,(SCAN:0.04895,SPYO:0.05873):0.01518):0.06113):0.07075):0.02153):0.01658):0.03187,SPLU:0.29810):0.03707):0.00858):0.00826):0.00707):0.01932):0.01226,(SENT:0.21943,((LCRE:0.20941,SANG:0.18534):0.05602,(LLAC:0.26689,(SDOW:0.21229,(SEQU:0.10621,SDEV:0.09462):0.11546):0.00494):0.01067):0.00639):0.01271,((SSAL:0.15322,((SINF:0.02812,SLUT:0.02713):0.02278,SEQU:0.04594):0.07464):0.12264,LLAC:0.29584):0.00488):0.00000;
(SPLU:0.26099,SPLU:0.26099):0.00000;
((((SINT:0.11392,(SMIT:0.00820,(SPSE:0.00313,SPNE:0.00566):0.00370):0.11721):0.02365,SSUI:0.10716):0.05104,(((SPNE:0.24099,(LLAC:0.00569,LCRE:0.00347):0.23317):0.03649,((SDYS:0.15870,(SMIT:0.13981,LCRE:0.14819):0.02620):0.09070,(SSUI:0.05746,SPSE:0.05394):0.19780):0.03933):0.05883,SPLU:0.28654):0.19458):0.00962,(SCAN:0.01750,(SPYO:0.00528,SDYS:0.00202):0.00796):0.16365,(LLAC:0.00493,LCRE:0.00740):0.15402):0.00000;
(SPLU:0.47669,LCRE:0.05569,LLAC:0.05467):0.00000;
(SPLU:0.04895,SPLU:0.04895):0.00000;
(SENT:0.08411,SPLU:0.08411):0.00000;
((((SPYO:0.06407,(SCAN:0.03401,SDYS:0.03024):0.02796):0.04509,SPLU:0.11139):0.03539,(SDOW:0.11362,((((((SMIT:0.00684,SPSE:0.00462):0.00729,SPNE:0.01709):0.11140,(SINT:0.08672,(SANG:0.01805,SCON:0.02052):0.03685):0.04616):0.03042,((LCRE:0.03608,LLAC:0.05339):0.14212,SSUI:0.15824):0.02583):0.01576,SENT:0.20655):0.01440,(SDEV:0.01507,SRAT:0.01863):0.11972):0.01561):0.00858):0.00813,((SINF:0.01864,SLUT:0.03325):0.01213,SEQU:0.02523):0.05530,((STHE:0.00276,SSAL:0.00846):0.00208,SVES:0.00633):0.10568):0.00000;
((SPSE:0.04120,((SANG:0.02766,SCON:0.05066):0.10316,((SPLU:0.19541,SSUI:0.15169):0.01178,SENT:0.18025):0.11982):0.09954):0.00875,SPNE:0.03182,SMIT:0.02857):0.00000;
((((LLAC:0.03219,LCRE:0.01874):0.22453,(SSUI:0.10479,(SPLU:0.07500,SENT:0.09563):0.00852):0.00989):0.00412,((SPSE:0.00236,(SMIT:0.00171,SPNE:0.00428):0.00254):0.04515,(SINT:0.02152,(SANG:0.01296,SCON:0.01533):0.00298):0.02794):0.06129):0.00323,((SDOW:0.08208,(SDEV:0.03203,SRAT:0.03994):0.04718):0.00921,(((SINF:0.00969,SLUT:0.01548):0.00409,SEQU:0.01619):0.04742,(SPYO:0.01632,(SCAN:0.00704,SDYS:0.00763):0.00240):0.04877):0.01284):0.02224,(STHE:0.02018,(SVES:0.01498,SSAL:0.00678):0.01244):0.06510):0.00000;
(SPLU:0.27108,((SPYO:0.22754,(SCAN:0.13578,SDYS:0.17857):0.04993):0.15096,(((STHE:0.02927,(SSAL:0.00000,SVES:0.00000):0.03217):0.32158,SSUI:0.29684):0.01062,SENT:0.32476):0.02294):0.00524,(((SRAT:0.08215,SDEV:0.09005):0.16289,(SEQU:0.11191,(SLUT:0.05233,SINF:0.04992):0.08135):0.08741):0.03146,(((SCON:0.04975,(SINT:0.05884,SANG:0.05671):0.00487):0.16941,(SMIT:0.02795,(SPSE:0.00398,SPNE:0.00203):0.03217):0.20607):0.11254,SDOW:0.30535):0.01588):0.01883):0.00000;
((((SDOW:0.17871,((SINF:0.02016,SLUT:0.02135):0.04166,SEQU:0.07257):0.10438):0.02431,((SCAN:0.02971,SDYS:0.03065):0.03574,SPYO:0.07624):0.12873):0.01638,(SPLU:0.09263,SSUI:0.10352):0.10114):0.01052,(((((SMIT:0.02003,SPSE:0.02030):0.00220,SPNE:0.01826):0.13902,(SANG:0.04605,(SCON:0.03936,SINT:0.04837):0.01010):0.08126):0.02837,(SVES:0.18725,SSAL:0.21060):0.01698):0.01955,(SDEV:0.03478,SRAT:0.04151):0.15898):0.00807,(LLAC:0.04409,LCRE:0.03345):0.47813):0.00000;
(SSUI:0.19076,SPLU:0.19076):0.00000;
(SPLU:0.02811,SCAN:0.20064,SSUI:0.02846):0.00000;
(((((((SINF:0.00829,SLUT:0.00895):0.01290,SEQU:0.01705):0.04229,((SCAN:0.00518,SPYO:0.00642):0.00676,SDYS:0.01645):0.06774):0.01353,SPLU:0.09410):0.00876,(SDEV:0.02337,SRAT:0.03048):0.05891):0.00977,SDOW:0.08505):0.00127,(((SMIT:0.01127,(SPSE:0.00616,SPNE:0.00611):0.00132):0.07446,(SANG:0.02338,(SINT:0.01528,SCON:0.01614):0.01184):0.06940):0.00898,(SSUI:0.08539,SENT:0.06594):0.02703):0.00957,((LCRE:0.01883,LLAC:0.00583):0.12020,((STHE:0.02171,SSAL:0.01169):0.00104,SVES:0.00920):0.07819):0.00747):0.00000;
(SSUI:0.04738,SPLU:0.04738):0.00000;
(((SDOW:0.22586,(((SINF:0.04528,SLUT:0.02017):0.03198,SEQU:0.06542):0.11168,(SVES:0.04265,(SSAL:0.01601,STHE:0.03566):0.01357):0.13815):0.02646):0.02032,((((SPNE:0.10228,SMIT:0.10415):0.07845,(SINT:0.06571,(SANG:0.02183,SCON:0.03023):0.02039):0.10022):0.02047,SSUI:0.20708):0.03586,SPLU:0.21748):0.00874):0.00776,SENT:0.24023,(SDEV:0.01953,SRAT:0.01914):0.18234):0.00000;
(SINF:0.30718,SPLU:0.30718):0.00000;
(SENT:0.20545,SPLU:0.20545):0.00000;
(((SMIT:0.03006,(SPSE:0.03791,SPNE:0.02041):0.01409):0.07106,(SANG:0.05979,(SINT:0.01488,SCON:0.02401):0.04062):0.06458):0.04635,(((SDYS:0.04986,SCAN:0.04544):0.04599,SPLU:0.09295):0.04625,((SINF:0.00471,SLUT:0.00645):0.00998,SEQU:0.01030):0.09567):0.01978,((SDOW:0.23966,((STHE:0.00905,SSAL:0.01053):0.00385,SVES:0.01853):0.14474):0.02440,SSUI:0.17631):0.01983):0.00000;
((SANG:0.01715,(((SINF:0.02157,(SLUT:0.00569,SEQU:0.00483):0.01704):0.00611,((STHE:0.01432,(SSAL:0.00171,SVES:0.00028):0.01282):0.01057,(((LCRE:0.00228,LLAC:0.00172):0.08985,SENT:0.03859):0.00712,(SPYO:0.01275,(((SMIT:0.00291,(SPSE:0.00000,SPNE:0.00000):0.00010):0.00463,(SCAN:0.00076,SDYS:0.00124):0.01379):0.00310,(SSUI:0.00962,SPLU:0.01192):0.00837):0.00088):0.00838):0.00744):0.00220):0.00340,((SINT:0.00871,SDOW:0.02756):0.00243,SRAT:0.02921):0.00222):0.00193):0.00057,SDEV:0.01677,SCON:0.01565):0.00000;
(SRAT:0.29777,SPLU:0.29777):0.00000;
(((((SINT:0.00793,SCON:0.00947):0.02209,SANG:0.02201):0.21970,SPLU:0.45619):0.04357,(SPYO:0.10803,SCAN:0.10591):0.14134):0.00731,(SRAT:0.06067,SDEV:0.06345):0.12018,(SPNE:0.01107,SMIT:0.02199):0.24320):0.00000;
((((SANG:0.00687,(SINT:0.01717,SCON:0.00094):0.00214):0.09611,SPLU:0.39486):0.08027,(SCAN:0.02002,SPYO:0.02676):0.08408):0.01256,(SDEV:0.00000,SRAT:0.00000):0.06093,(SMIT:0.18402,SPNE:0.01973):0.01233):0.00000;
((SPLU:0.19022,(SSUI:0.10215,SENT:0.12772):0.03134):0.02138,(SCAN:0.09464,SDYS:0.09479):0.11637,((SMIT:0.02432,(SPSE:0.00000,SPNE:0.00000):0.02961):0.09266,(SANG:0.03689,(SINT:0.01095,SCON:0.01398):0.02678):0.12099):0.07802):0.00000;
(SSUI:0.15110,SPLU:0.22379,(SENT:0.15159,SDYS:0.24365):0.01245):0.00000;
(SSUI:0.25429,SPLU:0.25429):0.00000;
(((SPLU:0.06105,SSUI:0.13090):0.18172,SRAT:0.20450):0.13346,SCAN:0.17758,SENT:0.18820):0.00000;
(SENT:0.11504,SPLU:0.10177,(((SSAL:0.00892,(STHE:0.01624,SVES:0.01021):0.00322):0.09888,(((LLAC:0.00824,LCRE:0.01201):0.29257,(((SMIT:0.00229,(SPSE:0.00577,SPNE:0.00281):0.00146):0.06256,(SINT:0.02137,(SANG:0.01556,SCON:0.01326):0.00434):0.04386):0.02363,SSUI:0.09647):0.02822):0.02664,SDOW:0.08853):0.00541):0.00360,((((SINF:0.00797,SLUT:0.00379):0.00574,SEQU:0.01457):0.05540,(SCAN:0.02189,(SPYO:0.03154,SDYS:0.01547):0.00218):0.05564):0.02067,(SDEV:0.01434,SRAT:0.01141):0.04972):0.00674):0.00281):0.00000;
(((((SPLU:0.11148,SENT:0.10604):0.08296,SEQU:0.35677):0.08833,(SCON:0.05681,(SINT:0.04161,SANG:0.04732):0.00784):0.11674):0.10002,SPNE:0.04919):0.00297,SPSE:0.03677,SMIT:0.03898):0.00000;
((((SINF:0.01862,SLUT:0.02519):0.01511,SEQU:0.03499):0.15302,((STHE:0.04587,(SSAL:0.01117,SVES:0.01244):0.03279):0.20376,(((((LLAC:0.04113,LCRE:0.04091):0.29482,(((SMIT:0.02606,(SPSE:0.02064,SPNE:0.01915):0.01352):0.23436,(SANG:0.07717,(SINT:0.08307,SCON:0.06929):0.00791):0.13078):0.04065,SSUI:0.26440):0.01395):0.06007,SENT:0.24778):0.00501,SPLU:0.24184):0.00406,SDOW:0.26233):0.01106):0.00373):0.00348,(SDEV:0.04425,SRAT:0.05112):0.15269,(SPYO:0.09442,(SDYS:0.03100,SCAN:0.03757):0.04191):0.12516):0.00000;
((SSUI:0.01772,SPLU:0.03277):0.00160,(((SVES:0.02850,(SMIT:0.00073,SPNE:0.01306):0.03454):0.04555,SDEV:0.28770):0.01797,(SDEV:0.05932,SDOW:0.09252):0.01529):0.03833,SANG:0.02124):0.00000;
(SPLU:0.15553,SENT:0.16085,SSUI:0.14967):0.00000;
((SPLU:0.24912,(SENT:0.27577,SSUI:0.20482):0.01503):0.02945,((((SMIT:0.00891,SPSE:0.00909):0.00356,SPNE:0.00930):0.14153,(SANG:0.04631,(SINT:0.02753,SCON:0.01852):0.01858):0.09583):0.07330,((SSAL:0.02274,(STHE:0.01855,SVES:0.02808):0.00078):0.13446,(SDOW:0.13941,(SDEV:0.05878,SRAT:0.05578):0.07978):0.01316):0.05667):0.00546,(LLAC:0.04221,LCRE:0.04963):0.33949):0.00000;
(SRAT:0.23182,SPLU:0.23182):0.00000;
(((SENT:0.02194,(SPLU:0.02427,(SDEV:0.00551,SRAT:0.00706):0.01965):0.00240):0.00505,(((STHE:0.00190,(SSAL:0.00000,SVES:0.00000):0.00121):0.04242,((SINF:0.00900,SLUT:0.00660):0.01067,SEQU:0.01746):0.01327):0.00493,(((SINT:0.02457,(SANG:0.01297,SCON:0.00884):0.00332):0.02147,(((SMIT:0.00000,SPSE:0.00000):0.00000,SPNE:0.00156):0.01986,SSUI:0.03085):0.00452):0.01898,SDOW:0.05245):0.00368):0.00447):0.00154,(SCAN:0.01982,(SPYO:0.01333,SDYS:0.01013):0.00602):0.04588,(LCRE:0.00673,LLAC:0.00576):0.11069):0.00000;
((((SPSE:0.00997,(SMIT:0.00392,SPNE:0.00302):0.00469):0.08283,(SINT:0.02483,(SANG:0.01887,SCON:0.02850):0.00405):0.05900):0.03558,((SSUI:0.11742,(SENT:0.11561,SENT:0.20528):0.01724):0.00577,((SCAN:0.02754,(SPYO:0.02540,SDYS:0.02296):0.00712):0.07959,SPLU:0.12442):0.01225):0.00716):0.00425,(SDOW:0.12158,(SDEV:0.01072,SRAT:0.01089):0.10496):0.00328,((SEQU:0.02352,(SLUT:0.01404,SINF:0.00717):0.01856):0.07234,(STHE:0.02010,(SSAL:0.00324,SVES:0.00601):0.00857):0.09415):0.01021):0.00000;
(SDYS:0.31618,SPLU:0.31618):0.00000;
(SMIT:0.31968,SPLU:0.31968):0.00000;
(SENT:0.15499,SPLU:0.15499):0.00000;
(((SPSE:0.01809,(((SCAN:0.01345,SPYO:0.01269):0.01230,SDYS:0.03356):0.04477,((SPLU:0.02036,SSUI:0.01909):0.08694,(SINT:0.01344,(SANG:0.00341,SCON:0.00436):0.00503):0.10402):0.34596):0.05760):0.00391,SPNE:0.00577):0.00105,SMIT:0.01141,SSAL:0.00926):0.00000;
((SINT:0.00556,(SPLU:0.02240,SSUI:0.02749):0.34421):0.00933,SCON:0.00413,SANG:0.00274):0.00000;
((SPSE:0.01112,(SSAL:0.02118,(((SPLU:0.02506,SSUI:0.03319):0.06825,(SINT:0.00808,(SANG:0.00574,SCON:0.00318):0.00158):0.10419):0.45589,(SCAN:0.01573,(SPYO:0.01244,SDYS:0.00913):0.00795):0.06390):0.05355):0.00873):0.00068,SPNE:0.02251,SMIT:0.01065):0.00000;
(SPLU:0.05499,SSUI:0.08217,SVES:0.34175):0.00000;
(SRAT:0.19026,SPLU:0.19026):0.00000;
(SRAT:0.20372,SPLU:0.20372):0.00000;
(SDYS:0.35637,SPLU:0.35637):0.00000;
(SMIT:0.20046,SPLU:0.20046):0.00000;
(SANG:0.15391,SPLU:0.15391):0.00000;
(SANG:0.23576,SPLU:0.23576):0.00000;
((SPNE:0.21218,SPLU:0.12115):0.00926,SENT:0.20979,SCAN:0.21752):0.00000;
(SENT:0.29503,SPLU:0.29503):0.00000;
(SENT:0.28759,SPLU:0.28759):0.00000;
(SPNE:0.17781,SPLU:0.17781):0.00000;
((((SMIT:0.03316,(SPSE:0.03032,SPNE:0.03029):0.01406):0.12889,(SANG:0.05486,(SINT:0.04882,SCON:0.04306):0.00959):0.10610):0.01999,((SENT:0.20632,SPLU:0.18422):0.00679,(((STHE:0.03544,(SSAL:0.01777,SVES:0.02291):0.01461):0.09627,SDOW:0.13724):0.01308,((((SINF:0.01222,SLUT:0.00967):0.01162,SEQU:0.01885):0.12716,(SCAN:0.09898,(SPYO:0.08741,SDYS:0.08760):0.01363):0.05865):0.00795,(SDEV:0.05996,SRAT:0.05704):0.10581):0.00294):0.01762):0.00643):0.00598,SSUI:0.22759,(LCRE:0.00801,LLAC:0.00995):0.26501):0.00000;
((((((SINF:0.00397,SLUT:0.00359):0.00805,SEQU:0.01040):0.10610,((SPYO:0.05397,(SCAN:0.04071,SDYS:0.03052):0.00451):0.05013,SDOW:0.10949):0.00933):0.00105,SPLU:0.14924):0.01395,((SSAL:0.00762,(STHE:0.00482,SVES:0.00588):0.00794):0.06945,(SDEV:0.00935,SRAT:0.00899):0.08296):0.00473):0.00417,(((LCRE:0.04601,LLAC:0.05237):0.15633,(SMIT:0.04538,(SPSE:0.01192,SPNE:0.01389):0.03961):0.10019):0.00300,SENT:0.13565):0.01303,((SINT:0.02933,(SANG:0.02863,SCON:0.02165):0.00844):0.08893,SSUI:0.13015):0.02749):0.00000;
(SPLU:0.11111,SPLU:0.11111):0.00000;
(SPLU:0.21237,SPLU:0.16907,(SPLU:0.20588,(SPLU:0.22621,(((SPLU:0.17400,SPLU:0.18784):0.06773,SPLU:0.22952):0.14406,SPLU:0.26548):0.02051):0.01258):0.00550):0.00000;
(SPLU:0.22330,SPLU:0.22990,SPLU:0.17276):0.00000;
(SPLU:0.28879,SPLU:0.28879):0.00000;
(SPLU:0.10892,SPLU:0.10892):0.00000;
((SDOW:0.15623,((SPLU:0.07305,SRAT:0.06252):0.01753,SANG:0.11013):0.53738):0.08014,(SPLU:0.00580,SDYS:0.00514):0.01434,SANG:0.02550):0.00000;
(SPLU:0.04808,SRAT:0.09733,SCON:0.19797):0.00000;
(SENT:0.06559,SPLU:0.06559):0.00000;
(SPNE:0.34566,SPLU:0.34566):0.00000;
(SPLU:0.32639,SPLU:0.32639):0.00000;
(((SANG:0.10683,((SPNE:0.02422,(SMIT:0.02768,SVES:0.02596):0.00138):0.25545,SENT:0.27178):0.07996):0.04627,SSUI:0.05232):0.00111,SDYS:0.04562,(SSUI:0.04244,SPLU:0.04936):0.00963):0.00000;
(((SDEV:0.04642,SRAT:0.04313):0.11219,(SSUI:0.11427,(((SPSE:0.00000,SPNE:0.00000):0.01733,SMIT:0.03267):0.07425,((SANG:0.01246,SCON:0.03169):0.00123,SINT:0.03299):0.06644):0.04849):0.01107):0.03404,(SPLU:0.14522,((SPYO:0.04213,(SCAN:0.00130,SDYS:0.00511):0.03265):0.18535,((((SSAL:0.01409,SVES:0.01661):0.00593,STHE:0.04735):0.06253,SDOW:0.10164):0.05186,((SINF:0.01274,SLUT:0.00488):0.03614,SEQU:0.03223):0.09326):0.02990):0.02611):0.00927,((LLAC:0.02176,LCRE:0.00855):0.30502,SENT:0.14995):0.01787):0.00000;
(SANG:0.42144,SCAN:0.29224,SSUI:0.29714):0.00000;
(SANG:0.25153,SENT:0.34562,SPLU:0.27413):0.00000;
(SENT:0.24616,(SANG:0.11517,SPLU:0.10676):0.23906,SEQU:0.31651):0.00000;
(SPLU:0.24658,SANG:0.24658):0.00000;
(SPLU:0.12789,SANG:0.12789):0.00000;
(SANG:0.42000,(SCAN:0.01559,SCAN:0.03591):0.09821,SINT:0.10088):0.00000;
(SPLU:0.16147,SANG:0.16147):0.00000;
(SPLU:0.12252,SANG:0.12252):0.00000;
(SPLU:0.03692,SANG:0.03692):0.00000;
(SPLU:0.02550,SANG:0.02550):0.00000;
(SPLU:0.06418,SANG:0.06418):0.00000;
(SPLU:0.06350,SANG:0.06350):0.00000;
(SPLU:0.05854,SANG:0.05854):0.00000;
(SPLU:0.26204,SANG:0.26204):0.00000;
(SPLU:0.10746,SANG:0.10746):0.00000;
(SANG:0.29983,(SCAN:0.12800,SENT:0.17214):0.02003,SPLU:0.19947):0.00000;
((SPNE:0.34197,SANG:0.20214):0.04133,SPLU:0.24816,(SENT:0.17329,SCAN:0.13931):0.00699):0.00000;
(SENT:0.11758,SANG:0.11758):0.00000;
(SINT:0.12754,SANG:0.12754):0.00000;
(SANG:0.05080,SINF:0.26124,SPLU:0.05493):0.00000;
(((((((((SCON:0.00403,SINT:0.00212):0.07016,SANG:0.06874):0.08969,(STHE:0.15625,SSAL:0.15041):0.02761):0.04728,(SEQU:0.08315,(SLUT:0.08212,SINF:0.08111):0.01622):0.12548):0.08900,(((SINT:0.05782,SCON:0.07291):0.13160,(SENT:0.13253,SSUI:0.15536):0.02470):0.04815,SPLU:0.23778):0.12468):0.26968,(SCAN:0.09666,SDYS:0.07400):0.08802):0.02569,(SMIT:0.02802,(SPSE:0.01893,SPNE:0.03062):0.01040):0.08178):0.08090,SVES:0.03553):0.00325,SSAL:0.03801,STHE:0.03438):0.00000;
(((SANG:0.05825,(SINT:0.03263,SCON:0.02903):0.03082):0.44469,SMIT:0.03062):0.01253,SPNE:0.03033,SPSE:0.01450):0.00000;
((SANG:0.05855,SINT:0.07797):0.12897,SMIT:0.24561,(SVES:0.03399,SSAL:0.03607):0.21272):0.00000;
(SCON:0.02704,SANG:0.02704):0.00000;
(((SPLU:0.22679,(SENT:0.20033,SDOW:0.19078):0.01019):0.00953,(((LLAC:0.08190,LCRE:0.06366):0.31071,SSUI:0.23359):0.01939,(((SPNE:0.01639,SMIT:0.01665):0.00103,SPSE:0.01203):0.20663,(SANG:0.04646,(SINT:0.02630,SCON:0.01982):0.01504):0.15326):0.02708):0.03216):0.00954,(((SDYS:0.04840,(SCAN:0.02700,SPYO:0.02969):0.01774):0.12627,((SINF:0.01151,SLUT:0.00984):0.05288,SEQU:0.07200):0.09769):0.01147,(SDEV:0.04077,SRAT:0.04264):0.16241):0.01105,(STHE:0.07821,(SVES:0.03010,SSAL:0.01290):0.05765):0.11138):0.00000;
((SMIT:0.18814,(SPNE:0.02699,SPSE:0.02148):0.17402):0.37778,SINT:0.11113,(SANG:0.08852,SCON:0.08393):0.00915):0.00000;
((SCAN:0.05249,((((SPLU:0.08563,(SDOW:0.00762,SSAL:0.01192):0.07134):0.10418,SVES:0.19424):0.10438,(SSAL:0.32284,(SANG:0.31866,(((SPLU:0.07371,SDEV:0.07311):0.04925,(SDEV:0.03468,SRAT:0.02785):0.08629):0.20002,(SSUI:0.20027,(SPNE:0.03469,SENT:0.03270):0.15049):0.10837):0.10235):0.06234):0.02217):0.10069,(SVES:0.16566,SANG:0.14937):0.11753):0.19294):0.04728,(SPLU:0.00429,SDYS:0.00085):0.00551,SSUI:0.00572):0.00000;
(SANG:0.00958,SCON:0.01930,SINT:0.07825):0.00000;
(SPNE:0.48363,SDEV:0.06875,SRAT:0.07348):0.00000;
((((SPLU:0.18542,SENT:0.20391):0.02403,SDOW:0.20593):0.03860,(((STHE:0.01208,SSAL:0.00833):0.00233,SVES:0.02043):0.19532,((((SPNE:0.03224,SPSE:0.00970):0.03736,SMIT:0.03991):0.12789,(SCON:0.02936,(SINT:0.03786,SANG:0.02385):0.00474):0.09890):0.04772,SSUI:0.26143):0.04034):0.01469):0.01034,((SRAT:0.01156,SDEV:0.01368):0.14507,((SINF:0.00000,SLUT:0.00000):0.01231,SEQU:0.01454):0.13078):0.02152,(SPYO:0.05877,(SCAN:0.03576,SDYS:0.02102):0.03981):0.11631):0.00000;
((SSUI:0.12402,(((STHE:0.01903,(SSAL:0.00623,SVES:0.00540):0.01004):0.03902,((SINF:0.00534,SLUT:0.01785):0.02072,SEQU:0.05150):0.02968):0.02570,((LCRE:0.03033,LLAC:0.05428):0.22089,((SANG:0.01887,(SINT:0.00000,SCON:0.00000):0.02538):0.04212,((SMIT:0.02205,SPNE:0.00762):0.00558,SPSE:0.00784):0.11513):0.02369):0.03915):0.00860):0.01094,((SENT:0.14736,(SCAN:0.03685,(SPYO:0.00000,SDYS:0.00000):0.01457):0.07034):0.01940,((SDEV:0.02551,SRAT:0.04096):0.04468,SDOW:0.06329):0.01318):0.00435,SPLU:0.12071):0.00000;
(((SPNE:0.13367,(SPYO:0.03751,(SCAN:0.01039,SDYS:0.01679):0.03162):0.21063):0.08482,SLUT:0.02525):0.02713,SINF:0.03298,STHE:0.04649):0.00000;
(((SCAN:0.03274,SPYO:0.02715):0.02159,SDYS:0.06717):0.15032,(SDEV:0.17965,((SRAT:0.16813,SPLU:0.22333):0.01016,(SSUI:0.20715,((SANG:0.02275,(SINT:0.00000,SCON:0.00000):0.01496):0.12886,(SPNE:0.01817,(SMIT:0.00665,SPSE:0.00974):0.00727):0.17408):0.01798):0.06300):0.01864):0.00986,((((SINF:0.00567,SLUT:0.00503):0.00829,SEQU:0.01399):0.15410,SDOW:0.13793):0.00645,((SSAL:0.00000,SVES:0.00000):0.02419,STHE:0.03167):0.14429):0.04441):0.00000;
(SMIT:0.11653,SPNE:0.11653):0.00000;
(SPNE:0.01049,SPSE:0.01189,SMIT:0.05506):0.00000;
((SDOW:0.16604,((((SSAL:0.00477,(STHE:0.00669,SVES:0.00154):0.02266):0.14461,((SCAN:0.05088,SPYO:0.05063):0.02570,SDYS:0.06787):0.08303):0.02147,((SINT:0.07372,(SANG:0.06570,SCON:0.04168):0.00513):0.05300,((SMIT:0.00910,SPSE:0.01543):0.00654,SPNE:0.02343):0.13760):0.07266):0.00473,SPLU:0.16116):0.01139):0.00771,((SSUI:0.13610,(SDEV:0.08054,SRAT:0.07868):0.02266):0.02073,(SINF:0.03276,(SEQU:0.02511,SLUT:0.02730):0.01048):0.10913):0.00339,((LCRE:0.04344,LLAC:0.05225):0.14777,SENT:0.12104):0.00486):0.00000;
(SPNE:0.56106,SDEV:0.03960,SRAT:0.04790):0.00000;
(SPNE:0.00482,(SPSE:0.00997,(SPLU:0.03633,SENT:0.02525):0.03566):0.00280,SMIT:0.00325):0.00000;
(SPNE:0.38300,SSAL:0.02374,SVES:0.04529):0.00000;
((SPNE:0.21293,(SPNE:0.26484,SSUI:0.28811):0.21461):0.18524,(SANG:0.00486,SCON:0.00354):0.01650,SINT:0.02306):0.00000;
(SENT:0.02443,SPNE:0.02443):0.00000;
(((((SANG:0.01563,SCON:0.02258):0.25720,(LLAC:0.14321,SCAN:0.14777):0.11732):0.32715,SPNE:0.00867):0.00517,SPSE:0.00889):0.00140,SMIT:0.00268,SVES:0.00847):0.00000;
(SPNE:0.27733,SLUT:0.37079,SSUI:0.35835):0.00000;
(SENT:0.02332,SPNE:0.02332):0.00000;
(SPNE:0.01279,SPSE:0.00000,SMIT:0.02719):0.00000;
(((SDEV:0.00385,SRAT:0.00294):0.03867,(SENT:0.05238,((((SINT:0.00515,(SANG:0.00676,SCON:0.00587):0.00179):0.01587,((SMIT:0.00032,SPSE:0.00079):0.00039,SPNE:0.00209):0.02824):0.01044,SSUI:0.03367):0.01247,(LCRE:0.00403,LLAC:0.00393):0.15164):0.00672):0.00525):0.00061,((SLUT:0.00293,(SINF:0.00302,SEQU:0.00214):0.00295):0.02061,((STHE:0.01100,(SSAL:0.00033,SVES:0.00161):0.00637):0.02342,(SPLU:0.02569,(SPYO:0.00338,(SCAN:0.00597,SDYS:0.00546):0.00142):0.01501):0.00220):0.00189):0.00319,SDOW:0.04115):0.00000;
(SPNE:0.00705,(SSUI:0.05526,SENT:0.05425):0.05690,SPSE:0.00473):0.00000;
((SPNE:0.29376,SPLU:0.29776):0.10148,SCON:0.27753,SENT:0.28324):0.00000;
(SDYS:0.24848,SPNE:0.24848):0.00000;
((SPNE:0.00458,SPSE:0.00732):0.01200,SMIT:0.02555,(SANG:0.04291,(SINT:0.00764,SCON:0.01796):0.05172):0.47407):0.00000;
(SPNE:0.18989,(((SCON:0.03388,SANG:0.03889):0.01182,SINT:0.06554):0.09225,(SPYO:0.04210,(SDYS:0.00768,SCAN:0.01471):0.01224):0.17592):0.00325,SSUI:0.15046):0.00000;
(SPSE:0.13905,SPNE:0.13905):0.00000;
(((SMIT:0.02046,(SPSE:0.01356,SPNE:0.01861):0.01019):0.13635,(SANG:0.03225,SCON:0.03103):0.08534):0.12374,(SSAL:0.01004,SVES:0.01456):0.00796,STHE:0.02857):0.00000;
(SPNE:0.28397,(SRAT:0.29257,SPLU:0.32481):0.09201,(SVES:0.03140,SSAL:0.03270):0.23058):0.00000;
(SCON:0.14057,SPNE:0.14057):0.00000;
((((((SINT:0.01506,(SANG:0.00642,SCON:0.00811):0.00271):0.06705,((SMIT:0.01508,SPSE:0.01235):0.01722,SPNE:0.03434):0.04896):0.02486,(SDEV:0.00792,SRAT:0.00882):0.05968):0.03974,((SSAL:0.01487,SVES:0.01378):0.07453,SDOW:0.10369):0.01101):0.00794,(SCAN:0.03364,SDYS:0.03628):0.09261):0.00566,SENT:0.11416,(SSUI:0.48542,SPLU:0.13513):0.00606):0.00000;
(SENT:0.28353,SPNE:0.28353):0.00000;
((SDOW:0.16245,((SANG:0.03763,(SINT:0.00463,SCON:0.00283):0.03637):0.06545,(SMIT:0.01746,(SPSE:0.01869,SPNE:0.01613):0.00766):0.09089):0.03811):0.00366,(SENT:0.14624,(((STHE:0.02904,(SSAL:0.01465,SVES:0.01841):0.01098):0.06215,SPLU:0.08629):0.05433,(SDEV:0.06420,SRAT:0.09083):0.03812):0.00710):0.01309,(((SINF:0.02084,SLUT:0.01941):0.00352,SEQU:0.02789):0.09350,((SSUI:0.28417,(LLAC:0.03860,LCRE:0.04260):0.31523):0.16107,((SCAN:0.03351,SPYO:0.02844):0.01872,SDYS:0.04343):0.09397):0.00957):0.00633):0.00000;
(SPSE:0.02632,SPNE:0.02632):0.00000;
((((((SMIT:0.00293,SPSE:0.00239):0.00214,SPNE:0.00318):0.07944,SENT:0.08346):0.23645,(SDYS:0.02779,(SCAN:0.02283,SPYO:0.02643):0.00929):0.06753):0.02652,(SSUI:0.12102,(SDEV:0.04787,SRAT:0.04151):0.02350):0.01328):0.00690,((STHE:0.01012,(SVES:0.00000,SSAL:0.00000):0.00454):0.05129,(SEQU:0.01343,(SINF:0.01415,SLUT:0.02363):0.00961):0.03435):0.01054,SDOW:0.07296):0.00000;
(SPNE:0.01027,SMIT:0.00590,SVES:0.03929):0.00000;
(SPLU:0.12381,SEQU:0.13868,SPNE:0.52112):0.00000;
((((SCAN:0.06008,(SPYO:0.01978,SDYS:0.01468):0.04829):0.03866,(SENT:0.10600,(((LLAC:0.02704,LCRE:0.02035):0.21086,(((SCON:0.02229,SANG:0.02496):0.00669,SINT:0.03981):0.06162,((SMIT:0.00945,SPSE:0.00621):0.01119,SPNE:0.00921):0.09772):0.02103):0.01869,SSUI:0.11760):0.01687):0.03167):0.01103,(SVES:0.01365,(STHE:0.00936,SSAL:0.01917):0.00331):0.05577):0.02969,(SLUT:0.02796,SEQU:0.02504):0.00656,SINF:0.03469):0.00000;
((((SPLU:0.17240,((SENT:0.24888,SSUI:0.20552):0.00382,((LLAC:0.03893,LCRE:0.02867):0.26100,(((SINT:0.04416,SCON:0.04053):0.00330,SANG:0.04374):0.14293,((SPNE:0.00220,SPSE:0.00183):0.03158,SMIT:0.03045):0.15747):0.02285):0.01577):0.00929):0.01793,(((SINF:0.00670,SLUT:0.00873):0.05718,SEQU:0.05663):0.10551,(SCAN:0.10090,(SPYO:0.07449,SDYS:0.08152):0.03566):0.10748):0.01464):0.00607,SDOW:0.19739):0.00445,(SRAT:0.05193,SDEV:0.04800):0.14024,(SSAL:0.03583,(SVES:0.01640,STHE:0.01903):0.02051):0.17275):0.00000;
(((LLAC:0.06200,LCRE:0.05484):0.12260,(((SMIT:0.00688,SPNE:0.00482):0.00165,SPSE:0.00951):0.04724,(STHE:0.01520,(SSAL:0.00386,SVES:0.00479):0.00331):0.05274):0.08531):0.01373,((((SINF:0.00941,SLUT:0.00906):0.01862,SEQU:0.02618):0.04126,SDOW:0.07469):0.00546,(SDEV:0.01442,SRAT:0.01376):0.05929):0.03214,(SSUI:0.09026,SPLU:0.09579):0.00901):0.00000;
((SPNE:0.11950,SPSE:0.11585):0.36965,SPLU:0.17373,SSUI:0.16915):0.00000;
(SPNE:0.45201,STHE:0.19827,SCAN:0.21120):0.00000;
(SPNE:0.00003,(SPSE:0.01019,((SSAL:0.02617,SVES:0.04869):0.21825,SPNE:0.04210):0.01141):0.00149,SMIT:0.00780):0.00000;
(SPSE:0.03623,(SVES:0.03324,SPNE:0.04436):0.00629,(LCRE:0.14298,(SSUI:0.02380,SPLU:0.01570):0.14169):0.11259):0.00000;
(SPNE:0.26714,SPNE:0.26714):0.00000;
(SPNE:0.05814,SPSE:0.05563,SMIT:0.00795):0.00000;
((((SPNE:0.00000,SPSE:0.00000):0.00811,SMIT:0.00751):0.20960,(SDOW:0.12566,((SEQU:0.04946,(SLUT:0.00974,SINF:0.04499):0.02724):0.09611,SENT:0.14664):0.05402):0.06490):0.00857,SSUI:0.25070,(SINT:0.15858,(SANG:0.04945,SCON:0.07074):0.01466):0.07646):0.00000;
(((LLAC:0.08434,LCRE:0.08220):0.14960,(((SDEV:0.05139,(SINF:0.02900,SEQU:0.02228):0.02976):0.15441,(((((SPSE:0.00765,SPNE:0.00384):0.00579,SCON:0.01062):0.07650,SSUI:0.07364):0.03977,(SCAN:0.03498,SPYO:0.03271):0.08253):0.01203,((SPLU:0.06874,(SSAL:0.06400,(SENT:0.05905,(SDEV:0.01309,SRAT:0.01554):0.04511):0.00173):0.01052):0.01130,(SANG:0.01840,(SINT:0.01540,SCON:0.01530):0.00571):0.05877):0.04064):0.09162):0.01880,(((SPLU:0.20083,((LLAC:0.14445,SEQU:0.12333):0.04821,((LCRE:0.01894,LLAC:0.01719):0.12193,(SPLU:0.09227,(SDOW:0.08649,(SENT:0.06628,(((SSAL:0.00503,SVES:0.00804):0.03756,SANG:0.04320):0.01364,(SRAT:0.01921,SDEV:0.02002):0.03628):0.00934):0.00772):0.01653):0.04264):0.02672):0.02183):0.03479,(SRAT:0.03990,SDEV:0.03904):0.21695):0.00602,((((LLAC:0.01169,LCRE:0.00926):0.26473,SDEV:0.31709):0.00736,(SEQU:0.04310,SLUT:0.04267):0.20431):0.03203,((LCRE:0.04658,LLAC:0.04289):0.28477,((((((SLUT:0.00681,SEQU:0.00524):0.15022,(SCAN:0.02697,(SDYS:0.01880,SPYO:0.01990):0.00978):0.14353):0.03188,((LLAC:0.02956,LCRE:0.03078):0.12234,LCRE:0.15731):0.03857):0.04406,SPNE:0.21619):0.03199,(((SPSE:0.01428,(SMIT:0.01434,SPNE:0.01592):0.00407):0.12487,((SSUI:0.12585,SSUI:0.11689):0.00594,(SCAN:0.00770,SPYO:0.01289):0.10921):0.02860):0.06333,(SDEV:0.09052,((SANG:0.02050,SCON:0.01848):0.00762,SINT:0.02547):0.06049):0.10819):0.03465):0.11185,(SPNE:0.25807,(((SLUT:0.00774,SEQU:0.00446):0.04575,SANG:0.05338):0.14091,(SINT:0.06089,((SANG:0.02552,(((SMIT:0.01285,SPSE:0.01023):0.00435,SPNE:0.01836):0.00707,(SINF:0.00544,SLUT:0.00432):0.01943):0.00344):0.01719,(((SSUI:0.00303,SPLU:0.00361):0.03303,(SSUI:0.02872,(SCAN:0.01276,SPYO:0.01499):0.01860):0.00526):0.00560,(SDOW:0.03514,(SDEV:0.01595,SRAT:0.01675):0.02315):0.00617):0.00521):0.00991):0.11981):0.06384):0.09770):0.05457):0.01052):0.06299):0.00559):0.00560):0.00126,(SEQU:0.01908,SINF:0.01739):0.23446,((((SLUT:0.00593,SEQU:0.00324):0.03521,(SDEV:0.02521,SRAT:0.02521):0.02325):0.01795,(((SSAL:0.00779,SVES:0.00860):0.01260,SPSE:0.02135):0.01077,(SANG:0.02629,SINT:0.02600):0.00458):0.03333):0.06359,(LLAC:0.02545,LCRE:0.01843):0.10794):0.09559):0.00000;
((SPSE:0.00397,SPNE:0.00092):0.02095,SCON:0.35024,SMIT:0.02118):0.00000;
((((SEQU:0.04900,(SLUT:0.01911,SINF:0.01550):0.04131):0.05812,(SRAT:0.03905,SDEV:0.02819):0.07539):0.00222,((SCAN:0.07970,(SPYO:0.00000,SDYS:0.00000):0.08368):0.08492,((SPLU:0.12059,SENT:0.16456):0.00595,((LLAC:0.03285,LCRE:0.03490):0.22311,(SSUI:0.16286,((SINT:0.04087,(SANG:0.02667,SCON:0.02989):0.00694):0.07261,((SMIT:0.00450,SPSE:0.00351):0.00567,SPNE:0.01259):0.10418):0.03222):0.01329):0.02737):0.00394):0.00445):0.00201,SDOW:0.13939,(SSAL:0.02139,(SVES:0.02165,STHE:0.02074):0.00132):0.13405):0.00000;
(SEQU:0.33597,SPNE:0.33597):0.00000;
(SPNE:0.01535,SPSE:0.00957,SMIT:0.01933):0.00000;
(SPNE:0.06992,SPSE:0.03260,SPSE:0.20133):0.00000;
(SENT:0.09978,SPNE:0.09978):0.00000;
(((SPLU:0.04261,(SANG:0.06685,(SPNE:0.15985,SENT:0.19921):0.42837):0.05068):0.00983,(SSUI:0.01451,SCAN:0.01144):0.00896):0.00545,SDYS:0.02408,SPLU:0.01803):0.00000;
((SPSE:0.00538,SPNE:0.01392):0.01807,(SANG:0.02106,SCON:0.01883):0.43659,SMIT:0.02196):0.00000;
(SPSE:0.14527,SPNE:0.14527):0.00000;
(SPNE:0.00567,SPSE:0.00643,SMIT:0.09751):0.00000;
(LLAC:0.05393,LCRE:0.05393):0.00000;
(LLAC:0.06995,LCRE:0.06995):0.00000;
((((SMIT:0.03517,(SPSE:0.03380,SPNE:0.02728):0.00289):0.09362,(SANG:0.03645,(SINT:0.01375,SCON:0.00984):0.03148):0.09550):0.01145,(LCRE:0.03253,LLAC:0.03018):0.22754):0.01224,(((STHE:0.03606,(SSAL:0.03096,SVES:0.02442):0.01048):0.07677,(SSUI:0.12758,SENT:0.17795):0.00511):0.01157,SDOW:0.10379):0.00676,((((SINF:0.00804,SLUT:0.01094):0.02308,SEQU:0.03631):0.08985,(SPLU:0.13714,((SCAN:0.03699,SPYO:0.03493):0.00912,SDYS:0.04761):0.08580):0.00175):0.00572,(SDEV:0.05361,SRAT:0.05448):0.06752):0.00185):0.00000;
(LLAC:0.02873,LCRE:0.02873):0.00000;
(LLAC:0.01288,LCRE:0.01288):0.00000;
(LLAC:0.05254,LCRE:0.05254):0.00000;
(LLAC:0.01265,LCRE:0.01265):0.00000;
((((((STHE:0.01444,SSAL:0.00403):0.00068,SVES:0.00791):0.05015,((((LCRE:0.03699,LLAC:0.03574):0.21027,SSUI:0.25134):0.13172,((LCRE:0.00581,LLAC:0.00638):0.17727,((SDEV:0.01173,SRAT:0.01119):0.10036,(SVES:0.08714,((((SINF:0.00305,SLUT:0.00401):0.00971,SEQU:0.01091):0.06572,(SCAN:0.01034,SDYS:0.01278):0.07012):0.00762,SDOW:0.08761):0.00312):0.04130):0.04718):0.17363):0.25639,(SENT:0.11239,(SPLU:0.07056,(SPYO:0.00904,(SCAN:0.00329,SDYS:0.00304):0.00744):0.04864):0.05190):0.00213):0.03926):0.01619,(SANG:0.01701,(SINT:0.00507,SCON:0.00390):0.02265):0.01032):0.03904,SPNE:0.00920):0.00231,SPSE:0.00116,SMIT:0.00717):0.00000;
(LLAC:0.11882,LCRE:0.11882):0.00000;
(LLAC:0.06538,LCRE:0.06538):0.00000;
(((LCRE:0.00796,LLAC:0.00670):0.13469,(SENT:0.07565,(SSUI:0.05330,((SMIT:0.00578,(SPSE:0.00179,SPNE:0.00222):0.00254):0.03045,(SANG:0.01606,(SINT:0.01318,SCON:0.01827):0.00379):0.02956):0.02635):0.00369):0.00136):0.01055,(((SINF:0.00417,SLUT:0.00577):0.00253,SEQU:0.00567):0.04080,(SDEV:0.01942,SRAT:0.02629):0.02303):0.00891,(((STHE:0.00831,(SSAL:0.00383,SVES:0.00301):0.00086):0.03388,(SPLU:0.04096,(SCAN:0.01005,(SPYO:0.01125,SDYS:0.00709):0.00037):0.02455):0.00459):0.00594,SDOW:0.05277):0.00337):0.00000;
(LLAC:0.04394,LCRE:0.04394):0.00000;
(LLAC:0.01249,LCRE:0.01249):0.00000;
(((STHE:0.01334,(SSAL:0.00668,SVES:0.00692):0.00068):0.03920,SENT:0.04202):0.01638,(((SINT:0.04088,(SANG:0.00851,SCON:0.01097):0.01434):0.03893,((SMIT:0.00263,(SPSE:0.00000,SPNE:0.00000):0.00387):0.05934,(SPYO:0.06689,(SCAN:0.03705,SDYS:0.01802):0.00714):0.03114):0.00659):0.00560,(SDOW:0.07230,(LCRE:0.01764,LLAC:0.01985):0.18250):0.01129):0.00718,(SDEV:0.05748,(((SSUI:0.03219,SPLU:0.03913):0.00998,((SINF:0.01536,SLUT:0.01129):0.01031,SEQU:0.02367):0.03987):0.00349,SRAT:0.05699):0.00089):0.00061):0.00000;
(LLAC:0.05767,LCRE:0.05767):0.00000;
((((SSUI:0.08005,SENT:0.07653):0.02353,(LCRE:0.01230,LLAC:0.01408):0.24648):0.02236,(SPYO:0.05347,(SDYS:0.03228,SCAN:0.02649):0.01250):0.07545):0.00250,(((SSAL:0.01547,(STHE:0.00940,SVES:0.00732):0.01068):0.04757,(SINF:0.00767,(SLUT:0.01125,SEQU:0.00539):0.00454):0.07504):0.01103,(SDOW:0.10198,(SDEV:0.02840,SRAT:0.03062):0.06022):0.00721):0.00514,((((SMIT:0.00455,SPSE:0.00701):0.00170,SPNE:0.00751):0.04857,(SANG:0.01606,(SINT:0.00724,SCON:0.00607):0.01616):0.03378):0.04008,SPLU:0.09790):0.00429):0.00000;
(((SDEV:0.05288,SRAT:0.06588):0.10214,(((SMIT:0.02414,(SPSE:0.01640,SPNE:0.01849):0.00984):0.08939,(SINT:0.06684,(SANG:0.03158,SCON:0.03155):0.01468):0.06801):0.04031,(LCRE:0.03373,LLAC:0.02650):0.28735):0.01183):0.00290,SSUI:0.16335,((SDOW:0.14702,(((STHE:0.03084,(SSAL:0.01599,SVES:0.02121):0.00507):0.07962,SPLU:0.12032):0.01852,SENT:0.14235):0.00960):0.00360,(((SINF:0.00946,SLUT:0.01999):0.01599,SEQU:0.03577):0.07500,(SCAN:0.05169,(SPYO:0.01287,SDYS:0.01833):0.03796):0.08356):0.02101):0.00880):0.00000;
((SLUT:0.04849,(((SPYO:0.13629,(SDYS:0.06719,SCAN:0.06696):0.04334):0.25657,((LCRE:0.08781,LLAC:0.08777):0.14978,(LLAC:0.00284,LLAC:0.00247):0.23823):0.04481):0.18975,SPNE:0.16887):0.11898):0.04097,STHE:0.01824,SINF:0.01838):0.00000;
(LLAC:0.01273,LCRE:0.01273):0.00000;
(LLAC:0.17682,LCRE:0.17682):0.00000;
(LLAC:0.01216,LCRE:0.01216):0.00000;
((SDOW:0.09306,(SANG:0.11774,(((STHE:0.02626,(SSAL:0.00909,SVES:0.01090):0.00631):0.04028,SMIT:0.06930):0.05067,((LLAC:0.02389,LCRE:0.02590):0.21221,(LCRE:0.00701,LLAC:0.01102):0.48511):0.07820):0.01652):0.02190):0.00629,(SRAT:0.02361,SDEV:0.01737):0.05416,((SINF:0.02451,SLUT:0.02446):0.01817,SEQU:0.03256):0.04939):0.00000;
(LCRE:0.01255,LLAC:0.01255,SDYS:0.41672):0.00000;
(LLAC:0.06440,LCRE:0.06440):0.00000;
((((SSUI:0.01530,SPLU:0.01329):0.15925,(SMIT:0.19982,((SCAN:0.23865,((LCRE:0.03703,LLAC:0.05411):0.23998,(LLAC:0.06040,LCRE:0.06542):0.29278):0.14266):0.04749,SCAN:0.21443):0.01526):0.01271):0.00974,SDOW:0.15876):0.01146,((SINF:0.05559,(SLUT:0.02138,SEQU:0.03312):0.03875):0.07482,(SDEV:0.07887,SRAT:0.10090):0.04620):0.00767,(SANG:0.14159,SSUI:0.09957):0.04160):0.00000;
(LLAC:0.06455,LCRE:0.06455):0.00000;
(LLAC:0.02313,LCRE:0.02313):0.00000;
(((((SPSE:0.01135,(SMIT:0.00418,SPNE:0.00747):0.00168):0.03703,(SANG:0.01556,(SINT:0.00887,SCON:0.00071):0.00629):0.04002):0.02701,SSUI:0.11859):0.01964,(LCRE:0.01037,LLAC:0.01600):0.27789):0.02643,(((STHE:0.01373,(SSAL:0.00892,SVES:0.00753):0.00366):0.04304,SDOW:0.09709):0.00895,(((SINF:0.00215,SLUT:0.01285):0.01480,SEQU:0.02040):0.04318,(SDEV:0.03491,SRAT:0.03113):0.05367):0.01422):0.00453,((SPLU:0.07650,SENT:0.10420):0.01580,(SCAN:0.01979,(SPYO:0.00943,SDYS:0.00552):0.00910):0.06343):0.00554):0.00000;
(((LCRE:0.02017,LLAC:0.02731):0.51205,((SDEV:0.10411,SRAT:0.09966):0.05938,(SSAL:0.04267,SVES:0.04697):0.13265):0.02374):0.01463,SDOW:0.21071,SDYS:0.22942):0.00000;
(LLAC:0.01079,LCRE:0.01079):0.00000;
(LLAC:0.07811,LCRE:0.07811):0.00000;
(LCRE:0.04307,LLAC:0.04252,SDEV:0.43048):0.00000;
(LLAC:0.06584,LCRE:0.06584):0.00000;
(((SENT:0.06568,(LCRE:0.00405,LLAC:0.00411):0.12113):0.00694,((((SMIT:0.00342,(SPSE:0.00250,SPNE:0.00345):0.00168):0.01057,(SINT:0.01110,(SANG:0.00245,SCON:0.00138):0.00356):0.01936):0.02979,SSUI:0.04903):0.00472,((SDEV:0.02193,SRAT:0.02940):0.02275,(((SINF:0.00615,SLUT:0.00575):0.00292,SEQU:0.00687):0.02611,SDOW:0.04112):0.00858):0.00581):0.00261):0.00219,((STHE:0.01374,(SSAL:0.00599,SVES:0.00382):0.00653):0.03168,(SPYO:0.02371,(SCAN:0.00611,SDYS:0.00325):0.01169):0.04050):0.00224,SPLU:0.03591):0.00000;
((SDOW:0.09907,(((SENT:0.14241,(SSUI:0.11286,((SCON:0.02633,SANG:0.02060):0.04396,(SINT:0.07583,(SPSE:0.00763,(SMIT:0.00538,SPNE:0.00795):0.00469):0.05228):0.00074):0.05139):0.03517):0.01415,(LLAC:0.01526,LCRE:0.01776):0.24193):0.03002,(SPLU:0.08871,((STHE:0.03872,(SSAL:0.00798,SVES:0.00722):0.02518):0.04610,((SCAN:0.03173,SPYO:0.03534):0.00642,SDYS:0.04292):0.03577):0.01189):0.01965):0.00587):0.00516,(SDEV:0.03120,SRAT:0.04518):0.06628,((SINF:0.01106,SLUT:0.01754):0.01388,SEQU:0.02905):0.05123):0.00000;
(LLAC:0.12110,LCRE:0.12110):0.00000;
((((SDYS:0.09184,SCAN:0.11425):0.20587,(LCRE:0.04217,LLAC:0.03943):0.35384):0.02985,((SINF:0.00323,SLUT:0.00535):0.08735,SEQU:0.10476):0.09443):0.00883,((SDEV:0.04563,SRAT:0.05245):0.13878,SDOW:0.22914):0.01383,((STHE:0.01540,SSAL:0.01954):0.02524,SVES:0.03466):0.16964):0.00000;
((LCRE:0.01796,LLAC:0.01832):0.68796,SDEV:0.01443,SRAT:0.02238):0.00000;
(LLAC:0.08108,LCRE:0.08108):0.00000;
(LLAC:0.00700,LCRE:0.00700):0.00000;
(LCRE:0.35000,LCRE:0.35000):0.00000;
((((SPSE:0.00941,(SMIT:0.00335,SPNE:0.00212):0.00562):0.10692,((SANG:0.00345,SINT:0.00608):0.01712,SCON:0.02097):0.06869):0.05478,((SPLU:0.16074,SDOW:0.11545):0.03515,(SSUI:0.18900,(((LLAC:0.05771,LCRE:0.04202):0.19136,((LLAC:0.01589,LCRE:0.04285):0.26044,((LLAC:0.02049,LCRE:0.02117):0.22498,(LLAC:0.01590,LCRE:0.01673):0.19565):0.00377):0.02100):0.16160,((LLAC:0.00000,LCRE:0.00000):0.21319,(LCRE:0.01788,LLAC:0.02009):0.21586):0.04397):0.08178):0.01286):0.02557):0.03707,((SDEV:0.00814,SRAT:0.00678):0.08307,((SINF:0.01236,(SLUT:0.01320,SEQU:0.00686):0.00169):0.05565,(SPYO:0.05754,(SCAN:0.02871,SDYS:0.03194):0.03217):0.02954):0.01547):0.01217,(STHE:0.03006,(SSAL:0.00000,SVES:0.00000):0.01731):0.07510):0.00000;
(((SPSE:0.25764,SINT:0.21071):0.03020,((SENT:0.38497,(LCRE:0.27646,LCRE:0.32715):0.10309):0.06797,(SCON:0.21346,(SANG:0.11066,SINT:0.09395):0.10948):0.04040):0.01013):0.00776,(SEQU:0.21508,SINT:0.16701):0.04652,((SPSE:0.03347,SPNE:0.02878):0.00348,SMIT:0.03276):0.24118):0.00000;
(SINT:0.31614,LCRE:0.31614):0.00000;
(LLAC:0.08301,LCRE:0.08301):0.00000;
(LLAC:0.00542,LCRE:0.00542):0.00000;
(LLAC:0.09389,LCRE:0.09389):0.00000;
(SPLU:0.05034,(((STHE:0.01760,(SSAL:0.00279,SVES:0.00258):0.00680):0.04313,(LCRE:0.01896,LLAC:0.01645):0.17847):0.00619,((SPYO:0.04746,(SCAN:0.01659,SDYS:0.02795):0.01229):0.01340,((SINT:0.01655,(SANG:0.00000,SCON:0.00000):0.01279):0.02839,SMIT:0.04449):0.01850):0.00552):0.00265,((SDEV:0.03794,(SDOW:0.03873,SRAT:0.03431):0.00392):0.00315,(SLUT:0.00990,(SINF:0.00851,SEQU:0.00656):0.00156):0.04184):0.00289):0.00000;
(((SPLU:0.18077,(SENT:0.19162,((LCRE:0.02025,LLAC:0.01681):0.30949,(((SMIT:0.05453,(SPSE:0.01618,SPNE:0.01790):0.05208):0.11754,(SANG:0.04355,(SINT:0.03874,SCON:0.03027):0.00885):0.12980):0.02020,SSUI:0.22539):0.01306):0.04112):0.01590):0.01550,(SDOW:0.10965,(SSAL:0.02139,(STHE:0.02224,SVES:0.01880):0.00376):0.11525):0.04725):0.00636,(SDEV:0.01773,SRAT:0.01311):0.14902,(((SINF:0.00620,SLUT:0.00953):0.01339,SEQU:0.02621):0.08555,(SPYO:0.06472,(SCAN:0.03858,SDYS:0.03048):0.01902):0.06508):0.01775):0.00000;
(SSUI:0.11178,((SCAN:0.01632,(SPYO:0.01183,SDYS:0.01173):0.00848):0.10225,(((SINF:0.01131,SLUT:0.00951):0.01471,SEQU:0.02700):0.10549,(((LCRE:0.01173,LLAC:0.01061):0.23792,(SDOW:0.09605,((STHE:0.00554,(SSAL:0.00179,SVES:0.00565):0.00283):0.06114,SPLU:0.09721):0.02442):0.03972):0.01263,((SMIT:0.00868,(SPSE:0.01332,SPNE:0.01285):0.00562):0.05834,(SINT:0.02859,(SANG:0.01466,SCON:0.02623):0.01359):0.04102):0.03177):0.03178):0.00996):0.00715,(SDEV:0.02478,SRAT:0.02827):0.04873):0.00000;
(LLAC:0.11333,LCRE:0.11333):0.00000;
(LLAC:0.10798,LCRE:0.10798):0.00000;
(LLAC:0.09569,LCRE:0.09569):0.00000;
((SSUI:0.14038,(LCRE:0.01140,LLAC:0.00591):0.18151):0.02285,((SLUT:0.00915,(SINF:0.01303,SEQU:0.00599):0.00623):0.08781,(SPYO:0.01067,(SCAN:0.00706,SDYS:0.01121):0.00433):0.06966):0.02192,(SMIT:0.06826,(SANG:0.01837,(SINT:0.00459,SCON:0.00782):0.00893):0.04826):0.03686):0.00000;
((((SSAL:0.02173,SVES:0.01930):0.07309,((SDEV:0.08918,SDOW:0.08978):0.00966,((SINF:0.02864,(SLUT:0.02004,SEQU:0.01838):0.01263):0.07249,SRAT:0.07311):0.00676):0.00290):0.00620,(((SPSE:0.02012,(SMIT:0.01922,SPNE:0.01475):0.00283):0.08346,(SINT:0.00462,SCON:0.00333):0.09267):0.02996,(((SSUI:0.21578,(SDEV:0.24876,(((SDOW:0.09903,(SEQU:0.08886,(SDEV:0.03764,SRAT:0.03384):0.05639):0.01568):0.00087,((((SSUI:0.01014,SPLU:0.01149):0.06407,SENT:0.08698):0.00663,(SPYO:0.00000,SDYS:0.00000):0.09322):0.01529,(((SSAL:0.01834,SVES:0.02082):0.03625,(SPSE:0.01169,SPNE:0.01645):0.04107):0.03489,(SANG:0.07575,(SCON:0.03439,SINT:0.04175):0.03001):0.02656):0.01765):0.00933):0.21008,((LLAC:0.06236,LCRE:0.06730):0.13114,SDOW:0.18440):0.12423):0.02011):0.01470):0.04987,((LLAC:0.00967,LCRE:0.00882):0.14019,(LCRE:0.06574,LLAC:0.07153):0.15827):0.00951):0.03063,SENT:0.16049):0.02066):0.01761):0.00066,SPLU:0.11683,(SPYO:0.03124,(SCAN:0.02997,SDYS:0.02485):0.01218):0.08278):0.00000;
((SDYS:0.02915,(LCRE:0.01546,LLAC:0.01326):0.42737):0.00558,SPLU:0.03242,SSUI:0.02853):0.00000;
(LLAC:0.05974,LCRE:0.05974):0.00000;
(LLAC:0.08434,LCRE:0.08434):0.00000;
(LLAC:0.09798,LCRE:0.09798):0.00000;
(LCRE:0.42676,(SPNE:0.00657,SMIT:0.00698):0.00582,SPSE:0.01212):0.00000;
(((SRAT:0.02928,SDEV:0.03832):0.08815,((STHE:0.21150,(((SANG:0.02308,(SINT:0.00667,SCON:0.00229):0.02280):0.06933,((SMIT:0.00622,SPSE:0.00345):0.00199,SPNE:0.00838):0.11453):0.01528,SSUI:0.12907):0.04119):0.01653,((SDOW:0.21792,((((LCRE:0.02773,LLAC:0.02345):0.05948,(LCRE:0.00534,LLAC:0.00707):0.11166):0.07240,((LCRE:0.04605,LLAC:0.05263):0.15062,(LCRE:0.02372,LLAC:0.02000):0.21086):0.00716):0.09645,(SDYS:0.25347,(SENT:0.15055,(SCAN:0.02914,SDYS:0.02847):0.12321):0.10494):0.26135):0.04285):0.02672,(SPLU:0.13807,((SEQU:0.05965,(SINF:0.01751,SLUT:0.01310):0.02916):0.07074,(STHE:0.02979,(SSAL:0.00708,SVES:0.00926):0.01631):0.12409):0.02154):0.03695):0.02016):0.03450):0.00765,(SPYO:0.02703,(SCAN:0.02017,SDYS:0.01146):0.00870):0.08758,SENT:0.15494):0.00000;
(SPSE:0.01026,(SPNE:0.00957,SMIT:0.00856):0.00166,((STHE:0.06374,(SSAL:0.01724,SVES:0.03213):0.04960):0.06399,((SANG:0.02813,(SINT:0.01133,SCON:0.00828):0.01858):0.10774,(((((SCAN:0.04947,SDYS:0.04649):0.03617,SPYO:0.08001):0.14204,((SINF:0.00718,SLUT:0.00544):0.02811,SEQU:0.03910):0.15347):0.02704,(SRAT:0.04149,SDEV:0.04552):0.17961):0.02020,SSUI:0.26718):0.28291):0.01453):0.12091):0.00000;
((SMIT:0.04309,(SPNE:0.07106,(SINT:0.07212,(((SDYS:0.02817,SCAN:0.04452):0.16403,(SRAT:0.11042,SDEV:0.09348):0.04394):0.00904,((SCON:0.06391,SINF:0.06665):0.02312,SANG:0.04803):0.08449):0.07996):0.01464):0.01214):0.00973,(SDOW:0.05700,SVES:0.04662):0.00839,SPSE:0.03369):0.00000;
(((SCAN:0.01741,SDYS:0.01016):0.11519,SRAT:0.19468):0.00920,SENT:0.10492,(SPLU:0.04081,SSUI:0.03711):0.12668):0.00000;
((SSAL:0.08110,((SCAN:0.00811,SPYO:0.00657):0.01162,SDYS:0.01659):0.05853):0.03931,(SINF:0.08374,SRAT:0.08209):0.01030,((LCRE:0.04927,LLAC:0.03892):0.15478,(SINT:0.03790,(SANG:0.00886,SCON:0.00778):0.02283):0.09804):0.01920):0.00000;
(((SVES:0.02073,(SSAL:0.01015,STHE:0.01224):0.01180):0.18742,(((SCAN:0.03834,SDYS:0.03430):0.01714,SPYO:0.05402):0.10946,((SINF:0.01248,SLUT:0.01193):0.03491,SEQU:0.04073):0.12187):0.03373):0.02404,(((SINT:0.04607,(SANG:0.02197,SCON:0.02484):0.02175):0.06328,(SMIT:0.02326,(SPNE:0.02130,SPSE:0.02303):0.00538):0.08439):0.08482,SDOW:0.20064):0.02824,((LLAC:0.03642,LCRE:0.03121):0.39768,SSUI:0.21434):0.01566):0.00000;
((((SSAL:0.01909,(STHE:0.03039,SVES:0.02030):0.00460):0.10180,SENT:0.14091):0.00521,((SCAN:0.05514,(SPYO:0.01150,SDYS:0.00755):0.04623):0.08379,SDOW:0.12680):0.01052):0.00376,((SEQU:0.04641,(SINF:0.02141,SLUT:0.02137):0.02412):0.07776,(SDEV:0.08287,SRAT:0.09415):0.04271):0.01724,(((LCRE:0.07686,LLAC:0.07736):0.19588,(((SMIT:0.02508,(SPSE:0.02153,SPNE:0.01915):0.00191):0.10197,(SANG:0.10722,(SINT:0.02714,SCON:0.03045):0.07272):0.01876):0.02618,SSUI:0.14465):0.02149):0.01266,SPLU:0.13598):0.00411):0.00000;
((((SINF:0.00421,SLUT:0.01389):0.00183,SEQU:0.01062):0.05232,(((SSAL:0.00457,(STHE:0.01004,SVES:0.00292):0.00263):0.07897,((LCRE:0.02790,LLAC:0.01483):0.23886,SDOW:0.07435):0.00629):0.00533,(SCAN:0.02173,(SPYO:0.00452,SDYS:0.00586):0.01461):0.07063):0.00790):0.00236,(SDEV:0.01701,SRAT:0.02329):0.05752,SPLU:0.09470):0.00000;
(SDYS:0.11146,(SCAN:0.03493,SPYO:0.03746):0.08415,SSUI:0.61352):0.00000;
(SDYS:0.00003,SPYO:0.00287,SCAN:0.04820):0.00000;
((SDYS:0.25119,((SINT:0.07202,(SANG:0.02111,SCON:0.02523):0.01713):0.09555,(SDEV:0.03647,SRAT:0.03077):0.13184):0.01952):0.03325,((((SPSE:0.01544,(SMIT:0.01359,SPNE:0.02500):0.00224):0.11603,(SSAL:0.01138,(SVES:0.01606,STHE:0.01567):0.00120):0.10023):0.01452,((SINF:0.03473,(SLUT:0.02363,SEQU:0.02929):0.00781):0.11051,SDOW:0.13568):0.04769):0.02523,(SPYO:0.12938,SCAN:0.10662):0.07202):0.01526,(SSUI:0.18742,SENT:0.16514):0.01004):0.00000;
(SPYO:0.17387,SDYS:0.17387):0.00000;
(SDYS:0.02689,SPYO:0.09126,SCAN:0.02327):0.00000;
(SPYO:0.01754,SDYS:0.01754):0.00000;
(SDYS:0.05403,SCAN:0.05036,LCRE:0.62450):0.00000;
(SSUI:0.21695,SDYS:0.21695):0.00000;
((((((LLAC:0.00610,LCRE:0.00720):0.24098,(LCRE:0.03954,LLAC:0.02498):0.09144):0.04277,SDOW:0.12973):0.00809,(SPLU:0.09349,SENT:0.10453):0.02842):0.01293,(SRAT:0.08582,(STHE:0.06482,((SDYS:0.02785,SPYO:0.01790):0.01686,SCAN:0.03057):0.02765):0.02292):0.00579):0.00071,((SINF:0.01049,SLUT:0.02241):0.00910,SEQU:0.02938):0.07071,SDEV:0.10183):0.00000;
((SCAN:0.03661,SDYS:0.03440):0.06499,SPYO:0.12148,((SPLU:0.12413,SSUI:0.10508):0.10066,SDOW:0.24651):0.07938):0.00000;
((((SPLU:0.10978,(SDYS:0.01133,SPYO:0.00841):0.11107):0.04550,SDEV:0.16688):0.17888,(SPYO:0.01482,SDYS:0.00381):0.06252):0.01475,(SDEV:0.00784,SRAT:0.00786):0.03457,SPLU:0.03359):0.00000;
((SDYS:0.01658,SCAN:0.01999):0.10884,SPLU:0.10430,SCON:0.10449):0.00000;
(((LLAC:0.01181,LCRE:0.01059):0.24428,(((SCAN:0.02560,(SPYO:0.01009,SDYS:0.01161):0.01788):0.04369,SDOW:0.07666):0.02869,(LCRE:0.00544,LLAC:0.00639):0.10372):0.07536):0.18645,(((SINF:0.00436,SLUT:0.00802):0.01027,SEQU:0.01277):0.07177,(SRAT:0.02211,SDEV:0.02657):0.06658):0.00250,(SANG:0.00391,SCON:0.00578):0.09841):0.00000;
(((SDYS:0.01722,SPYO:0.03772):0.00344,SCAN:0.03949):0.11335,((SANG:0.10256,(SINT:0.01652,SCON:0.02553):0.07950):0.05777,(SEQU:0.02947,(SLUT:0.02648,SINF:0.01811):0.02539):0.13632):0.01224,((SDOW:0.12694,(((LCRE:0.03387,LLAC:0.04142):0.16503,(SPSE:0.03327,(SMIT:0.02119,SPNE:0.02412):0.00999):0.10869):0.01291,(STHE:0.04782,(SSAL:0.01233,SVES:0.01967):0.03029):0.07761):0.00521):0.00563,((SENT:0.16174,(SSUI:0.02791,SPLU:0.02726):0.10582):0.00700,(SDEV:0.07751,SRAT:0.06726):0.08460):0.00657):0.00546):0.00000;
(SDYS:0.01082,SPYO:0.02542,SPLU:0.32494):0.00000;
(SDYS:0.50227,SCAN:0.16988,SCAN:0.16114):0.00000;
((((SSAL:0.02285,(STHE:0.02125,SVES:0.01422):0.00923):0.12444,(((SMIT:0.01306,(SPSE:0.00822,SPNE:0.00097):0.00530):0.12592,(SINT:0.03204,(SANG:0.02461,SCON:0.03030):0.00438):0.09037):0.02983,SPLU:0.11522):0.00663):0.00661,(((SINF:0.00709,SLUT:0.01044):0.02059,SEQU:0.02395):0.05094,(SPYO:0.04668,(SCAN:0.03945,SDYS:0.04268):0.01620):0.02517):0.02239):0.00179,(((LCRE:0.00864,LLAC:0.00490):0.21416,SSUI:0.11745):0.01762,(SDOW:0.11524,(SDEV:0.02307,SRAT:0.01790):0.07400):0.01589):0.00339,SENT:0.14094):0.00000;
((SPLU:0.00000,SDYS:0.00000):0.01603,(SPSE:0.03968,(SPNE:0.09911,SDOW:0.25205):0.02379):0.04023,SANG:0.01139):0.00000;
((SDYS:0.48173,SINF:0.17890):0.19486,SPYO:0.02476,SDYS:0.02589):0.00000;
((SDYS:0.00122,SPYO:0.00328):0.00881,SCAN:0.01106,SLUT:0.59817):0.00000;
(SCAN:0.07836,SDYS:0.07836):0.00000;
(((SINF:0.00659,SLUT:0.00727):0.05707,SEQU:0.05913):0.08050,((((SMIT:0.02474,(SPSE:0.01094,SPNE:0.01670):0.01131):0.09643,(SANG:0.04105,(SINT:0.04068,SCON:0.03235):0.02224):0.10135):0.01790,(SDEV:0.08113,SRAT:0.06333):0.14395):0.00691,(SSUI:0.14412,SPLU:0.12976):0.03668):0.00819,((SENT:0.15566,SDOW:0.15871):0.01958,((SSAL:0.03967,(STHE:0.02507,SVES:0.03049):0.02283):0.11748,(SDYS:0.05398,(SCAN:0.03728,SPYO:0.03493):0.01562):0.08518):0.00819):0.00572):0.00000;
((SSUI:0.00620,SPLU:0.00856):0.05079,(((LCRE:0.02151,LLAC:0.01236):0.09728,((SANG:0.01675,SCON:0.03220):0.02995,(((SPSE:0.00450,(SMIT:0.00919,SPNE:0.00442):0.00076):0.03959,SINT:0.03994):0.00996,SENT:0.05186):0.00553):0.00666):0.00400,(SDOW:0.06172,(((STHE:0.00820,SSAL:0.00690):0.00267,SVES:0.00533):0.02387,(SCAN:0.02950,(SPYO:0.00495,SDYS:0.00716):0.02019):0.00866):0.00943):0.01803):0.00598,(((SINF:0.00327,SLUT:0.00282):0.00056,SEQU:0.00117):0.03160,(SDEV:0.02098,SRAT:0.02562):0.02804):0.00560):0.00000;
(((SDEV:0.03768,SRAT:0.02293):0.06378,(SDOW:0.10975,(SPLU:0.06576,(SENT:0.13922,((LCRE:0.05775,LLAC:0.04320):0.13297,(SINT:0.25306,(SDYS:0.10835,(SCAN:0.08185,SPYO:0.08293):0.03545):0.23024):0.11353):0.07372):0.02905):0.00474):0.01562):0.00833,(SSUI:0.04865,((SINF:0.00196,SLUT:0.00433):0.00426,SEQU:0.00201):0.04640):0.00739,((STHE:0.00663,(SSAL:0.00149,SVES:0.00008):0.00914):0.01628,((SMIT:0.00000,SPSE:0.00000):0.00059,SPNE:0.01508):0.04014):0.00949):0.00000;
((SSUI:0.20487,((LLAC:0.04054,LCRE:0.04949):0.21156,(SDYS:0.30855,((SDYS:0.03159,SPYO:0.03560):0.40635,(LLAC:0.10086,LCRE:0.10128):0.21663):0.05001):0.05584):0.05706):0.02708,((SCAN:0.05072,SPYO:0.05313):0.11197,(SCAN:0.04559,(SPYO:0.00560,SDYS:0.00563):0.03802):0.12199):0.00512,(SENT:0.12435,(SENT:0.08270,(SCON:0.01685,SANG:0.01175):0.07286):0.02468):0.04158):0.00000;
(SDYS:0.15230,SPLU:0.11976,SSUI:0.20520):0.00000;
((SDYS:0.07935,SPLU:0.08929):0.03662,SSUI:0.12454,(LLAC:0.02400,LCRE:0.02812):0.43396):0.00000;
(SCAN:0.25926,SDYS:0.33626,SPYO:0.38607):0.00000;
(((SPLU:0.14398,(SDYS:0.02711,SPYO:0.03301):0.07605):0.01429,(SLUT:0.02041,SEQU:0.01248):0.12086):0.00768,((SMIT:0.02350,(SPSE:0.00706,SPNE:0.00761):0.02732):0.04443,(SANG:0.01023,(SINT:0.00276,SCON:0.00386):0.00780):0.07264):0.09851,(SSAL:0.00855,SVES:0.00959):0.11360):0.00000;
((SPNE:0.07655,(SSUI:0.11988,((SCAN:0.00819,SDYS:0.00455):0.00505,SPYO:0.01866):0.17813):0.04332):0.05279,(SANG:0.00477,SCON:0.01084):0.01107,SINT:0.01954):0.00000;
(((SPYO:0.05779,(SCAN:0.02585,SDYS:0.02923):0.01709):0.08572,(SDEV:0.01509,SRAT:0.01638):0.11376):0.00860,(((((SINF:0.00758,SLUT:0.00607):0.03195,SEQU:0.03550):0.11360,(STHE:0.01348,(SSAL:0.00461,SVES:0.00368):0.01188):0.14801):0.02278,((LLAC:0.01452,LCRE:0.01503):0.25735,((((SANG:0.01755,SCON:0.01509):0.01016,SINT:0.02105):0.11128,(SMIT:0.01082,(SPSE:0.00790,SPNE:0.00633):0.00663):0.13941):0.04118,SSUI:0.17530):0.01268):0.01891):0.00423,SDOW:0.18415):0.02513,(SPLU:0.15400,SENT:0.14859):0.01198):0.00000;
(SSAL:0.17674,SDYS:0.17674):0.00000;
(SDYS:0.08851,(SCAN:0.05830,SPYO:0.07890):0.02445,(SANG:0.21346,SPLU:0.14561):0.13179):0.00000;
(SDYS:0.04858,SPYO:0.07562,SCAN:0.18620):0.00000;
(SPLU:0.08692,SDYS:0.08692):0.00000;
(SDYS:0.14272,SCAN:0.16983,SPYO:0.33655):0.00000;
(((((LCRE:0.08147,LLAC:0.07467):0.17434,(SSUI:0.01139,SPLU:0.01634):0.13691):0.00704,((SMIT:0.01526,(SPSE:0.01755,SPNE:0.02399):0.00143):0.08080,SENT:0.13937):0.00761):0.01789,((SCAN:0.02753,SPYO:0.02565):0.00727,SDYS:0.01973):0.07718):0.01942,((((SSAL:0.03318,(STHE:0.01687,SVES:0.01412):0.02769):0.05427,(SANG:0.06496,(SINT:0.06967,SCON:0.05051):0.00885):0.03372):0.00781,SDOW:0.08038):0.00775,(SDEV:0.03255,SRAT:0.04315):0.04517):0.00350,((SINF:0.02600,SLUT:0.01470):0.00310,SEQU:0.01655):0.05852):0.00000;
(SDYS:0.01093,SCAN:0.02504,SSUI:0.37625):0.00000;
(((STHE:0.01556,(SSAL:0.00547,SVES:0.00646):0.00490):0.04922,(SCAN:0.03602,(SPYO:0.01333,SDYS:0.01474):0.01763):0.05296):0.00506,(((SSUI:0.08433,((SMIT:0.01043,(SPSE:0.01270,SPNE:0.01439):0.00171):0.05406,((SCON:0.02059,SINT:0.01167):0.01999,SANG:0.03640):0.03173):0.01319):0.01734,((LLAC:0.01272,LCRE:0.01243):0.17117,SENT:0.09679):0.00676):0.01176,(((SINF:0.01038,SLUT:0.01304):0.00466,SEQU:0.01366):0.04103,(SDOW:0.06571,(SDEV:0.03731,SRAT:0.02829):0.03770):0.00496):0.00813):0.00194,SPLU:0.07047):0.00000;
((((SMIT:0.01412,(SPSE:0.00578,SPNE:0.01501):0.00422):0.10002,(SANG:0.04017,(SINT:0.02131,SCON:0.02573):0.02746):0.06749):0.07526,(SDYS:0.04262,SCAN:0.04106):0.15736):0.03848,(SPLU:0.11659,SENT:0.12836):0.00306,SSUI:0.11749):0.00000;
(SDYS:0.08189,SPYO:0.07595,SCAN:0.09447):0.00000;
(((SDYS:0.01814,SPYO:0.01750):0.02767,SCAN:0.05120):0.15152,SENT:0.21223,((SPSE:0.03019,(SMIT:0.02976,SPNE:0.02714):0.00392):0.22501,(SANG:0.06178,(SINT:0.02234,SCON:0.02167):0.04693):0.10007):0.01497):0.00000;
(((((SSUI:0.00284,((SSAL:0.26499,((SDYS:0.11003,SENT:0.11334):0.12174,SENT:0.23934):0.02790):0.04045,LLAC:0.29972):0.38409):0.00137,(SSUI:0.00000,(SENT:0.00000,SCAN:0.00000):0.00000):0.00000):0.00000,SCON:0.00000):0.00000,SANG:0.00000):0.00000,SPNE:0.00000,SPSE:0.00000):0.00000;
(SDYS:0.04826,SPYO:0.07680,SCAN:0.05936):0.00000;
(((((SCAN:0.04599,SDYS:0.04237):0.01648,SPYO:0.07018):0.13162,(SPLU:0.15083,((SSAL:0.04456,(STHE:0.02935,SVES:0.02019):0.03124):0.13107,(SINF:0.03660,(SLUT:0.02403,SEQU:0.00614):0.02694):0.10350):0.01137):0.01169):0.01227,SDOW:0.18869):0.00265,((SSUI:0.20038,(SINT:0.06878,(SANG:0.01752,SCON:0.01825):0.03773):0.11823):0.03550,SENT:0.35870):0.02157,(SDEV:0.06397,SRAT:0.06495):0.10137):0.00000;
((SPYO:0.13120,(SPYO:0.18711,SDYS:0.16992):0.39985):0.01995,SDYS:0.10354,SCAN:0.08719):0.00000;
((SDYS:0.17981,SPNE:0.14770):0.46624,SVES:0.01143,SVES:0.01137):0.00000;
((((((SCAN:0.01006,SPYO:0.02189):0.00387,SDYS:0.02156):0.01399,(SDEV:0.00266,SRAT:0.02265):0.03676):0.01169,SDOW:0.03388):0.00457,((SINF:0.00119,SLUT:0.00548):0.00457,SEQU:0.00113):0.03086):0.00288,(SPLU:0.02096,SENT:0.05163):0.00918,((SSAL:0.01335,(STHE:0.02364,SVES:0.00456):0.00553):0.04302,((LCRE:0.00269,LLAC:0.00497):0.11545,((((SMIT:0.00167,SPSE:0.00683):0.00175,SPNE:0.01982):0.03013,((SANG:0.00539,SINT:0.00700):0.00066,SCON:0.01125):0.03265):0.03212,SSUI:0.03882):0.00701):0.00488):0.01215):0.00000;
((SPYO:0.01271,SDYS:0.02215):0.09920,(SCAN:0.04574,SPYO:0.04364):0.10696,(SENT:0.10140,(SCON:0.03890,SANG:0.03072):0.06700):0.38851):0.00000;
(SDYS:0.26483,SCAN:0.06645,SPYO:0.05583):0.00000;
((SINT:0.19256,(((LCRE:0.04473,LLAC:0.03627):0.20147,(SDYS:0.06950,SCAN:0.05924):0.21121):0.07438,SSUI:0.22962):0.05722):0.15061,(SPNE:0.03520,SMIT:0.03776):0.00171,SPSE:0.03481):0.00000;
(SDYS:0.21860,SPYO:0.03700,SCAN:0.05448):0.00000;
(((SPSE:0.00732,(SMIT:0.00267,SPNE:0.00311):0.00135):0.03997,(SCAN:0.01744,(SPYO:0.01528,SDYS:0.00763):0.00286):0.04929):0.00892,(SSUI:0.06968,((LCRE:0.09102,LLAC:0.07641):0.03750,(SDEV:0.03209,SRAT:0.04043):0.12558):0.04822):0.00832,(SANG:0.02368,(SINT:0.02345,SCON:0.02033):0.00283):0.05230):0.00000;
((SCAN:0.08781,SDYS:0.09295):0.01509,SPYO:0.12966,((SDYS:0.01842,SPYO:0.01962):0.26408,SDOW:0.26549):0.09727):0.00000;
(SDYS:0.02250,SPYO:0.02346,SCAN:0.28892):0.00000;
(SMIT:0.28221,SDYS:0.28221):0.00000;
(((((SMIT:0.00000,SPSE:0.00000):0.00225,SPNE:0.00161):0.04011,(SINT:0.02145,(SANG:0.00336,SCON:0.00115):0.01206):0.04564):0.04104,(SDYS:0.01462,SPYO:0.01048):0.08207):0.00380,((SMIT:0.00014,SPNE:0.00828):0.07027,SCAN:0.06007):0.08519,(SPLU:0.11934,SENT:0.12603):0.01623):0.00000;
((SSAL:0.02489,(STHE:0.01400,SVES:0.00638):0.02895):0.06331,(SENT:0.13191,(SPLU:0.11447,(SPYO:0.05156,(SCAN:0.02585,SDYS:0.02872):0.01304):0.08484):0.00879):0.00408,(((LCRE:0.01376,LLAC:0.01853):0.20169,((SMIT:0.00728,(SPSE:0.01081,SPNE:0.01172):0.00587):0.05900,((SANG:0.01721,SINT:0.01512):0.01320,SCON:0.02046):0.03516):0.04326):0.00877,((SSUI:0.08725,SDOW:0.07156):0.00772,(((SINF:0.02870,SLUT:0.01681):0.01344,SEQU:0.02776):0.05163,(SDEV:0.04886,SRAT:0.05601):0.01618):0.00622):0.00959):0.00859):0.00000;
(SCAN:0.05095,SDYS:0.05095):0.00000;
(SDYS:0.00001,SPYO:0.00581,SCAN:0.02391):0.00000;
(SDYS:0.04194,SPYO:0.04404,SCAN:0.08433):0.00000;
((SMIT:0.05855,(SDYS:0.11752,SCAN:0.06664):0.34852):0.01919,SPNE:0.03665,SPSE:0.06039):0.00000;
(SPNE:0.17797,SDYS:0.17797):0.00000;
((SCAN:0.06168,(SPYO:0.01056,SDYS:0.00767):0.05818):0.09773,(((SINF:0.01146,SLUT:0.00803):0.02223,SEQU:0.04126):0.07954,(SDEV:0.06863,SRAT:0.07668):0.03095):0.01255,(((((STHE:0.03917,(SSAL:0.00559,SVES:0.01103):0.02576):0.10930,((LCRE:0.03344,LLAC:0.03043):0.23922,(((SPSE:0.01000,(SMIT:0.00404,SPNE:0.00794):0.00137):0.10620,((SANG:0.02653,SCON:0.02926):0.01815,SINT:0.05475):0.09627):0.01769,SSUI:0.13502):0.02781):0.00991):0.00572,SPLU:0.16677):0.00446,SENT:0.14203):0.00745,SDOW:0.12561):0.00350):0.00000;
(SDYS:0.02342,SPYO:0.02342):0.00000;
((((SPLU:0.20009,(SPYO:0.01836,SDYS:0.00828):0.20475):0.08741,SDEV:0.27960):0.24033,(SPYO:0.06792,SDYS:0.04541):0.04578):0.02883,(SDEV:0.05304,SRAT:0.04464):0.03845,SPLU:0.08690):0.00000;
(SDEV:0.25087,SPYO:0.25087):0.00000;
(SDYS:0.08651,SPYO:0.08651):0.00000;
(SPYO:0.11255,SDYS:0.08420,SCAN:0.28902):0.00000;
(LCRE:0.14725,SPYO:0.14725):0.00000;
(SDYS:0.01471,SPYO:0.01471):0.00000;
(((STHE:0.08557,SINT:0.09071):0.13164,((SPYO:0.13412,SDYS:0.12360):0.04567,(SDOW:0.15980,((SANG:0.08448,((SINF:0.02648,SEQU:0.02431):0.02325,SLUT:0.04555):0.03080):0.04514,(SRAT:0.03243,SDEV:0.02691):0.08752):0.02277):0.01603):0.01515):0.01128,(LLAC:0.24107,(LCRE:0.32964,(SSUI:0.39113,((SVES:0.06498,SSAL:0.06208):0.27794,SCON:0.29382):0.01854):0.04510):0.02264):0.00934,SENT:0.23046):0.00000;
(((((SINF:0.00747,SLUT:0.01286):0.00523,SEQU:0.01250):0.03931,(SCAN:0.00963,(SPYO:0.00618,SDYS:0.00533):0.00365):0.05466):0.00995,((SPLU:0.09798,(SENT:0.14479,((((SDOW:0.13357,((SSAL:0.02271,SVES:0.02101):0.09370,SPYO:0.13607):0.03513):0.00486,(SDEV:0.07485,SRAT:0.05247):0.08426):0.01351,((SINF:0.01139,SLUT:0.01315):0.05792,SEQU:0.05422):0.08742):0.37424,(LLAC:0.00492,LCRE:0.00478):0.17496):0.05431):0.01909):0.01025,(STHE:0.01043,(SVES:0.00921,SSAL:0.00750):0.00492):0.09837):0.00672):0.01016,(SDOW:0.06201,(SDEV:0.01191,SRAT:0.01018):0.05831):0.00391,(((SMIT:0.00518,(SPSE:0.00989,SPNE:0.00840):0.00790):0.06605,(SINT:0.01283,(SANG:0.00868,SCON:0.00531):0.00249):0.03503):0.01983,SSUI:0.07846):0.01398):0.00000;
(((((SINF:0.02300,SLUT:0.02462):0.07960,SEQU:0.10001):0.10387,(((((SPSE:0.01922,SPNE:0.02362):0.00537,SMIT:0.02267):0.18283,((SINT:0.06028,SCON:0.05678):0.01841,SANG:0.07735):0.10196):0.07594,SSUI:0.26131):0.01698,(SDEV:0.05182,SRAT:0.05035):0.15489):0.01335):0.01168,(SPYO:0.14609,(SCAN:0.11049,SDYS:0.13131):0.02074):0.10694):0.00294,(SPLU:0.22723,SDOW:0.22223):0.00631,(SSAL:0.05858,(STHE:0.03607,SVES:0.03969):0.03000):0.17507):0.00000;
((((SINF:0.02245,(SLUT:0.00852,SEQU:0.00838):0.00630):0.07108,SPYO:0.12087):0.02299,(SCAN:0.03667,SDYS:0.02960):0.08083):0.00812,(((SPLU:0.01282,SSUI:0.01798):0.10754,SENT:0.13403):0.02786,(((SMIT:0.01463,SPSE:0.02638):0.00334,SPNE:0.01253):0.05326,(SANG:0.04557,(SINT:0.03090,SCON:0.03056):0.01822):0.02118):0.08202):0.00566,(LLAC:0.02835,LCRE:0.03704):0.35932):0.00000;
((SPYO:0.10032,SSUI:0.15731):0.04371,(SPSE:0.00000,SPNE:0.00000):0.08141,SMIT:0.09453):0.00000;
(SPYO:0.16155,SDYS:0.06601,SCAN:0.05623):0.00000;
((((SINF:0.00175,SLUT:0.00105):0.00161,SEQU:0.00238):0.01461,((SCAN:0.00638,SDYS:0.00436):0.00174,SPYO:0.00701):0.01890):0.00184,(SDOW:0.03672,((((LCRE:0.00131,LLAC:0.00189):0.09642,(((SMIT:0.00388,(SPSE:0.00399,SPNE:0.00039):0.00227):0.03889,(SANG:0.00827,(SINT:0.00008,SCON:0.00231):0.00946):0.01159):0.02664,SSUI:0.05940):0.00850):0.00344,(SPLU:0.05466,SENT:0.06840):0.00511):0.00433,(SDEV:0.01212,SRAT:0.00978):0.03501):0.00371):0.00313,(STHE:0.01750,(SSAL:0.00033,SVES:0.00127):0.01315):0.01535):0.00000;
((SINT:0.25071,SANG:0.24870):0.18735,(SPYO:0.27365,SDYS:0.26074):0.01194,SENT:0.30205):0.00000;
((SMIT:0.00205,((SSAL:0.01565,SVES:0.00637):0.01799,((((SPLU:0.12720,SENT:0.12551):0.38010,(LCRE:0.00988,LLAC:0.01024):0.12334):0.01391,(((SPYO:0.01057,SDYS:0.00986):0.01009,SCAN:0.02142):0.09400,((SINF:0.00432,SLUT:0.00477):0.00398,SEQU:0.00703):0.07279):0.02192):0.04176,(SANG:0.02932,SINT:0.03968):0.02759):0.03132):0.02872):0.00086,SPNE:0.01057,SPSE:0.00397):0.00000;
(SPYO:0.00954,SPYO:0.00954):0.00000;
((SDEV:0.24905,((SPSE:0.12220,(SSAL:0.03945,SVES:0.04250):0.08309):0.15230,((SPYO:0.01886,SCAN:0.01527):0.21795,SSUI:0.24867):0.16809):0.02206):0.01257,((SLUT:0.04294,SEQU:0.04112):0.10960,SRAT:0.16372):0.06443,(SINT:0.06361,SANG:0.05650):0.16088):0.00000;
((SPYO:0.06121,SCAN:0.05929):0.01988,SDYS:0.06672,(SSUI:0.19009,SINT:0.20236):0.25748):0.00000;
(SPYO:0.13850,SDYS:0.14172,SINF:0.42687):0.00000;
(((((SINF:0.00839,SLUT:0.01289):0.00804,SEQU:0.01434):0.06887,((SPYO:0.01662,SDYS:0.01308):0.04223,SCAN:0.06374):0.08288):0.02775,(SDEV:0.05221,SRAT:0.05612):0.06631):0.01017,(((((SMIT:0.01724,SPSE:0.02762):0.00312,SPNE:0.02684):0.09133,(SANG:0.04823,(SINT:0.01500,SCON:0.01899):0.03434):0.11821):0.01393,((STHE:0.02505,(SSAL:0.01452,SVES:0.01563):0.00326):0.09215,(SSUI:0.02728,SPLU:0.03080):0.09938):0.01539):0.00562,SDOW:0.14070):0.00512,((LLAC:0.01630,LCRE:0.02002):0.18331,SENT:0.17502):0.01889):0.00000;
((((SDYS:0.02559,(SPYO:0.02109,SCAN:0.02049):0.01005):0.10003,SDOW:0.12896):0.01386,((((SMIT:0.02192,(SPSE:0.02401,SPNE:0.02070):0.01380):0.07242,((SANG:0.01212,SINT:0.02476):0.00751,SCON:0.01610):0.07444):0.07237,(SSUI:0.16258,SPLU:0.12679):0.00803):0.01426,SENT:0.20668):0.01479):0.00476,(((SINF:0.00879,SLUT:0.00529):0.02650,SEQU:0.02286):0.05320,(SDEV:0.00000,SRAT:0.00000):0.08226):0.02922,(STHE:0.02836,(SSAL:0.00000,SVES:0.00000):0.01063):0.10615):0.00000;
(SCAN:0.03885,SDYS:0.05231,SSUI:0.37030):0.00000;
(SCAN:0.02871,SDYS:0.08043,SPYO:0.01477):0.00000;
(((SCAN:0.02236,(SPYO:0.00383,SDYS:0.00394):0.01559):0.09472,((LCRE:0.51046,LLAC:0.21873):0.05671,SSUI:0.12337):0.01743):0.08327,(SPSE:0.00825,SPNE:0.00667):0.00542,SMIT:0.00709):0.00000;
(SCAN:0.08734,SPYO:0.17266,SDYS:0.10934):0.00000;
((SCAN:0.00631,SDYS:0.00465):0.35763,LCRE:0.01293,LLAC:0.00904):0.00000;
((SENT:0.06477,((SCAN:0.04092,SPYO:0.02158):0.13968,(SDYS:0.00156,SPYO:0.00204):0.16719):0.23197):0.05773,SANG:0.01720,SCON:0.01227):0.00000;
(SCAN:0.03675,SDYS:0.05009,SPYO:0.08336):0.00000;
(SCAN:0.01189,SDYS:0.02396,SPYO:0.01679):0.00000;
(SPYO:0.19810,SCAN:0.19810):0.00000;
(SDYS:0.03412,SCAN:0.03412):0.00000;
(SCAN:0.11383,(SPYO:0.04323,SDYS:0.04145):0.05679,(LLAC:0.03157,LCRE:0.03221):0.51949):0.00000;
((SENT:0.16028,(((SPYO:0.11431,(SDYS:0.09493,SCAN:0.07995):0.02024):0.06327,(((LLAC:0.09186,LCRE:0.10919):0.14221,(SSUI:0.15247,((SINT:0.08397,(SANG:0.00000,SCON:0.00000):0.05870):0.05681,((SMIT:0.01756,SPNE:0.01109):0.00278,SPSE:0.01364):0.14533):0.00752):0.01515):0.01863,SDOW:0.16042):0.00921):0.01325,((SRAT:0.04746,SDEV:0.03818):0.09853,(SLUT:0.06347,SEQU:0.06281):0.08252):0.01676):0.01347):0.00427,SPLU:0.15233,(SSAL:0.03776,(STHE:0.02068,SVES:0.01175):0.03195):0.12395):0.00000;
(SENT:0.26853,SCAN:0.26853):0.00000;
(SCAN:0.50151,SPYO:0.01477,SDYS:0.00332):0.00000;
(SCAN:0.14225,SPYO:0.11033,SDYS:0.38920):0.00000;
(SCAN:0.00581,SDYS:0.00994,(SINF:0.41570,SDOW:0.22620):0.26280):0.00000;
(SDYS:0.07203,SCAN:0.07203):0.00000;
(SCAN:0.05013,SDYS:0.07282,SCAN:0.33496):0.00000;
(SCAN:0.04068,SDYS:0.04719,((SCAN:0.03665,SENT:0.05838):0.39165,SCAN:0.18228):0.13600):0.00000;
(((SPYO:0.06543,SCAN:0.05092):0.03417,SDYS:0.09040):0.16862,(((STHE:0.02187,(SSAL:0.01116,SVES:0.01317):0.00566):0.23676,SDOW:0.26175):0.03443,(SENT:0.21125,(SRAT:0.03975,SDEV:0.05341):0.13468):0.02750):0.02680,SPLU:0.23156):0.00000;
((SCAN:0.01405,(SANG:0.39087,SDYS:0.04157):0.02092):0.01784,SSUI:0.00405,SSUI:0.01716):0.00000;
((SINT:0.02661,(SCAN:0.02810,SDYS:0.02910):0.53223):0.02077,SCON:0.00897,SANG:0.01519):0.00000;
(SCAN:0.03857,(SPYO:0.00987,SDYS:0.01064):0.03187,(LLAC:0.03787,LCRE:0.03498):0.55774):0.00000;
(SPYO:0.16713,SCAN:0.16713):0.00000;
(SCAN:0.04261,SDYS:0.03042,LCRE:0.68338):0.00000;
(LCRE:0.04222,LLAC:0.04606,(SCAN:0.02593,SDYS:0.03581):0.40176):0.00000;
(SPLU:0.28271,SCAN:0.28271):0.00000;
((SCAN:0.09405,((SPSE:0.29543,SPLU:0.21048):0.07832,SPLU:0.13307):0.03141):0.01037,SINT:0.09182,SVES:0.11640):0.00000;
((SPYO:0.03865,SCAN:0.03417):0.10960,SDYS:0.14891,SPLU:0.56579):0.00000;
((SSUI:0.19703,((SPYO:0.04656,SCAN:0.05372):0.02567,SDYS:0.07977):0.13247):0.01917,SDOW:0.23388,(SVES:0.03162,SSAL:0.02801):0.17868):0.00000;
((SDEV:0.04210,(SMIT:0.07449,((SSAL:0.05364,SPSE:0.05537):0.02353,((SPLU:0.17456,SANG:0.15690):0.31656,(SENT:0.06676,(SPLU:0.02046,(SINT:0.01430,(SMIT:0.01388,SCAN:0.01561):0.00234):0.00548):0.05331):0.04165):0.01465):0.02112):0.01472):0.02837,(SDOW:0.01291,SRAT:0.00889):0.00406,SSAL:0.01586):0.00000;
(SCAN:0.10063,SINT:0.04210,SMIT:0.08783):0.00000;
((((SCAN:0.02718,SDYS:0.03520):0.01960,SPYO:0.04063):0.09238,(SEQU:0.07621,(SINF:0.00044,SLUT:0.00079):0.07504):0.08932):0.01312,SENT:0.18000,((LLAC:0.05478,LCRE:0.05989):0.19534,(LCRE:0.05993,LLAC:0.05375):0.32023):0.06263):0.00000;
((SCAN:0.04250,SDYS:0.03612):0.22062,(SDOW:0.08109,SRAT:0.08220):0.24875,SDEV:0.23646):0.00000;
(SCAN:0.06201,SDYS:0.06121,SPLU:0.54618):0.00000;
(SDYS:0.20626,SCAN:0.20626):0.00000;
((SCAN:0.13863,SDYS:0.15494):0.08975,(SPLU:0.20601,SENT:0.22640):0.07592,(LCRE:0.01711,LLAC:0.01462):0.31535):0.00000;
(SDYS:0.04818,SCAN:0.04818):0.00000;
(SCAN:0.04145,SPSE:0.05299,LLAC:0.17926):0.00000;
(SDYS:0.08783,SCAN:0.08783):0.00000;
((((SMIT:0.06278,(SPSE:0.00878,SPNE:0.00815):0.05284):0.08602,((SCAN:0.16602,SPYO:0.17436):0.07295,(SCON:0.01179,SANG:0.01621):0.21627):0.09766):0.06772,SSAL:0.04729):0.00121,SVES:0.04412,STHE:0.03567):0.00000;
(((LCRE:0.02749,LLAC:0.03416):0.24821,(SPYO:0.23053,SCAN:0.25798):0.03784):0.00617,(SPLU:0.20979,(SDEV:0.01803,SRAT:0.02358):0.17509):0.07372,(((SANG:0.01313,SCON:0.00910):0.20074,(SMIT:0.11104,((STHE:0.05948,(SSAL:0.05390,SVES:0.05685):0.00550):0.01844,(SPSE:0.00362,SPNE:0.00769):0.08429):0.03707):0.11309):0.00752,(SENT:0.00431,SPLU:0.00375):0.36151):0.00386):0.00000;
(SENT:0.26301,((SDEV:0.01842,SRAT:0.01117):0.12095,((SSAL:0.00011,(STHE:0.00334,SVES:0.00244):0.00300):0.15481,((SANG:0.02329,(SINT:0.01754,SCON:0.01619):0.00539):0.12139,((SPSE:0.07685,(SMIT:0.06524,SPNE:0.07518):0.01002):0.13118,((SSUI:0.19712,((SINF:0.09548,(SEQU:0.06827,SLUT:0.08963):0.01996):0.10852,SPLU:0.15505):0.02139):0.01936,((LCRE:0.06034,LLAC:0.01902):0.18974,((SPYO:0.05689,SCAN:0.08701):0.03116,SDYS:0.08694):0.13777):0.03101):0.01247):0.01160):0.01455):0.00950):0.00153,SDOW:0.12945):0.00000;
(SCAN:0.00348,SCAN:0.00348,SENT:0.43775):0.00000;
(SCAN:0.11217,SDYS:0.11454,SPYO:0.34674):0.00000;
(SCAN:0.01060,(SPYO:0.01176,SDYS:0.00665):0.00496,(SENT:0.17895,((SCON:0.00632,SINT:0.00669):0.22531,SANG:0.27265):0.12035):0.13295):0.00000;
(((SANG:0.02179,(SINT:0.02267,SCON:0.01153):0.00977):0.07772,(SDEV:0.07779,SRAT:0.07688):0.01503):0.01251,SSUI:0.07576,(SSAL:0.02829,SVES:0.02296):0.04338):0.00000;
((SPNE:0.02995,SCON:0.02446):0.02721,SANG:0.04774,SEQU:0.40142):0.00000;
((((SSUI:0.18538,(((SANG:0.01870,SCON:0.01090):0.00754,SINT:0.02119):0.13525,(SMIT:0.08542,(SPSE:0.01218,SPNE:0.00835):0.05262):0.12234):0.03178):0.02120,(SPLU:0.15741,((((SINF:0.02150,SLUT:0.04135):0.07504,SEQU:0.07858):0.13202,(SCAN:0.04976,(SPYO:0.03280,SDYS:0.03030):0.02402):0.10080):0.01284,((SSAL:0.02454,SVES:0.02777):0.10588,SDOW:0.16104):0.01396):0.00843):0.00864):0.00378,(SRAT:0.03409,SDEV:0.02821):0.13355):0.00168,SENT:0.16667,(LCRE:0.04665,LLAC:0.04904):0.22443):0.00000;
(SCON:0.27225,SENT:0.38758,SPLU:0.24428):0.00000;
(SCON:0.14359,(SCAN:0.01673,SDYS:0.02385):0.11272,SPLU:0.24564):0.00000;
(SCON:0.03716,(SCAN:0.00400,SDYS:0.01186):0.08501,SPLU:0.07269):0.00000;
((((LCRE:0.03676,LLAC:0.03607):0.18079,((SANG:0.01580,SCON:0.01971):0.01809,SINT:0.03187):0.27847):0.02944,(SDEV:0.02941,SRAT:0.03285):0.16120):0.00783,SPLU:0.20043,(SCAN:0.05059,SDYS:0.04754):0.15259):0.00000;
(SCON:0.08409,SANG:0.06840,SINT:0.51983):0.00000;
(SCON:0.04806,SINT:0.10946,SANG:0.08566):0.00000;
(SANG:0.03850,SCON:0.03850):0.00000;
((SDOW:0.25009,((STHE:0.03503,(SSAL:0.01105,SVES:0.01100):0.01717):0.20182,((SSUI:0.32359,SPLU:0.28669):0.07854,(((SCON:0.01022,SINT:0.01132):0.04200,SANG:0.03742):0.15203,(SPSE:0.02585,(SPNE:0.01746,SMIT:0.01085):0.00702):0.18589):0.12308):0.04024):0.01487):0.00613,(SDEV:0.04799,SRAT:0.05832):0.18511,((SDYS:0.04179,(SPYO:0.02951,SCAN:0.03176):0.01325):0.17875,(SEQU:0.02528,(SINF:0.02276,SLUT:0.00893):0.00649):0.14340):0.04501):0.00000;
((SCON:0.00302,SINT:0.00224):0.05215,SANG:0.05110,(LLAC:0.36866,(SDOW:0.25685,(SPLU:0.05613,SSUI:0.05907):0.19028):0.10100):0.25127):0.00000;
(SSUI:0.13595,(SINT:0.03275,(SANG:0.00875,SCON:0.01138):0.02098):0.10578,((SMIT:0.02842,(SPSE:0.01842,SPNE:0.01944):0.01308):0.11406,(SDOW:0.28445,((LLAC:0.03099,LCRE:0.02413):0.26199,(SCAN:0.23076,SDEV:0.19318):0.01320):0.02493):0.02860):0.00900):0.00000;
(((SINT:0.00966,(SANG:0.00326,SCON:0.00536):0.00478):0.02394,((SSAL:0.01204,SVES:0.01640):0.02630,(((LCRE:0.00391,LLAC:0.00416):0.16993,SSUI:0.31319):0.07346,((SPLU:0.06292,SENT:0.03362):0.01310,((SCAN:0.00607,SDYS:0.01626):0.04255,(SDOW:0.05968,(SDEV:0.01269,SRAT:0.01053):0.02593):0.00684):0.00286):0.02695):0.03893):0.01016):0.02053,(SPSE:0.00472,SPNE:0.00800):0.00214,SMIT:0.01133):0.00000;
(SCON:0.00000,SINT:0.00304,SANG:0.02916):0.00000;
((SENT:0.30263,(((SCON:0.01225,SINT:0.01480):0.04051,SANG:0.05636):0.13162,((SMIT:0.02494,SPSE:0.02945):0.00636,SPNE:0.03794):0.16208):0.03346):0.00556,(SSUI:0.21775,(((SPYO:0.05775,(SCAN:0.04805,SDYS:0.04749):0.00665):0.16560,(((SSAL:0.01414,(STHE:0.01227,SVES:0.01790):0.00373):0.11221,((SINF:0.01572,SLUT:0.01282):0.02199,SEQU:0.03674):0.08432):0.05887,SPLU:0.18906):0.00526):0.01923,((SDEV:0.05297,SRAT:0.04601):0.12490,SDOW:0.22498):0.01162):0.01712):0.00731,(LLAC:0.04268,LCRE:0.03344):0.27916):0.00000;
(SCON:0.02793,SINT:0.01530,SANG:0.14725):0.00000;
((SVES:0.02522,SSAL:0.02217):0.26865,((((SINF:0.05891,(SLUT:0.00661,SEQU:0.00384):0.06403):0.10494,(SPYO:0.10135,(SCAN:0.06020,SDYS:0.04737):0.03799):0.09028):0.02517,(SRAT:0.03859,SDEV:0.02804):0.20761):0.01762,(SENT:0.27477,(((SMIT:0.04471,(SPSE:0.02659,SPNE:0.03292):0.01610):0.17363,(SCON:0.04502,SANG:0.04731):0.12170):0.04072,SSUI:0.23980):0.03268):0.04847):0.00268,SDOW:0.22501):0.00000;
(((SCON:0.08564,SINT:0.09373):0.01831,SANG:0.08928):0.12869,((((LLAC:0.03052,LCRE:0.03912):0.30311,(SENT:0.25604,(SDYS:0.10591,SCAN:0.09763):0.11989):0.03544):0.00980,(SSUI:0.25587,(SPLU:0.22575,(SRAT:0.07287,SDEV:0.08089):0.13595):0.01464):0.00987):0.01049,((STHE:0.06155,(SSAL:0.00715,SVES:0.00708):0.03862):0.12333,(((SLUT:0.03361,SINF:0.03073):0.10847,SEQU:0.13672):0.07044,SDOW:0.20573):0.01465):0.00869):0.00501,(SPSE:0.04669,(SMIT:0.04056,SPNE:0.04616):0.00684):0.17068):0.00000;
(((((SINF:0.00249,SLUT:0.00669):0.01556,SEQU:0.01347):0.02808,SRAT:0.03953):0.00486,(SENT:0.11234,((SCAN:0.04273,SDYS:0.03995):0.06910,((((SMIT:0.00165,SPSE:0.00268):0.00104,SPNE:0.00285):0.03583,(SINT:0.02195,(SANG:0.01722,SCON:0.01656):0.01794):0.01303):0.02575,SSUI:0.07762):0.15893):0.00517):0.05017):0.00263,(SDEV:0.03367,((STHE:0.00533,(SSAL:0.00194,SVES:0.00065):0.00505):0.01957,SDOW:0.03846):0.02064):0.00499,SPLU:0.04111):0.00000;
(((SRAT:0.05229,SDEV:0.03234):0.10220,(SSUI:0.20091,((SPNE:0.04976,(SPSE:0.02391,SMIT:0.02037):0.02588):0.08966,((SANG:0.00485,SCON:0.00797):0.04814,SINT:0.06956):0.09662):0.06634):0.03049):0.02034,((SPLU:0.22083,SDOW:0.19778):0.01287,((STHE:0.02800,(SSAL:0.00000,SVES:0.00000):0.01505):0.15828,((SINF:0.01190,(SLUT:0.01393,SEQU:0.00276):0.01456):0.09046,((SCAN:0.04584,SDYS:0.04373):0.04333,SPYO:0.09796):0.05460):0.01047):0.00823):0.00081,SENT:0.17590):0.00000;
(((LCRE:0.37999,(SPNE:0.03234,(SPSE:0.01927,SMIT:0.01896):0.00283):0.19161):0.02042,SINT:0.15120):0.00680,SANG:0.19978,SRAT:0.17844):0.00000;
(((SENT:0.12632,(SLUT:0.03638,(SINF:0.00886,SEQU:0.01321):0.02655):0.04747):0.00983,((LLAC:0.01895,LCRE:0.01896):0.18114,((SSUI:0.09869,(((SMIT:0.00229,SPSE:0.00369):0.00894,SPNE:0.01977):0.05156,(SANG:0.01693,(SCON:0.01438,SINT:0.00911):0.00507):0.04782):0.02783):0.01411,(SDEV:0.01120,SRAT:0.00802):0.08522):0.00806):0.00620):0.00556,((SSAL:0.01285,(STHE:0.01592,SVES:0.00885):0.00707):0.07352,SDOW:0.07047):0.00305,(SPLU:0.09101,((SCAN:0.01530,SPYO:0.02695):0.00588,SDYS:0.02484):0.05847):0.00438):0.00000;
(SCON:0.10360,SINT:0.10360):0.00000;
(SDOW:0.17138,SINT:0.17138):0.00000;
(SINT:0.18357,SDOW:0.20767,SDEV:0.34967):0.00000;
(SSAL:0.23506,SINT:0.23506):0.00000;
(((LCRE:0.00256,LLAC:0.00243):0.06675,((SMIT:0.00744,SINT:0.00543):0.04004,SRAT:0.04847):0.05772):0.00211,SDOW:0.03902,(SVES:0.04117,(SINF:0.01037,(SLUT:0.00287,SEQU:0.00247):0.00566):0.02883):0.00934):0.00000;
(SEQU:0.19958,SINT:0.19958):0.00000;
(SSAL:0.18400,SINT:0.18400):0.00000;
(SSUI:0.26445,SINT:0.26445):0.00000;
((((LLAC:0.01408,LCRE:0.01572):0.30112,(SSAL:0.03262,(STHE:0.03203,SVES:0.02208):0.00620):0.19167):0.08050,(SINT:0.05170,SANG:0.04950):0.07711):0.11267,(SPSE:0.00912,SPNE:0.00860):0.01605,SMIT:0.02291):0.00000;
(SENT:0.05819,(((STHE:0.02129,(SSAL:0.01257,SVES:0.01085):0.00580):0.05723,((SINF:0.00807,SLUT:0.01398):0.01641,SEQU:0.01882):0.04600):0.00831,((LCRE:0.02178,LLAC:0.02061):0.19010,(SSUI:0.07005,((SMIT:0.01142,(SPSE:0.01109,SPNE:0.00848):0.00433):0.03793,(SANG:0.02776,(SCON:0.02085,SINT:0.02473):0.00507):0.04165):0.02776):0.00555):0.01489):0.00301,(((SCAN:0.01804,SPYO:0.02119):0.02331,SDYS:0.03849):0.04094,(SPLU:0.06928,(SDOW:0.02894,(SDEV:0.02729,SRAT:0.02978):0.02522):0.01258):0.00518):0.00677):0.00000;
(SINT:0.06085,(SANG:0.07052,SCON:0.05136):0.01646,(SPLU:0.25547,SMIT:0.26246):0.26148):0.00000;
(((SSUI:0.13797,((SPSE:0.03762,(SMIT:0.02047,SPNE:0.02170):0.01923):0.11524,(SANG:0.07032,(SINT:0.00254,SCON:0.00228):0.08379):0.08990):0.02417):0.02915,(((SPLU:0.14406,SENT:0.18644):0.03996,(SCAN:0.07732,SDYS:0.07295):0.13634):0.01047,(SDOW:0.16335,(SRAT:0.04135,SDEV:0.03960):0.10541):0.01157):0.01002):0.00805,(STHE:0.03654,(SSAL:0.00946,SVES:0.01798):0.01979):0.09017,((SINF:0.01856,SLUT:0.02854):0.02778,SEQU:0.04505):0.07881):0.00000;
(SCON:0.00104,SINT:0.00104):0.00000;
((((SPSE:0.02480,SMIT:0.02503):0.30223,(SPSE:0.02824,SPNE:0.03149):0.29146):0.06292,SSUI:0.33941):0.01742,SSUI:0.36302,(SMIT:0.36899,(((SPNE:0.01528,(SMIT:0.01149,SMIT:0.01275):0.00378):0.23094,SINT:0.23729):0.02351,SPLU:0.26989):0.04658):0.00518):0.00000;
(SINT:0.01844,SCON:0.01499,LLAC:0.53146):0.00000;
(SCON:0.01591,SINT:0.01591):0.00000;
(SINT:0.06405,SCON:0.03254,SANG:0.08580):0.00000;
((SINF:0.13127,SEQU:0.12285):0.13874,(SENT:0.28987,(((SSAL:0.05270,SVES:0.05834):0.07927,(SMIT:0.04251,(SPSE:0.02703,SPNE:0.02779):0.00756):0.11621):0.06303,SPLU:0.21153):0.04153):0.02367,(SINT:0.05702,SCON:0.04264):0.27737):0.00000;
(SCON:0.02364,SINT:0.02364):0.00000;
(SCON:0.03035,SINT:0.03035):0.00000;
(SCAN:0.23758,SINT:0.23758):0.00000;
(SCAN:0.31880,SINT:0.31880):0.00000;
(SINT:0.18727,SCAN:0.20666,SDYS:0.50537):0.00000;
(SCAN:0.23414,SINT:0.23414):0.00000;
(SCAN:0.30759,SINT:0.30759):0.00000;
(SCAN:0.18587,SINT:0.18587):0.00000;
(SCAN:0.27642,SINT:0.27642):0.00000;
(SINT:0.22021,SCAN:0.22515,SINF:0.33781):0.00000;
(SCAN:0.22569,SINT:0.22569):0.00000;
(SSAL:0.27740,SINT:0.27740):0.00000;
((SENT:0.17876,((SSAL:0.07968,(SVES:0.08591,(((SMIT:0.00306,SPSE:0.00426):0.00276,SPNE:0.00235):0.07391,((SANG:0.00199,SCON:0.00021):0.01064,SINT:0.01038):0.03172):0.02337):0.00863):0.00610,SDEV:0.08448):0.00800):0.00523,(SLUT:0.07196,(SPYO:0.03364,(SCAN:0.01754,SDYS:0.01851):0.01134):0.03304):0.01006,(LCRE:0.02231,LLAC:0.02888):0.05673):0.00000;
(SCON:0.08788,SINT:0.08788):0.00000;
(SINT:0.01003,(SPSE:0.00099,(SVES:0.05136,SENT:0.02007):0.01966):0.00193,((SCAN:0.01571,SENT:0.01571):0.03933,SMIT:0.03821):0.02507):0.00000;
((SSUI:0.19516,(SPLU:0.17065,SENT:0.17270):0.01658):0.01461,((SPNE:0.11264,(SINT:0.03323,(SANG:0.01242,SCON:0.01388):0.01041):0.12407):0.03264,(SDOW:0.13809,((SSAL:0.02163,SVES:0.02742):0.11146,(SEQU:0.07562,(SINF:0.06759,SLUT:0.05908):0.01074):0.08951):0.01596):0.02317):0.01364,SMIT:0.18299):0.00000;
(SANG:0.25204,SINT:0.25204):0.00000;
(SCON:0.11597,SINT:0.11597):0.00000;
(((SSUI:0.48177,((SANG:0.00768,SCON:0.02489):0.02546,SINT:0.03497):0.25176):0.25122,SMIT:0.04988):0.01067,SPNE:0.03964,SPSE:0.04737):0.00000;
(SCON:0.03696,SANG:0.03696):0.00000;
(((SINF:0.18292,(SDEV:0.02142,SRAT:0.02293):0.04881):0.04398,(SANG:0.07137,SCON:0.03925):0.14395):0.00882,((SINF:0.03611,SLUT:0.02450):0.02357,SEQU:0.05481):0.07913,(STHE:0.05450,(SSAL:0.00590,SVES:0.00311):0.00856):0.12372):0.00000;
(((((SANG:0.00479,SCON:0.00255):0.16174,SINT:0.14407):0.09344,(SPSE:0.02026,(SPNE:0.01167,SMIT:0.01407):0.00236):0.22971):0.03981,(SPLU:0.25402,SDYS:0.25467):0.03376):0.03074,SENT:0.29684,((SCAN:0.14113,(SMIT:0.00276,SPNE:0.00861):0.15712):0.07278,(SMIT:0.02000,(SPSE:0.00448,SPNE:0.00846):0.02238):0.22345):0.23086):0.00000;
((SPLU:0.25491,((LCRE:0.06351,LLAC:0.06435):0.14117,SENT:0.22228):0.28171):0.05986,SENT:0.21160,(SSUI:0.22398,(SCAN:0.02627,SPYO:0.04202):0.18029):0.04283):0.00000;
(LLAC:0.03914,LCRE:0.03914):0.00000;
(((SPLU:0.23288,((LCRE:0.02565,LLAC:0.04156):0.28037,((SINT:0.08725,(SANG:0.05328,SCON:0.05449):0.02315):0.10884,(SMIT:0.01510,(SPSE:0.00119,SPNE:0.00530):0.02373):0.17577):0.02559):0.01000):0.02365,((((SINF:0.02118,SLUT:0.03681):0.04462,SEQU:0.04979):0.07335,(SDEV:0.04742,SRAT:0.06603):0.12373):0.02014,(SCAN:0.09650,(SPYO:0.00573,SDYS:0.00311):0.09496):0.07067):0.02472):0.00628,(SENT:0.22921,SDOW:0.19176):0.00885,((STHE:0.07217,(SSAL:0.00939,SVES:0.01751):0.03316):0.09195,SSUI:0.14803):0.03006):0.00000;
((SDEV:0.14653,(SPSE:0.18312,((((SSAL:0.00939,(STHE:0.00383,SVES:0.00898):0.00575):0.15848,((SMIT:0.02362,(SPSE:0.02898,SPNE:0.02696):0.00070):0.12472,(SANG:0.05718,(SINT:0.01041,SCON:0.00794):0.06409):0.07562):0.00821):0.00993,SSUI:0.15736):0.00983,(LCRE:0.04841,LLAC:0.04943):0.25598):0.01236):0.02086):0.00147,(((SINF:0.02993,(SLUT:0.00297,SEQU:0.00211):0.02124):0.03189,SRAT:0.06433):0.04372,(SPLU:0.11470,SENT:0.13117):0.01256):0.01238,SCAN:0.15513):0.00000;
(LLAC:0.01277,LCRE:0.01277):0.00000;
(LLAC:0.01064,LCRE:0.01064):0.00000;
(LLAC:0.07533,LCRE:0.07533):0.00000;
((LCRE:0.06314,LLAC:0.07851):0.34957,(((SSAL:0.01805,SVES:0.01282):0.04820,STHE:0.06576):0.19021,(SPLU:0.02607,SSUI:0.02697):0.21284):0.03129,((SMIT:0.04283,(SPSE:0.01123,SPNE:0.01433):0.03867):0.14142,(SINT:0.08079,(SANG:0.07223,SCON:0.06217):0.01572):0.11745):0.04401):0.00000;
(((((((SSAL:0.02265,SVES:0.02360):0.00524,STHE:0.02671):0.24107,(((SMIT:0.01080,SPSE:0.01191):0.00736,SPNE:0.02027):0.21140,((SINT:0.01282,SCON:0.01096):0.05075,SANG:0.05055):0.16705):0.04396):0.02383,(SSUI:0.25605,(SENT:0.36983,(LCRE:0.04304,LLAC:0.04642):0.32673):0.00657):0.00729):0.01930,(SPLU:0.24736,SDOW:0.22323):0.01035):0.00784,(SDEV:0.06377,SRAT:0.05927):0.15342):0.00504,(SPYO:0.13260,(SDYS:0.09052,SCAN:0.08335):0.04199):0.11880,(SEQU:0.08829,(SLUT:0.03981,SINF:0.04209):0.05361):0.14489):0.00000;
(LLAC:0.02787,LCRE:0.02787):0.00000;
(LLAC:0.02229,LCRE:0.02229):0.00000;
((SDOW:0.13650,((((SMIT:0.01594,(SPSE:0.01084,SPNE:0.00736):0.00312):0.16396,(SINT:0.05377,(SANG:0.02873,SCON:0.03736):0.01307):0.08167):0.01920,SSUI:0.16107):0.02806,(SENT:0.21690,(LCRE:0.02733,LLAC:0.02911):0.28289):0.00388):0.01931):0.01486,((SDEV:0.03789,SRAT:0.04982):0.11577,((SPYO:0.03426,(SCAN:0.03008,SDYS:0.02455):0.00499):0.10080,((SINF:0.00351,SLUT:0.00588):0.00480,SEQU:0.01494):0.08823):0.00412):0.00857,((STHE:0.02297,(SSAL:0.00418,SVES:0.00698):0.01112):0.10905,SPLU:0.14185):0.00179):0.00000;
(LLAC:0.08434,LCRE:0.08434):0.00000;
(((SENT:0.11071,((SSUI:0.09398,SPLU:0.09067):0.03548,((((SMIT:0.00962,SPSE:0.00613):0.00153,SPNE:0.01340):0.09347,(SANG:0.02878,(SINT:0.02457,SCON:0.02662):0.00850):0.06047):0.01185,(LCRE:0.03031,LLAC:0.02696):0.19007):0.01008):0.00915):0.01541,((((SINF:0.01712,SLUT:0.01852):0.01771,SEQU:0.02778):0.04848,(SDEV:0.03797,SRAT:0.04203):0.07012):0.00162,(STHE:0.02657,(SVES:0.01156,SSAL:0.01188):0.00542):0.08495):0.00905):0.00152,SDOW:0.12135,((SCAN:0.03197,SPYO:0.03060):0.01647,SDYS:0.03876):0.06585):0.00000;
(LLAC:0.16432,LCRE:0.16432):0.00000;
(LLAC:0.03454,LCRE:0.03454):0.00000;
(LLAC:0.08954,LCRE:0.08954):0.00000;
(LLAC:0.14370,LCRE:0.14370):0.00000;
(LLAC:0.01111,LCRE:0.01111):0.00000;
(LCRE:0.29539,LCRE:0.29539):0.00000;
(LLAC:0.18750,LCRE:0.18750):0.00000;
((((SPLU:0.11388,SENT:0.09619):0.01736,(SSUI:0.07020,(SPYO:0.02265,(SDYS:0.02350,SCAN:0.03407):0.00896):0.04996):0.04365):0.01371,((LCRE:0.00545,LLAC:0.00470):0.41708,(((SPSE:0.01220,SPNE:0.00754):0.09086,SMIT:0.07765):0.01157,(SCON:0.03764,(SINT:0.03181,SANG:0.02082):0.00533):0.05650):0.04486):0.04492):0.03684,((SDEV:0.02737,SRAT:0.01511):0.10198,((SINF:0.03598,SLUT:0.03568):0.00491,SEQU:0.02939):0.05652):0.01201,((SSAL:0.03414,SVES:0.03823):0.06232,SDOW:0.11053):0.01834):0.00000;
(LLAC:0.02679,LCRE:0.02679):0.00000;
(LLAC:0.15264,LCRE:0.15264):0.00000;
(((LCRE:0.04705,LLAC:0.05786):0.45152,(LLAC:0.02717,LCRE:0.02809):0.20052):0.11805,((SDOW:0.10560,((SEQU:0.06971,(SINF:0.01164,SLUT:0.01395):0.03935):0.05718,(SSUI:0.04785,(SPLU:0.03248,(SDYS:0.00855,(SPYO:0.00856,SCAN:0.00989):0.00309):0.02007):0.00519):0.04313):0.00646):0.01013,((SDEV:0.01526,SRAT:0.00975):0.06857,(STHE:0.01579,(SSAL:0.00996,SVES:0.01073):0.00635):0.08943):0.01622):0.00529,(SENT:0.10355,(((SPNE:0.00455,SPSE:0.00867):0.00253,SMIT:0.00812):0.07764,((SCON:0.01018,SINT:0.01819):0.00627,SANG:0.01996):0.05253):0.03066):0.01679):0.00000;
((((SMIT:0.00330,(SPSE:0.00723,SPNE:0.00298):0.00340):0.05981,((SANG:0.02022,SINT:0.02656):0.00232,SCON:0.01604):0.03806):0.01202,(SSUI:0.07865,(LCRE:0.01067,LLAC:0.01044):0.16749):0.01344):0.01513,(SPLU:0.07610,((SPYO:0.02714,(SCAN:0.01127,SDYS:0.01345):0.00788):0.04230,((SINF:0.01715,(SLUT:0.01150,SEQU:0.00852):0.00748):0.03488,(SSAL:0.00539,(STHE:0.00966,SVES:0.00682):0.00506):0.04052):0.00403):0.00292):0.00565,(SENT:0.09318,(SDOW:0.07234,(SDEV:0.02048,SRAT:0.02034):0.05383):0.00560):0.00214):0.00000;
(LLAC:0.11313,LCRE:0.11313):0.00000;
(LCRE:0.06733,LLAC:0.07307,SCAN:0.51471):0.00000;
(LLAC:0.10983,LCRE:0.10983):0.00000;
(LLAC:0.05953,LCRE:0.05953):0.00000;
((((SPLU:0.11105,SENT:0.11939):0.10705,((LLAC:0.01543,LCRE:0.01730):0.29262,(LCRE:0.00239,LLAC:0.00632):0.27560):0.15964):0.17972,SCAN:0.03218):0.01809,SDYS:0.00783,SPYO:0.01380):0.00000;
(SSAL:0.13663,SSUI:0.13663):0.00000;
((((((SMIT:0.00677,SPSE:0.00797):0.00068,SPNE:0.01052):0.05068,(SANG:0.02304,(SINT:0.01179,SCON:0.01318):0.01703):0.02912):0.04342,((SINF:0.01313,SLUT:0.01402):0.01256,SEQU:0.02022):0.05469):0.01048,(SENT:0.09681,SSUI:0.54920):0.00841):0.00557,(SCAN:0.01655,(SPYO:0.00583,SDYS:0.00440):0.01079):0.06228,SPLU:0.08533):0.00000;
(SSUI:0.45976,SEQU:0.20631,SINF:0.20509):0.00000;
((SSUI:0.15577,(SINF:0.12160,SEQU:0.09641):0.04388):0.20818,(SPSE:0.00508,SPNE:0.00717):0.00481,SMIT:0.01281):0.00000;
(((SPLU:0.06040,(SENT:0.06248,((LLAC:0.00483,LCRE:0.00535):0.12839,(((SDYS:0.40391,((SVES:0.00945,SSAL:0.00990):0.38085,(SSUI:0.32105,((LCRE:0.01466,LLAC:0.02005):0.16924,((SENT:0.17412,SDOW:0.16972):0.00760,(((SPSE:0.01269,(SMIT:0.01139,SPNE:0.01521):0.00457):0.11096,((SINT:0.03836,(SANG:0.01196,SCON:0.01220):0.01967):0.07821,SSUI:0.12817):0.02270):0.01374,((SPYO:0.06441,(SCAN:0.03148,SDYS:0.03537):0.02656):0.06939,((SPLU:0.13516,((STHE:0.05257,(SSAL:0.01880,SVES:0.02008):0.02599):0.08024,((SINF:0.00874,SLUT:0.00823):0.02603,SEQU:0.03161):0.09188):0.01093):0.00527,(SDEV:0.02778,SRAT:0.03592):0.09011):0.00583):0.01962):0.00605):0.04349):0.10077):0.02028):0.05217):0.13546,(((SPSE:0.00231,SPNE:0.00236):0.02353,SDYS:0.02005):0.10938,(SINF:0.07813,(SDEV:0.05855,SLUT:0.04568):0.01423):0.07223):0.06679):0.00141,((LCRE:0.00000,LLAC:0.00000):0.10586,(SENT:0.07665,((SPYO:0.02954,(SCAN:0.00720,SDYS:0.00913):0.00665):0.05737,(SPLU:0.07298,(((STHE:0.01158,(SSAL:0.00152,SVES:0.00236):0.00859):0.05747,((SSUI:0.04966,(SINF:0.00610,(SLUT:0.00400,SEQU:0.00759):0.00318):0.02915):0.01055,(SDEV:0.00974,SRAT:0.00812):0.03701):0.00813):0.00194,(SDOW:0.06237,(((SPSE:0.00805,SPNE:0.00523):0.01598,SMIT:0.01407):0.02723,(SANG:0.01602,(SINT:0.00114,SCON:0.00433):0.01566):0.03950):0.01886):0.00334):0.00778):0.01267):0.01023):0.06780):0.07660):0.07580):0.08613):0.00309):0.00396,((STHE:0.02063,(SSAL:0.00000,SVES:0.00000):0.01128):0.04612,((SLUT:0.00554,(SINF:0.00662,SEQU:0.00135):0.00170):0.02295,(SDEV:0.00508,SRAT:0.00792):0.03360):0.00909):0.00540):0.00208,((SCAN:0.01085,(SPYO:0.01453,SDYS:0.00565):0.00142):0.02731,SDOW:0.06194):0.00492,(((SMIT:0.01687,(SPSE:0.00196,SPNE:0.00168):0.01660):0.01613,(SANG:0.00807,(SINT:0.00000,SCON:0.00000):0.01079):0.03891):0.01689,SSUI:0.02940):0.00930):0.00000;
(SSUI:0.61225,SSAL:0.00435,SVES:0.01096):0.00000;
(SSUI:0.45678,SEQU:0.11754,SPYO:0.13581):0.00000;
(SSUI:0.21988,(SEQU:0.04306,SINF:0.04451):0.18483,(SVES:0.01417,SSAL:0.01984):0.30591):0.00000;
((((SMIT:0.31791,SSUI:0.17281):0.09953,(SDYS:0.00475,SPLU:0.00319):0.11287):0.05834,SANG:0.09607):0.01959,SCAN:0.10750,SSUI:0.10149):0.00000;
((SCAN:0.02281,SSUI:0.00906):0.00952,(SPLU:0.00724,SDYS:0.00743):0.00446,(SENT:0.36441,(SPNE:0.01672,(SMIT:0.00906,SVES:0.01112):0.04511):0.23092):0.26065):0.00000;
(SSUI:0.63244,SCAN:0.02642,SCAN:0.04204):0.00000;
(SCAN:0.23161,SSUI:0.23161):0.00000;
(SSUI:0.28774,SSUI:0.28774):0.00000;
(((SEQU:0.04804,(SINF:0.01147,SLUT:0.00296):0.05462):0.12686,((SPYO:0.14462,(SCAN:0.10424,SDYS:0.12840):0.02376):0.10501,SSUI:0.20536):0.01807):0.01283,(SDEV:0.06881,SRAT:0.07736):0.07302,(SSAL:0.00964,SVES:0.01381):0.09722):0.00000;
((((SEQU:0.03632,SINF:0.05015):0.12531,SDOW:0.20818):0.01605,((SANG:0.06521,SCON:0.07474):0.14318,(SPSE:0.15275,SSUI:0.18182):0.01770):0.01253):0.01128,(SRAT:0.11489,SDEV:0.11456):0.08210,(SPLU:0.17616,(STHE:0.17456,(SVES:0.02797,SSAL:0.02935):0.05831):0.07964):0.00802):0.00000;
(((((SCAN:0.09873,SDYS:0.08024):0.01802,SPYO:0.11075):0.09038,(((SINF:0.03629,SLUT:0.04055):0.01983,SEQU:0.04585):0.11490,(SRAT:0.06921,SDEV:0.06739):0.11949):0.00714):0.03097,(((SPNE:0.01317,(SPSE:0.01213,SMIT:0.00815):0.00554):0.15401,(SANG:0.04841,(SINT:0.03732,SCON:0.02575):0.00806):0.11902):0.05434,SSUI:0.23212):0.01416):0.01283,(SENT:0.24539,((LCRE:0.06466,LLAC:0.05833):0.33389,SDOW:0.26866):0.00833):0.00257,((SSAL:0.04606,(SVES:0.04213,STHE:0.03577):0.01103):0.20180,SPLU:0.21239):0.02228):0.00000;
(((((LLAC:0.00595,LCRE:0.00697):0.32090,(((SPSE:0.00573,(SMIT:0.00689,SPNE:0.00869):0.00271):0.12016,(SANG:0.00533,(SINT:0.00000,SCON:0.00000):0.00624):0.11272):0.03964,SSUI:0.20914):0.02150):0.06794,(SENT:0.18208,(SRAT:0.01144,SDEV:0.01321):0.16046):0.01497):0.01642,SDOW:0.24749):0.01997,(SPLU:0.13465,(((SINF:0.00506,SLUT:0.00994):0.03742,SEQU:0.05201):0.06158,(SPYO:0.04623,(SCAN:0.01954,SDYS:0.02186):0.02045):0.05592):0.04927):0.00798,(STHE:0.04083,(SSAL:0.00449,SVES:0.01112):0.02714):0.16837):0.00000;
(((((SMIT:0.03933,(SPSE:0.00580,SPNE:0.00738):0.03227):0.10052,(SANG:0.03686,(SINT:0.01218,SCON:0.01520):0.03091):0.10660):0.03240,(SDEV:0.06582,SRAT:0.07157):0.12198):0.00302,SSUI:0.18823):0.00677,SENT:0.19316,(((STHE:0.02642,(SSAL:0.01278,SVES:0.01635):0.01970):0.13089,SPLU:0.16420):0.02896,((SCAN:0.06071,(SPYO:0.04710,SDYS:0.05092):0.01348):0.11470,(SDOW:0.14438,(SEQU:0.02496,(SINF:0.00863,SLUT:0.01415):0.01343):0.11996):0.01460):0.00435):0.00197):0.00000;
(SSUI:0.08564,((SSAL:0.00888,(STHE:0.00749,SVES:0.00355):0.00998):0.07975,((SDEV:0.05598,SRAT:0.05144):0.01458,SDOW:0.07033):0.00582):0.04419,((LLAC:0.02534,LCRE:0.02933):0.12953,((((SMIT:0.00936,SPSE:0.01083):0.00352,SPNE:0.01489):0.09514,(SANG:0.03517,SINT:0.04353):0.07864):0.01564,((SPLU:0.07350,SENT:0.10972):0.01398,((SINF:0.00999,SLUT:0.01141):0.01470,SEQU:0.01671):0.04474):0.00979):0.00783):0.00463):0.00000;
((SSUI:0.17338,((SSAL:0.17957,(SDEV:0.05036,SRAT:0.05996):0.09655):0.05171,SDOW:0.23439):0.01627):0.00704,(SPLU:0.12613,SDYS:0.15499):0.01558,SENT:0.15191):0.00000;
(SDYS:0.28953,SSUI:0.28953):0.00000;
(((((SSUI:0.17323,SPLU:0.21929):0.20246,(SVES:0.01620,SSAL:0.01516):0.19008):0.02440,(SANG:0.03550,(SINT:0.00564,SCON:0.00809):0.01437):0.19653):0.16492,SMIT:0.01626):0.01249,SPNE:0.01365,SPSE:0.02010):0.00000;
((SMIT:0.03517,((SVES:0.03090,SSAL:0.03134):0.19925,((SPLU:0.23995,SSUI:0.23047):0.05722,(SINT:0.04072,(SANG:0.01303,SCON:0.02416):0.01920):0.17882):0.03286):0.14539):0.00450,SPNE:0.02259,SPSE:0.01925):0.00000;
(((SSUI:0.09681,(SDEV:0.03401,SRAT:0.04231):0.06905):0.00650,((((SMIT:0.01306,SPSE:0.01194):0.00688,SPNE:0.02753):0.07581,(SANG:0.03565,(SINT:0.02756,SCON:0.02314):0.00832):0.04723):0.04049,((LCRE:0.02494,LLAC:0.03497):0.13240,(((LLAC:0.03520,LCRE:0.03986):0.19664,(SSUI:0.18960,(((SMIT:0.01974,(SPSE:0.01195,SPNE:0.01965):0.00260):0.11760,(SANG:0.03153,(SINT:0.03496,SCON:0.02695):0.00915):0.09422):0.05802,((SPLU:0.19098,((STHE:0.02979,(SSAL:0.02003,SVES:0.01790):0.00901):0.13570,((SDOW:0.14269,((SINF:0.01244,SLUT:0.01503):0.03268,SEQU:0.04803):0.09241):0.01409,(SDEV:0.04050,SRAT:0.04873):0.10624):0.00676):0.01931):0.00290,((SCAN:0.08334,SPYO:0.09519):0.02740,SDYS:0.09996):0.05948):0.01504):0.00936):0.00801):0.02557,SENT:0.22067):0.26719):0.03638):0.00619):0.01696,(SPLU:0.09542,(((SCAN:0.03483,SPYO:0.04048):0.02591,SDYS:0.05092):0.05508,SENT:0.14915):0.00670):0.00396,(((SSAL:0.01456,(STHE:0.01429,SVES:0.01007):0.00333):0.05008,((SINF:0.00559,SLUT:0.01150):0.02281,SEQU:0.03054):0.04645):0.01863,SDOW:0.08098):0.00571):0.00000;
((((SMIT:0.02712,SPNE:0.03171):0.11781,((SSUI:0.15210,SPLU:0.13569):0.10820,((SCAN:0.15459,(SPLU:0.01004,SSUI:0.01262):0.15280):0.15602,SDEV:0.31232):0.03240):0.15086):0.03046,(SINF:0.05055,(SLUT:0.00963,SEQU:0.01037):0.04126):0.06861):0.00076,SRAT:0.12380,SDEV:0.12952):0.00000;
((SPLU:0.00003,SSUI:0.03341):0.05987,SENT:0.05826,SINF:0.46901):0.00000;
(SSAL:0.31507,SPNE:0.26625,SSUI:0.35925):0.00000;
((SSUI:0.23879,SPYO:0.25042):0.46168,SDEV:0.01356,SRAT:0.01082):0.00000;
(SDOW:0.23930,SSUI:0.23930):0.00000;
((SENT:0.28190,SSUI:0.28201):0.12830,((SMIT:0.10384,(SPSE:0.03326,SPNE:0.03798):0.06506):0.27772,(SRAT:0.03276,SDEV:0.03835):0.27959):0.01780,(SDOW:0.34392,SPLU:0.33063):0.03612):0.00000;
((((SSAL:0.11677,(((SDOW:0.18112,(SDEV:0.03854,SRAT:0.04179):0.10583):0.04576,(SENT:0.24795,(SLUT:0.02708,SINF:0.05131):0.22897):0.03055):0.10193,((SPLU:0.07976,SSUI:0.09091):0.01474,SDYS:0.10056):0.11172):0.07442):0.01369,((SINT:0.05478,SCON:0.03525):0.01853,SANG:0.04424):0.06777):0.09355,SPNE:0.01465):0.00416,SPSE:0.01914,SMIT:0.00871):0.00000;
(((SPNE:0.03193,(SPSE:0.01864,SMIT:0.01466):0.01077):0.13642,SSUI:0.16318):0.01403,((SANG:0.07232,(SINT:0.03777,SCON:0.04722):0.04150):0.12529,((LLAC:0.09710,LCRE:0.09204):0.19475,(((SDEV:0.06302,SRAT:0.07178):0.11990,(SEQU:0.04827,(SINF:0.01066,SLUT:0.00416):0.04384):0.12461):0.00977,((SDOW:0.21601,(STHE:0.04406,(SVES:0.02027,SSAL:0.01973):0.02859):0.11787):0.01100,(SPLU:0.17111,(SPYO:0.08945,(SCAN:0.05043,SDYS:0.05516):0.02673):0.07575):0.01411):0.00984):0.00574):0.00869):0.00368,SENT:0.19506):0.00000;
(((SSUI:0.28811,(SINF:0.03985,(SLUT:0.02514,SEQU:0.00741):0.02637):0.15401):0.02112,SSAL:0.19859):0.01074,(SANG:0.05089,(SCON:0.04202,SINT:0.04941):0.01000):0.06832,(SMIT:0.02012,(SPSE:0.00608,SPNE:0.00326):0.01668):0.15969):0.00000;
((((SSUI:0.32281,SENT:0.35901):0.02760,(SMIT:0.04460,SPSE:0.07224):0.19735):0.21401,SPSE:0.03449):0.01498,SPNE:0.02955,SMIT:0.00884):0.00000;
(((SANG:0.04679,SCON:0.04543):0.19984,((LLAC:0.02560,LCRE:0.01986):0.34668,SSUI:0.24186):0.04994):0.01186,((STHE:0.01555,(SSAL:0.01039,SVES:0.00789):0.00977):0.18723,((((SINF:0.00363,SLUT:0.00549):0.01342,SEQU:0.01913):0.10426,(SDEV:0.05270,SRAT:0.04956):0.04661):0.01578,SDOW:0.14664):0.02963):0.03479,(SDYS:0.11350,SCAN:0.13457):0.14305):0.00000;
((SCON:0.04203,(((SPSE:0.01534,SPNE:0.02091):0.05370,SMIT:0.06604):0.13002,SSUI:0.36299):0.10119):0.00855,SANG:0.02786,SINT:0.02184):0.00000;
((((SPLU:0.15828,SENT:0.15350):0.01724,(SDEV:0.02529,SRAT:0.02949):0.11412):0.01273,(((LLAC:0.00830,LCRE:0.00713):0.25714,(((SMIT:0.01498,(SPSE:0.00463,SPNE:0.00831):0.01246):0.07516,(SANG:0.01161,(SINT:0.01406,SCON:0.01000):0.00223):0.07495):0.07539,SSUI:0.16541):0.01591):0.04210,SDOW:0.20178):0.01640):0.01026,(((SCAN:0.02001,SPYO:0.01995):0.00891,SDYS:0.02883):0.12220,((SINF:0.01164,SLUT:0.01731):0.03135,SEQU:0.05493):0.07066):0.04354,(STHE:0.03504,(SSAL:0.02438,SVES:0.02462):0.01044):0.16552):0.00000;
(SSUI:0.07532,(SPSE:0.12464,(SPLU:0.30375,SANG:0.15966):0.06462):0.03173,SPNE:0.11316):0.00000;
(((SENT:0.08863,SSUI:0.06145):0.01786,((SCAN:0.00547,(SPYO:0.00165,SDYS:0.00155):0.00151):0.05917,(SDEV:0.01104,SRAT:0.00732):0.04239):0.01011):0.00210,((SPLU:0.05387,((SINF:0.00051,SLUT:0.00150):0.00533,SEQU:0.00452):0.02628):0.01082,(((SMIT:0.00801,(SPSE:0.00287,SPNE:0.00550):0.00154):0.04951,(SINT:0.00977,(SANG:0.00573,SCON:0.00905):0.00202):0.02682):0.01395,((STHE:0.02475,(SSAL:0.00824,SVES:0.01618):0.00587):0.02668,SDOW:0.05004):0.00650):0.00614):0.00350,(LCRE:0.00350,LLAC:0.00483):0.11903):0.00000;
(SPLU:0.13848,SSUI:0.13848):0.00000;
(SMIT:0.16057,((SPNE:0.19545,SDEV:0.15893):0.02076,(SPLU:0.10560,SSUI:0.11491):0.23084):0.02008,(SRAT:0.12157,(SLUT:0.03476,(SINF:0.01366,SEQU:0.01132):0.01778):0.11146):0.01293):0.00000;
(SENT:0.50109,SPNE:0.16196,SSUI:0.17286):0.00000;
(((LLAC:0.00945,LCRE:0.00936):0.24433,(((SINT:0.03371,(SANG:0.02597,SCON:0.01812):0.01069):0.07012,((SPSE:0.00934,SPNE:0.02457):0.00577,SMIT:0.01772):0.08139):0.01523,SSUI:0.11198):0.01152):0.02184,(SPLU:0.13359,(SCAN:0.04629,(SDYS:0.04733,SPYO:0.04578):0.00620):0.11484):0.00699,((((SSAL:0.02769,(STHE:0.03458,SVES:0.02360):0.00999):0.07343,((SINF:0.00354,SLUT:0.00505):0.00474,SEQU:0.00708):0.08771):0.01382,SDOW:0.10199):0.01303,(SDEV:0.02664,SRAT:0.02264):0.08375):0.01240):0.00000;
((((SSAL:0.02320,SVES:0.02399):0.13017,(SENT:0.17157,(((LLAC:0.00659,LCRE:0.00750):0.21946,SSUI:0.24627):0.05281,SPLU:0.27613):0.23150):0.01325):0.15911,SPNE:0.01824):0.00291,SPSE:0.01787,SMIT:0.01316):0.00000;
((((SMIT:0.01271,(SPSE:0.00541,SPNE:0.00563):0.00534):0.08578,(SANG:0.04464,(SINT:0.01574,SCON:0.01225):0.02433):0.07004):0.03225,SSUI:0.15040):0.00738,(SDYS:0.20684,(((SSAL:0.00776,SVES:0.00882):0.08257,(SDEV:0.01200,SRAT:0.01148):0.07565):0.03185,SENT:0.14694):0.02153):0.00742,SPLU:0.18477):0.00000;
(SPLU:0.17972,SSUI:0.17972):0.00000;
((((LLAC:0.01506,LCRE:0.02117):0.22614,((SMIT:0.01294,(SPSE:0.00454,SPNE:0.00471):0.01095):0.11329,(SINT:0.05024,(SANG:0.01723,SCON:0.02354):0.01313):0.07600):0.07205):0.00895,SSUI:0.20505):0.00823,((SDEV:0.03179,SRAT:0.02606):0.17215,((SENT:0.20666,SPLU:0.15220):0.00859,((SCAN:0.04833,(SPYO:0.00108,SDYS:0.00239):0.05341):0.10319,((SLUT:0.00805,SINF:0.00665):0.04102,SEQU:0.05069):0.07827):0.01439):0.00822):0.00543,(SDOW:0.20943,(STHE:0.02000,(SSAL:0.01145,SVES:0.01170):0.00813):0.12748):0.01254):0.00000;
(SCAN:0.20607,SSUI:0.20607):0.00000;
(SSUI:0.71402,SSAL:0.01489,SVES:0.01057):0.00000;
(SENT:0.33750,SSUI:0.33750):0.00000;
(SSUI:0.26132,(SDEV:0.26550,SDOW:0.28913):0.15297,SSAL:0.25981):0.00000;
(SPLU:0.10962,SSUI:0.10962):0.00000;
(SSUI:0.01200,SENT:0.24257,SPLU:0.00629):0.00000;
((SSUI:0.26604,(SINT:0.15385,(SPNE:0.06472,SPSE:0.07813):0.07935):0.13433):0.02183,SPLU:0.34767,SDYS:0.29097):0.00000;
(SCON:0.32220,(SDYS:0.34598,SPNE:0.32831):0.00408,SDYS:0.35007):0.00000;
(((SCON:0.03032,SINT:0.04447):0.02604,SANG:0.05384):0.20392,(SDOW:0.25424,(SEQU:0.09973,(SLUT:0.03652,SINF:0.04323):0.06661):0.09482):0.01279,((SPYO:0.07578,(SCAN:0.04793,SDYS:0.05432):0.02534):0.12732,((SVES:0.03111,SSAL:0.01852):0.19492,(SLUT:0.05174,(SINF:0.00660,SEQU:0.00689):0.04803):0.17164):0.02344):0.03472):0.00000;
((((SENT:0.24282,(SENT:0.47099,((SSAL:0.14614,((SCON:0.01071,SINT:0.00810):0.01672,SANG:0.03142):0.07858):0.03257,(SMIT:0.01248,(SPSE:0.00377,SPNE:0.00054):0.00366):0.16308):0.08245):0.05454):0.03294,(SPYO:0.05242,(SCAN:0.03740,SDYS:0.03281):0.01102):0.13559):0.11500,SEQU:0.03940):0.01021,SLUT:0.02710,SINF:0.02582):0.00000;
((((LLAC:0.01241,LCRE:0.01368):0.30370,(((SCON:0.01643,SINT:0.02147):0.00684,SANG:0.02068):0.09423,(SPSE:0.01093,(SMIT:0.00562,SPNE:0.00386):0.00211):0.11337):0.09749):0.04644,((SSAL:0.02206,(STHE:0.01509,SVES:0.00936):0.01956):0.17674,SDOW:0.17734):0.01606):0.00901,((SDEV:0.00795,SRAT:0.01075):0.12381,((SPYO:0.04981,(SCAN:0.01601,SDYS:0.02014):0.01888):0.09918,((SINF:0.00473,SLUT:0.00242):0.02128,SEQU:0.02284):0.10728):0.02126):0.01602,(SPLU:0.14403,SENT:0.14549):0.01350):0.00000;
((((SDEV:0.02165,SRAT:0.02287):0.18360,(SSUI:0.22682,((SMIT:0.02842,(SPSE:0.00623,SPNE:0.01238):0.00634):0.17854,(SCON:0.04480,(SANG:0.01143,SINT:0.01421):0.02034):0.11596):0.04162):0.09002):0.01761,((SVES:0.01891,(SSAL:0.00847,STHE:0.01040):0.00686):0.22422,(SDOW:0.27549,SENT:0.22194):0.06573):0.00504):0.01742,(((SPYO:0.02552,SDYS:0.02858):0.02148,SCAN:0.04833):0.18405,((SINF:0.03606,SLUT:0.01727):0.00612,SEQU:0.02156):0.23235):0.00458,SPLU:0.23917):0.00000;
((SENT:0.16965,((((SMIT:0.00000,SPSE:0.00000):0.00958,SCON:0.03458):0.00192,(SANG:0.00831,SINT:0.01247):0.01178):0.00677,SPNE:0.01113):0.20564):0.00563,(((SINF:0.01601,(SEQU:0.00000,SLUT:0.00000):0.00950):0.14332,SRAT:0.08812):0.01696,((SPLU:0.16127,(STHE:0.08098,(SSAL:0.01327,SVES:0.00998):0.04438):0.02826):0.02588,(SDOW:0.11817,SDEV:0.08864):0.02404):0.00726):0.02007,SSUI:0.13660):0.00000;
(SCON:0.01723,SINT:0.00841,((LLAC:0.00446,LCRE:0.00489):0.35940,SANG:0.03702):0.03224):0.00000;
(SCON:0.00526,SINT:0.03729,SANG:0.02205):0.00000;
(SMIT:0.27998,SCON:0.27998):0.00000;
((SENT:0.27841,(SDOW:0.27591,((SCON:0.02751,SINT:0.02669):0.02527,SANG:0.04434):0.22156):0.03616):0.02467,((SDEV:0.04993,SRAT:0.06983):0.13062,((SDYS:0.07740,(SCAN:0.06958,SPYO:0.05863):0.03442):0.11585,(SINF:0.07303,SLUT:0.06106):0.12151):0.03662):0.00511,SPLU:0.19405):0.00000;
(SCON:0.01068,SINT:0.01508,SANG:0.09900):0.00000;
(SCAN:0.02310,SCON:0.02310):0.00000;
(SCAN:0.23887,SCON:0.23887):0.00000;
((SANG:0.01003,SCON:0.01402):0.01083,SINT:0.01679,(SDOW:0.15602,(SDEV:0.09035,SRAT:0.12514):0.03275):0.22777):0.00000;
((LCRE:0.01275,LLAC:0.01295):0.18194,((SANG:0.00422,(SINT:0.00501,SCON:0.00314):0.00510):0.07668,(SDEV:0.00780,SRAT:0.00745):0.05146):0.00210,((SLUT:0.00548,(SINF:0.00608,SEQU:0.01847):0.00302):0.04026,((((STHE:0.01074,(SSAL:0.00231,SVES:0.00297):0.00774):0.01122,(SPSE:0.01083,(SMIT:0.00289,SPNE:0.00708):0.00530):0.01177):0.01310,((SSUI:0.04774,(SPLU:0.02781,SENT:0.02752):0.00616):0.00616,(SCAN:0.00817,(SPYO:0.00255,SDYS:0.00155):0.00410):0.04926):0.00304):0.00963,SDOW:0.05149):0.00835):0.00546):0.00000;
((SDOW:0.19336,SCON:0.18465):0.07563,SRAT:0.01360,SDEV:0.00807):0.00000;
(((SPYO:0.04127,(SCAN:0.02694,SDYS:0.01830):0.01724):0.07517,(SENT:0.13627,(SPLU:0.10212,(((LLAC:0.00757,LCRE:0.00256):0.24229,((SPSE:0.01644,(SMIT:0.01378,SPNE:0.01624):0.00674):0.05407,(SANG:0.01038,(SINT:0.00647,SCON:0.00737):0.00646):0.07326):0.05511):0.02549,SSUI:0.11782):0.01648):0.00725):0.00700):0.00650,(SDOW:0.11535,(SDEV:0.01815,SRAT:0.01902):0.07898):0.00835,((STHE:0.02181,(SSAL:0.01016,SVES:0.01231):0.00385):0.09866,((SINF:0.01170,SLUT:0.00409):0.01933,SEQU:0.03381):0.04904):0.01464):0.00000;
((((SSUI:0.18345,SENT:0.19213):0.01285,(SCON:0.10412,(SANG:0.02918,SINT:0.02943):0.05254):0.08698):0.01219,((LCRE:0.04005,LLAC:0.04179):0.29299,(((SSAL:0.01285,SVES:0.01318):0.00310,STHE:0.02137):0.19594,((SDEV:0.02197,SRAT:0.01772):0.16195,(((SCAN:0.04150,SPYO:0.04213):0.01677,SDYS:0.05112):0.08973,((SINF:0.02226,SLUT:0.01854):0.06994,SEQU:0.09125):0.04168):0.02380):0.00366):0.01891):0.00889):0.00615,SPLU:0.17100,((SMIT:0.00626,SPSE:0.01048):0.00325,SPNE:0.00985):0.16310):0.00000;
((SCON:0.02970,SINT:0.02730):0.28780,(SPNE:0.05806,SPSE:0.06166):0.24409,(STHE:0.09719,SSAL:0.12005):0.26459):0.00000;
((((STHE:0.05650,(SSAL:0.01454,SVES:0.01968):0.02360):0.14159,(((SMIT:0.00658,SPSE:0.00499):0.00310,SPNE:0.01234):0.11207,(SINT:0.03411,(SANG:0.02269,SCON:0.02333):0.01078):0.11445):0.05135):0.02794,SPLU:0.22469):0.00729,((((SINF:0.12821,(SLUT:0.01714,SEQU:0.00773):0.06852):0.06821,(SPYO:0.13436,(SCAN:0.04720,SDYS:0.04505):0.03589):0.09591):0.01480,(SRAT:0.09473,SDEV:0.09671):0.08407):0.00286,SDOW:0.20104):0.03688,(((LLAC:0.01664,LCRE:0.01163):0.32091,SENT:0.23053):0.03431,SSUI:0.20806):0.01079):0.00000;
(((SINT:0.00701,(SANG:0.00700,SCON:0.00703):0.02142):0.06119,SSUI:0.28158):0.08506,(SPSE:0.00428,SPNE:0.00853):0.00269,SMIT:0.01768):0.00000;
((SEQU:0.10806,(SCON:0.19298,(SSAL:0.02501,SVES:0.02381):0.18160):0.39210):0.07865,SINF:0.03956,SLUT:0.04479):0.00000;
((SVES:0.01386,SSAL:0.01903):0.21571,SCON:0.21553,(SPLU:0.25701,SSUI:0.27065):0.03674):0.00000;
((SANG:0.02293,SCON:0.03430):0.00644,SINT:0.04122,((((LLAC:0.01037,LCRE:0.01015):0.26050,((LLAC:0.03112,LCRE:0.03028):0.27867,((SSAL:0.03595,SVES:0.04142):0.12865,(SLUT:0.00415,SEQU:0.00598):0.14691):0.10471):0.10215):0.06761,(SPYO:0.03519,SCAN:0.03690):0.19730):0.01705,(SRAT:0.03356,SDEV:0.03844):0.16829):0.17911):0.00000;
(((SPLU:0.11148,SENT:0.13148):0.00838,(SSUI:0.11875,((SMIT:0.00743,(SPSE:0.00000,SPNE:0.00000):0.00910):0.05581,((SCON:0.01010,SINT:0.01022):0.02808,SANG:0.03163):0.04102):0.02765):0.01192):0.00604,((SSAL:0.02683,(STHE:0.01423,SVES:0.01317):0.02028):0.08641,((LLAC:0.00456,LCRE:0.00385):0.16465,(SRAT:0.03880,SDEV:0.02979):0.06563):0.01085):0.00279,(((SINF:0.00468,SLUT:0.00579):0.01470,SEQU:0.02146):0.06223,(SPYO:0.07165,(SCAN:0.04882,SDYS:0.04748):0.01500):0.05137):0.01317):0.00000;
(SCON:0.01972,(SINT:0.02543,((SMIT:0.00332,(SPSE:0.00115,SPNE:0.00348):0.00150):0.05858,((LLAC:0.01693,LCRE:0.01934):0.23310,SSUI:0.11913):0.08196):0.05019):0.00188,SANG:0.02114):0.00000;
((SANG:0.06551,SCON:0.10796):0.01241,SINT:0.11817,SMIT:0.22501):0.00000;
(((SVES:0.05391,SSAL:0.05119):0.11208,SCON:0.18181):0.08726,(SSUI:0.27017,SENT:0.26700):0.01296,SINT:0.42515):0.00000;
(SCON:0.14269,SCON:0.14269):0.00000;
(SCON:0.00035,SINT:0.00035):0.00000;
(SINT:0.00047,SCON:0.00330,SANG:0.33916):0.00000;
(((SSAL:0.00405,(STHE:0.00107,SVES:0.00387):0.00953):0.09684,(SENT:0.12536,((LCRE:0.00000,LLAC:0.00000):0.18950,(((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.06548,((SANG:0.00531,SCON:0.00737):0.00481,SINT:0.01106):0.03760):0.03058,SSUI:0.10529):0.03332):0.02284):0.01163):0.01088,(((SPYO:0.03450,(SCAN:0.01090,SDYS:0.01671):0.01884):0.04028,(((SINF:0.00000,SLUT:0.00000):0.00354,SEQU:0.00733):0.04908,(SDEV:0.00314,SRAT:0.00542):0.06773):0.01133):0.00997,SDOW:0.06961):0.00402,SPLU:0.07631):0.00000;
(SINT:0.00551,SCON:0.16533,SANG:0.12235):0.00000;
(SINT:0.12247,SPNE:0.14792,SPSE:0.17936):0.00000;
(STHE:0.12989,SINT:0.12989):0.00000;
(SINT:0.03588,SCON:0.04730,SANG:0.04376):0.00000;
((SMIT:0.06119,((SANG:0.02069,SINT:0.02514):0.04170,(SDOW:0.07760,(SDEV:0.01634,SRAT:0.02929):0.02705):0.00924):0.03077):0.00886,SPNE:0.03805,(SSAL:0.00151,SVES:0.00031):0.03938):0.00000;
(SINT:0.03984,SCON:0.02421,SANG:0.07605):0.00000;
(SCON:0.09653,SINT:0.09653):0.00000;
((SCON:0.02770,SINT:0.01692):0.04074,(SPLU:0.35136,SDEV:0.16919):0.05732,SANG:0.07565):0.00000;
((SINT:0.00000,SANG:0.00000):0.07318,SMIT:0.06909,(STHE:0.48567,SDYS:0.22691):0.16691):0.00000;
(SCON:0.04531,SINT:0.04531):0.00000;
(SINT:0.45952,SRAT:0.05475,SDEV:0.04634):0.00000;
((SINT:0.16803,(SEQU:0.07991,SINF:0.09640):0.09094):0.07769,(SPNE:0.02990,(SPSE:0.02630,SMIT:0.02270):0.00379):0.24677,((SPSE:0.26534,SINT:0.23466):0.06193,(SEQU:0.06254,SINF:0.04642):0.43699):0.02013):0.00000;
(SCON:0.00428,SINT:0.00428):0.00000;
(SINT:0.29813,SSAL:0.21038,SDOW:0.25550):0.00000;
(SCON:0.01615,SINT:0.01615):0.00000;
((SINT:0.02488,SCON:0.03976):0.33498,SENT:0.26813,(SSUI:0.12560,SPLU:0.11724):0.14881):0.00000;
((SVES:0.12300,SINT:0.53362):0.03574,SVES:0.09835,STHE:0.07904):0.00000;
(SCON:0.00497,SINT:0.00497):0.00000;
((SMIT:0.00910,SINT:0.47692):0.00587,SPNE:0.00169,SPSE:0.00691):0.00000;
(SCAN:0.17041,SINT:0.17041):0.00000;
(SCAN:0.25094,SINT:0.25094):0.00000;
(SCAN:0.25290,SINT:0.25290):0.00000;
(SCAN:0.20691,SINT:0.20691):0.00000;
(((SINT:0.26917,(SRAT:0.07893,SDEV:0.09763):0.19617):0.37129,(SANG:0.04661,(SINF:0.01840,SEQU:0.00830):0.05212):0.01303):0.00860,SPLU:0.06951,(SMIT:0.00991,SPNE:0.01041):0.04314):0.00000;
(SENT:0.16958,(((SENT:0.21152,(SPLU:0.17081,(SPYO:0.05506,(SDYS:0.03364,SCAN:0.03628):0.00758):0.14319):0.04135):0.00925,SRAT:0.16927):0.04565,(((LCRE:0.00823,LLAC:0.00933):0.09455,(LCRE:0.00442,LLAC:0.00364):0.07863):0.13351,((((SMIT:0.00949,SPSE:0.00873):0.00190,SPNE:0.01869):0.10289,(SANG:0.02319,(SCON:0.01471,SINT:0.01269):0.01247):0.10477):0.07294,SSUI:0.19485):0.19247):0.02134):0.01998,((((SINF:0.00675,SLUT:0.00861):0.04648,SEQU:0.03808):0.04105,((SCAN:0.01019,SPYO:0.00494):0.01083,SDYS:0.01568):0.08265):0.04576,SPLU:0.13509):0.05266):0.00000;
(SANG:0.08673,SINT:0.08673):0.00000;
(SDOW:0.17520,SINT:0.17520):0.00000;
(((SDOW:0.10192,(((LLAC:0.03931,LCRE:0.05177):0.11049,(SDOW:0.57293,(SPYO:0.05620,(SCAN:0.04011,SDYS:0.03295):0.01188):0.11701):0.00963):0.00261,(SSUI:0.11946,(((SMIT:0.02890,(SPSE:0.01392,SPNE:0.00848):0.03176):0.07394,SENT:0.13279):0.00154,(SANG:0.06542,(SCON:0.02111,SINT:0.01521):0.05114):0.05637):0.01046):0.01005):0.00706):0.00666,(SDEV:0.02663,SRAT:0.02753):0.07538):0.00354,((SINF:0.01359,SLUT:0.01959):0.00439,SEQU:0.00959):0.10242,(((STHE:0.01877,SSAL:0.00840):0.00619,SVES:0.02161):0.05958,SPLU:0.10346):0.02042):0.00000;
(SANG:0.13619,SINT:0.13619):0.00000;
(SPNE:0.33548,SINT:0.33548):0.00000;
((((SANG:0.00000,((SSUI:0.00405,SENT:0.00904):0.00031,SCAN:0.00312):0.00000):0.00000,SSUI:0.00000):0.00000,SCON:0.00000):0.00000,SPNE:0.00000,SPSE:0.00000):0.00000;
(SDOW:0.19501,SANG:0.19501):0.00000;
(((SDEV:0.15607,((SINF:0.02136,SLUT:0.01435):0.07820,SEQU:0.08450):0.10049):0.02381,((SSAL:0.02762,(STHE:0.04359,SVES:0.01965):0.01627):0.10863,(SSUI:0.24489,(SANG:0.06228,SCON:0.05687):0.14132):0.06761):0.04864):0.01641,(SDOW:0.14674,SRAT:0.13621):0.01463,SDYS:0.20335):0.00000;
(SANG:0.03947,SDYS:0.00571,SPLU:0.00323):0.00000;
(SANG:0.01443,SCON:0.02373,SSUI:0.65602):0.00000;
((SPNE:0.06722,SANG:0.49863):0.01689,SMIT:0.09204,SPSE:0.04328):0.00000;
(SVES:0.29700,SANG:0.29700):0.00000;
((SANG:0.21338,(SINT:0.05707,SCON:0.06983):0.11105):0.00572,((STHE:0.07783,(SSAL:0.03250,SVES:0.02799):0.02843):0.16222,SDYS:0.26703):0.02913,((SMIT:0.05910,SPSE:0.06085):0.01754,SPNE:0.06332):0.12045):0.00000;
(((SANG:0.03436,(SINT:0.00324,SCON:0.01110):0.03458):0.26052,(((SINF:0.01153,SLUT:0.00762):0.07625,SEQU:0.06942):0.10751,(SRAT:0.07907,SDEV:0.08034):0.19097):0.01946):0.00421,(SSUI:0.14105,SPLU:0.11643):0.04072,SENT:0.24812):0.00000;
(SCON:0.04143,SANG:0.04143):0.00000;
((((SEQU:0.46327,(LCRE:0.04731,LLAC:0.05130):0.14589):0.01133,((SMIT:0.02596,(SPSE:0.00706,SPNE:0.00630):0.02270):0.09694,(SCON:0.04630,SANG:0.03220):0.10110):0.05019):0.00699,SENT:0.22303):0.00778,(((STHE:0.03234,(SVES:0.00683,SSAL:0.00555):0.01695):0.12504,(SEQU:0.06542,(SINF:0.02425,SLUT:0.03307):0.02742):0.09990):0.00729,(SDOW:0.11926,(SDEV:0.03066,SRAT:0.03052):0.07748):0.05151):0.00498,SSUI:0.16731):0.00000;
(SINT:0.00624,SANG:0.00624):0.00000;
((SSAL:0.05821,(STHE:0.03818,SVES:0.03374):0.00920):0.21257,(((SCAN:0.08684,(SDYS:0.06101,SPYO:0.05238):0.04316):0.18308,((LLAC:0.04026,LCRE:0.04441):0.29051,((SRAT:0.11484,SDEV:0.11676):0.11962,(SSUI:0.22971,((SANG:0.09865,(SINT:0.06588,SCON:0.05659):0.04048):0.08508,((SMIT:0.01111,SPSE:0.01713):0.02005,SPNE:0.03793):0.11968):0.05288):0.00414):0.02273):0.04716):0.00699,(SPLU:0.21218,(SINF:0.06538,(SLUT:0.03383,SEQU:0.01880):0.03525):0.12103):0.03311):0.00581,SDOW:0.26377):0.00000;
(((((STHE:0.02391,(SVES:0.00884,SSAL:0.00778):0.00874):0.08503,SDOW:0.11369):0.02980,((SDEV:0.04826,SRAT:0.04281):0.06765,(SENT:0.15067,(((LLAC:0.03560,LCRE:0.03246):0.27590,(LCRE:0.03600,LLAC:0.02975):0.18103):0.06552,(SSUI:0.14253,((SPNE:0.01366,(SPSE:0.01520,SMIT:0.00763):0.00341):0.09365,((SCON:0.01599,SINT:0.02279):0.01998,SANG:0.03486):0.06801):0.01818):0.03127):0.01192):0.01501):0.01151):0.00783,((SINF:0.01194,SLUT:0.00880):0.01221,SEQU:0.01606):0.07399):0.00714,(SCAN:0.03289,(SPYO:0.01717,SDYS:0.01491):0.01598):0.06274,SPLU:0.08603):0.00000;
(SSAL:0.05800,(SVES:0.04797,STHE:0.05582):0.00325,(SANG:0.18867,(SLUT:0.00277,SINF:0.00552):0.21817):0.31395):0.00000;
(((((SINF:0.03071,SLUT:0.03449):0.05352,SEQU:0.08512):0.10061,(SDEV:0.05879,SRAT:0.05356):0.12067):0.02616,(SENT:0.31182,(((LLAC:0.09526,LCRE:0.09071):0.23233,((LLAC:0.02946,LCRE:0.03082):0.27842,(SSUI:0.17453,(SDYS:0.04572,SCAN:0.05885):0.12798):0.11390):0.06929):0.04538,((((STHE:0.03622,(SSAL:0.03049,SVES:0.02653):0.00697):0.12631,SDOW:0.16141):0.04272,SSUI:0.22029):0.01749,((SMIT:0.02409,SPNE:0.02690):0.17742,(SANG:0.06062,SINT:0.05628):0.13346):0.03157):0.01469):0.02127):0.02523):0.00024,(SDYS:0.13279,(SCAN:0.07607,SPYO:0.08127):0.05602):0.09681,SPLU:0.20290):0.00000;
(SRAT:0.24471,SANG:0.24471):0.00000;
(((SCAN:0.22798,SENT:0.23688):0.08110,(((SEQU:0.07920,SPYO:0.08507):0.01076,SSUI:0.08590):0.20228,((SANG:0.23574,SDOW:0.25860):0.02493,(SRAT:0.11508,SDEV:0.10972):0.16927):0.02087):0.02030):0.00997,((((SRAT:0.21313,SVES:0.23131):0.15143,((SPSE:0.01027,SPNE:0.02264):0.33732,(SDEV:0.16489,(SENT:0.13729,(SDOW:0.10936,SSUI:0.11407):0.01933):0.03058):0.17978):0.01473):0.01192,((((SPYO:0.08562,(SCAN:0.04907,SDYS:0.05491):0.02868):0.26097,(((SDOW:0.19097,(SEQU:0.07322,(SLUT:0.04894,SINF:0.04986):0.02628):0.10511):0.06812,(SSAL:0.18777,((SANG:0.05672,(SINT:0.04612,SCON:0.04068):0.01585):0.11898,(SDEV:0.06089,SRAT:0.06377):0.11783):0.01586):0.08033):0.06178,SEQU:0.35325):0.05043):0.02759,(LCRE:0.30349,SPSE:0.34043):0.06316):0.01463,(SDEV:0.33885,SRAT:0.31428):0.07247):0.01340):0.01302,((SMIT:0.17721,((SVES:0.01350,SSAL:0.01417):0.14949,(SANG:0.03879,SINT:0.03562):0.11608):0.01155):0.13500,(SPYO:0.20168,SPLU:0.17875):0.11769):0.03556):0.00794,SINT:0.35761):0.00000;
((SINT:0.04839,SANG:0.05699):0.02614,SCON:0.08119,(SDOW:0.31750,(SRAT:0.07572,SDEV:0.06401):0.09221):0.15434):0.00000;
((SANG:0.04342,SCON:0.05943):0.02521,SINT:0.09667,(((SPLU:0.04501,SSUI:0.04978):0.11135,SENT:0.19092):0.07829,SINF:0.23181):0.13542):0.00000;
(SVES:0.16423,SANG:0.16423):0.00000;
(SVES:0.16873,SANG:0.16873):0.00000;
(SVES:0.31795,SANG:0.31795):0.00000;
(((SDEV:0.08864,SRAT:0.05931):0.11752,((SPYO:0.12679,(SCAN:0.06076,SDYS:0.07114):0.03431):0.09712,(SPLU:0.17609,(SENT:0.24112,(((LLAC:0.00299,LCRE:0.00299):0.25926,(SPNE:0.03245,(SPSE:0.01403,SMIT:0.01463):0.01829):0.22688):0.01744,(SSUI:0.23370,((SANG:0.02235,SCON:0.02561):0.07166,SINT:0.09335):0.13289):0.00844):0.02479):0.00965):0.01392):0.01178):0.00264,((STHE:0.02778,(SSAL:0.00751,SVES:0.00776):0.00985):0.17586,SDOW:0.22730):0.01140,((SINF:0.00238,SLUT:0.00178):0.01648,SEQU:0.01571):0.14608):0.00000;
((SDOW:0.36492,(SDEV:0.22191,SANG:0.18967):0.13283):0.06782,SRAT:0.34069,LCRE:0.34448):0.00000;
(((SPYO:0.15580,(SDYS:0.10319,SCAN:0.08891):0.02856):0.07699,(((SSAL:0.01843,STHE:0.01917):0.10145,SDOW:0.10438):0.07536,(SSUI:0.11210,((SMIT:0.16987,SANG:0.13650):0.01904,(SPSE:0.00897,SPNE:0.00775):0.12956):0.01597):0.02559):0.01936):0.00310,((SDEV:0.03325,SRAT:0.03448):0.08999,((SINF:0.00853,SLUT:0.00534):0.03145,SEQU:0.04339):0.08203):0.01176,(SPLU:0.18727,SENT:0.13928):0.00591):0.00000;
(SINT:0.06034,SANG:0.06034):0.00000;
(SANG:0.09222,SCON:0.00169,SINT:0.02090):0.00000;
((((SPLU:0.07396,((SSAL:0.02657,(STHE:0.03329,SVES:0.02178):0.01028):0.04616,(SINF:0.02170,(SLUT:0.00909,SEQU:0.01031):0.00302):0.04250):0.01907):0.01038,(SCAN:0.01377,(SPYO:0.02058,SDYS:0.02040):0.00804):0.10362):0.00846,(((LCRE:0.04028,LLAC:0.05589):0.12666,SSUI:0.16522):0.03404,((SPSE:0.01492,(SMIT:0.01718,SPNE:0.01519):0.00740):0.05172,((SINT:0.03064,SCON:0.02936):0.01427,SANG:0.03972):0.04506):0.02917):0.01692):0.00519,(SDOW:0.08946,(SDEV:0.05380,SRAT:0.04385):0.04263):0.00652,SENT:0.13004):0.00000;
(SCON:0.03373,SANG:0.03373):0.00000;
(SANG:0.01846,SCON:0.05561,SINT:0.01703):0.00000;
((SANG:0.21284,SPLU:0.20010):0.16470,SENT:0.22162,SCAN:0.18365):0.00000;
(SANG:0.02815,(SINT:0.00874,SCON:0.01427):0.01770,(SEQU:0.16941,(SDEV:0.03307,SRAT:0.04358):0.13770):0.24318):0.00000;
(SDOW:0.17551,SANG:0.17551):0.00000;
(SCON:0.00117,SANG:0.00117):0.00000;
(((SINF:0.03879,SLUT:0.06727):0.12211,(SANG:0.08642,SANG:0.08726):0.37726):0.20695,(SINT:0.00858,SCON:0.00621):0.01365,SANG:0.01685):0.00000;
((SANG:0.09355,SCON:0.05658):0.32670,(SDYS:0.22065,SENT:0.18422):0.05972,SPLU:0.21897):0.00000;
(SANG:0.17227,SCON:0.09878,SINT:0.22799):0.00000;
(SANG:0.02523,SINT:0.02109,SDOW:0.47341):0.00000;
((SANG:0.21758,(SSUI:0.10365,(SSUI:0.08639,(SPLU:0.00000,SDYS:0.00000):0.09525):0.06722):0.06285):0.04617,SENT:0.37737,((SMIT:0.01173,SPNE:0.01453):0.01307,SVES:0.06094):0.26535):0.00000;
((SMIT:0.01761,(((SENT:0.37820,((SCAN:0.09165,(SPLU:0.04111,(SSUI:0.04161,(SSUI:0.03379,SDYS:0.05065):0.01070):0.00889):0.03312):0.21736,SANG:0.30895):0.03388):0.26232,SPNE:0.03841):0.02057,SPNE:0.05490):0.00638):0.00260,SPNE:0.02637,SVES:0.02448):0.00000;
(((SINF:0.00002,(SLUT:0.00000,SEQU:0.00000):0.00357):0.01181,((((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.00523,((SANG:0.00154,SINT:0.00743):0.00195,SCON:0.00792):0.00330):0.00524,(SDEV:0.00374,SRAT:0.00075):0.00532):0.00895,SDOW:0.01004):0.00134):0.00099,((SPLU:0.01856,SENT:0.02468):0.00312,(SPYO:0.00672,(SCAN:0.00000,SDYS:0.00000):0.00225):0.00355):0.00323,((LCRE:0.00000,LLAC:0.00000):0.07030,((STHE:0.00888,(SSAL:0.00000,SVES:0.00000):0.00013):0.00785,SSUI:0.02732):0.00193):0.00506):0.00000;
(((((STHE:0.00112,(SSAL:0.00068,SVES:0.00072):0.00306):0.00204,(SINF:0.00478,(SLUT:0.00321,SEQU:0.00027):0.00428):0.01555):0.00660,(SPLU:0.01820,((((SINT:0.00323,(SANG:0.00065,SCON:0.00004):0.00024):0.01781,((SPSE:0.00035,(SMIT:0.00000,SPNE:0.00000):0.00314):0.01019,SSUI:0.00515):0.00675):0.00263,(SDEV:0.00807,SRAT:0.01689):0.01714):0.00886,(((LCRE:0.00863,LLAC:0.00337):0.11615,SENT:0.04822):0.00595,SDOW:0.01858):0.01295):0.00299):0.00321):0.00412,SDYS:0.00000):0.00000,SPYO:0.00000,SCAN:0.00000):0.00000;
((((((SANG:0.00000,(SINT:0.00000,SCON:0.00000):0.00000):0.03017,(((SPSE:0.00190,(SMIT:0.00000,SPNE:0.00000):0.00000):0.01849,SSUI:0.00807):0.00564,(SPLU:0.01752,((LCRE:0.00338,LLAC:0.00044):0.11652,SENT:0.02122):0.00600):0.00157):0.00427):0.00790,((SRAT:0.01429,(SDEV:0.01142,SDOW:0.01507):0.00323):0.00474,(SPYO:0.00000,SDYS:0.00000):0.01706):0.00572):0.00284,SCAN:0.00463):0.00146,(SINF:0.00040,(SLUT:0.00404,SEQU:0.00069):0.00244):0.00483):0.00212,(SSAL:0.00000,SVES:0.00000):0.00093,STHE:0.00570):0.00000;
((SDEV:0.02307,SRAT:0.02173):0.07027,((((SANG:0.05294,(SINT:0.00669,SCON:0.00889):0.05839):0.03332,((SPSE:0.02430,(SMIT:0.01648,SPNE:0.02388):0.00234):0.03947,(SSUI:0.01500,SPLU:0.00835):0.06286):0.01185):0.03572,((LCRE:0.03712,LLAC:0.03980):0.20676,SDYS:0.14491):0.01494):0.00671,(SENT:0.14184,SDOW:0.10906):0.00818):0.00582,((STHE:0.02210,(SSAL:0.00340,SVES:0.00418):0.00936):0.05305,((SINF:0.00968,SLUT:0.01522):0.01729,SEQU:0.02144):0.04896):0.01234):0.00000;
(SSUI:0.04961,(SPLU:0.05399,((STHE:0.00903,(SSAL:0.00960,SVES:0.00334):0.00388):0.04148,SDOW:0.06471):0.00284):0.00484,(((LCRE:0.00207,LLAC:0.00382):0.12002,SENT:0.06401):0.02125,((((SMIT:0.00700,SPSE:0.00335):0.00112,SPNE:0.00681):0.02292,(SANG:0.00913,(SINT:0.00438,SCON:0.00334):0.01256):0.02846):0.00560,((((SINF:0.00408,SLUT:0.00419):0.00429,SEQU:0.00488):0.03026,(SPYO:0.05786,(SCAN:0.02010,SDYS:0.01063):0.01173):0.02457):0.00807,(SDEV:0.01081,SRAT:0.01100):0.03076):0.00572):0.00445):0.00281):0.00000;
(((((STHE:0.00000,SSAL:0.00000):0.00332,SVES:0.00430):0.00588,(((SINT:0.01177,SCON:0.01698):0.00518,SRAT:0.01215):0.01038,(((((LCRE:0.00847,LLAC:0.00993):0.12059,(SSUI:0.00376,SPLU:0.00301):0.03442):0.01784,((SCAN:0.02534,SPYO:0.02226):0.00300,(SENT:0.02528,SDYS:0.01878):0.01252):0.00306):0.00291,(((SINF:0.00160,SLUT:0.00334):0.00078,SEQU:0.00124):0.02751,SDEV:0.02455):0.00691):0.00335,SDOW:0.01558):0.00619):0.00600):0.00591,SANG:0.00955):0.00107,(SPSE:0.00170,SPNE:0.00188):0.00573,SMIT:0.00573):0.00000;
(SDEV:0.43499,SRAT:0.09784,SINT:0.10901):0.00000;
(((SPYO:0.06969,((SINT:0.03337,SCON:0.03129):0.01288,SRAT:0.04529):0.01040):0.00791,(((STHE:0.02234,(SSAL:0.00719,SVES:0.00954):0.00467):0.01906,(SMIT:0.01344,(SPSE:0.00872,SPNE:0.01403):0.01311):0.02854):0.01862,(SDEV:0.07217,SDOW:0.05455):0.00881):0.00357):0.00191,(SENT:0.05958,((SSUI:0.03840,SPLU:0.01126):0.07958,(((LLAC:0.03808,LCRE:0.04082):0.27122,SANG:0.12845):0.01911,(SCAN:0.09046,SDYS:0.07603):0.00705):0.00622):0.00859):0.00407,((SINF:0.01182,SLUT:0.01126):0.01289,SEQU:0.01712):0.05528):0.00000;
(SDEV:0.04239,SRAT:0.04239):0.00000;
(((SANG:0.01934,((SINF:0.00997,SLUT:0.01000):0.00500,SEQU:0.01094):0.00727):0.01312,SRAT:0.03025):0.02184,(((SINT:0.01312,SCON:0.01136):0.03772,SPYO:0.04285):0.00968,((SCAN:0.06484,SDYS:0.06616):0.01177,((((SSUI:0.02223,SPLU:0.02256):0.06095,SENT:0.15182):0.00525,SDEV:0.07613):0.00156,SDOW:0.08534):0.00758):0.00529):0.00162,((STHE:0.02246,(SSAL:0.00547,SVES:0.01385):0.00456):0.01524,(SMIT:0.01351,(SPSE:0.01249,SPNE:0.01495):0.00396):0.02701):0.02415):0.00000;
(((SDEV:0.00873,SRAT:0.01530):0.07794,(SPLU:0.08037,((STHE:0.01515,(SSAL:0.00193,SVES:0.00731):0.00414):0.03826,SDOW:0.08895):0.00419):0.00947):0.00276,(((SINF:0.01200,SLUT:0.01679):0.01155,SEQU:0.01966):0.06039,((SCAN:0.01261,SPYO:0.03525):0.01381,SDYS:0.03125):0.04833):0.00625,((SANG:0.01694,(SINT:0.00142,SCON:0.00366):0.01268):0.06665,((SMIT:0.02117,(SPSE:0.00081,SPNE:0.00004):0.02516):0.08924,((((LLAC:0.11927,LCRE:0.14724):0.23831,((SCON:0.00618,SANG:0.00726):0.37497,SEQU:0.31332):0.02270):0.12664,(LCRE:0.02195,LLAC:0.01540):0.09413):0.01596,(SSUI:0.08178,SENT:0.07705):0.02056):0.00682):0.00474):0.01363):0.00000;
((((((LCRE:0.01434,LLAC:0.01030):0.22719,(((SMIT:0.01041,(SPSE:0.00000,SPNE:0.00000):0.00752):0.02140,(SANG:0.00325,(SINT:0.00000,SCON:0.00000):0.00694):0.00921):0.02228,SSUI:0.04338):0.02326):0.02309,SENT:0.13688):0.00545,(SDEV:0.01457,SRAT:0.00728):0.05013):0.00797,SDOW:0.04531):0.01026,(SPLU:0.05049,((SINF:0.00872,(SLUT:0.00171,SEQU:0.00211):0.00658):0.02773,(SCAN:0.00658,(SPYO:0.00249,SDYS:0.00006):0.00358):0.04159):0.00433):0.00429,(SSAL:0.01200,(STHE:0.00839,SVES:0.00190):0.00336):0.05112):0.00000;
(((SSAL:0.02307,(STHE:0.01025,SVES:0.00870):0.03167):0.03831,(SDEV:0.00147,SRAT:0.00483):0.07402):0.01287,((SPYO:0.05544,(SCAN:0.03872,SDYS:0.03090):0.01017):0.05139,(((SINF:0.00779,SLUT:0.00066):0.05794,SEQU:0.02836):0.01350,SDOW:0.06702):0.00798):0.00664,((((SMIT:0.01323,(SPSE:0.00948,SPNE:0.00107):0.00351):0.06187,(SINT:0.02685,(SANG:0.01105,SCON:0.01211):0.02145):0.02975):0.10516,SSUI:0.17473):0.01104,(SPLU:0.12715,((LLAC:0.06053,LCRE:0.04654):0.24095,SENT:0.16199):0.00537):0.03406):0.02736):0.00000;
(((((LLAC:0.01077,LCRE:0.01097):0.28285,SSUI:0.12295):0.03873,((SANG:0.01749,(SINT:0.00758,SCON:0.00392):0.00823):0.10740,SENT:0.13370):0.00774):0.02117,(((SSAL:0.02127,(STHE:0.03830,SVES:0.01826):0.01323):0.04645,((SCAN:0.00604,SPYO:0.00938):0.01837,SDYS:0.01694):0.07425):0.02710,(SPLU:0.14414,(SDEV:0.00380,SRAT:0.00932):0.08096):0.01198):0.00418):0.00417,SDOW:0.11548,((SINF:0.01273,SLUT:0.01352):0.01697,SEQU:0.01698):0.09013):0.00000;
((SPLU:0.14406,(SRAT:0.03139,SDEV:0.01768):0.06915):0.01170,((SCAN:0.03398,(SPYO:0.03221,SDYS:0.02127):0.00556):0.08381,((SLUT:0.00150,SINF:0.00465):0.01741,SEQU:0.03127):0.08251):0.01753,((SSAL:0.03495,(STHE:0.00799,SVES:0.00719):0.01634):0.13138,(SDOW:0.17989,(((LLAC:0.01537,LCRE:0.01496):0.29098,SSUI:0.20751):0.01198,((SMIT:0.01271,(SPSE:0.00427,SPNE:0.00291):0.00700):0.17719,(SANG:0.01991,(SINT:0.01686,SCON:0.00742):0.01250):0.12924):0.01089):0.05800):0.01275):0.01208):0.00000;
((((SSAL:0.01459,(STHE:0.01295,SVES:0.00786):0.00902):0.06005,(SPYO:0.11579,(SCAN:0.03577,SDYS:0.03544):0.05313):0.00703):0.01075,(SSUI:0.08850,((SPLU:0.10218,((SINF:0.00532,SLUT:0.00496):0.01558,SEQU:0.01579):0.08133):0.01327,(SDEV:0.03994,SRAT:0.05256):0.06158):0.00327):0.00885):0.00788,(((LLAC:0.01864,LCRE:0.01183):0.19100,(SPSE:0.01416,(SMIT:0.00089,SPNE:0.00024):0.01168):0.06293):0.00521,SDOW:0.11221):0.00240,((SANG:0.04128,(SINT:0.03502,SCON:0.02783):0.02240):0.05169,SENT:0.10951):0.01253):0.00000;
(SDOW:0.16950,SDEV:0.17401,SRAT:0.55229):0.00000;
(((((((SLUT:0.01109,(SINF:0.00192,SEQU:0.00000):0.00043):0.01188,((((SMIT:0.00006,(SPSE:0.00000,SPNE:0.00000):0.00185):0.01782,SSUI:0.01271):0.00312,(((SANG:0.00000,SINT:0.00000):0.00169,SCON:0.00021):0.01841,SENT:0.03492):0.01198):0.01042,(SRAT:0.01883,((LCRE:0.00000,LLAC:0.00000):0.12846,SDOW:0.06400):0.02798):0.01265):0.01264):0.00355,SDEV:0.01955):0.01102,(SCAN:0.00000,(SPYO:0.00000,SDYS:0.00000):0.00000):0.00614):0.01073,SPLU:0.01079):0.00068,SVES:0.00000):0.00000,SSAL:0.00000,STHE:0.00000):0.00000;
((((SINF:0.00000,(SLUT:0.00000,SEQU:0.00000):0.00000):0.01180,((SINT:0.00017,(SANG:0.00000,SCON:0.00000):0.00184):0.00367,((((STHE:0.00000,(SSAL:0.00000,SVES:0.00000):0.00000):0.00863,(SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.01368):0.00646,SPLU:0.01078):0.00474,((SSUI:0.05382,((LCRE:0.00000,LLAC:0.00000):0.10005,SENT:0.06837):0.00755):0.00457,((SDEV:0.00424,SRAT:0.02576):0.00912,SDOW:0.03688):0.00777):0.00779):0.00285):0.00422):0.00232,SDYS:0.00000):0.00000,SPYO:0.00000,SCAN:0.00000):0.00000;
(SDOW:0.31177,SRAT:0.31177):0.00000;
(((SDEV:0.02860,SRAT:0.01775):0.06252,((((SINF:0.00108,SLUT:0.00009):0.00699,SEQU:0.01279):0.02705,((SCAN:0.02413,SPYO:0.01899):0.00580,SDYS:0.02815):0.02764):0.01518,SDOW:0.06980):0.01426):0.00051,((LCRE:0.00699,LLAC:0.00225):0.14254,(((SSAL:0.01233,(STHE:0.00667,SVES:0.00382):0.00984):0.10635,((SMIT:0.00496,SPSE:0.00090):0.00602,SPNE:0.01271):0.09765):0.00481,SENT:0.12735):0.00483):0.01208,(SSUI:0.07828,((SANG:0.00801,(SINT:0.00000,SCON:0.00000):0.02109):0.06535,SPLU:0.10736):0.00795):0.00487):0.00000;
(((SANG:0.05071,(SINT:0.00524,SCON:0.00992):0.02915):0.00678,(((STHE:0.00614,(SSAL:0.00161,SVES:0.00119):0.00301):0.02817,((SINF:0.00926,SLUT:0.00828):0.00444,SEQU:0.01172):0.02833):0.00244,(SDEV:0.01818,SRAT:0.01742):0.02529):0.00428):0.00321,((SSUI:0.05420,(((LCRE:0.01369,LLAC:0.01793):0.12289,SENT:0.10954):0.00683,(SPYO:0.06672,(SCAN:0.05838,SDYS:0.05104):0.00686):0.02523):0.00516):0.00756,SDOW:0.05475):0.00215,((SMIT:0.00478,SPSE:0.00476):0.00116,SPNE:0.01185):0.04167):0.00000;
(((SDEV:0.01620,SRAT:0.01585):0.02992,(((SMIT:0.00000,SPSE:0.00000):0.00735,SPNE:0.00357):0.03471,(((SANG:0.00208,SINT:0.00877):0.00716,SCON:0.01239):0.00563,SDOW:0.03804):0.00940):0.00364):0.00359,((SSUI:0.03927,SENT:0.03091):0.01697,(SPLU:0.02264,(SPYO:0.00763,(SCAN:0.01238,SDYS:0.00287):0.00982):0.01428):0.00765):0.00670,((LCRE:0.00915,LLAC:0.01716):0.03952,(((STHE:0.00000,(SSAL:0.00000,SVES:0.00000):0.00000):0.00757,(SINF:0.03087,SLUT:0.00616):0.00989):0.00648,SEQU:0.00879):0.00981):0.00388):0.00000;
(((SPLU:0.04748,SENT:0.05499):0.00795,(((SANG:0.02361,(SINT:0.00393,SCON:0.00504):0.00542):0.05773,(SDEV:0.07571,SRAT:0.05264):0.01599):0.01931,(SSUI:0.04197,(((SMIT:0.00569,SPSE:0.00439):0.00564,SPNE:0.01174):0.04101,((SCAN:0.02930,(SPYO:0.02507,SDYS:0.00741):0.00205):0.07260,SDOW:0.11005):0.00766):0.02809):0.00435):0.00496):0.00307,((SINF:0.01286,SLUT:0.02422):0.00394,SEQU:0.01788):0.03120,((LCRE:0.03345,LLAC:0.03262):0.14631,(SSAL:0.00085,(STHE:0.00156,SVES:0.00626):0.00473):0.07053):0.00909):0.00000;
(((SDEV:0.02190,SRAT:0.02078):0.05048,((SSAL:0.00665,(STHE:0.01294,SVES:0.00609):0.00254):0.04955,SDOW:0.06389):0.00691):0.00847,(((SSUI:0.09701,SPLU:0.08903):0.00468,SENT:0.11361):0.00352,((((SMIT:0.01528,SPSE:0.02225):0.00339,SPNE:0.01868):0.04635,(SINT:0.01360,(SANG:0.01442,SCON:0.01112):0.00346):0.06845):0.05166,(((LLAC:0.04396,LCRE:0.03824):0.23444,(SDEV:0.36697,(SRAT:0.04626,SDEV:0.05985):0.31965):0.05597):0.13199,((SCAN:0.03824,SPYO:0.03627):0.01867,SDYS:0.05363):0.05165):0.00957):0.01508):0.00125,((SINF:0.00940,SLUT:0.01354):0.01266,SEQU:0.02406):0.06593):0.00000;
(SRAT:0.34363,SDOW:0.24183,SDEV:0.27372):0.00000;
((SSAL:0.00532,((((SDEV:0.02150,SRAT:0.04360):0.04431,SDOW:0.09975):0.01832,SEQU:0.12764):0.02549,(SMIT:0.01315,SPSE:0.01233):0.02312):0.02419):0.00103,SVES:0.00741,STHE:0.02133):0.00000;
(LCRE:0.46954,SRAT:0.21548,SDEV:0.22787):0.00000;
(((SDEV:0.02429,SRAT:0.02689):0.00899,SDOW:0.05927):0.00497,(SENT:0.05570,((SINF:0.01651,(SLUT:0.00447,SEQU:0.00122):0.00768):0.03725,((LLAC:0.00932,LCRE:0.00793):0.20414,((SSUI:0.03081,SPLU:0.02871):0.03821,(SCAN:0.00803,(SPYO:0.01072,SDYS:0.00626):0.00306):0.04413):0.01128):0.01941):0.00936):0.00958,((SSAL:0.02686,(STHE:0.01312,SVES:0.00480):0.01535):0.02148,(SPSE:0.00307,(SMIT:0.00345,SPNE:0.00034):0.00356):0.01640):0.01114):0.00000;
(((SPLU:0.12450,((SSAL:0.02374,(STHE:0.01405,SVES:0.01682):0.01418):0.08754,(SINF:0.00743,(SLUT:0.00435,SEQU:0.00425):0.00404):0.09020):0.00438):0.00630,(((((SMIT:0.00866,(SPSE:0.00464,SPNE:0.00853):0.00369):0.07269,(SANG:0.02803,(SINT:0.01324,SCON:0.01575):0.00800):0.06235):0.02068,SSUI:0.10982):0.01000,SENT:0.13825):0.00326,(((LLAC:0.01111,LCRE:0.01356):0.16925,((SPLU:0.17922,((SCAN:0.03232,(SPYO:0.01643,SDYS:0.02050):0.00499):0.16156,(SPNE:0.14605,((SANG:0.01988,SCON:0.01664):0.02647,SINT:0.04898):0.07774):0.03741):0.00793):0.24518,SINT:0.32421):0.12085):0.02669,(SRAT:0.02004,SDEV:0.02289):0.12232):0.00758):0.01341):0.00266,SDOW:0.12897,((SPYO:0.01198,SDYS:0.01080):0.00781,SCAN:0.01783):0.09918):0.00000;
(SCAN:0.31366,SRAT:0.31366):0.00000;
((SPLU:0.06644,SRAT:0.08532):0.00957,((SSAL:0.00907,SVES:0.01355):0.08210,(SMIT:0.09493,(SCAN:0.05496,SDYS:0.03272):0.07904):0.02264):0.00945,(SSUI:0.06487,((SINF:0.00577,(SLUT:0.00000,SEQU:0.00000):0.00436):0.06056,((LCRE:0.02195,LLAC:0.01898):0.12778,SDOW:0.08037):0.01419):0.00705):0.00827):0.00000;
(SDEV:0.05365,SRAT:0.05365):0.00000;
(((SRAT:0.04168,SDEV:0.03984):0.08240,((SMIT:0.09431,SCON:0.10206):0.04963,(SPYO:0.01818,SDYS:0.01338):0.11855):0.04321):0.01413,SPLU:0.15712,SDOW:0.24252):0.00000;
((((SDEV:0.02031,SRAT:0.02389):0.02512,SDOW:0.05586):0.00929,(SPYO:0.02770,SDYS:0.01322):0.03857):0.00894,((SMIT:0.05403,SCON:0.03258):0.02201,SPLU:0.08408):0.00315,(((SSAL:0.00795,(STHE:0.00087,SVES:0.00166):0.00375):0.06352,SANG:0.06106):0.01276,(SINF:0.00000,SLUT:0.00000):0.07026):0.53356):0.00000;
((SDEV:0.03232,SRAT:0.02362):0.05356,(((SINF:0.02592,(SLUT:0.00955,SEQU:0.00409):0.01688):0.04259,(SCAN:0.01892,(SPYO:0.01216,SDYS:0.01422):0.00686):0.06321):0.01885,SDOW:0.11603):0.00177,((STHE:0.01801,(SSAL:0.00975,SVES:0.01395):0.00825):0.10316,((((SMIT:0.01645,(SPSE:0.00812,SPNE:0.01833):0.00280):0.07062,(SINT:0.06021,(SANG:0.03029,SCON:0.03708):0.01489):0.04684):0.03149,SPLU:0.11963):0.00636,((LCRE:0.01224,LLAC:0.00978):0.15838,(SSUI:0.09290,SENT:0.14783):0.01279):0.00952):0.02118):0.01057):0.00000;
(((SDOW:0.12745,((SLUT:0.03370,SINF:0.02892):0.11725,(SRAT:0.03026,SDEV:0.03197):0.43186):0.01304):0.01025,((SDEV:0.05998,SRAT:0.05399):0.04227,((SPYO:0.00723,SDYS:0.01145):0.00292,SCAN:0.01366):0.09084):0.02508):0.00891,(SENT:0.08398,(SSUI:0.02904,SPLU:0.02746):0.04908):0.03336,(STHE:0.02815,(SSAL:0.02499,SVES:0.01659):0.01485):0.06469):0.00000;
(((SRAT:0.03067,SDEV:0.03659):0.17275,(((SINF:0.01231,SLUT:0.01254):0.04979,SEQU:0.05570):0.11184,(SPYO:0.04021,(SCAN:0.02400,SDYS:0.02985):0.01046):0.14792):0.03699):0.01029,(SPLU:0.24054,SENT:0.21907):0.02980,(((LLAC:0.03045,LCRE:0.03995):0.32118,SDOW:0.25857):0.01485,(SSAL:0.02908,(SVES:0.02067,STHE:0.03572):0.00827):0.22608):0.02397):0.00000;
((((((SSAL:0.00640,(STHE:0.01634,SVES:0.00712):0.00275):0.03514,((SINF:0.00918,SLUT:0.00738):0.00947,SEQU:0.01554):0.03589):0.00417,(SDEV:0.01929,SRAT:0.02833):0.05362):0.00532,SDOW:0.06156):0.01330,(SCAN:0.05229,(SPYO:0.04818,SDYS:0.03606):0.00658):0.06374):0.00246,(((LLAC:0.00763,LCRE:0.00448):0.18456,SSUI:0.10031):0.00495,(((SMIT:0.01305,(SPSE:0.00868,SPNE:0.01216):0.00325):0.10835,(SANG:0.03638,(SINT:0.03822,SCON:0.03283):0.01508):0.04576):0.03279,SENT:0.13812):0.00674):0.00535,SPLU:0.08979):0.00000;
((((((SMIT:0.00258,SPSE:0.00590):0.00784,SPNE:0.00037):0.04888,(SANG:0.01078,(SINT:0.01035,SCON:0.00863):0.00681):0.02305):0.06234,SSUI:0.11295):0.01465,(((SPSE:0.00673,SMIT:0.00915):0.19445,(SSUI:0.11872,SENT:0.11694):0.03937):0.21460,SENT:0.11512):0.02045):0.00516,((SPLU:0.13308,((STHE:0.01854,(SSAL:0.00509,SVES:0.00481):0.00938):0.07724,(((SINF:0.00836,SLUT:0.00646):0.00956,SEQU:0.01197):0.05371,(SPYO:0.05814,(SCAN:0.03754,SDYS:0.02676):0.01679):0.05744):0.00668):0.01022):0.01439,SDOW:0.10603):0.00474,(SDEV:0.01589,SRAT:0.00468):0.07479):0.00000;
((STHE:0.02967,(SSAL:0.00751,SVES:0.00514):0.02494):0.07128,((SCAN:0.01219,(SPYO:0.00619,SDYS:0.00492):0.00513):0.07599,(SDEV:0.01868,SRAT:0.01526):0.06525):0.02220,((SMIT:0.09105,((SANG:0.01322,SINT:0.01776):0.00386,SCON:0.01985):0.05160):0.03630,(((((LLAC:0.02014,LCRE:0.02417):0.23814,(LLAC:0.00990,LCRE:0.01015):0.24251):0.09600,((SSUI:0.13161,(SDOW:0.07762,((STHE:0.01987,(SSAL:0.00931,SVES:0.00935):0.00412):0.04171,((SINF:0.02271,SEQU:0.02273):0.01808,(SDEV:0.01887,SRAT:0.02422):0.02990):0.01613):0.01722):0.04752):0.17768,((LLAC:0.00362,LCRE:0.00403):0.12997,(LLAC:0.00378,LCRE:0.00438):0.14526):0.15588):0.05405):0.14929,((LLAC:0.02264,LCRE:0.02377):0.15542,(LCRE:0.01380,LLAC:0.01206):0.15210):0.07186):0.09598,SDOW:0.14940):0.02362):0.00522):0.00000;
((((LCRE:0.02080,LLAC:0.01893):0.03746,((SINF:0.00732,SLUT:0.00347):0.00662,SEQU:0.01364):0.03323):0.00485,(SPNE:0.04665,((SRAT:0.01018,SDOW:0.00807):0.00644,SDEV:0.01281):0.02288):0.00221):0.00112,(((STHE:0.01235,(SSAL:0.00151,SVES:0.00121):0.00158):0.02598,((SSUI:0.00663,SPLU:0.00760):0.00975,SENT:0.02617):0.00794):0.00750,(SCAN:0.00897,(SPYO:0.00217,SDYS:0.00259):0.00086):0.03329):0.00665,(SINT:0.00875,(SANG:0.00603,SCON:0.00742):0.00337):0.03381):0.00000;
((((SINT:0.00872,(SANG:0.00724,SCON:0.01176):0.00282):0.03655,(SSUI:0.02005,SPLU:0.02582):0.01663):0.00203,(((STHE:0.02844,(SSAL:0.00022,SVES:0.00364):0.01079):0.02740,((SINF:0.00220,SLUT:0.00939):0.00517,SEQU:0.01219):0.03102):0.01201,((SDEV:0.01375,SRAT:0.00994):0.02340,SDOW:0.03917):0.00815):0.01131):0.00180,(SENT:0.06969,((LLAC:0.02175,LCRE:0.01267):0.13396,((SCAN:0.02704,SPYO:0.03797):0.00861,(SPYO:0.01534,SDYS:0.00772):0.02487):0.03056):0.00651):0.00858,((SMIT:0.01870,SPSE:0.02798):0.00945,SPNE:0.03221):0.01804):0.00000;
((((SINF:0.00865,SLUT:0.00864):0.03489,SEQU:0.04534):0.12246,(SDEV:0.03535,SRAT:0.04660):0.09596):0.02538,(((SSUI:0.25996,((LLAC:0.03491,LCRE:0.03029):0.30510,((SPNE:0.02000,(SMIT:0.01738,SPSE:0.01878):0.00505):0.16897,((SINT:0.03826,SCON:0.03398):0.01412,SANG:0.04020):0.12340):0.07919):0.00923):0.01826,((SENT:0.29786,SPLU:0.23744):0.02393,(SPYO:0.12524,(SCAN:0.07352,SDYS:0.06618):0.06751):0.11441):0.00876):0.01048,SDOW:0.24095):0.00315,(STHE:0.02946,(SSAL:0.00410,SVES:0.00552):0.02578):0.20816):0.00000;
(SDEV:0.04984,SRAT:0.04984):0.00000;
(SRAT:0.25881,SDOW:0.29331,(LLAC:0.38574,(LCRE:0.17948,(LCRE:0.03485,LLAC:0.03452):0.13296):0.18252):0.01740):0.00000;
((SPYO:0.04988,((SSUI:0.02959,SPLU:0.01011):0.05285,((SPNE:0.08549,(SINT:0.03446,SCON:0.02151):0.04042):0.08048,(SRAT:0.00953,SDEV:0.00892):0.10703):0.00490):0.05217):0.00467,SDYS:0.03945,SCAN:0.02888):0.00000;
(SDYS:0.52415,SRAT:0.02852,SDEV:0.01878):0.00000;
((((STHE:0.00487,(SSAL:0.00223,SVES:0.00406):0.00142):0.02450,((SDEV:0.00908,SRAT:0.01197):0.01698,(((SINF:0.00202,SLUT:0.00335):0.00123,SEQU:0.00324):0.01508,SDOW:0.02993):0.01368):0.00306):0.00979,(((SMIT:0.00114,(SPSE:0.00346,SPNE:0.00377):0.00067):0.01341,(SANG:0.00791,(SINT:0.00653,SCON:0.00962):0.00714):0.00846):0.01562,(SPLU:0.01666,((SCAN:0.00445,SPYO:0.00230):0.00041,SDYS:0.00117):0.01310):0.00730):0.00558):0.00157,(SSUI:0.03986,SENT:0.09476):0.00405,(LCRE:0.00339,LLAC:0.00247):0.08925):0.00000;
(SDOW:0.26192,SRAT:0.26192):0.00000;
((SSAL:0.01151,(SVES:0.01644,((LLAC:0.00212,LCRE:0.00366):0.34230,((SSUI:0.01011,SPLU:0.01330):0.10208,(SRAT:0.04614,SDEV:0.03071):0.08523):0.01713):0.10692):0.00894):0.00330,SINF:0.02653,STHE:0.02090):0.00000;
(SSAL:0.24749,SRAT:0.24749):0.00000;
((((((SMIT:0.00228,(SPSE:0.00151,SPNE:0.00459):0.00154):0.02318,(SPYO:0.00307,(SCAN:0.00507,SDYS:0.00114):0.00119):0.01773):0.00848,((SINF:0.00948,(SLUT:0.00853,SEQU:0.00306):0.00174):0.02587,((SANG:0.00290,(SINT:0.00533,SCON:0.00378):0.00318):0.03323,(SDEV:0.00021,SRAT:0.00283):0.02337):0.01169):0.00388):0.00739,((STHE:0.00851,(SSAL:0.00000,SVES:0.00000):0.00159):0.03311,SDOW:0.03987):0.01110):0.00385,(SSUI:0.02222,SENT:0.02092):0.01900):0.00309,SPLU:0.03570,(LCRE:0.00000,LLAC:0.00000):0.12839):0.00000;
(SDEV:0.20795,SRAT:0.20795):0.00000;
(((SENT:0.11144,((LCRE:0.00636,LLAC:0.00571):0.16552,(SSUI:0.09819,((SINT:0.01392,(SCON:0.01282,SANG:0.00874):0.00449):0.02677,(SMIT:0.00470,(SPNE:0.00891,SPSE:0.00937):0.00327):0.03882):0.03415):0.01440):0.01799):0.01406,(SDEV:0.00313,SRAT:0.00625):0.06250):0.00262,((STHE:0.01581,(SSAL:0.00380,SVES:0.00512):0.00569):0.04959,SDOW:0.06953):0.00183,(SPLU:0.07850,(((SINF:0.00220,SLUT:0.00227):0.00811,SEQU:0.00941):0.03267,(SPYO:0.02270,(SCAN:0.00694,SDYS:0.00540):0.01052):0.03399):0.00675):0.01031):0.00000;
(SDEV:0.16047,SRAT:0.16047):0.00000;
(((SRAT:0.07004,SDEV:0.09850):0.12741,(SENT:0.27021,SDOW:0.24671):0.02876):0.00388,((SPSE:0.03507,SPNE:0.04497):0.01193,SMIT:0.04657):0.16813,(SVES:0.05257,SSAL:0.04225):0.17302):0.00000;
(((SINT:0.00112,SCON:0.00695):0.01723,(SRAT:0.01146,SDEV:0.01023):0.00837):0.01527,((SSUI:0.00025,SPLU:0.00126):0.05930,(SPYO:0.03581,(SCAN:0.00235,SDYS:0.00270):0.01409):0.01714):0.00329,SPNE:0.07302):0.00000;
(((SINF:0.00383,(SLUT:0.00439,SEQU:0.00280):0.00206):0.06709,(((((LLAC:0.02334,LCRE:0.02534):0.21295,SSUI:0.20473):0.11809,(SDYS:0.01132,SPYO:0.00802):0.35731):0.16442,(LCRE:0.00036,LLAC:0.00030):0.15244):0.03177,(SDEV:0.01516,SRAT:0.00667):0.11434):0.08307):0.00681,(SVES:0.05883,SDOW:0.05824):0.00545,(SCAN:0.02013,SDYS:0.00685):0.05961):0.00000;
(((((SINF:0.00220,SLUT:0.00158):0.00570,SEQU:0.00313):0.03777,(SCAN:0.00955,(SPYO:0.00233,SDYS:0.00208):0.00615):0.04952):0.02106,(SDEV:0.01168,SRAT:0.00987):0.03690):0.00830,SDOW:0.08300,((STHE:0.01432,(SSAL:0.00825,SVES:0.00304):0.00893):0.07426,(((LLAC:0.03246,LCRE:0.03223):0.45737,(((SMIT:0.00157,(SPSE:0.00000,SPNE:0.00000):0.00160):0.02781,(SANG:0.00429,(SINT:0.00000,SCON:0.00000):0.00401):0.03773):0.06773,(SENT:0.18180,SSUI:0.09047):0.01783):0.01508):0.05372,SPLU:0.09445):0.01469):0.01133):0.00000;
(((SPYO:0.04030,(SDYS:0.02717,SCAN:0.02685):0.00986):0.12416,(SRAT:0.02017,SDEV:0.02372):0.11444):0.01195,((((STHE:0.02027,SVES:0.01964):0.00687,SSAL:0.02080):0.18425,SDOW:0.19221):0.00788,(SPLU:0.20619,((LCRE:0.03135,LLAC:0.03549):0.32213,((SSUI:0.21063,((SMIT:0.05519,(SPSE:0.03479,SPNE:0.03598):0.00853):0.14471,(SANG:0.02111,(SINT:0.02353,SCON:0.02067):0.00219):0.12688):0.04210):0.00714,SENT:0.22574):0.00622):0.00812):0.01379):0.00556,(SEQU:0.02111,(SINF:0.00473,SLUT:0.00411):0.01686):0.14543):0.00000;
((SRAT:0.01068,SDEV:0.01654):0.14095,SCON:0.02053,SANG:0.00822):0.00000;
((SINT:0.03375,SCON:0.04470):0.40641,SRAT:0.21610,SDOW:0.21438):0.00000;
(SDOW:0.44050,SANG:0.07811,SCON:0.04521):0.00000;
((((SDOW:0.06657,(SDEV:0.04186,SRAT:0.03558):0.02371):0.03512,(((SINF:0.02299,SEQU:0.02517):0.00436,SLUT:0.03948):0.07681,(STHE:0.03207,(SSAL:0.01024,SVES:0.00977):0.01739):0.08054):0.00269):0.05132,(SCON:0.02928,SANG:0.03017):0.10967):0.00293,SSUI:0.16278,(LCRE:0.02482,LLAC:0.02736):0.20707):0.00000;
(((SDEV:0.26938,(SDOW:0.14595,SRAT:0.10704):0.13700):0.14025,(SDEV:0.24079,(SRAT:0.22006,(SRAT:0.16599,SDOW:0.15695):0.02460):0.10416):0.04185):0.00289,SDOW:0.27062,(SRAT:0.32987,SRAT:0.25135):0.05636):0.00000;
((((SPLU:0.34149,((SDOW:0.26070,SDEV:0.31156):0.08089,(SENT:0.16706,(SDEV:0.13580,((SVES:0.07180,(SMIT:0.03324,SINT:0.02847):0.02525):0.06753,(SSUI:0.01926,SPLU:0.01920):0.11766):0.00522):0.03512):0.17254):0.03805):0.02994,(SPLU:0.01046,SSUI:0.01891):0.26680):0.03436,SEQU:0.22366):0.04593,((SPLU:0.13607,SSUI:0.12569):0.09922,(SSAL:0.02648,(SVES:0.02012,(STHE:0.00671,SINF:0.01460):0.01855):0.01667):0.16052):0.00702,((SANG:0.02324,SCON:0.02860):0.11575,((SMIT:0.00916,SPSE:0.01026):0.00602,SPNE:0.01895):0.12750):0.03721):0.00000;
(SDEV:0.28467,SDOW:0.28467):0.00000;
(SDOW:0.27115,STHE:0.17179,(LLAC:0.00643,LCRE:0.00930):0.13126):0.00000;
(SDEV:0.34839,SDOW:0.34839):0.00000;
((SDEV:0.33562,(SLUT:0.35301,(SDEV:0.38881,(SDEV:0.43047,(LLAC:0.04379,LCRE:0.04663):0.36691):0.01376):0.02790):0.01535):0.06096,((SSUI:0.26701,(SEQU:0.06077,(SINF:0.01156,SLUT:0.01753):0.04354):0.19995):0.01467,((LCRE:0.08486,LLAC:0.08736):0.18154,((((SDEV:0.08266,SRAT:0.07422):0.09258,SDOW:0.17703):0.02212,((SINF:0.01471,SLUT:0.02040):0.03307,SEQU:0.06004):0.15053):0.00688,(SSAL:0.05095,(STHE:0.01698,SVES:0.01433):0.02947):0.14693):0.02121):0.02498):0.00657,(SPYO:0.14767,(SDYS:0.09614,SCAN:0.09216):0.05718):0.14844):0.00000;
(SRAT:0.23279,SDOW:0.23279):0.00000;
(SDOW:0.01515,SDOW:0.01515):0.00000;
(SRAT:0.15620,SDOW:0.15620):0.00000;
(((SENT:0.21843,(((SSUI:0.19710,(SINT:0.06057,(SCON:0.04097,SANG:0.03637):0.01773):0.16643):0.01577,(((SPNE:0.02183,(SPSE:0.01146,SMIT:0.01122):0.01064):0.10678,SVES:0.12861):0.16542,((LLAC:0.03253,LCRE:0.03140):0.29531,(((SENT:0.22387,((SINF:0.00417,SDYS:0.00497):0.10141,(SPLU:0.03663,SINF:0.04168):0.07493):0.14582):0.02579,((STHE:0.01425,(LLAC:0.00434,SLUT:0.00482):0.00911):0.02560,LCRE:0.03036):0.23145):0.11796,(((SDOW:0.14235,(SRAT:0.13138,(SEQU:0.05335,(SLUT:0.01893,SINF:0.02000):0.03430):0.08412):0.01165):0.19078,(SDYS:0.16306,((SDYS:0.00053,SPLU:0.00060):0.13630,SENT:0.13661):0.01864):0.14485):0.01962,SINT:0.38375):0.03900):0.03290):0.01138):0.05649):0.02437,(SCAN:0.11140,(SPYO:0.01315,SDYS:0.01321):0.09613):0.10716):0.01425):0.01683,(SPLU:0.16333,SDOW:0.13090):0.02418):0.01043,(((SINF:0.02015,SLUT:0.02297):0.03208,SEQU:0.04773):0.11980,(SRAT:0.06090,SDEV:0.06130):0.06083):0.01120,((SSAL:0.00558,SVES:0.00581):0.00606,STHE:0.01702):0.13014):0.00000;
(SDOW:0.60091,(SSAL:0.01725,SVES:0.01518):0.04474,STHE:0.05679):0.00000;
((SPLU:0.11945,((SPYO:0.05660,(SCAN:0.01570,SDYS:0.02839):0.01274):0.10517,((SSAL:0.02712,(STHE:0.02286,SVES:0.02087):0.00786):0.14336,((LCRE:0.01297,LLAC:0.00892):0.18653,SDOW:0.14917):0.01618):0.00532):0.00575):0.00402,(SENT:0.12791,(((SINF:0.01830,SLUT:0.01812):0.01000,SEQU:0.02795):0.07021,(SDEV:0.05423,SRAT:0.08130):0.03310):0.01839):0.00428,((((SMIT:0.01209,SPSE:0.00756):0.00093,SPNE:0.00927):0.11125,(SANG:0.02225,(SINT:0.00531,SCON:0.00434):0.01931):0.06761):0.01962,SSUI:0.13551):0.02159):0.00000;
(((SPLU:0.14065,(SENT:0.15054,(((LLAC:0.04706,LCRE:0.04893):0.46367,(((SPSE:0.01497,SPNE:0.02066):0.00393,SMIT:0.02762):0.09541,(SCON:0.08199,(SANG:0.06118,SINT:0.07067):0.01861):0.04292):0.03972):0.00994,SDOW:0.16007):0.00404):0.01242):0.00375,(SDEV:0.08846,SRAT:0.09290):0.03333):0.00177,(SLUT:0.03188,(SINF:0.01771,SEQU:0.01374):0.01233):0.11355,(SSAL:0.01395,SVES:0.02074):0.09238):0.00000;
((SDOW:0.22160,SRAT:0.22661):0.25092,(SCON:0.02235,SANG:0.01899):0.21559,SPLU:0.27370):0.00000;
(SRAT:0.14085,SDOW:0.14085):0.00000;
(SDOW:0.04171,(SDEV:0.01649,SRAT:0.02169):0.01491,(((LCRE:0.00176,LLAC:0.00232):0.11154,(SSAL:0.00924,(STHE:0.00334,SVES:0.00074):0.00162):0.05087):0.00442,((((SMIT:0.00395,SPSE:0.00399):0.00042,SPNE:0.00553):0.02000,(SANG:0.01488,(SINT:0.00765,SCON:0.01017):0.00545):0.01005):0.01078,((SSUI:0.00308,SPLU:0.00555):0.03856,((SINF:0.00136,SLUT:0.00317):0.00175,SEQU:0.00277):0.03304):0.00201):0.01049):0.00425):0.00000;
(((((SDEV:0.01199,SRAT:0.00949):0.12233,(SDOW:0.17646,((((SMIT:0.00707,SPSE:0.01540):0.00161,SPNE:0.01426):0.06782,(SANG:0.02194,(SINT:0.00422,SCON:0.00335):0.01797):0.04744):0.08723,(LLAC:0.00810,LCRE:0.01031):0.30381):0.00898):0.02405):0.02326,((SSUI:0.08777,SENT:0.11589):0.05129,(SPLU:0.09876,((SSAL:0.00575,SVES:0.00583):0.00824,STHE:0.03886):0.08424):0.02111):0.01134):0.03046,(SCAN:0.02237,SDYS:0.01339):0.06246):0.00564,SPYO:0.08513,((SINF:0.01173,SLUT:0.01219):0.00223,SEQU:0.00828):0.05492):0.00000;
(((SSUI:0.07763,((LCRE:0.02095,LLAC:0.01126):0.25937,SDOW:0.11525):0.00897):0.00967,(((STHE:0.01604,(SSAL:0.00000,SVES:0.00000):0.02051):0.00894,(SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.04123):0.05092,(SDEV:0.00000,SRAT:0.00000):0.04274):0.00769):0.00528,SPLU:0.05434,(SEQU:0.00934,(SLUT:0.00844,SINF:0.00564):0.01231):0.04590):0.00000;
(SSUI:0.09558,(((SINF:0.00784,SLUT:0.00611):0.00166,SEQU:0.00718):0.04627,(SDOW:0.06327,((STHE:0.00614,SSAL:0.00451):0.00241,SVES:0.01276):0.03688):0.02308):0.00983,((((LLAC:0.08184,LCRE:0.05192):0.15928,SDYS:0.21296):0.03026,SPLU:0.09854):0.01486,(SDEV:0.03450,SRAT:0.02631):0.03114):0.01354):0.00000;
(SDOW:0.49848,LCRE:0.09084,LLAC:0.08848):0.00000;
((((((SPLU:0.15682,(((LLAC:0.00000,LCRE:0.00000):0.25245,SSUI:0.13309):0.02481,(((STHE:0.01521,(SSAL:0.00062,SVES:0.00462):0.00874):0.07305,((SINF:0.00415,SLUT:0.00448):0.00456,SEQU:0.00797):0.10710):0.05049,SDOW:0.15149):0.02619):0.00634):0.00874,((SCAN:0.02428,(SPYO:0.00135,SDYS:0.00209):0.02297):0.03550,(SDEV:0.00594,SRAT:0.00447):0.06971):0.05697):0.00803,SENT:0.11551):0.08652,(SANG:0.01300,(SINT:0.01499,SCON:0.00944):0.00708):0.02829):0.01787,SPNE:0.01238):0.00284,SPSE:0.00335,SMIT:0.00533):0.00000;
(SDOW:0.37813,(SDYS:0.08592,SENT:0.10073):0.22265,SDOW:0.30098):0.00000;
((((((LCRE:0.01262,LLAC:0.02091):0.08216,SDOW:0.05402):0.01234,((SPYO:0.02988,(SCAN:0.01350,SDYS:0.01008):0.01993):0.00677,(((SINT:0.00748,SCON:0.00931):0.01582,(SANG:0.02246,(SLUT:0.00641,(SINF:0.00753,SEQU:0.00580):0.00149):0.01414):0.00389):0.01117,(SDEV:0.02441,SRAT:0.02288):0.02068):0.00648):0.00333):0.00203,((SSUI:0.01031,SPLU:0.01418):0.01925,SENT:0.05814):0.01307):0.02433,(SMIT:0.00522,(SPSE:0.00750,SPNE:0.00200):0.00180):0.00794):0.00227,(SSAL:0.00245,SVES:0.00547):0.00336,STHE:0.00953):0.00000;
(SDOW:0.05832,(((STHE:0.00969,(SSAL:0.00554,SVES:0.00542):0.00760):0.02769,((SINF:0.00948,SLUT:0.01145):0.01079,SEQU:0.01338):0.02451):0.02546,(SDEV:0.02204,SRAT:0.02388):0.03339):0.00235,(((LCRE:0.05227,LLAC:0.05521):0.12235,(SPSE:0.01303,SPNE:0.01804):0.13527):0.00536,SSUI:0.10355):0.03259):0.00000;
(SDOW:0.28834,((((SVES:0.03685,STHE:0.04427):0.03900,SSAL:0.07360):0.18038,SPLU:0.16437):0.01079,(((SEQU:0.02370,(SLUT:0.00786,SINF:0.00458):0.01589):0.12160,(SCAN:0.09514,(SPYO:0.05075,SDYS:0.04153):0.02711):0.09277):0.01226,(SRAT:0.03442,SDEV:0.03873):0.15920):0.01513):0.00991,(((SMIT:0.04246,(SPNE:0.03675,SPSE:0.03788):0.01734):0.07201,(SINT:0.03317,(SANG:0.00921,SCON:0.00648):0.02145):0.10227):0.00318,SSUI:0.14583):0.14141):0.00000;
(SINT:0.18562,SDOW:0.18562):0.00000;
(SDOW:0.19434,SDEV:0.14169,SRAT:0.13809):0.00000;
(SRAT:0.13305,SDOW:0.13305):0.00000;
(((((SINF:0.00309,SLUT:0.00535):0.01213,SEQU:0.01585):0.01503,((STHE:0.00421,(SSAL:0.00523,SVES:0.00054):0.00223):0.02441,SDOW:0.04043):0.00322):0.00491,((LCRE:0.01496,LLAC:0.01472):0.17566,((((SMIT:0.00350,(SPSE:0.00046,SPNE:0.00532):0.00406):0.02704,(SANG:0.00983,(SINT:0.00618,SCON:0.00413):0.01273):0.01797):0.01872,SSUI:0.05008):0.01377,(SDEV:0.03190,SRAT:0.02346):0.02540):0.00603):0.00991):0.00280,(SPYO:0.01032,(SCAN:0.00475,SDYS:0.00777):0.00107):0.03497,(SPLU:0.03578,SENT:0.04863):0.00401):0.00000;
(((SDEV:0.19794,SRAT:0.24143):0.00639,(SPLU:0.21321,(((SSAL:0.19692,(SMIT:0.03788,(SPNE:0.04081,SPSE:0.04330):0.00210):0.16747):0.03965,((SANG:0.04576,(SINT:0.00937,SCON:0.00954):0.03898):0.14158,SSUI:0.21208):0.00834):0.06817,SDOW:0.23150):0.02014):0.01104):0.00076,SDYS:0.25690,SENT:0.24643):0.00000;
((((LCRE:0.18712,LLAC:0.19975):0.18913,SDOW:0.32121):0.25379,SSAL:0.06289):0.01534,SVES:0.05047,STHE:0.04736):0.00000;
(SEQU:0.29990,SDOW:0.29990):0.00000;
(((((SINT:0.09198,(SCON:0.06924,SANG:0.05545):0.02792):0.15298,(SMIT:0.04165,(SPNE:0.02229,SPSE:0.01853):0.01920):0.20025):0.05375,SSUI:0.29175):0.03149,(SENT:0.25474,(SPLU:0.22684,((SDEV:0.05752,SRAT:0.05508):0.18820,((SCAN:0.04492,SPYO:0.04211):0.07066,SDYS:0.10396):0.12987):0.00670):0.01695):0.00981):0.00918,(SDOW:0.27293,((SINF:0.00503,SLUT:0.00417):0.07593,SEQU:0.08530):0.14530):0.01042,(SSAL:0.07794,(STHE:0.03899,SVES:0.04020):0.03262):0.20950):0.00000;
(((SENT:0.10332,(((SINT:0.00980,(SANG:0.00253,SCON:0.00663):0.00289):0.08671,((SMIT:0.00202,(SPSE:0.00534,SPNE:0.00106):0.00082):0.07033,(SSUI:0.09640,(SDEV:0.00663,SRAT:0.00263):0.06891):0.04434):0.01187):0.01397,((LCRE:0.00858,LLAC:0.00214):0.13953,(((SPNE:0.08696,(SINT:0.01781,(SANG:0.00000,SCON:0.00000):0.01609):0.07263):0.01011,(SSUI:0.08677,SDEV:0.08777):0.02445):0.02649,(SCAN:0.02443,(SPYO:0.00275,SDYS:0.00168):0.02265):0.09609):0.42834):0.04083):0.01354):0.02334,(((SINF:0.00785,SLUT:0.01134):0.01319,SEQU:0.02910):0.03807,SDOW:0.08968):0.00980):0.00426,(SPLU:0.06150,((SCAN:0.00869,SPYO:0.02403):0.00040,SDYS:0.00886):0.06301):0.00349,(STHE:0.00908,(SSAL:0.00091,SVES:0.00190):0.00461):0.07705):0.00000;
(((SPNE:0.11461,((LCRE:0.02675,LLAC:0.02645):0.26203,(SDEV:0.12542,(SCAN:0.01898,(SPYO:0.00521,SDYS:0.00694):0.01170):0.13770):0.02870):0.03811):0.10471,SCON:0.00157):0.00086,SINT:0.00000,SANG:0.00000):0.00000;
(SRAT:0.10080,SDEV:0.10080):0.00000;
((SDEV:0.07388,SRAT:0.09187):0.19732,SSAL:0.23653,SDOW:0.21202):0.00000;
(SDEV:0.06406,SRAT:0.07398,SDOW:0.23121):0.00000;
(SDEV:0.09933,SRAT:0.14779,SDOW:0.32491):0.00000;
(SDEV:0.07879,SRAT:0.06305,SDYS:0.55408):0.00000;
(SRAT:0.03883,SDEV:0.03883):0.00000;
(SRAT:0.00931,SDEV:0.00931):0.00000;
(SRAT:0.00542,SDEV:0.00542):0.00000;
(SDEV:0.00432,SRAT:0.01399,SCON:0.35597):0.00000;
((SPYO:0.02111,(((SINF:0.10548,SDOW:0.08874):0.02007,(((SDEV:0.01220,SRAT:0.01405):0.09707,SDOW:0.12498):0.41743,(LCRE:0.01489,LLAC:0.01382):0.13311):0.04424):0.03377,(SDEV:0.01115,SRAT:0.01452):0.04666):0.06314):0.00285,SDYS:0.01495,SCAN:0.01915):0.00000;
(SDEV:0.03005,SRAT:0.02449,SDOW:0.23184):0.00000;
((((LLAC:0.02544,LCRE:0.01453):0.34616,(SDEV:0.06302,SRAT:0.05778):0.20951):0.24949,SANG:0.03236):0.01349,SCON:0.01588,SINT:0.02130):0.00000;
(SRAT:0.06130,SDEV:0.06130):0.00000;
((SLUT:0.06750,(SDEV:0.09718,(((SSAL:0.02612,SVES:0.02143):0.00597,STHE:0.02463):0.15256,SDOW:0.13615):0.03866):0.04349):0.01110,SEQU:0.03217,SINF:0.03431):0.00000;
(SRAT:0.05026,SDEV:0.05026):0.00000;
(((SEQU:0.03761,(SLUT:0.01068,SINF:0.01037):0.03404):0.08783,((SPYO:0.05768,(SCAN:0.03317,SDYS:0.03202):0.01689):0.08036,(SDEV:0.04124,SRAT:0.04706):0.09219):0.00770):0.00418,((SDOW:0.14279,SPLU:0.12878):0.00921,((((LLAC:0.02373,LCRE:0.02695):0.23117,SENT:0.17898):0.00377,SSUI:0.17110):0.00945,((SMIT:0.00519,(SPSE:0.00000,SPNE:0.00000):0.00800):0.13125,(SANG:0.01744,(SINT:0.02215,SCON:0.01155):0.00550):0.08684):0.04648):0.00780):0.00166,(STHE:0.02735,(SSAL:0.00677,SVES:0.00827):0.01547):0.12081):0.00000;
(((STHE:0.00806,(SSAL:0.00182,SVES:0.00189):0.00308):0.04670,(SDEV:0.03637,SRAT:0.04696):0.01044):0.00508,(((SANG:0.01380,(SINT:0.00897,SCON:0.00880):0.01763):0.03575,(((SMIT:0.00035,SPSE:0.00526):0.00304,SPNE:0.00865):0.05861,((SSUI:0.05720,SPLU:0.06561):0.01258,SENT:0.07597):0.02224):0.00944):0.00788,((LCRE:0.02486,LLAC:0.02248):0.09637,((SPYO:0.03963,(SCAN:0.01041,SDYS:0.00553):0.02035):0.03807,SDOW:0.05431):0.00531):0.00617):0.00586,((SINF:0.00516,SLUT:0.00510):0.00522,SEQU:0.01064):0.04883):0.00000;
(SRAT:0.33501,SDEV:0.33501):0.00000;
(SDEV:0.56990,(SCAN:0.03141,(SPYO:0.02662,SDYS:0.01693):0.01655):0.15178,(SPLU:0.18076,(SSUI:0.14316,SENT:0.19237):0.02130):0.01500):0.00000;
((SPYO:0.02765,(SDEV:0.27918,SLUT:0.35266):0.33740):0.02630,SCAN:0.01920,SDYS:0.02397):0.00000;
(SDEV:0.17559,SLUT:0.15834,SINF:0.15499):0.00000;
(SRAT:0.03216,SDEV:0.03216):0.00000;
(SRAT:0.13178,SDEV:0.13178):0.00000;
(((SDOW:0.14304,(SSAL:0.02274,(STHE:0.04220,SVES:0.02723):0.00684):0.10661):0.03494,(SDEV:0.08831,SRAT:0.06942):0.08258):0.02074,((SINF:0.03060,SLUT:0.05188):0.02361,SEQU:0.04708):0.13218,(SMIT:0.03875,(SPSE:0.01892,SPNE:0.02439):0.02056):0.18409):0.00000;
((SDEV:0.05098,SRAT:0.07197):0.11166,SDOW:0.27706,(LLAC:0.08615,LCRE:0.09951):0.27937):0.00000;
(SRAT:0.02283,SDEV:0.02283):0.00000;
(SRAT:0.03978,SDEV:0.03978):0.00000;
(SRAT:0.08634,SDEV:0.08634):0.00000;
(SRAT:0.09701,SDEV:0.09701):0.00000;
(SRAT:0.01984,SDEV:0.01984):0.00000;
(((SDEV:0.24651,SRAT:0.24968):0.07300,SDEV:0.34713):0.01885,(SCON:0.36884,((SPSE:0.00927,(SPNE:0.00984,SMIT:0.00479):0.00746):0.28336,(SPSE:0.01056,(SPNE:0.00612,SMIT:0.00865):0.00346):0.23183):0.06252):0.05074,((SPSE:0.01845,SPNE:0.01715):0.01106,SMIT:0.02067):0.40991):0.00000;
((((SCON:0.05722,(SINT:0.05858,SANG:0.05182):0.00506):0.17100,SDOW:0.21695):0.02452,((STHE:0.04420,(SSAL:0.00942,SVES:0.01609):0.01614):0.20155,(((SDEV:0.05928,SRAT:0.06029):0.10613,(SPYO:0.04041,(SDYS:0.01303,SCAN:0.02112):0.02407):0.13075):0.02366,(SEQU:0.03992,(SLUT:0.00658,SINF:0.00413):0.02950):0.16374):0.02145):0.01464):0.00792,(SPLU:0.25868,SSUI:0.28757):0.02532,SENT:0.33990):0.00000;
((((SDEV:0.08307,SDOW:0.08290):0.03411,SRAT:0.11213):0.09777,((((LCRE:0.03787,LLAC:0.03997):0.25155,(SSAL:0.20691,SSAL:0.19580):0.05355):0.05991,((SCAN:0.03322,SPYO:0.03504):0.09609,SDYS:0.14164):0.15362):0.01422,SDOW:0.23109):0.00762):0.00680,(SEQU:0.08441,(SLUT:0.03090,SINF:0.03351):0.06325):0.09535,(SDEV:0.09723,SRAT:0.08490):0.10344):0.00000;
(SRAT:0.12354,SDEV:0.12354):0.00000;
(((SDEV:0.05660,SRAT:0.05451):0.17595,SDOW:0.24366):0.02425,(SDYS:0.15381,SPYO:0.18979):0.15736,SENT:0.35231):0.00000;
((SDEV:0.17749,SRAT:0.22565):0.01568,(SANG:0.25396,((SPSE:0.10492,SMIT:0.12278):0.17762,(SSUI:0.32295,SDOW:0.35158):0.04967):0.02935):0.04448,(SVES:0.03897,SSAL:0.03593):0.19528):0.00000;
(SDEV:0.35249,SDEV:0.35249):0.00000;
(SDEV:0.30944,SDEV:0.33898,SMIT:0.29753):0.00000;
((SPYO:0.08451,(SDEV:0.13013,SRAT:0.09729):0.30409):0.04267,SDYS:0.05645,SCAN:0.06461):0.00000;
(SRAT:0.02113,SDEV:0.02113):0.00000;
(SDEV:0.32570,SDEV:0.32570):0.00000;
(SRAT:0.13617,SDEV:0.13617):0.00000;
(SPYO:0.30223,SDEV:0.30223):0.00000;
(SDEV:0.21139,SPYO:0.01898,SDYS:0.02366):0.00000;
(SDEV:0.09162,SRAT:0.07098,SPSE:0.25472):0.00000;
(SDOW:0.26898,SDEV:0.26898):0.00000;
(((SENT:0.14015,(SPSE:0.00762,(SMIT:0.00353,SPNE:0.00417):0.00812):0.11985):0.01850,(((SSUI:0.12515,SCAN:0.14050):0.02851,SPLU:0.18197):0.01889,(SDEV:0.48115,(SCAN:0.04601,SDYS:0.05194):0.13454):0.00844):0.01656):0.00390,(SPYO:0.17697,(((SINF:0.02104,SLUT:0.01150):0.04886,SEQU:0.06234):0.09260,(SDEV:0.03567,SRAT:0.03571):0.07433):0.00811):0.00929,SANG:0.14593):0.00000;
(SRAT:0.13042,SDEV:0.13042):0.00000;
(((SENT:0.14580,((((SANG:0.03004,SINT:0.03577):0.01619,SCON:0.05411):0.05528,(SDEV:0.02138,SRAT:0.01368):0.07914):0.00928,((SSAL:0.00902,(STHE:0.01588,SVES:0.00395):0.01231):0.08917,SDOW:0.10151):0.02914):0.00705):0.00931,(SPLU:0.12805,((SCAN:0.03060,SPYO:0.05230):0.00516,SDYS:0.04567):0.10161):0.03499):0.00758,((SINF:0.00921,SLUT:0.00693):0.00706,SEQU:0.01177):0.12905,((SMIT:0.01278,(SPSE:0.00394,SPNE:0.00065):0.01823):0.12926,SSUI:0.15238):0.02444):0.00000;
(SDEV:0.08854,SRAT:0.09781,SCON:0.26710):0.00000;
(((SLUT:0.07373,SEQU:0.05223):0.09051,((SDEV:0.15211,(SDEV:0.08838,SRAT:0.06895):0.07952):0.08118,(LCRE:0.02761,LLAC:0.01722):0.12609):0.16070):0.04403,SANG:0.10095,SDOW:0.13750):0.00000;
(SRAT:0.05671,SDEV:0.05671):0.00000;
(SRAT:0.06275,SDEV:0.06275):0.00000;
((SMIT:0.18478,SDEV:0.38445):0.01334,(SRAT:0.16122,(SPLU:0.17785,SCON:0.13951):0.01280):0.00609,(SDYS:0.05377,SPYO:0.05345):0.12928):0.00000;
(((SDOW:0.10299,(((SINF:0.09897,SEQU:0.04191):0.01541,SRAT:0.09133):0.01924,(SDEV:0.07490,SPLU:0.10433):0.01401):0.02640):0.10718,(SDEV:0.15739,SRAT:0.16270):0.31353):0.15550,(SDOW:0.08560,((SDEV:0.01983,SRAT:0.01768):0.02449,(SANG:0.01808,SINT:0.02625):0.03513):0.01244):0.00417,((SSAL:0.01058,SVES:0.00912):0.06351,(SMIT:0.01482,SPNE:0.01590):0.06012):0.00959):0.00000;
(SRAT:0.03289,SDEV:0.03289):0.00000;
(((SENT:0.04296,((SSUI:0.03864,(SDEV:0.01233,SRAT:0.00390):0.03254):0.01496,((SPNE:0.01550,(SANG:0.01063,SCON:0.01619):0.00774):0.12284,((LLAC:0.00500,LCRE:0.00963):0.35317,(SDEV:0.00355,SRAT:0.00328):0.23646):0.16643):0.09176):0.01224):0.01234,(SDOW:0.04712,((SINF:0.01299,SLUT:0.01620):0.02203,SEQU:0.03493):0.01479):0.01151):0.00838,(SPLU:0.03128,(SCAN:0.00501,(SPYO:0.00089,SDYS:0.00151):0.00368):0.02392):0.00028,(STHE:0.00850,(SSAL:0.00289,SVES:0.00552):0.00231):0.02678):0.00000;
(((SDOW:0.13872,((SENT:0.17145,((LLAC:0.01466,LCRE:0.01365):0.21727,((LCRE:0.00550,LLAC:0.00577):0.23099,(SDEV:0.03386,SRAT:0.03769):0.22935):0.09996):0.08183):0.01117,((((SPSE:0.00296,SPNE:0.00516):0.00465,SMIT:0.01009):0.10050,(SANG:0.01616,(SCON:0.01643,SINT:0.01458):0.00789):0.08682):0.03101,SSUI:0.13931):0.04118):0.02522):0.00835,((SDEV:0.01215,SRAT:0.01811):0.09309,(((SINF:0.01448,SLUT:0.00797):0.00867,SEQU:0.01501):0.07773,((SDYS:0.02675,SCAN:0.02709):0.02063,SPYO:0.05707):0.05637):0.00692):0.00750):0.00212,SPLU:0.12106,(STHE:0.02509,(SVES:0.00425,SSAL:0.00611):0.01494):0.11004):0.00000;
(((SPNE:0.13088,(SDOW:0.13976,(((SDYS:0.00246,SPYO:0.00219):0.01282,SCAN:0.01181):0.52212,(SDEV:0.09544,SDEV:0.07392):0.07120):0.01321):0.01088):0.01139,SSUI:0.13374):0.00330,((SCON:0.02044,SANG:0.01361):0.01343,SINT:0.02158):0.08256,(SPYO:0.02929,(SCAN:0.01416,SDYS:0.01590):0.00745):0.09981):0.00000;
((((((SMIT:0.01052,SPSE:0.00513):0.00114,SPNE:0.01400):0.05997,(SINT:0.03014,(SANG:0.01256,SCON:0.01831):0.01278):0.04485):0.00516,((LLAC:0.00945,LCRE:0.00847):0.21753,SSUI:0.07011):0.00711):0.00750,(SENT:0.09680,(SCAN:0.03743,(SPYO:0.00377,SDYS:0.00089):0.03069):0.03638):0.00539):0.00479,((SINF:0.01182,(SLUT:0.00444,SEQU:0.00281):0.00343):0.04853,(SDEV:0.04890,SRAT:0.04666):0.02985):0.00241,(((STHE:0.01029,(SSAL:0.00757,SVES:0.00274):0.00336):0.04297,SPLU:0.05979):0.00675,SDOW:0.06875):0.01280):0.00000;
((((SLUT:0.01881,SEQU:0.01590):0.08939,SINF:0.07198):0.12168,((SDYS:0.00000,SPYO:0.00000):0.02433,SCAN:0.01876):0.16839):0.02327,(SDOW:0.21370,SPLU:0.24950):0.01980,(SENT:0.30358,((LLAC:0.02837,LCRE:0.03498):0.22413,(SRAT:0.05030,SDEV:0.04947):0.18794):0.04879):0.02127):0.00000;
(SDYS:0.00404,SPYO:0.00404,SCAN:0.14580):0.00000;
((SPYO:0.00203,SDYS:0.00191):0.01033,((((LCRE:0.02957,LLAC:0.03114):0.20953,(SSUI:0.11156,(SPNE:0.00091,SPSE:0.00180):0.11350):0.07991):0.03690,((SRAT:0.00370,SDEV:0.00238):0.31027,SDEV:0.31233):0.00216):0.20196,(SCON:0.05584,SDEV:0.04655):0.03196):0.05928,SCAN:0.01310):0.00000;
((SDYS:0.00000,SCAN:0.00000):0.07108,SPLU:0.08797,SCON:0.03628):0.00000;
((SPYO:0.05243,(SCAN:0.04509,SDYS:0.03523):0.01148):0.06374,((SSUI:0.16781,SANG:0.19055):0.04820,SDOW:0.11421):0.03625,((SSAL:0.02094,(STHE:0.01842,SVES:0.01912):0.01265):0.07345,(SLUT:0.01631,(SINF:0.01690,SEQU:0.00924):0.00701):0.05031):0.00618):0.00000;
(SDYS:0.23450,SCAN:0.06486,SDYS:0.01631):0.00000;
(((((SPSE:0.01692,SPNE:0.02128):0.00883,SMIT:0.02397):0.16032,(SSUI:0.20579,((SINT:0.00556,SCON:0.00330):0.06180,SANG:0.07117):0.08325):0.02152):0.02190,((SCAN:0.04641,SDYS:0.05088):0.02645,SPYO:0.11821):0.12449):0.00930,((((STHE:0.04872,(SSAL:0.02756,SVES:0.01738):0.02207):0.14468,SPLU:0.18241):0.01596,SDOW:0.20772):0.02538,((SENT:0.20604,(SDEV:0.04679,SRAT:0.05231):0.12148):0.01233,((SINF:0.02061,SLUT:0.01621):0.03388,SEQU:0.06015):0.10779):0.00814):0.01443,(LLAC:0.03080,LCRE:0.03008):0.23090):0.00000;
(SCAN:0.23750,SDYS:0.23750):0.00000;
((SCAN:0.05267,(SDYS:0.03988,SPYO:0.02641):0.04872):0.01769,((SENT:0.04779,(SLUT:0.01896,(SINF:0.00151,SEQU:0.00745):0.00791):0.01479):0.00884,(((LCRE:0.01583,LLAC:0.00988):0.10811,((STHE:0.00000,SSAL:0.00000):0.00863,SVES:0.00923):0.01231):0.01166,(SDOW:0.04664,(SRAT:0.00556,SDEV:0.04400):0.02222):0.01101):0.00428):0.00337,((((SMIT:0.00656,SPSE:0.00777):0.01363,SPNE:0.03221):0.07495,(SINT:0.04599,(SANG:0.00694,SCON:0.03021):0.01830):0.03820):0.02404,(SSUI:0.00295,SPLU:0.01102):0.07193):0.00966):0.00000;
(SDYS:0.19815,SPYO:0.15828,SCAN:0.07088):0.00000;
(SDYS:0.00892,SPYO:0.07875,SCAN:0.02080):0.00000;
((((SPLU:0.04922,((SCAN:0.03718,SDYS:0.03200):0.00462,SPYO:0.04616):0.02478):0.00569,((SINF:0.00795,SLUT:0.00325):0.01612,SEQU:0.01751):0.04097):0.01753,SENT:0.10281):0.01308,(((SMIT:0.00371,(SPSE:0.00279,SPNE:0.00832):0.00323):0.05187,(SANG:0.01365,(SINT:0.01030,SCON:0.01620):0.00589):0.04536):0.02672,((STHE:0.02281,(SSAL:0.01549,SVES:0.01738):0.00311):0.07013,SSUI:0.06247):0.00539):0.00301,(LCRE:0.01881,LLAC:0.00856):0.22072):0.00000;
((SINT:0.02443,(((SMIT:0.00000,SPSE:0.00000):0.00122,SPNE:0.00317):0.02863,(((LCRE:0.01292,LLAC:0.00914):0.24860,(((SPLU:0.06587,((SCAN:0.03826,SDYS:0.01774):0.00992,SPYO:0.03201):0.04161):0.00528,(SINF:0.01236,(SLUT:0.00205,SEQU:0.00142):0.00324):0.05555):0.00407,SENT:0.05733):0.03341):0.03525,((SSAL:0.02350,(STHE:0.01393,SVES:0.00798):0.00925):0.05962,SSUI:0.07732):0.00874):0.04219):0.01615):0.00149,SCON:0.01179,SANG:0.02688):0.00000;
((((((((((SMIT:0.00805,SPSE:0.00402):0.00171,SPNE:0.00775):0.14145,SSUI:0.12749):0.01276,(SDEV:0.01363,SRAT:0.01391):0.10347):0.00687,(SDOW:0.14231,(SPLU:0.11613,(STHE:0.01610,(SSAL:0.01018,SVES:0.00086):0.02023):0.15553):0.02862):0.01367):0.03083,SINF:0.18934):0.30859,(LCRE:0.00000,LLAC:0.00000):0.11087):0.00702,((((SINF:0.00946,SLUT:0.01856):0.01260,SEQU:0.01805):0.04103,(SPYO:0.04881,(SCAN:0.01434,SDYS:0.00796):0.02066):0.02812):0.01275,((((STHE:0.00188,SSAL:0.00872):0.00253,SVES:0.01251):0.04904,SDOW:0.07790):0.01454,(SDEV:0.01347,SRAT:0.00938):0.07595):0.01305):0.01080):0.00675,((SPNE:0.00847,(SPSE:0.00483,SMIT:0.00231):0.00226):0.07261,(SPLU:0.10072,SENT:0.10693):0.03216):0.00907):0.00337,SSUI:0.11730,(SANG:0.01671,(SINT:0.01926,SCON:0.03925):0.00728):0.06189):0.00000;
((((SMIT:0.00249,SPSE:0.00157):0.00661,SPNE:0.00725):0.03703,((((STHE:0.01462,(SSAL:0.00092,SVES:0.00426):0.00670):0.03530,(SCAN:0.01689,(SPYO:0.01637,SDYS:0.00737):0.00368):0.02992):0.01279,SDOW:0.05368):0.00682,((SINF:0.00744,SLUT:0.00410):0.00862,SEQU:0.01155):0.04754):0.00763):0.00631,(SSUI:0.04092,SENT:0.08321):0.01506,SPLU:0.05185):0.00000;
(((((SSUI:0.11067,((SDYS:0.00927,SPYO:0.02259):0.00102,SCAN:0.02103):0.03984):0.01352,(SPLU:0.06827,SENT:0.07221):0.00905):0.04255,(SMIT:0.00327,(SPSE:0.00434,SPNE:0.00552):0.00561):0.02734):0.02453,SVES:0.00674):0.00114,SSAL:0.00368,STHE:0.01130):0.00000;
(SDYS:0.39360,SDEV:0.02673,SRAT:0.03301):0.00000;
(((LCRE:0.03177,LLAC:0.04247):0.16164,(SENT:0.25336,((SCAN:0.07698,SDYS:0.08253):0.03039,SPYO:0.13051):0.06712):0.01298):0.00741,((SDEV:0.04697,SRAT:0.06766):0.11134,((SSAL:0.03638,(STHE:0.01985,SVES:0.01326):0.01204):0.11518,SDOW:0.19171):0.00745):0.00884,((SPLU:0.18190,(SSUI:0.19558,(((SPSE:0.01029,SPNE:0.01040):0.11362,SMIT:0.13662):0.05351,(SANG:0.03743,(SINT:0.04241,SCON:0.04110):0.00717):0.08687):0.01827):0.00832):0.00564,((SINF:0.01937,SLUT:0.02158):0.02610,SEQU:0.03909):0.11110):0.00788):0.00000;
((((((SMIT:0.00000,SPSE:0.00000):0.00315,SPNE:0.00202):0.02118,(SINT:0.00591,(SANG:0.00120,SCON:0.00200):0.00172):0.02252):0.00613,(((SDYS:0.00246,SPYO:0.00270):0.00330,SCAN:0.00875):0.03078,((LLAC:0.00054,LCRE:0.00528):0.11647,(SENT:0.04041,(SPLU:0.01007,SSUI:0.01824):0.01988):0.05004):0.00591):0.02391):0.00570,((SINF:0.00192,(SLUT:0.00431,SEQU:0.00234):0.00417):0.01444,(SDEV:0.00495,SRAT:0.00438):0.00930):0.00860):0.00546,SDOW:0.02678,(STHE:0.01411,(SSAL:0.00309,SVES:0.00185):0.00777):0.00890):0.00000;
(((SDYS:0.02739,SCAN:0.03058):0.20778,SENT:0.24206):0.15809,(SDYS:0.05009,SCAN:0.04137):0.06221,SPYO:0.06305):0.00000;
(((SDOW:0.05212,(((SINF:0.00788,SLUT:0.00126):0.00407,SEQU:0.00506):0.02006,(SPYO:0.00522,(SCAN:0.00435,SDYS:0.00219):0.00057):0.02566):0.00688):0.00496,((LLAC:0.00000,LCRE:0.00000):0.29121,(SDEV:0.00780,SRAT:0.00177):0.04336):0.00419):0.00072,SENT:0.06140,((((SMIT:0.00171,(SPSE:0.00308,SPNE:0.00704):0.00411):0.04083,(SINT:0.00623,(SANG:0.00542,SCON:0.00975):0.00212):0.01899):0.01673,SSUI:0.05879):0.01470,((STHE:0.00977,(SSAL:0.00000,SVES:0.00000):0.00285):0.04065,SPLU:0.04930):0.00310):0.00533):0.00000;
(SCAN:0.03374,SDYS:0.03374):0.00000;
(((STHE:0.00801,(SSAL:0.00797,SVES:0.00724):0.00610):0.02427,((LCRE:0.01732,LLAC:0.00784):0.20893,((SENT:0.07886,(SPLU:0.08303,((SCAN:0.01118,SDYS:0.01068):0.02370,SPYO:0.04449):0.02328):0.01746):0.00989,(SSUI:0.00839,SINF:0.01693):0.03309):0.01319):0.02930):0.02573,(SPSE:0.00458,SPNE:0.00331):0.00142,SMIT:0.00140):0.00000;
(SDYS:0.02533,SCAN:0.01557,SENT:0.29795):0.00000;
((SSAL:0.01099,(((SSUI:0.07988,(SDYS:0.01700,SCAN:0.02527):0.06244):0.02172,SENT:0.05487):0.02370,SPLU:0.04868):0.05931):0.00828,SVES:0.01319,STHE:0.02052):0.00000;
(SDYS:0.13555,SENT:0.18818,SENT:0.48068):0.00000;
(SENT:0.10376,SDYS:0.10376):0.00000;
(((SINT:0.12633,(((LLAC:0.01251,LCRE:0.01076):0.20651,(SDYS:0.01095,(SCAN:0.01188,SPYO:0.01528):0.00359):0.16283):0.09643,SSUI:0.19786):0.06410):0.08654,SMIT:0.02028):0.01845,SPNE:0.00043,SPSE:0.00311):0.00000;
(SPYO:0.00917,SDYS:0.00917):0.00000;
((((SDOW:0.14788,((((SDEV:0.03486,SRAT:0.03943):0.12420,(SDOW:0.11458,(SSAL:0.07892,(SMIT:0.00786,SPSE:0.00867):0.10412):0.03736):0.02764):0.08997,((SCAN:0.03368,SDYS:0.02337):0.12024,((SPLU:0.10147,((STHE:0.00776,(SSAL:0.00000,SVES:0.00000):0.01117):0.04963,((SINF:0.01341,SLUT:0.01198):0.01423,SEQU:0.02370):0.05281):0.00908):0.03304,SDOW:0.14082):0.00361):0.15033):0.12302,((SPLU:0.23324,(SRAT:0.03799,(SDEV:0.03140,(SENT:0.01816,(SPYO:0.02203,(SCAN:0.04072,SDYS:0.01894):0.00664):0.02821):0.02338):0.00495):0.05347):0.10867,(((STHE:0.05983,SSAL:0.02375):0.05118,(SINT:0.01522,SCON:0.02524):0.06861):0.01872,(SPSE:0.01587,SPNE:0.01529):0.09265):0.12829):0.07964):0.10824):0.02484,(SENT:0.07976,(SINF:0.01697,SLUT:0.05488):0.04642):0.05521):0.03548,SSUI:0.08270):0.00423,(SINT:0.12942,(SANG:0.02978,SCON:0.04859):0.01293):0.03972,(SSAL:0.11207,((SMIT:0.00000,SPSE:0.00000):0.01438,SPNE:0.01306):0.07659):0.01953):0.00000;
((((((LLAC:0.00044,LCRE:0.00076):0.29354,SPNE:0.26624):0.01324,(SSUI:0.09205,(SCAN:0.00532,SPYO:0.00673):0.06845):0.20161):0.04126,((SLUT:0.00098,SEQU:0.00088):0.07235,(SDEV:0.06209,(SINT:0.02786,(SANG:0.00198,SCON:0.00776):0.01785):0.04150):0.00537):0.25050):0.30964,(SCAN:0.02542,(SPYO:0.00842,SDYS:0.00299):0.02183):0.03967):0.00122,((SANG:0.00678,(SINT:0.00053,SCON:0.00268):0.00540):0.04378,SSUI:0.05808):0.00402,SPNE:0.06394):0.00000;
(SENT:0.21731,SPNE:0.21731):0.00000;
(((SCAN:0.04669,(SANG:0.06566,(SENT:0.19311,(SVES:0.00166,(SMIT:0.00000,SPNE:0.00000):0.00606):0.09343):0.06278):0.01276):0.03222,(SSUI:0.02541,SDYS:0.00639):0.00515):0.00239,SPLU:0.00547,SSUI:0.00406):0.00000;
(((SSUI:0.22685,((STHE:0.02281,SVES:0.01496):0.09632,(SRAT:0.05211,SDEV:0.04548):0.05505):0.15104):0.01083,((SANG:0.09880,(SINT:0.02466,SCON:0.02106):0.06466):0.07953,(SMIT:0.05325,(SPSE:0.03704,SPNE:0.03200):0.02181):0.12141):0.02700):0.01032,((SINF:0.09529,SEQU:0.08889):0.09997,SDOW:0.17723):0.01138,((SCAN:0.06944,SDYS:0.07683):0.16320,(SPLU:0.21453,SENT:0.20705):0.02059):0.01086):0.00000;
(((SPLU:0.08656,SENT:0.11727):0.00706,((LLAC:0.00954,LCRE:0.01104):0.19397,(SSUI:0.07625,((SANG:0.01122,(SINT:0.00774,SCON:0.00358):0.01159):0.03965,((SPNE:0.00202,SPSE:0.00486):0.00592,SMIT:0.00570):0.03815):0.02755):0.01839):0.01052):0.00428,(((SSAL:0.01706,(STHE:0.00453,SVES:0.00633):0.01108):0.03681,SDOW:0.05689):0.00695,(((SINF:0.00805,SLUT:0.00845):0.00765,SEQU:0.01405):0.05243,(SDEV:0.01277,SRAT:0.01451):0.05113):0.01380):0.00150,((SCAN:0.02683,SPYO:0.03835):0.00403,SDYS:0.02901):0.04493):0.00000;
(((((STHE:0.01815,(SSAL:0.00410,SVES:0.00312):0.01084):0.02631,SPLU:0.04886):0.00440,SENT:0.06415):0.00333,((LLAC:0.00521,LCRE:0.00638):0.14294,(((SANG:0.01151,(SINT:0.00846,SCON:0.00582):0.01047):0.02088,SSUI:0.04315):0.00304,((SMIT:0.00420,SPSE:0.00569):0.00101,SPNE:0.00918):0.03637):0.01932):0.00982):0.00471,((SCAN:0.00935,(SPYO:0.00478,SDYS:0.00200):0.00815):0.03766,(SDEV:0.01844,SRAT:0.02136):0.02594):0.00027,((SINF:0.00771,(SLUT:0.00752,SEQU:0.00091):0.00524):0.03300,SDOW:0.05403):0.00408):0.00000;
((((STHE:0.04690,(SVES:0.03121,SSAL:0.02475):0.01903):0.09054,(SDOW:0.14796,(((SANG:0.03616,(SINT:0.02049,SCON:0.01545):0.02244):0.10569,(SMIT:0.02359,(SPSE:0.01626,SPNE:0.01519):0.01283):0.12290):0.00562,SSUI:0.14871):0.01318):0.00327):0.00358,(SDYS:0.08548,(SCAN:0.02314,SPYO:0.02196):0.05710):0.06836):0.00252,(SPLU:0.13115,((SEQU:0.03593,(SINF:0.01468,SLUT:0.01745):0.03528):0.06705,(SDEV:0.05882,SRAT:0.04736):0.07841):0.00457):0.01812,SENT:0.15677):0.00000;
(((SSUI:0.06160,((SPLU:0.04000,((LCRE:0.00188,LLAC:0.00195):0.13010,((SCAN:0.00755,SPYO:0.01141):0.00317,SDYS:0.00489):0.05735):0.00800):0.00768,(((SANG:0.00776,SINT:0.00615):0.00356,SCON:0.00663):0.02982,((SMIT:0.00055,SPSE:0.00405):0.00173,SPNE:0.01025):0.02292):0.03715):0.00711):0.00279,(SDOW:0.03549,(SDEV:0.01297,SRAT:0.02531):0.01351):0.02158):0.00226,(SENT:0.03104,((SINF:0.00681,SLUT:0.00538):0.00190,SEQU:0.01165):0.04396):0.00622,(STHE:0.01407,(SSAL:0.00571,SVES:0.00540):0.00394):0.02797):0.00000;
(SPNE:0.01280,SCAN:0.01654,SENT:0.62182):0.00000;
(SANG:0.17241,SPNE:0.17241):0.00000;
(((SCAN:0.03000,(SPYO:0.00993,SDYS:0.00812):0.01641):0.11454,((SDEV:0.02872,SRAT:0.03144):0.05553,(SENT:0.10353,(SDOW:0.14404,((((SPNE:0.00800,SPSE:0.00756):0.00338,SMIT:0.01046):0.08721,(SANG:0.03211,(SINT:0.02346,SCON:0.01703):0.01593):0.06902):0.02243,SSUI:0.15109):0.11687):0.00767):0.01682):0.00281):0.01652,((SSAL:0.00936,(STHE:0.00963,SVES:0.01439):0.00995):0.08957,SPLU:0.10194):0.00077,((SINF:0.06977,SLUT:0.06502):0.01416,SEQU:0.07530):0.02081):0.00000;
(SPNE:0.00365,SPNE:0.30503,SPSE:0.00238):0.00000;
((SINT:0.06271,SPNE:0.08230):0.03958,SDEV:0.11056,SLUT:0.53135):0.00000;
(SPNE:0.01458,(SINT:0.08960,((SSAL:0.02111,SVES:0.03944):0.04784,SDEV:0.19999):0.04028):0.07208,(SMIT:0.00711,SPSE:0.00804):0.00464):0.00000;
((((SINF:0.00538,SLUT:0.00502):0.10120,SEQU:0.10653):0.10915,(((SPYO:0.16495,(SCAN:0.05525,SDYS:0.05524):0.07002):0.08494,(SPNE:0.37721,((SDYS:0.06750,SPYO:0.06826):0.25567,((SMIT:0.12019,SSAL:0.11180):0.19290,SPLU:0.30526):0.05004):0.02045):0.13242):0.02004,(SRAT:0.03414,SDEV:0.04269):0.14468):0.00821):0.00726,SDOW:0.20630,SSUI:0.18979):0.00000;
(((SPNE:0.02558,SPSE:0.02163):0.04467,SMIT:0.05188):0.29511,SANG:0.04052,(SINT:0.03748,SCON:0.04803):0.00678):0.00000;
((SPNE:0.01856,SPLU:0.29099):0.00653,SPSE:0.01700,SMIT:0.00695):0.00000;
((((SINF:0.01568,SLUT:0.00393):0.02486,SEQU:0.03462):0.08446,(SPNE:0.07630,(SMIT:0.01101,SPSE:0.02575):0.02110):0.08212):0.00829,((SPLU:0.09641,SDEV:0.13830):0.00714,(((SANG:0.03784,SINT:0.04280):0.01196,SCON:0.04721):0.06094,SSUI:0.12299):0.01333):0.00674,((SENT:0.11459,((STHE:0.04465,SSAL:0.02539):0.01025,SVES:0.03758):0.06499):0.02603,(SDOW:0.11096,((SPYO:0.10051,(SCAN:0.06693,SDYS:0.05792):0.01274):0.05682,(LCRE:0.02026,LLAC:0.02256):0.19683):0.00995):0.00569):0.00317):0.00000;
(SMIT:0.03148,SPNE:0.03148):0.00000;
(SENT:0.30701,SPNE:0.30701):0.00000;
(SMIT:0.11371,SPNE:0.11371):0.00000;
((SVES:0.03476,SPNE:0.46798):0.00876,STHE:0.01833,SSAL:0.01506):0.00000;
(SPSE:0.27349,SPNE:0.27349):0.00000;
(SPNE:0.00043,SPSE:0.00130,SMIT:0.00692):0.00000;
((SPSE:0.04555,SPNE:0.03525):0.00671,SPNE:0.04871,SPSE:0.06845):0.00000;
(SPNE:0.07951,SPNE:0.07951):0.00000;
(SCAN:0.26243,SPNE:0.26243):0.00000;
(SPSE:0.58258,SDYS:0.10603,(SCAN:0.09235,SPYO:0.10787):0.00393):0.00000;
(((SSUI:0.22138,(SPLU:0.21578,SENT:0.19817):0.00981):0.00845,(((SPSE:0.00383,SPNE:0.00268):0.07186,SMIT:0.09254):0.12195,(SANG:0.02936,(SCON:0.02472,SINT:0.02814):0.01349):0.11737):0.03423):0.01833,((SVES:0.05511,SSAL:0.04780):0.17839,(SDOW:0.20029,((SEQU:0.08194,(SLUT:0.01501,SINF:0.01945):0.08119):0.10911,((SDEV:0.04029,SRAT:0.03560):0.10937,(SPYO:0.13147,(SCAN:0.08368,SDYS:0.07583):0.02683):0.08082):0.01541):0.01605):0.01078):0.01018,(LLAC:0.05640,LCRE:0.05155):0.30551):0.00000;
(((SDEV:0.05448,SRAT:0.03812):0.14593,(SENT:0.19705,(((SINF:0.00939,(SLUT:0.00634,SEQU:0.00172):0.00401):0.12776,(SPLU:0.13699,(SCAN:0.02529,(SPYO:0.04169,SDYS:0.01759):0.00345):0.08696):0.02608):0.01903,(SSUI:0.15188,((SPSE:0.01994,(SMIT:0.00000,SPNE:0.00000):0.00666):0.08364,(SINT:0.01418,(SANG:0.00000,SCON:0.00000):0.02826):0.10133):0.05185):0.03686):0.01109):0.01872):0.00953,SDOW:0.21382,(SSAL:0.02891,(STHE:0.01018,SVES:0.02173):0.01098):0.16543):0.00000;
(((STHE:0.01800,(SSAL:0.00314,SVES:0.00438):0.00422):0.04992,((LLAC:0.00163,LCRE:0.00042):0.15968,((((LCRE:0.00346,LLAC:0.00310):0.15383,(((SMIT:0.02077,(SPSE:0.00000,SPNE:0.00000):0.02641):0.01261,(SANG:0.00675,(SINT:0.00390,SCON:0.00078):0.00526):0.03878):0.03285,((((SINF:0.00299,SLUT:0.00161):0.00117,SEQU:0.00475):0.05432,((STHE:0.00960,(SSAL:0.00025,SVES:0.00041):0.00831):0.04069,(SPLU:0.04961,(SCAN:0.01059,(SPYO:0.00479,SDYS:0.00363):0.00491):0.05303):0.00426):0.00778):0.00188,(SDOW:0.06900,(SSUI:0.03931,(SENT:0.03446,(SDEV:0.00453,SRAT:0.00319):0.03217):0.02152):0.01228):0.00391):0.00664):0.06391):0.15770,((SDYS:0.03892,(SPNE:0.00416,SPSE:0.00218):0.03403):0.14932,((SLUT:0.04294,SDEV:0.03824):0.04284,SINF:0.06610):0.07696):0.16854):0.09166,(((SPNE:0.00000,SPSE:0.00000):0.03571,SDYS:0.02527):0.19435,((SLUT:0.08718,SDEV:0.07925):0.01994,SINF:0.10272):0.09747):0.10187):0.16648):0.09592):0.01050,(SPLU:0.04847,((SSUI:0.03174,((SCAN:0.00123,SPYO:0.00827):0.00368,SDYS:0.00446):0.03135):0.00817,(SENT:0.06182,((((SINF:0.00449,SLUT:0.00025):0.00100,SEQU:0.00509):0.02891,(SDEV:0.01405,SRAT:0.01103):0.03165):0.00834,SDOW:0.06180):0.00390):0.00508):0.00520):0.00084,((SMIT:0.00914,(SPSE:0.00472,SPNE:0.00142):0.01779):0.02178,(SANG:0.00852,(SINT:0.00389,SCON:0.00227):0.00750):0.03006):0.01339):0.00000;
(SPNE:0.00000,SPSE:0.00000):0.00000;
(((SMIT:0.03581,(SPNE:0.01240,SPSE:0.01004):0.03414):0.08406,(((SDYS:0.01404,(SPYO:0.00000,SDYS:0.00000):0.01731):0.10809,(SINF:0.10065,SEQU:0.06262):0.11896):0.05804,SSUI:0.18936):0.08135):0.00292,((STHE:0.10144,SSAL:0.00932):0.04083,SVES:0.04461):0.10137,(SDOW:0.15109,(((SLUT:0.00404,SINF:0.01408):0.04902,STHE:0.06899):0.03141,SPNE:0.10673):0.05856):0.03808):0.00000;
(SINT:0.09615,SPSE:0.09615):0.00000;
(SPSE:0.08909,SANG:0.11288,LLAC:0.38382):0.00000;
(SPNE:0.28445,SPSE:0.28445):0.00000;
(SPNE:0.00000,SPSE:0.00000):0.00000;
(SENT:0.11891,SPSE:0.11891):0.00000;
(SINF:0.20814,SPSE:0.20814):0.00000;
((SPSE:0.01185,SPNE:0.03246):0.44118,LCRE:0.04112,LLAC:0.03699):0.00000;
((((LLAC:0.04821,LCRE:0.04158):0.31495,((SPSE:0.00360,SPNE:0.00394):0.29025,SSUI:0.26893):0.06081):0.16116,(SCAN:0.05841,(SPYO:0.00722,SDYS:0.00893):0.04772):0.19339):0.02246,SCON:0.23917,SDEV:0.19520):0.00000;
(SPNE:0.03395,SPSE:0.03395):0.00000;
(SANG:0.17613,SPSE:0.17613):0.00000;
(SPSE:0.13781,SCON:0.14285,SSUI:0.27967):0.00000;
(SPSE:0.10093,SDYS:0.08736,SPYO:0.04947):0.00000;
(SPNE:0.00887,SPSE:0.00887):0.00000;
(SPNE:0.01976,SPSE:0.01976):0.00000;
(SENT:0.20329,SSUI:0.18833,SPSE:0.34057):0.00000;
(((STHE:0.03934,SSAL:0.03295):0.11161,((SPNE:0.02610,(SPSE:0.03721,SPNE:0.03217):0.00875):0.08598,(SPSE:0.19946,(SCON:0.33527,(SDYS:0.20625,(SINT:0.04799,SANG:0.00548):0.10798):0.03788):0.01543):0.26326):0.05949):0.05139,(SINT:0.02634,SCON:0.00264):0.01741,SANG:0.04318):0.00000;
(((SSAL:0.00164,SVES:0.01130):0.04571,(SMIT:0.00604,SPSE:0.00477):0.05033):0.01677,((SDOW:0.09194,(SRAT:0.03189,SDEV:0.02359):0.04687):0.22468,(SSUI:0.02836,SPLU:0.02254):0.07658):0.01474,(SINT:0.04726,(SCON:0.03026,SANG:0.01497):0.02248):0.03605):0.00000;
(SPSE:0.00196,SPNE:0.00380,SMIT:0.02045):0.00000;
(SDOW:0.12208,SPSE:0.12208):0.00000;
((SPSE:0.37899,SPSE:0.28253):0.22781,SINF:0.15531,SSUI:0.17596):0.00000;
(SPNE:0.00135,SPSE:0.00135):0.00000;
((SMIT:0.08913,SPSE:0.05151):0.02639,SPNE:0.07404,LLAC:0.59162):0.00000;
(SPNE:0.00371,SPSE:0.00371):0.00000;
(SPSE:0.00557,SPNE:0.00168,SMIT:0.17044):0.00000;
(SPSE:0.02357,SPNE:0.01593,(SANG:0.23825,SENT:0.23050):0.19025):0.00000;
(SPSE:0.01349,SPNE:0.03647,SMIT:0.04375):0.00000;
(SPSE:0.47199,SVES:0.15493,SSAL:0.17002):0.00000;
((SPSE:0.12134,SENT:0.18903):0.10639,(SSAL:0.00900,SVES:0.01912):0.00472,STHE:0.02136):0.00000;
(SPSE:0.35861,SPSE:0.35861):0.00000;
((((LLAC:0.01790,LCRE:0.02732):0.30068,SSUI:0.21325):0.01837,((SPNE:0.02066,(SMIT:0.02635,SPSE:0.02151):0.00417):0.15984,((SANG:0.01773,SCON:0.01887):0.01004,SINT:0.03236):0.10799):0.04168):0.02724,(((SDOW:0.15542,SPLU:0.14876):0.01398,(SEQU:0.04238,(SINF:0.00572,SLUT:0.01006):0.04141):0.11484):0.01776,((SRAT:0.05301,SDEV:0.04037):0.12447,(STHE:0.01533,(SSAL:0.01299,SVES:0.01435):0.00801):0.14367):0.01641):0.00279,(SENT:0.20345,((SCAN:0.04619,SPYO:0.04764):0.00447,SDYS:0.06759):0.12269):0.01353):0.00000;
(SCON:0.29690,SPSE:0.29690):0.00000;
(SPSE:0.04629,SPNE:0.03079,SSAL:0.04317):0.00000;
(SPSE:0.08525,SPNE:0.10404,((SINT:0.19328,(SMIT:0.08896,SPNE:0.06874):0.10472):0.31373,(SPNE:0.04047,SPSE:0.04241):0.16746):0.09488):0.00000;
(SPSE:0.02614,SPSE:0.02614):0.00000;
(SPSE:0.00451,SPNE:0.00605,SVES:0.35336):0.00000;
(SPSE:0.01032,SPNE:0.01032,SMIT:0.59507):0.00000;
(SPNE:0.04301,SPSE:0.04301):0.00000;
(SPSE:0.01658,SPNE:0.02433,SPNE:0.38009):0.00000;
(SPNE:0.06066,SPSE:0.06066):0.00000;
(SANG:0.14296,SPSE:0.14296):0.00000;
((SDEV:0.08663,SDOW:0.12096):0.00826,((SINF:0.03332,(SLUT:0.01693,SEQU:0.00423):0.03294):0.16628,(SPSE:0.16551,SPSE:0.25019):0.00912):0.05565,SRAT:0.10218):0.00000;
(LLAC:0.00000,LCRE:0.00000):0.00000;
((((((SCON:0.04529,SANG:0.05125):0.00789,SINT:0.07411):0.06994,(((SMIT:0.00405,SPSE:0.00614):0.00467,SPNE:0.01465):0.08227,SSUI:0.14559):0.01703):0.03685,(SDOW:0.13909,(LCRE:0.00000,LLAC:0.00000):0.24221):0.01318):0.00920,(SDEV:0.03268,SRAT:0.03494):0.10786):0.00373,(((STHE:0.01244,(SSAL:0.00403,SVES:0.01036):0.00137):0.06560,SPLU:0.09500):0.04353,((SINF:0.00433,SLUT:0.00488):0.00137,SEQU:0.00273):0.10191):0.01314,(SENT:0.11612,(SDYS:0.04221,(SCAN:0.01600,SPYO:0.02726):0.01597):0.09062):0.00562):0.00000;
((SEQU:0.02276,(((SANG:0.00000,(SINT:0.00000,SCON:0.00000):0.00000):0.04004,(SPYO:0.00972,(SCAN:0.00000,SDYS:0.00000):0.00136):0.00982):0.01256,(SDOW:0.05958,(SPLU:0.00993,(SENT:0.06504,(SSUI:0.04446,(((SMIT:0.00000,SPSE:0.00000):0.00506,SPNE:0.02287):0.06031,(LCRE:0.00000,LLAC:0.00000):0.20906):0.02151):0.01081):0.00632):0.00313):0.00532):0.01495):0.00311,((STHE:0.00000,(SSAL:0.00000,SVES:0.00000):0.00000):0.00968,(SDEV:0.00880,SRAT:0.00234):0.03323):0.02278,(SINF:0.00001,SLUT:0.00278):0.00372):0.00000;
(LLAC:0.00000,LCRE:0.00000):0.00000;
((SENT:0.09183,((LCRE:0.00000,LLAC:0.00000):0.59240,(((SMIT:0.00628,(SPSE:0.00161,SPNE:0.00374):0.00264):0.02575,(SINT:0.01441,(SANG:0.00946,SCON:0.00475):0.00783):0.02594):0.07782,(SDOW:0.08755,(SDEV:0.02704,SRAT:0.01713):0.04966):0.00813):0.00439):0.01215):0.00286,(((SSAL:0.00473,(STHE:0.01579,SVES:0.01247):0.00053):0.04517,SPLU:0.06816):0.00730,(SPYO:0.04884,(SCAN:0.00933,SDYS:0.01519):0.02742):0.01597):0.01628,SSUI:0.07011):0.00000;
((LCRE:0.00000,LLAC:0.00000):0.58146,SDEV:0.01973,SRAT:0.02431):0.00000;
((SENT:0.11883,(LCRE:0.00000,LLAC:0.00000):0.49693):0.02452,(SSUI:0.08315,((SPLU:0.12078,(SDOW:0.09126,(SDEV:0.02960,SRAT:0.02051):0.01893):0.01678):0.01331,((STHE:0.02194,(SVES:0.00159,SSAL:0.00443):0.00399):0.09246,((SINF:0.00000,(SLUT:0.00000,SEQU:0.00000):0.00000):0.04420,(SPYO:0.02726,(SDYS:0.00015,SCAN:0.01096):0.01941):0.01886):0.00791):0.02935):0.01201):0.00528,(((SMIT:0.00259,SPSE:0.01745):0.00961,SPNE:0.01050):0.10706,(SANG:0.02592,(SINT:0.00000,SCON:0.00000):0.01756):0.07200):0.01452):0.00000;
((((SPLU:0.13744,SENT:0.16720):0.02371,(((SINT:0.02410,(SANG:0.01756,SCON:0.01436):0.00784):0.07498,(SMIT:0.02121,(SPNE:0.00834,SPSE:0.00730):0.01454):0.12080):0.04350,(SSUI:0.19620,(LCRE:0.01204,LLAC:0.01207):0.30191):0.01344):0.04406):0.01963,SDOW:0.12547):0.00878,(((SPYO:0.01830,(SCAN:0.00778,SDYS:0.01257):0.01527):0.04333,(SEQU:0.01405,(SINF:0.00616,SLUT:0.00726):0.00460):0.05796):0.02069,(SRAT:0.02233,SDEV:0.01786):0.08727):0.00831,((SVES:0.00390,STHE:0.00555):0.01246,SSAL:0.01609):0.10956):0.00000;
(LLAC:0.04959,LCRE:0.04959):0.00000;
(LLAC:0.10238,LCRE:0.10238):0.00000;
((((((STHE:0.01231,SSAL:0.02015):0.00566,SVES:0.00573):0.03599,SPLU:0.04358):0.00641,(SENT:0.11234,(((((SMIT:0.01430,SPSE:0.00201):0.00741,SPNE:0.00292):0.06866,(SANG:0.02407,(SINT:0.01607,SCON:0.02726):0.01125):0.05842):0.03939,SSUI:0.11389):0.03008,((LCRE:0.00696,LLAC:0.00739):0.30013,(LCRE:0.00547,LLAC:0.00420):0.12575):0.02484):0.02557):0.02477):0.00513,SDOW:0.07662):0.00839,((SCAN:0.00804,(SPYO:0.03843,SDYS:0.00801):0.00326):0.02192,(SDEV:0.01206,SRAT:0.00855):0.01695):0.00676,((SINF:0.00934,SLUT:0.00587):0.01687,SEQU:0.01349):0.00944):0.00000;
(LCRE:0.08442,LLAC:0.03819,LCRE:0.42899):0.00000;
(LLAC:0.05695,LCRE:0.05695):0.00000;
(LLAC:0.04482,LCRE:0.04482):0.00000;
(LLAC:0.01020,LCRE:0.01020):0.00000;
((((((SMIT:0.01337,SPNE:0.00508):0.17661,(SINT:0.02243,(SANG:0.00000,SCON:0.00000):0.02176):0.13459):0.02056,SSUI:0.16974):0.00825,(SPLU:0.18416,((LCRE:0.01757,LLAC:0.01218):0.37506,(LLAC:0.00300,LCRE:0.00436):0.18270):0.03976):0.01310):0.01376,(STHE:0.03939,(SVES:0.01349,SSAL:0.02290):0.00904):0.13033):0.00860,(((SINF:0.00793,SLUT:0.00953):0.00399,SEQU:0.01362):0.07858,(SDOW:0.05396,(SDEV:0.01343,SRAT:0.01753):0.03391):0.07456):0.00229,(SPYO:0.05890,(SCAN:0.03408,SDYS:0.02633):0.01659):0.06649):0.00000;
(LLAC:0.03264,LCRE:0.03264):0.00000;
((LCRE:0.02202,LLAC:0.02620):0.17425,(LLAC:0.00909,LCRE:0.01061):0.26336,SPYO:0.40688):0.00000;
(LLAC:0.07572,LCRE:0.07572):0.00000;
(LLAC:0.01615,LCRE:0.01615):0.00000;
(((SINT:0.24244,(LLAC:0.03046,LCRE:0.03846):0.15489):0.04576,LCRE:0.19638):0.06656,SDOW:0.17205,((SCON:0.03989,SANG:0.03738):0.11327,(SRAT:0.07426,SDEV:0.07657):0.08960):0.01291):0.00000;
(LLAC:0.00448,LCRE:0.00448):0.00000;
((((((SMIT:0.00231,SPNE:0.02233):0.03800,(SANG:0.00912,(SINT:0.01021,SCON:0.00483):0.00378):0.03350):0.02352,SSUI:0.10094):0.01336,(LCRE:0.00772,LLAC:0.00443):0.16614):0.00700,(SPLU:0.04896,((SSAL:0.00000,SVES:0.00208):0.00020,STHE:0.01019):0.02329):0.02449):0.00451,((SPYO:0.04814,(SCAN:0.02041,SDYS:0.01820):0.01068):0.02021,(SDOW:0.05369,(SDEV:0.02030,SRAT:0.01972):0.00796):0.01198):0.00282,(SINF:0.01159,(SLUT:0.00627,SEQU:0.00687):0.00210):0.04833):0.00000;
((SPSE:0.00950,(((SANG:0.02645,(SINT:0.00601,SCON:0.01213):0.00170):0.00923,(((SENT:0.05428,(LCRE:0.02464,LLAC:0.01953):0.32179):0.01333,((SDEV:0.02010,SRAT:0.03010):0.02883,(((SLUT:0.00629,(SINF:0.00457,SEQU:0.00907):0.00348):0.04283,((STHE:0.01107,(SSAL:0.00000,SVES:0.00000):0.00056):0.04626,(SCAN:0.02560,(SPYO:0.00100,SDYS:0.00100):0.01849):0.01578):0.01599):0.01589,SPLU:0.06467):0.00974):0.02291):0.00976,SDOW:0.12527):0.01080):0.01088,SSUI:0.01957):0.00372):0.00257,SPNE:0.00032,SMIT:0.00773):0.00000;
((LCRE:0.05207,LLAC:0.04277):0.36544,SPNE:0.25680,(SDOW:0.16126,SDEV:0.16280):0.18379):0.00000;
(LCRE:0.58348,LLAC:0.02065,LCRE:0.02129):0.00000;
(((SSUI:0.15075,(SPNE:0.01955,(SMIT:0.00000,SPSE:0.00000):0.01387):0.06381):0.01366,(((SSAL:0.00371,SVES:0.00941):0.00418,STHE:0.00637):0.06713,(LCRE:0.00783,LLAC:0.00267):0.25633):0.02069):0.02651,(SENT:0.13486,(((((SANG:0.01947,SINT:0.05572):0.00579,SCON:0.02230):0.07584,SDOW:0.08298):0.02235,((SCAN:0.02776,SDYS:0.02071):0.01149,SPYO:0.05495):0.04558):0.00325,(SDEV:0.04042,SRAT:0.02953):0.03261):0.00823):0.00125,(SPLU:0.18028,(SLUT:0.00798,(SINF:0.03508,SEQU:0.01947):0.00111):0.04894):0.03108):0.00000;
(LLAC:0.01489,LCRE:0.01489):0.00000;
(LLAC:0.00599,LCRE:0.00599):0.00000;
((LCRE:0.01762,LLAC:0.01817):0.59690,LCRE:0.02271,LLAC:0.04320):0.00000;
(LLAC:0.07034,LCRE:0.07034):0.00000;
(LLAC:0.06237,LCRE:0.06237):0.00000;
(LLAC:0.02640,LCRE:0.02640):0.00000;
((LLAC:0.02276,LCRE:0.02197):0.48043,LCRE:0.01112,LLAC:0.01742):0.00000;
(LLAC:0.12093,LCRE:0.12093):0.00000;
(LLAC:0.04688,LCRE:0.04688):0.00000;
(LLAC:0.00497,LCRE:0.00497):0.00000;
(LLAC:0.00653,LCRE:0.00653):0.00000;
(LLAC:0.00328,LCRE:0.00328):0.00000;
(LLAC:0.06352,LCRE:0.06352):0.00000;
(LLAC:0.01399,LCRE:0.01399):0.00000;
(LLAC:0.00239,LCRE:0.00239):0.00000;
(LLAC:0.04847,LCRE:0.04847):0.00000;
((SDEV:0.00228,SRAT:0.00185):0.11933,((SPLU:0.16397,SENT:0.12410):0.00863,(((SSAL:0.02033,(STHE:0.01203,SVES:0.01831):0.01073):0.12049,((((SMIT:0.02746,(SPSE:0.01987,SPNE:0.01305):0.01040):0.06203,((SANG:0.01592,SINT:0.01838):0.00117,SCON:0.02140):0.06230):0.02281,SSUI:0.15432):0.02147,SDOW:0.12322):0.02301):0.02447,(LCRE:0.01244,LLAC:0.00895):0.48930):0.02655):0.00843,((SPYO:0.01889,(SCAN:0.00603,SDYS:0.00233):0.00618):0.09188,(SINF:0.00399,(SLUT:0.00445,SEQU:0.00584):0.00537):0.09005):0.03015):0.00000;
(LLAC:0.01471,LCRE:0.01471):0.00000;
(LLAC:0.00000,LCRE:0.00000):0.00000;
(LLAC:0.02192,LCRE:0.02192):0.00000;
(LLAC:0.01766,LCRE:0.01766):0.00000;
(LLAC:0.03548,LCRE:0.03548):0.00000;
(((((SSUI:0.04772,SPLU:0.05195):0.12613,((SSAL:0.02402,SVES:0.01069):0.01654,STHE:0.03788):0.15119):0.03998,((SPYO:0.02633,(SCAN:0.03046,SDYS:0.01748):0.00440):0.08586,(SEQU:0.04195,(SLUT:0.01862,SINF:0.02318):0.03250):0.10094):0.04630):0.02132,(SDOW:0.20332,(LCRE:0.01518,LLAC:0.00934):0.28947):0.04767):0.00701,(SRAT:0.00906,SDEV:0.00263):0.19264,(((SPSE:0.01720,SPNE:0.00866):0.00665,SMIT:0.00513):0.17457,((SANG:0.00897,SINT:0.01323):0.00182,SCON:0.00708):0.13085):0.04428):0.00000;
(LLAC:0.02583,LCRE:0.02583):0.00000;
(LLAC:0.02980,LCRE:0.02980):0.00000;
(LLAC:0.02799,LCRE:0.02799):0.00000;
(LLAC:0.01762,LCRE:0.01762):0.00000;
((SINT:0.04087,((SMIT:0.01003,(SPSE:0.00000,SPNE:0.00000):0.01076):0.03988,(((((STHE:0.00234,SSAL:0.00234):0.01075,SVES:0.00794):0.04491,(SSUI:0.02184,SPLU:0.01807):0.01702):0.01319,((SDOW:0.09081,(LCRE:0.01428,LLAC:0.00246):0.34354):0.04596,(SDEV:0.05377,SRAT:0.02048):0.04560):0.01636):0.03192,((SINF:0.01127,SLUT:0.02353):0.00666,SEQU:0.00266):0.04984):0.00391):0.01665):0.00336,SCON:0.02799,SANG:0.02575):0.00000;
(LLAC:0.01889,LCRE:0.01889):0.00000;
(((SINF:0.04640,SEQU:0.04365):0.08084,((SSUI:0.11451,SENT:0.15908):0.04137,((LCRE:0.05426,LLAC:0.02682):0.24809,((SANG:0.01329,SCON:0.02453):0.03083,SPNE:0.12549):0.19614):0.04002):0.04228):0.00868,(SDEV:0.03278,SRAT:0.02491):0.07497,SDYS:0.12824):0.00000;
(LLAC:0.00559,LCRE:0.00559):0.00000;
(LLAC:0.07756,LCRE:0.07756):0.00000;
((((((SMIT:0.00973,SPSE:0.00803):0.00471,SPNE:0.01473):0.06094,(SINT:0.03572,(SANG:0.01356,SCON:0.01610):0.00519):0.04289):0.01354,SSUI:0.07659):0.02111,((SPLU:0.09893,SENT:0.11065):0.00482,(LCRE:0.01041,LLAC:0.01019):0.18853):0.00515):0.00738,(((SSAL:0.01935,(STHE:0.00671,SVES:0.00455):0.02760):0.05743,((SLUT:0.01131,(SINF:0.00755,SEQU:0.00626):0.00284):0.05034,SDOW:0.07086):0.00716):0.00655,(SDEV:0.02453,SRAT:0.02695):0.06516):0.00275,((SCAN:0.01961,SPYO:0.02738):0.01739,SDYS:0.05137):0.05745):0.00000;
((SPLU:0.12200,((LCRE:0.02864,LLAC:0.01876):0.35368,(((SPSE:0.01169,(SMIT:0.00694,SPNE:0.01289):0.00026):0.11202,((SANG:0.02979,SINT:0.03112):0.00344,SCON:0.03090):0.07229):0.00788,SSUI:0.13672):0.01837):0.00671):0.01012,((((SSAL:0.01819,(STHE:0.00542,SVES:0.00585):0.01697):0.08266,(SLUT:0.01874,(SINF:0.00307,SEQU:0.00024):0.01896):0.07752):0.00868,SDOW:0.10937):0.00349,(((SCAN:0.00617,SPYO:0.00841):0.02303,SDYS:0.02891):0.08120,(SDEV:0.03123,SRAT:0.02480):0.07093):0.00975):0.00324,SENT:0.15747):0.00000;
(LLAC:0.19742,LCRE:0.19742):0.00000;
(((SCAN:0.00404,(SPYO:0.00209,SDYS:0.00852):0.01718):0.05833,((((SMIT:0.00660,(SPSE:0.00071,SPNE:0.00197):0.00142):0.06001,(SINT:0.03113,(SANG:0.01250,SCON:0.00321):0.03431):0.03904):0.05869,SSUI:0.09922):0.03556,(LCRE:0.00672,LLAC:0.00658):0.23979):0.07540):0.02035,((SDOW:0.06828,(((STHE:0.00000,SSAL:0.00000):0.00236,SVES:0.00555):0.02929,(SENT:0.07648,(SDEV:0.02404,SRAT:0.03370):0.02719):0.01932):0.00704):0.01166,((SINF:0.02623,SLUT:0.02518):0.04972,SEQU:0.05986):0.05890):0.00887,SPLU:0.09988):0.00000;
((((((SMIT:0.01255,SPSE:0.01247):0.00463,SPNE:0.01493):0.09456,(SINT:0.03317,(SANG:0.00231,SCON:0.00876):0.02477):0.10351):0.01621,SSUI:0.15664):0.01058,(LCRE:0.03552,LLAC:0.03409):0.14378):0.03084,((SDEV:0.02052,SRAT:0.01536):0.12491,((SINF:0.01566,SLUT:0.01702):0.04483,SEQU:0.06675):0.05239):0.00335,((SPLU:0.13656,SENT:0.14164):0.01431,((SPYO:0.08356,(SCAN:0.06899,SDYS:0.05197):0.02329):0.05639,((STHE:0.04042,(SSAL:0.02503,SVES:0.01764):0.00883):0.10249,SDOW:0.12570):0.04827):0.00686):0.00608):0.00000;
(LLAC:0.01538,LCRE:0.01538):0.00000;
(LLAC:0.02254,LCRE:0.02254):0.00000;
((((((SPYO:0.00379,SDYS:0.00726):0.02586,SCAN:0.02391):0.12922,((SDEV:0.09722,(SEQU:0.04064,(SLUT:0.01164,SINF:0.02068):0.02046):0.05502):0.08202,SRAT:0.15378):0.01438):0.05499,(SDOW:0.30585,(LCRE:0.00787,LLAC:0.00275):0.41812):0.01357):0.17199,(SINT:0.01294,(SANG:0.00117,SCON:0.00402):0.01647):0.01769):0.02100,(SPSE:0.00246,SPNE:0.01311):0.00694,SMIT:0.00172):0.00000;
(LLAC:0.06810,LCRE:0.06810):0.00000;
(((SANG:0.00401,SCON:0.01095):0.00956,((STHE:0.00223,(SSAL:0.00000,SVES:0.00000):0.00537):0.02012,((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.04842,(((SSUI:0.07145,(SCAN:0.00000,(SPYO:0.00000,SDYS:0.00000):0.00000):0.13108):0.01420,(LCRE:0.01056,LLAC:0.00699):0.36007):0.01969,((SPLU:0.09605,((SINF:0.00296,SLUT:0.00706):0.01465,SEQU:0.02049):0.00755):0.00813,SRAT:0.05406):0.01728):0.01983):0.01023):0.01534):0.00793,SDOW:0.03355,SINT:0.03345):0.00000;
((SSUI:0.12867,(((SMIT:0.01300,(SPSE:0.00000,SPNE:0.00000):0.01065):0.08290,(SANG:0.02701,(SINT:0.00159,SCON:0.00824):0.02399):0.04496):0.05965,(LCRE:0.02631,LLAC:0.01866):0.26387):0.00719):0.01306,((SPLU:0.09190,(SDEV:0.02370,SRAT:0.03162):0.07719):0.02712,((SSAL:0.01747,(STHE:0.03004,SVES:0.01189):0.00570):0.13336,(SDOW:0.11438,((SPYO:0.08672,(SCAN:0.06302,SDYS:0.07164):0.01060):0.01439,((SINF:0.02184,SLUT:0.01820):0.03451,SEQU:0.04254):0.08089):0.03040):0.01448):0.01141):0.00394,SENT:0.15310):0.00000;
(((SENT:0.06581,((SCAN:0.01491,SPYO:0.01433):0.00819,SDYS:0.02446):0.02370):0.01498,((SLUT:0.00794,(SINF:0.00246,SEQU:0.00240):0.02133):0.03630,((LCRE:0.01230,LLAC:0.01108):0.31261,(SSUI:0.06993,((SMIT:0.00389,(SPSE:0.00000,SPNE:0.00000):0.00342):0.05720,(SINT:0.01176,(SCON:0.01683,SANG:0.01634):0.00177):0.03720):0.00825):0.17673):0.19239):0.01170):0.00716,(SDEV:0.01871,SRAT:0.02101):0.07537,((STHE:0.01408,(SSAL:0.01175,SVES:0.00919):0.00257):0.03314,(SPLU:0.06527,SDOW:0.04934):0.01825):0.00938):0.00000;
(LLAC:0.02544,LCRE:0.02544):0.00000;
(LLAC:0.09041,LCRE:0.09041):0.00000;
(LLAC:0.01495,LCRE:0.01495):0.00000;
(LLAC:0.00143,LCRE:0.00143):0.00000;
((SPLU:0.10114,(((((SMIT:0.00490,(SPSE:0.00713,SPNE:0.00577):0.00248):0.03366,(SINT:0.00525,(SANG:0.00540,SCON:0.00874):0.00214):0.03852):0.04965,SSUI:0.10753):0.06608,((((((LCRE:0.01415,LLAC:0.01630):0.20697,(SDYS:0.08068,(SPYO:0.04493,SCAN:0.04311):0.02643):0.15415):0.07862,((SINT:0.12745,(SPNE:0.02507,(SPSE:0.01350,SMIT:0.01341):0.01300):0.10971):0.10767,SSUI:0.22974):0.11762):0.03199,(((SSAL:0.02828,SVES:0.02529):0.07744,STHE:0.10030):0.26065,((SPLU:0.27368,((SDOW:0.17408,SRAT:0.18091):0.02714,(SVES:0.03612,SSAL:0.03264):0.16561):0.06867):0.02262,(SPLU:0.25525,SEQU:0.23193):0.01929):0.04109):0.06494):0.03678,((SCAN:0.17695,(SPNE:0.02517,SMIT:0.01773):0.15199):0.16420,(((((SMIT:0.02350,(SPSE:0.01240,SPNE:0.01747):0.00617):0.08155,(SINT:0.02897,(SANG:0.00989,SCON:0.00762):0.01682):0.08681):0.05213,SENT:0.14105):0.00983,(SPYO:0.04808,SDYS:0.03150):0.11200):0.02442,SPLU:0.18305):0.14084):0.02882):0.16771,SSUI:0.20951):0.03439):0.06209,(LLAC:0.00588,LCRE:0.01158):0.12687):0.04797):0.00495,((((SINF:0.00648,SLUT:0.00318):0.00770,SEQU:0.01406):0.05188,SDOW:0.07623):0.00664,((SDEV:0.01436,SRAT:0.01852):0.03924,(SENT:0.08210,((SCAN:0.00740,SPYO:0.00661):0.00700,SDYS:0.01371):0.05410):0.00497):0.01335):0.00548,(STHE:0.03500,(SSAL:0.01725,SVES:0.01736):0.00941):0.05555):0.00000;
(LLAC:0.01745,LCRE:0.01745):0.00000;
(LLAC:0.05016,LCRE:0.05016):0.00000;
(LLAC:0.07419,LCRE:0.07419):0.00000;
(LLAC:0.00508,LCRE:0.00508):0.00000;
(LLAC:0.02551,LCRE:0.02551):0.00000;
(((SDEV:0.04274,((SANG:0.01740,(SINT:0.01436,SCON:0.00008):0.01871):0.08276,(SDOW:0.10080,((SPSE:0.01090,(SMIT:0.00000,SPNE:0.00000):0.00380):0.13699,(LCRE:0.00767,LLAC:0.00562):0.46152):0.02227):0.02648):0.00906):0.00602,(STHE:0.02890,(SSAL:0.00000,SVES:0.00000):0.00660):0.10513):0.00540,(SENT:0.07592,((SPYO:0.02595,(SCAN:0.00000,SDYS:0.00000):0.00007):0.02888,((SLUT:0.01112,(SINF:0.04337,SEQU:0.01733):0.01949):0.01065,SRAT:0.02083):0.03462):0.01300):0.01869,(SSUI:0.05246,SPLU:0.06897):0.02103):0.00000;
(LLAC:0.01423,LCRE:0.01423):0.00000;
(LLAC:0.16906,LCRE:0.16906):0.00000;
(((SDEV:0.04739,SRAT:0.04756):0.12689,(LCRE:0.06427,LLAC:0.04962):0.20217):0.01476,((SDOW:0.13428,(SENT:0.06470,SPLU:0.07816):0.01190):0.02372,((SSAL:0.03142,(STHE:0.00597,SVES:0.01444):0.01506):0.12816,(SSUI:0.15293,((SANG:0.03057,(SINT:0.01223,SCON:0.01341):0.01694):0.07076,((SMIT:0.01836,SPSE:0.03007):0.00872,SPNE:0.03133):0.09489):0.05334):0.02214):0.01683):0.01185,(((SINF:0.00000,SLUT:0.00000):0.03981,SEQU:0.04254):0.06481,(SPYO:0.06653,(SCAN:0.02328,SDYS:0.03554):0.03983):0.06802):0.01732):0.00000;
((((SMIT:0.05601,(SPSE:0.00163,SPNE:0.00108):0.09596):0.07030,SENT:0.11655):0.00717,(((SINF:0.00374,SLUT:0.00175):0.03667,SEQU:0.03307):0.06824,(((SPYO:0.03930,(SCAN:0.03225,SDYS:0.02560):0.01272):0.06974,(SDEV:0.03285,SRAT:0.02573):0.07162):0.00520,(SDOW:0.14351,((STHE:0.04901,(SSAL:0.00140,SVES:0.00065):0.02626):0.09431,((SANG:0.02836,(SINT:0.01218,SCON:0.00824):0.01272):0.13609,((LLAC:0.00819,LCRE:0.01599):0.14823,(LCRE:0.00596,LLAC:0.00930):0.15424):0.19325):0.00528):0.00938):0.00892):0.00644):0.01562):0.00373,SPLU:0.10352,SSUI:0.08256):0.00000;
((((SENT:0.08219,((SPLU:0.06993,SSUI:0.06562):0.01099,((SCAN:0.01581,SDYS:0.02031):0.02277,SPYO:0.06534):0.02889):0.00913):0.12806,(LCRE:0.00029,LLAC:0.00014):0.15540):0.07892,(SRAT:0.00544,SDEV:0.00441):0.09725):0.00263,((SPSE:0.00480,(SMIT:0.00740,SPNE:0.00676):0.00035):0.08392,(SDOW:0.07663,(((STHE:0.00688,SSAL:0.00298):0.01820,SVES:0.01266):0.05049,((SINF:0.00566,SLUT:0.00554):0.01250,SEQU:0.03282):0.04064):0.01065):0.02097):0.03165,((SINT:0.00379,SCON:0.00257):0.00595,SANG:0.00592):0.09574):0.00000;
(LLAC:0.01352,LCRE:0.01352):0.00000;
(LLAC:0.11780,LCRE:0.11780):0.00000;
(LLAC:0.02921,LCRE:0.02921):0.00000;
(LLAC:0.02177,LCRE:0.02177):0.00000;
(LLAC:0.10401,LCRE:0.10401):0.00000;
(LLAC:0.02987,LCRE:0.02987):0.00000;
(((((SINF:0.01163,SLUT:0.01610):0.00281,SEQU:0.00738):0.05499,(SDEV:0.02789,SRAT:0.03175):0.02413):0.00614,((SSUI:0.09024,SDOW:0.07953):0.00629,(((SMIT:0.00776,(SPSE:0.00462,SPNE:0.00800):0.00357):0.07085,(SANG:0.01608,(SINT:0.00370,SCON:0.00841):0.01377):0.04865):0.01219,(LCRE:0.00943,LLAC:0.00631):0.18665):0.01212):0.01119):0.00247,(SDYS:0.03061,(SCAN:0.02165,SPYO:0.02226):0.00309):0.04990,(STHE:0.01933,(SSAL:0.00488,SVES:0.00899):0.00444):0.04307):0.00000;
(((((SMIT:0.02108,SPSE:0.01488):0.00138,SPNE:0.02241):0.11008,SENT:0.17517):0.02555,((SINT:0.02923,(SANG:0.02812,SCON:0.01646):0.01256):0.07674,(LCRE:0.00402,LLAC:0.00314):0.14235):0.04839):0.00542,((((SSAL:0.01209,(STHE:0.01809,SVES:0.01117):0.00555):0.07030,((SINF:0.01368,SLUT:0.00723):0.04435,SEQU:0.05108):0.04194):0.02040,((SRAT:0.03314,SDEV:0.03646):0.09379,SDOW:0.11284):0.02336):0.01328,(SPYO:0.10041,(SCAN:0.07074,SDYS:0.05145):0.02237):0.06068):0.01368,(SSUI:0.15241,SPLU:0.14988):0.01839):0.00000;
(LLAC:0.03167,LCRE:0.03167):0.00000;
(LLAC:0.03125,LCRE:0.03125):0.00000;
(LLAC:0.01874,LCRE:0.01874):0.00000;
(LLAC:0.02594,LCRE:0.02594):0.00000;
((((SINF:0.00442,SLUT:0.00703):0.00044,SEQU:0.00137):0.04135,((((((SMIT:0.00029,SPSE:0.00577):0.00360,SPNE:0.00429):0.03337,(SANG:0.01436,(SINT:0.01220,SCON:0.00857):0.00390):0.02380):0.06564,(LCRE:0.00689,LLAC:0.00248):0.35755):0.00627,SSUI:0.10995):0.01916,(SDOW:0.08594,(SENT:0.06989,(SDEV:0.02701,SRAT:0.02784):0.04714):0.00608):0.01987):0.02466):0.00447,(SPLU:0.05561,(SCAN:0.00956,(SPYO:0.00536,SDYS:0.00311):0.01070):0.01703):0.00568,(SSAL:0.00401,(STHE:0.00180,SVES:0.01049):0.00661):0.03344):0.00000;
(((SCON:0.15063,(SDEV:0.15571,LLAC:0.14390):0.02267):0.22704,((LLAC:0.04386,LCRE:0.04420):0.26631,(LLAC:0.33021,(((SDOW:0.25187,((SRAT:0.17530,SDEV:0.19582):0.01256,SDOW:0.24694):0.06333):0.08123,(LCRE:0.05619,LLAC:0.08553):0.22403):0.01979,SDOW:0.30111):0.06104):0.03383):0.01214):0.02370,(((SPNE:0.00660,SPSE:0.00883):0.15463,SPLU:0.21619):0.03515,(SSUI:0.18875,((SLUT:0.10120,SEQU:0.12000):0.03905,(SDEV:0.02143,SRAT:0.01948):0.15515):0.03539):0.02727):0.01236,SENT:0.27494):0.00000;
(LLAC:0.07725,LCRE:0.07725):0.00000;
(LLAC:0.03579,LCRE:0.03579):0.00000;
((SPLU:0.07675,((SCAN:0.01483,(SPYO:0.03271,SDYS:0.04976):0.01401):0.02342,((((SINF:0.00000,SLUT:0.00000):0.00512,SEQU:0.02345):0.02450,(SDEV:0.07592,SRAT:0.03783):0.02673):0.02849,((LCRE:0.02717,LLAC:0.00535):0.43018,((((SMIT:0.01478,SPSE:0.00092):0.00421,SPNE:0.00364):0.05785,(SANG:0.04307,(SINT:0.00000,SCON:0.00000):0.01878):0.06226):0.03958,(SSUI:0.12744,SENT:0.10414):0.02764):0.00740):0.02772):0.01512):0.01221):0.01028,(SVES:0.00408,SDOW:0.04042):0.00462,(STHE:0.01850,SSAL:0.00233):0.00707):0.00000;
((((SEQU:0.04003,(SLUT:0.02533,SINF:0.01646):0.02794):0.16729,(((SPYO:0.02065,SDYS:0.00890):0.03012,SCAN:0.02540):0.20340,(LCRE:0.03659,LLAC:0.02078):0.27843):0.00704):0.01217,(SPLU:0.27588,(SRAT:0.03002,SDEV:0.02755):0.11263):0.04049):0.00756,(SDOW:0.19792,SENT:0.17050):0.03207,(SSUI:0.20791,((SPNE:0.00362,(SPSE:0.00000,SMIT:0.00000):0.00260):0.11377,(SINT:0.03749,(SCON:0.01551,SANG:0.01545):0.02378):0.09436):0.01957):0.09707):0.00000;
((((STHE:0.00339,(SSAL:0.00000,SVES:0.00000):0.00004):0.00358,((SSUI:0.02155,((SPLU:0.00874,SENT:0.01352):0.00456,((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.01303,(LCRE:0.00443,LLAC:0.00261):0.16789):0.00737):0.00351):0.00275,(((SANG:0.00657,(SINT:0.00000,SCON:0.00000):0.00027):0.00183,(SPYO:0.00158,(SCAN:0.00000,SDYS:0.00000):0.00526):0.00544):0.00020,(SDEV:0.00020,SRAT:0.01177):0.00130):0.00288):0.00119):0.00155,(SEQU:0.00000,SDOW:0.00000):0.00000):0.00000,SLUT:0.00000,SINF:0.00000):0.00000;
(((LCRE:0.00548,LLAC:0.00850):0.25840,(SPLU:0.11734,(SEQU:0.05770,(SINF:0.00868,SLUT:0.00455):0.05548):0.07719):0.21871):0.31541,((SMIT:0.02835,SPSE:0.04888):0.11363,(SANG:0.02126,SINT:0.02961):0.07678):0.05068,(SSAL:0.05460,SVES:0.06956):0.06656):0.00000;
(((SCAN:0.25000,(LCRE:0.03926,LLAC:0.03005):0.35959):0.03713,((SENT:0.16849,((SSUI:0.15331,SPLU:0.13269):0.03368,SENT:0.18336):0.01800):0.02898,((SPSE:0.00969,(SMIT:0.01006,SPNE:0.00672):0.00547):0.07607,(SANG:0.02867,(SINT:0.00467,SCON:0.00504):0.02187):0.06349):0.06760):0.01961):0.01548,(SPYO:0.00370,SDYS:0.00203):0.15843,SCAN:0.16860):0.00000;
(LCRE:0.01651,LLAC:0.00683,SDOW:0.60288):0.00000;
(LCRE:0.01820,LLAC:0.01749,SDEV:0.69274):0.00000;
(LLAC:0.03630,LCRE:0.03630):0.00000;
(LLAC:0.03173,LCRE:0.03173):0.00000;
(LLAC:0.02146,LCRE:0.02146):0.00000;
(LLAC:0.05373,LCRE:0.05373):0.00000;
(((SPLU:0.11576,SDOW:0.09034):0.00722,(((SSAL:0.02011,(STHE:0.01467,SVES:0.00636):0.01126):0.12211,(((SINF:0.00457,SLUT:0.01146):0.03391,SEQU:0.04357):0.06698,(SDEV:0.02577,SRAT:0.01976):0.08392):0.01516):0.00954,((SSUI:0.12137,((SMIT:0.00177,(SPSE:0.00000,SPNE:0.00000):0.01397):0.11718,(SINT:0.03811,(SANG:0.02951,SCON:0.01974):0.00758):0.07513):0.04200):0.00641,(LCRE:0.00836,LLAC:0.01004):0.25522):0.00664):0.00595):0.00342,SENT:0.14057,(SPYO:0.10980,(SCAN:0.03472,SDYS:0.04570):0.03249):0.06197):0.00000;
(((LCRE:0.02811,LLAC:0.03114):0.70304,SCAN:0.01374):0.00665,SDYS:0.00879,SPYO:0.01113):0.00000;
(((SPLU:0.27516,(SSUI:0.29893,((((SANG:0.29906,(LLAC:0.10433,LCRE:0.09713):0.18749):0.04303,((SEQU:0.05742,(SLUT:0.01892,SINF:0.02468):0.03875):0.22345,(SRAT:0.06686,SDEV:0.06681):0.20354):0.04691):0.03571,((((SPNE:0.03319,(SPSE:0.02239,SMIT:0.02381):0.01180):0.19443,(SANG:0.04096,SCON:0.04108):0.16254):0.10697,SSAL:0.27653):0.01350,(SEQU:0.28144,((SINF:0.12785,SEQU:0.11931):0.21056,(SSUI:0.27868,SENT:0.26678):0.03168):0.00829):0.00813):0.02240):0.08559,(LCRE:0.01646,LLAC:0.01730):0.31226):0.02303):0.01824):0.01449,(((SSAL:0.02240,SVES:0.02683):0.01027,STHE:0.04090):0.21514,((SDYS:0.03470,(SPYO:0.04245,SCAN:0.04261):0.00348):0.18788,(SRAT:0.06055,SDEV:0.04831):0.18391):0.00717):0.01373):0.01534,(SDOW:0.22023,(SEQU:0.04036,(SLUT:0.01750,SINF:0.01718):0.02293):0.20527):0.00440,((SPSE:0.02609,(SMIT:0.02210,SPNE:0.02118):0.00372):0.07113,(SINT:0.02269,(SANG:0.01469,SCON:0.01724):0.01020):0.07408):0.18689):0.00000;
(SSAL:0.14136,LCRE:0.14136):0.00000;
(((((SINF:0.01031,SLUT:0.01256):0.00990,SEQU:0.02209):0.02713,(SDEV:0.02728,SRAT:0.03033):0.03801):0.00493,(((SMIT:0.00208,(SPSE:0.00154,SPNE:0.00266):0.00119):0.05940,(SINT:0.04963,(SANG:0.02104,SCON:0.01620):0.03170):0.00683):0.01784,(SENT:0.08172,(SSUI:0.09773,((SDOW:0.09563,(SRAT:0.02218,SDEV:0.02271):0.06838):0.40510,(LCRE:0.01658,LLAC:0.01246):0.12857):0.04523):0.00628):0.00407):0.01153):0.00481,((STHE:0.02603,(SSAL:0.00488,SVES:0.00869):0.01166):0.02454,(SPLU:0.08403,(SPYO:0.04109,(SCAN:0.01601,SDYS:0.01501):0.02306):0.01084):0.00638):0.00633,SDOW:0.06271):0.00000;
(SENT:0.08582,((((SINF:0.00441,SLUT:0.00749):0.00393,SEQU:0.00813):0.06153,(SPLU:0.05417,(SCAN:0.01536,(SPYO:0.01932,SDYS:0.00663):0.00357):0.04777):0.00243):0.00849,(((((SMIT:0.00254,SPSE:0.01293):0.00351,SPNE:0.01375):0.04194,(SANG:0.01808,(SINT:0.00872,SCON:0.00534):0.01195):0.04146):0.02867,SSUI:0.07713):0.01356,(LCRE:0.00632,LLAC:0.01102):0.20854):0.01099):0.00176,((STHE:0.01760,(SSAL:0.00420,SVES:0.00700):0.00190):0.06211,((SDEV:0.03312,SRAT:0.02879):0.04685,SDOW:0.07656):0.01059):0.00292):0.00000;
((SCAN:0.13291,((SSAL:0.00334,SVES:0.00255):0.12495,((LCRE:0.08078,LLAC:0.09088):0.10494,(SANG:0.10960,((SPYO:0.02522,SDYS:0.02612):0.11978,(SDOW:0.02314,(SDEV:0.01570,SRAT:0.00900):0.01066):0.10070):0.01510):0.03725):0.04794):0.01204):0.00504,((SENT:0.13443,((SINF:0.00927,SLUT:0.01116):0.00848,SEQU:0.01415):0.08013):0.01663,(SCON:0.08690,(SINT:0.04591,STHE:0.05160):0.03274):0.01899):0.00531,(SSUI:0.08028,SPLU:0.09823):0.03020):0.00000;
(LLAC:0.20250,LCRE:0.20250):0.00000;
(((SCAN:0.02459,(SPYO:0.00066,SDYS:0.00662):0.01640):0.06817,((LCRE:0.05713,LLAC:0.05901):0.20661,(LCRE:0.00250,LLAC:0.00224):0.33265):0.03136):0.00781,((SDEV:0.01005,SRAT:0.02298):0.03635,((SPLU:0.05963,((STHE:0.01878,(SSAL:0.00621,SVES:0.01121):0.00642):0.03453,SDOW:0.05667):0.00673):0.04777,((SSUI:0.06250,SENT:0.07453):0.02394,((SMIT:0.00286,(SPSE:0.00113,SPNE:0.00435):0.01086):0.02753,(SINT:0.01556,(SANG:0.01236,SCON:0.02197):0.00250):0.03052):0.02654):0.00408):0.00305):0.00112,((SINF:0.00677,SLUT:0.01027):0.02086,SEQU:0.02304):0.07253):0.00000;
(((SRAT:0.08201,SDEV:0.07166):0.02592,((SSUI:0.16162,(LCRE:0.01795,LLAC:0.02214):0.18629):0.09749,SENT:0.09905):0.00475):0.01110,(((SLUT:0.02448,(SINF:0.00993,SEQU:0.00537):0.01378):0.02103,((SANG:0.01914,SCON:0.02464):0.00403,SINT:0.03610):0.02757):0.03779,SDOW:0.07889):0.00312,(SPLU:0.08382,((SCAN:0.02505,(SPYO:0.01944,SDYS:0.01248):0.02630):0.03652,((STHE:0.01132,(SSAL:0.00509,SVES:0.00340):0.00333):0.01087,(SPNE:0.02311,(SMIT:0.00817,SPSE:0.01096):0.00664):0.01275):0.04949):0.00892):0.01550):0.00000;
(((((STHE:0.04824,(SSAL:0.01388,SVES:0.01979):0.00811):0.08682,SPLU:0.14035):0.01480,(SDEV:0.03003,SRAT:0.04574):0.13319):0.00851,(SDOW:0.14015,(LCRE:0.07690,LLAC:0.06828):0.16274):0.03534):0.00304,(SSUI:0.14352,((SPSE:0.02851,(SMIT:0.03238,SPNE:0.03444):0.00494):0.12361,(((SINF:0.07453,SLUT:0.08233):0.02965,SEQU:0.09458):0.05309,(SINT:0.13355,(SANG:0.04626,SCON:0.05798):0.05883):0.05808):0.00174):0.01807):0.00569,(SENT:0.14568,(SCAN:0.07420,(SPYO:0.05478,SDYS:0.04559):0.03817):0.06544):0.02183):0.00000;
(LLAC:0.02996,LCRE:0.02996):0.00000;
(LLAC:0.01520,LCRE:0.01520):0.00000;
(LLAC:0.03350,LCRE:0.03350):0.00000;
(((SENT:0.09588,(SDEV:0.02605,SRAT:0.03658):0.07076):0.00736,((LCRE:0.02628,LLAC:0.02047):0.12886,(((LCRE:0.07649,LLAC:0.08201):0.18584,(SENT:0.17996,((SDOW:0.15749,((SSUI:0.08667,SPLU:0.08044):0.08843,(((SINT:0.05983,(SCON:0.03060,SANG:0.02699):0.03205):0.07652,((SMIT:0.01721,SPSE:0.01610):0.01152,SPNE:0.03271):0.10701):0.01910,((((SINF:0.01127,SLUT:0.01386):0.02018,SEQU:0.03276):0.10239,(SSAL:0.03632,(SVES:0.02365,STHE:0.02549):0.01160):0.08983):0.01503,(SDEV:0.07352,SRAT:0.06868):0.07333):0.01642):0.00702):0.00334):0.01847,(SPYO:0.13475,(SCAN:0.09701,SDYS:0.10022):0.02210):0.06817):0.00527):0.06824):0.15100,((LCRE:0.03424,LLAC:0.03491):0.22291,(SENT:0.15957,((SSUI:0.13861,((SINT:0.02982,(SANG:0.03095,SCON:0.02219):0.01251):0.08566,(SPNE:0.02322,(SPSE:0.00660,SMIT:0.00628):0.01168):0.10054):0.01641):0.02479,(((SDOW:0.15281,(((SINF:0.01624,SLUT:0.01647):0.01450,SEQU:0.03687):0.07136,(SDEV:0.03725,SRAT:0.03454):0.09250):0.00969):0.01501,((STHE:0.01194,(SSAL:0.00360,SVES:0.00589):0.00638):0.14332,SPLU:0.15615):0.00115):0.01580,(SDYS:0.03497,(SPYO:0.02100,SCAN:0.02808):0.01111):0.11551):0.00553):0.01495):0.06982):0.13051):0.17451):0.04865):0.00384,((((SMIT:0.00899,(SPSE:0.00401,SPNE:0.01247):0.00189):0.03663,((SANG:0.01258,SINT:0.01102):0.01793,SCON:0.03363):0.03361):0.00793,SSUI:0.06012):0.03589,(((SSAL:0.00494,(STHE:0.01363,SVES:0.00630):0.00203):0.04162,((SINF:0.00549,SLUT:0.00635):0.00816,SEQU:0.00961):0.04309):0.01167,SPLU:0.07939):0.00655):0.00759,((SPYO:0.02789,(SCAN:0.02063,SDYS:0.02150):0.00960):0.07806,SDOW:0.09395):0.01074):0.00000;
(LLAC:0.05065,LCRE:0.05065):0.00000;
((SDOW:0.17578,((SCAN:0.03642,SDYS:0.03305):0.18480,(LCRE:0.04339,LLAC:0.03832):0.34154):0.02717):0.00568,(((SINF:0.02649,SLUT:0.02622):0.01442,SEQU:0.03181):0.12400,(SDEV:0.02556,SRAT:0.02983):0.12022):0.01940,(STHE:0.03509,(SVES:0.01392,SSAL:0.00660):0.01921):0.17528):0.00000;
(LLAC:0.01481,LCRE:0.01481):0.00000;
(LCRE:0.02248,LLAC:0.00933,SDOW:0.36085):0.00000;
(LLAC:0.00202,LCRE:0.00202):0.00000;
((LCRE:0.30574,LCRE:0.23726):0.01141,(((SPLU:0.32878,(SEQU:0.12350,SPYO:0.18879):0.09303):0.02360,(SPNE:0.20035,(SENT:0.17293,SANG:0.16905):0.04210):0.04556):0.09130,LCRE:0.27141):0.03280,LLAC:0.26283):0.00000;
(((((SINF:0.00650,SLUT:0.00107):0.00504,SEQU:0.01135):0.05716,(SCAN:0.01379,(SPYO:0.00967,SDYS:0.00734):0.00985):0.06964):0.00522,(((((SMIT:0.00108,SPSE:0.00210):0.00076,SPNE:0.00368):0.04455,(SINT:0.02068,(SANG:0.00781,SCON:0.00798):0.00554):0.03210):0.00455,SSUI:0.08195):0.02052,(LCRE:0.04112,LLAC:0.02882):0.22888):0.00861):0.00090,((SDEV:0.01005,SRAT:0.02100):0.06066,((SPLU:0.07535,SENT:0.08121):0.01649,SDOW:0.08071):0.00173):0.00396,(STHE:0.01193,(SSAL:0.00344,SVES:0.00541):0.00451):0.06437):0.00000;
((((SMIT:0.00471,(SPSE:0.00000,SPNE:0.00000):0.01396):0.16714,(SANG:0.01802,(SINT:0.00687,SCON:0.01276):0.01217):0.08323):0.02320,(SSUI:0.15684,(LCRE:0.00219,LLAC:0.00315):0.30536):0.01609):0.02728,(((SSAL:0.00815,(STHE:0.01431,SVES:0.01268):0.00534):0.10198,(((SINF:0.01190,SLUT:0.00521):0.01684,SEQU:0.02400):0.04675,(SDEV:0.01421,SRAT:0.01728):0.07089):0.02608):0.00854,((SENT:0.16940,(SPYO:0.03956,(SCAN:0.02425,SDYS:0.02399):0.00552):0.08384):0.00676,SDOW:0.14722):0.00743):0.00447,SPLU:0.16957):0.00000;
(LLAC:0.02647,LCRE:0.02647):0.00000;
(LLAC:0.01907,LCRE:0.01907):0.00000;
(LLAC:0.13806,LCRE:0.13806):0.00000;
(((LCRE:0.23127,LLAC:0.26781):0.00871,(LCRE:0.01431,LLAC:0.02408):0.20321):0.01585,((LLAC:0.22205,(LLAC:0.23406,LLAC:0.24437):0.02642):0.02508,(LLAC:0.21498,LLAC:0.24917):0.03857):0.00607,(LCRE:0.24127,((LLAC:0.05371,LCRE:0.04728):0.26176,(LCRE:0.29674,(LCRE:0.24223,((LCRE:0.19221,(LLAC:0.09668,LCRE:0.08818):0.07343):0.04871,LCRE:0.21564):0.03491):0.01671):0.01479):0.00601):0.02048):0.00000;
(LLAC:0.05886,LCRE:0.05886):0.00000;
(LLAC:0.04107,LCRE:0.04107):0.00000;
((SSUI:0.25607,(LCRE:0.07011,LLAC:0.08451):0.30188):0.05064,(SPSE:0.02442,SMIT:0.02852):0.14845,SANG:0.22310):0.00000;
(LLAC:0.04228,LCRE:0.04228):0.00000;
((((SENT:0.17760,((SSAL:0.05378,(STHE:0.01674,SVES:0.01809):0.04431):0.09628,(((((SMIT:0.00932,SPSE:0.01156):0.00189,SPNE:0.00984):0.09567,(SINT:0.02229,(SANG:0.01389,SCON:0.02576):0.00511):0.07041):0.03448,SSUI:0.14612):0.01274,(LCRE:0.00744,LLAC:0.00835):0.20569):0.00606):0.01351):0.00491,(SDEV:0.02206,SRAT:0.02543):0.09403):0.00766,(SPLU:0.12193,SDOW:0.13864):0.00556):0.00339,(SPYO:0.05749,(SCAN:0.03861,SDYS:0.03610):0.01978):0.08164,((SINF:0.00416,SLUT:0.00989):0.02948,SEQU:0.03746):0.07967):0.00000;
((LCRE:0.02802,LLAC:0.02620):0.20744,(SPLU:0.17757,((SSAL:0.10128,((SMIT:0.02933,(SPSE:0.02729,SPNE:0.03217):0.00931):0.04819,SINT:0.09614):0.03303):0.02733,((SCAN:0.06078,(SPYO:0.01272,SDYS:0.00491):0.03099):0.09514,(SEQU:0.04917,(SINF:0.02292,SLUT:0.02743):0.02335):0.06477):0.01335):0.02262):0.01160,SSUI:0.20273):0.00000;
((((SDYS:0.12482,SCAN:0.11367):0.16071,SSUI:0.23745):0.14004,(LCRE:0.01109,LLAC:0.00707):0.28173):0.06808,(LLAC:0.01424,LCRE:0.01338):0.26885,(SDYS:0.05557,SCAN:0.06243):0.21491):0.00000;
((SENT:0.07337,((((SPSE:0.01434,(SMIT:0.00463,SPNE:0.00468):0.00835):0.04987,(SANG:0.00698,(SINT:0.00397,SCON:0.00478):0.00815):0.04964):0.01014,(SSUI:0.03985,SPLU:0.03515):0.04162):0.01524,(LLAC:0.01167,LCRE:0.02261):0.11888):0.00641):0.00610,(((STHE:0.00780,(SSAL:0.00000,SVES:0.00000):0.00563):0.03158,SDOW:0.04335):0.00526,(SDEV:0.00627,SRAT:0.00894):0.04793):0.00477,(((SINF:0.00301,SLUT:0.00283):0.00753,SEQU:0.00619):0.04980,(SPYO:0.03940,(SCAN:0.01713,SDYS:0.01097):0.00463):0.01876):0.00731):0.00000;
(LLAC:0.03333,LCRE:0.03333):0.00000;
(((((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.03969,(SANG:0.00000,(SINT:0.00000,SCON:0.00000):0.00000):0.02881):0.03383,SSUI:0.08010):0.02277,(SPLU:0.05941,(SENT:0.07388,((LLAC:0.00000,LCRE:0.00000):0.21927,(((LCRE:0.00850,LLAC:0.00820):0.14995,(SENT:0.10134,((((SMIT:0.00313,(SPSE:0.00000,SPNE:0.00000):0.00729):0.06629,(SINT:0.01550,(SANG:0.00226,SCON:0.00817):0.00834):0.06960):0.00918,SSUI:0.09885):0.01207,((STHE:0.05597,(SSAL:0.01395,SVES:0.01151):0.01427):0.07351,(SDOW:0.08184,((SPLU:0.02831,(SPYO:0.01482,(SCAN:0.01260,SDYS:0.00077):0.00378):0.03727):0.02119,(((SINF:0.00000,SLUT:0.00000):0.01381,SEQU:0.01266):0.04320,(SDEV:0.00378,SRAT:0.00917):0.04861):0.00762):0.00877):0.00911):0.01184):0.00515):0.02516):0.10647,(((LCRE:0.04604,LLAC:0.04841):0.20857,(LCRE:0.00715,LLAC:0.00892):0.32574):0.01490,((LCRE:0.30062,(LLAC:0.06348,LCRE:0.05168):0.19055):0.01789,(LLAC:0.11495,LCRE:0.08339):0.11260):0.02625):0.02677):0.05373):0.11012):0.00897):0.00622):0.01179,(((SSAL:0.00487,(STHE:0.01287,SVES:0.00812):0.00337):0.01416,SDOW:0.06347):0.01286,(SDEV:0.00547,SRAT:0.00355):0.04865):0.00080,((SINF:0.00000,(SLUT:0.00000,SEQU:0.00000):0.00000):0.03562,(SPYO:0.01633,(SCAN:0.00555,SDYS:0.00047):0.00327):0.01050):0.01675):0.00000;
(((SENT:0.25935,SDOW:0.21357):0.01527,(((SANG:0.02298,(SINT:0.00000,SCON:0.00000):0.02682):0.18658,(SPNE:0.04051,(SPSE:0.02510,SMIT:0.03064):0.00871):0.16416):0.06332,(((SSAL:0.01657,SVES:0.02473):0.06704,STHE:0.09238):0.21569,(LCRE:0.04635,LLAC:0.04858):0.32401):0.01390):0.01821):0.00531,((SPLU:0.23317,(SPYO:0.15940,(SDYS:0.13672,SCAN:0.12728):0.00735):0.09877):0.02070,((SRAT:0.04092,SDEV:0.03718):0.18015,(SEQU:0.06108,(SLUT:0.01371,SINF:0.01409):0.06053):0.15701):0.02975):0.00796,SSUI:0.26281):0.00000;
(((SINT:0.01458,(SANG:0.00354,SCON:0.00463):0.00674):0.07020,(LCRE:0.00453,LLAC:0.00217):0.18140):0.00513,(((SLUT:0.02450,(SINF:0.02678,SEQU:0.01834):0.00336):0.03900,SDOW:0.06933):0.01214,(SDEV:0.02140,SRAT:0.02215):0.03408):0.00669,(STHE:0.01394,(SSAL:0.00454,SVES:0.00459):0.00434):0.05003):0.00000;
((((((SMIT:0.01631,SPSE:0.01534):0.00651,SPNE:0.02580):0.06232,SANG:0.08967):0.00881,(SINT:0.01086,SCON:0.01220):0.07039):0.03380,(((LLAC:0.00257,LCRE:0.00233):0.19276,((((SMIT:0.01169,SPSE:0.00510):0.07834,(SINT:0.04097,(SANG:0.01424,SCON:0.01915):0.01872):0.05025):0.02759,SSUI:0.11009):0.01186,(SDOW:0.11489,(((SSAL:0.02333,(STHE:0.02810,SVES:0.02294):0.00373):0.07730,(SENT:0.11103,(SPYO:0.03567,(SCAN:0.03459,SDYS:0.03242):0.00964):0.07649):0.00264):0.00460,((SDEV:0.06458,SRAT:0.06191):0.04735,((SLUT:0.02403,SEQU:0.02318):0.00639,SINF:0.03786):0.06766):0.01504):0.00539):0.00967):0.08621):0.25750,(LCRE:0.03614,LLAC:0.03915):0.19891):0.07045):0.01342,(((SCAN:0.06295,(SPYO:0.04541,SDYS:0.04577):0.01550):0.05031,(((STHE:0.02363,(SSAL:0.02216,SVES:0.01926):0.00056):0.05818,((SINF:0.01689,SLUT:0.01944):0.00241,SEQU:0.01334):0.06171):0.00709,(SDEV:0.05763,SRAT:0.06122):0.03051):0.00524):0.01834,(SDOW:0.11932,SPLU:0.11447):0.00762):0.00276,(SSUI:0.10914,SENT:0.12985):0.01240):0.00000;
(((((SINF:0.00904,SLUT:0.01062):0.04347,SEQU:0.04340):0.05893,(((((SMIT:0.00730,SPSE:0.00600):0.00286,SPNE:0.01337):0.10195,(SINT:0.03057,(SANG:0.01519,SCON:0.02280):0.00226):0.07665):0.03455,SSUI:0.15799):0.01188,(SDOW:0.13426,(LCRE:0.00632,LLAC:0.00867):0.26622):0.01923):0.01430):0.00553,(SDEV:0.01938,SRAT:0.02603):0.10541):0.00246,((SPLU:0.11304,SENT:0.10140):0.01495,((SCAN:0.01814,SPYO:0.01921):0.00119,SDYS:0.01722):0.09865):0.00311,(SSAL:0.01432,(STHE:0.01296,SVES:0.01493):0.00579):0.08436):0.00000;
((LLAC:0.02338,LCRE:0.04029):0.07549,LLAC:0.02626,LCRE:0.02586):0.00000;
((SPLU:0.12328,(((LCRE:0.00593,LLAC:0.00804):0.12442,(((SANG:0.03132,SINT:0.02931):0.01096,SCON:0.04607):0.12887,(LCRE:0.03227,LLAC:0.02904):0.45476):0.02902):0.01989,SDOW:0.10983):0.00655):0.01470,(((SPSE:0.01152,(SPNE:0.00596,SMIT:0.00194):0.00348):0.06902,(STHE:0.00526,(SSAL:0.00000,SVES:0.00000):0.00199):0.05586):0.01073,(SSUI:0.06107,(SDEV:0.00681,SRAT:0.00366):0.05819):0.04535):0.00225,((SINF:0.00137,SLUT:0.00189):0.01345,SEQU:0.01815):0.05742):0.00000;
(LLAC:0.04202,LCRE:0.04202):0.00000;
((((SINF:0.00691,SLUT:0.02256):0.01413,SEQU:0.02002):0.09256,(((SSUI:0.00633,SPLU:0.01237):0.02024,SENT:0.04177):0.04728,((SDEV:0.05391,SRAT:0.03595):0.05404,(LCRE:0.00639,LLAC:0.00639):0.35774):0.02838):0.04430):0.02020,((SCAN:0.00000,(SPYO:0.00000,SDYS:0.00000):0.00000):0.02947,SDOW:0.04146):0.01416,((SMIT:0.01665,SPSE:0.02473):0.00797,(((SSAL:0.03057,(STHE:0.02046,SVES:0.00500):0.02452):0.01413,SPNE:0.01890):0.00677,((SANG:0.00132,SINT:0.00556):0.01622,SCON:0.02047):0.00909):0.00655):0.00431):0.00000;
(((SSUI:0.07650,SDOW:0.12141):0.01535,(SENT:0.13439,(LCRE:0.00825,LLAC:0.00487):0.14831):0.02010):0.01255,(SPLU:0.06803,((((SINF:0.00991,SLUT:0.01359):0.00126,SEQU:0.00287):0.03662,(SDEV:0.07751,SRAT:0.06115):0.01142):0.00901,(SPYO:0.01898,(SCAN:0.00500,SDYS:0.00560):0.00695):0.06487):0.00588):0.00367,((SSAL:0.02520,(STHE:0.00532,SVES:0.00406):0.01226):0.01901,((SPSE:0.00516,(SMIT:0.00000,SPNE:0.00000):0.00070):0.03058,(SANG:0.02394,(SINT:0.01093,SCON:0.00905):0.02486):0.01637):0.01540):0.01237):0.00000;
(LLAC:0.10192,LCRE:0.10192):0.00000;
(LLAC:0.02593,LCRE:0.02593):0.00000;
(LCRE:0.44293,SDEV:0.25192,LLAC:0.20087):0.00000;
((LCRE:0.24272,SPLU:0.24518):0.02131,SPLU:0.28424,(SSAL:0.28865,SPNE:0.31231):0.11701):0.00000;
(LLAC:0.04230,LCRE:0.04230):0.00000;
((((SDEV:0.01865,SRAT:0.01664):0.06306,((((SMIT:0.00564,(SPSE:0.00000,SPNE:0.00000):0.00490):0.01991,(SANG:0.01293,(SINT:0.00062,SCON:0.00539):0.00915):0.02907):0.02714,SSUI:0.06968):0.01931,(LCRE:0.01431,LLAC:0.01409):0.35470):0.01834):0.02244,(SPLU:0.08278,SDOW:0.06936):0.00264):0.00163,(((STHE:0.00919,(SSAL:0.00467,SVES:0.00585):0.00832):0.04521,(SINF:0.00811,(SLUT:0.00381,SEQU:0.00023):0.00654):0.04834):0.00235,((SCAN:0.01420,SPYO:0.01423):0.00268,SDYS:0.01671):0.03674):0.00407,SENT:0.06806):0.00000;
(LLAC:0.01685,LCRE:0.01685):0.00000;
(LLAC:0.01389,LCRE:0.01389):0.00000;
((SMIT:0.02040,(LCRE:0.11062,LLAC:0.10204):0.35133):0.00496,SPSE:0.01083,SPNE:0.01292):0.00000;
(LLAC:0.01739,LCRE:0.01739):0.00000;
((((SPLU:0.39163,SPLU:0.38656):0.01152,(SPLU:0.04415,SENT:0.04099):0.31905):0.15208,(LCRE:0.00330,LLAC:0.00388):0.11838):0.06100,(SMIT:0.00448,SPSE:0.00476):0.05643,(SCAN:0.01463,SDYS:0.01228):0.03876):0.00000;
(LLAC:0.34692,LCRE:0.34692):0.00000;
(LLAC:0.02818,LCRE:0.02818):0.00000;
(LLAC:0.01904,LCRE:0.01904):0.00000;
(LCRE:0.32122,LCRE:0.32122):0.00000;
(LCRE:0.10999,LLAC:0.09958,LLAC:0.24381):0.00000;
((SDOW:0.12418,(((SRAT:0.00391,SDEV:0.00226):0.10660,(STHE:0.02682,(SSAL:0.01805,SVES:0.01499):0.00588):0.08714):0.00551,((SSUI:0.15100,((SMIT:0.04000,(SPSE:0.00487,SPNE:0.00622):0.03877):0.04641,((SANG:0.00571,SINT:0.01158):0.00069,SCON:0.01105):0.05632):0.05445):0.02768,(LCRE:0.02747,LLAC:0.02833):0.30523):0.03087):0.00730):0.00598,((((SINF:0.00665,SLUT:0.00217):0.00482,SEQU:0.00755):0.10003,(SPYO:0.01778,(SCAN:0.00400,SDYS:0.00748):0.00960):0.08243):0.01366,SPLU:0.14441):0.00383,SENT:0.13045):0.00000;
(LLAC:0.07274,LCRE:0.07274):0.00000;
(LLAC:0.06525,LCRE:0.06525):0.00000;
(LLAC:0.11552,LCRE:0.11552):0.00000;
(LLAC:0.09924,LCRE:0.09924):0.00000;
(LLAC:0.00879,LCRE:0.00879):0.00000;
(((STHE:0.03252,(SSAL:0.01393,SVES:0.01110):0.01111):0.07213,((((SSUI:0.02174,SPLU:0.02137):0.10844,(SDEV:0.03588,SRAT:0.03547):0.09932):0.02020,(LCRE:0.03272,LLAC:0.02544):0.46314):0.01535,(SPNE:0.00285,(SPSE:0.00000,SMIT:0.00000):0.00433):0.13324):0.02401):0.01462,((SINF:0.03535,SLUT:0.02048):0.08529,SDOW:0.09211):0.01275,SINF:0.14297):0.00000;
(LCRE:0.51969,LCRE:0.08497,LLAC:0.10000):0.00000;
((SINT:0.03154,((SRAT:0.01371,SDEV:0.01196):0.38083,(LCRE:0.02058,LLAC:0.01456):0.30135):0.26540):0.01296,SSAL:0.01880,SMIT:0.02787):0.00000;
(LLAC:0.12975,LCRE:0.16276,SDYS:0.42565):0.00000;
(LLAC:0.03867,LCRE:0.03867):0.00000;
(((SENT:0.14882,((LLAC:0.08899,LCRE:0.06918):0.06319,SDEV:0.16736):0.00481):0.00701,(SDOW:0.13108,((SCAN:0.02477,SPYO:0.03055):0.01003,SDYS:0.03527):0.06911):0.00966):0.00567,SLUT:0.12534,((SSAL:0.07179,SVES:0.06486):0.00818,((SMIT:0.01950,(SPSE:0.01120,SPNE:0.00960):0.01342):0.04991,(SINT:0.01500,(SANG:0.01766,SCON:0.01227):0.00059):0.05636):0.01141):0.01618):0.00000;
(((((SSAL:0.02065,(STHE:0.01223,SVES:0.00942):0.01210):0.06641,(SSUI:0.06233,SPLU:0.06857):0.02701):0.00827,((((SMIT:0.00398,SPSE:0.00635):0.00136,SPNE:0.00818):0.05695,((SANG:0.00699,SINT:0.00728):0.00155,SCON:0.00796):0.05083):0.02253,((SENT:0.05393,(SPYO:0.02704,(SCAN:0.01302,SDYS:0.01506):0.00930):0.03724):0.00671,(SDEV:0.00874,SRAT:0.00554):0.04540):0.02253):0.00882):0.00713,((LCRE:0.00556,LLAC:0.00639):0.11395,(SPLU:0.35242,((SPLU:0.08614,SENT:0.09171):0.19654,(((SDYS:0.04306,SCAN:0.03548):0.05080,(SMIT:0.00503,SPSE:0.00672):0.10112):0.02287,(LCRE:0.01922,LLAC:0.02099):0.08910):0.14038):0.01813):0.25297):0.02327):0.00598,((SINF:0.01010,SLUT:0.01182):0.00329,SEQU:0.00865):0.07063,SDOW:0.08886):0.00000;
(SDYS:0.05079,SPYO:0.11479,SCAN:0.06328):0.00000;
(SDYS:0.22040,(SDOW:0.26434,SDOW:0.19951):0.04881,SSUI:0.28341):0.00000;
(SDYS:0.00292,SPYO:0.00758,SCAN:0.02388):0.00000;
(SDYS:0.21141,SCAN:0.14399,SPYO:0.37105):0.00000;
(SPYO:0.21960,SDYS:0.21960):0.00000;
((((SEQU:0.31230,(LCRE:0.01033,LLAC:0.02617):0.23925):0.01774,SDEV:0.13818):0.00916,((SDYS:0.02524,SCAN:0.02159):0.09108,(SSUI:0.12385,(SMIT:0.01238,SPSE:0.01168):0.11229):0.00606):0.01456):0.00743,(SANG:0.05493,SCON:0.04600):0.07152,((SSAL:0.05063,SVES:0.04396):0.11358,SDOW:0.13495):0.03209):0.00000;
(((((SEQU:0.24318,(LLAC:0.01605,LCRE:0.01066):0.20734):0.01324,(SVES:0.03570,SSAL:0.03418):0.16555):0.03941,SSUI:0.14398):0.01176,((SCAN:0.02484,SDYS:0.02640):0.09136,((SMIT:0.01398,SPSE:0.01748):0.08885,SDOW:0.08334):0.00855):0.01363):0.00613,SDEV:0.15216,(SANG:0.01245,SCON:0.01238):0.10307):0.00000;
((((STHE:0.03657,(SSAL:0.01635,SVES:0.03258):0.01854):0.08009,(SVES:0.00913,SSAL:0.00503):0.11653):0.06483,((SINF:0.07863,(SLUT:0.06239,SEQU:0.06121):0.01611):0.06730,SDYS:0.23401):0.01127):0.00879,((SPLU:0.17107,(SDEV:0.01607,SRAT:0.01798):0.14786):0.03364,SDOW:0.19793):0.00394,((SMIT:0.01938,SPNE:0.02835):0.13840,SSUI:0.18633):0.11135):0.00000;
((SDOW:0.13121,((LCRE:0.02050,LLAC:0.01577):0.13678,SDYS:0.53920):0.02208):0.01387,(((SINF:0.01538,SLUT:0.01051):0.01354,SEQU:0.02155):0.06780,SRAT:0.08068):0.01015,(STHE:0.06252,(SSAL:0.01081,SVES:0.01642):0.02129):0.06923):0.00000;
(SINF:0.11504,SDYS:0.11504):0.00000;
(SENT:0.33040,SDYS:0.33040):0.00000;
(SPYO:0.14462,SDYS:0.14462):0.00000;
(SCAN:0.09361,SDYS:0.09361):0.00000;
(SDYS:0.20961,SPLU:0.07914,SSUI:0.09981):0.00000;
(((SINF:0.01265,SLUT:0.01974):0.05299,SEQU:0.06039):0.03735,(SDOW:0.09377,((SDEV:0.01609,SRAT:0.01765):0.04288,((STHE:0.01825,(SSAL:0.00956,SVES:0.00164):0.01194):0.02907,(SDYS:0.00387,(SCAN:0.00480,SPYO:0.00132):0.00038):0.04381):0.00631):0.00526):0.00262,(((SANG:0.01479,SCON:0.01242):0.01853,SPNE:0.04258):0.24443,((SSUI:0.00421,SPLU:0.00430):0.04385,SENT:0.03225):0.03317):0.00881):0.00000;
((((STHE:0.01269,SVES:0.00731):0.07981,(((SCAN:0.01104,(SPYO:0.00598,SDYS:0.00427):0.00730):0.05775,((SINF:0.00788,(SLUT:0.00542,SEQU:0.00278):0.00222):0.04008,(SSAL:0.05443,SDOW:0.05587):0.00470):0.01310):0.04653,(LCRE:0.00739,LLAC:0.00615):0.11551):0.22463):0.00775,((SPLU:0.06748,(SDEV:0.02181,SRAT:0.02288):0.04897):0.00883,(SPNE:0.05537,SENT:0.04853):0.02879):0.02105):0.01496,((SANG:0.02046,(SINT:0.01554,SCON:0.01433):0.00614):0.04458,SSUI:0.06379):0.00169,(SMIT:0.00813,(SPSE:0.00663,SPNE:0.00750):0.00262):0.05476):0.00000;
(SDYS:0.16914,SSUI:0.29005,SDYS:0.34509):0.00000;
(SDYS:0.00000,SPLU:0.00000,SANG:0.10108):0.00000;
(((SPLU:0.02662,SDYS:0.02246):0.00498,(SANG:0.29798,SCAN:0.05528):0.01562):0.00077,SSUI:0.03037,SSUI:0.03090):0.00000;
((SPNE:0.01557,((SSAL:0.06895,SVES:0.06196):0.01638,((((((SANG:0.01825,SCON:0.01708):0.00661,SINT:0.02252):0.42448,(LLAC:0.01427,LCRE:0.01280):0.18650):0.03543,SSUI:0.19027):0.02484,((SDYS:0.00760,SPYO:0.00588):0.03454,SCAN:0.04258):0.10958):0.01137,(SRAT:0.04604,SDEV:0.04182):0.07872):0.05819):0.06328):0.00448,SPSE:0.00543,SMIT:0.00450):0.00000;
(SDYS:0.45628,SPYO:0.09402,SCAN:0.01709):0.00000;
((((SSAL:0.00282,(STHE:0.00000,SVES:0.00000):0.00414):0.01188,((SSUI:0.00130,SPLU:0.00043):0.01024,(SENT:0.00842,(SCAN:0.00106,(SPYO:0.00016,SDYS:0.02042):0.00755):0.00625):0.01051):0.00433):0.00704,(SDEV:0.00600,SRAT:0.00448):0.01694):0.00163,((SINF:0.00905,(SLUT:0.00172,SEQU:0.00002):0.00658):0.01151,SDOW:0.03267):0.00471,((LCRE:0.00025,LLAC:0.01374):0.11981,((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.00157,(SANG:0.00000,(SINT:0.00000,SCON:0.00000):0.00000):0.00711):0.02458):0.02037):0.00000;
(SCAN:0.25982,SDYS:0.25982):0.00000;
(SSUI:0.32276,SDYS:0.32276):0.00000;
(SCAN:0.10389,SDYS:0.10389):0.00000;
(SPYO:0.22900,SDYS:0.22900):0.00000;
(SDYS:0.09004,SPYO:0.09004):0.00000;
(((SSUI:0.07076,SPLU:0.05661):0.04098,((LCRE:0.05430,LLAC:0.06659):0.19191,(SPYO:0.26839,((STHE:0.05640,(SANG:0.02845,SINT:0.02748):0.04201):0.09248,(SENT:0.13582,(SCAN:0.11772,SDYS:0.10582):0.02853):0.00915):0.17171):0.07491):0.07761):0.03193,(SVES:0.00501,SSAL:0.00405):0.08736,SCON:0.08096):0.00000;
(SDYS:0.07873,SPYO:0.07873):0.00000;
(SDYS:0.02124,SPYO:0.02124):0.00000;
(SDYS:0.00000,SPYO:0.00000):0.00000;
(SENT:0.24703,SPYO:0.24703):0.00000;
(((SDYS:0.02813,(SCAN:0.01782,SPYO:0.01901):0.02488):0.04222,(SDEV:0.02429,SRAT:0.01922):0.05936):0.00769,(SPLU:0.09320,SENT:0.08400):0.00606,((SEQU:0.01724,(SLUT:0.00062,SINF:0.00476):0.01455):0.09002,((((SSAL:0.00527,SVES:0.00938):0.00572,STHE:0.02657):0.11973,SDOW:0.12000):0.00847,((LCRE:0.00056,LLAC:0.00022):0.17378,(((SMIT:0.00130,(SPSE:0.00107,SPNE:0.00527):0.00265):0.03666,((SANG:0.00085,SINT:0.00072):0.00372,SCON:0.00176):0.03426):0.04921,SSUI:0.08262):0.02296):0.02247):0.00702):0.00732):0.00000;
(SPLU:0.39811,(SPYO:0.10666,SCAN:0.10521):0.15013,((SINT:0.01127,(SCON:0.00680,SANG:0.00918):0.00149):0.26019,((SPNE:0.02190,SMIT:0.01646):0.19962,(SDEV:0.03494,SRAT:0.03634):0.15291):0.02007):0.01414):0.00000;
((SENT:0.08313,((SCAN:0.01314,SDYS:0.01829):0.01756,SPYO:0.04782):0.03760):0.00827,((((STHE:0.00488,SSAL:0.00861):0.00455,SVES:0.00631):0.04507,(((SINF:0.00349,SLUT:0.00064):0.01031,SEQU:0.01007):0.04653,SDOW:0.07905):0.01088):0.00468,(SDEV:0.04415,SRAT:0.03830):0.02015):0.00228,(((LCRE:0.00292,LLAC:0.00748):0.17409,(((SPSE:0.01048,(SMIT:0.00609,SPNE:0.01087):0.00475):0.02411,(SANG:0.03319,(SINT:0.02926,SCON:0.02613):0.00888):0.01513):0.01644,SSUI:0.07523):0.01094):0.01850,SPLU:0.09179):0.00384):0.00000;
(SPLU:0.31326,SPYO:0.31326):0.00000;
((((((SINF:0.01144,SLUT:0.01548):0.03116,SEQU:0.02739):0.08143,((SMIT:0.01995,(SPSE:0.01040,SPNE:0.01540):0.00431):0.08800,(SINT:0.04164,(SCON:0.03489,SANG:0.03100):0.00511):0.06941):0.02591):0.00428,(SDOW:0.11086,(SDEV:0.03072,SRAT:0.03228):0.07874):0.00898):0.00727,((SPYO:0.09319,(SCAN:0.04901,SDYS:0.06395):0.01016):0.08545,((LCRE:0.03711,LLAC:0.02988):0.14400,SSUI:0.18936):0.01512):0.00759):0.00180,SENT:0.15999,((SSAL:0.01627,(STHE:0.01021,SVES:0.00604):0.01532):0.10466,SPLU:0.11424):0.02104):0.00000;
((SPYO:0.20842,SDOW:0.16810):0.27013,SMIT:0.03049,SPNE:0.03089):0.00000;
(((SPYO:0.01745,(SCAN:0.00986,SDYS:0.00779):0.00438):0.07156,((((((LCRE:0.04672,LLAC:0.04626):0.12385,SSUI:0.20210):0.10841,(((LCRE:0.00355,LLAC:0.00591):0.12354,(((STHE:0.02156,SVES:0.00721):0.07233,SDOW:0.07741):0.01359,((((SINF:0.00912,SLUT:0.00228):0.00976,SEQU:0.01612):0.05279,(SCAN:0.01516,SDYS:0.00984):0.06941):0.00410,(SRAT:0.02207,SDEV:0.02321):0.05388):0.02386):0.02622):0.09723,(((SPLU:0.06276,SENT:0.06879):0.01398,((SCAN:0.00807,SPYO:0.00743):0.00982,SDYS:0.02021):0.05469):0.00394,(((SPSE:0.01011,(SMIT:0.00579,SPNE:0.00642):0.00241):0.03942,(SINT:0.01038,(SANG:0.00658,SCON:0.00820):0.00505):0.03759):0.01232,(STHE:0.00744,(SSAL:0.00330,SVES:0.00367):0.00461):0.06027):0.01283):0.14986):0.05374):0.08258,(SPYO:0.01902,SDYS:0.01453):0.37279):0.00936,((LLAC:0.04644,LCRE:0.05168):0.20961,SSUI:0.23032):0.06095):0.06038,((LLAC:0.00490,LCRE:0.00338):0.12722,(SDOW:0.10456,((SVES:0.07770,(SDEV:0.01035,SRAT:0.01778):0.06461):0.00402,(((SINF:0.00227,SLUT:0.00270):0.00544,SEQU:0.00919):0.05642,(SCAN:0.03941,SDYS:0.03456):0.04094):0.01089):0.00545):0.02474):0.10089):0.15030):0.00523,((((SMIT:0.00105,SPSE:0.00829):0.00135,SPNE:0.00360):0.04496,(SANG:0.01209,(SINT:0.00376,SCON:0.00447):0.00569):0.04546):0.00680,(STHE:0.02003,(SSAL:0.00365,SVES:0.00230):0.00727):0.05019):0.03103,(SPLU:0.05814,SENT:0.08480):0.01027):0.00000;
(SPYO:0.27285,((LLAC:0.21615,SPNE:0.27648):0.03884,(SLUT:0.18104,SPYO:0.18704):0.04755):0.01879,SCAN:0.26498):0.00000;
(SPYO:0.11858,SDYS:0.07158,SCAN:0.04856):0.00000;
((SPYO:0.14489,SDYS:0.14147):0.10315,SDOW:0.27895,STHE:0.26828):0.00000;
(((SPYO:0.05822,SDYS:0.04526):0.01509,SCAN:0.05744):0.07968,(SPLU:0.14749,(((SSAL:0.01927,SVES:0.01660):0.00890,STHE:0.02873):0.11896,((SINF:0.00851,SLUT:0.01614):0.03450,SEQU:0.03197):0.09988):0.00792):0.00345,(SDOW:0.14144,((SDEV:0.02409,SRAT:0.02859):0.13207,(SENT:0.18344,((LCRE:0.05001,LLAC:0.04715):0.25516,(((SPSE:0.01001,(SMIT:0.00999,SPNE:0.00982):0.00142):0.09953,(SINT:0.03343,(SANG:0.02274,SCON:0.02836):0.00290):0.07812):0.06110,SSUI:0.19388):0.00206):0.03831):0.00984):0.00881):0.00428):0.00000;
(SPYO:0.64802,LCRE:0.00817,LLAC:0.01327):0.00000;
(SENT:0.32984,SPYO:0.32984):0.00000;
(((((LLAC:0.04615,LCRE:0.04712):0.37168,((SPNE:0.03015,(SPSE:0.02420,SMIT:0.02389):0.00128):0.21478,(SINT:0.06873,(SCON:0.03449,SANG:0.02884):0.02940):0.12512):0.05964):0.00888,SENT:0.29369):0.00592,((((SEQU:0.04712,(SLUT:0.01642,SINF:0.01391):0.03336):0.08550,(SDEV:0.03880,SRAT:0.04320):0.09497):0.06147,((SDYS:0.08563,SCAN:0.09489):0.02117,SPYO:0.12765):0.12417):0.00580,((STHE:0.03527,(SSAL:0.01158,SVES:0.01431):0.01920):0.15938,SPLU:0.22021):0.01585):0.03101):0.00160,SDOW:0.25835,SSUI:0.24184):0.00000;
((SDOW:0.29863,(SPYO:0.14031,(SCAN:0.10732,SDYS:0.10742):0.03172):0.17838):0.03661,SPLU:0.32063,((SINT:0.10339,SANG:0.09697):0.15441,((SPSE:0.02114,SPNE:0.02362):0.06932,SMIT:0.10068):0.19240):0.05327):0.00000;
(SPSE:0.27024,SPYO:0.27024):0.00000;
(SENT:0.28386,SPYO:0.28386):0.00000;
(SPYO:0.07637,SDYS:0.05180,SCAN:0.04225):0.00000;
(SPYO:0.04054,SPYO:0.02931,(SEQU:0.16351,SDOW:0.33824):0.13490):0.00000;
(SPYO:0.08852,SEQU:0.32389,SVES:0.10087):0.00000;
(SPYO:0.45541,SENT:0.13887,SINF:0.11988):0.00000;
(SENT:0.16417,SPYO:0.16417):0.00000;
(SPSE:0.21733,SPYO:0.21733):0.00000;
(SENT:0.27367,SPYO:0.27367):0.00000;
(SENT:0.25513,SPYO:0.25513):0.00000;
(SENT:0.33684,SPYO:0.33684):0.00000;
(SPYO:0.02167,SDYS:0.04906,SPYO:0.03935):0.00000;
(SPYO:0.01986,SPYO:0.01986):0.00000;
(SPYO:0.00789,SDYS:0.01147,SCAN:0.58301):0.00000;
((SPYO:0.26150,(SPYO:0.16669,SDYS:0.13635):0.05568):0.02482,SPYO:0.24295,SCAN:0.37310):0.00000;
(SPYO:0.05123,(SCAN:0.03266,SDYS:0.02884):0.01295,SSUI:0.46541):0.00000;
(SDYS:0.00589,SPYO:0.00589):0.00000;
((((SCAN:0.00000,SSUI:0.00000):0.00000,SCON:0.00000):0.00000,SANG:0.00000):0.00000,SPNE:0.00192,SPSE:0.00000):0.00000;
(SCAN:0.00000,SCON:0.00000,SCON:0.13939):0.00000;
((((SCAN:0.00000,SENT:0.00000):0.00000,SSUI:0.00000):0.00000,SCON:0.00000):0.00000,SANG:0.00000,SPSE:0.00000):0.00000;
((((((SCAN:0.00000,SENT:0.00000):0.00000,SSUI:0.00000):0.00000,SSUI:0.00188):0.00000,SCON:0.00000):0.00000,SANG:0.00000):0.00000,SPNE:0.00000,SPSE:0.00000):0.00000;
(SCAN:0.00559,(SCON:0.01553,SCON:0.00719):0.00135,SCAN:0.44611):0.00000;
((SCAN:0.00391,(SSUI:0.00113,(SPSE:0.01097,(((SVES:0.00495,SSUI:0.00774):0.07453,SPLU:0.13213):0.11630,(SSUI:0.02212,SENT:0.01191):0.00392):0.00532):0.01311):0.00200):0.00079,SCON:0.00289,SANG:0.00015):0.00000;
(((((SCAN:0.00000,SENT:0.00000):0.00000,SSUI:0.00000):0.00000,SCON:0.00000):0.00000,SANG:0.00000):0.00000,SPNE:0.00000,SPSE:0.00000):0.00000;
(((((SCAN:0.00000,SENT:0.00000):0.00000,SSUI:0.00000):0.00000,SCON:0.00000):0.00000,SANG:0.00000):0.00000,SPNE:0.00000,SPSE:0.00000):0.00000;
((SCAN:0.15102,SCON:0.16754):0.17546,(SDYS:0.02239,SCAN:0.02641):0.38826,SINT:0.36482):0.00000;
(((((SCAN:0.00000,SENT:0.00000):0.00000,SSUI:0.00000):0.00000,SCON:0.01546):0.00000,SANG:0.00000):0.00000,SPNE:0.00000,SPSE:0.00000):0.00000;
(((((SCAN:0.00000,SENT:0.00000):0.00000,SSUI:0.00000):0.00000,SCON:0.00000):0.00000,SANG:0.00000):0.00000,SPNE:0.00000,SPSE:0.00000):0.00000;
((SCON:0.30462,(SINT:0.33333,(SEQU:0.39271,(SEQU:0.39599,(SINT:0.33481,(((SCON:0.27062,(SANG:0.09075,(SINT:0.02145,SCON:0.02094):0.07132):0.19191):0.03202,SCON:0.29128):0.00878,SCAN:0.29262):0.02695):0.03092):0.01939):0.02375):0.02526):0.00893,SCAN:0.33596,((SANG:0.08864,(SCON:0.01364,SINT:0.01377):0.07685):0.18755,SCON:0.26644):0.02382):0.00000;
(((((SCAN:0.00000,SENT:0.00000):0.00000,SSUI:0.00000):0.00000,SCON:0.00000):0.00000,SANG:0.00000):0.00000,SPNE:0.00000,SPSE:0.00000):0.00000;
(((((SCAN:0.00000,SENT:0.00000):0.00000,SSUI:0.00000):0.00000,SCON:0.00000):0.00000,SANG:0.00000):0.00000,SPNE:0.00000,SPSE:0.00000):0.00000;
(SPYO:0.00000,SCAN:0.00000):0.00000;
(((((SCAN:0.00000,SENT:0.00000):0.00000,SSUI:0.00000):0.00000,SSUI:0.00000):0.00000,SCON:0.00000):0.00000,SANG:0.00000,SPNE:0.00000):0.00000;
(SCAN:0.00000,SCON:0.00000,SCON:0.15044):0.00000;
(((SCAN:0.00000,SENT:0.00000):0.00000,SSUI:0.00000):0.00000,(SPNE:0.00000,(SCON:0.00000,SSUI:0.00000):0.00000):0.01835,SANG:0.00000):0.00000;
(((((SCAN:0.00000,SENT:0.00000):0.00000,SSUI:0.00000):0.00000,SCON:0.00000):0.00000,SANG:0.00000):0.00000,SPNE:0.00000,SPSE:0.00000):0.00000;
(SMIT:0.25792,SCAN:0.25792):0.00000;
(SCAN:0.05061,SCAN:0.05061):0.00000;
(SPYO:0.05238,SCAN:0.05238):0.00000;
(SDYS:0.00418,SCAN:0.00418):0.00000;
(SENT:0.30074,SCAN:0.30074):0.00000;
(SDYS:0.10563,SCAN:0.10563):0.00000;
((SCAN:0.19941,SENT:0.25275):0.28503,SCAN:0.11384,SENT:0.12145):0.00000;
((SCAN:0.08704,SENT:0.07827):0.11579,SPLU:0.27197,SANG:0.23916):0.00000;
(((((LLAC:0.01880,LCRE:0.03075):0.16508,SENT:0.15688):0.01894,((SEQU:0.06970,(SLUT:0.03555,SINF:0.02888):0.04316):0.09207,((SPYO:0.10418,SCAN:0.08739):0.00281,SDYS:0.09561):0.10465):0.00727):0.00901,(SSUI:0.15436,((SDEV:0.05407,SRAT:0.06335):0.05865,((STHE:0.01743,(SSAL:0.00286,SVES:0.00335):0.01534):0.10616,SDOW:0.12065):0.01644):0.01295):0.01513):0.00760,SPLU:0.16702,((SMIT:0.03842,(SPSE:0.00000,SPNE:0.00000):0.05783):0.08416,((SANG:0.07859,SINT:0.07690):0.02530,SCON:0.11704):0.05193):0.01865):0.00000;
(SCAN:0.12217,SDYS:0.11274,SPYO:0.10093):0.00000;
(SPYO:0.21685,SCAN:0.21685):0.00000;
(((SSUI:0.06137,SPLU:0.05461):0.06113,(SCAN:0.58057,(SPYO:0.02124,(SCAN:0.02074,SDYS:0.01924):0.00876):0.12160):0.05746):0.02114,(SINT:0.02598,SCON:0.02775):0.04132,SPNE:0.06528):0.00000;
(SENT:0.27832,SCAN:0.27832):0.00000;
((SPYO:0.02713,SCAN:0.02310):0.03039,SDYS:0.06775,(LLAC:0.02786,LCRE:0.02528):0.42855):0.00000;
(SCAN:0.00217,SCON:0.00000,SCON:0.15589):0.00000;
((((SENT:0.12027,(SINF:0.01642,SEQU:0.02142):0.06713):0.00450,(((LCRE:0.03429,LLAC:0.03405):0.22675,((((SMIT:0.00385,SPSE:0.00751):0.00487,SPNE:0.01530):0.07565,(SINT:0.03013,(SANG:0.01584,SCON:0.01808):0.01434):0.06107):0.01666,SSUI:0.10392):0.00787):0.00873,(SPLU:0.09864,(SPYO:0.06929,(SDYS:0.03367,SCAN:0.03388):0.02103):0.06320):0.00433):0.00424):0.00798,(SDEV:0.02968,SRAT:0.02202):0.05512):0.00162,SDOW:0.08854,(STHE:0.03168,(SSAL:0.00660,SVES:0.00748):0.01396):0.06963):0.00000;
(SPYO:0.06439,SCAN:0.06439):0.00000;
(((SSUI:0.24624,(((SSAL:0.02308,SVES:0.02372):0.00580,STHE:0.03819):0.23536,((SCAN:0.02094,(SPYO:0.00543,SDYS:0.00266):0.01299):0.12956,((SINF:0.00608,SLUT:0.00735):0.05384,SEQU:0.07362):0.08947):0.05474):0.00850):0.00583,((SPLU:0.24301,(SRAT:0.05752,SDEV:0.04001):0.17476):0.00947,SDOW:0.26743):0.01046):0.00528,(((SPSE:0.00085,SPNE:0.00258):0.01149,SMIT:0.00845):0.21304,(SINT:0.03301,(SANG:0.01141,SCON:0.01328):0.01698):0.19876):0.07934,((LLAC:0.00735,LCRE:0.00725):0.31867,SENT:0.23682):0.02370):0.00000;
((SVES:0.01717,(SSAL:0.03437,(((LCRE:0.05743,LLAC:0.03964):0.27502,((SEQU:0.10972,SLUT:0.11221):0.08963,(SCAN:0.09348,SDYS:0.07696):0.13246):0.01659):0.02682,(SRAT:0.07591,SDEV:0.06886):0.12141):0.14076):0.01951):0.00397,SINF:0.02740,STHE:0.01234):0.00000;
(SCAN:0.04481,SDYS:0.04450,SPYO:0.32446):0.00000;
((((SPNE:0.01473,SPSE:0.01490):0.35582,SPSE:0.26543):0.02332,SCAN:0.30445):0.01096,(SPNE:0.00973,SPSE:0.00961):0.23818,SCON:0.21044):0.00000;
(SCAN:0.02233,SDYS:0.02651,SPYO:0.04214):0.00000;
(SCAN:0.03585,SDYS:0.04621,SPYO:0.09583):0.00000;
(SINT:0.25087,SCAN:0.25087):0.00000;
(SINT:0.26765,SCAN:0.26765):0.00000;
(SINT:0.30744,SCAN:0.30744):0.00000;
(SINT:0.24942,SCAN:0.24942):0.00000;
(((SMIT:0.00148,SPNE:0.00055):0.02631,SCAN:0.02905):0.21991,(SPSE:0.00398,SPNE:0.00320):0.00193,SMIT:0.00654):0.00000;
(SINT:0.21504,SCAN:0.21504):0.00000;
(((SCAN:0.26131,SDOW:0.25527):0.09901,SINF:0.18491):0.05350,(SDYS:0.04079,SDYS:0.04769):0.08280,SCAN:0.11792):0.00000;
((SCAN:0.09313,SSUI:0.08908):0.10168,(SPSE:0.00451,SPNE:0.00330):0.16710,(SCON:0.00169,SINT:0.00110):0.43172):0.00000;
((SCAN:0.09362,SDYS:0.07236):0.47104,LCRE:0.05754,LLAC:0.04107):0.00000;
((SINT:0.01254,(SPNE:0.03714,(SSUI:0.04306,(SRAT:0.09770,(((SCAN:0.00972,SPYO:0.01007):0.00055,SDYS:0.00520):0.13260,(SRAT:0.16737,((((LCRE:0.01032,LLAC:0.01115):0.12632,((LCRE:0.01437,LLAC:0.00760):0.13074,(LCRE:0.03469,LLAC:0.03799):0.10868):0.02107):0.09345,SCAN:0.31770):0.03073,SDOW:0.20945):0.02315):0.00512):0.06734):0.00889):0.02650):0.03538):0.00168,SCON:0.00718,SANG:0.00483):0.00000;
((SCAN:0.24177,SDOW:0.20286):0.12109,(LLAC:0.02560,LCRE:0.02539):0.21655,LCRE:0.32074):0.00000;
(((SCAN:0.11712,SDOW:0.10417):0.05398,(LLAC:0.01532,LCRE:0.01632):0.17473):0.03374,LCRE:0.20737,SDOW:0.49475):0.00000;
(SINT:0.15292,SCAN:0.15292):0.00000;
(SDYS:0.13325,SCAN:0.13325):0.00000;
(((((((SLUT:0.00000,SEQU:0.00000):0.02207,(SPYO:0.00505,(SCAN:0.00000,SDYS:0.00000):0.00196):0.04098):0.00860,(((LCRE:0.01088,LLAC:0.01193):0.13830,(SINT:0.01070,(SANG:0.00000,SCON:0.00000):0.01374):0.00890):0.01679,((SDOW:0.00815,(SRAT:0.00654,SDEV:0.00214):0.01442):0.04609,((STHE:0.01420,(SSAL:0.00371,SVES:0.00676):0.00151):0.00843,SINF:0.01943):0.00387):0.02116):0.00494):0.00796,(SSUI:0.01298,SENT:0.02211):0.01895):0.00826,SPLU:0.01278):0.00632,SPNE:0.01223):0.00001,SPSE:0.00000,SMIT:0.00000):0.00000;
((((SSUI:0.08526,(SINF:0.03362,(SLUT:0.02514,SEQU:0.03056):0.01235):0.05671):0.00966,((SSAL:0.00585,(STHE:0.00047,SVES:0.00206):0.00173):0.08427,(SDEV:0.05487,SRAT:0.03523):0.03334):0.00413):0.00794,(SPLU:0.15529,SDOW:0.08370):0.01434):0.00287,(((LCRE:0.02666,LLAC:0.03304):0.12932,(((SMIT:0.01127,SPSE:0.01602):0.00366,SPNE:0.02928):0.10208,(SANG:0.05798,(SINT:0.02200,SCON:0.02082):0.02775):0.05715):0.02556):0.01697,((SCAN:0.03420,SPYO:0.04610):0.01050,SDYS:0.06364):0.05157):0.00326,SENT:0.13214):0.00000;
((((SINT:0.02368,(SANG:0.01044,SCON:0.01181):0.00714):0.04930,(((SMIT:0.00000,SPSE:0.00000):0.00043,SPNE:0.00177):0.07924,SSUI:0.07104):0.01175):0.01887,((SINF:0.01166,SLUT:0.00772):0.01605,SEQU:0.02758):0.05712):0.02779,(SPLU:0.11727,((SENT:0.08296,(SPYO:0.05749,(SCAN:0.03394,SDYS:0.02150):0.01387):0.02958):0.01167,(SDOW:0.05827,(SDEV:0.02219,SRAT:0.03258):0.03118):0.01094):0.00874):0.00268,((LCRE:0.00547,LLAC:0.00268):0.24958,((STHE:0.00442,SSAL:0.00222):0.00130,SVES:0.00865):0.08180):0.00565):0.00000;
(((SEQU:0.23855,(SRAT:0.00412,SDEV:0.00412):0.12020):0.08196,SANG:0.02645):0.00873,SCON:0.02304,SINT:0.03481):0.00000;
(((SDOW:0.13080,((SPYO:0.02121,(SCAN:0.01801,SDYS:0.02374):0.00233):0.06714,((SINF:0.00298,SLUT:0.00615):0.04884,SEQU:0.03436):0.05057):0.01138):0.01071,(SDEV:0.02172,SRAT:0.01791):0.08009):0.00088,((((SMIT:0.01134,(SPSE:0.00486,SPNE:0.00177):0.00887):0.06942,(SINT:0.02708,(SANG:0.00464,SCON:0.00325):0.01288):0.05346):0.06849,SSUI:0.14930):0.04883,((STHE:0.03306,(SSAL:0.00800,SVES:0.01067):0.00511):0.10419,SENT:0.17846):0.00360):0.01602,SPLU:0.13092):0.00000;
(SEQU:0.00794,SLUT:0.06190,SINF:0.13492):0.00000;
(SEQU:0.18968,SPLU:0.44036,SINT:0.29238):0.00000;
(((SPYO:0.02459,(SCAN:0.00596,SDYS:0.00359):0.01591):0.02974,((SINF:0.00358,SLUT:0.00503):0.01049,SEQU:0.01247):0.04680):0.02067,((SSAL:0.01966,(STHE:0.02180,SVES:0.02576):0.00360):0.06141,(SDOW:0.07041,(SDEV:0.00561,SRAT:0.00543):0.07085):0.01273):0.00083,(SPLU:0.08848,((((LCRE:0.00787,LLAC:0.00462):0.18642,((SMIT:0.04947,(SPSE:0.00680,SPNE:0.00606):0.04200):0.03473,(SANG:0.01598,(SINT:0.01007,SCON:0.00829):0.01299):0.06164):0.01111):0.00505,SSUI:0.09185):0.01421,SENT:0.10605):0.00276):0.00460):0.00000;
(SPYO:0.13311,SEQU:0.13311):0.00000;
(SINT:0.25766,SEQU:0.23884,SEQU:0.25537):0.00000;
((((SINF:0.01679,(SLUT:0.01030,SEQU:0.00228):0.00837):0.06113,(SPYO:0.04350,SDYS:0.03975):0.06022):0.01438,SENT:0.10953):0.01130,SSUI:0.14421,((SMIT:0.00480,SPSE:0.00312):0.10451,(SANG:0.02524,(SINT:0.00190,SCON:0.00683):0.02229):0.04877):0.02780):0.00000;
(((SINF:0.00594,SLUT:0.00692):0.02274,SEQU:0.02663):0.08928,((SRAT:0.08001,(SINT:0.07328,SMIT:0.08012):0.00377):0.39050,SDOW:0.13349):0.01291,(STHE:0.02439,(SSAL:0.00937,SVES:0.01317):0.01265):0.11334):0.00000;
(SEQU:0.02734,SLUT:0.01682,SPLU:0.14237):0.00000;
(SEQU:0.04597,SLUT:0.03799,SPLU:0.24550):0.00000;
((SPNE:0.04154,SPSE:0.04150):0.27878,SCON:0.46629,SEQU:0.37418):0.00000;
((SEQU:0.23583,SINT:0.24824):0.47363,SPSE:0.00742,SPNE:0.00836):0.00000;
(SEQU:0.09194,SEQU:0.09194):0.00000;
(((SEQU:0.11573,SLUT:0.10463):0.08814,SPLU:0.18590):0.01905,(((LLAC:0.09786,LCRE:0.09869):0.26953,(SVES:0.40393,(SDOW:0.24500,LCRE:0.22540):0.12101):0.05723):0.04605,(SPNE:0.07926,SVES:0.06932):0.20467):0.06947,SENT:0.23253):0.00000;
((((SMIT:0.01998,SPSE:0.01836):0.07659,SANG:0.07466):0.02918,((SINF:0.00537,SLUT:0.00355):0.01812,SEQU:0.02105):0.08472):0.01239,((STHE:0.02617,(SSAL:0.00742,SVES:0.00873):0.01200):0.04651,SDOW:0.07025):0.03231,((SSUI:0.07377,SPLU:0.07199):0.06571,(SPYO:0.03634,(SCAN:0.01747,SDYS:0.01936):0.00861):0.09742):0.01888):0.00000;
((SEQU:0.04964,SLUT:0.05072):0.01418,SINF:0.08184,(SENT:0.26755,(SPLU:0.18531,(LCRE:0.07079,LLAC:0.04994):0.16822):0.06599):0.10702):0.00000;
((STHE:0.04858,(((((SINF:0.01225,SLUT:0.00973):0.02415,SEQU:0.04928):0.05361,SDOW:0.08136):0.00677,SDEV:0.13844):0.14838,(SPSE:0.00282,SPNE:0.00001):0.05885):0.03232):0.02184,SVES:0.00355,SSAL:0.00300):0.00000;
(SINT:0.42282,SEQU:0.28628,SCON:0.25249):0.00000;
(SEQU:0.21959,SINF:0.02810,SLUT:0.05056):0.00000;
(((((SANG:0.06559,(SINT:0.00546,SCON:0.00752):0.05555):0.08395,(SPNE:0.05318,(SMIT:0.01964,SPSE:0.02211):0.03559):0.12358):0.03774,((SVES:0.30101,(SPSE:0.14485,(SSAL:0.01727,STHE:0.01770):0.11884):0.18197):0.25368,(SPLU:0.18622,(SRAT:0.12664,SDEV:0.11098):0.05589):0.03604):0.01164):0.03115,(SEQU:0.09879,SINF:0.09069):0.08408):0.00633,SSUI:0.15139,(SSAL:0.08626,(STHE:0.02042,(SSAL:0.00869,SVES:0.01158):0.00426):0.08640):0.07621):0.00000;
((((SPNE:0.03130,(SPSE:0.02144,SMIT:0.02239):0.00662):0.20312,(SANG:0.02543,(SINT:0.00998,SCON:0.00661):0.02188):0.18736):0.08261,(SSUI:0.22804,(((SSAL:0.07519,SVES:0.04773):0.03348,(STHE:0.01400,(SSAL:0.00377,SVES:0.00563):0.00477):0.07963):0.10425,(SINF:0.12361,SEQU:0.12699):0.06513):0.04925):0.04036):0.04916,(SDYS:0.27704,(SRAT:0.09708,SDEV:0.11537):0.12966):0.00729,SPLU:0.26936):0.00000;
((SEQU:0.04933,((LLAC:0.01640,LCRE:0.01030):0.46452,SDOW:0.18253):0.15448):0.03192,SLUT:0.01486,SINF:0.01325):0.00000;
(SPYO:0.28633,SEQU:0.28633):0.00000;
(SDEV:0.06186,SRAT:0.04948,(SEQU:0.08839,SLUT:0.09993):0.51334):0.00000;
(SPSE:0.28791,SPSE:0.28791):0.00000;
(SPSE:0.16270,SCAN:0.22460,SSUI:0.20354):0.00000;
(SPSE:0.12394,SPSE:0.09579,SPSE:0.07237):0.00000;
(SPNE:0.04819,SPSE:0.04819):0.00000;
(SPNE:0.01478,SPSE:0.01478):0.00000;
(SPNE:0.03511,SPSE:0.03511):0.00000;
(SINT:0.29566,SPSE:0.29566):0.00000;
(SPNE:0.03477,SPSE:0.03477):0.00000;
(SPSE:0.05556,SPNE:0.00021,SMIT:0.04038):0.00000;
(SPNE:0.00282,SPSE:0.00282):0.00000;
(SPSE:0.11642,SPSE:0.04675,SPSE:0.12387):0.00000;
(SPNE:0.00873,SPSE:0.00873):0.00000;
(SPNE:0.06553,SPSE:0.06553):0.00000;
(SPSE:0.04943,SPNE:0.01926,SMIT:0.10239):0.00000;
(SMIT:0.38246,SPSE:0.20415,SPLU:0.20087):0.00000;
(SMIT:0.00518,((SINT:0.07585,SANG:0.07128):0.29425,SPNE:0.01173):0.01320,SPSE:0.01541):0.00000;
(SMIT:0.10728,SPNE:0.21287,SPSE:0.17347):0.00000;
((((SANG:0.09667,(SCON:0.01861,SINT:0.00437):0.09261):0.16013,(SENT:0.29774,SMIT:0.26462):0.03631):0.04161,(SSUI:0.14855,SINF:0.16724):0.02403):0.01596,SDOW:0.16707,SDEV:0.14395):0.00000;
((SSUI:0.15576,((LLAC:0.00407,LCRE:0.00347):0.27082,(((SPSE:0.01560,SMIT:0.02017):0.02186,SPNE:0.04223):0.07978,(SANG:0.00308,(SINT:0.00910,SCON:0.00035):0.00482):0.06832):0.06595):0.02878):0.01511,((SPLU:0.15059,((STHE:0.02712,(SSAL:0.00775,SVES:0.00492):0.00755):0.11552,SDOW:0.13014):0.00892):0.01224,(((SINF:0.02940,(SLUT:0.00516,SEQU:0.00719):0.02474):0.04771,(SPYO:0.04133,(SCAN:0.01227,SDYS:0.00937):0.01112):0.05580):0.00762,(SDEV:0.00989,SRAT:0.00865):0.08906):0.00893):0.00776,SENT:0.12660):0.00000;
(SMIT:0.01400,((SCON:0.06598,(SINT:0.06170,SANG:0.07747):0.01581):0.41629,SPNE:0.04562):0.01150,SPSE:0.03295):0.00000;
(((SRAT:0.03158,SDEV:0.03270):0.49169,(SPSE:0.00743,SMIT:0.01237):0.10380):0.02406,SCON:0.11140,(SANG:0.04422,SINT:0.05224):0.06134):0.00000;
(SPNE:0.05212,SMIT:0.05212):0.00000;
(SSUI:0.22810,SMIT:0.22810):0.00000;
(SMIT:0.05334,SPNE:0.04535,SPSE:0.03883):0.00000;
(SMIT:0.01658,SPNE:0.04821,SPSE:0.04453):0.00000;
(SANG:0.18255,SMIT:0.18255):0.00000;
(((SPSE:0.04334,SPNE:0.04238):0.03918,SMIT:0.07345):0.04586,((SSAL:0.21956,(SSUI:0.19449,(SDOW:0.25247,((LLAC:0.08831,LCRE:0.06087):0.18798,SANG:0.41235):0.06888):0.00906):0.03941):0.01558,((SRAT:0.09821,SDEV:0.09178):0.05805,((SENT:0.16194,(SINF:0.05030,(SLUT:0.00968,SEQU:0.00579):0.03088):0.09034):0.01408,(SCAN:0.05014,SDYS:0.04100):0.07978):0.01944):0.01225):0.03633,((SINT:0.06272,SCON:0.05999):0.05209,SANG:0.09848):0.00312):0.00000;
((((SSAL:0.03016,(STHE:0.01073,SVES:0.01270):0.00861):0.11367,((SINF:0.00827,SLUT:0.01630):0.02204,SEQU:0.02586):0.05861):0.00379,(SPLU:0.12224,(SENT:0.11390,(((LCRE:0.01845,LLAC:0.02432):0.13958,SSUI:0.10386):0.00522,((SANG:0.01876,(SINT:0.00386,SCON:0.00516):0.02118):0.05972,(SPNE:0.01788,(SPSE:0.00999,SMIT:0.01627):0.00427):0.07605):0.01456):0.01032):0.01511):0.02959):0.01163,(SDEV:0.04478,SRAT:0.04568):0.04434,((SPYO:0.06802,(SCAN:0.02191,SDYS:0.01625):0.02036):0.04095,SDOW:0.07351):0.00389):0.00000;
(((((SANG:0.01818,SINT:0.02112):0.00749,SCON:0.02371):0.08002,(SMIT:0.02020,(SPSE:0.01046,SPNE:0.00826):0.00362):0.10137):0.03180,((LCRE:0.02235,LLAC:0.02000):0.17754,((SSAL:0.04095,(STHE:0.03732,SVES:0.01664):0.02491):0.09745,(SDOW:0.13861,(SEQU:0.02206,(SINF:0.00844,SLUT:0.01054):0.02390):0.07269):0.02583):0.06244):0.02251):0.00739,(SPLU:0.06553,SSUI:0.06886):0.10814,((SPYO:0.07264,(SCAN:0.03381,SDYS:0.02812):0.01920):0.10651,(SENT:0.10774,((SPYO:0.02271,(SCAN:0.01150,SDYS:0.01114):0.00679):0.08748,(SDEV:0.00777,SRAT:0.00985):0.08251):0.01247):0.01707):0.01566):0.00000;
(SCON:0.08792,SMIT:0.08792):0.00000;
((((SSUI:0.27153,((SMIT:0.02493,(SPSE:0.01635,SPNE:0.01532):0.01161):0.14742,(SANG:0.04000,(SINT:0.03113,SCON:0.02350):0.01928):0.15604):0.02975):0.02960,((SCAN:0.09543,SDYS:0.08081):0.03972,SPYO:0.13658):0.14442):0.00690,((((SDOW:0.15102,((SLUT:0.01391,SINF:0.01260):0.03788,SEQU:0.04684):0.10497):0.02301,(SDEV:0.04400,SRAT:0.04922):0.12364):0.01600,((STHE:0.03553,(SSAL:0.01472,SVES:0.02356):0.01010):0.15177,(SSAL:0.01524,SVES:0.01630):0.14726):0.03739):0.01654,SPLU:0.22970):0.01111):0.00437,((LLAC:0.02124,LCRE:0.01918):0.30601,((SCAN:0.08960,SPYO:0.08364):0.00344,SDYS:0.08365):0.22851):0.01251,SENT:0.38685):0.00000;
(SMIT:0.05182,SPNE:0.02980,SPSE:0.02024):0.00000;
((SINF:0.11518,SEQU:0.08631):0.40763,SMIT:0.00838,(SPSE:0.00984,SPNE:0.01187):0.00305):0.00000;
(SMIT:0.02419,SPNE:0.01891,SPSE:0.03885):0.00000;
(SPSE:0.18421,SMIT:0.18421):0.00000;
((SMIT:0.06455,SPNE:0.06607):0.19948,SINT:0.23108,(SSUI:0.27794,SENT:0.29540):0.06704):0.00000;
(SPSE:0.05302,SMIT:0.05302):0.00000;
(SPSE:0.03072,SMIT:0.03072):0.00000;
(SMIT:0.03344,SVES:0.03243,SPNE:0.54584):0.00000;
((SMIT:0.00923,(SPSE:0.00527,SPNE:0.00724):0.00599):0.34400,(SDYS:0.05564,SCAN:0.05998):0.10584,(SSUI:0.17163,(SPLU:0.16087,((SINF:0.01818,SLUT:0.02306):0.03034,SEQU:0.04700):0.09122):0.01402):0.01082):0.00000;
(((LCRE:0.00207,LLAC:0.00835):0.25827,(SENT:0.23546,(SSUI:0.18208,(((SINT:0.03730,SCON:0.03301):0.00128,SANG:0.03060):0.10562,((SPSE:0.01481,SMIT:0.01480):0.01989,SPNE:0.04778):0.08042):0.06146):0.05996):0.01548):0.01648,(SDOW:0.14285,(((SINF:0.01957,(SLUT:0.01732,SEQU:0.01527):0.00804):0.06523,((SCAN:0.00721,SPYO:0.00960):0.00575,SDYS:0.02229):0.08984):0.01384,(SDEV:0.04092,SRAT:0.03271):0.05799):0.03850):0.00498,(STHE:0.04904,(SSAL:0.03743,SVES:0.01794):0.00699):0.12296):0.00000;
((SPNE:0.03787,SMIT:0.03665):0.07507,SDEV:0.27237,SPSE:0.09429):0.00000;
(SMIT:0.02125,SPNE:0.02649,SPSE:0.02148):0.00000;
((SENT:0.21379,(((LLAC:0.04889,LCRE:0.04938):0.22054,LLAC:0.26974):0.15245,(SSUI:0.20988,(SMIT:0.04821,(SPSE:0.01278,SPNE:0.01309):0.03479):0.13473):0.03243):0.01892):0.00761,(SCAN:0.11756,(SDYS:0.10521,SPYO:0.11142):0.01222):0.12008,SPLU:0.22098):0.00000;
(SMIT:0.04464,(SPSE:0.03614,SPNE:0.03866):0.01928,(SVES:0.43496,((SINT:0.02151,SCON:0.02057):0.07292,SANG:0.09115):0.17295):0.26214):0.00000;
(((SPYO:0.11054,(SDYS:0.05737,SCAN:0.05945):0.04690):0.13644,(((SEQU:0.07454,(SLUT:0.03714,SINF:0.03432):0.03966):0.12920,SPLU:0.24894):0.01250,(SENT:0.27477,((LLAC:0.06515,LCRE:0.05843):0.30603,(SSUI:0.27780,(((SINT:0.03498,SCON:0.03033):0.01564,SANG:0.04101):0.15305,(SMIT:0.01497,(SPSE:0.01262,SPNE:0.01201):0.00015):0.25206):0.02441):0.01470):0.01686):0.00867):0.01747):0.00532,((SRAT:0.05130,SDEV:0.04657):0.17221,SDOW:0.25327):0.00897,((SSAL:0.02632,SVES:0.03183):0.00141,STHE:0.03436):0.22808):0.00000;
(SPNE:0.09199,SMIT:0.09199):0.00000;
(SMIT:0.02511,(SPNE:0.02521,SENT:0.28066):0.00335,SPSE:0.02122):0.00000;
(SSUI:0.25902,SMIT:0.25902):0.00000;
((LCRE:0.03981,LLAC:0.04532):0.20398,((SMIT:0.04678,SINT:0.03807):0.24118,(SRAT:0.23347,(SVES:0.26246,SDOW:0.21249):0.01668):0.02349):0.00376,(SEQU:0.04786,(SLUT:0.03635,SINF:0.03416):0.01214):0.19774):0.00000;
(SINF:0.31567,SMIT:0.31567):0.00000;
(SPNE:0.04219,SMIT:0.04219):0.00000;
(SPSE:0.07759,SMIT:0.07759):0.00000;
(SPSE:0.01321,SMIT:0.01321):0.00000;
(SMIT:0.01054,SPSE:0.00404,SPSE:0.56344):0.00000;
(SMIT:0.17475,(SPLU:0.21571,(SPNE:0.10569,SPSE:0.06880):0.07637):0.01499,LLAC:0.48301):0.00000;
(SMIT:0.36811,SVES:0.07316,SPNE:0.02236):0.00000;
(SMIT:0.14457,SPNE:0.07427,SPSE:0.04485):0.00000;
(SPSE:0.07726,SMIT:0.07726):0.00000;
((SPNE:0.01652,(((SDEV:0.02509,SRAT:0.01750):0.28816,SINT:0.28879):0.01694,SMIT:0.27775):0.33456):0.00611,SMIT:0.00836,SPSE:0.01640):0.00000;
((SSAL:0.03035,(SMIT:0.28611,SDOW:0.30025):0.19984):0.00699,SVES:0.01855,STHE:0.02866):0.00000;
(SPSE:0.03639,SMIT:0.03639):0.00000;
(SPNE:0.02427,SMIT:0.02427):0.00000;
((SMIT:0.02663,((SINT:0.04446,(SANG:0.02015,SCON:0.03690):0.02453):0.10002,((STHE:0.03943,(SSAL:0.02160,SVES:0.03148):0.00774):0.12963,SSUI:0.17490):0.10665):0.11426):0.00489,SPNE:0.02370,SPSE:0.02736):0.00000;
((SVES:0.01593,SSAL:0.02138):0.00826,STHE:0.03335,SDEV:0.22561):0.00000;
((SVES:0.02627,(SENT:0.35110,SPSE:0.15487):0.12354):0.00698,SSAL:0.01634,STHE:0.02685):0.00000;
((((SCON:0.01755,SINT:0.02257):0.30661,SPLU:0.24514):0.02837,((STHE:0.08822,SVES:0.02832):0.09979,SSAL:0.12995):0.12081):0.00827,(SDEV:0.22065,SDOW:0.20017):0.00659,(SMIT:0.06758,(SPSE:0.03273,SPNE:0.03839):0.05052):0.12355):0.00000;
((((SEQU:0.02296,(SLUT:0.01091,SINF:0.00815):0.01640):0.09644,((STHE:0.01816,(SSAL:0.00752,SVES:0.00907):0.00818):0.10290,(SDEV:0.07371,SRAT:0.08019):0.03585):0.01269):0.02556,SDOW:0.16010):0.02198,(((SMIT:0.02846,(SPSE:0.00822,SPNE:0.00787):0.01722):0.13193,((SINT:0.01503,SCON:0.02415):0.04463,SANG:0.04584):0.10158):0.02411,SSUI:0.18971):0.00987,(LLAC:0.04846,LCRE:0.05614):0.26769):0.00000;
(SVES:0.06070,SSAL:0.06007,(((SLUT:0.01983,SINF:0.01041):0.14269,SEQU:0.12075):0.44467,STHE:0.11769):0.07754):0.00000;
((((SPYO:0.05101,(SCAN:0.02003,SDYS:0.02439):0.01475):0.06594,(((SLUT:0.00880,(SINF:0.00572,SEQU:0.00292):0.00574):0.04685,SDOW:0.06372):0.02681,(SDEV:0.04007,SRAT:0.03416):0.04209):0.00644):0.00738,(SPLU:0.07623,((SVES:0.00411,SSAL:0.00203):0.01359,STHE:0.01839):0.05856):0.02041):0.00246,(LCRE:0.18030,(SSUI:0.12081,((SANG:0.02485,(SINT:0.01844,SCON:0.01074):0.01188):0.01875,(SMIT:0.01020,(SPSE:0.01149,SPNE:0.01468):0.00244):0.03809):0.03631):0.00958):0.01145,SENT:0.10994):0.00000;
((SVES:0.00786,(SMIT:0.05926,SINF:0.17893):0.05097):0.00021,SSAL:0.00014,STHE:0.00344):0.00000;
((((SINF:0.02233,(SLUT:0.00053,SEQU:0.00345):0.01381):0.09909,(SDOW:0.16831,(STHE:0.03520,(SSAL:0.01821,SVES:0.02378):0.00728):0.09355):0.00606):0.05144,((((SMIT:0.00181,SPSE:0.00328):0.00166,SPNE:0.00399):0.05800,((SANG:0.00401,SINT:0.00620):0.00536,SCON:0.00709):0.04962):0.04545,((SENT:0.09068,(SPYO:0.01774,(SCAN:0.00678,SDYS:0.00335):0.00592):0.06594):0.01239,(SDEV:0.00591,SRAT:0.00640):0.09130):0.01672):0.02061):0.00751,(SSUI:0.07177,SPLU:0.09396):0.06501,(LLAC:0.01177,LCRE:0.00882):0.24336):0.00000;
((SVES:0.01572,SSAL:0.02911):0.04194,STHE:0.05086,(SRAT:0.02492,SDEV:0.01418):0.52721):0.00000;
((((LCRE:0.00528,LLAC:0.00536):0.15983,(((((SPSE:0.01969,SPNE:0.01381):0.02979,SMIT:0.03805):0.13113,(SANG:0.07832,(SCON:0.05106,SINT:0.05144):0.02224):0.10490):0.07600,((SSUI:0.19415,(SPLU:0.15269,(((SINF:0.03428,SLUT:0.03922):0.00792,SEQU:0.05427):0.08755,(STHE:0.02818,(SSAL:0.02048,SVES:0.01574):0.00740):0.11870):0.03466):0.02895):0.00482,((SCAN:0.03318,SPYO:0.04249):0.07777,SDYS:0.12644):0.10999):0.04134):0.08506,((LLAC:0.01613,LCRE:0.02121):0.26311,((SPSE:0.02124,(SMIT:0.02497,SPNE:0.02417):0.00140):0.15719,(((((SSAL:0.04236,(STHE:0.02895,SVES:0.04305):0.01550):0.08217,SPLU:0.13344):0.00953,SDOW:0.17132):0.01185,((SSUI:0.10572,((SINF:0.03042,SLUT:0.03668):0.04480,SEQU:0.06814):0.04716):0.01750,(SINT:0.03433,SCON:0.03304):0.11846):0.01800):0.01915,(SENT:0.16122,(SDYS:0.08650,SPYO:0.08805):0.11930):0.00833):0.01871):0.05945):0.03088):0.17320):0.08152,(((SPSE:0.00179,(SMIT:0.00000,SPNE:0.00000):0.00148):0.02232,(SINT:0.00727,(SANG:0.00555,SCON:0.00590):0.00416):0.03321):0.00773,SSUI:0.04478):0.03434):0.00272,((SENT:0.05063,((SSAL:0.00481,(STHE:0.01550,SVES:0.00889):0.00171):0.04448,((SINF:0.00418,SLUT:0.00074):0.00765,SEQU:0.00627):0.03312):0.00421):0.00481,(SDEV:0.03523,SRAT:0.02894):0.03451):0.00572,((SPLU:0.04281,(SCAN:0.02219,(SPYO:0.01690,SDYS:0.00618):0.00249):0.03186):0.00671,SDOW:0.06613):0.00556):0.00000;
(SDOW:0.32111,SVES:0.32111):0.00000;
(SVES:0.02591,SSAL:0.06332,STHE:0.06083):0.00000;
((SDOW:0.17985,((STHE:0.02930,SSAL:0.01313):0.01013,SVES:0.02651):0.15890):0.01201,(SDEV:0.08175,SRAT:0.09299):0.09689,(SEQU:0.11539,(SLUT:0.02966,SINF:0.02017):0.07195):0.05518):0.00000;
((SSUI:0.08473,SPLU:0.06631):0.15496,(SENT:0.21761,(((SPNE:0.02864,(SPSE:0.02336,SMIT:0.01363):0.00905):0.18992,((SINT:0.00611,SCON:0.01194):0.01615,SANG:0.02419):0.21133):0.15834,((((SINF:0.00615,SLUT:0.02628):0.02341,SEQU:0.05106):0.14330,((STHE:0.02516,SSAL:0.03568):0.00454,SVES:0.02792):0.13000):0.04752,(SDOW:0.16582,(SDEV:0.10082,SRAT:0.10389):0.06698):0.01994):0.06925):0.03255):0.01512,(SPYO:0.06464,(SCAN:0.02461,SDYS:0.02225):0.04478):0.18670):0.00000;
(((STHE:0.00923,(SSAL:0.00365,SVES:0.00188):0.00462):0.06018,((SINF:0.02644,(SLUT:0.01220,SEQU:0.01048):0.00311):0.03218,(SDOW:0.05825,((SINT:0.00100,(SANG:0.00605,SCON:0.00817):0.01231):0.05596,(SDEV:0.00482,SRAT:0.00465):0.05138):0.01271):0.00580):0.00727):0.00269,(SPLU:0.07963,(SCAN:0.01855,(SPYO:0.00000,SDYS:0.00000):0.01083):0.05888):0.00696,(((LCRE:0.00839,LLAC:0.00663):0.12688,((SMIT:0.00400,SPSE:0.00343):0.07524,(SSUI:0.06612,SENT:0.07989):0.01047):0.00969):0.00822,(SPSE:0.04973,(SENT:0.15322,SDYS:0.05388):0.04757):0.00883):0.01616):0.00000;
(SVES:0.05728,SPNE:0.05730,SMIT:0.19010):0.00000;
(SLUT:0.27620,(((SPSE:0.09312,SMIT:0.10317):0.13500,((SENT:0.13356,(SPLU:0.03071,SDYS:0.03804):0.11001):0.11412,(((SVES:0.07307,(STHE:0.03930,SVES:0.04714):0.04442):0.04266,(SPNE:0.08868,SDYS:0.09500):0.03257):0.01400,SENT:0.14477):0.07054):0.02666):0.01414,(((SSAL:0.12187,SMIT:0.13751):0.02025,((SMIT:0.01402,SINT:0.01804):0.03914,(SPLU:0.02753,SCAN:0.02412):0.02668):0.09468):0.26592,LLAC:0.30376):0.03830):0.00197,(SPLU:0.23594,(SINT:0.20931,SCAN:0.19530):0.02011):0.04553):0.00000;
(SVES:0.03072,SSAL:0.05570,STHE:0.09534):0.00000;
((((((LLAC:0.00285,LCRE:0.00509):0.43515,SENT:0.23946):0.11706,(((SMIT:0.01051,SPSE:0.00947):0.00446,SPNE:0.00511):0.05034,(SANG:0.00451,(SINT:0.00928,SCON:0.00706):0.00094):0.02962):0.05146):0.01882,(SPLU:0.11253,(SSUI:0.07119,((SCAN:0.01111,SPYO:0.00727):0.00991,SDYS:0.02278):0.09303):0.01146):0.00875):0.00843,(STHE:0.04392,(SSAL:0.00457,SVES:0.01443):0.00108):0.08839):0.02221,(SDOW:0.06745,(SDEV:0.02145,SRAT:0.02720):0.03413):0.00146,((SINF:0.00830,SLUT:0.01064):0.00611,SEQU:0.01820):0.05054):0.00000;
(SSAL:0.01406,SVES:0.01406):0.00000;
((((SPNE:0.01090,SPSE:0.01104):0.17921,(STHE:0.14562,(SEQU:0.08472,SINF:0.06781):0.08943):0.03604):0.08280,(((LCRE:0.02157,LLAC:0.01544):0.24753,((SDYS:0.11565,SCAN:0.10467):0.16984,(((((SINF:0.02319,SLUT:0.02778):0.04441,SEQU:0.07485):0.09235,(STHE:0.01660,(SSAL:0.00862,SVES:0.00971):0.01092):0.13280):0.02608,SDOW:0.17617):0.03362,(SDEV:0.04589,SRAT:0.04651):0.15264):0.00827):0.03935):0.04192,((LLAC:0.01838,LCRE:0.01884):0.33565,(SRAT:0.34418,((((SINF:0.03466,(SLUT:0.00321,SEQU:0.00344):0.02974):0.08815,SPSE:0.12251):0.01404,(SDOW:0.08916,(SRAT:0.04403,SDEV:0.04371):0.03298):0.04084):0.29838,SDOW:0.40576):0.02919):0.02193):0.00824):0.05123):0.04942,((SPLU:0.19513,SENT:0.16975):0.03155,((SRAT:0.02190,SDEV:0.02259):0.12880,(SDOW:0.15347,((SCAN:0.04387,(SPYO:0.01737,SDYS:0.01779):0.02757):0.11315,(((SINF:0.04026,SLUT:0.04566):0.00862,SEQU:0.04796):0.06481,((STHE:0.00711,SSAL:0.00823):0.00300,SVES:0.01163):0.11083):0.01211):0.02436):0.03692):0.02186):0.01550,((SANG:0.02413,(SINT:0.00702,SCON:0.00439):0.01792):0.08331,(SPNE:0.00637,(SPSE:0.00203,SMIT:0.00511):0.00579):0.10696):0.11068):0.00000;
(SVES:0.01676,(STHE:0.01354,((SPLU:0.12971,((SPSE:0.00639,SPNE:0.00667):0.14383,(SSUI:0.17233,(SDEV:0.06730,SRAT:0.08324):0.05514):0.01141):0.04515):0.03732,SDOW:0.08145):0.05796):0.00565,SSAL:0.00675):0.00000;
(((SPYO:0.43457,(SMIT:0.10512,SPSE:0.11250):0.23937):0.01954,((SSAL:0.30922,SVES:0.26335):0.03796,(SEQU:0.34635,(SEQU:0.22715,SINF:0.22641):0.08781):0.01502):0.00497):0.00450,SDOW:0.40044,((SPLU:0.29751,SENT:0.30240):0.05817,(SSAL:0.35482,(SSAL:0.38626,((SPYO:0.10706,(SDYS:0.06614,SCAN:0.06781):0.03915):0.25841,SDOW:0.35910):0.02398):0.00705):0.00458):0.00785):0.00000;
(SVES:0.25937,SVES:0.25937):0.00000;
(((SDEV:0.18418,((STHE:0.02795,SSAL:0.02872):0.01445,SVES:0.03392):0.17537):0.00638,(SSUI:0.16252,SENT:0.22968):0.02861):0.01062,(((SEQU:0.02959,(SLUT:0.02627,SINF:0.02935):0.01902):0.17239,SRAT:0.15314):0.01404,(SDOW:0.22433,(SMIT:0.03044,(SPSE:0.01723,SPNE:0.02434):0.01780):0.13926):0.00769):0.00684,(LLAC:0.41607,((SINT:0.01410,SCON:0.01063):0.00316,SANG:0.01567):0.27389):0.01685):0.00000;
(((SPLU:0.06511,SDOW:0.05323):0.01057,(SSUI:0.06002,(SENT:0.09291,((STHE:0.01822,SSAL:0.00794):0.00648,SVES:0.01717):0.03255):0.00971):0.00292):0.00330,(((SINF:0.02087,SLUT:0.00842):0.00645,SEQU:0.01272):0.03719,(((LCRE:0.00620,LLAC:0.00671):0.13746,(((SMIT:0.00484,SPSE:0.00309):0.00161,SPNE:0.00434):0.06685,(SINT:0.01233,(SANG:0.00492,SCON:0.00808):0.01201):0.03664):0.01650):0.01936,(SDEV:0.03043,SRAT:0.03277):0.03551):0.00262):0.00252,((SCAN:0.01830,SPYO:0.01834):0.00948,SDYS:0.02375):0.02791):0.00000;
(SVES:0.14945,(SLUT:0.02832,SEQU:0.02141):0.09289,(SVES:0.00907,SSAL:0.00812):0.27499):0.00000;
(((SSUI:0.07781,SDOW:0.10606):0.02953,((STHE:0.02021,SSAL:0.00631):0.00034,SVES:0.00799):0.09461):0.00387,((LLAC:0.03639,LCRE:0.03668):0.51906,(SDEV:0.05350,SRAT:0.06566):0.06756):0.00987,(SANG:0.10164,((SINF:0.01508,SLUT:0.02288):0.00471,SEQU:0.01117):0.09170):0.01169):0.00000;
(SPLU:0.41609,SVES:0.15455,SENT:0.23855):0.00000;
((SENT:0.18420,((SSUI:0.25961,((SANG:0.04142,(SINT:0.04552,SCON:0.03391):0.02363):0.16899,SPLU:0.20750):0.01456):0.01504,(((STHE:0.01687,SVES:0.01226):0.07117,SSAL:0.08351):0.09728,(SMIT:0.01075,(SPSE:0.00816,SPNE:0.00960):0.00114):0.14480):0.05163):0.02434):0.01408,(SDEV:0.12696,(SRAT:0.10990,(SINF:0.02611,(SLUT:0.00454,SEQU:0.00321):0.02754):0.07366):0.01052):0.00739,SCAN:0.15838):0.00000;
((((SDYS:0.08923,(SCAN:0.02891,SPYO:0.02095):0.05204):0.07970,SDEV:0.14675):0.22031,(LLAC:0.05954,LCRE:0.05885):0.17047):0.03072,(((((SPSE:0.02969,SPNE:0.03177):0.00291,SMIT:0.03024):0.13296,((SINT:0.01710,SCON:0.01635):0.05618,SANG:0.06029):0.09074):0.01325,SSUI:0.17315):0.01135,(((SDEV:0.04888,SRAT:0.03887):0.04533,(SPLU:0.08937,(SLUT:0.00852,(SINF:0.00832,SEQU:0.00793):0.00162):0.07230):0.01133):0.03767,SDOW:0.14426):0.04660):0.00825,((SVES:0.01936,SSAL:0.02548):0.04263,STHE:0.08276):0.12125):0.00000;
((SANG:0.06076,(((SDOW:0.46052,SENT:0.12378):0.00924,(SVES:0.01871,(SMIT:0.01633,SPNE:0.01109):0.00723):0.14830):0.03831,SDYS:0.11665):0.02962):0.04313,(SCAN:0.02455,((SSUI:0.00626,SSUI:0.00741):0.00658,SDYS:0.02874):0.00596):0.00390,SPLU:0.02841):0.00000;
(SDOW:0.15217,SSAL:0.15217):0.00000;
((((((SVES:0.18522,SANG:0.17157):0.04911,(SCAN:0.07888,(SSUI:0.01356,(SPLU:0.00000,SDYS:0.00000):0.01303):0.06628):0.15260):0.11314,(SSUI:0.11611,(SPNE:0.00981,SENT:0.02689):0.07582):0.18834):0.00546,((SSAL:0.00739,SDOW:0.02416):0.09325,SPLU:0.13586):0.13019):0.02802,(SSAL:0.25776,SANG:0.28456):0.03145):0.00584,(SVES:0.00000,STHE:0.00000):0.30502,SVES:0.26641):0.00000;
(((SPYO:0.16431,(SCAN:0.13842,SDYS:0.12502):0.03939):0.16600,(((SSAL:0.03176,SVES:0.03808):0.01303,STHE:0.05034):0.24874,(SDOW:0.26745,SENT:0.33721):0.01656):0.02595):0.00473,(SRAT:0.03542,SDEV:0.04406):0.19679,(SEQU:0.11646,(SLUT:0.01875,SINF:0.01508):0.08702):0.17918):0.00000;
(((((((SPYO:0.16906,((SEQU:0.03639,(SLUT:0.01040,SINF:0.00720):0.02796):0.12894,((SDOW:0.13818,(SRAT:0.07487,SDEV:0.07712):0.06298):0.01957,(SVES:0.01714,SSAL:0.01419):0.11960):0.02334):0.00614):0.17521,(SRAT:0.07058,(SEQU:0.04786,(SINF:0.00349,SLUT:0.00182):0.04694):0.02741):0.22958):0.01425,SRAT:0.29689):0.00197,((LCRE:0.00150,LLAC:0.00207):0.11348,((SPYO:0.03165,(SCAN:0.02002,SDYS:0.02335):0.01130):0.05774,(SENT:0.09234,(SDOW:0.07753,((SSAL:0.01192,SVES:0.01020):0.04916,(((((SPSE:0.00748,(SMIT:0.00078,SPNE:0.00099):0.00668):0.02750,((SANG:0.00065,SINT:0.00023):0.00139,SCON:0.00567):0.02662):0.01217,SSUI:0.03964):0.00452,SPLU:0.04869):0.00442,(((SINF:0.00812,SLUT:0.01049):0.00762,SEQU:0.01363):0.03239,(SDEV:0.00565,SRAT:0.00585):0.03725):0.00522):0.00394):0.01736):0.01281):0.00498):0.02937):0.20154):0.02664,((LLAC:0.02837,LCRE:0.02471):0.32197,((SEQU:0.06598,(SLUT:0.03728,SINF:0.03483):0.03618):0.27757,(((SSUI:0.15572,SPLU:0.16722):0.03769,((SPYO:0.00460,SDYS:0.00790):0.16056,(SANG:0.00648,(SINT:0.00409,SCON:0.00667):0.00247):0.14997):0.03877):0.11753,(((SLUT:0.05144,((SPSE:0.01245,SPNE:0.01051):0.00190,SMIT:0.01053):0.03089):0.09552,(SSAL:0.01444,SVES:0.01928):0.11639):0.13245,SPNE:0.28626):0.06598):0.01145):0.00943):0.01353):0.00384,(SLUT:0.39928,((((((STHE:0.02222,SSAL:0.02237):0.00104,SVES:0.02597):0.15163,(SDOW:0.08507,(SDEV:0.04931,SRAT:0.04256):0.03346):0.07409):0.11659,((SVES:0.21916,(SSUI:0.20531,SMIT:0.18922):0.00666):0.04817,((SLUT:0.01220,SINF:0.01082):0.13111,SEQU:0.13751):0.11383):0.04501):0.06572,((SCAN:0.16592,(((SMIT:0.05015,(SPSE:0.00216,SPNE:0.00202):0.04266):0.05307,(SVES:0.02476,SSAL:0.02194):0.07126):0.01745,(SINT:0.04755,(SCON:0.02521,SANG:0.03006):0.01881):0.06472):0.04361):0.16370,SPLU:0.29348):0.02032):0.01556,((SCAN:0.31990,((SVES:0.03051,SSAL:0.02806):0.15204,((SINT:0.06009,SANG:0.04792):0.10159,SMIT:0.14645):0.02025):0.20875):0.00601,(SDYS:0.38870,((SEQU:0.15250,(SPYO:0.08976,SVES:0.08615):0.06734):0.14028,(SRAT:0.12400,SANG:0.12166):0.15669):0.05967):0.00773):0.00556):0.00421):0.00747):0.00568,((((LLAC:0.00219,LCRE:0.00211):0.15029,((SPLU:0.13229,(SDEV:0.01118,SRAT:0.01497):0.10702):0.00847,(((SINF:0.00343,SLUT:0.00357):0.00406,SEQU:0.00816):0.09068,((SSAL:0.01009,(SVES:0.00786,STHE:0.00958):0.00473):0.06730,(SPYO:0.00891,(SCAN:0.00735,SDYS:0.00487):0.00375):0.06911):0.01351):0.02340):0.04718):0.02960,(SDOW:0.26628,(SSUI:0.21391,(((SPSE:0.01988,SPNE:0.01464):0.02435,SMIT:0.03409):0.12129,(SANG:0.05098,(SCON:0.01611,SINT:0.01601):0.03461):0.10049):0.04395):0.12989):0.01432):0.07605,(LCRE:0.17271,(LLAC:0.02057,LCRE:0.02574):0.16822):0.11889):0.01887,((((SDYS:0.04916,(SPNE:0.00400,SPSE:0.00426):0.05025):0.22338,((LLAC:0.00000,LCRE:0.00000):0.12746,(((SMIT:0.03126,(SPSE:0.00394,SPNE:0.00527):0.02700):0.03915,(SSUI:0.05923,(SINT:0.00322,(SANG:0.00106,SCON:0.00317):0.00101):0.05665):0.01445):0.01965,(SENT:0.07750,(((SSAL:0.00594,(STHE:0.00495,SVES:0.00259):0.00242):0.04016,SPLU:0.05164):0.00391,((((SINF:0.00182,SLUT:0.00235):0.00120,SEQU:0.00172):0.03647,SDOW:0.04263):0.00462,((SDEV:0.00365,SRAT:0.00384):0.03475,(SPYO:0.00829,(SCAN:0.00171,SDYS:0.00245):0.00335):0.02602):0.00818):0.01038):0.01172):0.02489):0.04282):0.12572):0.02094,(SINF:0.15164,(SLUT:0.14543,SDEV:0.14262):0.01224):0.15755):0.02039,(LLAC:0.11311,(SPSE:0.07862,SCAN:0.07841):0.03802):0.26280):0.00108):0.00000;
((((LLAC:0.01095,LCRE:0.01096):0.25376,(LLAC:0.00707,LCRE:0.00731):0.23009):0.08840,(((SLUT:0.03455,SEQU:0.03045):0.07886,(SANG:0.00768,SINT:0.00892):0.11203):0.07534,(((SVES:0.00517,SSAL:0.00497):0.02023,SPSE:0.02984):0.06705,(SDEV:0.07321,SRAT:0.06303):0.04676):0.08100):0.17768):0.01909,((SSUI:0.11787,SPNE:0.12128):0.16926,(SPNE:0.08825,(SINT:0.00177,(SANG:0.00160,SCON:0.00028):0.00292):0.06726):0.19728):0.07033,(LLAC:0.39423,(LCRE:0.29921,SPNE:0.32366):0.05133):0.01135):0.00000;
(SSAL:0.00439,(SPSE:0.04055,(((SINF:0.00668,SLUT:0.00608):0.00946,SEQU:0.00972):0.24926,(SANG:0.02556,SINT:0.03567):0.06474):0.04152):0.02112,SVES:0.01108):0.00000;
(SSUI:0.18159,SSAL:0.18159):0.00000;
(((SPSE:0.04536,SPSE:0.03328):0.01151,SSAL:0.48079):0.00794,(SMIT:0.02475,SPSE:0.02537):0.01574,SMIT:0.04172):0.00000;
((SSAL:0.01314,STHE:0.01699):0.15683,SENT:0.21074,SMIT:0.30620):0.00000;
((SLUT:0.04250,SINF:0.04391):0.16461,((SRAT:0.04094,SDEV:0.04676):0.15548,SSAL:0.25414):0.12650,SDEV:0.18311):0.00000;
(SVES:0.03946,SSAL:0.03946):0.00000;
((SSAL:0.33430,((SRAT:0.08450,SDEV:0.08761):0.25920,(SDOW:0.15869,(SDEV:0.12472,SRAT:0.12635):0.04429):0.16587):0.03561):0.01847,(SENT:0.28218,((SINF:0.12781,SLUT:0.11517):0.07575,(SPYO:0.11468,SDYS:0.10360):0.10798):0.05959):0.02657,(SINT:0.06016,(SANG:0.04553,SCON:0.04227):0.01302):0.24980):0.00000;
((SSAL:0.34778,(((SEQU:0.14541,SINF:0.16730):0.09341,SEQU:0.28884):0.04080,((STHE:0.29787,SSAL:0.22840):0.07446,(((SANG:0.01402,SINT:0.01720):0.00366,SCON:0.01733):0.11320,(SMIT:0.00835,(SPSE:0.00369,SPNE:0.00249):0.00553):0.13072):0.22088):0.02841):0.00514):0.01415,(((SSUI:0.07637,SPLU:0.07727):0.06554,SENT:0.15739):0.07669,((SDEV:0.19886,SDOW:0.23106):0.06237,((SCON:0.02240,(SINT:0.00875,SANG:0.00538):0.01021):0.19342,((SMIT:0.00925,SPSE:0.01380):0.00406,SPNE:0.01177):0.19155):0.04080):0.02299):0.00223,(((SPYO:0.05742,(SDYS:0.03321,SCAN:0.03153):0.00626):0.15700,(SSAL:0.16263,SDOW:0.15635):0.03525):0.06519,(SSAL:0.21474,SVES:0.19054):0.02452):0.01293):0.00000;
(SDOW:0.20319,SSAL:0.20319):0.00000;
(SVES:0.07353,SSAL:0.07353):0.00000;
(SVES:0.01459,SSAL:0.01459):0.00000;
(SVES:0.04359,SSAL:0.04359):0.00000;
(SVES:0.06727,SSAL:0.06727):0.00000;
(SVES:0.01890,SSAL:0.01890):0.00000;
((((SVES:0.00339,SSAL:0.00497):0.12248,SPSE:0.14116):0.16632,(SRAT:0.07427,SDEV:0.08807):0.26649):0.13777,(SANG:0.03155,SINT:0.04345):0.19329,(SEQU:0.04738,SLUT:0.05539):0.18039):0.00000;
(SINT:0.20514,SSAL:0.20514):0.00000;
(SINT:0.15023,SSAL:0.15023):0.00000;
(SINT:0.12014,SSAL:0.12014):0.00000;
((SSAL:0.21457,SPNE:0.31743):0.04961,SSUI:0.28556,SPLU:0.30644):0.00000;
(SENT:0.36708,SSAL:0.36708):0.00000;
(SSAL:0.43037,SPNE:0.22098,SPLU:0.27949):0.00000;
(SVES:0.17431,SSAL:0.17431):0.00000;
(((SPYO:0.13340,(SCAN:0.08943,SDYS:0.08659):0.03000):0.16124,(((SPLU:0.25988,SPLU:0.24331):0.12258,((SEQU:0.14280,(SLUT:0.07563,SINF:0.06989):0.09607):0.16840,(((SMIT:0.03130,SPNE:0.03438):0.15058,(SCON:0.06345,SANG:0.05861):0.11354):0.10566,SENT:0.33318):0.04486):0.01114):0.05495,SDOW:0.29221):0.02132):0.00995,((SDEV:0.06558,SRAT:0.06657):0.15940,(SVES:0.05576,SSAL:0.03884):0.17395):0.02295,SPLU:0.24147):0.00000;
((((LLAC:0.07161,LCRE:0.06972):0.29222,(SCAN:0.05460,(SPYO:0.04796,SDYS:0.04801):0.01128):0.16543):0.01210,(SSAL:0.12356,SRAT:0.12644):0.06382):0.00929,(SPLU:0.17351,SENT:0.16755):0.01477,SSUI:0.17274):0.00000;
((SEQU:0.17417,SSAL:0.43709):0.16571,SLUT:0.01812,SINF:0.01141):0.00000;
((SDOW:0.31471,SSAL:0.16860):0.01921,SRAT:0.20284,SINT:0.15771):0.00000;
(((SDOW:0.27180,SSAL:0.24064):0.08730,SANG:0.11294):0.04264,SRAT:0.07004,SDEV:0.07282):0.00000;
(SVES:0.00785,SSAL:0.00785):0.00000;
((SSAL:0.10632,SVES:0.12100):0.18735,((SDOW:0.18780,(SRAT:0.10485,SDEV:0.08859):0.08814):0.01934,(((LLAC:0.09589,LCRE:0.09862):0.20630,SPLU:0.24489):0.02578,(SENT:0.20317,(SCAN:0.06052,SDYS:0.04687):0.17143):0.02391):0.01470):0.00581,(((SPSE:0.00609,SPNE:0.01274):0.05024,SMIT:0.05177):0.19908,(SSUI:0.20134,(SANG:0.09587,(SCON:0.00644,SINT:0.00815):0.10474):0.07085):0.01527):0.02867):0.00000;
(SVES:0.07039,SSAL:0.07039):0.00000;
(SVES:0.02357,SSAL:0.02357):0.00000;
(SSAL:0.08341,STHE:0.11184,SPLU:0.42137):0.00000;
(((LCRE:0.32615,LLAC:0.42074):0.02468,((SANG:0.06840,SCON:0.05284):0.14585,SSAL:0.20732):0.02294):0.00791,(SPLU:0.18472,(SEQU:0.06003,(SLUT:0.00349,SINF:0.00615):0.04332):0.13908):0.05583,SENT:0.26739):0.00000;
((((SDOW:0.04560,(STHE:0.01450,(SVES:0.00195,SSAL:0.00293):0.00363):0.03378):0.00989,SPLU:0.06620):0.00429,(SENT:0.06091,(SSUI:0.07615,((LCRE:0.00505,LLAC:0.00661):0.09948,((SMIT:0.00347,(SPSE:0.00379,SPNE:0.00732):0.00070):0.04634,(SINT:0.01629,(SANG:0.01094,SCON:0.01519):0.00339):0.02989):0.02000):0.00569):0.00335):0.00417):0.00238,(((SINF:0.00913,SLUT:0.00976):0.00127,SEQU:0.00482):0.04555,(SDEV:0.01673,SRAT:0.01664):0.03503):0.00353,(SPYO:0.03161,(SCAN:0.01885,SDYS:0.01276):0.00226):0.04446):0.00000;
((SRAT:0.12332,(SSAL:0.29352,SDOW:0.39291):0.15743):0.01024,SINT:0.10010,SDEV:0.09602):0.00000;
((SMIT:0.18788,SSAL:0.13942):0.03113,SINF:0.16224,(LCRE:0.09270,LLAC:0.09415):0.07610):0.00000;
(SMIT:0.22230,SSAL:0.22230):0.00000;
(((SSAL:0.07881,SVES:0.06732):0.16152,(SMIT:0.11401,SPNE:0.13371):0.15518):0.19057,(SCON:0.06729,SANG:0.06201):0.04608,SINT:0.11861):0.00000;
(SMIT:0.20722,SSAL:0.20722):0.00000;
((((SINF:0.04887,(SLUT:0.02936,SEQU:0.03466):0.00584):0.05688,(SVES:0.01627,SSAL:0.01898):0.05527):0.02502,(SDOW:0.16664,((SPLU:0.10638,(SPYO:0.08372,(SCAN:0.04685,SDYS:0.03909):0.01289):0.03138):0.01492,((SMIT:0.01454,(SPSE:0.00148,SPNE:0.00632):0.00154):0.08203,(SSUI:0.10407,(SDEV:0.07407,SRAT:0.06863):0.00529):0.01344):0.00735):0.01236):0.00813):0.00413,((SINT:0.05380,(SANG:0.03997,SCON:0.03306):0.00723):0.05955,SENT:0.13027):0.00453,(LCRE:0.01448,LLAC:0.02023):0.15901):0.00000;
(SINT:0.15753,SSAL:0.15753):0.00000;
(SVES:0.03114,SSAL:0.03114):0.00000;
(SVES:0.00869,SSAL:0.00869):0.00000;
(SDOW:0.39302,(SSAL:0.05174,SVES:0.03207):0.02429,STHE:0.07630):0.00000;
(SPSE:0.14346,SSAL:0.14346):0.00000;
((SSAL:0.02133,SVES:0.02515):0.04590,STHE:0.10839,SEQU:0.56559):0.00000;
(SSAL:0.04498,(STHE:0.04517,SVES:0.02229):0.01744,((SEQU:0.12196,(SLUT:0.03137,SINF:0.03778):0.10113):0.12102,(SDYS:0.08233,(SPYO:0.01947,SCAN:0.04064):0.06615):0.31019):0.20741):0.00000;
(SRAT:0.30169,SSAL:0.30169):0.00000;
((SPLU:0.25665,((SINF:0.04127,SLUT:0.03092):0.09901,SEQU:0.13085):0.27245):0.00963,SSUI:0.23009,((SVES:0.04394,SSAL:0.03157):0.16994,(SPNE:0.20366,(SCON:0.07917,SANG:0.07494):0.10513):0.01510):0.03405):0.00000;
((SEQU:0.22183,SLUT:0.23025):0.06489,(SDOW:0.21659,(SRAT:0.01283,SDEV:0.02065):0.18412):0.18540,SSAL:0.33012):0.00000;
(SLUT:0.00659,SINF:0.04217,SEQU:0.24480):0.00000;
((((SINF:0.00871,SLUT:0.00615):0.04721,SEQU:0.04919):0.09031,SPLU:0.17551):0.00589,((SENT:0.22501,(SRAT:0.06454,SDEV:0.06846):0.10793):0.00601,(((SSAL:0.03090,(SVES:0.01846,STHE:0.02365):0.00532):0.22659,(SSUI:0.24982,SMIT:0.24107):0.25516):0.01693,SDOW:0.24989):0.02694):0.00955,(SPYO:0.05587,(SDYS:0.03367,SCAN:0.03937):0.02227):0.14633):0.00000;
((STHE:0.13961,SLUT:0.12862):0.01364,SENT:0.21152,LCRE:0.19219):0.00000;
(SRAT:0.13427,SLUT:0.13427):0.00000;
((SPSE:0.03892,(((SINF:0.03350,SLUT:0.06747):0.06604,SEQU:0.10002):0.19277,(SSAL:0.04086,SVES:0.04514):0.14550):0.12743):0.01390,SPNE:0.03119,SMIT:0.03724):0.00000;
((((SVES:0.02391,SSAL:0.02043):0.29332,(SANG:0.10528,(SCON:0.00136,SINT:0.00176):0.09731):0.25989):0.24955,SLUT:0.05103):0.02449,(SPSE:0.01821,SPNE:0.01698):0.00715,SMIT:0.03263):0.00000;
(((SINF:0.02795,SLUT:0.03188):0.08502,SEQU:0.09268):0.05436,SEQU:0.29111,((SDEV:0.05862,SRAT:0.06408):0.20270,SPLU:0.34070):0.12406):0.00000;
(SINF:0.02655,SLUT:0.02655):0.00000;
(SLUT:0.06031,SEQU:0.15096,SINF:0.00198):0.00000;
(SLUT:0.16145,SEQU:0.16444,SRAT:0.39212):0.00000;
((SINT:0.05617,(SSUI:0.30516,(SINF:0.00152,SDYS:0.00152):0.46672):0.13828):0.00762,SCON:0.04436,SANG:0.04396):0.00000;
(((SEQU:0.01500,(SLUT:0.00493,SINF:0.00656):0.01062):0.08800,SDOW:0.11795):0.01176,SVES:0.12963,((LLAC:0.00000,LCRE:0.00000):0.14845,(SDEV:0.07909,(SPYO:0.00790,SDYS:0.01485):0.07882):0.44456):0.01506):0.00000;
((SLUT:0.01867,SINF:0.01146):0.10188,SEQU:0.16135,SRAT:0.20056):0.00000;
(SEQU:0.09456,SINF:0.09456):0.00000;
(((SPLU:0.22926,(SINF:0.07646,SEQU:0.08566):0.11994):0.01135,(SPNE:0.23644,((SVES:0.05263,SSAL:0.05088):0.14618,(SRAT:0.11794,SDEV:0.08967):0.17558):0.01058):0.02754):0.00910,(SENT:0.19784,(SCAN:0.07962,(SDYS:0.00034,SPYO:0.01262):0.08096):0.15918):0.02835,(LLAC:0.08556,LCRE:0.07942):0.18262):0.00000;
(((SINF:0.10037,(SLUT:0.02305,SEQU:0.02742):0.06336):0.19978,SENT:0.32768):0.18191,(SDYS:0.07180,SCAN:0.06135):0.04985,SPYO:0.11345):0.00000;
((((SCAN:0.05690,(SPYO:0.03827,SDYS:0.02726):0.01768):0.17407,(SINF:0.16789,SEQU:0.15231):0.06772):0.03916,((STHE:0.05225,SVES:0.04393):0.02082,SSAL:0.06342):0.11292):0.12003,(SPNE:0.02917,SPSE:0.03613):0.00816,SMIT:0.04542):0.00000;
(((((SEQU:0.01101,SLUT:0.01389):0.10380,SINF:0.10742):0.11315,SDOW:0.21535):0.00679,SSUI:0.22660):0.18865,(SVES:0.05506,SSAL:0.04907):0.00129,STHE:0.06155):0.00000;
((SDOW:0.12129,((SDEV:0.04046,SRAT:0.04150):0.09781,(SINF:0.10114,SEQU:0.10655):0.07666):0.00969):0.00737,(SSAL:0.04960,(STHE:0.03738,SVES:0.02188):0.02391):0.15769,SSUI:0.14773):0.00000;
((SMIT:0.19177,(((SLUT:0.01757,SINF:0.00933):0.01817,SEQU:0.03496):0.21429,(SDOW:0.16993,(SANG:0.03743,(SINT:0.00000,SCON:0.00000):0.01767):0.20833):0.06497):0.07002):0.15554,(STHE:0.07986,SVES:0.02546):0.02057,SSAL:0.03601):0.00000;
(SINF:0.03673,SLUT:0.02577,SEQU:0.45687):0.00000;
(SEQU:0.03441,SINF:0.03441):0.00000;
(SLUT:0.01335,SINF:0.01335):0.00000;
(((SLUT:0.01795,SINF:0.01786):0.08101,SEQU:0.10096):0.25358,(SSUI:0.30585,((SANG:0.05658,(SINT:0.03441,SCON:0.03283):0.02262):0.17820,((SPSE:0.01685,SPNE:0.02101):0.01693,SMIT:0.03673):0.18715):0.04363):0.10897,(((SPYO:0.03845,SDYS:0.02817):0.12374,SCAN:0.13287):0.18018,SPLU:0.32903):0.02075):0.00000;
(SINF:0.08121,SEQU:0.13151,SLUT:0.00368):0.00000;
(SLUT:0.00088,SINF:0.00088):0.00000;
(SLUT:0.01385,SINF:0.01385):0.00000;
((SEQU:0.02690,(SLUT:0.01290,SINF:0.01275):0.01924):0.07515,(SENT:0.15328,SCAN:0.16872):0.01342,(SPLU:0.12291,(SDEV:0.01810,SRAT:0.02042):0.09093):0.00533):0.00000;
((((SINF:0.03453,(SLUT:0.03219,SEQU:0.03154):0.01410):0.15051,SDOW:0.20572):0.16615,SSAL:0.23532):0.01653,(SANG:0.04330,(SINT:0.00313,SCON:0.01126):0.04484):0.14345,(SDEV:0.02979,SRAT:0.03022):0.16357):0.00000;
(SDOW:0.31154,SINF:0.31154):0.00000;
(SDOW:0.47494,SINF:0.18448,SDYS:0.17240):0.00000;
(SINF:0.25808,SDOW:0.39553,SDYS:0.26780):0.00000;
(SINF:0.18665,SDYS:0.17290,SDOW:0.30168):0.00000;
(SINT:0.30981,SINF:0.30981):0.00000;
(SPNE:0.05979,SINF:0.05979):0.00000;
(SINF:0.01498,SEQU:0.19850,SLUT:0.04494):0.00000;
(SINF:0.23455,SEQU:0.27075,SSUI:0.28416):0.00000;
(SLUT:0.00903,SINF:0.00903):0.00000;
(SINF:0.21027,(SEQU:0.06257,SLUT:0.11779):0.15520,(SSAL:0.08508,SVES:0.10926):0.27970):0.00000;
((SINF:0.10853,(SINF:0.21769,(SINF:0.30176,(SRAT:0.34332,SRAT:0.29907):0.06260):0.07816):0.06231):0.02528,SPYO:0.27044,SPNE:0.13529):0.00000;
((SPYO:0.17201,SINF:0.32145):0.08598,SINF:0.10954,SPNE:0.13397):0.00000;
(SSAL:0.21144,SINF:0.21144):0.00000;
((STHE:0.29892,SINF:0.28735):0.01701,(SSAL:0.33769,(SDOW:0.22526,SDEV:0.26425):0.10838):0.08183,(SCON:0.06973,(SANG:0.03246,SINT:0.02737):0.02643):0.29000):0.00000;
((SEQU:0.03579,(SLUT:0.01467,SINF:0.01466):0.02914):0.05492,(((((SPSE:0.02079,(SMIT:0.01068,SPNE:0.01142):0.00885):0.02902,SINT:0.05241):0.01468,(SANG:0.07806,SCON:0.05876):0.02097):0.03165,(((SDEV:0.03526,SRAT:0.03190):0.07177,(SSAL:0.01499,(STHE:0.01787,SVES:0.01211):0.00497):0.08434):0.01255,((LLAC:0.04427,LCRE:0.04087):0.34856,SSUI:0.13197):0.00958):0.00502):0.00153,((SCAN:0.01458,(SPYO:0.01134,SDYS:0.01011):0.00778):0.06745,SDOW:0.11929):0.00670):0.00128,(SENT:0.09511,SPLU:0.10330):0.01174):0.00000;
(SINF:0.16994,SLUT:0.16854,SDEV:0.17761):0.00000;
(((((LLAC:0.03351,LCRE:0.03223):0.30214,((SVES:0.03111,SSAL:0.02962):0.14335,(SCON:0.01671,(SINT:0.01012,SANG:0.00499):0.00494):0.14502):0.26092):0.04597,((SLUT:0.01448,SINF:0.00961):0.03241,SEQU:0.04789):0.23151):0.01125,SENT:0.31527):0.00883,((SVES:0.04631,SSAL:0.05598):0.22014,SPLU:0.32490):0.02101,SDOW:0.33353):0.00000;
((((SINT:0.20864,SCON:0.20832):0.08562,(SDYS:0.25291,SCAN:0.24041):0.08407):0.00662,((SDEV:0.27548,((SLUT:0.01979,SINF:0.01927):0.08151,SEQU:0.10634):0.16329):0.01966,(SPYO:0.27867,(SRAT:0.22352,SDOW:0.25682):0.00931):0.01969):0.01110):0.00335,SENT:0.31888,SSUI:0.34964):0.00000;
((SINF:0.00555,SEQU:0.00383):0.18234,(SANG:0.16823,(SRAT:0.06168,SDEV:0.07151):0.16401):0.10196,SLUT:0.40256):0.00000;
(SINF:0.00000,SLUT:0.00000,SEQU:0.45675):0.00000;
((SINF:0.07477,SEQU:0.06672):0.60681,SMIT:0.02752,SSAL:0.01868):0.00000;
((((SSUI:0.01721,SPLU:0.04406):0.00946,((((LLAC:0.03419,LCRE:0.03738):0.30150,((SPNE:0.00693,SPSE:0.00991):0.05534,SSUI:0.06595):0.20306):0.11515,((SCON:0.05351,SDEV:0.05471):0.01088,(SCAN:0.00000,(SPYO:0.00000,SDYS:0.00000):0.00000):0.05838):0.28382):0.25701,(SPNE:0.06533,(SINT:0.00395,SCON:0.00468):0.02107):0.07550):0.06288):0.01784,(SDEV:0.00929,SRAT:0.00586):0.02331):0.01619,(SPYO:0.00000,SDYS:0.00000):0.00179,SCAN:0.00905):0.00000;
(SVES:0.27343,SPSE:0.27343):0.00000;
(SPSE:0.19253,SSUI:0.35665,SCON:0.19836):0.00000;
(SPSE:0.05779,SCAN:0.04573,LLAC:0.18415):0.00000;
(SPSE:0.39216,STHE:0.01248,SSAL:0.01154):0.00000;
((SCAN:0.10837,(SPNE:0.00614,SPSE:0.00030):0.10752):0.03372,SDOW:0.18564,(((SRAT:0.04308,SDEV:0.04966):0.03999,SPSE:0.10170):0.18226,SINF:0.33420):0.19455):0.00000;
(SANG:0.30580,SPSE:0.30580):0.00000;
(SPSE:0.01118,(SPNE:0.04876,SSUI:0.14227):0.02026,SPSE:0.03471):0.00000;
(SPNE:0.06990,SPSE:0.06990):0.00000;
(SCON:0.27892,SPSE:0.27892):0.00000;
(SPNE:0.06301,SPSE:0.06301):0.00000;
(SCAN:0.20409,SPSE:0.20409):0.00000;
(SPSE:0.13636,SPSE:0.13636):0.00000;
(SDYS:0.32362,SPSE:0.32362):0.00000;
(SPNE:0.01445,SPSE:0.01445):0.00000;
(SPNE:0.06785,SPSE:0.06785):0.00000;
(SPSE:0.33730,SPSE:0.37094,(SPSE:0.09164,STHE:0.08513):0.29007):0.00000;
(SPNE:0.04132,SPSE:0.04132):0.00000;
(SPNE:0.00142,SPSE:0.00142):0.00000;
(SPNE:0.04441,SPSE:0.04441):0.00000;
(SPSE:0.27561,SINF:0.15293,SENT:0.17196):0.00000;
(SPSE:0.18694,SDOW:0.40098,(SRAT:0.01900,SDEV:0.02594):0.14499):0.00000;
(SPNE:0.02331,SPSE:0.02331):0.00000;
(SPSE:0.00753,(SMIT:0.01383,((SSAL:0.01387,SVES:0.02379):0.03335,((SANG:0.01821,(SINT:0.01652,SCON:0.01552):0.01014):0.08816,((SDOW:0.08618,(SRAT:0.02864,SDEV:0.02899):0.04982):0.34001,(SSUI:0.09777,SPLU:0.07983):0.09297):0.05447):0.04636):0.03944):0.00503,SPNE:0.01899):0.00000;
((SCAN:0.04654,(SPSE:0.07688,(SRAT:0.05263,SDEV:0.06252):0.11175):0.37993):0.06600,SPSE:0.00843,SPNE:0.01729):0.00000;
(SPSE:0.01192,SPNE:0.00575,SMIT:0.02325):0.00000;
((STHE:0.31763,SPSE:0.13572):0.07455,(SSUI:0.01264,SCAN:0.01275):0.00341,(SSAL:0.00245,SVES:0.00485):0.02324):0.00000;
(SPSE:0.01795,SPNE:0.00168,SMIT:0.06123):0.00000;
(SMIT:0.05398,SPSE:0.05398):0.00000;
((SPNE:0.01115,SPSE:0.00912):0.13388,SSUI:0.13197,SDOW:0.42996):0.00000;
((SPSE:0.00656,SPNE:0.01395):0.01399,SMIT:0.01298,(STHE:0.29919,(SANG:0.08672,(SINT:0.00326,SCON:0.01067):0.09373):0.09734):0.20618):0.00000;
(SPSE:0.12372,SCAN:0.12870,LLAC:0.30638):0.00000;
(SPSE:0.01607,SPNE:0.01730,SDEV:0.62679):0.00000;
(SPSE:0.29972,SLUT:0.32190,SPSE:0.30256):0.00000;
(((SSUI:0.12784,((SMIT:0.03426,(SPSE:0.00263,SPNE:0.00105):0.03277):0.03091,(SANG:0.00366,(SINT:0.00570,SCON:0.00169):0.00280):0.05148):0.05840):0.03542,((LCRE:0.00000,LLAC:0.00000):0.19586,((SPNE:0.00000,SPSE:0.00000):0.08352,SDYS:0.07133):0.37212):0.06040):0.02853,((SPYO:0.02407,(SCAN:0.01529,SDYS:0.00971):0.00509):0.03561,(SDEV:0.01751,SRAT:0.01101):0.03911):0.02933,((SPLU:0.07762,SENT:0.07423):0.01573,(((SINF:0.00150,SLUT:0.00407):0.00681,SEQU:0.00615):0.06428,((STHE:0.04142,(SSAL:0.00630,SVES:0.00389):0.01740):0.06038,SDOW:0.10568):0.01075):0.00890):0.00496):0.00000;
(SPNE:0.03737,SPSE:0.03737):0.00000;
(SPSE:0.08052,SPSE:0.14012,SMIT:0.16948):0.00000;
(SPNE:0.00000,SPSE:0.00000):0.00000;
(SPNE:0.01728,SPSE:0.01728):0.00000;
(SMIT:0.10951,SPSE:0.10951):0.00000;
(SCAN:0.06489,SPSE:0.06489):0.00000;
((SPSE:0.09062,(SPSE:0.06032,(SPSE:0.00243,((SMIT:0.04147,SPSE:0.04336):0.06643,(SPSE:0.03076,SPSE:0.11910):0.03649):0.04681):0.02375):0.02724):0.01232,SPSE:0.14081,SPSE:0.49406):0.00000;
(SPNE:0.00825,SPSE:0.00825):0.00000;
(SCAN:0.21698,SPSE:0.21698):0.00000;
(SDYS:0.11121,SDYS:0.32169,SCAN:0.24047):0.00000;
((((LLAC:0.03328,LCRE:0.01643):0.29952,((SDYS:0.00476,SPYO:0.01209):0.04487,SCAN:0.05513):0.09385):0.00905,(SEQU:0.07943,(SLUT:0.03416,SINF:0.01426):0.04203):0.06227):0.01694,((((STHE:0.00579,SSAL:0.00959):0.02469,SVES:0.02147):0.07333,((SMIT:0.01053,SPSE:0.03232):0.00684,SPNE:0.03194):0.18911):0.01022,((SINT:0.08966,(SANG:0.02206,SCON:0.03676):0.05420):0.03070,SSUI:0.10745):0.02340):0.00327,SENT:0.16150):0.00000;
(SPYO:0.00734,SDYS:0.00734):0.00000;
((((LLAC:0.00886,LCRE:0.00919):0.25863,((SCAN:0.00734,SDYS:0.01060):0.00713,SPYO:0.02281):0.05793):0.00562,(SPLU:0.08387,(SSUI:0.04968,SENT:0.06801):0.02533):0.01114):0.00797,(((((SMIT:0.00470,SPSE:0.00780):0.00247,SPNE:0.00658):0.03194,SINT:0.03946):0.02598,(SANG:0.00548,SCON:0.00838):0.06468):0.00934,(((SINF:0.01093,SLUT:0.01199):0.02591,SEQU:0.02487):0.02717,(SDOW:0.07100,(SDEV:0.02048,SRAT:0.02658):0.05772):0.00739):0.00326):0.00175,(STHE:0.02931,(SSAL:0.00883,SVES:0.01260):0.00840):0.04042):0.00000;
(((((SSAL:0.01677,(STHE:0.00579,SVES:0.00322):0.01171):0.04769,SDOW:0.07716):0.00568,((SINF:0.00989,SLUT:0.01591):0.00268,SEQU:0.01163):0.04193):0.02480,((SPLU:0.06601,(SDEV:0.00347,SRAT:0.00219):0.06338):0.00767,SDYS:0.06472):0.00784):0.00576,((SPSE:0.00050,(SMIT:0.00000,SPNE:0.00000):0.00021):0.03931,(SANG:0.00512,(SINT:0.00250,SCON:0.01239):0.00197):0.02955):0.03371,SSUI:0.09863):0.00000;
((SSUI:0.15871,((((SSAL:0.02971,(STHE:0.00319,SVES:0.00252):0.03467):0.12684,(SDOW:0.18265,((SEQU:0.05096,(SINF:0.04314,SLUT:0.04434):0.01846):0.10590,(SDYS:0.07288,(SCAN:0.04505,SPYO:0.04145):0.02523):0.08750):0.01800):0.01189):0.00393,SPLU:0.18418):0.00290,(SENT:0.16838,(SDEV:0.05194,SRAT:0.05599):0.11536):0.00813):0.00750):0.00099,((SPSE:0.01912,(SMIT:0.02018,SPNE:0.02070):0.00215):0.15218,(SANG:0.05966,(SINT:0.03846,SCON:0.05068):0.01717):0.07586):0.04057,(LLAC:0.04638,LCRE:0.04971):0.22020):0.00000;
((SDYS:0.24391,SSUI:0.28866):0.42420,LCRE:0.01263,LLAC:0.02608):0.00000;
((SPLU:0.04977,((((LLAC:0.01097,LCRE:0.01057):0.14857,((SMIT:0.00442,(SPSE:0.00666,SPNE:0.00885):0.00532):0.03492,(SANG:0.00697,(SINT:0.00390,SCON:0.00406):0.00541):0.03939):0.00385):0.01336,SSUI:0.06902):0.00739,((((SINF:0.00498,SLUT:0.00606):0.00412,SEQU:0.00935):0.03391,(SCAN:0.02497,(SPYO:0.00479,SDYS:0.00533):0.02020):0.02586):0.00510,(SDOW:0.06020,(SDEV:0.01353,SRAT:0.01625):0.04592):0.00593):0.00360):0.00495):0.00363,SENT:0.06906,(SSAL:0.00690,(STHE:0.00302,SVES:0.00363):0.00308):0.03358):0.00000;
(SDYS:0.17483,SPYO:0.08130,SDYS:0.06353):0.00000;
((SDYS:0.21834,SENT:0.27447):0.29276,SANG:0.04984,SPLU:0.04661):0.00000;
(SDYS:0.06252,SPYO:0.12153,SCAN:0.06335):0.00000;
((SPYO:0.00581,SDYS:0.00323):0.01314,(SCON:0.13881,SDEV:0.09307):0.08258,SCAN:0.01935):0.00000;
(SDYS:0.02670,SCAN:0.01700,SCAN:0.55605):0.00000;
(SDYS:0.19435,SDOW:0.32769,SINF:0.31483):0.00000;
((SANG:0.09798,(((SPNE:0.01025,(SMIT:0.01148,SVES:0.02212):0.00395):0.16679,((SCAN:0.26772,(SDYS:0.15478,SINF:0.16379):0.07887):0.03075,SDOW:0.35353):0.21748):0.01251,SENT:0.19309):0.07860):0.07805,(SCAN:0.02152,(SSUI:0.02341,SDYS:0.02190):0.00481):0.00338,(SSUI:0.02498,SPLU:0.01395):0.00989):0.00000;
((SDYS:0.02459,(SANG:0.06560,((SMIT:0.00665,(SVES:0.00061,SPNE:0.00033):0.00087):0.20330,(SENT:0.26224,(((SDYS:0.19873,SINF:0.21866):0.04792,SDOW:0.24365):0.07675,SCAN:0.33028):0.17292):0.04007):0.14915):0.04322):0.01019,SSUI:0.01862,SSUI:0.01182):0.00000;
(SDOW:0.31839,SDYS:0.31839):0.00000;
(SPSE:0.22394,SDYS:0.22394):0.00000;
((SINT:0.02373,(SANG:0.01046,SCON:0.01583):0.00472):0.00769,((((STHE:0.01467,(SSAL:0.00181,SVES:0.00747):0.00280):0.01338,((SMIT:0.00405,SPSE:0.01165):0.00304,SPNE:0.01182):0.00811):0.00489,SPYO:0.03905):0.00726,(SDEV:0.03340,(SDOW:0.04358,(((SSUI:0.01540,SPLU:0.02220):0.04638,((LCRE:0.02152,LLAC:0.01294):0.13906,SENT:0.06670):0.00634):0.01471,(SCAN:0.06751,SDYS:0.04213):0.01273):0.00558):0.00348):0.00440):0.00307,((SINF:0.01035,(SLUT:0.01498,SEQU:0.00540):0.00101):0.01323,SRAT:0.02137):0.00423):0.00000;
(((SDYS:0.06528,SCAN:0.07216):0.20671,(((SDEV:0.04219,SRAT:0.04739):0.12975,(SEQU:0.02163,(SINF:0.02590,SLUT:0.02575):0.00672):0.16333):0.08638,SDYS:0.54896):0.01275):0.01137,SDOW:0.19347,(SSAL:0.05325,(STHE:0.05532,SVES:0.03764):0.02399):0.18335):0.00000;
(LCRE:0.28901,SDYS:0.28901):0.00000;
((SDYS:0.01288,SCAN:0.01010):0.06239,((SINF:0.00689,SLUT:0.00834):0.00979,SEQU:0.01052):0.06357,(SPLU:0.06494,(SSUI:0.10471,(((SMIT:0.02255,SPSE:0.01689):0.00621,SPNE:0.02159):0.11084,SENT:0.10087):0.00822):0.00611):0.00564):0.00000;
(((SPLU:0.06351,SENT:0.11273):0.00823,(SSUI:0.09538,(((SMIT:0.00593,(SPSE:0.00634,SPNE:0.00324):0.00756):0.05903,(SANG:0.02237,(SINT:0.01073,SCON:0.01432):0.00502):0.05197):0.03890,((LCRE:0.02790,LLAC:0.02474):0.18688,SDYS:0.15008):0.02190):0.00619):0.00944):0.00583,((SDEV:0.01849,SRAT:0.02358):0.06233,SDOW:0.10402):0.00222,((SSAL:0.02183,(STHE:0.00848,SVES:0.00676):0.01675):0.05626,((SINF:0.01157,SLUT:0.01240):0.01298,SEQU:0.02581):0.04767):0.01212):0.00000;
((SPYO:0.00826,SDYS:0.00621):0.02356,(SDEV:0.00813,SRAT:0.00698):0.03754,SPLU:0.05197):0.00000;
(((STHE:0.01459,(SSAL:0.00294,SVES:0.00229):0.00276):0.02381,(SPLU:0.02301,(SPYO:0.01009,(SCAN:0.01329,SDYS:0.00907):0.00387):0.02638):0.00475):0.00518,(SDOW:0.06210,(((SINF:0.00975,SLUT:0.00552):0.00315,SEQU:0.00487):0.02481,(SDEV:0.01867,SRAT:0.01176):0.02665):0.00800):0.00482,(SSUI:0.04203,((LCRE:0.00219,LLAC:0.00084):0.10723,((((SMIT:0.00190,SPSE:0.00219):0.00092,SPNE:0.00224):0.03006,(SANG:0.02054,(SINT:0.00870,SCON:0.00295):0.01623):0.02370):0.01860,SENT:0.07318):0.01242):0.01172):0.01019):0.00000;
((((LLAC:0.01431,LCRE:0.01139):0.17985,SENT:0.10219):0.00861,(SPLU:0.10231,((SDYS:0.00686,SPYO:0.00053):0.02618,SCAN:0.02609):0.05951):0.00879):0.00752,((SINF:0.01800,SLUT:0.01289):0.01616,SEQU:0.02012):0.06710,(((SSAL:0.01105,SVES:0.01119):0.03445,(SMIT:0.00330,(SPSE:0.01005,SPNE:0.00800):0.00148):0.04883):0.03668,(SANG:0.03855,SINT:0.04267):0.06431):0.02506):0.00000;
(SDYS:0.00139,SPYO:0.00533,SCAN:0.30172):0.00000;
(((SDYS:0.00436,SDYS:0.00682):0.00843,SDYS:0.00529):0.00571,(SPYO:0.00195,SPYO:0.00212):0.01234,((SINF:0.00149,SINF:0.00237):0.37251,SINF:0.40575):0.30200):0.00000;
(SPLU:0.29224,SDYS:0.29224):0.00000;
(SDYS:0.00602,SDYS:0.11073,SDYS:0.00393):0.00000;
(SDYS:0.02020,SCAN:0.02184,SPLU:0.39786):0.00000;
(SDYS:0.00552,SPYO:0.00552):0.00000;
((SPYO:0.08189,(SPLU:0.16590,((SMIT:0.28851,(SPSE:0.36990,(SDEV:0.22219,(SDOW:0.06096,(SRAT:0.04629,SSAL:0.05643):0.00579):0.17784):0.04701):0.00542):0.08615,SENT:0.27212):0.09015):0.06289):0.01342,SMIT:0.07270,(SINT:0.05477,SCAN:0.03955):0.01483):0.00000;
(((SDEV:0.01650,SRAT:0.02337):0.14058,(((SMIT:0.00517,(SPSE:0.00000,SPNE:0.00000):0.00808):0.13472,((SANG:0.00642,(SINT:0.00045,SCON:0.00288):0.02348):0.08454,SSUI:0.11214):0.02892):0.05522,((STHE:0.01752,(SSAL:0.00356,SVES:0.01624):0.00889):0.15265,(SPYO:0.06693,(SCAN:0.01951,SDYS:0.00672):0.02532):0.04004):0.02403):0.03373):0.00940,(SENT:0.15676,((SINF:0.00917,SLUT:0.00749):0.00639,SEQU:0.00687):0.09811):0.01222,(SPLU:0.18228,SDOW:0.28504):0.00949):0.00000;
(SDYS:0.30230,SPYO:0.30230):0.00000;
(SDYS:0.05485,SPYO:0.05485):0.00000;
(SDYS:0.00723,SPYO:0.00723):0.00000;
((SDOW:0.17232,(SSAL:0.01473,(STHE:0.01232,SVES:0.01091):0.00271):0.19354):0.01076,((SENT:0.24076,SPLU:0.16594):0.03299,(SSUI:0.14268,((((SMIT:0.00355,SPSE:0.01001):0.00342,SPNE:0.02705):0.06081,((SANG:0.01590,SINT:0.02450):0.01297,SCON:0.03850):0.02913):0.04707,(SRAT:0.09457,SDEV:0.13462):0.02215):0.00759):0.01476):0.01165,(((SINF:0.00897,SLUT:0.00186):0.04412,SEQU:0.02523):0.07920,((SCAN:0.03155,SDYS:0.02714):0.08839,SPYO:0.11261):0.02977):0.02224):0.00000;
(((((((SMIT:0.00000,SPSE:0.00000):0.00176,SPNE:0.00863):0.06023,(SINT:0.03937,(SANG:0.00438,SCON:0.00400):0.01083):0.02288):0.02113,SSUI:0.13302):0.04508,(LCRE:0.02851,LLAC:0.02067):0.18166):0.01470,(SPLU:0.11622,((((SINF:0.00046,SLUT:0.01171):0.02008,SEQU:0.01448):0.06321,((STHE:0.00000,SSAL:0.00000):0.00285,SVES:0.00528):0.09004):0.00313,(SDYS:0.01698,(SCAN:0.02846,SPYO:0.03972):0.01527):0.06888):0.01644):0.01028):0.00225,(SENT:0.14404,(SDEV:0.04921,SRAT:0.05162):0.06301):0.00692,SDOW:0.14104):0.00000;
(LCRE:0.16555,SPYO:0.16555):0.00000;
(SPYO:0.21601,SCAN:0.22889,LLAC:0.47272):0.00000;
(SCAN:0.34231,SPYO:0.34231):0.00000;
((((SENT:0.26325,SCAN:0.16059):0.01582,SPYO:0.10927):0.03233,(SINT:0.05627,SDEV:0.05280):0.03308):0.00934,SCON:0.05152,SANG:0.06554):0.00000;
(SDYS:0.00219,SPYO:0.00219):0.00000;
(SPYO:0.03800,(SCAN:0.02786,SDYS:0.01888):0.00855,SSUI:0.64776):0.00000;
((SPYO:0.06840,(SCAN:0.06051,SDYS:0.03949):0.01165):0.06251,((SEQU:0.02460,(SINF:0.01264,SLUT:0.01036):0.02319):0.07473,((((SANG:0.01195,SINT:0.01705):0.01610,SCON:0.03510):0.05607,((SSAL:0.01473,(STHE:0.00888,SVES:0.00516):0.00758):0.06276,(SMIT:0.01408,(SPSE:0.01103,SPNE:0.01444):0.00230):0.04333):0.04048):0.03416,(SDOW:0.08422,(SDEV:0.01603,SRAT:0.01229):0.06117):0.01988):0.00948):0.00853,(SENT:0.10730,SPLU:0.13458):0.00957):0.00000;
((((SANG:0.00785,(SINT:0.00491,SCON:0.00016):0.01096):0.02676,SPLU:0.09670):0.00430,(SCAN:0.02364,SPYO:0.02206):0.02539):0.00164,(SDEV:0.00515,SRAT:0.01043):0.01829,(SMIT:0.00090,SPNE:0.00037):0.05847):0.00000;
(SPYO:0.16759,SCAN:0.12791,SDYS:0.18770):0.00000;
((SINT:0.07429,((((SPYO:0.06893,(SCAN:0.02114,SDYS:0.02178):0.04832):0.14697,(SEQU:0.02682,(SINF:0.00641,SLUT:0.00395):0.02285):0.20433):0.10533,SDOW:0.27370):0.23633,((SPSE:0.02577,SPNE:0.02742):0.01744,SMIT:0.02955):0.18336):0.15247):0.02213,SCON:0.01582,SANG:0.02145):0.00000;
(((SCAN:0.01682,SPYO:0.01441):0.01951,SDYS:0.03382):0.17158,(SMIT:0.00696,(SSAL:0.01164,SPNE:0.00519):0.00437):0.00307,SPSE:0.01185):0.00000;
(SDYS:0.00514,SPYO:0.00514):0.00000;
(SDYS:0.03924,SPYO:0.03924):0.00000;
(((((((LLAC:0.00879,LCRE:0.02503):0.19686,(((SSUI:0.00262,SPLU:0.01140):0.01207,SENT:0.01831):0.02111,SPYO:0.08936):0.01853):0.01237,(SCAN:0.02434,SDYS:0.01331):0.01405):0.00897,(SINF:0.02389,(SLUT:0.00000,SEQU:0.00000):0.00670):0.01124):0.00249,(SANG:0.01832,(SINT:0.00714,SCON:0.00695):0.01459):0.01245):0.01017,SPNE:0.02425):0.00169,SPSE:0.00000,SMIT:0.00000):0.00000;
((SDOW:0.06546,(((SPYO:0.17380,SDYS:0.17182):0.17120,(SSUI:0.14583,SPLU:0.17062):0.22149):0.11142,((SPSE:0.02102,SPNE:0.01196):0.03312,SMIT:0.04231):0.24266):0.24660):0.00408,SSAL:0.04726,SVES:0.04106):0.00000;
((SPLU:0.17130,(SDOW:0.16447,((SEQU:0.13389,(SLUT:0.03443,SINF:0.03169):0.09223):0.07673,(((LCRE:0.11342,LLAC:0.09474):0.18758,((((SMIT:0.02834,SPSE:0.01860):0.00384,SPNE:0.03212):0.12641,((SANG:0.02745,SINT:0.03514):0.00976,SCON:0.03837):0.11075):0.11202,SSUI:0.24852):0.01060):0.00617,(SPYO:0.11291,(SCAN:0.07696,SDYS:0.09368):0.02504):0.17641):0.02703):0.01564):0.00881):0.00539,(SRAT:0.03706,SDEV:0.03331):0.16722,((SSAL:0.01941,SVES:0.01921):0.02624,STHE:0.05363):0.16385):0.00000;
((((LLAC:0.02391,LCRE:0.03547):0.20972,(((SMIT:0.01321,(SPSE:0.00670,SPNE:0.01104):0.00827):0.08746,(SINT:0.07604,(SANG:0.03258,SCON:0.05286):0.01941):0.04839):0.03174,SENT:0.18023):0.01113):0.01069,(SPLU:0.12911,(SDOW:0.12799,((SSAL:0.01177,(SVES:0.01241,STHE:0.01958):0.00330):0.05584,(SCAN:0.04775,(SDYS:0.00699,SPYO:0.00625):0.03015):0.02267):0.01240):0.01981):0.03168):0.00603,(((SINF:0.01078,SLUT:0.00515):0.00619,SEQU:0.00923):0.07507,(SDEV:0.04054,SRAT:0.03675):0.06327):0.02565,SSUI:0.08877):0.00000;
(SPYO:0.01767,SDYS:0.01890,((LLAC:0.05564,LCRE:0.05343):0.41103,SENT:0.20802):0.18533):0.00000;
(SPYO:0.28463,SSUI:0.33362,SANG:0.31417):0.00000;
(SPYO:0.00000,SPYO:0.00000):0.00000;
(SPYO:0.20756,SDYS:0.17549,SCAN:0.16474):0.00000;
(SDYS:0.00036,SPYO:0.00036):0.00000;
((SPSE:0.12272,SPYO:0.12489):0.02043,(LCRE:0.36681,SSUI:0.25035):0.08896,(STHE:0.07122,SDOW:0.08285):0.08952):0.00000;
(SDYS:0.25803,SPYO:0.25803):0.00000;
(SDYS:0.26439,SPYO:0.26439):0.00000;
(SCAN:0.12676,SPYO:0.12676):0.00000;
(((SRAT:0.01469,SLUT:0.01076):0.22021,((LLAC:0.01405,LCRE:0.01313):0.15038,SPYO:0.15909):0.05703):0.16182,SEQU:0.03883,(SINF:0.00754,SLUT:0.01219):0.02903):0.00000;
(SDYS:0.26484,SPYO:0.26484):0.00000;
(SDYS:0.34439,SPYO:0.34439):0.00000;
((((SANG:0.03884,(SINT:0.02453,SCON:0.01410):0.02532):0.12744,SDOW:0.19021):0.01511,((SPNE:0.05212,SMIT:0.05284):0.19488,(((LLAC:0.12313,LCRE:0.11388):0.16623,(SRAT:0.03500,SDEV:0.03216):0.24181):0.02632,SPYO:0.39277):0.12101):0.01771):0.01056,(((SINF:0.01624,SLUT:0.01642):0.05383,SEQU:0.06260):0.11312,((SSAL:0.03539,SVES:0.03888):0.01602,STHE:0.06415):0.14998):0.01663,SSUI:0.21231):0.00000;
(SPYO:0.34023,SPYO:0.34023):0.00000;
((((((SEQU:0.04126,(SLUT:0.01526,SINF:0.01316):0.02646):0.15102,((SCAN:0.07739,SPYO:0.08457):0.01258,SDYS:0.09327):0.12199):0.02387,(SDOW:0.20350,(SRAT:0.05064,SDEV:0.04846):0.14310):0.01061):0.00443,(SSAL:0.04861,(SVES:0.03423,STHE:0.03400):0.01987):0.18949):0.01096,SPLU:0.25878):0.01365,((((SPSE:0.02586,SPNE:0.02620):0.00427,SMIT:0.02852):0.24212,(SANG:0.04327,(SCON:0.02806,SINT:0.03040):0.01945):0.16796):0.01474,SSUI:0.26007):0.00054,((LCRE:0.02938,LLAC:0.03249):0.31099,SENT:0.28107):0.02357):0.00000;
((SPYO:0.07029,SDYS:0.04001):0.26095,(SDEV:0.03316,SRAT:0.03957):0.19078,SPLU:0.12930):0.00000;
(SDYS:0.08093,SPYO:0.08093):0.00000;
(SPYO:0.01065,SDYS:0.02093,SCAN:0.07714):0.00000;
((SPNE:0.01339,(SINT:0.08527,(((LLAC:0.03421,LCRE:0.03194):0.16877,((SPYO:0.02490,SDYS:0.02427):0.02786,SCAN:0.05604):0.17616):0.07528,SSUI:0.22860):0.12852):0.08063):0.00719,SPSE:0.01022,SMIT:0.01261):0.00000;
((SENT:0.16126,(SPYO:0.28313,(SPYO:0.10089,SCAN:0.07532):0.24807):0.23453):0.11134,SANG:0.03715,SCON:0.03011):0.00000;
(((SPYO:0.14161,(SCAN:0.04074,SDYS:0.03563):0.05969):0.08201,(SDOW:0.17799,((SSAL:0.02127,SVES:0.03343):0.13358,(SPLU:0.15117,((SINF:0.03101,SLUT:0.01939):0.06675,SEQU:0.07650):0.06164):0.01099):0.01819):0.03769):0.01095,(SDEV:0.03060,SRAT:0.03654):0.13908,((SSUI:0.26637,(SINT:0.04537,(SANG:0.04823,SCON:0.02951):0.00612):0.17506):0.06704,SENT:0.23285):0.01903):0.00000;
(SDYS:0.00207,SPYO:0.00207):0.00000;
((((SVES:0.01604,SSAL:0.01822):0.18293,((SCAN:0.06753,SPYO:0.08092):0.01227,SDYS:0.07240):0.11842):0.03328,((SMIT:0.07809,(SPSE:0.00118,SPNE:0.00127):0.07085):0.19767,(SPYO:0.00381,SDYS:0.00466):0.44060):0.01855):0.00636,((SSUI:0.23189,(((SLUT:0.00183,SEQU:0.00212):0.05332,SINF:0.05302):0.10718,SENT:0.17339):0.01695):0.01339,((SRAT:0.02758,SDEV:0.03302):0.13189,SDOW:0.18726):0.05745):0.00230,(SCON:0.03553,SANG:0.02617):0.21763):0.00000;
(SPYO:0.01465,SDYS:0.04646,SCAN:0.05247):0.00000;
((SCAN:0.00733,(SDYS:0.00146,SPYO:0.00597):0.00358):0.04232,(((SSUI:0.03680,SPLU:0.02473):0.02182,SENT:0.05682):0.01649,(((LCRE:0.00340,LLAC:0.00050):0.13851,(SANG:0.00187,(SINT:0.00054,SCON:0.00221):0.00167):0.06272):0.01729,((SINF:0.00913,SEQU:0.00652):0.04782,(SDOW:0.04649,(SDEV:0.00473,SRAT:0.00306):0.03652):0.01241):0.00377):0.00572):0.00147,(((STHE:0.00535,SSAL:0.00204):0.00052,SVES:0.00279):0.01965,(SMIT:0.00569,(SPSE:0.00499,SPNE:0.00477):0.00094):0.02973):0.01343):0.00000;
(SDYS:0.01660,SPYO:0.01660):0.00000;
(SENT:0.21728,SPYO:0.21728):0.00000;
((SPYO:0.02295,SCAN:0.02397):0.03058,SDYS:0.09021,SDEV:0.64795):0.00000;
((((SANG:0.02125,(SINT:0.00057,SCON:0.00799):0.01134):0.05346,((SMIT:0.00241,(SPSE:0.01593,SPNE:0.04374):0.00590):0.05320,((((LCRE:0.00549,LLAC:0.00303):0.24365,(STHE:0.01357,(SSAL:0.00651,SVES:0.00373):0.00861):0.04616):0.01614,(SPLU:0.06480,(SLUT:0.01535,(SINF:0.00000,SEQU:0.00000):0.00687):0.03710):0.01737):0.00665,(SSUI:0.05627,((SPYO:0.00000,SDYS:0.00000):0.00388,SCAN:0.00812):0.05972):0.01548):0.00581):0.00589):0.00982,(SENT:0.07918,SRAT:0.02925):0.00830):0.00675,SDOW:0.04277,SDEV:0.05050):0.00000;
(SCAN:0.07903,SDYS:0.05656,SPYO:0.05580):0.00000;
(((SSAL:0.03507,SVES:0.02078):0.10189,(SCAN:0.25758,(SINT:0.05576,(SANG:0.02777,SCON:0.02474):0.02545):0.10471):0.07651):0.10112,(SPSE:0.01434,SPNE:0.02548):0.01090,SMIT:0.02270):0.00000;
(((((SLUT:0.01951,SINF:0.03605):0.04200,SEQU:0.04640):0.12839,(SRAT:0.11353,SDEV:0.11418):0.07734):0.03347,(((((SPSE:0.03592,SPNE:0.02692):0.00760,SMIT:0.04368):0.15381,(SANG:0.07825,(SINT:0.00980,SCON:0.01038):0.07358):0.14447):0.07653,SSUI:0.25003):0.05588,((LLAC:0.10552,LCRE:0.11171):0.21934,((SCAN:0.06683,SDYS:0.07153):0.06773,SPYO:0.14381):0.09068):0.01794):0.01733):0.01201,(((SSAL:0.01964,SVES:0.02503):0.00661,STHE:0.01787):0.16143,SENT:0.17133):0.01760,(SPLU:0.21669,SDOW:0.20413):0.00825):0.00000;
((SPSE:0.09127,((SCAN:0.03006,SDYS:0.02990):0.05265,SPYO:0.07902):0.14681):0.06847,(SINT:0.01391,SCON:0.00934):0.01518,SANG:0.03681):0.00000;
(SINF:0.35819,SCAN:0.35819):0.00000;
((SCAN:0.05297,SDYS:0.05588):0.52715,SDYS:0.10275,SCAN:0.12069):0.00000;
((SCAN:0.25497,(LLAC:0.02316,LCRE:0.02576):0.26680):0.06351,SCAN:0.39659,SSUI:0.36343):0.00000;
(SCAN:0.02806,SDYS:0.00898,SPYO:0.00112):0.00000;
((SPLU:0.10000,SSUI:0.06450):0.20500,(SENT:0.13753,SDOW:0.16894):0.08205,((SCAN:0.02470,SDYS:0.01759):0.16717,SRAT:0.15074):0.07286):0.00000;
(SCAN:0.11815,SDYS:0.21643,SPYO:0.07726):0.00000;
(SCAN:0.03258,(SPYO:0.05872,SDYS:0.03017):0.02075,(SRAT:0.01834,SDEV:0.01979):0.38965):0.00000;
(SCAN:0.11135,SDYS:0.14162,SPYO:0.19086):0.00000;
(SCAN:0.01431,SDYS:0.03588,SPYO:0.09896):0.00000;
(((SCAN:0.01034,(SPYO:0.00788,SDYS:0.00760):0.00515):0.24854,((((SMIT:0.01857,SPSE:0.02188):0.00689,SPNE:0.03144):0.09920,(SANG:0.01031,(SINT:0.00298,SCON:0.00583):0.00474):0.11156):0.07572,((LLAC:0.00417,LCRE:0.00338):0.24698,((SPLU:0.25360,SENT:0.27259):0.03418,SSUI:0.27248):0.04657):0.01833):0.03395):0.01517,(((STHE:0.04993,(SSAL:0.00000,SVES:0.00000):0.02767):0.09897,(SLUT:0.02002,(SINF:0.01531,SEQU:0.01151):0.00478):0.10031):0.02118,SDOW:0.15014):0.02758,(SDEV:0.04476,SRAT:0.03794):0.12524):0.00000;
(((((SRAT:0.02162,SDEV:0.02340):0.04049,SENT:0.06469):0.00479,((SSUI:0.05620,(SLUT:0.01797,(SINF:0.01008,SEQU:0.01071):0.00276):0.04302):0.01337,((LLAC:0.01151,LCRE:0.01812):0.10880,SDOW:0.04887):0.01411):0.00585):0.00515,((SCAN:0.02766,SDYS:0.02409):0.00465,SPYO:0.06302):0.03295):0.00478,((STHE:0.00758,SSAL:0.00617):0.00290,SVES:0.00790):0.04287,((((SMIT:0.00791,SPSE:0.00490):0.00162,SPNE:0.00479):0.03002,(SANG:0.02398,(SINT:0.00724,SCON:0.00353):0.02387):0.01749):0.01326,SPLU:0.05537):0.00199):0.00000;
(((SPSE:0.26806,((SCAN:0.07615,SPYO:0.07775):0.02194,SDYS:0.11013):0.14950):0.27067,((SANG:0.05606,(SINT:0.02644,SCON:0.02473):0.02810):0.07499,(SMIT:0.01874,(SPSE:0.00732,SPNE:0.00721):0.00792):0.13049):0.02501):0.01304,SENT:0.16668,(SCAN:0.04700,(SPYO:0.01253,SDYS:0.00369):0.02875):0.10062):0.00000;
(SENT:0.24794,((SPYO:0.03688,SCAN:0.03675):0.00978,SDYS:0.04178):0.18981,(((LLAC:0.02065,LCRE:0.02287):0.29420,SINF:0.21710):0.03706,(SRAT:0.02179,SDEV:0.02551):0.18637):0.01943):0.00000;
(((SPYO:0.00652,SDYS:0.00472):0.03793,SCAN:0.03690):0.09094,(((SINF:0.00938,SLUT:0.00861):0.02509,SEQU:0.03613):0.05376,SDEV:0.06089):0.00676,(SRAT:0.07001,((((SCON:0.01284,SINT:0.00937):0.11531,SPLU:0.16019):0.05400,(((SMIT:0.00944,SPSE:0.00789):0.00199,SPNE:0.00879):0.06715,SANG:0.08248):0.03427):0.01631,(SSUI:0.11296,SENT:0.14377):0.01447):0.01103):0.00922):0.00000;
(((SDOW:0.05640,(((SINF:0.00538,SLUT:0.00772):0.00627,SEQU:0.00830):0.04244,(SDYS:0.02093,(SPYO:0.02653,SCAN:0.02117):0.00345):0.03753):0.00519):0.00295,((((((SCAN:0.02384,(SPYO:0.00649,SDYS:0.00516):0.01631):0.07415,(SENT:0.08656,((STHE:0.01626,(SSAL:0.00283,SVES:0.00610):0.01055):0.06532,(((((SMIT:0.00623,SPSE:0.00871):0.00694,SPNE:0.01427):0.04921,(SINT:0.02465,(SANG:0.00764,SCON:0.01273):0.01488):0.02834):0.01645,(SSUI:0.01353,SPLU:0.01165):0.06273):0.00249,(SDOW:0.08001,(((SINF:0.00798,SLUT:0.00835):0.00820,SEQU:0.01510):0.05688,(SDEV:0.02037,SRAT:0.02227):0.05377):0.00452):0.00466):0.00403):0.00764):0.00284):0.03084,(LCRE:0.00878,LLAC:0.00874):0.13428):0.35723,(LCRE:0.00491,LLAC:0.00372):0.10357):0.03402,(((SMIT:0.01125,(SPSE:0.00565,SPNE:0.00691):0.00843):0.04087,(SANG:0.01453,(SINT:0.01248,SCON:0.01352):0.00355):0.03873):0.01340,SSUI:0.06456):0.00651):0.01029,(SENT:0.05500,(SDEV:0.01211,SRAT:0.01012):0.04462):0.00530):0.00415):0.00260,SPLU:0.05380,(STHE:0.00281,(SSAL:0.00497,SVES:0.00762):0.00304):0.05828):0.00000;
((SPSE:0.12705,SANG:0.13189):0.12359,(SDOW:0.34000,((SLUT:0.31531,((SPSE:0.02276,SMIT:0.02247):0.19718,(SCAN:0.03010,SPYO:0.04843):0.18895):0.02975):0.03571,SSUI:0.28638):0.02277):0.01649,SPSE:0.31584):0.00000;
(((SMIT:0.21143,SSAL:0.12035):0.22259,(SCAN:0.00815,SPLU:0.00163):0.02946):0.02183,SINT:0.04921,SMIT:0.01177):0.00000;
(SCAN:0.11094,SCAN:0.11094):0.00000;
(SCAN:0.05181,SCAN:0.05181):0.00000;
((SCAN:0.18499,SENT:0.21436):0.02020,SPSE:0.30504,(SDYS:0.00000,SPLU:0.00000):0.38268):0.00000;
((SPSE:0.23238,SINT:0.19117):0.10194,(SCAN:0.25985,(SCAN:0.14348,SPYO:0.14193):0.18660):0.01157,(SEQU:0.02399,SINF:0.02819):0.22854):0.00000;
(SPYO:0.25361,SCAN:0.25361):0.00000;
(((SSAL:0.02800,SVES:0.03931):0.13219,SCAN:0.33127):0.14517,(SPSE:0.02138,SPNE:0.01681):0.00704,SMIT:0.02787):0.00000;
(SDYS:0.09524,SCAN:0.09524):0.00000;
(SSUI:0.18943,SCAN:0.18943):0.00000;
(((((LLAC:0.06243,LCRE:0.05830):0.19168,(LLAC:0.02390,LCRE:0.01445):0.20447):0.06194,SCAN:0.31985):0.00902,(SENT:0.19152,((((SINF:0.00790,SLUT:0.00986):0.02044,SEQU:0.03330):0.08038,(SDEV:0.04349,SRAT:0.06139):0.05933):0.03079,(((SANG:0.03013,(SINT:0.03562,SCON:0.02637):0.01205):0.08449,(SMIT:0.07642,(SSAL:0.01692,SVES:0.02600):0.06331):0.04948):0.03179,(SPLU:0.10083,SSUI:0.08819):0.05418):0.01429):0.01856):0.10982):0.00683,((LLAC:0.12240,LCRE:0.13456):0.25324,(LLAC:0.05214,LCRE:0.04121):0.26920):0.02826,(LLAC:0.33102,SENT:0.32442):0.02271):0.00000;
(SPYO:0.11189,SCAN:0.11189):0.00000;
(((SDYS:0.03095,(SPYO:0.01731,SCAN:0.02018):0.00184):0.08998,((((STHE:0.01572,(SSAL:0.00475,SVES:0.00457):0.01603):0.03837,SPLU:0.08446):0.02789,SDOW:0.08317):0.02460,(((SINF:0.00303,SLUT:0.00689):0.00365,SEQU:0.01054):0.04000,(SDEV:0.02022,SRAT:0.02499):0.03094):0.03803):0.00960):0.00194,((SMIT:0.01363,(SPSE:0.00520,SPNE:0.00793):0.00813):0.12776,((SINF:0.01159,SLUT:0.00921):0.01729,SEQU:0.02204):0.09962):0.00666,SSUI:0.12748):0.00000;
(((SEQU:0.11119,SINF:0.11355):0.08394,(SCAN:0.08287,SDYS:0.06879):0.14251):0.09680,(SSUI:0.24786,(SRAT:0.04757,SDEV:0.05121):0.17394):0.00795,(SCON:0.07309,(SINT:0.04463,SANG:0.05578):0.01686):0.17154):0.00000;
((SCAN:0.02002,SDYS:0.01810):0.10786,SSUI:0.08372,(LCRE:0.00395,LLAC:0.00349):0.38791):0.00000;
(((SCAN:0.07260,SDYS:0.07418):0.15294,SSUI:0.20105):0.09325,((LLAC:0.03580,LCRE:0.03484):0.36399,((LLAC:0.03804,LCRE:0.04481):0.20185,(SDYS:0.03322,SCAN:0.02013):0.20825):0.08140):0.00910,(LLAC:0.04637,LCRE:0.05263):0.25984):0.00000;
((SPYO:0.14046,(SCAN:0.09077,SDYS:0.09369):0.04096):0.18233,(((SLUT:0.04080,SINF:0.05294):0.15082,SEQU:0.23061):0.14388,SDOW:0.34604):0.01676,SENT:0.31532):0.00000;
(SCAN:0.04055,SCAN:0.04055):0.00000;
(SCAN:0.00525,SCAN:0.00525):0.00000;
(SCAN:0.00617,SCAN:0.00617):0.00000;
(((LLAC:0.05999,LCRE:0.05503):0.17279,((((((SCAN:0.09038,SDYS:0.10210):0.04006,SPYO:0.14098):0.12984,(SPLU:0.14858,SSUI:0.15151):0.09804):0.08636,(SINT:0.30871,SCON:0.28332):0.01644):0.00717,SEQU:0.33864):0.01284,SCAN:0.33018):0.20539):0.04429,(SVES:0.17096,(((((SPSE:0.01413,(SMIT:0.01484,SPNE:0.01796):0.00265):0.11728,(SANG:0.04595,(SINT:0.00581,SCON:0.00655):0.04571):0.07782):0.02044,SSUI:0.14568):0.00856,SDOW:0.15324):0.00723,((SDEV:0.03184,SRAT:0.03661):0.09567,(SEQU:0.05309,(SINF:0.02364,SLUT:0.02304):0.03158):0.08731):0.01224):0.00801):0.00544,SENT:0.17842):0.00000;
(LLAC:0.32162,SCAN:0.32162):0.00000;
((SCAN:0.06794,SDYS:0.05456):0.19348,SENT:0.26941,LCRE:0.40254):0.00000;
(((SSUI:0.08303,((SINF:0.00658,SLUT:0.00217):0.02106,SEQU:0.01653):0.06605):0.01918,((((SRAT:0.07738,SDOW:0.07705):0.17774,(SDYS:0.01488,SCAN:0.01299):0.21490):0.23578,(LLAC:0.00059,LCRE:0.00028):0.19988):0.07778,SDOW:0.11707):0.01523):0.00719,((SMIT:0.00092,SPSE:0.00521):0.07786,(SINT:0.01455,(SANG:0.00144,SCON:0.00293):0.00459):0.04926):0.02268,(STHE:0.01953,(SSAL:0.00591,SVES:0.00453):0.00648):0.11862):0.00000;
(SEQU:0.01317,SLUT:0.00136,SINF:0.04805):0.00000;
((SCON:0.15530,SEQU:0.12902):0.05624,(SDOW:0.17567,SDEV:0.17595):0.03027,LLAC:0.31626):0.00000;
((SEQU:0.03480,SDYS:0.27196):0.04746,SLUT:0.01000,SINF:0.01012):0.00000;
(SEQU:0.03953,SDEV:0.31687,SINF:0.07696):0.00000;
((SEQU:0.03817,(SDEV:0.03103,SRAT:0.03397):0.27402):0.00880,SLUT:0.00060,SINF:0.00426):0.00000;
(SEQU:0.04460,(SANG:0.16181,SDOW:0.20314):0.11037,SLUT:0.06454):0.00000;
(((SDEV:0.03454,SRAT:0.03380):0.12990,((((SCON:0.15082,(SPNE:0.03811,SPSE:0.02306):0.10859):0.23770,SRAT:0.23767):0.00775,(SEQU:0.09887,SINF:0.07818):0.13918):0.00439,(SDEV:0.14267,SRAT:0.12559):0.13211):0.01573):0.00474,((SINF:0.08459,SEQU:0.07475):0.02887,SLUT:0.11292):0.09707,SDOW:0.18501):0.00000;
(SEQU:0.40462,LCRE:0.05846,LLAC:0.02615):0.00000;
(((SDOW:0.19177,SRAT:0.18743):0.01610,((SDYS:0.08723,SCAN:0.06846):0.12338,(((SINF:0.03130,SLUT:0.03082):0.01803,SEQU:0.03514):0.12188,((SEQU:0.00590,SLUT:0.00817):0.00633,SINF:0.01680):0.19071):0.03923):0.00960):0.00554,(SSUI:0.17759,((SPSE:0.02431,(SMIT:0.01925,SPNE:0.01850):0.00145):0.11366,(SANG:0.03461,(SCON:0.02707,SINT:0.02445):0.02100):0.11416):0.08580):0.03178,((STHE:0.03893,(SSAL:0.01233,SVES:0.01248):0.03293):0.11148,SPLU:0.16699):0.01321):0.00000;
(SEQU:0.17511,SINF:0.19744,SSUI:0.28697):0.00000;
(((SPLU:0.20684,(((STHE:0.06793,SVES:0.03626):0.01766,SSAL:0.05329):0.09551,(SDEV:0.04567,SRAT:0.05953):0.10645):0.00729):0.01553,(SINF:0.15464,SEQU:0.12587):0.04189):0.00316,(SDOW:0.21653,((LLAC:0.02695,LCRE:0.02364):0.29392,(((((SPSE:0.05443,SPNE:0.04893):0.02603,SMIT:0.08530):0.32050,(SCON:0.17001,(SANG:0.16852,SINT:0.15656):0.03732):0.12557):0.02015,SSUI:0.35309):0.02910,((SMIT:0.04589,(SPSE:0.03244,SPNE:0.03882):0.00863):0.12137,((SANG:0.05083,SCON:0.05431):0.01065,SINT:0.07088):0.10209):0.13193):0.01915):0.01893):0.01942,(SPYO:0.11802,(SCAN:0.07476,SDYS:0.07117):0.06079):0.10560):0.00000;
(SEQU:0.21944,SMIT:0.16356,SDYS:0.16165):0.00000;
(SEQU:0.02614,(SDEV:0.02493,SRAT:0.02927):0.05892,SLUT:0.03568):0.00000;
(SPLU:0.15573,SENT:0.21500,(SEQU:0.10421,(SINF:0.04103,SLUT:0.05421):0.11171):0.03282):0.00000;
(SEQU:0.14746,(((SDEV:0.03208,SRAT:0.02729):0.12972,(SPYO:0.00205,SDYS:0.00048):0.16318):0.00920,((((SPSE:0.01323,SPNE:0.00952):0.14200,(SANG:0.05421,(SCON:0.03827,SINT:0.04409):0.01280):0.08461):0.02609,SSAL:0.16622):0.01441,(SPLU:0.19813,((SSUI:0.22802,((LLAC:0.03465,LCRE:0.03876):0.28060,(SDOW:0.15315,(SPLU:0.11618,(SSUI:0.00351,SENT:0.00240):0.11327):0.02939):0.29122):0.01459):0.02330,SDOW:0.23225):0.02192):0.01835):0.00799):0.00446,SENT:0.18839):0.00000;
(SEQU:0.25674,(SPLU:0.28856,SINT:0.27284):0.10194,LCRE:0.30022):0.00000;
(SEQU:0.34113,SEQU:0.34113):0.00000;
((SEQU:0.01597,SLUT:0.01806):0.03951,SINF:0.06065,(((SPSE:0.00795,SPNE:0.01081):0.18689,(LLAC:0.11998,LCRE:0.11559):0.06388):0.18599,(SRAT:0.12169,SDEV:0.15261):0.10923):0.12848):0.00000;
((SDOW:0.12751,((SINF:0.01662,SLUT:0.01768):0.00666,SEQU:0.02088):0.09542):0.01211,((SDYS:0.05761,(SCAN:0.02807,SPYO:0.02991):0.02467):0.10476,(SDEV:0.04456,SRAT:0.03533):0.10239):0.00318,(((((LLAC:0.01344,LCRE:0.01153):0.39858,SENT:0.21817):0.02932,(((SMIT:0.02041,SPSE:0.01176):0.00468,SPNE:0.02391):0.17113,(SANG:0.03707,(SCON:0.02367,SINT:0.03711):0.02029):0.10775):0.02808):0.00475,SSUI:0.17191):0.02143,((STHE:0.03472,(SSAL:0.01722,SVES:0.01188):0.01433):0.11356,SPLU:0.15062):0.01444):0.00546):0.00000;
(SEQU:0.26106,(SRAT:0.17893,SDEV:0.16806):0.10043,(LLAC:0.01821,LCRE:0.02410):0.40235):0.00000;
((((SSAL:0.04203,SVES:0.03707):0.13258,SENT:0.17220):0.01209,((SINF:0.02020,SLUT:0.02324):0.05789,SEQU:0.08976):0.07369):0.00778,(((SPNE:0.16654,(((SCON:0.04266,SANG:0.03170):0.01852,SINT:0.05613):0.06257,SSUI:0.18232):0.00523):0.04866,SPLU:0.16775):0.01218,SDOW:0.19664):0.01045,SMIT:0.43564):0.00000;
(SEQU:0.26090,SRAT:0.29256,SRAT:0.24218):0.00000;
(((SDEV:0.27708,(SEQU:0.06954,SRAT:0.09288):0.24505):0.06395,((SDEV:0.02467,SRAT:0.03356):0.06783,SPNE:0.10105):0.06713):0.01289,SRAT:0.24740,LCRE:0.19360):0.00000;
(SCON:0.21529,SEQU:0.21529):0.00000;
(SCON:0.39622,SEQU:0.23327,SCON:0.28071):0.00000;
(SEQU:0.05590,SDEV:0.30900,SINF:0.04493):0.00000;
(SLUT:0.19968,SSUI:0.24224,SANG:0.53754):0.00000;
(SLUT:0.00000,SEQU:0.08411,SINF:0.00000):0.00000;
((((LLAC:0.05481,LCRE:0.05392):0.28738,SSAL:0.06806):0.01209,(SEQU:0.01617,(SINF:0.00555,SLUT:0.01559):0.01163):0.03184):0.00681,(SDEV:0.04236,SRAT:0.05608):0.00581,SDOW:0.07309):0.00000;
(SLUT:0.01352,(SEQU:0.03549,((LLAC:0.01132,LCRE:0.01107):0.45375,(SDEV:0.02148,SRAT:0.01599):0.05857):0.05535):0.02442,SINF:0.00713):0.00000;
(SLUT:0.00555,(SEQU:0.03588,SDYS:0.28960):0.02523,SINF:0.01236):0.00000;
(((SDOW:0.13328,(SPYO:0.06276,(SCAN:0.03601,SDYS:0.02842):0.02576):0.07705):0.10115,((SINF:0.04333,SEQU:0.04324):0.02906,SLUT:0.09608):0.05593):0.01256,(SDEV:0.01161,SRAT:0.01442):0.07831,SSUI:0.16911):0.00000;
(SLUT:0.20536,SLUT:0.20536):0.00000;
((((SINF:0.01949,(SEQU:0.01135,SLUT:0.01389):0.00940):0.03453,(SDEV:0.00350,SRAT:0.00653):0.05642):0.00444,SDOW:0.05808):0.00297,((SSAL:0.01039,(STHE:0.01179,SVES:0.01217):0.00380):0.04654,(SPYO:0.02223,(SCAN:0.00927,SDYS:0.01424):0.00428):0.04511):0.00472,((((SMIT:0.00538,SPSE:0.01029):0.00130,SPNE:0.00898):0.05600,((SANG:0.00379,SINT:0.00723):0.00127,SCON:0.00565):0.04402):0.02506,(SPLU:0.05788,(SSUI:0.08182,((LCRE:0.00793,LLAC:0.01089):0.13067,SENT:0.16487):0.01655):0.01117):0.00529):0.00451):0.00000;
((SDOW:0.17512,(((SINF:0.00285,SLUT:0.00505):0.01845,SEQU:0.02256):0.10920,((SCAN:0.00921,SDYS:0.00999):0.01701,SPYO:0.03233):0.10938):0.02932):0.00707,(((SENT:0.24259,((LCRE:0.01700,LLAC:0.01853):0.33946,(((SMIT:0.04682,(SPSE:0.00453,SPNE:0.00436):0.04704):0.09464,(SANG:0.02406,(SINT:0.02619,SCON:0.02480):0.00559):0.08485):0.05646,SSUI:0.19060):0.01301):0.01535):0.00639,SPLU:0.20978):0.01140,(SDEV:0.02099,SRAT:0.01951):0.14109):0.00372,(SSAL:0.01485,(STHE:0.01681,SVES:0.01133):0.00588):0.18616):0.00000;
(SDEV:0.34424,SLUT:0.34424):0.00000;
(SINF:0.02293,SLUT:0.02293):0.00000;
(SLUT:0.01793,(SEQU:0.05616,(((SPNE:0.00490,SPSE:0.00375):0.20097,(LCRE:0.06898,LLAC:0.07668):0.10516):0.13805,(SDEV:0.09845,SRAT:0.07917):0.08971):0.10919):0.03278,SINF:0.02087):0.00000;
(((SRAT:0.05179,SDEV:0.04677):0.26621,((SINF:0.01289,SLUT:0.01627):0.05490,SEQU:0.06174):0.13631):0.11455,SPYO:0.14505,(SCAN:0.09211,SDYS:0.09809):0.03492):0.00000;
((((SPLU:0.02891,SENT:0.02571):0.01477,SDOW:0.06883):0.00372,((((SMIT:0.00056,(SPSE:0.00300,SPNE:0.00621):0.00072):0.02370,(SINT:0.01214,(SANG:0.00106,SCON:0.00406):0.00652):0.01910):0.01775,SSUI:0.03398):0.00910,(((SLUT:0.23115,((((SMIT:0.00617,(SPSE:0.00136,SPNE:0.00229):0.00584):0.03471,(SINT:0.00554,(SANG:0.00014,SCON:0.00038):0.00383):0.04975):0.07196,(SSUI:0.09573,((LCRE:0.00920,LLAC:0.00854):0.10322,((((SINF:0.00679,SLUT:0.00414):0.02961,SEQU:0.03238):0.03819,((SPYO:0.01470,(SCAN:0.00438,SDYS:0.00603):0.00482):0.05616,(SDEV:0.07250,SRAT:0.05957):0.00240):0.00600):0.01520,((SSAL:0.00867,SVES:0.00852):0.08404,(SPLU:0.06851,(SDEV:0.04867,SRAT:0.04101):0.03266):0.00625):0.00365):0.02055):0.00734):0.00962):0.00775,SDOW:0.12544):0.10008):0.08786,((SPNE:0.03357,(SPSE:0.00238,SMIT:0.00361):0.01622):0.26659,(SPNE:0.14088,(SPSE:0.00000,SPNE:0.00000):0.15223):0.14502):0.02432):0.23677,(LCRE:0.01310,LLAC:0.01010):0.09704):0.03928):0.00691):0.00042,(((SINF:0.00396,SLUT:0.00523):0.00764,SEQU:0.00973):0.03231,(SDEV:0.01776,SRAT:0.01602):0.02719):0.00649,((STHE:0.01312,(SSAL:0.00388,SVES:0.00328):0.00527):0.02979,(SCAN:0.00520,(SPYO:0.00481,SDYS:0.00336):0.00168):0.04469):0.00351):0.00000;
(SLUT:0.01059,SINF:0.12230,STHE:0.00442):0.00000;
(STHE:0.05551,SVES:0.02827,SSAL:0.00097):0.00000;
(STHE:0.07303,SVES:0.02790,SSAL:0.00014):0.00000;
((STHE:0.01411,SVES:0.01540):0.04572,SSAL:0.05926,(SRAT:0.07048,SDEV:0.07456):0.41748):0.00000;
((SPLU:0.13491,((SSAL:0.00397,(SVES:0.00580,STHE:0.00675):0.00440):0.10203,((SENT:0.15603,(SENT:0.27944,((LLAC:0.00757,LCRE:0.00900):0.17514,((((SPSE:0.00480,SPNE:0.00721):0.00366,SMIT:0.00588):0.13075,(SANG:0.01835,(SINT:0.01450,SCON:0.01351):0.00653):0.08608):0.01084,(SDEV:0.01406,SRAT:0.01145):0.12218):0.01363):0.02043):0.01177):0.01951,SDOW:0.11917):0.01584):0.01336):0.02420,(SSUI:0.08825,(SCAN:0.02625,(SPYO:0.00292,SDYS:0.00630):0.01843):0.04886):0.00466,((SINF:0.00651,SLUT:0.00616):0.00264,SEQU:0.00652):0.05739):0.00000;
((SENT:0.19452,(((LLAC:0.02320,LCRE:0.03278):0.23875,(SSUI:0.21201,((SPNE:0.06321,(SPSE:0.04874,SMIT:0.04032):0.02932):0.08441,(SINT:0.03961,(SANG:0.02087,SCON:0.02201):0.00799):0.10022):0.02904):0.01186):0.02892,(SDOW:0.17686,(SSAL:0.02568,(SVES:0.02009,STHE:0.02714):0.01206):0.16941):0.01465):0.00980):0.00900,((SINF:0.03698,(SLUT:0.00838,SEQU:0.00409):0.03687):0.11595,((SPYO:0.04289,(SCAN:0.02748,SDYS:0.02430):0.01255):0.09478,(SDEV:0.02102,SRAT:0.01607):0.12563):0.00778):0.00562,SPLU:0.16864):0.00000;
(SSAL:0.08847,STHE:0.08847):0.00000;
((SDEV:0.06808,SRAT:0.07124):0.25146,STHE:0.02553,(SSAL:0.01077,SVES:0.01233):0.00967):0.00000;
(STHE:0.03471,SVES:0.02461,SSAL:0.06584):0.00000;
(((STHE:0.03928,SVES:0.02608):0.05188,SSAL:0.07491):0.25718,(SDOW:0.29477,(SDEV:0.06220,SRAT:0.07593):0.19637):0.01020,((SEQU:0.09694,(SINF:0.01905,SLUT:0.02346):0.07258):0.17942,(SDYS:0.13092,(SPYO:0.10332,SCAN:0.08025):0.03674):0.17021):0.01883):0.00000;
(STHE:0.02766,SVES:0.01874,SSAL:0.00496):0.00000;
(STHE:0.00019,SVES:0.04321,SSAL:0.09636):0.00000;
((SENT:0.10639,(((LCRE:0.02202,LLAC:0.01592):0.09198,((LCRE:0.02853,LLAC:0.03349):0.15326,STHE:0.39165):0.04483):0.04303,(SPLU:0.08670,((SCAN:0.04850,SDYS:0.04704):0.01077,SPYO:0.06851):0.05213):0.01023):0.00619):0.00440,((SSUI:0.07162,((SSAL:0.01012,(STHE:0.01642,SVES:0.00812):0.00377):0.07440,((SINF:0.00627,SLUT:0.01043):0.00739,SEQU:0.01471):0.04119):0.00963):0.01334,(SDOW:0.08091,(SDEV:0.01760,SRAT:0.01664):0.09531):0.01140):0.00451,((SMIT:0.00395,(SPSE:0.00615,SPNE:0.00685):0.00028):0.04980,(SANG:0.02133,(SINT:0.01025,SCON:0.00778):0.01753):0.04479):0.03493):0.00000;
(STHE:0.01384,SVES:0.00969,SSAL:0.03616):0.00000;
((STHE:0.05268,SVES:0.08245):0.00750,SSAL:0.05012,(SINT:0.14083,SDOW:0.32779):0.19999):0.00000;
((((SSAL:0.01617,(SVES:0.00746,STHE:0.00762):0.00460):0.11725,SDOW:0.14584):0.04163,(SRAT:0.02487,SDEV:0.02221):0.08098):0.01052,(SPLU:0.15164,((SINF:0.02133,SLUT:0.02242):0.02441,SEQU:0.03832):0.09915):0.01053,((LCRE:0.07707,LLAC:0.08526):0.17914,SSUI:0.18380):0.02679):0.00000;
(STHE:0.09445,SVES:0.00992,SSAL:0.01477):0.00000;
(STHE:0.02519,SVES:0.15609,SSAL:0.05484):0.00000;
(STHE:0.01114,SDYS:0.39343,SINF:0.02195):0.00000;
(SSAL:0.13532,STHE:0.13532):0.00000;
(STHE:0.15992,SVES:0.03152,SSAL:0.02872):0.00000;
(STHE:0.05129,SVES:0.06060,SSAL:0.00466):0.00000;
(STHE:0.05986,SVES:0.03478,SSAL:0.01851):0.00000;
(SSAL:0.02865,STHE:0.02865):0.00000;
(STHE:0.10441,SVES:0.03180,SSAL:0.05401):0.00000;
(STHE:0.12478,SVES:0.04555,SSAL:0.02003):0.00000;
(SPLU:0.12333,STHE:0.12333):0.00000;
(SMIT:0.19436,STHE:0.19436):0.00000;
((LCRE:0.03825,LLAC:0.03726):0.16427,((SDOW:0.12635,((SSAL:0.02996,(SVES:0.01864,STHE:0.02711):0.01389):0.05881,((SINF:0.01454,SLUT:0.01606):0.02324,SEQU:0.04681):0.05175):0.03307):0.00547,(((SMIT:0.01155,SPSE:0.00781):0.01850,SPNE:0.01589):0.10441,(((SANG:0.02339,SINT:0.03716):0.00703,SCON:0.03267):0.05279,(SDEV:0.03087,SRAT:0.03115):0.04346):0.03425):0.00846):0.01602,(((SSUI:0.16203,SPLU:0.12147):0.07113,SINF:0.18978):0.01605,((SCAN:0.04252,SPYO:0.03403):0.01446,SDYS:0.04767):0.13088):0.00220):0.00000;
(SDOW:0.15666,STHE:0.15666):0.00000;
(STHE:0.08323,(SVES:0.07751,(SRAT:0.29445,SDOW:0.21865):0.09875):0.02124,SSAL:0.03534):0.00000;
((STHE:0.01340,STHE:0.00095):0.00131,((STHE:0.01786,STHE:0.01184):0.00391,STHE:0.01098):0.00047,STHE:0.00263):0.00000;
(((SMIT:0.25604,((SVES:0.07729,STHE:0.06163):0.01503,SANG:0.08054):0.19049):0.04499,SDOW:0.32013):0.01746,SDOW:0.35046,LCRE:0.34325):0.00000;
(SANG:0.02384,STHE:0.02384):0.00000;
((STHE:0.03154,SVES:0.02977):0.00910,SSAL:0.03989,(SRAT:0.16768,SDEV:0.20824):0.32110):0.00000;
(STHE:0.03775,(SVES:0.01507,(SINF:0.09980,SDEV:0.09340):0.07990):0.00362,SSAL:0.01078):0.00000;
((STHE:0.23459,SSAL:0.16879):0.04405,((SANG:0.02648,SCON:0.03166):0.03992,SINT:0.06859):0.19099,((SLUT:0.10926,(SEQU:0.07976,SEQU:0.07413):0.01576):0.23004,SDEV:0.36106):0.03874):0.00000;
(SVES:0.17737,STHE:0.17737):0.00000;
(SENT:0.32990,STHE:0.32990):0.00000;
((((SCAN:0.01564,(SPYO:0.01075,SDYS:0.01100):0.00295):0.00505,(((SPSE:0.00754,(SMIT:0.00078,SPNE:0.00543):0.00209):0.00727,(SSUI:0.00000,SPLU:0.00000):0.02644):0.00440,(((((SANG:0.00621,SINT:0.00929):0.00486,SCON:0.00848):0.02645,SENT:0.02838):0.00355,(LCRE:0.00192,LLAC:0.00166):0.20801):0.00525,((SINF:0.00000,(SLUT:0.00000,SEQU:0.00000):0.00000):0.02284,(SDEV:0.01111,SRAT:0.01111):0.02290):0.00400):0.00790):0.00503):0.00818,SDOW:0.02446):0.00229,(SSAL:0.00032,SVES:0.00589):0.00238,STHE:0.00382):0.00000;
(LLAC:0.05946,LCRE:0.05025,SDEV:0.64198):0.00000;
((SENT:0.08525,((SPSE:0.02514,(SMIT:0.02184,SPNE:0.01198):0.00393):0.07815,((SANG:0.04030,SINT:0.05747):0.05519,(LCRE:0.05840,LLAC:0.03001):0.15094):0.01147):0.03082):0.01868,(SPLU:0.07847,(SDOW:0.06703,(((SSAL:0.01057,(STHE:0.00813,SVES:0.00354):0.00410):0.04013,(SLUT:0.02072,(SINF:0.02169,SEQU:0.02423):0.00775):0.04757):0.00561,(SDEV:0.04109,SRAT:0.05129):0.01579):0.00731):0.00754):0.00380,SSUI:0.09808):0.00000;
((((SINF:0.00233,(SLUT:0.00258,SEQU:0.00012):0.00037):0.01206,(SPYO:0.00584,(SCAN:0.00521,SDYS:0.00287):0.00520):0.00983):0.00803,(SENT:0.05122,(((((SMIT:0.00057,SPSE:0.00214):0.00100,SPNE:0.00225):0.02695,(SANG:0.00257,(SINT:0.00136,SCON:0.00079):0.00281):0.02422):0.00279,SSUI:0.03324):0.01985,(LCRE:0.00239,LLAC:0.00073):0.20616):0.02049):0.00724):0.00476,(((STHE:0.00654,(SSAL:0.00000,SVES:0.00000):0.00154):0.01690,SDOW:0.01512):0.00631,(SDEV:0.00245,SRAT:0.00238):0.02750):0.00150,SPLU:0.03438):0.00000;
(((STHE:0.02882,(SSAL:0.00789,SVES:0.00623):0.00902):0.07488,(((LLAC:0.05981,LCRE:0.06799):0.16932,SENT:0.13816):0.01328,(((SMIT:0.01583,(SPSE:0.01668,SPNE:0.00778):0.01318):0.10972,(SANG:0.01453,(SINT:0.00584,SCON:0.00560):0.00658):0.09958):0.02268,(SSUI:0.10895,(SDEV:0.02688,SRAT:0.03032):0.08371):0.01998):0.01753):0.01605):0.01069,((SCAN:0.03688,(SPYO:0.01789,SDYS:0.01875):0.01655):0.06439,(SPLU:0.09672,SDOW:0.13398):0.00703):0.00416,((SINF:0.00804,SLUT:0.01246):0.01005,SEQU:0.02471):0.06330):0.00000;
(LCRE:0.07035,LLAC:0.07035):0.00000;
(LLAC:0.02490,(LLAC:0.20201,LLAC:0.23738):0.08371,LCRE:0.00972):0.00000;
(LCRE:0.07716,LLAC:0.07716):0.00000;
(LCRE:0.04282,LLAC:0.04282):0.00000;
(LCRE:0.00000,LLAC:0.00000):0.00000;
(((SSUI:0.06813,((SINF:0.01167,SLUT:0.01000):0.01127,SEQU:0.01305):0.05079):0.00867,((SPLU:0.07641,SENT:0.09923):0.00696,(LCRE:0.02094,LLAC:0.02066):0.09457):0.00642):0.00271,(SDOW:0.08240,(((SCAN:0.02554,SPYO:0.02258):0.00448,SDYS:0.02192):0.04010,(SDEV:0.01139,SRAT:0.01263):0.04271):0.01368):0.01327,(((STHE:0.01074,(SSAL:0.01023,SVES:0.00923):0.00245):0.02811,(SPSE:0.01570,(SMIT:0.00628,SPNE:0.00752):0.00436):0.03195):0.03682,(SANG:0.02096,(SINT:0.02054,SCON:0.01741):0.00295):0.04557):0.00848):0.00000;
(LCRE:0.04839,LLAC:0.04839):0.00000;
((LLAC:0.03167,LCRE:0.01751):0.17581,(SRAT:0.11518,((SINF:0.02612,SLUT:0.00745):0.03236,SEQU:0.03213):0.05051):0.01664,((STHE:0.04348,(SSAL:0.00111,SVES:0.00616):0.01425):0.06035,SDOW:0.12722):0.02396):0.00000;
((LLAC:0.05054,LCRE:0.06899):0.16866,(SCAN:0.04242,SDYS:0.04640):0.12671,(SMIT:0.01702,SPSE:0.01802):0.13503):0.00000;
(((SENT:0.08600,SDOW:0.08351):0.01260,(LLAC:0.00912,LCRE:0.00362):0.26609):0.00642,((SDEV:0.04188,SRAT:0.03341):0.04899,((SINF:0.00841,SLUT:0.00909):0.00399,SEQU:0.00779):0.07391):0.01532,((((SMIT:0.00184,(SPSE:0.00522,SPNE:0.00089):0.00223):0.03413,(SANG:0.01760,(SINT:0.02061,SCON:0.00926):0.00722):0.02405):0.04828,(SSUI:0.04593,SPLU:0.05250):0.02136):0.01232,((STHE:0.01452,(SSAL:0.00433,SVES:0.00450):0.00892):0.05279,(SCAN:0.02893,(SPYO:0.01236,SDYS:0.00600):0.02035):0.05242):0.01811):0.01087):0.00000;
(LCRE:0.02816,LLAC:0.02816):0.00000;
((((SDEV:0.00654,((SCAN:0.00000,(SPYO:0.00000,SDYS:0.00000):0.00000):0.01101,((SINF:0.00000,(SLUT:0.00000,SEQU:0.00000):0.00000):0.00213,(SDOW:0.00731,(SENT:0.03802,(SPLU:0.03689,(((SINT:0.00316,(SANG:0.00138,SCON:0.00941):0.00765):0.01152,((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.04711,SSUI:0.03637):0.00490):0.02652,(LCRE:0.00000,LLAC:0.00000):0.07444):0.00596):0.00207):0.00346):0.01232):0.00551):0.00267):0.00051,SRAT:0.01049):0.00034,SVES:0.00000):0.00000,SSAL:0.00000,STHE:0.00000):0.00000;
(SPLU:0.05317,((SPYO:0.02192,(SCAN:0.02213,SDYS:0.00327):0.00452):0.02932,((SSUI:0.03432,(((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.02468,(SANG:0.00000,(SINT:0.00000,SCON:0.00000):0.00000):0.03437):0.00593,SENT:0.04502):0.00310):0.00714,(((SINF:0.00940,(SLUT:0.00718,SEQU:0.00042):0.00056):0.02017,SDOW:0.02564):0.00294,(((STHE:0.01040,SSAL:0.00100):0.00440,SVES:0.00605):0.01365,(SDEV:0.00954,SRAT:0.02848):0.02310):0.00663):0.00346):0.00195):0.00139,(LCRE:0.00000,LLAC:0.00000):0.09372):0.00000;
((LCRE:0.02514,LLAC:0.03423):0.25221,LLAC:0.03889,LCRE:0.01231):0.00000;
((LLAC:0.02521,LLAC:0.02804):0.01001,STHE:0.09510,LCRE:0.11448):0.00000;
((SENT:0.37843,LLAC:0.40729):0.18357,SENT:0.09459,SDYS:0.08196):0.00000;
(LCRE:0.06250,LLAC:0.06250):0.00000;
(LLAC:0.16292,SENT:0.24222,SDEV:0.15663):0.00000;
(((SDEV:0.09190,SRAT:0.08517):0.03324,((((SSAL:0.02190,SVES:0.01543):0.05343,((SMIT:0.00675,SPSE:0.01133):0.00576,SPNE:0.02045):0.05197):0.01391,(SANG:0.04161,(SINT:0.02083,SCON:0.02254):0.01429):0.04011):0.02876,(LLAC:0.00957,LCRE:0.00650):0.15598):0.02623):0.00446,((SENT:0.14744,SSUI:0.15066):0.01682,(((SINF:0.03457,(SLUT:0.00819,SEQU:0.00736):0.02410):0.05788,SDOW:0.14938):0.00981,(SPYO:0.03430,(SCAN:0.02451,SDYS:0.01879):0.00548):0.09744):0.00853):0.00088,(SSAL:0.01554,(STHE:0.02566,SVES:0.02025):0.00333):0.14078):0.00000;
((SENT:0.07220,(LCRE:0.00695,LLAC:0.00316):0.13143):0.01165,(((SINF:0.00446,SLUT:0.00845):0.00254,SEQU:0.00860):0.04338,((SCAN:0.02060,(SPYO:0.00618,SDYS:0.00796):0.01832):0.02733,SDEV:0.05417):0.00245):0.00101,(((SMIT:0.00637,(SPSE:0.00332,SPNE:0.00547):0.00096):0.03033,(SINT:0.02859,(SANG:0.00962,SCON:0.01912):0.00244):0.01914):0.02070,(SSUI:0.01548,SPLU:0.01577):0.01767):0.01150):0.00000;
((((STHE:0.01589,(SSAL:0.00269,SVES:0.00174):0.00281):0.03396,((((SPSE:0.00784,(SMIT:0.00379,SPNE:0.00011):0.00046):0.01713,(SANG:0.01137,(SINT:0.00153,SCON:0.00091):0.00663):0.01353):0.03236,SSUI:0.06946):0.01897,(LCRE:0.01067,LLAC:0.00932):0.13924):0.00550):0.00481,(SDOW:0.04304,(SDEV:0.00223,SRAT:0.00218):0.03341):0.00721):0.00032,(((SINF:0.00059,SLUT:0.00334):0.00698,SEQU:0.00385):0.02893,(SCAN:0.01166,(SPYO:0.00616,SDYS:0.00468):0.00707):0.02376):0.01283,(SPLU:0.04790,SENT:0.04618):0.00302):0.00000;
((SDOW:0.10811,(LLAC:0.06408,LCRE:0.04446):0.34812):0.02936,(SDEV:0.06079,SRAT:0.05652):0.01499,(SSAL:0.06978,((SINF:0.00235,SLUT:0.01352):0.02476,SEQU:0.02668):0.03125):0.00362):0.00000;
(LLAC:0.00928,LLAC:0.01459,LLAC:0.00928):0.00000;
(LCRE:0.02835,LLAC:0.02835):0.00000;
(LLAC:0.17928,LLAC:0.17928):0.00000;
((SDYS:0.02593,((LCRE:0.06029,LLAC:0.03940):0.10934,LLAC:0.11540):0.29120):0.00643,SCAN:0.00793,SPYO:0.01473):0.00000;
(((((SPSE:0.01059,(SMIT:0.00669,SPNE:0.01350):0.00278):0.10414,SANG:0.11150):0.03954,SSUI:0.13740):0.01646,(LCRE:0.05475,LLAC:0.05014):0.20733):0.02253,((STHE:0.02182,(SSAL:0.01423,SVES:0.01813):0.00545):0.10675,(((SINF:0.01088,SLUT:0.01064):0.03175,SEQU:0.03646):0.08930,(SDEV:0.02063,SRAT:0.01742):0.09914):0.00549):0.00819,(SENT:0.16408,SDOW:0.15865):0.00783):0.00000;
((((((LCRE:0.01567,LLAC:0.01573):0.08076,(LLAC:0.00436,LLAC:0.00477):0.08134):0.14822,SENT:0.18409):0.05098,SENT:0.19667):0.12461,SDYS:0.03860):0.02086,SPYO:0.02143,SCAN:0.02844):0.00000;
(LLAC:0.01131,(SDOW:0.06849,SRAT:0.07087):0.15235,LCRE:0.00942):0.00000;
((((SANG:0.01558,(SINT:0.01307,SCON:0.01176):0.01162):0.04305,(SMIT:0.00446,(SPSE:0.00199,SPNE:0.00163):0.00515):0.06531):0.07234,(LLAC:0.00944,LCRE:0.01349):0.27602):0.01895,((SDEV:0.01594,SRAT:0.01586):0.10649,((SPYO:0.04843,(SCAN:0.02734,SDYS:0.02629):0.01078):0.07842,(((SVES:0.00719,SSAL:0.00501):0.09050,SDOW:0.11045):0.02505,(SPLU:0.09779,(SEQU:0.02917,(SINF:0.01780,SLUT:0.02004):0.00636):0.06474):0.00849):0.00718):0.00581):0.00157,SSUI:0.12169):0.00000;
(LCRE:0.20745,LLAC:0.20745):0.00000;
(LCRE:0.27465,LLAC:0.27465):0.00000;
(LCRE:0.06320,LLAC:0.06320):0.00000;
(LCRE:0.09367,LLAC:0.09367):0.00000;
(LLAC:0.00928,SPLU:0.31973,LCRE:0.00625):0.00000;
(((SPNE:0.09843,((SCON:0.05931,SDEV:0.03358):0.08383,(SPLU:0.14623,LLAC:0.17368):0.10739):0.05351):0.01392,(SINT:0.02687,SRAT:0.02776):0.01620):0.00852,(SPYO:0.01246,(SCAN:0.00845,SDYS:0.00792):0.00153):0.04504,(SSUI:0.00468,SPLU:0.00780):0.07002):0.00000;
((LCRE:0.13546,(LCRE:0.40613,LLAC:0.32203):0.14631):0.06580,(LCRE:0.06357,LLAC:0.04918):0.06832,(LLAC:0.03994,LLAC:0.03653):0.05040):0.00000;
(LCRE:0.09735,LLAC:0.09735):0.00000;
(LCRE:0.05382,LLAC:0.05382):0.00000;
((SPYO:0.02438,((((SSAL:0.01221,SVES:0.02238):0.12921,((((SDYS:0.16649,(SPLU:0.10527,SENT:0.11803):0.01679):0.08183,(SSUI:0.15594,(((SMIT:0.03127,SPSE:0.03512):0.01230,SPNE:0.04045):0.07320,(SINT:0.00683,(SANG:0.00263,SCON:0.00384):0.00287):0.09332):0.02913):0.05174):0.27283,(LLAC:0.00538,LCRE:0.00335):0.27761):0.12072,SDOW:0.17152):0.03139):0.02318,(SINF:0.01866,(SLUT:0.01361,SEQU:0.01518):0.00659):0.10707):0.01007,(SDEV:0.03753,SRAT:0.04308):0.03844):0.07123):0.00228,SDYS:0.01854,SCAN:0.02263):0.00000;
((SMIT:0.00794,(((SSUI:0.09012,(LLAC:0.05564,LCRE:0.05106):0.23268):0.05545,(STHE:0.02863,(SSAL:0.00222,SVES:0.00901):0.01035):0.04049):0.01346,SANG:0.08387):0.04411):0.00845,SPNE:0.00483,SPSE:0.00587):0.00000;
(LLAC:0.51225,SPYO:0.03004,SDYS:0.03197):0.00000;
(LLAC:0.27233,LLAC:0.19077,LLAC:0.22599):0.00000;
((((((SMIT:0.01670,(SPSE:0.00870,SPNE:0.01068):0.00507):0.11449,((SANG:0.01084,SCON:0.01621):0.02514,SINT:0.03272):0.08487):0.05010,((STHE:0.02287,(SSAL:0.01148,SVES:0.01786):0.00301):0.16956,((SPLU:0.15333,SENT:0.14597):0.00941,(SCAN:0.04927,SDYS:0.06079):0.12574):0.00834):0.01029):0.00636,(LLAC:0.10011,LCRE:0.09484):0.19723):0.01024,SDOW:0.17136):0.00694,(((SINF:0.00866,SLUT:0.01149):0.02027,SEQU:0.02833):0.10393,(SDEV:0.04374,SRAT:0.03651):0.09434):0.00579,SSUI:0.16007):0.00000;
(LCRE:0.06996,LLAC:0.06996):0.00000;
(LCRE:0.03994,LLAC:0.03994):0.00000;
(((SDEV:0.00248,SRAT:0.00006):0.02179,(SPLU:0.01676,(SENT:0.03779,((((SMIT:0.00476,(SPSE:0.00749,SPNE:0.01808):0.00805):0.00748,(SINT:0.00756,(SANG:0.00000,SCON:0.00000):0.00009):0.01225):0.01260,SSUI:0.05166):0.03029,(SDOW:0.07964,((SSAL:0.01743,(STHE:0.00537,SVES:0.02911):0.03204):0.03341,(LLAC:0.01532,LCRE:0.01545):0.29079):0.03212):0.02349):0.00810):0.01841):0.00667):0.01005,((SCAN:0.00730,(SPYO:0.00769,SDYS:0.00507):0.00032):0.01326,(SLUT:0.00000,SEQU:0.00000):0.00459):0.00325,SINF:0.01441):0.00000;
(LLAC:0.02361,LCRE:0.02886,SDOW:0.51752):0.00000;
(LLAC:0.34359,LLAC:0.34359):0.00000;
(LCRE:0.16194,LLAC:0.16194):0.00000;
((((SDOW:0.15495,(SDEV:0.05357,SRAT:0.05485):0.09847):0.02086,((SSUI:0.17353,((SINT:0.04135,(SCON:0.01319,SANG:0.01875):0.02523):0.08385,(SMIT:0.02715,(SPNE:0.02153,SPSE:0.02306):0.00623):0.13080):0.04100):0.02299,(LLAC:0.06862,LCRE:0.07218):0.20815):0.01758):0.01005,(SPLU:0.17152,((SINF:0.00862,SLUT:0.01630):0.04229,SEQU:0.04904):0.09966):0.01476):0.00782,SENT:0.17570,(((SSAL:0.00791,SVES:0.00626):0.02730,STHE:0.02941):0.22423,(SPYO:0.11476,(SCAN:0.10893,SDYS:0.11071):0.00968):0.14738):0.00233):0.00000;
(LCRE:0.26498,LLAC:0.26498):0.00000;
(LCRE:0.03641,LLAC:0.03641):0.00000;
((((SDOW:0.02681,(LCRE:0.00483,LLAC:0.00361):0.07572):0.00433,((SPLU:0.02409,SENT:0.03812):0.00411,((SLUT:0.00264,(SINF:0.00306,SEQU:0.00033):0.00159):0.01823,(SDEV:0.00186,SRAT:0.00196):0.02326):0.00320):0.00166):0.00024,(SCAN:0.00474,(SPYO:0.00051,SDYS:0.00120):0.00440):0.01909):0.00023,(((SMIT:0.00224,(SPSE:0.00287,SPNE:0.00223):0.00052):0.00887,(SINT:0.00275,(SANG:0.00000,SCON:0.00000):0.00107):0.00662):0.01567,SSUI:0.03210):0.01180,(STHE:0.00667,(SSAL:0.00000,SVES:0.00000):0.00608):0.02266):0.00000;
(LLAC:0.03237,(LCRE:0.02051,LLAC:0.02142):0.27833,LCRE:0.04145):0.00000;
(LCRE:0.04737,LLAC:0.04737):0.00000;
(((((SMIT:0.07662,(SPSE:0.00067,SPNE:0.00822):0.06724):0.05826,(SINT:0.01532,(SANG:0.00904,SCON:0.01155):0.00405):0.09124):0.03261,(SSUI:0.16455,((LLAC:0.01313,LCRE:0.01200):0.13168,LLAC:0.14643):0.18141):0.01917):0.00908,SPLU:0.15272):0.01122,((STHE:0.02714,(SSAL:0.01394,SVES:0.01363):0.01411):0.10850,(SDOW:0.10543,((((SINF:0.02053,SLUT:0.00543):0.01514,SEQU:0.02797):0.05988,(SPYO:0.03673,(SCAN:0.01477,SDYS:0.01512):0.01562):0.06532):0.01436,(SDEV:0.01058,SRAT:0.01170):0.07698):0.01299):0.01224):0.00556,SENT:0.17579):0.00000;
(LCRE:0.15870,LLAC:0.15870):0.00000;
(LCRE:0.24512,LLAC:0.24512):0.00000;
(LCRE:0.05769,LLAC:0.05769):0.00000;
(LLAC:0.16135,LCRE:0.13835,LLAC:0.41318):0.00000;
(((SPLU:0.11811,SENT:0.15852):0.01783,((LLAC:0.02553,LCRE:0.02556):0.17610,(SSUI:0.13347,((SINT:0.04446,(SANG:0.03680,SCON:0.03410):0.00690):0.07127,((SMIT:0.01395,SPSE:0.01333):0.00365,SPNE:0.02347):0.10524):0.03041):0.01571):0.00752):0.00424,((SCAN:0.06505,(SPYO:0.03890,SDYS:0.03237):0.03059):0.08300,(SDOW:0.11689,(SDEV:0.03721,SRAT:0.04124):0.07400):0.00438):0.00401,((SSAL:0.02457,(STHE:0.01802,SVES:0.01189):0.01147):0.10433,((SINF:0.01299,SLUT:0.01820):0.02244,SEQU:0.03675):0.06742):0.00719):0.00000;
((((SSAL:0.00000,SVES:0.00000):0.00654,(STHE:0.01229,(((LCRE:0.00441,LLAC:0.00209):0.10563,(((SANG:0.00269,(SINT:0.00000,SCON:0.00000):0.00391):0.02108,(((SINF:0.00015,SLUT:0.00233):0.00176,SEQU:0.00566):0.03174,SDOW:0.02916):0.00408):0.00720,(SDEV:0.00677,SRAT:0.00232):0.02910):0.00436):0.00368,(((SSUI:0.01244,SPLU:0.00995):0.02147,SENT:0.02156):0.01023,((SCAN:0.00314,SPYO:0.00099):0.00492,SDYS:0.01072):0.05626):0.00913):0.01554):0.00402):0.00917,SPNE:0.00000):0.00000,SPSE:0.00000,SMIT:0.00000):0.00000;
(SPLU:0.34496,LLAC:0.34496):0.00000;
(((LCRE:0.04171,LLAC:0.04272):0.19156,(((SMIT:0.03158,(SPSE:0.02843,SPNE:0.03803):0.00199):0.22116,SSUI:0.24349):0.13703,LLAC:0.27607):0.04528):0.07446,((SDEV:0.04890,SRAT:0.05793):0.11998,(((STHE:0.02070,(SSAL:0.01033,SVES:0.01934):0.00378):0.09532,((SINF:0.01133,SLUT:0.01738):0.00367,SEQU:0.01814):0.07501):0.03221,(SPLU:0.14869,(SCAN:0.05180,SDYS:0.06814):0.08493):0.03861):0.02105):0.01159,SDOW:0.16057):0.00000;
((LLAC:0.01629,LCRE:0.02274):0.20305,(LCRE:0.29339,LLAC:0.34917):0.02700,LCRE:0.29064):0.00000;
((((SINF:0.00785,SLUT:0.01067):0.02412,SEQU:0.02998):0.13264,((SSUI:0.16520,(LLAC:0.04550,LCRE:0.05504):0.21837):0.00425,(SENT:0.20757,(((SMIT:0.01322,SPSE:0.01216):0.00916,SPNE:0.02817):0.12292,(SANG:0.03991,(SCON:0.04404,SINT:0.04803):0.00819):0.10425):0.02802):0.00953):0.01282):0.00403,((((SCAN:0.03893,SPYO:0.04181):0.03609,SDYS:0.07330):0.10630,SDOW:0.15835):0.00443,(SDEV:0.08827,SRAT:0.08133):0.06383):0.00047,((STHE:0.02925,(SSAL:0.01620,SVES:0.02076):0.00665):0.11046,SPLU:0.13935):0.02062):0.00000;
((SDOW:0.11302,(SPLU:0.09577,((SDEV:0.07771,SRAT:0.06429):0.03555,(SENT:0.12102,(((((SMIT:0.00949,SPSE:0.00830):0.00531,SPNE:0.01511):0.05443,(SINT:0.03425,(SANG:0.02405,SCON:0.02439):0.00710):0.04884):0.04358,SSUI:0.13466):0.00503,(LLAC:0.02427,LCRE:0.02426):0.27472):0.00688):0.01346):0.00491):0.00349):0.00343,(((SINF:0.00860,SLUT:0.00957):0.01012,SEQU:0.01981):0.07012,(STHE:0.01842,(SSAL:0.00692,SVES:0.00970):0.00393):0.05201):0.00422,(SCAN:0.01708,(SPYO:0.01026,SDYS:0.00909):0.00565):0.09549):0.00000;
(LCRE:0.18371,LLAC:0.18371):0.00000;
(LCRE:0.30234,LLAC:0.30234):0.00000;
((((LLAC:0.01917,LCRE:0.02181):0.32678,LLAC:0.36834):0.13702,((SCAN:0.06697,SDYS:0.07064):0.04429,SPYO:0.13654):0.10353):0.06361,(SSUI:0.11410,(SRAT:0.04314,SDEV:0.04092):0.08752):0.01659,(((SINF:0.01257,SLUT:0.01761):0.06826,SEQU:0.08587):0.06165,SDOW:0.15624):0.00819):0.00000;
(LCRE:0.02446,LLAC:0.02446):0.00000;
(((SPLU:0.11860,SDOW:0.11200):0.01277,(SENT:0.16553,((((SPNE:0.01904,(SPSE:0.01079,SMIT:0.01205):0.00670):0.11656,(SANG:0.03523,(SINT:0.03349,SCON:0.03479):0.01410):0.08080):0.02099,SSUI:0.12854):0.03469,(LLAC:0.04435,LCRE:0.03832):0.25521):0.02810):0.01762):0.00325,((SCAN:0.03651,SPYO:0.04013):0.03321,SDYS:0.06948):0.06683,((STHE:0.02446,(SSAL:0.00905,SVES:0.01050):0.01286):0.11487,((SRAT:0.03869,SDEV:0.03411):0.08203,((SINF:0.01365,SLUT:0.01684):0.02956,SEQU:0.04126):0.07357):0.00575):0.01015):0.00000;
(LCRE:0.19580,LLAC:0.19580):0.00000;
((LCRE:0.26847,(SSAL:0.36647,LLAC:0.39652):0.05609):0.01418,(((SPLU:0.17733,(STHE:0.01615,(SSAL:0.01077,SVES:0.01322):0.00311):0.15993):0.00979,SDOW:0.19457):0.01904,(SPNE:0.17985,(SSAL:0.02025,SVES:0.02557):0.15771):0.05331):0.00565,SRAT:0.21935):0.00000;
(((SINF:0.00251,(SLUT:0.00206,SEQU:0.00423):0.00821):0.10276,((SPLU:0.17646,SENT:0.13383):0.01594,(SDOW:0.19599,((LLAC:0.05729,LCRE:0.05192):0.38277,(SSUI:0.13867,(SPNE:0.15954,((SANG:0.01590,SCON:0.01850):0.00635,SINT:0.03191):0.07882):0.03024):0.01319):0.04931):0.02012):0.01015):0.00539,((SDEV:0.01349,SRAT:0.01223):0.14197,(STHE:0.05252,(SSAL:0.03143,SVES:0.02943):0.00843):0.10351):0.00487,(SPYO:0.03523,(SCAN:0.02341,SDYS:0.02165):0.01091):0.08243):0.00000;
(SDYS:0.18882,(SDOW:0.20783,SCAN:0.34866):0.04915,SINF:0.14464):0.00000;
(SINT:0.29300,SCAN:0.29300):0.00000;
(SDYS:0.09524,SCAN:0.09524):0.00000;
((SEQU:0.08242,(SRAT:0.01272,SDEV:0.02224):0.09480):0.15054,SANG:0.04523,(SINT:0.02413,SCON:0.01301):0.02270):0.00000;
((((SEQU:0.01484,SLUT:0.01660):0.01457,SINF:0.03461):0.16410,(SDOW:0.34703,((SPLU:0.01022,SSUI:0.00935):0.21307,((SPSE:0.00685,SPNE:0.03203):0.00573,SMIT:0.00832):0.24669):0.01875):0.03132):0.00943,(SPYO:0.10441,SCAN:0.07755):0.15295,((SRAT:0.06017,SDEV:0.04309):0.13844,(STHE:0.03921,(SSAL:0.02389,SVES:0.00233):0.00873):0.24002):0.02004):0.00000;
(((SSUI:0.21480,((SINF:0.00000,SLUT:0.00000):0.05211,SEQU:0.04883):0.10414):0.03213,(SPYO:0.05258,(SCAN:0.02016,SDYS:0.01812):0.03642):0.11820):0.01138,(((LLAC:0.07334,LCRE:0.05913):0.29745,((SMIT:0.11091,(SPSE:0.00246,SPNE:0.00449):0.11389):0.17156,SENT:0.28894):0.01043):0.01864,((SSAL:0.05331,(STHE:0.01944,SVES:0.01902):0.06748):0.19244,(SDOW:0.23613,SPLU:0.30524):0.01504):0.01612):0.01446,(((SANG:0.00831,SINT:0.01224):0.01036,SCON:0.01481):0.18030,(SDEV:0.01609,SRAT:0.01928):0.13959):0.01700):0.00000;
(((SINF:0.00764,(SLUT:0.00000,SEQU:0.00000):0.00321):0.10042,(SDOW:0.03916,(SDEV:0.05601,SRAT:0.05017):0.00557):0.01473):0.01685,(SENT:0.10585,((SSUI:0.00914,SPLU:0.01775):0.03916,((SANG:0.01721,(SINT:0.02488,SCON:0.02691):0.00391):0.04412,(SCAN:0.01188,(SPYO:0.01059,SDYS:0.00752):0.00189):0.04902):0.00149):0.00880):0.00248,((STHE:0.04416,(SSAL:0.01864,SVES:0.01614):0.00695):0.02107,((SMIT:0.01077,SPSE:0.01735):0.01284,SPNE:0.00188):0.02899):0.02208):0.00000;
(((STHE:0.05248,(LLAC:0.00456,LCRE:0.00617):0.02664):0.19635,(SENT:0.15348,((SINF:0.00227,SLUT:0.00392):0.00787,SEQU:0.01960):0.10574):0.00979):0.08652,(SCAN:0.01178,SDYS:0.00885):0.00342,SPYO:0.02787):0.00000;
((SDOW:0.04275,((SINF:0.00198,SLUT:0.00332):0.00593,SEQU:0.00695):0.02891):0.00158,(((((SMIT:0.00598,(SPSE:0.00456,SPNE:0.00229):0.00352):0.03440,(SANG:0.00924,(SINT:0.00937,SCON:0.01009):0.00179):0.02194):0.00928,((LCRE:0.00351,LLAC:0.00103):0.09742,SSUI:0.05609):0.00493):0.00805,SENT:0.05317):0.00399,((SPYO:0.01431,(SCAN:0.00689,SDYS:0.00599):0.00178):0.01933,(SDEV:0.00532,SRAT:0.00414):0.03341):0.00988):0.00403,((STHE:0.01722,(SSAL:0.00499,SVES:0.00491):0.00393):0.01646,SPLU:0.04384):0.00161):0.00000;
(((((SINF:0.01779,SLUT:0.02072):0.01705,SEQU:0.04061):0.09077,(SPYO:0.05085,(SCAN:0.03615,SDYS:0.03289):0.01652):0.10632):0.03750,SENT:0.16489):0.00611,(((SMIT:0.01843,(SPSE:0.01171,SPNE:0.01297):0.00622):0.09207,(SSAL:0.10737,(SANG:0.02570,(SINT:0.01790,SCON:0.01454):0.00503):0.09219):0.00317):0.02885,SSUI:0.16065):0.01006,SPLU:0.13012):0.00000;
(SEQU:0.21684,SINF:0.02825,SLUT:0.02956):0.00000;
(SLUT:0.01361,SINF:0.01616,SEQU:0.52125):0.00000;
((STHE:0.12944,(((LCRE:0.08109,LLAC:0.09185):0.05366,((SSAL:0.00495,SVES:0.00384):0.08500,SCON:0.08949):0.01188):0.00778,(SPLU:0.16931,(SINT:0.12974,(SSUI:0.17354,SENT:0.18274):0.00292):0.01486):0.00831):0.01068):0.00313,((SLUT:0.10277,(SDOW:0.09434,(SINF:0.00483,SEQU:0.00332):0.08223):0.02133):0.00866,(SANG:0.10333,(SDEV:0.00939,SRAT:0.01210):0.09418):0.00646):0.00148,(SPYO:0.07297,SDYS:0.06677):0.06723):0.00000;
(SEQU:0.11910,(SINF:0.01733,SLUT:0.01857):0.10602,(SSAL:0.36292,SENT:0.41926):0.19320):0.00000;
((SDOW:0.04043,(SENT:0.17428,((SINF:0.01724,SLUT:0.01392):0.02875,SEQU:0.02992):0.07402):0.08862):0.00398,SRAT:0.03038,SDEV:0.03274):0.00000;
((LLAC:0.15519,((LLAC:0.02302,LCRE:0.02586):0.36895,((((SDEV:0.04395,SEQU:0.03253):0.01699,SRAT:0.07424):0.03328,SDOW:0.11110):0.09284,LLAC:0.18889):0.15552):0.21323):0.02997,(SDOW:0.10565,(SCON:0.07454,SEQU:0.05406):0.03042):0.02278,SDEV:0.12825):0.00000;
((LLAC:0.05388,LCRE:0.04744):0.23941,SEQU:0.24521,((SRAT:0.05674,SDEV:0.03271):0.16992,SDOW:0.22551):0.03640):0.00000;
(SINF:0.13310,SEQU:0.13310):0.00000;
((((SSAL:0.03732,(STHE:0.02076,SVES:0.01701):0.02360):0.05726,((SINF:0.03040,SLUT:0.04297):0.01941,SEQU:0.06057):0.04542):0.02362,SDOW:0.13619):0.00094,(SSUI:0.15609,((SCAN:0.02974,SPYO:0.02124):0.01377,SDYS:0.05883):0.09872):0.00899,(SDEV:0.02808,SRAT:0.04809):0.11788):0.00000;
(SLUT:0.15690,SEQU:0.15690):0.00000;
(((LCRE:0.14852,LLAC:0.13959):0.20127,(SMIT:0.03004,(SPSE:0.00573,SPNE:0.00776):0.01610):0.35919):0.05803,((SMIT:0.01819,SPSE:0.01470):0.01309,SPNE:0.03097):0.21276,(SSUI:0.20791,(SEQU:0.10217,SINF:0.11861):0.08829):0.02014):0.00000;
(SSAL:0.24628,((SDOW:0.18834,SDOW:0.19651):0.01357,(SEQU:0.03872,SINF:0.04098):0.16575):0.00440,(((SDOW:0.16357,SDOW:0.16530):0.11198,(((SRAT:0.04500,SDEV:0.03765):0.13676,SDOW:0.18765):0.06943,((SDEV:0.03835,SRAT:0.04078):0.15634,(SSAL:0.22309,(SSAL:0.25484,SSAL:0.22203):0.00451):0.02237):0.01244):0.00334):0.04134,(SSAL:0.20985,SSAL:0.18189):0.03646):0.00427):0.00000;
(SINT:0.33156,SEQU:0.33156):0.00000;
(SEQU:0.01612,SINF:0.01503,SSUI:0.64377):0.00000;
(((((SDYS:0.02951,(SCAN:0.03325,SPYO:0.02058):0.00604):0.07950,((SDOW:0.08580,(SPLU:0.07542,(STHE:0.01465,(SSAL:0.00573,SVES:0.01138):0.00620):0.05771):0.01624):0.00958,((SRAT:0.03177,SDEV:0.02468):0.06291,(SEQU:0.01549,(SLUT:0.00505,SINF:0.00594):0.00952):0.06903):0.00579):0.00453):0.00827,SENT:0.12051):0.00882,((SPNE:0.01674,(SPSE:0.00765,SMIT:0.00776):0.00405):0.10063,(SANG:0.01867,(SINT:0.00767,SCON:0.00749):0.02034):0.06291):0.01900):0.00226,SSUI:0.12267,(LCRE:0.02801,LLAC:0.02923):0.23088):0.00000;
(((SCAN:0.01593,SPYO:0.02464):0.01532,SDYS:0.02932):0.04849,((STHE:0.01857,(SSAL:0.01126,SVES:0.01479):0.00939):0.05509,((SINF:0.01074,SLUT:0.01528):0.00541,SEQU:0.01445):0.05883):0.00110,(((((LCRE:0.02556,LLAC:0.02835):0.21281,(SANG:0.05582,((SMIT:0.01070,(SPSE:0.01393,SPNE:0.01077):0.00380):0.03818,(SINT:0.02384,SCON:0.01839):0.02035):0.00671):0.05009):0.00516,((SSUI:0.03203,SPLU:0.04037):0.05886,SENT:0.11107):0.00677):0.00882,SDOW:0.07909):0.00611,(SDEV:0.06136,SRAT:0.07154):0.01223):0.00661):0.00000;
((SEQU:0.03267,(SLUT:0.00584,SINF:0.00513):0.03786):0.18080,(SSAL:0.00468,SVES:0.00513):0.00347,STHE:0.01691):0.00000;
(SEQU:0.23011,(SDEV:0.13420,SDOW:0.12199):0.12352,SSAL:0.23904):0.00000;
(SSUI:0.09608,(SPLU:0.06944,(SENT:0.10423,(((LLAC:0.00951,LCRE:0.00657):0.15525,(LLAC:0.00978,LCRE:0.01025):0.11621):0.02974,(((SRAT:0.00983,SDEV:0.00745):0.14268,((SMIT:0.02077,(SPSE:0.00773,SPNE:0.01014):0.02572):0.05140,(SANG:0.07333,(SINT:0.01234,SCON:0.01033):0.04555):0.01939):0.01699):0.02642,((STHE:0.01684,(SSAL:0.00239,SVES:0.00904):0.00702):0.08581,((SINF:0.00276,SLUT:0.00511):0.01293,SEQU:0.01338):0.11497):0.01832):0.01210):0.01670):0.03702):0.00744,((SPYO:0.02286,(SCAN:0.00734,SDYS:0.00978):0.00552):0.05769,SDOW:0.09431):0.01134):0.00000;
(SINF:0.00000,SLUT:0.00000):0.00000;
((((SLUT:0.00000,SINF:0.00000):0.02943,((STHE:0.00033,(SSAL:0.00000,SVES:0.00000):0.00150):0.04598,SANG:0.03460):0.00262):0.47821,(SCON:0.04715,SMIT:0.06949):0.01667):0.00093,((SPLU:0.06137,(SPYO:0.01191,SDYS:0.01364):0.06333):0.01987,(SDEV:0.01185,SRAT:0.01777):0.04724):0.01209,SDOW:0.08860):0.00000;
(SEQU:0.13321,SLUT:0.13321):0.00000;
(SEQU:0.02491,SLUT:0.02491):0.00000;
(SLUT:0.00594,SEQU:0.10745,SINF:0.00199):0.00000;
((((SPYO:0.09039,(SDYS:0.04858,SCAN:0.05280):0.02573):0.07746,(SINF:0.01503,(SEQU:0.01401,SLUT:0.01525):0.00349):0.09711):0.01345,SDOW:0.14429):0.01078,((((SANG:0.00771,(SINT:0.00377,SCON:0.00809):0.00459):0.11264,(SMIT:0.00920,(SPSE:0.00367,SPNE:0.00718):0.00833):0.11698):0.04734,SSUI:0.14631):0.01098,((LLAC:0.03242,LCRE:0.03508):0.28821,SENT:0.19419):0.01952):0.00502,(((STHE:0.03173,(SSAL:0.00343,SVES:0.00675):0.01534):0.11362,SPLU:0.12340):0.00569,(SDEV:0.03135,SRAT:0.02808):0.10565):0.01835):0.00000;
(SLUT:0.02436,SEQU:0.01980,SPLU:0.17333):0.00000;
(((((SPNE:0.03137,(SMIT:0.02099,SPSE:0.02456):0.00774):0.39464,SDOW:0.34648):0.00982,((SINT:0.07680,SANG:0.07380):0.31627,((SCON:0.31248,(((SINF:0.01160,SLUT:0.00895):0.13405,SEQU:0.12911):0.13411,(SRAT:0.05775,SDOW:0.05561):0.19801):0.02047):0.04633,(SMIT:0.15949,SSUI:0.17357):0.18675):0.01195):0.01232):0.00582,(((SDOW:0.15692,((((SSAL:0.04264,SVES:0.04629):0.00614,SMIT:0.05922):0.05959,(SANG:0.08835,(SDEV:0.03106,SRAT:0.03065):0.05288):0.02033):0.02833,SENT:0.13861):0.00672):0.09030,(LLAC:0.06881,LCRE:0.07486):0.18972):0.09683,((SEQU:0.23692,(SENT:0.20970,((SRAT:0.16054,SSAL:0.13981):0.02954,(SMIT:0.17602,(SINT:0.17850,(SPLU:0.12358,(SDEV:0.04649,SRAT:0.04173):0.08551):0.03962):0.01523):0.00006):0.01783):0.03778):0.09634,(SPSE:0.32643,((LCRE:0.28676,SDEV:0.28299):0.02360,SDOW:0.28658):0.01353):0.02500):0.00949):0.01411):0.00505,(SPLU:0.38719,(((LLAC:0.09332,LCRE:0.10801):0.24630,(SENT:0.20176,(SDYS:0.07416,SCAN:0.07919):0.13361):0.16404):0.01019,SPYO:0.38433):0.01504):0.00906,(SDOW:0.34611,((SDYS:0.10781,((STHE:0.01327,(SSAL:0.00928,SVES:0.00957):0.00248):0.06902,(((((SMIT:0.00721,SPSE:0.00454):0.00286,SPNE:0.00805):0.03560,(SANG:0.00839,(SINT:0.00801,SCON:0.00606):0.01430):0.02987):0.02668,(SSUI:0.06241,SPLU:0.06366):0.00327):0.00242,(SDOW:0.06636,((SINF:0.02801,(SLUT:0.02183,SEQU:0.02121):0.00442):0.03039,(SDEV:0.01459,SRAT:0.01193):0.04038):0.01421):0.00510):0.00839):0.01463):0.20970,SDYS:0.38545):0.06429):0.00860):0.00000;
(SINF:0.08948,SLUT:0.08948):0.00000;
(((((SPSE:0.00897,(SMIT:0.00292,SPNE:0.01036):0.00133):0.08950,((SINT:0.03152,(SANG:0.01978,SCON:0.01380):0.00596):0.07612,((STHE:0.00717,(SSAL:0.00199,SVES:0.00241):0.00348):0.06730,SDOW:0.11289):0.02056):0.00474):0.00817,(((((SENT:0.25544,(SDYS:0.24660,(SANG:0.09246,(SCON:0.01301,SINT:0.01286):0.07682):0.15032):0.03035):0.14022,(((LLAC:0.00732,LCRE:0.00573):0.26126,((SENT:0.20045,((SDOW:0.14767,(SDEV:0.02631,SRAT:0.03099):0.12034):0.03252,(SPLU:0.16822,(((STHE:0.01235,SSAL:0.00970):0.00965,SVES:0.02452):0.13641,(((SCAN:0.02145,SPYO:0.02249):0.00147,SDYS:0.02503):0.12818,((SINF:0.00971,SLUT:0.00731):0.04536,SEQU:0.05113):0.07842):0.00485):0.02371):0.00944):0.01143):0.02314,(((SMIT:0.01014,(SPSE:0.00186,SPNE:0.00309):0.00856):0.09148,(SANG:0.01205,(SINT:0.01376,SCON:0.01309):0.00354):0.08212):0.08968,SSUI:0.20360):0.01886):0.04080):0.19814,((SENT:0.23298,(SSUI:0.21645,((SANG:0.03634,(SCON:0.02187,SINT:0.02060):0.01743):0.10502,(SMIT:0.02110,(SPSE:0.01915,SPNE:0.01589):0.00108):0.15349):0.05011):0.03519):0.02488,(((SDYS:0.11128,(SPYO:0.03117,SCAN:0.03550):0.08220):0.13347,(((SINF:0.01465,SLUT:0.01648):0.04474,SEQU:0.05414):0.13939,(SSAL:0.03824,(STHE:0.03387,SVES:0.02976):0.00540):0.13794):0.03918):0.00468,((SPLU:0.20920,SDOW:0.24548):0.01047,(SDEV:0.04957,SRAT:0.04856):0.17250):0.01780):0.01630):0.09908):0.00326):0.04117,((LLAC:0.02935,LCRE:0.02695):0.22200,((((SINT:0.03190,(SANG:0.01185,SCON:0.01145):0.01750):0.08019,((SMIT:0.00756,SPSE:0.00977):0.00258,SPNE:0.01251):0.09325):0.09172,SSUI:0.20466):0.04776,(SENT:0.21797,((STHE:0.04052,(SSAL:0.02103,SVES:0.01838):0.01619):0.13661,((SDOW:0.16294,(SDYS:0.06862,(SPYO:0.03146,SCAN:0.02514):0.03034):0.11727):0.01530,(SPLU:0.18079,((SEQU:0.03709,(SINF:0.02863,SLUT:0.02477):0.01058):0.13412,(SRAT:0.02001,SDEV:0.02385):0.13906):0.01848):0.00203):0.00669):0.00446):0.03682):0.02301):0.06205):0.16090,(LLAC:0.01624,LCRE:0.01734):0.18082):0.05471,SENT:0.12090):0.01392):0.00547,(SDEV:0.04768,SRAT:0.04542):0.06596):0.00311,((SLUT:0.00922,(SINF:0.00591,SEQU:0.00646):0.00788):0.07621,((SCAN:0.02280,SPYO:0.02318):0.00611,SDYS:0.03589):0.08692):0.01456,SPLU:0.09511):0.00000;
(((((SLUT:0.02912,SEQU:0.02886):0.03003,SINF:0.07075):0.12864,(SPYO:0.12372,(SCAN:0.07091,SDYS:0.05962):0.07306):0.12113):0.01657,(((LLAC:0.03202,LCRE:0.03048):0.26042,SSUI:0.22022):0.02400,(((SINT:0.00238,SCON:0.00529):0.02674,SANG:0.02687):0.13499,((SPSE:0.00359,SMIT:0.00078):0.00738,SPNE:0.03030):0.20287):0.06699):0.04489):0.00742,((SSAL:0.03797,(STHE:0.02922,SVES:0.02866):0.01727):0.22372,SDOW:0.25592):0.02072,(SENT:0.31139,(SPLU:0.25454,(SRAT:0.04964,SDEV:0.04037):0.16404):0.01063):0.01045):0.00000;
((((SMIT:0.03861,(SPSE:0.02489,SPNE:0.03237):0.01366):0.13775,(SSAL:0.06215,SVES:0.04234):0.10848):0.05272,SENT:0.21328):0.03409,(SRAT:0.05842,SDEV:0.04184):0.18894,(SANG:0.07879,(SINT:0.01528,SCON:0.01093):0.06933):0.34304):0.00000;
(SMIT:0.25522,SPNE:0.06815,SPSE:0.17141):0.00000;
(SPYO:0.24163,SMIT:0.24163):0.00000;
(SMIT:0.07692,SPNE:0.02746,SPSE:0.02523):0.00000;
(SPSE:0.05635,SMIT:0.05635):0.00000;
((SMIT:0.05075,SPNE:0.05198):0.07290,SPSE:0.15239,SSAL:0.40132):0.00000;
(SPSE:0.02891,SMIT:0.02891):0.00000;
(SMIT:0.00710,((SDEV:0.41144,(SCON:0.01184,SINT:0.02475):0.21826):0.18523,SPNE:0.03339):0.00898,SPSE:0.03951):0.00000;
((SPSE:0.00316,SMIT:0.00754):0.07302,(SCAN:0.00933,SDYS:0.01751):0.06816,(LLAC:0.01691,LCRE:0.01391):0.27476):0.00000;
(((LLAC:0.00528,LCRE:0.00369):0.31485,(((STHE:0.00000,(SSAL:0.00000,SVES:0.00000):0.00000):0.12283,(SANG:0.00353,(SINT:0.00000,SCON:0.00000):0.02256):0.09988):0.05398,(SPSE:0.00000,(SMIT:0.00000,SPNE:0.00000):0.00000):0.12944):0.02921):0.01123,(SDOW:0.18938,(SRAT:0.15456,(SEQU:0.06417,(SLUT:0.01082,SINF:0.03635):0.03666):0.04937):0.02484):0.02401,((SCAN:0.00932,SPYO:0.02360):0.04286,SDYS:0.05748):0.14967):0.00000;
(((SDYS:0.13870,SPYO:0.16096):0.12135,((SSUI:0.36337,(SMIT:0.02125,SPSE:0.02133):0.29150):0.01063,(SANG:0.05343,(SINT:0.01007,SCON:0.00450):0.03857):0.19784):0.03135):0.00829,SENT:0.28421,(SINF:0.06701,(SEQU:0.00909,SLUT:0.01080):0.05380):0.17227):0.00000;
(SPSE:0.01954,SMIT:0.01954):0.00000;
(SMIT:0.08278,SPNE:0.00494,SPSE:0.01537):0.00000;
(SMIT:0.00181,(SPNE:0.00898,SINT:0.06483):0.00538,SPSE:0.00196):0.00000;
(SSUI:0.22643,(((((LLAC:0.07074,LCRE:0.08078):0.34894,(LLAC:0.06609,LCRE:0.06724):0.23540):0.03758,SPLU:0.26741):0.01599,SENT:0.23730):0.00620,(((SDEV:0.04713,SRAT:0.04674):0.06953,SDOW:0.13925):0.04466,(((SSAL:0.01631,SVES:0.02072):0.04950,STHE:0.07113):0.12610,((SCAN:0.04009,(SPYO:0.02291,SDYS:0.02114):0.02101):0.13120,((SINF:0.02517,SLUT:0.02616):0.03491,SEQU:0.05419):0.09752):0.01303):0.00417):0.01361):0.00180,(((SCON:0.02984,SANG:0.02869):0.01132,SINT:0.04067):0.11083,(SMIT:0.03302,(SPSE:0.01239,SPNE:0.01272):0.01345):0.13141):0.07575):0.00000;
(SMIT:0.00727,SPNE:0.01022,SPSE:0.01264):0.00000;
((SMIT:0.01012,SINT:0.01056):0.02763,SPSE:0.03794,SDEV:0.37666):0.00000;
(((((STHE:0.04947,SVES:0.03233):0.03388,SSAL:0.05546):0.06722,SDOW:0.12839):0.05825,((LLAC:0.00413,LCRE:0.00323):0.15085,((LLAC:0.01405,LCRE:0.01263):0.20205,(((SMIT:0.01577,(SPSE:0.01258,SPNE:0.01920):0.00481):0.07341,(SDOW:0.06508,(SDEV:0.01527,SRAT:0.01549):0.06344):0.04663):0.35878,((SSUI:0.15557,(((SCAN:0.01452,SPYO:0.02096):0.01874,SDYS:0.03477):0.09317,((SMIT:0.00467,SPSE:0.00623):0.00906,SPNE:0.01857):0.11021):0.03517):0.01759,(((LLAC:0.01299,LCRE:0.00403):0.19857,((SSUI:0.09550,(SCAN:0.01414,SDYS:0.01527):0.07188):0.00760,(SANG:0.01415,SCON:0.01111):0.10376):0.03929):0.03089,(LCRE:0.16604,LLAC:0.13909):0.02899):0.04933):0.08937):0.04936):0.08214):0.03528):0.00339,(((SANG:0.00867,(SINT:0.00179,SCON:0.00095):0.01114):0.09147,(SMIT:0.01489,(SPNE:0.01878,SPSE:0.01150):0.00965):0.08326):0.02235,(SDEV:0.01382,SRAT:0.01368):0.11598):0.00995,(((SPYO:0.07801,(SCAN:0.02245,SDYS:0.02178):0.04677):0.01032,(SPLU:0.07887,SSUI:0.04890):0.03989):0.01758,((SINF:0.00647,SLUT:0.00313):0.05070,SEQU:0.06392):0.03075):0.01980):0.00000;
((SDYS:0.08142,SCAN:0.06912):0.18956,(((SANG:0.10893,((SPSE:0.00954,SMIT:0.01331):0.02128,SPNE:0.03710):0.06990):0.04821,(SINF:0.02009,SLUT:0.00841):0.16493):0.04415,((((SDEV:0.24520,(SPSE:0.03673,(SPNE:0.05828,SMIT:0.02571):0.00191):0.23268):0.04462,SSUI:0.19452):0.03464,SDOW:0.30692):0.12976,(STHE:0.07604,(STHE:0.02177,(SSAL:0.00000,SVES:0.00000):0.02149):0.03337):0.14305):0.02804):0.01851,SENT:0.23517):0.00000;
(SMIT:0.02743,SPNE:0.02421,SPSE:0.00239):0.00000;
((((SPLU:0.34684,(((STHE:0.07322,(SSAL:0.00303,SVES:0.00236):0.06139):0.23623,SSUI:0.28810):0.01993,((SANG:0.04270,SCON:0.05175):0.21206,((SMIT:0.09984,SPNE:0.11687):0.02222,SPSE:0.12862):0.12568):0.05868):0.03394):0.01058,(SDEV:0.08590,SRAT:0.08176):0.24540):0.00933,SDOW:0.36198):0.00684,((SPYO:0.15348,(SCAN:0.08692,SDYS:0.09356):0.05829):0.11041,((SLUT:0.02171,SINF:0.01495):0.14328,SEQU:0.15362):0.09060):0.04925,SENT:0.29327):0.00000;
(((SMIT:0.23312,SMIT:0.20390):0.05247,((SMIT:0.00777,SPSE:0.00694):0.00203,SPNE:0.00618):0.43347):0.01927,SMIT:0.27865,SMIT:0.25693):0.00000;
((SMIT:0.14499,SRAT:0.18546):0.29061,LLAC:0.04947,LCRE:0.04144):0.00000;
(SPSE:0.01684,SMIT:0.01684):0.00000;
(SMIT:0.23537,(SINT:0.07664,SANG:0.06443):0.18850,(SVES:0.00814,SSAL:0.00706):0.26186):0.00000;
(SMIT:0.02034,(SPNE:0.01888,(SPLU:0.06113,SENT:0.08358):0.06418):0.00509,SPSE:0.01802):0.00000;
((SPSE:0.03911,(SPNE:0.02822,SMIT:0.02463):0.01460):0.00122,SPNE:0.03762,((SPLU:0.32979,SENT:0.33265):0.08216,(SANG:0.13331,(SINT:0.03593,SCON:0.02574):0.10019):0.19589):0.26002):0.00000;
(SPNE:0.03864,SMIT:0.03864):0.00000;
((SEQU:0.16462,(LCRE:0.25128,SMIT:0.28533):0.06762):0.13633,(SCON:0.01328,SINT:0.00614):0.02493,SANG:0.04723):0.00000;
((SMIT:0.05749,(SPSE:0.00245,SPNE:0.00733):0.04776):0.19779,(SPLU:0.24738,SDYS:0.27696):0.00812,((STHE:0.20447,(SPYO:0.07717,SCAN:0.08147):0.11760):0.03118,(SEQU:0.10646,SINF:0.10972):0.12865):0.17767):0.00000;
((((SPSE:0.00898,SPNE:0.01389):0.12407,(SMIT:0.17931,SINF:0.19088):0.07907):0.03180,(SPLU:0.26565,((SDYS:0.11857,SPYO:0.12773):0.03614,SCAN:0.23590):0.07965):0.00685):0.00595,((SCON:0.02532,(SINT:0.02347,SANG:0.01492):0.00849):0.11249,((STHE:0.03098,(SSAL:0.01506,SVES:0.01771):0.00908):0.08309,(SDEV:0.06535,SRAT:0.07758):0.06122):0.01029):0.03200,((SLUT:0.04050,SEQU:0.04088):0.11717,((SINF:0.04858,(SLUT:0.02062,SEQU:0.01184):0.03188):0.12896,SDOW:0.15478):0.01416):0.01166):0.00000;
(((((STHE:0.03023,(SSAL:0.00478,SVES:0.00770):0.02573):0.11875,(SANG:0.04318,(SCON:0.01629,SINT:0.01519):0.02561):0.09976):0.00533,(SRAT:0.09912,SDEV:0.09669):0.08736):0.02528,((SPSE:0.00675,SMIT:0.01052):0.08397,SPNE:0.09224):0.14693):0.00963,(SPLU:0.21063,(LCRE:0.38610,(((SLUT:0.01043,(SINF:0.00786,SEQU:0.01075):0.00151):0.06868,SDOW:0.09909):0.07380,((SCAN:0.03199,SPYO:0.03795):0.07325,SDYS:0.13774):0.07678):0.13135):0.03657):0.00435,((SCAN:0.05130,SPYO:0.05085):0.04604,SDYS:0.08705):0.14577):0.00000;
(((SPLU:0.05396,(SCAN:0.03922,(SPYO:0.06019,SDYS:0.01124):0.01574):0.05487):0.02030,((SENT:0.07769,(SDEV:0.05454,SRAT:0.02936):0.04174):0.01322,((LLAC:0.00676,LCRE:0.00498):0.23155,((SSUI:0.16041,(SANG:0.04277,(SCON:0.03503,SINT:0.03141):0.02351):0.03825):0.01580,((SMIT:0.01096,SPNE:0.01644):0.00994,SPSE:0.01146):0.08591):0.05918):0.02641):0.00524):0.00426,((SLUT:0.01732,(SINF:0.01199,SEQU:0.00153):0.01969):0.05883,SDOW:0.10290):0.00979,(STHE:0.02325,(SSAL:0.00306,SVES:0.01394):0.00387):0.05484):0.00000;
(((SPNE:0.01594,(SPSE:0.02690,SMIT:0.01895):0.00259):0.22649,SSUI:0.18409):0.01503,(SENT:0.26935,(SCAN:0.07015,(SPYO:0.06620,SDYS:0.05613):0.01203):0.15928):0.02662,SPLU:0.18140):0.00000;
((((SRAT:0.05304,SDEV:0.04059):0.15558,(SDYS:0.11512,(SCAN:0.06193,SPYO:0.05742):0.03549):0.12717):0.11631,(SMIT:0.02573,(SPSE:0.02692,SPNE:0.02650):0.00234):0.36576):0.00920,((SSAL:0.09129,(STHE:0.07428,SVES:0.08033):0.01934):0.26192,SDOW:0.33741):0.04363,(LLAC:0.02657,LCRE:0.03550):0.34246):0.00000;
((((SMIT:0.18897,SMIT:0.19944):0.01452,(((SPNE:0.06115,(SPSE:0.05093,SMIT:0.05075):0.01048):0.08426,(SCON:0.01748,(SINT:0.02449,SANG:0.01989):0.00043):0.11428):0.01380,SMIT:0.21093):0.03654):0.01260,(SENT:0.19179,(SPLU:0.16708,(SCAN:0.02020,(SDYS:0.01433,SPYO:0.01143):0.00676):0.15780):0.05755):0.03332):0.00722,(((((SSAL:0.11798,(STHE:0.06007,(STHE:0.03899,(SSAL:0.02924,SVES:0.03122):0.01316):0.00849):0.06338):0.02094,(SSAL:0.02919,SVES:0.02970):0.11865):0.00385,(SMIT:0.08206,(SPSE:0.00000,SPNE:0.00000):0.07938):0.05698):0.02910,(SINT:0.01465,(SANG:0.00891,SCON:0.00814):0.00137):0.13978):0.02567,((SPNE:0.02849,(SPSE:0.01723,SMIT:0.01539):0.01286):0.09267,(SANG:0.02037,(SINT:0.01347,SCON:0.01432):0.00526):0.09248):0.04744):0.02520,SMIT:0.25250):0.00000;
(((SMIT:0.16432,(((LLAC:0.03735,LCRE:0.03775):0.42316,(SENT:0.19921,(SENT:0.23930,(((SPLU:0.12573,SSUI:0.11695):0.05094,(SDEV:0.09173,SCAN:0.10509):0.05901):0.02005,SENT:0.21682):0.02278):0.00755):0.05182):0.02492,(((SDYS:0.16046,(SSAL:0.07436,SMIT:0.07792):0.12673):0.00446,((SINF:0.02260,SLUT:0.02091):0.00370,SEQU:0.02940):0.11914):0.01842,SMIT:0.19173):0.03663):0.03381):0.02191,((SPYO:0.10961,(SDYS:0.05229,SCAN:0.05044):0.04670):0.09897,(SPLU:0.19539,SDYS:0.22435):0.01401):0.03707):0.01202,(SDOW:0.13343,(SRAT:0.04005,SDEV:0.04433):0.09779):0.00823,((SINF:0.04850,SLUT:0.06224):0.07202,(STHE:0.01344,(SSAL:0.00447,SVES:0.00639):0.00651):0.10631):0.01794):0.00000;
((((((STHE:0.02282,SSAL:0.02536):0.02101,SVES:0.05863):0.15765,SPLU:0.19103):0.01911,(SENT:0.22169,((SCAN:0.08515,SDYS:0.08122):0.02926,SPYO:0.11809):0.08841):0.01495):0.02008,(SDOW:0.22539,((SCON:0.09909,(SINT:0.00992,SANG:0.01697):0.08307):0.07192,((SPSE:0.01353,SMIT:0.00638):0.01062,SPNE:0.02021):0.16210):0.07615):0.03011):0.00868,(SSUI:0.19401,(((SINF:0.01058,SLUT:0.00901):0.08155,SEQU:0.09108):0.08329,(SRAT:0.06394,SDEV:0.06638):0.10250):0.06814):0.06510,(LLAC:0.07014,LCRE:0.08252):0.38909):0.00000;
((SDOW:0.05333,(STHE:0.00650,(SSAL:0.00000,SVES:0.00000):0.00259):0.02641):0.01542,(((LCRE:0.00922,LLAC:0.00922):0.16698,(SPYO:0.08456,(SCAN:0.02583,SDYS:0.02692):0.00863):0.01632):0.00741,(((SINT:0.02339,(SANG:0.01767,SCON:0.03140):0.00685):0.02688,((SINF:0.00000,SLUT:0.00000):0.00208,SEQU:0.00248):0.02368):0.00487,(SDEV:0.00840,SRAT:0.01201):0.05199):0.01683):0.00295,(((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.05498,SSUI:0.05090):0.00880,(SPLU:0.04842,SENT:0.07914):0.01466):0.01111):0.00000;
((SENT:0.21438,(SSAL:0.01073,(STHE:0.01817,SVES:0.00171):0.00624):0.10873):0.00413,(SDOW:0.18413,((SPLU:0.20837,((SINF:0.02796,SLUT:0.02406):0.01563,SEQU:0.03240):0.06969):0.02296,((SPYO:0.03856,SDYS:0.02144):0.12351,SCAN:0.14090):0.08882):0.04659):0.01908,(SRAT:0.04968,SDEV:0.02813):0.17967):0.00000;
((((SPNE:0.02743,(SPSE:0.02220,SMIT:0.02330):0.00771):0.22644,((SVES:0.00298,SSAL:0.00126):0.05489,STHE:0.06568):0.26345):0.05677,(SPLU:0.07188,SSUI:0.09429):0.11892):0.15048,(SDYS:0.02276,SCAN:0.02784):0.02155,SPYO:0.05643):0.00000;
(SVES:0.00000,SSAL:0.00000,STHE:0.01860):0.00000;
((SVES:0.00000,SINF:0.05800):0.00000,SSAL:0.00000,STHE:0.00000):0.00000;
((((SPSE:0.00000,SPNE:0.00000):0.08344,(SANG:0.05733,(SINT:0.02415,SCON:0.01719):0.03036):0.00615):0.01389,((SSUI:0.08149,SENT:0.09255):0.01550,((SINF:0.00673,SLUT:0.00401):0.00319,SEQU:0.00753):0.06077):0.00301):0.00027,((((((SSAL:0.01040,SVES:0.01241):0.03433,SDOW:0.06800):0.01715,SMIT:0.06606):0.15650,(LLAC:0.00809,LCRE:0.00844):0.19213):0.03747,((SSAL:0.00521,SVES:0.00603):0.01103,STHE:0.06510):0.06790):0.00881,(SDEV:0.07175,(SDOW:0.05141,SRAT:0.02712):0.09863):0.02411):0.00570,(SCAN:0.00741,(SPYO:0.00660,SDYS:0.00172):0.00996):0.07717):0.00000;
((SVES:0.00000,SINF:0.05470):0.00000,SSAL:0.00000,STHE:0.00000):0.00000;
((((SMIT:0.04162,(SPSE:0.00886,SPNE:0.00319):0.03681):0.15274,(((SENT:0.12043,(((SEQU:0.02406,(SINF:0.00000,SLUT:0.00000):0.02238):0.07550,((STHE:0.01116,(SSAL:0.00000,SVES:0.00000):0.01128):0.03643,SDOW:0.05828):0.03205):0.08771,(SSUI:0.15955,((LCRE:0.00000,LLAC:0.00000):0.17993,SPLU:0.17699):0.04779):0.03847):0.05837):0.02620,(SDEV:0.03007,SRAT:0.03204):0.07889):0.03590,(SCAN:0.00000,(SPYO:0.00000,SDYS:0.00000):0.00000):0.06583):0.05306):0.04954,SCON:0.00000):0.00000,SINT:0.00000,SANG:0.00000):0.00000;
(SVES:0.00000,((SDEV:0.12832,SDOW:0.10273):0.30897,SSAL:0.01772):0.01331,STHE:0.00000):0.00000;
(SVES:0.01066,SSAL:0.08504,STHE:0.09185):0.00000;
(SVES:0.10024,SSAL:0.08001,STHE:0.05426):0.00000;
((SSAL:0.00001,SVES:0.00330):0.00911,SINF:0.30589,STHE:0.01568):0.00000;
(((SDEV:0.02314,SRAT:0.04033):0.05998,(SSUI:0.13679,(STHE:0.01355,(SSAL:0.02578,SVES:0.02866):0.00123):0.10284):0.01060):0.03621,(SPLU:0.09274,SENT:0.11111):0.00752,SDOW:0.12434):0.00000;
((SENT:0.13256,((LLAC:0.00831,LCRE:0.00757):0.30871,(SPLU:0.10428,((SLUT:0.02070,(SINF:0.01266,SEQU:0.01079):0.00992):0.06624,(STHE:0.02087,(SSAL:0.00770,SVES:0.01416):0.00637):0.10580):0.00953):0.00850):0.00512):0.00394,(SDOW:0.11728,((SCAN:0.02050,(SPYO:0.01968,SDYS:0.01121):0.00399):0.06858,(SDEV:0.01186,SRAT:0.01959):0.07975):0.01604):0.00655,(((SPSE:0.00732,(SMIT:0.00253,SPNE:0.00668):0.00477):0.06129,(SINT:0.02249,(SANG:0.01323,SCON:0.03025):0.00771):0.05748):0.02029,SSUI:0.10603):0.02350):0.00000;
(SVES:0.00929,SSAL:0.00929,STHE:0.14861):0.00000;
((SSAL:0.04519,(STHE:0.01113,SVES:0.00443):0.03224):0.05849,(((SINF:0.00274,SLUT:0.00302):0.00488,SEQU:0.00577):0.04658,SDOW:0.09669):0.00361,((SANG:0.00529,(SINT:0.00458,SCON:0.00686):0.00496):0.06957,(((LLAC:0.00829,LCRE:0.00577):0.12923,(SENT:0.12275,((SPLU:0.07960,SSUI:0.06346):0.02376,(SPSE:0.01239,(SMIT:0.00431,SPNE:0.00605):0.00785):0.07665):0.02569):0.24834):0.04260,(SCAN:0.02538,(SPYO:0.00623,SDYS:0.00687):0.00838):0.06438):0.01989):0.01276):0.00000;
((((SMIT:0.00496,SPSE:0.01008):0.00573,SPNE:0.03787):0.07499,(SSAL:0.01817,SVES:0.03068):0.06188):0.00731,((SANG:0.01853,SCON:0.02364):0.06720,(SINT:0.07509,(SSUI:0.07537,SPLU:0.04732):0.03506):0.00831):0.00830,(SDOW:0.05642,(SDEV:0.03230,SRAT:0.03045):0.03352):0.35704):0.00000;
(((SPYO:0.01684,(SCAN:0.00862,SDYS:0.00254):0.00967):0.02300,((SPLU:0.03472,SENT:0.05288):0.00421,((((SMIT:0.00243,(SPSE:0.00103,SPNE:0.00352):0.00178):0.02243,((SANG:0.00526,SINT:0.01086):0.00154,SCON:0.01333):0.01439):0.01662,SSUI:0.04216):0.00494,((LCRE:0.00174,LLAC:0.00000):0.10636,((LLAC:0.00426,LCRE:0.00444):0.18685,(((((SMIT:0.01514,(SPSE:0.00501,SPNE:0.00581):0.01838):0.04473,((SANG:0.01564,SINT:0.01106):0.00171,SCON:0.01057):0.03523):0.03980,SSUI:0.09742):0.01546,(((SPYO:0.02016,(SCAN:0.01198,SDYS:0.00823):0.00760):0.06891,(((SINF:0.00391,SLUT:0.00544):0.00702,SEQU:0.01402):0.06069,((SVES:0.00457,SSAL:0.00409):0.01039,STHE:0.01485):0.05499):0.01154):0.00111,(SPLU:0.07601,((SDEV:0.01170,SRAT:0.00956):0.06861,SDOW:0.07438):0.00190):0.00396):0.02100):0.01126,SENT:0.12448):0.06542):0.33649):0.05748):0.00551):0.00571):0.00322,((SDEV:0.00756,SRAT:0.00500):0.01857,SDOW:0.02885):0.00472,((SSAL:0.00237,(STHE:0.00836,SVES:0.00248):0.00078):0.02203,((SINF:0.00251,SLUT:0.00134):0.00365,SEQU:0.00684):0.02052):0.00040):0.00000;
((((((SMIT:0.01844,SPSE:0.03038):0.00854,SPNE:0.03817):0.07684,((SINT:0.03658,(SANG:0.01053,SCON:0.00666):0.01871):0.05003,SSUI:0.08755):0.01586):0.01088,SDOW:0.14402):0.00620,((SVES:0.03148,SSAL:0.02556):0.10053,((LCRE:0.00958,LLAC:0.00936):0.15178,SPYO:0.38581):0.00329):0.02605):0.00111,((SDEV:0.02006,SRAT:0.01875):0.08188,((SINF:0.00268,SLUT:0.00541):0.01243,SEQU:0.00916):0.09551):0.01145,((SPLU:0.08000,SENT:0.10421):0.02593,(SCAN:0.02208,SDYS:0.01777):0.08013):0.00640):0.00000;
(SSAL:0.05610,SVES:0.05610):0.00000;
(SSAL:0.03777,SVES:0.03777):0.00000;
(((SSAL:0.02303,(STHE:0.01381,SVES:0.01953):0.00607):0.04693,SDOW:0.07595):0.02257,(((SRAT:0.05373,SDEV:0.04498):0.06141,(((SMIT:0.01021,(SPSE:0.00885,SPNE:0.00765):0.00385):0.07229,(SANG:0.03038,SINT:0.04464):0.07780):0.04569,(((LCRE:0.01562,LLAC:0.01873):0.20619,SSUI:0.14200):0.01574,SENT:0.13725):0.00691):0.01036):0.00566,(SLUT:0.01603,(SINF:0.00231,SEQU:0.00256):0.00766):0.07975):0.00477,(SPLU:0.09679,(SPYO:0.05865,(SCAN:0.02603,SDYS:0.03041):0.03478):0.05842):0.00611):0.00000;
(SVES:0.03764,SSAL:0.09135,STHE:0.01735):0.00000;
(((LLAC:0.00888,LCRE:0.00517):0.32676,((SPSE:0.03412,SMIT:0.02676):0.17306,SSUI:0.19571):0.07766):0.17327,(STHE:0.04168,SVES:0.00729):0.02640,SSAL:0.03425):0.00000;
(((SANG:0.07699,(SINT:0.05178,SCON:0.04193):0.05162):0.07825,((SVES:0.00474,SSAL:0.01354):0.00828,STHE:0.02538):0.16897):0.00943,((SSUI:0.04887,SPLU:0.06681):0.09188,((SEQU:0.02444,(SINF:0.00393,SLUT:0.01293):0.02695):0.10932,(SPYO:0.02310,(SCAN:0.01762,SDYS:0.02150):0.00661):0.08764):0.04635):0.01183,(SENT:0.20111,(SDOW:0.15230,(SRAT:0.05064,SDEV:0.04719):0.11246):0.00766):0.02408):0.00000;
(((STHE:0.03317,SVES:0.03346):0.04091,SSAL:0.07214):0.17563,(((((LLAC:0.08113,LCRE:0.08082):0.27575,SSUI:0.23762):0.01636,(((SPSE:0.01312,SPNE:0.01863):0.01539,SMIT:0.02603):0.21548,(SANG:0.05770,(SINT:0.03931,SCON:0.03905):0.01957):0.15985):0.04068):0.02930,SENT:0.26409):0.02179,(((SPYO:0.14717,(SCAN:0.11866,SDYS:0.12110):0.02068):0.07558,(SEQU:0.07317,(SLUT:0.02776,SINF:0.02437):0.06248):0.10458):0.01647,(SRAT:0.06715,SDEV:0.05402):0.16533):0.01434):0.00855,(SPLU:0.23097,SDOW:0.22370):0.01192):0.00000;
(SANG:0.15429,SVES:0.15429):0.00000;
((SVES:0.07335,SSAL:0.06511):0.10463,(SSAL:0.14954,(STHE:0.04745,SVES:0.04129):0.12192):0.22169,SSAL:0.18590):0.00000;
((SSAL:0.00239,SVES:0.00478):0.00077,((SMIT:0.00950,SPNE:0.02885):0.04171,SINF:0.24530):0.05280,STHE:0.01218):0.00000;
(((SSUI:0.17359,((SANG:0.01860,(SCON:0.01631,SINT:0.01439):0.00311):0.06974,((SMIT:0.00498,SPSE:0.00578):0.00084,SPNE:0.00863):0.07645):0.06301):0.11414,((SVES:0.00989,SSAL:0.01540):0.01828,STHE:0.04031):0.12055):0.00285,(((SEQU:0.01541,(SINF:0.00903,SLUT:0.01073):0.00939):0.13407,((SENT:0.12279,(SPLU:0.04094,(SSUI:0.00006,SENT:0.00291):0.03788):0.08788):0.01579,(SDEV:0.05064,SRAT:0.04279):0.11516):0.00498):0.00637,(SPYO:0.09636,(SCAN:0.04309,SDYS:0.03667):0.04544):0.07936):0.01203,SDOW:0.16882):0.00000;
(SPNE:0.01641,SVES:0.01641):0.00000;
(((SANG:0.18882,(SENT:0.27980,((SMIT:0.03441,SVES:0.02103):0.14103,SPNE:0.13368):0.15095):0.12711):0.05997,SSUI:0.10431):0.04412,SDYS:0.04587,SPLU:0.04808):0.00000;
((SPLU:0.02875,(SANG:0.10214,((SMIT:0.01698,SVES:0.01185):0.00351,SPNE:0.01851):0.43735):0.10959):0.01364,(SSUI:0.01083,SDYS:0.00301):0.01169,SSUI:0.02184):0.00000;
(SVES:0.30415,SSUI:0.25849,SMIT:0.28396):0.00000;
(SVES:0.00772,(SSAL:0.01585,(((SLUT:0.01285,SEQU:0.00226):0.07868,SPLU:0.14452):0.11900,((SMIT:0.00843,SPSE:0.00429):0.00650,SPNE:0.02027):0.08556):0.09384):0.00267,STHE:0.00216):0.00000;
((SSAL:0.02145,SVES:0.02064):0.00975,(((SINF:0.01937,SLUT:0.02731):0.01195,SEQU:0.02396):0.08870,SDOW:0.07783):0.05918,STHE:0.03009):0.00000;
(STHE:0.08095,SVES:0.08095):0.00000;
(SVES:0.06927,(STHE:0.08318,SVES:0.04489):0.00972,(SDYS:0.07026,SPNE:0.06981):0.19878):0.00000;
(SSAL:0.09586,SVES:0.09586):0.00000;
((((((SINF:0.01379,SLUT:0.01509):0.02470,SEQU:0.03223):0.04561,SPYO:0.09778):0.00726,(SDOW:0.09597,(SPLU:0.08618,((STHE:0.01915,SSAL:0.01138):0.00450,SVES:0.01851):0.05931):0.00968):0.01907):0.00295,(SDEV:0.03728,SRAT:0.03624):0.06608):0.00217,(SCAN:0.03604,SDYS:0.04168):0.08105,(LCRE:0.19975,(((((SMIT:0.00894,SPSE:0.01144):0.00146,SPNE:0.00918):0.09104,(SINT:0.03271,(SANG:0.02386,SCON:0.02222):0.01146):0.05668):0.02837,SSUI:0.12782):0.01403,SENT:0.12662):0.00677):0.00848):0.00000;
(SSAL:0.00922,SVES:0.02194,SPNE:0.24719):0.00000;
(SSAL:0.00832,SPNE:0.15030,SVES:0.02271):0.00000;
(SSAL:0.18978,STHE:0.18844,(SSUI:0.30048,SDEV:0.25705):0.10876):0.00000;
(SDOW:0.29412,SSAL:0.29412):0.00000;
(((LLAC:0.03414,LCRE:0.02666):0.11753,(((SINF:0.01663,SLUT:0.01196):0.00069,SEQU:0.01116):0.01976,SSAL:0.03634):0.03324):0.02741,(SPLU:0.10543,((SRAT:0.01681,SDEV:0.01471):0.02879,SDOW:0.06187):0.01137):0.00340,((SVES:0.01111,STHE:0.01954):0.02471,(SPSE:0.00378,SMIT:0.00484):0.03364):0.02853):0.00000;
(((SPSE:0.01515,(SPNE:0.02502,SMIT:0.01555):0.01103):0.22609,(SDOW:0.19360,((SSAL:0.00928,SVES:0.00760):0.20326,(((SINF:0.01496,SLUT:0.02052):0.03007,SEQU:0.04423):0.10036,(SRAT:0.03485,SDEV:0.04393):0.10702):0.01639):0.01543):0.01394):0.01073,((SSUI:0.21777,(SANG:0.07738,(SINT:0.03138,SCON:0.03310):0.04745):0.19898):0.01349,((SPYO:0.04253,SDYS:0.04431):0.03519,SCAN:0.10098):0.14714):0.00651,SPLU:0.20591):0.00000;
(((SSAL:0.01330,SVES:0.01021):0.02492,STHE:0.04102):0.15821,(((SEQU:0.03309,(SLUT:0.02726,SINF:0.03502):0.01920):0.13157,(((SANG:0.03305,SCON:0.02551):0.00675,SINT:0.03176):0.17749,(SRAT:0.03698,SDEV:0.03425):0.14133):0.01784):0.03700,SDOW:0.24710):0.01004,((SSAL:0.02106,SVES:0.01725):0.26187,STHE:0.07918):0.32217):0.00000;
((((STHE:0.03400,(SVES:0.01259,SSAL:0.00938):0.00766):0.05350,((SENT:0.10977,((SCAN:0.02073,SDYS:0.01409):0.07706,SPLU:0.08612):0.01221):0.11338,SSUI:0.10783):0.05741):0.02249,(SINT:0.00725,SCON:0.02320):0.03501):0.03091,(SPSE:0.00777,SPNE:0.01612):0.00233,SMIT:0.01338):0.00000;
(SSAL:0.04540,SPLU:0.32413,SVES:0.06417):0.00000;
(((SDOW:0.22276,(SDEV:0.05730,SRAT:0.05982):0.12091):0.00872,((SEQU:0.04434,(SLUT:0.01212,SINF:0.01264):0.02818):0.21618,((SSUI:0.24703,SENT:0.26144):0.05073,((SSAL:0.06856,STHE:0.07234):0.20732,((SANG:0.05653,(SINT:0.03868,SCON:0.03436):0.03746):0.14485,((SPSE:0.00875,SPNE:0.00623):0.01720,SMIT:0.02852):0.20534):0.06763):0.03947):0.01050):0.04338):0.00667,(SCAN:0.09748,SDYS:0.07407):0.14513,SPLU:0.23157):0.00000;
(SVES:0.18689,SSAL:0.18689):0.00000;
(SVES:0.02206,SSAL:0.02206):0.00000;
(((SSAL:0.12782,SMIT:0.14020):0.17974,SDOW:0.26393):0.01211,SRAT:0.27721,SINT:0.25710):0.00000;
((((SSAL:0.02988,SVES:0.02402):0.22261,SANG:0.25293):0.12799,SDOW:0.20725):0.09317,(SDEV:0.05926,SRAT:0.06101):0.13494,(SINF:0.01661,SEQU:0.02012):0.17154):0.00000;
(SSAL:0.22434,SDOW:0.25228,LCRE:0.22631):0.00000;
(SANG:0.07558,((SDEV:0.08221,SRAT:0.07803):0.12164,(SSAL:0.31178,SDOW:0.43858):0.13662):0.11038,(SCON:0.01078,SINT:0.01126):0.03956):0.00000;
(SSAL:0.09157,(STHE:0.04089,SVES:0.04089):0.05809,SDYS:0.51226):0.00000;
(SSAL:0.02399,SVES:0.02875,SENT:0.50735):0.00000;
((SDYS:0.06094,((LLAC:0.02283,LCRE:0.02703):0.43419,(SSAL:0.02407,(STHE:0.01538,SVES:0.02024):0.01291):0.27184):0.18314):0.00537,SCAN:0.06927,SPYO:0.05464):0.00000;
(((SEQU:0.04871,SINF:0.04464):0.15363,(SVES:0.03285,SSAL:0.02547):0.18798):0.12553,SRAT:0.03482,SDEV:0.05107):0.00000;
(SSAL:0.01102,SPSE:0.23408,STHE:0.02223):0.00000;
(SSAL:0.29527,SSAL:0.29527):0.00000;
((((LCRE:0.00623,LLAC:0.00307):0.05938,SSAL:0.60511):0.04995,((((SINF:0.00235,SLUT:0.00294):0.00183,SEQU:0.00396):0.01523,(SPYO:0.00854,(SCAN:0.00462,SDYS:0.00702):0.00608):0.00526):0.00565,(SDOW:0.03961,(SDEV:0.01279,SRAT:0.01168):0.01477):0.00392):0.00329):0.00270,((SSUI:0.00323,SPLU:0.00342):0.01342,SENT:0.02215):0.00781,((STHE:0.01253,(SSAL:0.00210,SVES:0.00156):0.00460):0.00652,((SANG:0.01006,SINT:0.00909):0.00932,((SPSE:0.00241,(SMIT:0.00164,SPNE:0.00168):0.00008):0.00441,SCON:0.00830):0.00642):0.00450):0.00522):0.00000;
(SSAL:0.16573,SSAL:0.31387,SSAL:0.26402):0.00000;
(SVES:0.02703,SSAL:0.02703):0.00000;
(SVES:0.03754,SSAL:0.03754):0.00000;
((SSAL:0.24396,((SPYO:0.01323,SDYS:0.00715):0.04884,SCAN:0.06558):0.24813):0.02770,SENT:0.22907,(SSUI:0.10820,SPLU:0.12077):0.14513):0.00000;
(SEQU:0.33373,SSAL:0.33373):0.00000;
(SMIT:0.26343,SSAL:0.26343):0.00000;
((SDOW:0.23372,((SEQU:0.03065,(SLUT:0.01328,SINF:0.01275):0.01423):0.14028,(SSAL:0.03904,SVES:0.04777):0.16671):0.00692):0.00537,((SSUI:0.19139,SPNE:0.19550):0.00615,(SINT:0.08369,(SANG:0.03347,SCON:0.04318):0.03141):0.09367):0.05384,(SPLU:0.21718,SENT:0.19986):0.02369):0.00000;
(SENT:0.29104,SSAL:0.29104):0.00000;
((SANG:0.04572,(SSAL:0.15568,((LLAC:0.19771,LCRE:0.22169):0.12236,SDOW:0.25522):0.14961):0.12968):0.00561,SVES:0.03664,STHE:0.03645):0.00000;
((SANG:0.02323,SSAL:0.02169):0.00423,(SLUT:0.39531,(SSUI:0.08021,SPLU:0.07050):0.04626):0.07258,SVES:0.02480):0.00000;
(SMIT:0.10522,SSAL:0.10522):0.00000;
(SMIT:0.22775,((SENT:0.40601,SENT:0.19646):0.06023,SSAL:0.18122):0.01984,SDYS:0.16034):0.00000;
(SDOW:0.27437,SSAL:0.40531,SANG:0.28405):0.00000;
(SSAL:0.32662,SENT:0.26334,SMIT:0.28866):0.00000;
((((STHE:0.01137,(SSAL:0.00603,SVES:0.00966):0.00243):0.04098,(SDOW:0.04693,(SDEV:0.01346,SRAT:0.01809):0.03777):0.01528):0.01077,(SANG:0.09168,((SDOW:0.19649,(SSAL:0.46120,(LLAC:0.00201,LCRE:0.00183):0.21428):0.04034):0.04373,((((SMIT:0.01198,(SPSE:0.00000,SPNE:0.00000):0.01210):0.03519,(SINT:0.01566,SCON:0.01797):0.02225):0.03695,(SPYO:0.03412,(SCAN:0.00993,SDYS:0.01572):0.00557):0.07007):0.00731,(SSUI:0.04208,SENT:0.06234):0.05792):0.02858):0.01616):0.01979):0.00495,SPLU:0.05597,((SINF:0.00045,SLUT:0.00382):0.00150,SEQU:0.00610):0.05066):0.00000;
(SMIT:0.25979,SSAL:0.25979):0.00000;
(SPNE:0.32393,SSAL:0.32393):0.00000;
((SPYO:0.19635,((SVES:0.02731,SSAL:0.03046):0.15407,SDOW:0.23293):0.02605):0.00942,(SRAT:0.13802,SDEV:0.12693):0.10632,((SINF:0.00956,SLUT:0.01474):0.04890,SEQU:0.05735):0.12465):0.00000;
((SDEV:0.18859,(SDOW:0.24648,(SSAL:0.01502,SVES:0.03035):0.30612):0.01455):0.00555,SRAT:0.21635,(SEQU:0.01540,SINF:0.03869):0.16963):0.00000;
((SDOW:0.23985,(SSAL:0.02843,SVES:0.02802):0.21247):0.01246,(SDEV:0.07687,SRAT:0.07428):0.17715,((SMIT:0.01518,(SPSE:0.00108,SPNE:0.00386):0.02514):0.12667,SANG:0.13975):0.09649):0.00000;
((((SSUI:0.01884,SPLU:0.01581):0.07550,SENT:0.11143):0.00997,((SDEV:0.03455,SRAT:0.03760):0.09037,((LCRE:0.02802,LLAC:0.02735):0.15216,((LLAC:0.02405,LCRE:0.02415):0.17537,((SCAN:0.04711,(SPYO:0.02233,SDYS:0.02387):0.02173):0.07765,((SSUI:0.11311,((SANG:0.04004,(SINT:0.03626,SCON:0.03296):0.01590):0.04619,((SMIT:0.00668,SPSE:0.00831):0.00398,SPNE:0.01308):0.08042):0.01366):0.00762,((SENT:0.08529,SPLU:0.08540):0.01425,((SRAT:0.07847,SDEV:0.08480):0.00986,((SLUT:0.01629,(SINF:0.01397,SEQU:0.00764):0.00287):0.06928,(STHE:0.02135,(SSAL:0.00641,SVES:0.00975):0.00856):0.06688):0.00531):0.01477):0.00908):0.01853):0.06559):0.32538):0.05958):0.01102):0.00093,(((STHE:0.02481,(SSAL:0.01628,SVES:0.01680):0.00262):0.05482,(SINF:0.00996,(SLUT:0.00593,SEQU:0.00312):0.00378):0.06282):0.01060,((SCAN:0.04966,(SPYO:0.02779,SDYS:0.03869):0.00978):0.07812,SDOW:0.10904):0.00293):0.00737,((SMIT:0.01272,(SPSE:0.00883,SPNE:0.01571):0.00332):0.06193,(SANG:0.06450,(SINT:0.01526,SCON:0.01132):0.05022):0.02008):0.03261):0.00000;
(SSAL:0.51698,SVES:0.14295,SSAL:0.12056):0.00000;
((((SSAL:0.03409,SVES:0.03337):0.00733,STHE:0.03956):0.12708,SDOW:0.13477):0.00658,(SDEV:0.06560,SRAT:0.07725):0.12604,(SINF:0.05538,(SLUT:0.04106,SEQU:0.03074):0.02250):0.11688):0.00000;
(SEQU:0.14545,SSAL:0.14545):0.00000;
(SINT:0.32860,SSAL:0.32860):0.00000;
(SSAL:0.19562,(SDOW:0.22088,SDOW:0.21957):0.05252,SSAL:0.16979):0.00000;
((SINT:0.12428,SSAL:0.14173):0.08528,(SPNE:0.01658,SMIT:0.01425):0.00184,SPSE:0.00785):0.00000;
(SVES:0.12633,SSAL:0.12633):0.00000;
(SDOW:0.01518,SSAL:0.01518):0.00000;
(SSAL:0.02025,SDOW:0.01660,SRAT:0.28005):0.00000;
(SSAL:0.24095,(SRAT:0.06690,SDEV:0.07071):0.27037,SSAL:0.39873):0.00000;
(((((((((SRAT:0.00000,((LCRE:0.00000,(LLAC:0.00000,(SMIT:0.00000,(SPSE:0.00000,(SPNE:0.00000,(SANG:0.00000,(SINT:0.00000,(SCON:0.00000,SSUI:0.00000):0.00000):0.00000):0.00000):0.00000):0.00000):0.00000):0.00000):0.00956,(SINF:0.00000,(SLUT:0.00000,(SEQU:0.00000,SDOW:0.00000):0.00000):0.00000):0.00480):0.01425):0.00000,SDEV:0.00000):0.00000,SDYS:0.00000):0.00000,SPYO:0.00000):0.00000,SCAN:0.00000):0.00000,SENT:0.00000):0.00000,SPLU:0.00000):0.00000,SVES:0.00000):0.00000,SSAL:0.00000,STHE:0.00000):0.00000;
(((SPLU:0.00457,((((SINF:0.00000,SLUT:0.00000):0.00088,SEQU:0.00080):0.00570,SPYO:0.00101):0.00276,((STHE:0.00000,(SSAL:0.00000,SVES:0.00000):0.00000):0.00688,((SENT:0.03596,(SANG:0.00000,(SINT:0.00000,(SCON:0.00000,(SDEV:0.00000,SRAT:0.00000):0.00000):0.00000):0.00000):0.00378):0.00677,((LCRE:0.00000,LLAC:0.00000):0.10602,SDOW:0.04016):0.00348):0.00338):0.00184):0.00121):0.00047,SDYS:0.00840):0.00001,SCAN:0.00000,((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.00504,SSUI:0.00000):0.00168):0.00000;
(((((((((((((LCRE:0.00000,LLAC:0.00000):0.06106,(SMIT:0.00000,(SPSE:0.00000,(SPNE:0.00000,(SANG:0.00000,(SINT:0.00000,SCON:0.00000):0.00000):0.00000):0.00000):0.00000):0.00706):0.01704,SSUI:0.00490):0.00801,(SPLU:0.01367,SENT:0.01126):0.00220):0.00521,(SDEV:0.00000,SRAT:0.00000):0.00726):0.00103,(SDYS:0.00000,SDOW:0.00000):0.00000):0.00000,SPYO:0.00000):0.00000,SCAN:0.00000):0.00000,SEQU:0.00000):0.00000,SLUT:0.00000):0.00000,SINF:0.00000):0.00000,SVES:0.00000):0.00000,SSAL:0.00000,STHE:0.00000):0.00000;
(((((((LCRE:0.00000,LLAC:0.00000):0.10092,(((SANG:0.00000,(SINT:0.00000,SCON:0.00000):0.00000):0.00460,((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.01055,SSUI:0.01289):0.00129):0.00422,(SPLU:0.00000,SENT:0.00000):0.00950):0.00727):0.00270,((SINF:0.00000,SLUT:0.00000):0.00070,((SRAT:0.00023,SDOW:0.00174):0.00178,(SEQU:0.00000,SDEV:0.00000):0.00019):0.00126):0.00254):0.00445,(SCAN:0.00000,SDYS:0.00000):0.00141):0.00055,SPYO:0.00196):0.00000,SVES:0.00000):0.00000,SSAL:0.00000,STHE:0.00000):0.00000;
((SDEV:0.02188,SRAT:0.01686):0.01840,SDOW:0.03116,(((STHE:0.02991,SSAL:0.00235):0.00595,SVES:0.00480):0.03643,(((((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.03156,(SANG:0.00000,(SINT:0.00000,SCON:0.00000):0.00000):0.06698):0.06950,(SSUI:0.15831,SPLU:0.09800):0.01308):0.02961,(SLUT:0.00498,(SINF:0.00000,SEQU:0.00000):0.00222):0.08958):0.00555,(SENT:0.09822,(SCAN:0.01981,(SPYO:0.00031,SDYS:0.00329):0.01603):0.04723):0.02400):0.02412):0.00467):0.00000;
((((SSUI:0.02630,(((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.01627,(SENT:0.04046,(SDEV:0.00000,SRAT:0.00000):0.00619):0.00401):0.01086,(((LCRE:0.01455,LLAC:0.01495):0.12039,(SCAN:0.00000,(SPYO:0.00000,SDYS:0.00000):0.00000):0.04247):0.01411,(((SSAL:0.00000,SVES:0.00000):0.00505,(STHE:0.02725,SPLU:0.01623):0.00223):0.02302,SDOW:0.02419):0.01182):0.00283):0.00856):0.00650,(SINF:0.00000,(SLUT:0.00000,SEQU:0.00000):0.00000):0.01957):0.00368,SCON:0.00000):0.00000,SINT:0.00000,SANG:0.00000):0.00000;
((SSAL:0.01061,(((((SINF:0.00000,SLUT:0.00000):0.00404,SEQU:0.00399):0.07933,((SPLU:0.06839,(SCAN:0.01243,(SPYO:0.00189,SDYS:0.00014):0.00988):0.07071):0.01147,(SSUI:0.10882,(SENT:0.16646,((LLAC:0.01642,LCRE:0.00528):0.23332,((SINT:0.03582,(SANG:0.00142,SCON:0.02202):0.03261):0.05965,(SDEV:0.03515,SRAT:0.02760):0.07320):0.02274):0.03647):0.02630):0.02098):0.01368):0.01361,SDOW:0.07369):0.07735,(SMIT:0.00564,(SPSE:0.00240,SPNE:0.01951):0.01030):0.01407):0.02917):0.00130,SVES:0.00000,STHE:0.00000):0.00000;
((((STHE:0.00000,(SSAL:0.00000,SVES:0.00000):0.00000):0.01238,((SPLU:0.00088,SENT:0.01488):0.00915,(((((SCAN:0.00000,SPYO:0.00000):0.00184,SDYS:0.00816):0.00872,SRAT:0.03122):0.01482,SDOW:0.01407):0.00692,(((LCRE:0.00000,LLAC:0.00000):0.05596,((SANG:0.00000,(SINT:0.00000,SCON:0.00000):0.00000):0.05255,(((SMIT:0.00000,SPSE:0.00000):0.00045,SPNE:0.01522):0.00675,SSUI:0.01038):0.00324):0.00849):0.00314,SDEV:0.00969):0.00219):0.00655):0.00488):0.00343,SEQU:0.00000):0.00000,SLUT:0.00000,SINF:0.00000):0.00000;
((((SSAL:0.00726,((STHE:0.01402,(SPLU:0.00150,(SINF:0.00000,(SLUT:0.00000,SEQU:0.00000):0.00000):0.01183):0.00265):0.00656,((((SANG:0.01681,(SINT:0.00000,SCON:0.00000):0.01565):0.00520,((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.01670,SSUI:0.02905):0.00459):0.01751,(SENT:0.06518,(SDEV:0.00959,SRAT:0.00982):0.03029):0.00391):0.01609,((LCRE:0.00000,LLAC:0.00000):0.13735,SDOW:0.02437):0.01058):0.01015):0.02092):0.01204,SDYS:0.00000):0.00000,SPYO:0.00000):0.00000,SCAN:0.00000,SVES:0.00000):0.00000;
(((((((((((SDEV:0.00000,SRAT:0.00000):0.00015,((SCAN:0.00626,(SPYO:0.00000,SDYS:0.00000):0.00000):0.00006,SDOW:0.00619):0.00142):0.00221,(SINF:0.00469,(SLUT:0.00000,SEQU:0.00000):0.00000):0.00561):0.00371,((LCRE:0.00000,LLAC:0.00000):0.08823,SENT:0.00566):0.00254):0.00027,SPLU:0.00169):0.00146,((SSAL:0.01394,(STHE:0.00000,SVES:0.00000):0.00004):0.00154,SSUI:0.00002):0.00006):0.00619,SCON:0.00000):0.00000,SINT:0.00000):0.00000,SANG:0.00000):0.00000,SPNE:0.00000):0.00000,SPSE:0.00000,SMIT:0.00000):0.00000;
((SCAN:0.00925,(SPYO:0.00468,SDYS:0.00580):0.00069):0.03480,(((((SMIT:0.00087,(SPSE:0.00000,SPNE:0.00000):0.00536):0.02767,(SANG:0.00311,(SINT:0.00000,SCON:0.00000):0.01047):0.02632):0.01696,SSUI:0.05188):0.00531,(SPLU:0.03736,((LCRE:0.00000,LLAC:0.00000):0.08541,SENT:0.08996):0.02252):0.00343):0.00674,(((SINF:0.00000,SLUT:0.00000):0.00437,SEQU:0.00294):0.02256,((SSAL:0.00319,(STHE:0.00328,SVES:0.00296):0.00357):0.02784,(SDEV:0.00516,SRAT:0.00008):0.02415):0.00279):0.00826):0.00148,SDOW:0.05714):0.00000;
(((SDEV:0.02647,SRAT:0.02101):0.00338,((((SSUI:0.00782,SPLU:0.00724):0.03610,((LCRE:0.01554,LLAC:0.01011):0.16130,SENT:0.07439):0.00481):0.00566,(((SMIT:0.00450,SPSE:0.01157):0.00921,SPNE:0.02207):0.01455,(SCAN:0.00939,(SPYO:0.00915,SDYS:0.00694):0.00916):0.02604):0.00360):0.00903,((STHE:0.00689,(SSAL:0.00040,SVES:0.00216):0.00532):0.02593,SDOW:0.03071):0.00531):0.00737):0.00028,(SINF:0.01070,(SLUT:0.00971,SEQU:0.00574):0.00152):0.01844,(SANG:0.02171,(SINT:0.02817,SCON:0.01681):0.01358):0.00732):0.00000;
(SRAT:0.33481,SPLU:0.22308,SPNE:0.24677):0.00000;
(SDEV:0.05001,SRAT:0.05001):0.00000;
((SRAT:0.20740,(SDYS:0.01357,SCAN:0.00704):0.18624):0.34697,(SCON:0.01558,SANG:0.01763):0.01713,SINT:0.01612):0.00000;
((SRAT:0.14831,(SCAN:0.01445,SDYS:0.01059):0.13812):0.25747,(SCON:0.02996,SINT:0.03396):0.01051,SANG:0.04416):0.00000;
(SDEV:0.09992,SRAT:0.09992):0.00000;
((SPSE:0.03049,(SMIT:0.02040,SPNE:0.02263):0.00771):0.07958,((((STHE:0.01062,SSAL:0.00454):0.00273,SVES:0.01005):0.07158,((SINF:0.02492,SLUT:0.05548):0.02156,SEQU:0.05973):0.04254):0.01384,(SDEV:0.06623,SRAT:0.04888):0.07521):0.01964,((LLAC:0.08229,LCRE:0.08702):0.16728,SDOW:0.14900):0.00942):0.00000;
((LCRE:0.05651,LLAC:0.05855):0.14639,(SMIT:0.01635,(SPSE:0.00655,SPNE:0.00647):0.00243):0.12171,(((((STHE:0.01079,SSAL:0.01193):0.00640,SVES:0.01623):0.08335,(SINF:0.05546,SEQU:0.06184):0.04263):0.01978,(SDEV:0.04610,SRAT:0.05261):0.06364):0.02936,SDOW:0.15589):0.00583):0.00000;
((((((SMIT:0.00952,(SPSE:0.00000,SPNE:0.00000):0.00283):0.02991,(SANG:0.02665,(SINT:0.00686,SCON:0.00129):0.01583):0.00624):0.01277,((LLAC:0.02317,LCRE:0.00603):0.31442,SSUI:0.04086):0.01241):0.02430,((SINF:0.00000,SLUT:0.00000):0.01091,SEQU:0.00129):0.01854):0.00559,(SDEV:0.01906,SRAT:0.00538):0.03761):0.00770,SDOW:0.04962,((STHE:0.00907,(SSAL:0.00346,SVES:0.00461):0.00706):0.02719,((SPLU:0.06620,SENT:0.02119):0.01086,(SCAN:0.01523,(SPYO:0.01575,SDYS:0.01474):0.00683):0.05407):0.00899):0.00179):0.00000;
(((((((SMIT:0.00913,SPSE:0.00877):0.00248,SPNE:0.01666):0.07344,(SANG:0.02092,(SINT:0.00954,SCON:0.00597):0.02157):0.05933):0.02847,SSUI:0.11315):0.01286,SDOW:0.11194):0.00346,(SENT:0.16443,(((SMIT:0.31338,(LCRE:0.21061,((((SMIT:0.00883,SPSE:0.00869):0.00367,SPNE:0.01507):0.09481,SANG:0.11314):0.06454,((SSAL:0.01828,SVES:0.02281):0.11632,(((SSUI:0.11026,SENT:0.09989):0.00769,(SPLU:0.11545,(SDEV:0.03357,SRAT:0.03294):0.07016):0.01808):0.00987,((SCAN:0.04016,(SPYO:0.00536,SDYS:0.00508):0.03702):0.06027,((SINF:0.03753,(SLUT:0.03308,SEQU:0.01925):0.01174):0.05850,SDOW:0.09754):0.00995):0.01608):0.01641):0.05408):0.01438):0.08596):0.04373,(SRAT:0.39095,(((SSUI:0.04775,((SINF:0.00986,(SLUT:0.00705,SEQU:0.00583):0.00257):0.04145,(((SPSE:0.00436,(SMIT:0.00000,SPNE:0.00000):0.00251):0.02253,(SANG:0.00659,(SINT:0.00378,SCON:0.00138):0.00372):0.02087):0.01960,(SDEV:0.00485,SRAT:0.00549):0.03414):0.00427):0.00248):0.01070,(SPLU:0.06450,((STHE:0.01109,(SSAL:0.00663,SVES:0.01056):0.00351):0.04168,SDOW:0.05283):0.00628):0.00160):0.01694,SDYS:0.08903):0.33361):0.02786):0.16473,(LCRE:0.01409,LLAC:0.01290):0.14092):0.01001):0.02125):0.00098,(((STHE:0.01373,(SSAL:0.00831,SVES:0.01447):0.00369):0.10149,SPLU:0.08799):0.01017,(((SINF:0.01265,SLUT:0.01103):0.02565,SEQU:0.02665):0.05765,(SDEV:0.01587,SRAT:0.02611):0.06475):0.00331):0.00518,(SPYO:0.05295,(SCAN:0.03029,SDYS:0.03084):0.01604):0.06815):0.00000;
((SSAL:0.01073,(STHE:0.00574,SVES:0.00128):0.00875):0.05821,(SDEV:0.03073,SRAT:0.02422):0.04272,(((SSUI:0.08547,SPLU:0.08254):0.01417,((SINF:0.00617,SLUT:0.00937):0.00678,SEQU:0.01729):0.05456):0.00815,((LLAC:0.03294,LCRE:0.03601):0.31262,SDOW:0.08756):0.00759):0.00538):0.00000;
((SSUI:0.08552,(SDEV:0.03036,SRAT:0.01530):0.06303):0.01783,(((SPSE:0.00589,(SMIT:0.00065,SPNE:0.00306):0.00246):0.05129,SINT:0.05444):0.01055,((SANG:0.02254,SCON:0.03579):0.04883,SDOW:0.08517):0.00996):0.01631,(((((SSAL:0.01465,(STHE:0.00458,SVES:0.00794):0.00771):0.08272,(((SINF:0.00952,SLUT:0.00462):0.03920,SEQU:0.05014):0.05014,((SCAN:0.02466,SDYS:0.01951):0.04313,SPYO:0.08074):0.01275):0.01698):0.09875,(LLAC:0.02835,LCRE:0.03287):0.16068):0.24514,SPLU:0.11219):0.00763,SENT:0.13791):0.00607):0.00000;
(SRAT:0.49441,SCAN:0.04906,SDYS:0.04596):0.00000;
(SDEV:0.17189,SRAT:0.17189):0.00000;
((((SINT:0.02785,(((((STHE:0.00551,(SSAL:0.00000,SVES:0.00000):0.00022):0.01475,(SRAT:0.00064,(SDEV:0.00078,SDOW:0.00349):0.00079):0.01448):0.01151,((SPLU:0.01309,SENT:0.00537):0.01262,(SPYO:0.00756,(SCAN:0.00143,SDYS:0.00000):0.00101):0.00304):0.00220):0.00192,(SINF:0.00031,(SLUT:0.00000,SEQU:0.00143):0.00541):0.01282):0.00881,((LCRE:0.00001,LLAC:0.00430):0.06642,SSUI:0.00675):0.00823):0.00176):0.00242,(SANG:0.00000,SCON:0.00000):0.00142):0.00155,SPNE:0.00033):0.00111,SPSE:0.00866,SMIT:0.00137):0.00000;
((((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.02235,(SANG:0.00559,(SINT:0.00013,SCON:0.00250):0.00759):0.00752):0.00466,(((SSUI:0.00175,SPLU:0.00704):0.02188,SENT:0.03400):0.00938,((SINF:0.00492,(SLUT:0.00000,SEQU:0.00000):0.00034):0.02682,(SCAN:0.00025,(SPYO:0.00757,SDYS:0.00032):0.00062):0.01679):0.00525):0.01257):0.00294,((STHE:0.01451,(SSAL:0.00217,SVES:0.00135):0.00433):0.01956,((LCRE:0.00927,LLAC:0.00573):0.10411,(SDEV:0.01357,SRAT:0.00395):0.01717):0.00681):0.00507,SDOW:0.03727):0.00000;
(((LCRE:0.01485,LLAC:0.01501):0.17930,SSUI:0.08468):0.01126,(SENT:0.06697,(SPLU:0.03160,((STHE:0.02421,(SSAL:0.00111,SVES:0.00222):0.00783):0.02971,SDOW:0.06543):0.00883):0.01561):0.00836,((SPYO:0.00369,(SCAN:0.01372,SDYS:0.00292):0.00519):0.04811,((((SMIT:0.00000,SPSE:0.00000):0.00081,SPNE:0.00360):0.01915,(SANG:0.01679,(SINT:0.00000,SCON:0.00000):0.01773):0.01161):0.02968,((SINF:0.00924,(SLUT:0.00000,SEQU:0.00000):0.01637):0.03135,(SDEV:0.03593,SRAT:0.01803):0.01646):0.00928):0.01097):0.00893):0.00000;
((((STHE:0.03242,(SSAL:0.01061,SVES:0.01481):0.00480):0.08635,(((SEQU:0.02264,(SLUT:0.01300,SINF:0.01694):0.01853):0.07320,(SDEV:0.01212,SRAT:0.01666):0.06528):0.00474,SDOW:0.06843):0.01636):0.00672,(((LCRE:0.04067,LLAC:0.06179):0.13868,SENT:0.22558):0.02897,(SPYO:0.02189,(SCAN:0.00644,SDYS:0.00539):0.01048):0.10670):0.00760):0.00449,(SSUI:0.09790,SPLU:0.09967):0.00859,((SMIT:0.00081,(SPSE:0.00054,SPNE:0.00256):0.00074):0.08563,(SINT:0.03556,(SANG:0.02080,SCON:0.02137):0.02167):0.02276):0.03327):0.00000;
((((SMIT:0.00467,SPSE:0.00357):0.00179,SPNE:0.00572):0.04161,(((SINF:0.00285,SLUT:0.00244):0.00428,SEQU:0.00467):0.04752,(((SSAL:0.01952,(STHE:0.00558,SVES:0.00438):0.02003):0.00542,(SDEV:0.01270,SRAT:0.01454):0.01228):0.00949,(((SANG:0.01482,(SINT:0.00937,SCON:0.00976):0.00475):0.04275,(LCRE:0.01030,LLAC:0.00762):0.16427):0.00276,SDOW:0.05255):0.00995):0.00598):0.00223):0.00976,(SENT:0.07595,(SPYO:0.01622,(SCAN:0.00293,SDYS:0.00501):0.00760):0.03770):0.00093,(SSUI:0.00820,SPLU:0.00356):0.06161):0.00000;
((((SINF:0.01353,SLUT:0.02180):0.02002,SEQU:0.03817):0.04493,((LCRE:0.05314,LLAC:0.04916):0.34354,SRAT:0.06609):0.01402):0.00815,(SDEV:0.04392,SDOW:0.06912):0.01107,SSAL:0.07297):0.00000;
(((SDEV:0.01756,SRAT:0.03339):0.02415,(SSAL:0.04619,SDOW:0.11669):0.01326):0.01258,SEQU:0.04286,(SINF:0.01401,SLUT:0.03188):0.01896):0.00000;
((((STHE:0.01276,SINF:0.01113):0.01739,(SLUT:0.01634,SEQU:0.02469):0.00782):0.00476,(((LLAC:0.00000,LCRE:0.00000):0.08268,((SRAT:0.04182,SDEV:0.03304):0.30935,(SDYS:0.39229,(LCRE:0.25099,(SRAT:0.05101,SDOW:0.07798):0.19015):0.07437):0.03806):0.24705):0.01151,((((SMIT:0.02495,(SPSE:0.00071,SPNE:0.00196):0.02384):0.00764,(SSUI:0.02488,SENT:0.06688):0.02051):0.00720,(SPLU:0.04162,(SPYO:0.00778,(SCAN:0.00000,SDYS:0.00000):0.00156):0.03738):0.01355):0.00586,(SDEV:0.01270,SRAT:0.00858):0.02867):0.01866):0.00804):0.00307,SDOW:0.04990,((SSAL:0.00394,SVES:0.00467):0.01933,(SANG:0.00343,(SINT:0.00513,SCON:0.00216):0.00252):0.01726):0.01462):0.00000;
(SDEV:0.09476,SRAT:0.09476):0.00000;
(((SSAL:0.00000,SVES:0.00000):0.00253,(((((SANG:0.00000,(SINT:0.00000,SCON:0.00000):0.00000):0.01883,((LCRE:0.00054,LLAC:0.00317):0.24155,((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.01717,SSUI:0.02013):0.00850):0.00691):0.01432,((SPLU:0.00682,SENT:0.00802):0.00156,((SCAN:0.00115,SPYO:0.00000):0.00294,SDYS:0.00052):0.02530):0.00421):0.00350,(SDEV:0.00868,SRAT:0.00497):0.01668):0.00167,SDOW:0.02225):0.01246):0.00267,(SINF:0.00401,(SLUT:0.00035,SEQU:0.00764):0.00284):0.00153,STHE:0.00761):0.00000;
((((SPSE:0.00000,SPNE:0.00000):0.00672,((SINT:0.00763,(SDEV:0.00062,SRAT:0.00106):0.00915):0.00053,((SPLU:0.00563,((SSUI:0.00360,((LCRE:0.00254,LLAC:0.00254):0.10772,SENT:0.02633):0.00399):0.00692,(SPYO:0.00498,SDYS:0.00008):0.00489):0.00232):0.00048,(((STHE:0.00000,(SSAL:0.00000,SVES:0.00000):0.00000):0.00110,SCON:0.00058):0.00378,(SINF:0.00983,((SLUT:0.00000,SEQU:0.00000):0.00001,SDOW:0.01007):0.00025):0.00043):0.00039):0.00055):0.00031):0.00000,SCAN:0.00000):0.00000,SANG:0.00000,SMIT:0.00000):0.00000;
(((SDEV:0.06381,SRAT:0.07687):0.08627,((STHE:0.01742,(SSAL:0.00641,SVES:0.00918):0.00697):0.13880,SDOW:0.14235):0.00284):0.00186,(((SINF:0.00832,SLUT:0.00973):0.01678,SEQU:0.01977):0.10153,((SCAN:0.03775,SPYO:0.04322):0.02725,SDYS:0.06435):0.09200):0.01216,(((LLAC:0.04408,LCRE:0.04102):0.27380,(((SMIT:0.01865,(SPSE:0.01414,SPNE:0.01416):0.00714):0.11142,(SANG:0.03641,(SINT:0.02712,SCON:0.02147):0.02459):0.10404):0.02043,SSUI:0.13624):0.00635):0.01119,SPLU:0.16035):0.01092):0.00000;
((((SINF:0.00369,SLUT:0.01225):0.00858,SEQU:0.01441):0.04872,(SDEV:0.04389,SRAT:0.05121):0.03208):0.00868,((((LLAC:0.03457,LCRE:0.03329):0.11854,(SDYS:0.09492,(SPYO:0.04864,SCAN:0.05771):0.01785):0.45858):0.03932,(SSUI:0.10514,SPLU:0.12357):0.01022):0.00532,((STHE:0.02204,(SSAL:0.00714,SVES:0.00546):0.01251):0.06790,SDOW:0.11871):0.00887):0.00262,((SPSE:0.00979,(SMIT:0.00747,SPNE:0.01334):0.00117):0.10079,(SANG:0.03260,(SINT:0.01285,SCON:0.00789):0.03723):0.05639):0.00819):0.00000;
((((LCRE:0.01936,LLAC:0.01668):0.13645,((SCAN:0.06634,SPYO:0.06456):0.01320,SDYS:0.07485):0.07817):0.02225,((SANG:0.02414,(SINT:0.01381,SCON:0.01346):0.01354):0.04617,(SDEV:0.01762,SRAT:0.02291):0.05552):0.01557):0.01884,((SMIT:0.01358,(SPSE:0.01009,SPNE:0.00808):0.00205):0.02854,((((STHE:0.00523,SSAL:0.00181):0.00244,SVES:0.00763):0.01407,(SLUT:0.01164,(SINF:0.00224,SEQU:0.00432):0.00149):0.02097):0.00668,SDOW:0.05362):0.00770):0.01045,(SSUI:0.04502,SPLU:0.03654):0.00632):0.00000;
((STHE:0.02195,(SSAL:0.01674,SVES:0.01473):0.00728):0.08023,(SINT:0.02457,(SANG:0.01429,SCON:0.01323):0.01721):0.06927,(((SMIT:0.00975,SPSE:0.00807):0.00125,SPNE:0.01222):0.11627,(((((SINF:0.01390,SLUT:0.01251):0.02840,SEQU:0.03820):0.04271,SRAT:0.09288):0.01560,SDOW:0.11855):0.01174,((((LLAC:0.00496,LCRE:0.00694):0.34809,(SDYS:0.03398,(SPYO:0.02672,SCAN:0.03141):0.00952):0.16626):0.02480,SSUI:0.13496):0.01750,SPLU:0.14988):0.00780):0.01501):0.00658):0.00000;
((((((SLUT:0.01319,(SINF:0.00373,SEQU:0.00298):0.00557):0.02747,(SDEV:0.01149,SRAT:0.02182):0.02285):0.00551,(((((LLAC:0.00842,LCRE:0.01262):0.19156,SSUI:0.09187):0.01785,SENT:0.10641):0.00568,(SPLU:0.05315,((SCAN:0.01759,SPYO:0.02650):0.00454,SDYS:0.02898):0.06847):0.01510):0.01089,SDOW:0.04723):0.01439):0.01683,((SANG:0.00257,SINT:0.00754):0.01404,SCON:0.01957):0.02277):0.00647,SPNE:0.03031):0.02010,(SSAL:0.00518,SVES:0.00622):0.00197,STHE:0.00841):0.00000;
((((((LLAC:0.04512,LCRE:0.03722):0.15970,(((SSAL:0.00915,SVES:0.01040):0.07283,(SANG:0.06020,SCON:0.06412):0.01338):0.03997,(SSUI:0.10083,(SPLU:0.08265,SLUT:0.08759):0.00137):0.03307):0.15749):0.03423,SSUI:0.16201):0.00802,(SENT:0.17871,((SINF:0.00713,SLUT:0.00940):0.02398,SEQU:0.01784):0.13155):0.00799):0.00371,(((SSAL:0.00885,SVES:0.00844):0.11407,(STHE:0.10607,(SANG:0.06533,(SINT:0.01523,SCON:0.01193):0.05385):0.04286):0.01054):0.02019,((SDEV:0.05530,SRAT:0.05294):0.07563,SDOW:0.12024):0.00907):0.00484):0.00212,((SCAN:0.03579,SPYO:0.02822):0.02354,SDYS:0.05342):0.10841,SPLU:0.17048):0.00000;
(((SRAT:0.03534,SDEV:0.03257):0.15757,(((((SINF:0.01828,SLUT:0.00704):0.01571,SEQU:0.01888):0.09849,((SCAN:0.02129,SPYO:0.02091):0.01820,SDYS:0.04837):0.10756):0.05203,(SSUI:0.15403,((SPNE:0.01066,(SMIT:0.00598,SPSE:0.00263):0.00177):0.15685,(SANG:0.03336,(SINT:0.01667,SCON:0.01154):0.02987):0.11243):0.00534):0.02506):0.01188,(SENT:0.24591,SPLU:0.18862):0.01907):0.01101):0.00773,(SDOW:0.19254,(STHE:0.03583,(SSAL:0.01311,SVES:0.01749):0.01245):0.14076):0.00632,(LLAC:0.03122,LCRE:0.02898):0.28017):0.00000;
(((SPLU:0.08032,(((SINF:0.00252,SLUT:0.01265):0.01351,SEQU:0.00746):0.05688,(SDEV:0.03099,SRAT:0.03246):0.04637):0.00680):0.00443,((STHE:0.01618,(SSAL:0.00216,SVES:0.00331):0.00538):0.06592,SDOW:0.11075):0.00961):0.00888,(SENT:0.13351,(SCAN:0.02732,(SPYO:0.02779,SDYS:0.02918):0.01029):0.09873):0.00157,(((SMIT:0.00581,(SPSE:0.00474,SPNE:0.00863):0.00119):0.05589,(SINT:0.02924,(SANG:0.00544,SCON:0.00248):0.01861):0.02911):0.05122,SSUI:0.10382):0.08362):0.00000;
(((SDEV:0.01093,SRAT:0.01845):0.07118,((((LCRE:0.01720,LLAC:0.01713):0.12659,SPLU:0.07883):0.01564,((SCAN:0.01872,SPYO:0.02937):0.00553,SDYS:0.02574):0.07973):0.01150,(SENT:0.08404,(((SINF:0.01235,SLUT:0.01696):0.02273,SEQU:0.02413):0.04479,((SSAL:0.00774,(STHE:0.01658,SVES:0.01028):0.00264):0.05363,SDOW:0.07021):0.01032):0.00470):0.01420):0.01425):0.00234,SSUI:0.07223,((SPSE:0.00939,(SMIT:0.00513,SPNE:0.00910):0.00126):0.04850,(SINT:0.03334,(SANG:0.01057,SCON:0.01015):0.01755):0.04559):0.00831):0.00000;
((SRAT:0.15647,SEQU:0.19940):0.34551,LCRE:0.02470,LLAC:0.03718):0.00000;
(SDEV:0.14595,SRAT:0.14595):0.00000;
(((SMIT:0.00309,SPSE:0.00384):0.00566,SPNE:0.00949):0.06040,((SINT:0.00816,(SANG:0.00357,SCON:0.01078):0.00027):0.06198,(SENT:0.08988,((SRAT:0.00699,SDEV:0.00554):0.06489,(SPYO:0.01661,(SCAN:0.00396,SDYS:0.00358):0.00656):0.04039):0.01303):0.00400):0.00354,(((LLAC:0.00298,LCRE:0.00459):0.18378,(SSUI:0.07013,SPLU:0.11180):0.02703):0.00976,((SDOW:0.14947,(STHE:0.02906,(SSAL:0.02114,SVES:0.01276):0.00337):0.06473):0.01156,(SINF:0.01811,(SLUT:0.00471,SEQU:0.00716):0.00596):0.06062):0.03114):0.01033):0.00000;
((SDEV:0.03953,SRAT:0.04450):0.17089,(((STHE:0.05290,(SSAL:0.00069,SVES:0.00159):0.03739):0.15553,((SEQU:0.08199,(SINF:0.01359,SLUT:0.01338):0.06945):0.07106,((SCAN:0.03071,SPYO:0.03276):0.03795,SDYS:0.06901):0.13267):0.01574):0.00984,SDOW:0.19122):0.00757,((((LLAC:0.04073,LCRE:0.04735):0.26014,SSUI:0.26380):0.01338,((SPSE:0.03168,(SMIT:0.01906,SPNE:0.01609):0.01646):0.17641,((SANG:0.02985,SINT:0.01937):0.00369,SCON:0.02700):0.14355):0.04728):0.00839,(SPLU:0.18525,SENT:0.22381):0.06823):0.02214):0.00000;
((((SPLU:0.10419,SSUI:0.18855):0.01372,(((STHE:0.02144,(SSAL:0.01780,SVES:0.02421):0.00803):0.14757,(((SINF:0.00046,SLUT:0.01275):0.02010,SEQU:0.02395):0.08435,((SDYS:0.04606,SCAN:0.02643):0.03508,SPYO:0.05874):0.09295):0.01495):0.02026,(SDEV:0.04704,SRAT:0.05186):0.08364):0.00841):0.00841,((LLAC:0.03281,LCRE:0.03246):0.22103,SDOW:0.16378):0.01322):0.00298,SENT:0.26251,((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.11451,(SANG:0.05675,(SCON:0.00493,SINT:0.01847):0.03910):0.06981):0.05167):0.00000;
(SDEV:0.22346,SRAT:0.22346):0.00000;
(SRAT:0.24494,SDEV:0.24349,SCON:0.25165):0.00000;
(((SDEV:0.03266,SRAT:0.03270):0.07532,SDOW:0.13287):0.00956,(SPSE:0.00750,SPNE:0.00653):0.15274,(LCRE:0.08837,LLAC:0.09149):0.16847):0.00000;
((((((((((((SMIT:0.00736,SPSE:0.00497):0.00079,SPNE:0.00448):0.02301,(SINT:0.01371,(SANG:0.01000,SCON:0.01072):0.00128):0.01716):0.00735,(SSUI:0.00278,SPLU:0.00234):0.03526):0.00428,(((SINF:0.00196,SLUT:0.00373):0.00484,SEQU:0.00625):0.02858,(SDEV:0.00921,SRAT:0.01154):0.02656):0.00717):0.00459,SDOW:0.04578):0.00155,((STHE:0.00852,(SSAL:0.00617,SVES:0.00612):0.00167):0.03718,((SCAN:0.00617,SPYO:0.00917):0.00050,SDYS:0.00657):0.04346):0.00474):0.00960,SENT:0.05865):0.01880,(LCRE:0.00791,LLAC:0.00387):0.06077):0.32267,(LCRE:0.00516,LLAC:0.00409):0.06911):0.01963,(SDOW:0.04521,(SDEV:0.00669,SRAT:0.00892):0.03287):0.00464):0.00202,((((SMIT:0.00455,(SPSE:0.00211,SPNE:0.00119):0.00235):0.03020,(SANG:0.00278,(SINT:0.00240,SCON:0.00182):0.00550):0.02533):0.00250,SSUI:0.04192):0.01103,((SPLU:0.03607,SENT:0.04973):0.00919,(SPYO:0.01737,(SCAN:0.01016,SDYS:0.00916):0.00283):0.03878):0.00147):0.00095,((STHE:0.01735,(SSAL:0.00222,SVES:0.00379):0.00393):0.02710,((SINF:0.00104,SLUT:0.00316):0.00396,SEQU:0.00294):0.03529):0.01057):0.00000;
(((((STHE:0.00049,SSAL:0.00047):0.00418,SVES:0.00917):0.02947,SDOW:0.04228):0.02762,(SENT:0.11101,(SSUI:0.08211,(((SMIT:0.03460,(SPSE:0.00010,SPNE:0.00559):0.02127):0.06117,SANG:0.05714):0.03932,(SPLU:0.15921,(((LLAC:0.00877,LCRE:0.00812):0.19072,((SPLU:0.13506,(((((SCAN:0.01845,SPYO:0.02034):0.00910,SDYS:0.02162):0.05599,((SINF:0.00697,(SLUT:0.00365,SEQU:0.00498):0.00512):0.04471,(SDEV:0.00857,SRAT:0.01143):0.04735):0.02590):0.02331,SDOW:0.10439):0.01425,(STHE:0.00190,(SSAL:0.00000,SVES:0.00000):0.00247):0.09855):0.01309):0.01990,(SSUI:0.11090,((SMIT:0.00280,SPSE:0.00245):0.00538,SPNE:0.00944):0.08788):0.02739):0.05350):0.13807,(((((SDYS:0.14425,(SPLU:0.13145,(SDOW:0.09692,((STHE:0.00952,(SSAL:0.00508,(SSAL:0.00000,SVES:0.00000):0.00417):0.00251):0.09467,(((SINF:0.00248,SLUT:0.00410):0.01684,SEQU:0.01517):0.05842,(SDEV:0.01023,SRAT:0.01576):0.06141):0.01300):0.01369):0.02293):0.01260):0.01484,((SPSE:0.00926,(SMIT:0.01095,SPNE:0.00769):0.00100):0.11493,SSUI:0.13106):0.02775):0.22149,(SPLU:0.18157,(((SMIT:0.00168,SPNE:0.00095):0.13255,SSUI:0.12223):0.04551,(SDYS:0.15026,(((STHE:0.01389,(SSAL:0.00224,(SSAL:0.00000,SVES:0.00000):0.00201):0.01163):0.07287,SDOW:0.10523):0.00601,((SDEV:0.00731,SRAT:0.01056):0.05277,(SINF:0.01294,(SEQU:0.01076,SLUT:0.01206):0.00102):0.04873):0.01813):0.06697):0.01609):0.02355):0.19931):0.01284,(SSUI:0.32195,(((SSAL:0.11393,SRAT:0.12368):0.02165,(SCAN:0.02820,(SPYO:0.01254,SDYS:0.01882):0.01494):0.11521):0.08628,((SSUI:0.03332,SPLU:0.03709):0.07134,SENT:0.11090):0.11937):0.11425):0.02174):0.00595,(((SINF:0.04449,(SEQU:0.00544,SLUT:0.00531):0.04117):0.05811,(SPSE:0.10250,(SDEV:0.04113,(SDOW:0.04287,SRAT:0.04031):0.00276):0.03882):0.02000):0.27979,((SINF:0.06630,(SLUT:0.01898,SEQU:0.01148):0.04833):0.08753,(SPSE:0.16020,(SDOW:0.07194,(SDEV:0.05078,SRAT:0.04854):0.02138):0.07609):0.01206):0.21902):0.02253):0.03390):0.18886):0.02299):0.01429):0.00945):0.01367):0.00509,(SDEV:0.00441,SRAT:0.00704):0.03988,(((SINF:0.00603,SLUT:0.00438):0.00643,SEQU:0.01483):0.04450,(SCAN:0.01768,(SPYO:0.01404,SDYS:0.00204):0.00836):0.04850):0.00719):0.00000;
(((((SSAL:0.04710,(STHE:0.03916,SVES:0.04391):0.01081):0.13374,(SRAT:0.01179,SDEV:0.01380):0.15368):0.02013,SDOW:0.21973):0.01171,(((SINF:0.01390,SLUT:0.01328):0.04330,SEQU:0.06534):0.10192,(SPYO:0.17623,(SCAN:0.08752,SDYS:0.08601):0.05774):0.04811):0.03432):0.00467,((SSUI:0.26239,((SMIT:0.10032,(SPSE:0.07047,SPNE:0.07038):0.03574):0.05027,(SANG:0.02751,(SCON:0.01378,SINT:0.02010):0.00524):0.12092):0.10822):0.04572,((LLAC:0.02606,LCRE:0.03116):0.38284,SENT:0.31018):0.03231):0.02896,SPLU:0.21932):0.00000;
(((((SPNE:0.01051,(SPSE:0.00600,SMIT:0.00628):0.00177):0.11306,(SINT:0.05064,(SCON:0.03755,SANG:0.02512):0.00979):0.08661):0.01489,SSUI:0.14790):0.01145,(((SEQU:0.02814,(SLUT:0.01523,SINF:0.01323):0.01252):0.08489,((SSAL:0.03124,(SVES:0.00785,STHE:0.01133):0.02522):0.06848,(SDEV:0.04249,SRAT:0.04354):0.07669):0.00745):0.00674,(SPLU:0.13985,SDOW:0.11336):0.00359):0.00888):0.00214,((SCAN:0.02345,SPYO:0.02149):0.05976,SDYS:0.08010):0.08118,SENT:0.20007):0.00000;
((SRAT:0.06291,SDEV:0.06583):0.18301,SPLU:0.14377,SDEV:0.23762):0.00000;
(SDEV:0.05205,SRAT:0.05205):0.00000;
(SRAT:0.06928,(SSUI:0.31163,(SINF:0.03118,(SLUT:0.00677,SEQU:0.00353):0.03172):0.03035):0.00275,((SMIT:0.00811,SPNE:0.00692):0.07087,SPLU:0.06841):0.00623):0.00000;
(((LLAC:0.03122,LCRE:0.03550):0.20638,SRAT:0.06476):0.05216,(SEQU:0.01778,SLUT:0.01598):0.01502,SINF:0.02411):0.00000;
((((SDEV:0.00378,SRAT:0.00378):0.01126,(((SLUT:0.00243,(SINF:0.00000,SEQU:0.00000):0.00134):0.02078,((SPLU:0.01342,SENT:0.03557):0.01205,((STHE:0.01396,(SSAL:0.00000,SVES:0.00000):0.00241):0.01217,(SCAN:0.01077,(SPYO:0.00229,SDYS:0.00398):0.00869):0.01105):0.01015):0.00604):0.00382,SDOW:0.02982):0.00068):0.01143,((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.01609,((LCRE:0.00000,LLAC:0.00000):0.06924,SSUI:0.01925):0.00652):0.00198):0.00590,(SINT:0.00000,SCON:0.00000):0.00000,SANG:0.00000):0.00000;
((((SINF:0.00012,SLUT:0.00235):0.00652,SEQU:0.00770):0.03531,(SDEV:0.02689,SRAT:0.01225):0.03911):0.00580,(SENT:0.07432,(((STHE:0.02075,(SSAL:0.00629,SVES:0.01079):0.00705):0.04730,(((SPSE:0.01721,(SMIT:0.01031,SPNE:0.00876):0.00493):0.05732,((SANG:0.00415,SINT:0.00812):0.00533,SCON:0.00818):0.04148):0.01461,SSUI:0.08661):0.01828):0.00574,((LCRE:0.00475,LLAC:0.00623):0.27118,SDOW:0.07564):0.01582):0.00752):0.00875,(SPLU:0.05200,(SPYO:0.01526,(SCAN:0.01251,SDYS:0.01591):0.00483):0.03113):0.00282):0.00000;
(SRAT:0.26241,SDOW:0.21554,SDEV:0.27237):0.00000;
(((SANG:0.02086,(SINT:0.00160,SCON:0.00613):0.02532):0.09252,(SRAT:0.01382,SDEV:0.00644):0.06068):0.03274,(SPLU:0.23158,(SCAN:0.01574,SPYO:0.01633):0.11802):0.01219,(SPNE:0.00316,SMIT:0.00685):0.12247):0.00000;
(((SSAL:0.07396,SVES:0.07787):0.30578,(SRAT:0.07523,SDEV:0.08123):0.27269):0.01502,(SSAL:0.07498,SVES:0.06497):0.22271,(SDOW:0.23407,SDOW:0.23452):0.08380):0.00000;
(SRAT:0.34039,SDOW:0.11626,SINT:0.11742):0.00000;
((SRAT:0.22715,(SDOW:0.25920,SDEV:0.22336):0.22031):0.09203,SINF:0.16760,SDOW:0.15745):0.00000;
(((SSAL:0.00207,(SINF:0.00000,(SLUT:0.00000,SEQU:0.00000):0.00000):0.00446):0.00306,(SPLU:0.00893,((SDEV:0.00000,SRAT:0.00000):0.00292,SDOW:0.01661):0.00300):0.00344):0.00084,(SPYO:0.00474,(SENT:0.03451,(SCAN:0.00000,SDYS:0.00000):0.00012):0.01259):0.00988,(SVES:0.00374,(((LCRE:0.00000,LLAC:0.00000):0.11574,STHE:0.00382):0.00981,((SANG:0.01422,(SMIT:0.00000,(SPSE:0.00000,(SPNE:0.00000,(SINT:0.00000,SCON:0.00000):0.00000):0.00000):0.00000):0.00103):0.02526,SSUI:0.02447):0.01141):0.00198):0.00164):0.00000;
(((((((SMIT:0.00673,(SPSE:0.00000,SPNE:0.00000):0.01198):0.06036,((SANG:0.01640,SINT:0.01957):0.00665,SCON:0.03004):0.02581):0.01135,(SSUI:0.05562,SENT:0.08703):0.01456):0.00758,((SDEV:0.02440,SRAT:0.03059):0.01734,SDOW:0.04896):0.01883):0.00862,(SPYO:0.08237,(SCAN:0.02678,SDYS:0.01626):0.00974):0.03328):0.00450,((STHE:0.02037,(SSAL:0.00555,SVES:0.00596):0.00979):0.01079,(SINF:0.02271,(SLUT:0.02660,SEQU:0.01495):0.00597):0.01034):0.01942):0.00191,SPLU:0.04989,(LCRE:0.00738,LLAC:0.00533):0.32897):0.00000;
((SSUI:0.23223,SRAT:0.30009):0.02493,(SDOW:0.11281,(SPSE:0.00228,SPNE:0.00333):0.12015):0.11506,(SPSE:0.02103,SMIT:0.01595):0.17729):0.00000;
((SPLU:0.07348,((((SANG:0.00582,(SINT:0.02142,SCON:0.00008):0.01302):0.00533,((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.01027,SSUI:0.01432):0.00365):0.01554,(SINF:0.00000,(SLUT:0.00000,SEQU:0.00000):0.00000):0.01896):0.00563,(SENT:0.01910,(SDEV:0.00715,SRAT:0.00800):0.04786):0.01422):0.00496):0.00371,((SCAN:0.00000,(SPYO:0.00000,SDYS:0.00000):0.00000):0.01509,SDOW:0.02090):0.00272,((LCRE:0.01399,LLAC:0.00787):0.14735,(STHE:0.01713,(SSAL:0.00998,SVES:0.00077):0.00979):0.05098):0.01628):0.00000;
(((((((SMIT:0.02100,SPSE:0.02557):0.00384,SPNE:0.02559):0.08851,SINT:0.12703):0.01469,(SANG:0.03243,SCON:0.04033):0.09371):0.01477,((SSUI:0.02967,SPLU:0.01996):0.10103,(SENT:0.15293,(LCRE:0.05256,LLAC:0.05775):0.24827):0.01550):0.02055):0.01408,SDOW:0.14479):0.01238,((SSAL:0.02461,(STHE:0.04008,SVES:0.03826):0.00380):0.06861,(SCAN:0.04630,(SPYO:0.03444,SDYS:0.02603):0.01033):0.09831):0.00610,((SINF:0.02476,(SLUT:0.00880,SEQU:0.00175):0.01800):0.10510,(SDEV:0.06385,SRAT:0.07774):0.04999):0.00989):0.00000;
((((SEQU:0.08843,(SINF:0.01517,SLUT:0.01201):0.06306):0.25602,(SSUI:0.39314,(LLAC:0.02433,LCRE:0.02200):0.35111):0.01103):0.01276,(SENT:0.43789,SDOW:0.32379):0.03545):0.00354,(SRAT:0.03324,SDEV:0.02854):0.26357,((SSAL:0.09539,(STHE:0.05935,SVES:0.03066):0.06152):0.26795,((SMIT:0.04400,(SPSE:0.00193,SPNE:0.00406):0.04708):0.26340,((SANG:0.05481,SINT:0.07933):0.01009,SCON:0.06582):0.16863):0.04554):0.01328):0.00000;
(SDOW:0.21688,SDOW:0.21688):0.00000;
(SDOW:0.36113,SINF:0.09240,SLUT:0.10626):0.00000;
((SDOW:0.08068,(((LLAC:0.03534,LCRE:0.04132):0.26416,(SMIT:0.01425,(SPSE:0.00838,SPNE:0.01183):0.00875):0.11152):0.01211,(SDEV:0.04625,SRAT:0.04770):0.04810):0.02938):0.00366,(SINF:0.04381,SEQU:0.04084):0.03498,(STHE:0.01168,(SSAL:0.00627,SVES:0.00799):0.00194):0.06252):0.00000;
(SRAT:0.08145,SDOW:0.08145):0.00000;
((SDOW:0.23512,(LLAC:0.03479,LCRE:0.02793):0.27454):0.18397,SDEV:0.04880,SRAT:0.06173):0.00000;
((SDOW:0.05401,((((LCRE:0.01010,LLAC:0.01050):0.11482,(SINT:0.01615,(SANG:0.00621,SCON:0.00439):0.00803):0.05921):0.01715,SSUI:0.07287):0.01040,((SMIT:0.00268,(SPSE:0.00058,SPNE:0.00008):0.00061):0.04917,(SDEV:0.01207,SRAT:0.00558):0.06066):0.00911):0.00482):0.00358,(SENT:0.05388,((SSAL:0.00704,(STHE:0.00673,SVES:0.00257):0.00227):0.02883,(SPLU:0.02858,((SCAN:0.00308,SPYO:0.00872):0.01258,SDYS:0.00744):0.02894):0.00959):0.00673):0.00648,((SINF:0.00253,SLUT:0.00408):0.00690,SEQU:0.02616):0.01909):0.00000;
(SINT:0.13640,SDOW:0.13640):0.00000;
((((SANG:0.01071,(SINT:0.01086,SCON:0.00687):0.00420):0.05823,((SPSE:0.00772,SPNE:0.00661):0.00090,SMIT:0.00749):0.08411):0.02344,((LLAC:0.00671,LCRE:0.00729):0.16940,((SSAL:0.00203,SVES:0.00324):0.09765,(SDOW:0.11449,((SLUT:0.01037,SEQU:0.00970):0.00297,SINF:0.01127):0.06741):0.02241):0.00718):0.00398):0.00346,((SSUI:0.02823,SPLU:0.04900):0.04486,SENT:0.09699):0.01881,((SCAN:0.01949,(SPYO:0.01242,SDYS:0.00820):0.00988):0.07598,(SDEV:0.01967,SRAT:0.01512):0.05503):0.00995):0.00000;
(SDOW:0.40037,SDOW:0.16072,(SDEV:0.06375,SRAT:0.06046):0.06300):0.00000;
((SENT:0.15177,SDOW:0.14788):0.00511,((((SSAL:0.02039,(STHE:0.02120,SVES:0.01845):0.00305):0.10683,SPLU:0.09866):0.02632,(((SDEV:0.07434,SRAT:0.09213):0.02345,((SINF:0.01697,SLUT:0.01940):0.02874,SEQU:0.05947):0.03690):0.00457,((SCAN:0.02541,SPYO:0.02537):0.01841,SDYS:0.04805):0.07048):0.01555):0.01562,((SMIT:0.02821,(SPSE:0.01304,SPNE:0.02572):0.01053):0.09896,(SANG:0.05930,(SINT:0.02496,SCON:0.02127):0.02280):0.08969):0.02381):0.00358,(SSUI:0.27014,(LCRE:0.04534,LLAC:0.05324):0.27289):0.21081):0.00000;
((SSAL:0.00233,((SPSE:0.04339,(((SINF:0.01151,(SLUT:0.00212,SEQU:0.00150):0.01407):0.02950,((SLUT:0.09113,((((LCRE:0.00000,LLAC:0.00000):0.09598,(SANG:0.00237,(SINT:0.00281,SCON:0.00264):0.00127):0.05052):0.00860,(SENT:0.06336,(SSUI:0.06909,(SPLU:0.03588,(SCAN:0.00427,(SPYO:0.00305,SDYS:0.00240):0.00209):0.01898):0.01415):0.00188):0.03214):0.00413,(((LLAC:0.02098,LCRE:0.02708):0.24698,((SDOW:0.28985,(((SPLU:0.11152,(SANG:0.07859,((SINF:0.00877,SLUT:0.00809):0.00932,SEQU:0.01727):0.05521):0.02841):0.05781,SDEV:0.16266):0.02252,(STHE:0.04809,(SSAL:0.01859,SVES:0.02179):0.02612):0.15947):0.07631):0.01454,(LLAC:0.05074,LCRE:0.04249):0.23799):0.10867):0.04073,(LLAC:0.01159,LCRE:0.01250):0.23070):0.17839):0.00950):0.01935,SDEV:0.04631):0.01064):0.00132,SDOW:0.04468):0.01732):0.00809,(SMIT:0.00406,SPNE:0.00199):0.00943):0.01514):0.00190,SVES:0.00249,STHE:0.01865):0.00000;
(((LCRE:0.04352,LLAC:0.03854):0.16911,((SSUI:0.15163,SPLU:0.22396):0.01001,((SENT:0.14274,((STHE:0.01068,(SVES:0.00286,SSAL:0.00181):0.00568):0.19870,SDOW:0.17810):0.00975):0.02623,((SPYO:0.04839,(SCAN:0.04055,SDYS:0.04053):0.00375):0.07975,((SINF:0.01662,SLUT:0.01400):0.03826,SEQU:0.03964):0.08623):0.01012):0.00397):0.01030):0.00543,((SMIT:0.00161,(SPSE:0.00000,SPNE:0.00000):0.00190):0.11082,((SINT:0.01497,SANG:0.01883):0.00596,SCON:0.02708):0.08222):0.03683,(SRAT:0.04586,SDEV:0.02748):0.12544):0.00000;
((((SANG:0.02955,(SINT:0.01152,SCON:0.00990):0.02029):0.07134,(LCRE:0.39762,SDOW:0.24008):0.17306):0.11029,(SVES:0.00453,SSAL:0.01579):0.00685):0.00449,SINF:0.01848,STHE:0.01285):0.00000;
(SDOW:0.11791,((SPYO:0.02930,(SCAN:0.01117,SDYS:0.00680):0.02087):0.07873,SENT:0.12298):0.02003,((LCRE:0.01306,LLAC:0.03070):0.20972,((SDEV:0.01087,SDEV:0.01501):0.01095,SRAT:0.04286):0.08227):0.00505):0.00000;
(((((STHE:0.01257,(SSAL:0.00087,SVES:0.00357):0.00406):0.01141,SPYO:0.01891):0.00484,((SINF:0.00709,(SLUT:0.00933,SEQU:0.00507):0.00287):0.01841,SDOW:0.02147):0.00499):0.00255,(SDEV:0.01345,SRAT:0.01426):0.01268):0.00155,(SENT:0.03894,(SCAN:0.01180,SDYS:0.01315):0.01414):0.00387,((((LCRE:0.00974,LLAC:0.00779):0.16243,(SENT:0.09046,((((SPSE:0.00469,(SMIT:0.00731,SPNE:0.00608):0.00067):0.03640,(SINT:0.02187,(SANG:0.01456,SCON:0.01752):0.00524):0.02184):0.00282,SSUI:0.05495):0.02557,((SDEV:0.00883,SRAT:0.01308):0.05075,(((SPLU:0.04255,((STHE:0.00237,(SSAL:0.00123,SVES:0.00090):0.00189):0.02875,((SINF:0.00181,SLUT:0.00194):0.00278,SEQU:0.00204):0.02669):0.00025):0.00424,SDOW:0.03315):0.01228,(SPYO:0.05066,(SDYS:0.01913,SCAN:0.01104):0.03795):0.00398):0.00447):0.01804):0.00674):0.06812):0.42971,(LCRE:0.00126,LLAC:0.00097):0.09675):0.07306,((((SMIT:0.00444,SPSE:0.00166):0.00218,SPNE:0.01000):0.00953,(SANG:0.00750,(SINT:0.00820,SCON:0.00949):0.00385):0.01248):0.00371,(SSUI:0.01404,SPLU:0.01699):0.00585):0.01395):0.00196):0.00000;
(SDEV:0.10795,SRAT:0.13798,SDOW:0.43639):0.00000;
((SENT:0.11798,SDOW:0.07592):0.00987,SDEV:0.09938,(((SINF:0.00791,SLUT:0.00610):0.01163,SEQU:0.01576):0.07360,((STHE:0.09579,(SSAL:0.01361,SVES:0.02324):0.04059):0.03137,(((LLAC:0.10084,(LCRE:0.14898,LCRE:0.14180):0.00109):0.06830,((((SPLU:0.12379,SENT:0.13798):0.02553,(SDEV:0.02753,SRAT:0.03562):0.10687):0.15569,((LLAC:0.02071,LCRE:0.02258):0.20783,SRAT:0.26132):0.16043):0.09925,((SSUI:0.06416,SPLU:0.06535):0.06861,((SANG:0.05944,(SINT:0.02620,SCON:0.03125):0.01567):0.07105,(SPSE:0.04706,(SPNE:0.02213,SMIT:0.02346):0.01197):0.15698):0.01717):0.04376):0.01711):0.03073,(SPYO:0.05889,(SCAN:0.03695,SDYS:0.06255):0.00288):0.12531):0.02594):0.00376):0.00349):0.00000;
(SDOW:0.34751,SDOW:0.34751):0.00000;
(SRAT:0.30210,SDOW:0.30210):0.00000;
((SDOW:0.23053,((SRAT:0.03716,SDEV:0.04477):0.20749,(((SPYO:0.05914,(SCAN:0.03536,SDYS:0.03385):0.03069):0.10165,((SINF:0.00739,SLUT:0.00549):0.04876,SEQU:0.04728):0.10651):0.02914,SPLU:0.25302):0.02461):0.03242):0.00899,SSUI:0.28453,((LLAC:0.05890,LCRE:0.05365):0.25276,(SSAL:0.03830,(SVES:0.01691,STHE:0.02582):0.02172):0.27159):0.01652):0.00000;
(SSAL:0.28333,SDOW:0.28333):0.00000;
((SSAL:0.20696,(SDOW:0.21335,SEQU:0.46637):0.02152):0.03988,(SRAT:0.13131,SANG:0.10215):0.01255,SDEV:0.10649):0.00000;
(SENT:0.12808,(((LLAC:0.01574,LCRE:0.01407):0.42988,((SVES:0.03053,SSAL:0.03047):0.07884,((SMIT:0.02227,(SPSE:0.01107,SPNE:0.01109):0.00812):0.06582,((SANG:0.00743,SCON:0.00339):0.02130,SINT:0.02761):0.05658):0.03825):0.07023):0.03044,((SCAN:0.03484,SDYS:0.03769):0.07373,(SDEV:0.01602,SRAT:0.01567):0.07112):0.04547):0.01296,(SPLU:0.10045,SDOW:0.11347):0.02576):0.00000;
(SDOW:0.26293,SSUI:0.37357,(SVES:0.05018,SSAL:0.07851):0.23628):0.00000;
(SDOW:0.15840,(SINF:0.02173,SEQU:0.00687):0.10295,(SVES:0.00598,SSAL:0.00624):0.17058):0.00000;
(SDOW:0.21194,(SDEV:0.07138,SRAT:0.07068):0.07795,SSAL:0.18668):0.00000;
(SRAT:0.24890,SDOW:0.24890):0.00000;
(SENT:0.31121,SDOW:0.31121):0.00000;
((SDOW:0.05261,((STHE:0.00707,(SSAL:0.00381,SVES:0.00696):0.00078):0.03425,(SDEV:0.01040,SRAT:0.02280):0.01767):0.00313):0.00210,((((SLUT:0.01979,(SEQU:0.00994,SINF:0.01682):0.00916):0.44042,(LCRE:0.00842,LLAC:0.00392):0.11105):0.03696,SENT:0.05609):0.00541,(((((SMIT:0.00191,SPSE:0.00058):0.00336,SPNE:0.01321):0.02168,(SINT:0.00522,(SANG:0.00000,SCON:0.00000):0.00306):0.01599):0.01653,SSUI:0.03746):0.02483,(SPYO:0.02597,(SPLU:0.02604,(SCAN:0.00670,SDYS:0.00243):0.02253):0.00955):0.01661):0.00765):0.00514,(SINF:0.01073,(SLUT:0.00741,SEQU:0.00165):0.00206):0.02764):0.00000;
(((SDOW:0.04879,((SPLU:0.02857,(SCAN:0.01160,(SPYO:0.00251,SDYS:0.00321):0.00616):0.02719):0.01266,(((SINF:0.00552,SLUT:0.00668):0.00174,SEQU:0.00942):0.03960,((SSUI:0.03721,SENT:0.06557):0.00417,((LCRE:0.00938,LLAC:0.00899):0.12695,((SINT:0.01628,(SANG:0.00833,SCON:0.00674):0.01634):0.01034,(SDEV:0.01238,SRAT:0.01215):0.03279):0.03959):0.02525):0.01200):0.00886):0.01298):0.00731,(SPSE:0.00555,(SMIT:0.00188,SPNE:0.00381):0.00055):0.02147):0.01089,(SSAL:0.00135,SVES:0.00354):0.00237,STHE:0.00576):0.00000;
((SSUI:0.08656,(SPLU:0.06073,SDOW:0.06318):0.00390):0.00727,(((STHE:0.07006,(SSAL:0.00366,SVES:0.00984):0.05990):0.10671,((SMIT:0.01721,(SPSE:0.00891,SPNE:0.00580):0.01449):0.11012,((((LCRE:0.02009,LLAC:0.02312):0.03446,(LCRE:0.00933,LLAC:0.01009):0.05065):0.06739,SSUI:0.09080):0.00921,(((STHE:0.02460,(SSAL:0.00411,SVES:0.00149):0.01797):0.04478,SDOW:0.07391):0.00450,(SPLU:0.07811,(((SPSE:0.02273,(SMIT:0.00690,SPNE:0.00607):0.00772):0.05509,(SANG:0.00960,(SINT:0.00663,SCON:0.00630):0.00558):0.05218):0.02010,(((SINF:0.00601,SLUT:0.00240):0.01034,SEQU:0.01488):0.03045,(SDEV:0.02428,SRAT:0.02496):0.02061):0.01207):0.00462):0.00732):0.01109):0.01778):0.01120):0.00967,(SDEV:0.03490,SRAT:0.02649):0.07671):0.00418,((SINF:0.00719,SLUT:0.00427):0.01893,SEQU:0.02064):0.04505):0.00000;
(SDOW:0.64619,SDEV:0.00000,SRAT:0.00000):0.00000;
(((SDOW:0.04563,(((((SPSE:0.00114,(SMIT:0.00000,SPNE:0.00000):0.00065):0.03013,(SINT:0.02243,(SANG:0.01192,SCON:0.01197):0.00438):0.01751):0.00452,SSUI:0.02403):0.01075,((SCAN:0.00651,SPYO:0.00206):0.00247,SDYS:0.00520):0.03054):0.00332,((LCRE:0.00328,LLAC:0.00397):0.12324,(SDEV:0.01663,SRAT:0.01901):0.02386):0.00452):0.00460):0.00383,(SPLU:0.01939,SENT:0.02786):0.00458):0.00135,(STHE:0.00829,(SSAL:0.00114,SVES:0.00247):0.00141):0.02406,((SLUT:0.00333,SEQU:0.00253):0.00093,SINF:0.00133):0.02258):0.00000;
((SRAT:0.04547,(SSAL:0.04129,(SSUI:0.11206,(SANG:0.17309,(SENT:0.29275,SDOW:0.33896):0.06805):0.03477):0.06921):0.02630):0.02057,SPNE:0.00000,SPSE:0.00943):0.00000;
(((((SPYO:0.17018,(SCAN:0.10988,SDYS:0.12206):0.04719):0.05165,(SPLU:0.16682,SENT:0.17919):0.01185):0.03751,((SLUT:0.08159,SEQU:0.07942):0.06291,SINF:0.11358):0.04664):0.01618,(SDOW:0.18726,(SSAL:0.05186,(SVES:0.01934,STHE:0.02202):0.03351):0.14242):0.00472):0.00201,((((SPSE:0.03248,SPNE:0.03722):0.00565,SMIT:0.03116):0.19112,(SANG:0.08789,(SINT:0.04422,SCON:0.02783):0.05606):0.07578):0.02091,(SDEV:0.07304,SRAT:0.07925):0.08651):0.01913,(LLAC:0.07274,LCRE:0.08013):0.23167):0.00000;
((SSAL:0.06508,SVES:0.06276):0.30991,SDOW:0.22813,SDEV:0.18902):0.00000;
((((STHE:0.00822,(SSAL:0.00180,SVES:0.00512):0.00542):0.01404,(SMIT:0.01114,(SPSE:0.01305,SPNE:0.00725):0.00492):0.02146):0.02449,((SCAN:0.00736,(SPYO:0.00414,SDYS:0.00400):0.00118):0.03652,SDOW:0.05487):0.01169):0.00483,(SSUI:0.04786,((SINF:0.00595,(SLUT:0.00825,SEQU:0.00428):0.00174):0.04998,(SENT:0.10609,((LCRE:0.01053,LLAC:0.00620):0.15556,((SINT:0.02619,(SANG:0.01641,SCON:0.01596):0.02336):0.02706,(SDEV:0.04090,SRAT:0.03441):0.02927):0.01044):0.01445):0.00835):0.00582):0.01209,SPLU:0.05145):0.00000;
((((LLAC:0.00000,LCRE:0.00000):0.43378,(SPLU:0.28115,SENT:0.27736):0.02066):0.01384,SDOW:0.22053):0.01855,((((SMIT:0.00396,(SPSE:0.00294,SPNE:0.00447):0.00160):0.11796,(SINT:0.00842,(SANG:0.00000,SCON:0.00000):0.00437):0.12032):0.05246,((SINF:0.00293,(SLUT:0.00000,SEQU:0.00000):0.00612):0.08848,(SCAN:0.02173,(SPYO:0.02621,SDYS:0.00766):0.00599):0.08500):0.05153):0.01754,(SRAT:0.02682,SDEV:0.01919):0.15294):0.00468,((STHE:0.00809,(SSAL:0.00000,SVES:0.00000):0.00807):0.22942,SSUI:0.16614):0.00846):0.00000;
((((SRAT:0.03658,SDEV:0.02881):0.15797,SDOW:0.18758):0.01334,(((SINF:0.02157,SLUT:0.02108):0.02116,SEQU:0.04118):0.15827,((SDYS:0.07061,SCAN:0.07129):0.03354,SPYO:0.12324):0.09616):0.01358):0.00118,(SENT:0.23973,((STHE:0.04542,(SSAL:0.02089,SVES:0.03056):0.01198):0.21213,((LLAC:0.05867,LCRE:0.04369):0.25456,((((SANG:0.03196,SINT:0.04615):0.10065,SCON:0.15363):0.02699,((SMIT:0.01883,SPSE:0.02407):0.01558,SPNE:0.03080):0.15728):0.07077,SSUI:0.24765):0.00719):0.01473):0.00625):0.02116,SPLU:0.22589):0.00000;
(SDOW:0.29229,SDOW:0.29229):0.00000;
(((STHE:0.03004,(SSAL:0.01234,SVES:0.01565):0.00910):0.11364,(((((SMIT:0.01118,SPSE:0.01508):0.00530,SPNE:0.02341):0.08710,((SCON:0.03329,SANG:0.02333):0.01334,SINT:0.04113):0.06947):0.02210,((LLAC:0.02622,LCRE:0.02201):0.23253,SSUI:0.16022):0.00553):0.01102,(SDOW:0.14734,(SDEV:0.02515,SRAT:0.02103):0.09119):0.00433):0.00481):0.00711,(((SINF:0.01561,SLUT:0.01601):0.02328,SEQU:0.03648):0.08009,(SCAN:0.05570,(SPYO:0.04643,SDYS:0.03514):0.01370):0.06541):0.00206,(SENT:0.15418,SPLU:0.16103):0.01120):0.00000;
((SPLU:0.14024,(((SINF:0.02737,SLUT:0.03499):0.02030,SEQU:0.03952):0.08712,SDOW:0.13261):0.01054):0.00106,(((LCRE:0.01384,LLAC:0.00636):0.23033,((SANG:0.08499,(SINT:0.00000,SCON:0.00000):0.07553):0.02152,((SMIT:0.01597,SPSE:0.03858):0.01169,SPNE:0.04531):0.07521):0.01674):0.02308,(((STHE:0.06098,(SVES:0.01138,SSAL:0.00903):0.00645):0.11475,SSUI:0.13223):0.01548,(SENT:0.11903,(SPYO:0.13632,(SCAN:0.02383,SDYS:0.06195):0.04937):0.02551):0.01862):0.00131):0.00256,(SDEV:0.04674,SRAT:0.04773):0.06217):0.00000;
(SRAT:0.08612,SDOW:0.08612):0.00000;
((SSUI:0.00458,((SANG:0.05667,(SCAN:0.06623,((SPNE:0.00727,(SVES:0.00445,SMIT:0.00630):0.00071):0.10134,(SENT:0.11974,((SCAN:0.26865,(SDOW:0.19585,SDYS:0.20672):0.03835):0.08523,(SCON:0.02019,(SCON:0.00384,SCAN:0.00596):0.01430):0.34802):0.20102):0.01267):0.03759):0.00783):0.04225,SDYS:0.01685):0.00682):0.00221,SPLU:0.00566,SSUI:0.00856):0.00000;
(SINF:0.26824,SDOW:0.26824):0.00000;
((SDYS:0.11994,SINF:0.10947):0.12733,SCAN:0.37759,SDOW:0.25112):0.00000;
(SPSE:0.25701,SDOW:0.25701):0.00000;
(STHE:0.26890,SDOW:0.26890):0.00000;
(SDOW:0.02913,SDOW:0.02913):0.00000;
((SCAN:0.01717,(SDYS:0.10261,(SDYS:0.13392,(SDOW:0.14255,(SDOW:0.01466,SDOW:0.01076):0.53774):0.02778):0.02033):0.08502):0.00437,SCAN:0.01221,SCAN:0.01323):0.00000;
(SDOW:0.00051,SDOW:0.00051):0.00000;
(SDEV:0.66215,SPSE:0.00408,SPNE:0.00839):0.00000;
(SPLU:0.13179,SDEV:0.13179):0.00000;
(SPLU:0.02778,SDEV:0.02778):0.00000;
(((SPSE:0.01942,(SMIT:0.00675,SPNE:0.01508):0.00038):0.08426,(SDEV:0.06550,SRAT:0.05865):0.07137):0.00719,((((SINF:0.01159,SLUT:0.00614):0.01844,SEQU:0.02018):0.07951,(SCAN:0.06504,(SPYO:0.03487,SDYS:0.02594):0.04992):0.03641):0.00627,((SSUI:0.09971,SPLU:0.09228):0.01665,((STHE:0.01590,(SSAL:0.03156,SVES:0.01445):0.00587):0.07829,SDOW:0.19270):0.00775):0.00550):0.00045,((SINT:0.05029,(SANG:0.00808,SCON:0.00838):0.04031):0.07434,((LLAC:0.01362,LCRE:0.00783):0.16698,SENT:0.14136):0.00971):0.01492):0.00000;
(SDEV:0.05689,SRAT:0.05689,SDOW:0.45671):0.00000;
(SDOW:0.11751,SDEV:0.11751):0.00000;
(SDOW:0.08712,SDEV:0.08712):0.00000;
(SRAT:0.04375,SDEV:0.04375):0.00000;
(SRAT:0.10961,SDEV:0.10961):0.00000;
(SRAT:0.04604,SDEV:0.04604):0.00000;
((SPLU:0.16323,(((((SINF:0.00506,SLUT:0.01606):0.00852,SEQU:0.01537):0.11181,((SCAN:0.03477,SPYO:0.04385):0.00377,SDYS:0.03851):0.08753):0.01452,SDEV:0.12369):0.02270,SRAT:0.23937):0.01944):0.01119,((((LLAC:0.00000,LCRE:0.00000):0.31465,((SSAL:0.02946,(STHE:0.01427,SVES:0.01309):0.01708):0.22862,(SDOW:0.25480,(SPLU:0.21112,((SDEV:0.03863,SRAT:0.03870):0.15864,(((SINF:0.00050,SLUT:0.00081):0.01713,SEQU:0.01428):0.15543,((SPYO:0.04213,SDYS:0.04325):0.01528,SCAN:0.05155):0.13842):0.01174):0.03819):0.01513):0.03032):0.20412):0.04014,(SSUI:0.22744,((SANG:0.01657,(SINT:0.01928,SCON:0.02239):0.00223):0.09928,((SMIT:0.00000,SPSE:0.00000):0.00941,SPNE:0.02150):0.12192):0.12944):0.03702):0.04022,SDOW:0.18583):0.00597,(STHE:0.00910,(SSAL:0.00519,SVES:0.00912):0.00520):0.16461):0.00000;
(((STHE:0.02500,(SSAL:0.00397,SVES:0.00430):0.01324):0.07660,((SPLU:0.10450,SENT:0.10292):0.01368,((LLAC:0.01206,LCRE:0.00791):0.30597,(((SMIT:0.00881,SPNE:0.01375):0.08273,(SANG:0.01496,(SINT:0.00000,SCON:0.00000):0.02080):0.05257):0.04167,(SSUI:0.13655,(SDEV:0.04771,SRAT:0.03626):0.06922):0.03440):0.01046):0.02688):0.00952):0.00597,(((SCAN:0.01558,SPYO:0.01485):0.00561,SDYS:0.01505):0.07866,SDOW:0.09283):0.01375,((SINF:0.00902,SLUT:0.00960):0.00579,SEQU:0.01311):0.07285):0.00000;
(SDEV:0.32268,SPNE:0.22673,SENT:0.22822):0.00000;
(SDEV:0.35987,SENT:0.34645,(SMIT:0.19202,(SDOW:0.00227,SSAL:0.00320):0.20729):0.14430):0.00000;
((((SDEV:0.11682,SRAT:0.11226):0.15730,SENT:0.33697):0.32574,SMIT:0.07745):0.01285,SPNE:0.03186,SPSE:0.04135):0.00000;
((SSAL:0.00834,(SDEV:0.03213,SINF:0.05248):0.07658):0.02600,SVES:0.02171,STHE:0.00874):0.00000;
((SEQU:0.20115,(SDEV:0.02737,SRAT:0.02018):0.17863):0.18961,(SANG:0.02435,SCON:0.04518):0.02745,SINT:0.06474):0.00000;
(((SDEV:0.07888,SRAT:0.06685):0.10162,(SINT:0.24545,SEQU:0.22074):0.02923):0.02649,SDOW:0.17327,SSAL:0.16007):0.00000;
(SRAT:0.04909,SDEV:0.04909):0.00000;
((SDEV:0.01567,SRAT:0.01601):0.34452,(SPLU:0.12865,SSAL:0.11583):0.18468,SDEV:0.31516):0.00000;
(((SDEV:0.01960,SRAT:0.02614):0.06259,(SSUI:0.11668,(((SMIT:0.01913,(SPSE:0.00956,SPNE:0.01378):0.00269):0.08598,((SCON:0.02322,SANG:0.01524):0.01104,SINT:0.02656):0.04988):0.04831,((LCRE:0.02268,LLAC:0.02032):0.16743,((SDEV:0.04501,SRAT:0.06156):0.28982,(SPNE:0.11139,(SRAT:0.07406,SDEV:0.05703):0.04353):0.27624):0.10369):0.01784):0.01817):0.03644):0.01902,((((SINF:0.00000,SLUT:0.00090):0.00401,SEQU:0.00588):0.05623,SDOW:0.07213):0.01250,(SPLU:0.07049,(SCAN:0.02643,(SPYO:0.00621,SDYS:0.00807):0.00876):0.04845):0.01106):0.00793,((STHE:0.02446,(SSAL:0.00489,SVES:0.00049):0.01367):0.06459,SENT:0.12015):0.01560):0.00000;
((SSAL:0.01038,SVES:0.01552):0.09594,(SLUT:0.00502,(SINF:0.00162,SEQU:0.00208):0.00094):0.08955,(((LLAC:0.18329,LLAC:0.18898):0.15443,(SSUI:0.12612,((SENT:0.00960,SENT:0.01563):0.09888,(SCAN:0.08441,SDEV:0.08452):0.01825):0.01542):0.01093):0.01647,((((STHE:0.05874,SMIT:0.06862):0.00509,SMIT:0.07603):0.03097,SENT:0.10610):0.01210,SDYS:0.07692):0.00877):0.00555):0.00000;
(SDEV:0.46066,SPLU:0.14617,SPLU:0.14157):0.00000;
(SDEV:0.11488,SDOW:0.11383,SINT:0.07160):0.00000;
(SDOW:0.11731,SINT:0.11370,SDEV:0.51658):0.00000;
(SMIT:0.29443,SDEV:0.29443):0.00000;
(SRAT:0.03704,SDEV:0.03704):0.00000;
(SRAT:0.01816,SDEV:0.01816):0.00000;
(((SEQU:0.38901,(SDEV:0.09454,SRAT:0.08345):0.20613):0.09279,(SPNE:0.18592,(SDEV:0.04265,SRAT:0.03697):0.17832):0.12559):0.04852,LCRE:0.25805,SRAT:0.26847):0.00000;
((STHE:0.20279,SDEV:0.12792):0.01742,SENT:0.25592,(SEQU:0.00705,SINF:0.00502):0.24536):0.00000;
(SRAT:0.00902,SDEV:0.00902):0.00000;
(SRAT:0.10708,SDEV:0.10708):0.00000;
(SDEV:0.28727,SDOW:0.38223,((SINT:0.06954,(SCON:0.00290,SANG:0.00075):0.07564):0.22184,(SANG:0.05687,SCON:0.06504):0.23863):0.01428):0.00000;
(SPYO:0.27403,SDOW:0.25369,(SDEV:0.13064,SRAT:0.14446):0.11567):0.00000;
((SDEV:0.04191,SRAT:0.03562):0.11760,SANG:0.18928,SENT:0.24307):0.00000;
((((((LLAC:0.08038,LCRE:0.08639):0.19384,SANG:0.22864):0.05198,(SDYS:0.11121,SCAN:0.09797):0.14542):0.03379,SPLU:0.20795):0.02481,(SDEV:0.03756,SRAT:0.03443):0.14719):0.01206,SDOW:0.15645,(STHE:0.05156,(SSAL:0.02898,SVES:0.04436):0.00654):0.12000):0.00000;
((SDEV:0.05399,SRAT:0.05265):0.29405,LLAC:0.13206,LCRE:0.13077):0.00000;
((SDEV:0.08627,SRAT:0.07017):0.29682,SINF:0.11485,SEQU:0.10971):0.00000;
(((SDEV:0.02625,SRAT:0.02327):0.09595,SDOW:0.09432):0.02620,SDYS:0.23954,SPLU:0.15646):0.00000;
(SRAT:0.03205,SDEV:0.03205):0.00000;
(SDEV:0.04564,SRAT:0.06492,SDOW:0.50462):0.00000;
(SRAT:0.06139,SDEV:0.06139):0.00000;
(SDEV:0.20724,(SLUT:0.08570,SEQU:0.08585):0.17322,LLAC:0.35238):0.00000;
((SSUI:0.00084,SDYS:0.01412):0.00048,(SPLU:0.00158,(((SMIT:0.00162,(SVES:0.00146,SPNE:0.00346):0.00575):0.20895,SENT:0.20781):0.04302,(SANG:0.06525,SCAN:0.04793):0.00882):0.06556):0.00263,SSUI:0.01014):0.00000;
(SDYS:0.06283,SCAN:0.07802,SENT:0.21162):0.00000;
(SENT:0.31670,SDYS:0.31670):0.00000;
((SDYS:0.00000,(SANG:0.01126,(SENT:0.04705,(((SVES:0.00000,SMIT:0.00000):0.00112,SPNE:0.01431):0.07828,SCAN:0.02742):0.00522):0.03286):0.00935):0.00000,SPLU:0.00000,SSUI:0.00000):0.00000;
(SENT:0.00457,SPLU:0.00457):0.00000;
(SPLU:0.45307,SSAL:0.03099,SVES:0.02381):0.00000;
(SPSE:0.53393,SPLU:0.12778,SANG:0.10195):0.00000;
((SCAN:0.25041,SPLU:0.32470):0.13097,SENT:0.02212,SENT:0.01771):0.00000;
(SANG:0.29130,SSUI:0.29130):0.00000;
(SINF:0.02192,SSUI:0.02192):0.00000;
((SSUI:0.00000,(SPLU:0.16376,SENT:0.01481):0.01481):0.00000,SPNE:0.00000,SPSE:0.00000):0.00000;
(((SINT:0.08884,(SANG:0.02694,SCON:0.04603):0.06018):0.04522,((SSUI:0.00000,SPLU:0.00000):0.32074,SDYS:0.41518):0.19678):0.02060,SPSE:0.11667,SMIT:0.12458):0.00000;
((((SSAL:0.01634,(STHE:0.03792,SVES:0.01634):0.00327):0.10061,SDOW:0.12524):0.01637,(SENT:0.19580,(((LLAC:0.01824,LCRE:0.01343):0.22148,((SPSE:0.01290,(SMIT:0.00129,SPNE:0.00341):0.00747):0.09741,(SINT:0.02776,(SANG:0.01180,SCON:0.01056):0.01209):0.05747):0.08160):0.02123,SSUI:0.20726):0.01391):0.01492):0.01129,((SDEV:0.00557,SRAT:0.00737):0.10551,(((SINF:0.00137,SLUT:0.00019):0.00342,SEQU:0.00436):0.09017,(SPYO:0.02222,(SCAN:0.00409,SDYS:0.01651):0.01244):0.07574):0.01076):0.00819,SPLU:0.14349):0.00000;
(((((LCRE:0.00263,LLAC:0.00288):0.28788,SPLU:0.10965):0.00781,SENT:0.11554):0.00875,(((SMIT:0.00341,(SPSE:0.00572,SPNE:0.00165):0.00350):0.05593,(SINT:0.03236,(SANG:0.02075,SCON:0.02957):0.00378):0.04819):0.02810,SSUI:0.10843):0.01153):0.00680,((SDEV:0.01506,SRAT:0.02147):0.06404,(STHE:0.01347,(SSAL:0.00695,SVES:0.01375):0.00186):0.10637):0.00635,((((SINF:0.01459,SLUT:0.01219):0.00420,SEQU:0.01734):0.06310,(SPYO:0.02812,(SCAN:0.02528,SDYS:0.01772):0.00535):0.06975):0.01649,SDOW:0.08475):0.00765):0.00000;
(((SSUI:0.09376,SENT:0.12183):0.02588,SPLU:0.16377):0.02614,((((LLAC:0.01366,LCRE:0.02405):0.22405,((SANG:0.05051,(SINT:0.02898,SCON:0.01129):0.02959):0.09730,(SPSE:0.01198,(SMIT:0.00000,SPNE:0.00000):0.00786):0.15217):0.03820):0.02518,(((SINF:0.02138,SLUT:0.02475):0.03493,SEQU:0.08242):0.07506,(SCAN:0.02584,(SPYO:0.02975,SDYS:0.03193):0.00353):0.12467):0.03565):0.01183,SDOW:0.18724):0.00842,((STHE:0.04399,(SSAL:0.02344,SVES:0.01830):0.00871):0.09208,(SDEV:0.03296,SRAT:0.03259):0.10501):0.00962):0.00000;
(((SDEV:0.02469,SRAT:0.02077):0.07240,(((SCAN:0.01287,(SPYO:0.00000,SDYS:0.00000):0.02196):0.06676,(SINF:0.01220,(SLUT:0.00000,SEQU:0.00000):0.00280):0.08679):0.03125,(SPLU:0.24161,((SANG:0.00000,(SINT:0.00000,SCON:0.00000):0.00000):0.12554,((SPSE:0.03215,(SMIT:0.00000,SPNE:0.00000):0.05316):0.13735,SSUI:0.20557):0.04169):0.02710):0.01135):0.02053):0.02946,(SDOW:0.17370,SENT:0.14360):0.00697,(STHE:0.03995,(SSAL:0.00344,SVES:0.01164):0.02502):0.11374):0.00000;
((SPYO:0.02023,(((SINF:0.00000,SLUT:0.00000):0.00470,SEQU:0.00682):0.02070,((SDOW:0.06949,((STHE:0.02012,(SSAL:0.00486,SVES:0.00206):0.00633):0.07266,(SPLU:0.08062,(SENT:0.15671,((LCRE:0.00427,LLAC:0.00786):0.19473,(((SMIT:0.01354,(SPSE:0.00163,SPNE:0.00218):0.01693):0.03138,((SANG:0.00317,SINT:0.00292):0.00208,SCON:0.00858):0.05233):0.05084,SSUI:0.11356):0.05353):0.01133):0.03053):0.00931):0.00528):0.01336,(SDEV:0.01096,SRAT:0.00758):0.05169):0.01397):0.01695):0.00178,SDYS:0.00650,SCAN:0.00973):0.00000;
(((SPLU:0.13148,(((LCRE:0.02897,LLAC:0.04239):0.18741,(SENT:0.15259,SSUI:0.16881):0.04022):0.01653,(SCAN:0.04743,(SDYS:0.01401,SPYO:0.02393):0.03147):0.11834):0.01444):0.00919,((STHE:0.03347,(SSAL:0.03410,SVES:0.03823):0.00424):0.05406,((SINF:0.01092,SLUT:0.00774):0.00768,SEQU:0.01823):0.09297):0.02838):0.00390,(SDOW:0.19512,(SDEV:0.05798,SRAT:0.06163):0.05952):0.02069,(((SPSE:0.01113,SPNE:0.02100):0.00940,SMIT:0.01733):0.09231,(SINT:0.07699,(SANG:0.01078,SCON:0.01066):0.04345):0.05120):0.04129):0.00000;
(((LCRE:0.00900,LLAC:0.00939):0.15692,((SANG:0.00847,(SINT:0.00221,SCON:0.00664):0.01697):0.09688,((SMIT:0.03765,(SPSE:0.00585,SPNE:0.02405):0.04824):0.08663,SSUI:0.10825):0.01322):0.02068):0.01677,((SVES:0.11325,SDOW:0.09549):0.13669,((SINF:0.00434,SLUT:0.01526):0.01837,SEQU:0.04217):0.12285):0.01245,(SENT:0.13053,SDEV:0.14339):0.03968):0.00000;
((SPLU:0.07971,(SDOW:0.09688,((LCRE:0.00752,LLAC:0.00811):0.23154,(((SPSE:0.00355,(SMIT:0.00302,SPNE:0.00764):0.00140):0.04234,(SANG:0.00854,(SINT:0.00562,SCON:0.00466):0.00495):0.03616):0.04949,SSUI:0.09335):0.00978):0.02709):0.00157):0.00129,(((STHE:0.00965,(SSAL:0.00206,SVES:0.00097):0.00644):0.07361,(((SINF:0.00318,SLUT:0.00139):0.00159,SEQU:0.00393):0.04569,(SCAN:0.00436,(SPYO:0.00367,SDYS:0.00281):0.00287):0.05130):0.00904):0.00323,(SDEV:0.00530,SRAT:0.00687):0.05820):0.00317,SENT:0.08198):0.00000;
(((SDEV:0.03866,SRAT:0.03767):0.13552,((SSAL:0.03646,(STHE:0.02196,SVES:0.01659):0.02708):0.15311,((SPLU:0.19105,SENT:0.22258):0.00883,((SSUI:0.22932,((SINT:0.03253,(SANG:0.01929,SCON:0.02588):0.01176):0.09962,((SPSE:0.01597,SPNE:0.01734):0.02253,SMIT:0.05159):0.10693):0.06322):0.02966,(LCRE:0.08102,LLAC:0.08212):0.22588):0.03086):0.00666):0.00858):0.00752,((SPYO:0.04717,(SCAN:0.01348,SDYS:0.01600):0.02940):0.10912,(SEQU:0.04979,(SINF:0.01705,SLUT:0.01699):0.03601):0.09896):0.01648,SDOW:0.17254):0.00000;
(((SEQU:0.08726,(SLUT:0.01462,SINF:0.01056):0.07896):0.18503,((SSAL:0.01887,(STHE:0.00900,SVES:0.01071):0.01128):0.25566,SCAN:0.27434):0.01791):0.00392,(SENT:0.26249,(((LLAC:0.08220,LCRE:0.08666):0.26499,((SANG:0.05177,(SINT:0.01288,SCON:0.01493):0.05382):0.09325,(SPNE:0.02097,(SPSE:0.01773,SMIT:0.01966):0.00485):0.13325):0.23555):0.02298,((SSUI:0.26239,SPLU:0.29964):0.05448,(LLAC:0.06790,LCRE:0.06212):0.26679):0.05662):0.09267):0.01643,SPLU:0.25779):0.00000;
((SANG:0.02204,(SINT:0.03689,SCON:0.01867):0.00939):0.17339,SSUI:0.29136,((SPNE:0.02802,(SPSE:0.01631,SMIT:0.01535):0.02419):0.26701,((SDEV:0.01547,SRAT:0.00958):0.17903,(SEQU:0.15175,SLUT:0.13264):0.13029):0.05758):0.02388):0.00000;
(((((SSAL:0.01755,SVES:0.02506):0.01085,STHE:0.03186):0.18742,((LLAC:0.01577,LCRE:0.02184):0.34061,SSUI:0.29953):0.04624):0.04927,(SANG:0.04929,(SINT:0.02143,SCON:0.03186):0.03807):0.10827):0.13546,(SPSE:0.01878,SPNE:0.01754):0.00174,SMIT:0.02148):0.00000;
((((SCAN:0.05458,(SPYO:0.00443,SDYS:0.01010):0.04507):0.07688,SDOW:0.11951):0.00729,(SPLU:0.12083,((LCRE:0.02376,LLAC:0.02499):0.14998,(((SPSE:0.00667,SPNE:0.01117):0.01165,SMIT:0.02477):0.15437,SSUI:0.14623):0.16770):0.01764):0.00894):0.00707,(((SINF:0.03949,SLUT:0.04905):0.00534,SEQU:0.03945):0.04708,(SDEV:0.06312,SRAT:0.06747):0.03507):0.01357,(SSAL:0.01245,(STHE:0.01200,SVES:0.00453):0.00579):0.09960):0.00000;
(SPLU:0.16055,(SANG:0.04903,SSAL:0.04527):0.11255,SSUI:0.53283):0.00000;
(SDEV:0.26898,SSUI:0.26898):0.00000;
(SSUI:0.09661,SRAT:0.08973,(SRAT:0.35828,SRAT:0.21961):0.26287):0.00000;
((((SANG:0.02038,(SINT:0.00861,SCON:0.00877):0.00904):0.21298,SENT:0.28017):0.00712,SSUI:0.25260):0.03753,((SSAL:0.01179,(STHE:0.02181,SVES:0.01107):0.00642):0.18467,(SPLU:0.18834,SDOW:0.22882):0.01051):0.00297,((SPYO:0.04968,(SDYS:0.01872,SCAN:0.02275):0.02226):0.12151,(((SINF:0.00584,SLUT:0.00479):0.03222,SEQU:0.03204):0.11510,(SDEV:0.00992,SRAT:0.01036):0.10597):0.00438):0.02118):0.00000;
((SENT:0.25189,(((LLAC:0.05050,LCRE:0.05160):0.30554,(SVES:0.01623,(SSAL:0.01439,STHE:0.01741):0.00476):0.25106):0.01755,((((SPSE:0.01009,SPNE:0.01890):0.00411,SMIT:0.01658):0.12958,((SINT:0.03391,SCON:0.02898):0.00724,SANG:0.03214):0.09264):0.04745,SSUI:0.19786):0.01546):0.01003):0.00031,(SDOW:0.22243,(((SEQU:0.03869,(SLUT:0.01751,SINF:0.01743):0.03195):0.08480,(SRAT:0.02943,SDEV:0.02645):0.10328):0.00687,(SPYO:0.05950,(SDYS:0.03320,SCAN:0.03921):0.01699):0.08696):0.02298):0.01122,SPLU:0.19646):0.00000;
((((((SINT:0.03117,SCON:0.02130):0.04627,SANG:0.08186):0.09407,(LLAC:0.04087,LCRE:0.05122):0.10772):0.14916,SENT:0.23005):0.04916,(SSUI:0.06045,SPLU:0.06235):0.12302):0.13128,(SPYO:0.01152,SDYS:0.01851):0.00690,SCAN:0.02346):0.00000;
(((SRAT:0.09743,SDEV:0.06178):0.04044,((LLAC:0.04663,LCRE:0.05014):0.23497,SSUI:0.28828):0.04571):0.01934,((SPYO:0.07830,(SCAN:0.04494,SDYS:0.04856):0.01843):0.05014,(((SINF:0.01038,SLUT:0.00712):0.01347,SEQU:0.02026):0.06142,SENT:0.10971):0.01363):0.00560,(SVES:0.04959,SSAL:0.04425):0.08953):0.00000;
((((SRAT:0.00314,SDEV:0.00181):0.02678,((SCAN:0.01046,SPYO:0.00339):0.00918,SDYS:0.00864):0.03169):0.00581,(((SANG:0.00274,(SINT:0.01740,SCON:0.00466):0.00174):0.01266,SSUI:0.05418):0.00225,(SPSE:0.00298,(SMIT:0.00055,SPNE:0.00045):0.00101):0.04050):0.00899):0.00560,(((SINF:0.00169,SLUT:0.00031):0.01553,SEQU:0.02047):0.00688,SDOW:0.05373):0.00403,((STHE:0.00684,(SSAL:0.00306,SVES:0.00796):0.00219):0.03802,((LCRE:0.00437,LLAC:0.00565):0.11186,(SPLU:0.04020,SENT:0.04105):0.00684):0.00689):0.00278):0.00000;
((((SMIT:0.08996,(SPSE:0.00885,SPNE:0.01052):0.10490):0.28022,SSUI:0.32108):0.24112,SANG:0.04964):0.01442,SCON:0.02487,SINT:0.04303):0.00000;
(((SSUI:0.23087,(SDOW:0.18157,SENT:0.21222):0.02850):0.01015,((SANG:0.10170,(SCON:0.04127,SINT:0.04506):0.07901):0.07112,((SMIT:0.05725,(SPSE:0.01095,SPNE:0.00656):0.05389):0.18641,SPLU:0.24012):0.01085):0.00731):0.00210,((LLAC:0.11763,LCRE:0.11010):0.15442,(((SINF:0.02062,SLUT:0.02552):0.07900,SEQU:0.09599):0.07961,((SSAL:0.08081,(STHE:0.03425,SVES:0.02962):0.05496):0.13059,(SDYS:0.11549,(SPYO:0.09244,SCAN:0.10316):0.02567):0.09312):0.00506):0.02064):0.01132,(SDEV:0.08547,SRAT:0.06690):0.11336):0.00000;
(SSUI:0.24894,SSUI:0.28103,SENT:0.31787):0.00000;
(SSUI:0.63478,LCRE:0.01389,LLAC:0.00991):0.00000;
(((SEQU:0.04329,(SLUT:0.03415,SINF:0.02810):0.01699):0.13943,((((SPNE:0.03644,SMIT:0.05010):0.23926,((SANG:0.06855,SCON:0.06236):0.01168,SINT:0.10648):0.15736):0.02123,SSUI:0.26539):0.04472,SDOW:0.25406):0.01890):0.00726,(SRAT:0.03922,SDEV:0.03868):0.18529,(SSAL:0.01711,(STHE:0.01158,SVES:0.01467):0.00738):0.17303):0.00000;
((SDOW:0.16866,((SPLU:0.21675,SENT:0.25785):0.00328,((LLAC:0.01688,LCRE:0.01719):0.32962,(((SMIT:0.07473,(SPNE:0.00787,SPSE:0.00776):0.07567):0.07071,((SANG:0.01099,SCON:0.00931):0.00803,SINT:0.01876):0.10350):0.06853,SSUI:0.19447):0.02523):0.02334):0.04061):0.01102,((((SINF:0.00722,SLUT:0.00713):0.00791,SEQU:0.01864):0.07266,(SPYO:0.03143,(SCAN:0.01869,SDYS:0.01682):0.01141):0.06309):0.02657,(SDEV:0.00856,SRAT:0.00922):0.10675):0.01000,(SSAL:0.01600,(STHE:0.02209,SVES:0.01321):0.00536):0.11161):0.00000;
(SSUI:0.32919,SINF:0.00893,SEQU:0.00289):0.00000;
(((SSUI:0.29121,(SCAN:0.06914,(SPYO:0.05526,SDYS:0.06403):0.00167):0.36476):0.07416,SINT:0.21732):0.16442,(SPNE:0.00795,SPSE:0.00711):0.03967,SMIT:0.04928):0.00000;
((SPNE:0.01826,(SINT:0.18726,SSUI:0.50910):0.19582):0.01390,SMIT:0.00340,SPSE:0.00147):0.00000;
(SSUI:0.48859,SCAN:0.15077,SDYS:0.12110):0.00000;
(SSUI:0.27774,SCAN:0.16710,SINT:0.14062):0.00000;
((LLAC:0.01046,LCRE:0.00924):0.43133,SDEV:0.25883,(SSUI:0.21111,SDOW:0.19087):0.07267):0.00000;
(((SENT:0.16649,SSUI:0.26193):0.03268,(SRAT:0.03622,SDEV:0.03479):0.08496):0.00239,((SPSE:0.02618,(SMIT:0.01999,SPNE:0.03015):0.00711):0.10224,(SCON:0.06048,(SINT:0.05474,SANG:0.04158):0.00757):0.06452):0.01402,(SDOW:0.14313,((SPYO:0.08011,(SDYS:0.05914,SCAN:0.05584):0.00943):0.06271,(((SINF:0.00382,SLUT:0.00618):0.01527,SEQU:0.02504):0.09703,(SSAL:0.02848,(STHE:0.01587,SVES:0.01545):0.01815):0.08847):0.01375):0.00393):0.00848):0.00000;
(SENT:0.29575,SPLU:0.20713,((((SMIT:0.01037,(SPSE:0.01082,SPNE:0.01748):0.00175):0.11676,((SANG:0.02172,SCON:0.05090):0.02012,SINT:0.04790):0.08073):0.11779,((LLAC:0.09111,LCRE:0.11754):0.24213,(((STHE:0.03455,(SVES:0.02157,SSAL:0.02346):0.02088):0.07150,(SDEV:0.04948,SRAT:0.01744):0.11920):0.01460,SDOW:0.13624):0.06207):0.01694):0.04467,SSUI:0.21218):0.00935):0.00000;
(SSUI:0.34472,SPSE:0.00235,SPNE:0.00084):0.00000;
(SPNE:0.14795,SSUI:0.14795):0.00000;
((SDYS:0.03035,((SENT:0.11799,SPLU:0.10703):0.01339,SSUI:0.30786):0.08553):0.00800,SPYO:0.02336,SCAN:0.03215):0.00000;
(SPLU:0.30626,SSUI:0.30626):0.00000;
(SENT:0.15126,SSUI:0.15126):0.00000;
(SENT:0.27361,SSUI:0.27361):0.00000;
(SSUI:0.32483,SENT:0.36193,SSAL:0.42254):0.00000;
(SSUI:0.15892,SENT:0.14534,SPLU:0.10383):0.00000;
((SSUI:0.24837,((SSAL:0.01949,(STHE:0.01659,SVES:0.01180):0.00537):0.20056,(SPLU:0.21111,(SDOW:0.20357,((SPYO:0.05401,(SCAN:0.02855,SDYS:0.02445):0.02546):0.09582,((SRAT:0.03087,SDEV:0.03093):0.11351,(SEQU:0.04125,(SINF:0.00799,SLUT:0.00679):0.03899):0.10302):0.00116):0.02596):0.00880):0.02329):0.01185):0.00430,((SCON:0.03483,SANG:0.04289):0.00815,SINT:0.04994):0.15856,(SENT:0.23149,((SMIT:0.02049,(SPSE:0.01237,SPNE:0.00772):0.00765):0.17259,SCON:0.17917):0.03980):0.00871):0.00000;
((SPLU:0.14432,(SENT:0.21518,SSUI:0.33431):0.08119):0.03195,SMIT:0.10974,SSAL:0.13199):0.00000;
((SSUI:0.31132,((STHE:0.03166,SSAL:0.02972):0.22221,SDOW:0.26944):0.04592):0.01593,SENT:0.27264,(SINF:0.03836,(SLUT:0.01075,SEQU:0.01444):0.03077):0.22886):0.00000;
(SSUI:0.30910,(SPLU:0.14997,(SCAN:0.00508,SDYS:0.01622):0.15327):0.00576,(SDEV:0.05116,SRAT:0.02880):0.11547):0.00000;
(SPLU:0.16607,SSUI:0.16607):0.00000;
(SPLU:0.11286,SSUI:0.11286):0.00000;
(SCON:0.00104,(SINT:0.00509,((SEQU:0.11022,SINF:0.10753):0.10945,(SDOW:0.34388,SSUI:0.18248):0.01649):0.19062):0.00208,SANG:0.00374):0.00000;
(((SSUI:0.13686,SPLU:0.07968):0.00842,((SINT:0.02329,(SANG:0.01226,SCON:0.01813):0.00362):0.04289,(SDEV:0.04178,SRAT:0.03747):0.01347):0.01342):0.01258,((SENT:0.16524,((SCAN:0.06924,SPYO:0.09969):0.02362,SDYS:0.06505):0.06717):0.01865,((STHE:0.04150,(SSAL:0.01500,SVES:0.01644):0.00560):0.07746,((SINF:0.00494,SLUT:0.01404):0.04987,SDOW:0.10032):0.02418):0.01074):0.00921,((SMIT:0.00000,SPSE:0.00000):0.00168,SPNE:0.00231):0.13754):0.00000;
(((SSAL:0.02356,SVES:0.01599):0.01571,STHE:0.03438):0.13679,(((((LLAC:0.01257,LCRE:0.01526):0.25308,((((SANG:0.03769,SCON:0.03964):0.00802,SINT:0.05050):0.12570,((SPNE:0.01870,SPSE:0.00839):0.12264,SMIT:0.11798):0.07311):0.10119,SSUI:0.27374):0.05877):0.01417,((SRAT:0.01803,SDEV:0.01672):0.18281,SENT:0.23769):0.03842):0.05545,SDOW:0.21540):0.02298,(((SINF:0.00316,SLUT:0.00477):0.01732,SEQU:0.02444):0.11546,((SCAN:0.03160,SDYS:0.02652):0.00794,SPYO:0.04371):0.11632):0.02157):0.01413,SPLU:0.18892):0.00000;
((((LCRE:0.04914,LLAC:0.03041):0.28846,(((STHE:0.02058,(SSAL:0.00706,SVES:0.00659):0.01805):0.12659,(SMIT:0.00890,(SPSE:0.00989,SPNE:0.01173):0.00249):0.12354):0.03075,((SCON:0.00209,SINT:0.00137):0.02559,SANG:0.03099):0.13080):0.09215):0.07019,((SDEV:0.06392,SRAT:0.06038):0.12028,SSUI:0.20052):0.02917):0.02194,(SPYO:0.10366,(SDYS:0.07467,SCAN:0.08096):0.01897):0.11922,((SINF:0.01354,SLUT:0.01639):0.00913,SEQU:0.02638):0.15506):0.00000;
(SINT:0.03608,SCON:0.03608):0.00000;
((SINT:0.00000,SCON:0.00000):0.02300,((SSUI:0.03453,SPLU:0.03578):0.05328,((SCAN:0.02105,(SPYO:0.00795,SDYS:0.00944):0.00754):0.58030,(SPYO:0.01173,(SCAN:0.00079,SDYS:0.00043):0.00410):0.14364):0.04306):0.03460,SPNE:0.05281):0.00000;
(SINT:0.03818,SCON:0.03818):0.00000;
(((SDOW:0.14628,(((LCRE:0.02606,LLAC:0.02301):0.19433,(SSUI:0.10064,((SCON:0.00944,SINT:0.01257):0.02697,SANG:0.03870):0.06073):0.00666):0.00162,((SMIT:0.00770,SPSE:0.00782):0.00746,SPNE:0.01883):0.09340):0.00379):0.00250,(SPLU:0.08938,(((SINF:0.01314,SLUT:0.00922):0.01412,SEQU:0.01762):0.04314,(SSAL:0.01277,(SVES:0.01315,STHE:0.01205):0.00883):0.06102):0.00667):0.00976):0.00206,(SDEV:0.06142,SRAT:0.05694):0.04791,(SENT:0.14100,(SCAN:0.03536,(SPYO:0.00833,SDYS:0.00521):0.04130):0.07277):0.01501):0.00000;
((STHE:0.30895,((SCON:0.00301,SINT:0.00076):0.08484,SANG:0.06556):0.07422):0.17408,(SPSE:0.02493,SPNE:0.02039):0.00397,SMIT:0.02628):0.00000;
(((SSUI:0.23810,((((SCON:0.00258,SINT:0.00496):0.04205,SANG:0.03715):0.17491,((SDOW:0.12442,(SLUT:0.04145,(SEQU:0.03740,SINF:0.03367):0.00223):0.09294):0.05477,(SPLU:0.15375,(SMIT:0.03938,(SPSE:0.01926,SPNE:0.02550):0.01095):0.11659):0.01962):0.01417):0.01452,(LLAC:0.07417,LCRE:0.08139):0.24976):0.05563):0.01733,(SDYS:0.13489,(SCAN:0.14500,SPYO:0.16380):0.01326):0.07276):0.01057,(SDEV:0.01193,SRAT:0.00960):0.16081,((SSAL:0.02774,SVES:0.04205):0.00393,STHE:0.05638):0.14711):0.00000;
(((LLAC:0.02474,LCRE:0.02196):0.24571,(((SMIT:0.04507,(SPSE:0.00696,SPNE:0.00915):0.05297):0.03387,(SINT:0.02589,(SANG:0.00939,SCON:0.00530):0.01400):0.06149):0.06713,SSUI:0.15172):0.02608):0.03539,((SPLU:0.16755,(((SINF:0.01128,SLUT:0.00915):0.01352,SEQU:0.02211):0.09461,(SPYO:0.03872,(SCAN:0.01943,SDYS:0.02182):0.01541):0.09015):0.02034):0.01957,(((STHE:0.02268,(SSAL:0.00387,SVES:0.00469):0.01000):0.14880,(SDEV:0.01526,SRAT:0.01976):0.12642):0.00720,SDOW:0.13240):0.00927):0.00257,SENT:0.21504):0.00000;
(((SANG:0.05557,(SINT:0.01499,SCON:0.01843):0.03147):0.17705,(SMIT:0.16571,SDOW:0.16622):0.05245):0.01613,(SCAN:0.11336,SDYS:0.11156):0.11792,SSUI:0.20427):0.00000;
(SANG:0.05708,SCON:0.05708):0.00000;
((SSUI:0.11923,((SMIT:0.01840,(SPSE:0.01041,SPNE:0.01521):0.00730):0.06364,(SINT:0.05380,(SANG:0.03179,SCON:0.04354):0.00938):0.06568):0.01562):0.00735,(((SSAL:0.01602,(STHE:0.01826,SVES:0.02577):0.00430):0.06840,(((SINF:0.00215,SLUT:0.00853):0.01451,SEQU:0.02207):0.04129,(SCAN:0.02624,(SPYO:0.00448,SDYS:0.00219):0.01448):0.05678):0.01670):0.00614,(SDOW:0.11196,(SPLU:0.09225,(SDEV:0.04868,SRAT:0.04199):0.07048):0.00598):0.00856):0.01115,((LLAC:0.03069,LCRE:0.02529):0.20172,SENT:0.11415):0.00432):0.00000;
(SCON:0.03263,(SPSE:0.17086,((LLAC:0.05943,LCRE:0.05675):0.31319,SENT:0.26331):0.08999):0.14213,(SANG:0.00537,SINT:0.00421):0.02844):0.00000;
((((SCAN:0.09041,(SPYO:0.00505,SDYS:0.00745):0.09619):0.06011,SDOW:0.15971):0.00812,(((LCRE:0.05658,LLAC:0.05132):0.17864,SSUI:0.15904):0.01559,((SMIT:0.01603,(SPSE:0.01690,SPNE:0.01370):0.00623):0.16613,(SANG:0.05768,(SINT:0.00400,SCON:0.01015):0.05755):0.10552):0.02776):0.02321):0.00854,(((SINF:0.02487,SLUT:0.03530):0.03189,SEQU:0.05405):0.07867,(SENT:0.16561,(SDEV:0.08846,SRAT:0.07163):0.05401):0.01239):0.00652,((SSAL:0.04841,(STHE:0.03297,SVES:0.03099):0.02187):0.09882,SPLU:0.14411):0.00698):0.00000;
(SCON:0.00746,SINT:0.00201,SANG:0.11754):0.00000;
((((SCON:0.00228,SINT:0.00228):0.02426,SANG:0.02291):0.24243,SPLU:0.30183):0.02994,((SDEV:0.02825,SRAT:0.02541):0.11236,(SSAL:0.01643,SVES:0.03683):0.14513):0.01847,(((SINF:0.00923,SLUT:0.00724):0.01798,SEQU:0.02262):0.10956,SDYS:0.17722):0.02290):0.00000;
((SANG:0.01753,SCON:0.01025):0.02731,SINT:0.03237,(SDOW:0.35412,SRAT:0.35206):0.41615):0.00000;
(((LCRE:0.00733,LLAC:0.00621):0.24818,((SMIT:0.01517,(SPSE:0.00253,SPNE:0.00968):0.01831):0.05913,((SANG:0.00949,SINT:0.00957):0.00214,SCON:0.01440):0.05979):0.04111):0.01563,((SPLU:0.10765,((STHE:0.01948,(SSAL:0.01722,SVES:0.01179):0.00821):0.09255,((((SINF:0.01097,SLUT:0.01303):0.02071,SEQU:0.03343):0.04291,(SPYO:0.01840,(SCAN:0.01089,SDYS:0.01548):0.00610):0.06426):0.01101,SDOW:0.09941):0.00581):0.00579):0.00587,(SENT:0.10723,(SDEV:0.01155,SRAT:0.01417):0.07086):0.00685):0.00352,SSUI:0.11085):0.00000;
(((SINF:0.01457,SLUT:0.00847):0.03546,SEQU:0.03965):0.10750,((STHE:0.03997,(SSAL:0.02275,SVES:0.02422):0.01230):0.15262,(SANG:0.02538,SCON:0.02172):0.19417):0.02827,(SINF:0.13606,(SDEV:0.02566,SRAT:0.03844):0.09440):0.00834):0.00000;
((SENT:0.05462,(SPSE:0.03065,(SANG:0.01286,SCON:0.01124):0.03940):0.01091):0.02242,((SSUI:0.03935,SPLU:0.04713):0.02268,(((SMIT:0.00670,SPNE:0.00517):0.01730,SINT:0.03105):0.00831,(SCAN:0.00497,(SPYO:0.00937,SDYS:0.00756):0.00195):0.03615):0.02019):0.00490,((LLAC:0.00644,LCRE:0.00665):0.12557,(SDOW:0.05169,((SDEV:0.01625,SRAT:0.01523):0.02530,(SINF:0.00468,(SLUT:0.00638,SEQU:0.00263):0.00071):0.03870):0.01525):0.09376):0.31112):0.00000;
(SCON:0.05283,SCAN:0.02164,SCON:0.00762):0.00000;
(SCON:0.10016,SCAN:0.00745,SCON:0.00003):0.00000;
(SINT:0.35390,SCON:0.35390):0.00000;
(SCON:0.30871,(SPYO:0.07468,SCAN:0.07829):0.09486,(STHE:0.34997,SCAN:0.32027):0.04421):0.00000;
(SCON:0.11243,SCAN:0.00749,SCON:0.00342):0.00000;
(SCON:0.08301,SCAN:0.04421,SCON:0.03682):0.00000;
(SCON:0.16449,SCAN:0.03373,SCON:0.03818):0.00000;
((LLAC:0.35351,SCAN:0.34252):0.45714,SCON:0.01734,(SCON:0.01426,SCAN:0.01762):0.00447):0.00000;
((SENT:0.21759,(((LCRE:0.03512,LLAC:0.03574):0.31098,(SSUI:0.18842,((SMIT:0.05555,(SPSE:0.01379,SPNE:0.01993):0.04514):0.09843,((SCON:0.03482,SINT:0.02844):0.01042,SANG:0.03336):0.09961):0.02948):0.03634):0.02691,((((STHE:0.02060,SVES:0.01922):0.00773,SSAL:0.02470):0.19681,(SDOW:0.19902,(SEQU:0.03441,(SINF:0.00796,SLUT:0.00784):0.03263):0.13911):0.01185):0.00684,(SDYS:0.07611,SCAN:0.06720):0.15245):0.00900):0.00795):0.00773,(SRAT:0.01371,SDEV:0.01608):0.15785,SPLU:0.19229):0.00000;
((SSAL:0.00571,(((SMIT:0.00531,(SPSE:0.00115,SPNE:0.00291):0.00078):0.02265,(((SANG:0.01011,(SINT:0.00206,SCON:0.00182):0.00926):0.02049,(((SSUI:0.03459,SENT:0.03590):0.00361,(SCAN:0.00027,(SPYO:0.00000,SDYS:0.00000):0.00074):0.02160):0.01051,((LCRE:0.00494,LLAC:0.00004):0.05707,(SDEV:0.00336,SRAT:0.00068):0.02390):0.01355):0.00840):0.00911,SDOW:0.04585):0.00488):0.00876,((SINF:0.00371,SLUT:0.00336):0.00476,SEQU:0.00282):0.01012):0.01043):0.00386,SVES:0.00420,STHE:0.00486):0.00000;
(SCON:0.44533,SRAT:0.06368,SDEV:0.06627):0.00000;
((SCON:0.05879,(SMIT:0.14169,SPLU:0.28681):0.12061):0.00999,SINT:0.03618,SANG:0.02416):0.00000;
(SANG:0.04717,SCON:0.04717):0.00000;
(((SPLU:0.06638,(SDOW:0.08717,((SSUI:0.04010,((LLAC:0.02401,LCRE:0.02361):0.20715,((SMIT:0.01895,(SPSE:0.00000,SPNE:0.00000):0.00066):0.00164,(SANG:0.02086,(SINT:0.02174,SCON:0.02277):0.00851):0.01177):0.11081):0.07837):0.04322,(SENT:0.10806,((SCAN:0.05536,SPYO:0.03063):0.01306,SDYS:0.02729):0.02558):0.02362):0.01512):0.00810):0.00756,(SINF:0.00938,(SLUT:0.00000,SEQU:0.00000):0.00011):0.01093):0.00290,(SSAL:0.00111,(STHE:0.00000,SVES:0.00000):0.01155):0.00346,(SDEV:0.00909,SRAT:0.02256):0.00368):0.00000;
(SPNE:0.02069,(SPSE:0.01389,SMIT:0.00542):0.00237,(SCON:0.03087,SANG:0.04274):0.44488):0.00000;
(((SINT:0.00511,SANG:0.01013):0.07047,SMIT:0.07528):0.03052,(SSAL:0.02044,SVES:0.02345):0.10888,((LLAC:0.00417,LCRE:0.00515):0.21822,(SPLU:0.12927,(SEQU:0.02755,(SINF:0.00375,SLUT:0.02466):0.02591):0.08947):0.17213):0.13266):0.00000;
(SCAN:0.20773,SINT:0.20773):0.00000;
(SCAN:0.17834,SINT:0.17834):0.00000;
(SCAN:0.30797,SINT:0.30797):0.00000;
(SCON:0.01850,SINT:0.01850):0.00000;
(SCON:0.03654,SINT:0.03654):0.00000;
(((SMIT:0.13762,SSAL:0.13972):0.20575,SINT:0.27660):0.02575,SRAT:0.23430,SDOW:0.29823):0.00000;
(SCON:0.01288,SINT:0.01288):0.00000;
((SINT:0.00703,SCON:0.00556):0.30742,(SENT:0.30459,SDOW:0.28534):0.02898,((SMIT:0.19363,SSAL:0.15003):0.02964,SPLU:0.20937):0.07467):0.00000;
((((SENT:0.23851,((LCRE:0.03535,LLAC:0.04095):0.26349,SINT:0.43630):0.05603):0.04314,((SPNE:0.02748,(SPSE:0.01883,SMIT:0.02372):0.01216):0.16430,(SDYS:0.06540,SCAN:0.05806):0.10079):0.01415):0.03176,(SSAL:0.03120,(STHE:0.02537,SVES:0.02554):0.01288):0.13419):0.00497,(SPLU:0.12869,SSUI:0.14868):0.04495,(SDOW:0.14512,(SDEV:0.03471,SRAT:0.03733):0.09317):0.00852):0.00000;
((SINT:0.01350,SCON:0.01355):0.27108,(SDOW:0.29803,(SENT:0.35392,(SPLU:0.18849,(SSAL:0.14227,SMIT:0.15782):0.06344):0.11404):0.01810):0.00832,SSUI:0.28964):0.00000;
(SINT:0.03472,SCON:0.02245,SANG:0.06970):0.00000;
(SINT:0.01578,SCON:0.02586,SANG:0.21849):0.00000;
(SDOW:0.15067,SINT:0.15067):0.00000;
(SINT:0.17396,SINT:0.17396):0.00000;
(SCON:0.00133,SINT:0.00133):0.00000;
((((SANG:0.02772,(SCON:0.01733,SINT:0.00508):0.02954):0.08231,SSUI:0.09538):0.08854,SSAL:0.11982):0.01943,SENT:0.14187,SPLU:0.11809):0.00000;
(SINF:0.24005,SINT:0.24005):0.00000;
(SINT:0.01223,SCON:0.00648,SSAL:0.44454):0.00000;
((((SINT:0.61991,SDEV:0.06058):0.00955,(SCAN:0.01018,(SPYO:0.00898,SDYS:0.00824):0.00666):0.04941):0.02132,SSUI:0.03803):0.00535,(SINT:0.00983,(SANG:0.00091,SCON:0.00170):0.00618):0.01662,SPNE:0.03908):0.00000;
(SINT:0.04396,((SMIT:0.04954,(SPSE:0.01416,SPNE:0.01081):0.03033):0.03534,SSUI:0.25837):0.05898,(SANG:0.01780,SCON:0.01591):0.01294):0.00000;
((SCON:0.01286,SINT:0.02996):0.04790,SSUI:0.35522,SANG:0.04386):0.00000;
(((((SPSE:0.05288,(SMIT:0.04096,SPSE:0.05951):0.00671):0.20745,(SSUI:0.26774,(((SSAL:0.05170,(SVES:0.01881,STHE:0.01707):0.03342):0.26967,((SPLU:0.00510,SPLU:0.00496):0.27998,((SEQU:0.10654,(SLUT:0.04468,(SINF:0.02217,SINF:0.01674):0.01324):0.06297):0.16514,(SPYO:0.09967,(SCAN:0.10031,(SDYS:0.00456,SDYS:0.00651):0.08400):0.01095):0.10894):0.03380):0.02227):0.01302,(SRAT:0.02273,SDEV:0.02467):0.22067):0.02374):0.02826):0.12363,((SINT:0.01313,SINT:0.00150):0.00256,SINT:0.02127):0.04632):0.02085,SCON:0.04254):0.04278,(SANG:0.01875,SANG:0.00834):0.00188,SANG:0.00552):0.00000;
(((SPLU:0.21866,SSUI:0.21209):0.06181,(SANG:0.06636,(SINT:0.00885,SCON:0.01817):0.03786):0.25025):0.01604,SDOW:0.27521,(SVES:0.02862,SSAL:0.02100):0.25998):0.00000;
((((SPYO:0.05630,(SCAN:0.02434,SDYS:0.02929):0.01611):0.09753,((STHE:0.01960,(SSAL:0.00000,SVES:0.00000):0.03008):0.19853,((SDEV:0.01148,SRAT:0.01572):0.10497,((SINF:0.00142,SLUT:0.00636):0.04068,SEQU:0.02323):0.13217):0.01815):0.01279):0.01581,((SMIT:0.15410,((SINT:0.02372,SCON:0.01588):0.00352,SANG:0.01306):0.12957):0.05272,SSUI:0.20794):0.03996):0.01114,(SENT:0.18099,(SPLU:0.18746,(LLAC:0.00352,LCRE:0.00257):0.27874):0.02176):0.00839,SDOW:0.18811):0.00000;
(SINT:0.03985,SANG:0.03985):0.00000;
(SANG:0.00000,SCON:0.00000,SINT:0.28205):0.00000;
((((((SINF:0.01122,SLUT:0.01000):0.00826,SEQU:0.01623):0.05980,(SDEV:0.00722,SRAT:0.01147):0.04906):0.02059,(((SANG:0.03611,(SINT:0.03919,SCON:0.02987):0.00710):0.09959,((SMIT:0.01182,SPSE:0.00980):0.00476,SPNE:0.01959):0.08863):0.01537,((SENT:0.23686,SSUI:0.15165):0.00987,(LCRE:0.01887,LLAC:0.01592):0.19215):0.01762):0.01776):0.01525,(SPLU:0.11251,(SDYS:0.04607,(SCAN:0.03084,SPYO:0.02906):0.01856):0.06293):0.01762):0.00460,SDOW:0.10435,(STHE:0.02498,(SSAL:0.00000,SVES:0.00276):0.01078):0.08374):0.00000;
(SINT:0.26161,SANG:0.26161):0.00000;
((SANG:0.00000,SCON:0.00000):0.60519,LLAC:0.03985,LCRE:0.04407):0.00000;
(SANG:0.03298,SCON:0.04837,SINT:0.21044):0.00000;
((SDOW:0.17454,((LLAC:0.23058,(SSUI:0.15264,(((SMIT:0.00210,SPNE:0.00364):0.00089,SPSE:0.00389):0.08307,(SANG:0.01074,(SINT:0.00524,SCON:0.00517):0.00542):0.07709):0.05037):0.02655):0.01146,(STHE:0.03088,(SVES:0.02021,SSAL:0.02303):0.00213):0.17241):0.01224):0.00589,(((SLUT:0.06079,(SINF:0.00520,SEQU:0.00358):0.05116):0.08579,(SCAN:0.01859,(SPYO:0.01781,SDYS:0.01309):0.00463):0.12915):0.01877,(SDEV:0.06428,SRAT:0.05498):0.08326):0.00282,(SPLU:0.19656,SENT:0.18232):0.01139):0.00000;
((SSAL:0.04037,(SDOW:0.18701,((SANG:0.05978,(SINT:0.03723,SCON:0.02302):0.03638):0.06064,(SCAN:0.04724,SDYS:0.04667):0.07065):0.01040):0.08080):0.01409,(SPSE:0.00724,SPNE:0.00894):0.01937,SMIT:0.01746):0.00000;
((((((SMIT:0.00876,SPSE:0.00607):0.00177,SPNE:0.00248):0.20460,((SANG:0.06090,SCON:0.07441):0.01196,SINT:0.07715):0.14749):0.13604,(SEQU:0.10966,(SLUT:0.01725,SINF:0.03983):0.08238):0.11965):0.03577,((SSUI:0.23029,SDOW:0.14687):0.02217,(SDEV:0.04321,SRAT:0.05483):0.14218):0.01390):0.00394,SENT:0.19432,STHE:0.21227):0.00000;
(((SEQU:0.18586,(SINF:0.02003,SLUT:0.02833):0.08264):0.11428,((SANG:0.09742,(SINT:0.12146,SCON:0.13741):0.00960):0.25467,SPYO:0.36834):0.06107):0.01071,SPLU:0.30797,((SSAL:0.01164,SVES:0.02554):0.01213,STHE:0.03691):0.25218):0.00000;
((SRAT:0.15082,(SDOW:0.21097,(((SSUI:0.20038,SPLU:0.21988):0.14652,((SINT:0.05108,SANG:0.03706):0.01574,SCON:0.06584):0.16472):0.00532,SCAN:0.30352):0.11396):0.02294):0.00775,((SINF:0.01737,SLUT:0.00892):0.05032,SEQU:0.04805):0.06736,SDEV:0.09545):0.00000;
(LCRE:0.05031,LLAC:0.05031):0.00000;
((SSAL:0.00825,SVES:0.01537):0.00607,LLAC:0.63717,STHE:0.01802):0.00000;
((LCRE:0.00000,LLAC:0.00000):0.51131,LCRE:0.06768,LLAC:0.08424):0.00000;
((((SENT:0.01166,(SSUI:0.00584,((SINF:0.00000,(SLUT:0.00000,SEQU:0.00000):0.00000):0.02635,((SANG:0.00088,SINT:0.00387):0.00327,(SCON:0.01962,(LCRE:0.00000,LLAC:0.00000):0.16527):0.00204):0.01541):0.00587):0.00115):0.00039,((((STHE:0.00709,SSAL:0.00086):0.00613,SVES:0.00101):0.01013,SPLU:0.01368):0.00107,((SDEV:0.00219,SDOW:0.02787):0.00401,SRAT:0.00314):0.00169):0.00185):0.00048,(SCAN:0.00772,(SPYO:0.00000,SDYS:0.00000):0.00017):0.00595):0.00036,(SPSE:0.00000,SPNE:0.00000):0.00000,SMIT:0.00634):0.00000;
((((SINF:0.00261,(SLUT:0.00000,SEQU:0.00000):0.00000):0.02063,(((STHE:0.03842,(SSAL:0.00000,SVES:0.00000):0.00085):0.00756,SPLU:0.03171):0.02141,((SENT:0.02829,(SDEV:0.01188,SRAT:0.01396):0.05076):0.00420,(SDOW:0.05634,((((SMIT:0.00866,SPSE:0.00705):0.01451,SPNE:0.02673):0.01473,(((SANG:0.00000,SINT:0.00000):0.00347,SCON:0.00958):0.02605,SSUI:0.04192):0.02120):0.03162,(LCRE:0.00000,LLAC:0.00000):0.40930):0.03553):0.01198):0.01374):0.00585):0.01331,SDYS:0.00261):0.00000,SPYO:0.00000,SCAN:0.00000):0.00000;
(LLAC:0.00000,LCRE:0.00000):0.00000;
(((SDEV:0.01995,SRAT:0.01883):0.03465,SDOW:0.07234):0.00499,(((SMIT:0.00434,SPSE:0.00483):0.08361,(((LCRE:0.04856,LLAC:0.04069):0.17116,SSUI:0.10498):0.01483,SPLU:0.08383):0.00882):0.00837,((SINF:0.01528,SLUT:0.00937):0.00400,SEQU:0.01061):0.05446):0.00397,(STHE:0.03755,(SSAL:0.00483,SVES:0.00779):0.05907):0.01382):0.00000;
((((SDEV:0.01531,SRAT:0.01488):0.02926,SDOW:0.05488):0.00251,((STHE:0.00806,(SSAL:0.00360,SVES:0.00580):0.00025):0.04825,(SPYO:0.01970,(SCAN:0.01690,SDYS:0.01246):0.00237):0.03390):0.00375):0.00245,((SINF:0.00626,SLUT:0.01125):0.01691,SEQU:0.03216):0.03574,(((((SDOW:0.08626,SINF:0.09031):0.08841,((SCAN:0.04030,SDYS:0.04134):0.02384,SPYO:0.06487):0.27160):0.04806,(LCRE:0.00478,LLAC:0.00516):0.13324):0.06020,(((SMIT:0.00579,(SPSE:0.00066,SPNE:0.00149):0.00684):0.02993,((SANG:0.00633,SINT:0.00874):0.01136,SCON:0.02032):0.02439):0.02209,SSUI:0.06839):0.00894):0.01258,(SPLU:0.06470,SENT:0.06565):0.00585):0.00680):0.00000;
((SRAT:0.13256,SDEV:0.14106):0.05945,(SINF:0.07303,(SLUT:0.01321,SEQU:0.00776):0.06423):0.12950,((LLAC:0.10999,LCRE:0.10422):0.11069,(SPNE:0.00189,SPSE:0.00124):0.23748):0.22802):0.00000;
((SDEV:0.09710,SRAT:0.07069):0.01730,((SINF:0.02657,(SLUT:0.00848,SEQU:0.01457):0.01851):0.05898,SDOW:0.10378):0.00782,((LLAC:0.06963,LCRE:0.06876):0.29697,(STHE:0.03202,(SSAL:0.01862,SVES:0.02437):0.00869):0.10668):0.01765):0.00000;
(SDEV:0.29094,SRAT:0.29094):0.00000;
(SDOW:0.16724,SRAT:0.16724):0.00000;
(((SRAT:0.07121,SDEV:0.07680):0.18849,((SLUT:0.04561,SINF:0.04716):0.15139,SDOW:0.24023):0.09974):0.05871,SENT:0.26505,SVES:0.26071):0.00000;
((((SDEV:0.02455,SRAT:0.02967):0.06509,((SPYO:0.04675,(SCAN:0.03490,SDYS:0.02945):0.01845):0.05537,((STHE:0.02177,(SSAL:0.00769,SVES:0.00877):0.00835):0.06434,SDOW:0.08816):0.00770):0.00807):0.00754,((SINF:0.00914,SLUT:0.01727):0.00641,SEQU:0.01131):0.07060):0.00745,(((SMIT:0.01234,(SPSE:0.00568,SPNE:0.00906):0.00204):0.08619,(SINT:0.03540,(SANG:0.02737,SCON:0.01998):0.00833):0.05521):0.02717,((SSUI:0.01991,SPLU:0.02382):0.04883,SENT:0.09665):0.01390):0.00395,(LLAC:0.01479,LCRE:0.01395):0.19706):0.00000;
((SEQU:0.09351,(SRAT:0.10612,SDOW:0.21460):0.08635):0.05675,SINF:0.00699,SLUT:0.02260):0.00000;
((SPYO:0.00773,((((SINF:0.00000,SLUT:0.00000):0.00904,SEQU:0.00009):0.01211,((((LCRE:0.00000,LLAC:0.00000):0.21476,(SSAL:0.00729,(STHE:0.00347,SVES:0.00794):0.00414):0.02667):0.00584,((SANG:0.01338,(SINT:0.00000,SCON:0.00000):0.01401):0.00345,((SMIT:0.00355,(SPSE:0.00074,SPNE:0.00835):0.02486):0.01774,((SSUI:0.01731,SPLU:0.00319):0.01735,SENT:0.03944):0.01286):0.00772):0.01790):0.00332,(SDEV:0.00298,SRAT:0.00383):0.02939):0.02266):0.00398,SDOW:0.02981):0.01072):0.00368,SDYS:0.00000,SCAN:0.00000):0.00000;
((SDEV:0.01743,SRAT:0.01242):0.00993,((SCAN:0.00812,(SPYO:0.00811,SDYS:0.00717):0.00354):0.02230,((STHE:0.01036,(SSAL:0.00244,SVES:0.00038):0.00373):0.02254,(SPLU:0.03930,((((SPSE:0.00125,(SMIT:0.00019,SPNE:0.00223):0.00036):0.02642,(SINT:0.01150,(SANG:0.00222,SCON:0.00420):0.00214):0.02609):0.00807,((LCRE:0.00000,LLAC:0.00000):0.08782,SSUI:0.05285):0.00599):0.00078,(SENT:0.04715,SDOW:0.03686):0.01538):0.00778):0.00521):0.00214):0.00123,((SINF:0.00222,SLUT:0.00302):0.00852,SEQU:0.00822):0.01811):0.00000;
(((SDEV:0.01717,SRAT:0.01939):0.01023,SDOW:0.02987):0.00012,((((STHE:0.00464,SSAL:0.00019):0.00024,SVES:0.00298):0.01709,(SINF:0.00652,(SLUT:0.00116,SEQU:0.00422):0.00476):0.01001):0.00633,(((SMIT:0.00298,(SPSE:0.00320,SPNE:0.00003):0.00187):0.01795,SPYO:0.01565):0.00449,(((SSUI:0.01160,SPLU:0.00558):0.01178,SENT:0.01910):0.00366,(SCAN:0.01909,SDYS:0.00731):0.00812):0.00423):0.00293):0.00305,((LCRE:0.00027,LLAC:0.00027):0.06566,((SANG:0.01215,SINT:0.02122):0.01187,SCON:0.01130):0.02259):0.00837):0.00000;
((SRAT:0.01209,(((LLAC:0.05741,LCRE:0.05201):0.36836,SSUI:0.16309):0.05103,(SCAN:0.14968,SDYS:0.10272):0.01537):0.09230):0.00280,(SINT:0.01694,SCON:0.00733):0.00621,SANG:0.01867):0.00000;
(SDEV:0.17408,SRAT:0.17408):0.00000;
((((SINF:0.00782,SLUT:0.00619):0.01300,SEQU:0.01482):0.03710,(SDEV:0.01068,SRAT:0.00864):0.04202):0.00309,SDOW:0.08422,((STHE:0.01815,(SSAL:0.00478,SVES:0.00463):0.00557):0.04726,(((SPSE:0.00492,(SMIT:0.00170,SPNE:0.00065):0.00121):0.10755,((LCRE:0.05399,LLAC:0.05135):0.15731,SSUI:0.09947):0.00912):0.01150,SPLU:0.06671):0.01160):0.00222):0.00000;
((((SMIT:0.00333,(SPSE:0.00000,SPNE:0.00000):0.00687):0.03083,(SANG:0.00000,(SINT:0.00000,SCON:0.00000):0.00000):0.01576):0.04241,((STHE:0.01633,(SSAL:0.00112,SVES:0.00733):0.00650):0.03341,((SCAN:0.01362,(SPYO:0.00311,SDYS:0.00200):0.00509):0.03653,((SINF:0.01105,(SLUT:0.00000,SEQU:0.00000):0.00596):0.01229,(SDEV:0.00508,SRAT:0.00509):0.01819):0.00487):0.00723):0.00853):0.00277,(SSUI:0.04647,SDOW:0.04196):0.00790,(SPLU:0.05026,((LCRE:0.00685,LLAC:0.00348):0.21864,SENT:0.08197):0.01249):0.00752):0.00000;
((((SPLU:0.00211,(((LLAC:0.00000,LCRE:0.00000):0.20586,SENT:0.02831):0.00685,((SMIT:0.00000,(SPSE:0.00000,(SPNE:0.00000,SSUI:0.00000):0.00000):0.00000):0.00726,(STHE:0.01183,(((SINF:0.00183,SLUT:0.00133):0.01366,((SSAL:0.00000,SVES:0.00000):0.00001,SEQU:0.00946):0.00211):0.00404,((SDEV:0.00240,SRAT:0.01342):0.03225,SDOW:0.03105):0.00847):0.00237):0.00694):0.00458):0.00583):0.00418,(SCAN:0.00000,(SPYO:0.00000,SDYS:0.00000):0.00000):0.00314):0.00000,SCON:0.00000):0.00000,SINT:0.00000,SANG:0.00000):0.00000;
((SENT:0.07160,((SPYO:0.05600,(SCAN:0.00864,SDYS:0.01148):0.01938):0.03308,((SINF:0.00244,(SLUT:0.00107,SEQU:0.00127):0.00108):0.03484,(SDEV:0.00280,SRAT:0.00517):0.06105):0.00621):0.00350):0.00559,(((LCRE:0.00900,LLAC:0.00839):0.16645,SPLU:0.06700):0.00726,((STHE:0.02776,(SSAL:0.00728,SVES:0.00586):0.00652):0.05790,SDOW:0.07679):0.00922):0.00185,((((SMIT:0.00064,SPSE:0.00170):0.00509,SPNE:0.01222):0.06752,(SINT:0.01119,(SANG:0.00728,SCON:0.00954):0.00445):0.05241):0.02012,SSUI:0.07405):0.02570):0.00000;
((SRAT:0.10144,SDEV:0.07779):0.01039,(SINF:0.02906,SEQU:0.01366):0.08063,SPLU:0.07219):0.00000;
(SEQU:0.18628,SRAT:0.18628):0.00000;
((((SINF:0.00000,SLUT:0.00527):0.00343,SEQU:0.00577):0.00332,(SDEV:0.01415,SRAT:0.00160):0.00324):0.00102,(((((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.00291,SSUI:0.00367):0.00870,(((LCRE:0.00000,LLAC:0.00000):0.08110,SPLU:0.00190):0.00667,SENT:0.02034):0.00116):0.00728,(SCAN:0.00340,(SPYO:0.00000,SDYS:0.00000):0.00450):0.00481):0.00207,((SINT:0.00307,(SANG:0.00045,SCON:0.01527):0.00876):0.00404,SDOW:0.00912):0.00228):0.00132,(STHE:0.00000,(SSAL:0.00000,SVES:0.00000):0.00000):0.00556):0.00000;
((SANG:0.01494,((SDOW:0.10570,(SPLU:0.09767,(SDEV:0.01344,SRAT:0.01214):0.09341):0.08065):0.00911,(SEQU:0.02374,(SLUT:0.01538,SINF:0.01774):0.01106):0.07146):0.07065):0.00204,SCON:0.01162,SINT:0.01914):0.00000;
(SRAT:0.03756,SDOW:0.03756):0.00000;
(((STHE:0.05300,(SSAL:0.02827,SVES:0.04587):0.00721):0.15107,SDOW:0.19709):0.01836,(((SINF:0.03293,SLUT:0.03678):0.02673,SEQU:0.06083):0.12628,(SDEV:0.10005,SRAT:0.09911):0.05979):0.02708,(LLAC:0.02068,LCRE:0.01781):0.47733):0.00000;
((SDOW:0.14453,((((SINF:0.01868,SLUT:0.01877):0.02472,SEQU:0.04055):0.06786,((SCAN:0.03478,SDYS:0.03060):0.00711,SPYO:0.03310):0.07351):0.00817,SPLU:0.15761):0.01020):0.00412,(((SPSE:0.01097,(SMIT:0.01086,SPNE:0.00758):0.00199):0.09172,((SINT:0.02089,(SCON:0.02196,SANG:0.01612):0.00248):0.08058,SSUI:0.12624):0.00728):0.01775,(SDEV:0.02384,SRAT:0.02570):0.09720):0.00883,(LLAC:0.03182,LCRE:0.02798):0.15824):0.00000;
(((SINF:0.00542,(SLUT:0.00419,SEQU:0.00091):0.00138):0.02947,SDOW:0.04359):0.00215,(((SPSE:0.00466,(SMIT:0.00046,SPNE:0.00380):0.00086):0.03769,(SENT:0.04205,((SSUI:0.00830,SPLU:0.00234):0.02698,SPYO:0.03029):0.00804):0.00223):0.00880,((LCRE:0.00599,LLAC:0.00207):0.09653,((SCAN:0.01039,SDYS:0.00707):0.04888,((SANG:0.02896,(SINT:0.02342,SCON:0.03042):0.00461):0.02050,(SDEV:0.01519,SRAT:0.01781):0.03802):0.00212):0.01231):0.02038):0.00417,(STHE:0.01832,(SSAL:0.00048,SVES:0.00164):0.01293):0.01135):0.00000;
(SEQU:0.23569,SDOW:0.23569):0.00000;
((((SSAL:0.01007,SVES:0.00697):0.12079,(SDEV:0.01753,SRAT:0.01658):0.09666):0.09850,SDOW:0.18886):0.01390,((SMIT:0.10079,(SMIT:0.00812,SPNE:0.00751):0.10128):0.07277,(SINT:0.03999,SCON:0.04515):0.09091):0.07154,((SENT:0.06459,SPLU:0.05884):0.04144,SSUI:0.10610):0.32787):0.00000;
((((SINF:0.00948,(SLUT:0.00231,SEQU:0.00267):0.01340):0.03032,(SCAN:0.03582,(SPYO:0.00607,SDYS:0.00238):0.01410):0.02600):0.00589,SDOW:0.05060):0.00116,(((((SPSE:0.00350,(SMIT:0.00345,SPNE:0.00304):0.00164):0.01720,(SANG:0.01443,(SINT:0.00492,SCON:0.00611):0.01627):0.00959):0.01243,SSUI:0.04222):0.02105,SENT:0.05717):0.00553,((LCRE:0.00358,LLAC:0.00647):0.19606,(SDEV:0.00501,SRAT:0.01015):0.04238):0.00434):0.00467,((STHE:0.00693,(SSAL:0.00413,SVES:0.00507):0.00226):0.04762,SPLU:0.06116):0.00804):0.00000;
(((SDEV:0.20708,((LLAC:0.07634,LCRE:0.07447):0.25001,((SINT:0.08239,SDOW:0.06699):0.07850,SRAT:0.12964):0.18951):0.13069):0.09244,SANG:0.11727):0.04322,SCON:0.06776,SINT:0.06830):0.00000;
(((SDEV:0.08164,SRAT:0.09405):0.10788,(((SEQU:0.10733,(SINF:0.05257,SLUT:0.06529):0.04222):0.08525,(SSAL:0.06516,(SVES:0.04537,STHE:0.06312):0.02996):0.11390):0.02784,SDOW:0.22579):0.02682):0.01479,(SCAN:0.07554,(SPYO:0.03962,SDYS:0.04245):0.03685):0.14012,SSUI:0.28407):0.00000;
((SSUI:0.03640,SENT:0.03421):0.02323,((((LCRE:0.00000,LLAC:0.00000):0.09763,((SLUT:0.01805,SEQU:0.00944):0.05790,(SDOW:0.05611,((SINT:0.01084,(SANG:0.00169,SCON:0.00163):0.00700):0.03873,(SDEV:0.01821,SRAT:0.01365):0.02972):0.01089):0.01778):0.12353):0.01200,SDOW:0.12138):0.02082,((((STHE:0.00671,(SSAL:0.00000,SVES:0.00000):0.00266):0.02586,SPLU:0.02769):0.01496,((SINF:0.00326,SLUT:0.00284):0.00543,SEQU:0.01287):0.02501):0.01309,((SDEV:0.01736,SRAT:0.01708):0.03154,SRAT:0.09662):0.00711):0.00431):0.00427,((SPSE:0.00981,(SMIT:0.00226,SPNE:0.00429):0.00207):0.01762,((SCAN:0.00207,SPYO:0.00568):0.00155,SDYS:0.00457):0.02499):0.01360):0.00000;
((SDOW:0.28360,SDOW:0.31338):0.30628,(SSAL:0.03055,SVES:0.02080):0.00853,STHE:0.03629):0.00000;
(SDOW:0.12638,(SDEV:0.02774,SRAT:0.04618):0.11433,(SSAL:0.17933,((SINF:0.00982,SLUT:0.00964):0.03178,SEQU:0.03245):0.08681):0.02105):0.00000;
(((((STHE:0.00633,SSAL:0.00430):0.00366,SVES:0.00961):0.15798,SENT:0.17444):0.00902,(((SINF:0.01388,SLUT:0.01533):0.01148,SEQU:0.01861):0.12386,(SDOW:0.15333,(SDEV:0.00675,SRAT:0.00664):0.10705):0.02814):0.00577):0.00268,((LCRE:0.07273,LLAC:0.07250):0.27063,(SPYO:0.06609,(SCAN:0.03638,SDYS:0.02911):0.01252):0.11956):0.01713,((SSUI:0.14283,(((SPSE:0.01163,SPNE:0.00623):0.00374,SMIT:0.01460):0.08903,(SANG:0.01526,(SCON:0.00658,SINT:0.01234):0.00448):0.07891):0.08237):0.04058,SPLU:0.14238):0.00672):0.00000;
(SINT:0.24593,SDOW:0.24593):0.00000;
((SLUT:0.00758,((((LLAC:0.06894,LCRE:0.06465):0.36418,SDOW:0.06005):0.02200,(SSAL:0.01928,SRAT:0.02489):0.00638):0.00941,SDEV:0.02533):0.02531):0.00044,SEQU:0.00366,SINF:0.00435):0.00000;
(SDOW:0.34300,SDEV:0.00007,SRAT:0.00632):0.00000;
((SENT:0.09915,SDOW:0.53563):0.09840,SANG:0.01771,SCON:0.01380):0.00000;
(SDOW:0.37207,(SSAL:0.00268,SVES:0.00802):0.00668,STHE:0.01601):0.00000;
((((((SSUI:0.05998,((((SMIT:0.00221,SPSE:0.00006):0.00112,SPNE:0.00969):0.03762,(SANG:0.01190,(SINT:0.01322,SCON:0.00500):0.01914):0.03247):0.00956,SENT:0.04861):0.00416):0.00501,((LCRE:0.00654,LLAC:0.00608):0.08784,SDOW:0.03948):0.00582):0.01725,(SDEV:0.04325,SRAT:0.02369):0.00773):0.00502,(SCAN:0.01921,(SPYO:0.01977,SDYS:0.01114):0.00570):0.02576):0.00965,((SINF:0.00452,SLUT:0.00009):0.00575,SEQU:0.00260):0.01967):0.00108,SPLU:0.05557,(STHE:0.01428,(SSAL:0.00260,SVES:0.00371):0.00351):0.02007):0.00000;
(SANG:0.21111,SDOW:0.21111):0.00000;
(SDOW:0.27111,(SDOW:0.21166,SDOW:0.20722):0.04889,(SSAL:0.35284,(SRAT:0.06698,SDEV:0.06307):0.15392):0.02754):0.00000;
((SDOW:0.10746,((((((SDYS:0.04188,(SPYO:0.03244,SCAN:0.02714):0.00714):0.11066,SENT:0.17287):0.21139,(LLAC:0.01510,LCRE:0.02031):0.31204):0.10903,(SPNE:0.04172,(SANG:0.01326,SCON:0.01856):0.03842):0.10482):0.06862,(SLUT:0.05776,(SINF:0.04017,SEQU:0.04467):0.02153):0.04578):0.00560,((SSUI:0.06615,SENT:0.05540):0.02703,(SDEV:0.00502,SRAT:0.00438):0.09615):0.00745):0.00715):0.00622,(SPLU:0.06722,(SCAN:0.01050,(SPYO:0.00149,SDYS:0.00027):0.01064):0.06033):0.00288,(STHE:0.01975,(SSAL:0.00373,SVES:0.00391):0.00601):0.05509):0.00000;
((SPLU:0.21559,((((SINF:0.01284,SLUT:0.01094):0.01151,SEQU:0.03141):0.13406,(SPYO:0.05112,(SCAN:0.02528,SDYS:0.02658):0.01944):0.11696):0.01218,SDOW:0.25071):0.00728):0.00313,((STHE:0.01512,(SSAL:0.00509,SVES:0.00338):0.00802):0.25110,SENT:0.23958):0.01294,(((((SMIT:0.02543,(SPSE:0.00225,SPNE:0.00629):0.02775):0.09835,(SINT:0.03666,(SANG:0.01545,SCON:0.01383):0.00585):0.10129):0.03424,SSUI:0.15506):0.03158,(LCRE:0.03488,LLAC:0.02999):0.19304):0.02541,(SDEV:0.01365,SRAT:0.01981):0.13815):0.00646):0.00000;
((SDOW:0.08694,(SDEV:0.03892,SRAT:0.04559):0.03419):0.01237,(((SSUI:0.00780,SPLU:0.00206):0.08635,((SSUI:0.05219,SCAN:0.06157):0.03776,SPYO:0.10338):0.01112):0.01587,(((SRAT:0.05929,SDEV:0.03377):0.39566,(SINT:0.04469,(SANG:0.03277,SCON:0.03445):0.01033):0.22901):0.11880,((SLUT:0.00584,(SINF:0.00029,SEQU:0.00111):0.00112):0.11717,(SCAN:0.02933,(SPYO:0.02602,SDYS:0.02046):0.01177):0.08710):0.00761):0.01521):0.01329,((SMIT:0.00283,(SPSE:0.00451,SPNE:0.01802):0.00139):0.06876,SANG:0.05500):0.03065):0.00000;
(((((SANG:0.00409,SINT:0.00048):0.00995,SCON:0.01749):0.01116,((LCRE:0.00000,LLAC:0.00000):0.09790,((SSUI:0.00000,SPLU:0.00000):0.01092,SDOW:0.01488):0.00385):0.00667):0.00388,(((SSAL:0.00741,(STHE:0.00457,SVES:0.00000):0.00020):0.01234,(SCAN:0.00000,(SPYO:0.00000,SDYS:0.00000):0.00000):0.00899):0.00227,(SDEV:0.01644,SRAT:0.00960):0.00605):0.00340):0.00117,(SINF:0.01116,(SLUT:0.00000,SEQU:0.00000):0.00101):0.00799,((SMIT:0.00351,(SPSE:0.00000,SPNE:0.00000):0.00261):0.00708,SENT:0.00211):0.01182):0.00000;
((SSUI:0.19690,(SDOW:0.37874,(SVES:0.04486,SSAL:0.05356):0.21576):0.22351):0.15630,SPSE:0.01151,SMIT:0.01149):0.00000;
((SDYS:0.17344,(((STHE:0.02205,(SSAL:0.01119,SVES:0.00764):0.01439):0.08490,(SEQU:0.02649,(SLUT:0.01590,SINF:0.01619):0.00940):0.06966):0.01386,SDOW:0.12475):0.06066):0.00578,(SPLU:0.12943,(SDEV:0.01876,SRAT:0.01244):0.09663):0.03617,(((SMIT:0.00967,(SPSE:0.00281,SPNE:0.00187):0.01556):0.05733,(SANG:0.01196,(SINT:0.00977,SCON:0.00576):0.00812):0.03287):0.13860,SSUI:0.19215):0.03334):0.00000;
((SANG:0.04327,(SDOW:0.28614,(SDEV:0.00833,SRAT:0.03362):0.18631):0.11062):0.05055,SCON:0.00471,SINT:0.01514):0.00000;
((SDOW:0.06383,(SDEV:0.02300,SRAT:0.02565):0.07241):0.01916,(SPSE:0.00000,SPNE:0.00000):0.13569,(LCRE:0.06712,LLAC:0.04826):0.06927):0.00000;
((SDEV:0.03704,SRAT:0.04037):0.15267,(SEQU:0.05795,(SINF:0.00587,SLUT:0.00623):0.05059):0.12795,(((SPYO:0.04734,(SCAN:0.03554,SDYS:0.02910):0.01120):0.15397,(SSAL:0.02650,SVES:0.02844):0.18416):0.00894,(SPLU:0.19294,(SENT:0.25237,((((SMIT:0.01489,(SPSE:0.01009,SPNE:0.01346):0.00680):0.11947,(SANG:0.01635,(SCON:0.01309,SINT:0.01009):0.00684):0.10815):0.08747,SSUI:0.24396):0.03472,((LLAC:0.03331,LCRE:0.03093):0.27552,SDOW:0.21222):0.01256):0.00599):0.00970):0.00525):0.00150):0.00000;
((SPYO:0.13393,(SDYS:0.10503,SCAN:0.10492):0.00681):0.13362,(SPLU:0.28426,((SEQU:0.12897,(SLUT:0.02779,SINF:0.03455):0.09443):0.13826,(SRAT:0.02442,SDEV:0.02799):0.23603):0.03921):0.00500,SDOW:0.29241):0.00000;
(SDOW:0.00449,SDOW:0.00449):0.00000;
(SDOW:0.58695,SPYO:0.02634,SDYS:0.03975):0.00000;
(SSAL:0.27550,SDOW:0.27550):0.00000;
(SINT:0.28517,SDOW:0.28517):0.00000;
(((SMIT:0.16640,(SINF:0.12117,(SDEV:0.04453,(SSAL:0.01864,SRAT:0.00869):0.05231):0.03301):0.05011):0.01970,(SENT:0.19119,(((SMIT:0.00898,SINT:0.00735):0.01572,SPLU:0.03328):0.00652,SCAN:0.02909):0.13173):0.03995):0.00558,SANG:0.26788,(SSAL:0.06923,SPSE:0.10219):0.11248):0.00000;
(((((SDEV:0.00000,SRAT:0.00000):0.14834,(SCAN:0.00848,(SPYO:0.00734,SDYS:0.00617):0.00600):0.12090):0.11360,((SANG:0.00186,SINT:0.01555):0.00899,SCON:0.02365):0.00750):0.01209,SPNE:0.00859):0.00493,SPSE:0.00024,SMIT:0.00749):0.00000;
(SRAT:0.00000,SDEV:0.00000):0.00000;
(((SENT:0.36821,(((LLAC:0.01478,LCRE:0.01569):0.34329,(((SINT:0.05667,(SCON:0.01889,SANG:0.02646):0.02265):0.17628,(SPSE:0.01994,(SPNE:0.01183,SMIT:0.01054):0.00235):0.23868):0.08742,SSUI:0.33694):0.00627):0.00877,SPLU:0.31248):0.00842):0.01459,(SDEV:0.02886,SRAT:0.03094):0.24512):0.00449,((SSAL:0.06766,(SVES:0.03588,STHE:0.03598):0.02067):0.26256,(SEQU:0.08011,(SLUT:0.02419,SINF:0.02367):0.05598):0.17649):0.01932,SDOW:0.26996):0.00000;
((SSUI:0.15957,((SDEV:0.17393,SRAT:0.16775):0.02076,SDOW:0.20364):0.14854):0.00411,((SPYO:0.18151,(SCAN:0.08442,SDYS:0.10034):0.06082):0.07304,SPLU:0.28488):0.00526,(SENT:0.27339,(SPSE:0.04499,SPNE:0.03464):0.20062):0.01085):0.00000;
(SRAT:0.02369,SDEV:0.02369):0.00000;
(SRAT:0.07053,SDEV:0.07053):0.00000;
(SPLU:0.05695,((SPYO:0.02439,(SCAN:0.01374,SDYS:0.01064):0.00391):0.04879,(((LCRE:0.00817,LLAC:0.00822):0.08533,(SDEV:0.15911,SRAT:0.12749):0.34687):0.02136,((((SMIT:0.00347,SPSE:0.00346):0.00210,SPNE:0.01278):0.05356,(SANG:0.01866,(SINT:0.01193,SCON:0.01749):0.00945):0.03462):0.00837,(SENT:0.05461,SSUI:0.04864):0.01175):0.01200):0.00569):0.00540,((((STHE:0.00719,SSAL:0.00450):0.00078,SVES:0.01069):0.04416,((SINF:0.01260,SLUT:0.01887):0.00448,SEQU:0.01580):0.03071):0.00617,(SDOW:0.05040,(SDEV:0.01323,SRAT:0.01576):0.04379):0.00908):0.00089):0.00000;
(SRAT:0.01890,SDEV:0.01890):0.00000;
((((SENT:0.03614,SCAN:0.06087):0.02542,((SSUI:0.02256,SPLU:0.00362):0.07446,SDYS:0.04694):0.00920):0.01332,(SPYO:0.04760,(SDOW:0.03335,SDEV:0.02782):0.01493):0.00585):0.00514,(((SINF:0.00375,SLUT:0.00633):0.00981,SEQU:0.00276):0.05877,SRAT:0.03155):0.00643,(((LCRE:0.05064,LLAC:0.06450):0.21545,(((STHE:0.02186,(SSAL:0.00052,SVES:0.01452):0.00449):0.01943,(SMIT:0.02654,(SPSE:0.01012,SPNE:0.00375):0.01507):0.00630):0.00811,SANG:0.06815):0.00986):0.00686,(SINT:0.02573,SCON:0.02703):0.02301):0.00577):0.00000;
(SVES:0.12736,SDEV:0.12736):0.00000;
(SRAT:0.02377,SDEV:0.02377):0.00000;
(SDEV:0.05884,SRAT:0.06792,SDOW:0.48060):0.00000;
(SRAT:0.04501,SDEV:0.04501):0.00000;
(SRAT:0.03496,SDEV:0.03496):0.00000;
(SRAT:0.00697,SDEV:0.00697):0.00000;
(SRAT:0.02715,SDEV:0.02715):0.00000;
(SRAT:0.02347,SDEV:0.02347):0.00000;
((SENT:0.39186,SDEV:0.34540):0.06026,SDOW:0.25484,SSUI:0.27998):0.00000;
((LLAC:0.05026,LCRE:0.06864):0.43105,SMIT:0.19194,(SDEV:0.05534,SRAT:0.05177):0.16325):0.00000;
((SANG:0.17376,SDEV:0.15210):0.02783,SEQU:0.23488,(SSAL:0.02496,SVES:0.11502):0.15217):0.00000;
((SRAT:0.08194,SPNE:0.09140):0.16885,(SRAT:0.29200,((SDEV:0.20473,SDEV:0.22146):0.14656,(SRAT:0.05167,SEQU:0.04488):0.32242):0.08002):0.02405,LCRE:0.25392):0.00000;
(SDEV:0.13282,SRAT:0.12524,SPNE:0.56566):0.00000;
(SRAT:0.04433,SDEV:0.04433):0.00000;
((((SDEV:0.02022,SRAT:0.01721):0.19802,(SPYO:0.04525,(SDYS:0.02930,SCAN:0.02872):0.01383):0.19076):0.07168,(SPLU:0.19260,SSUI:0.15987):0.05798):0.01483,SPNE:0.24290,(SINT:0.00584,SCON:0.00344):0.17923):0.00000;
(SRAT:0.00000,SDEV:0.00000):0.00000;
(((SCON:0.05423,(SSUI:0.00429,SPLU:0.00492):0.02106):0.00708,(SPNE:0.08273,((SINT:0.02050,SDEV:0.03019):0.00247,SRAT:0.03695):0.04219):0.01668):0.02818,(SPYO:0.01824,SDYS:0.01005):0.00164,SCAN:0.00824):0.00000;
(((SINT:0.02646,SCON:0.01832):0.00755,(SDEV:0.01690,SRAT:0.02624):0.01908):0.00132,((SSUI:0.01480,SPLU:0.00825):0.01856,(SCAN:0.01029,(SPYO:0.01116,SDYS:0.00643):0.00337):0.02187):0.00680,SPNE:0.03163):0.00000;
((SDYS:0.27611,(SDEV:0.00508,SRAT:0.00957):0.25025):0.04173,SDEV:0.27733,SDEV:0.39587):0.00000;
(SRAT:0.03173,SDEV:0.03173):0.00000;
(SRAT:0.02660,SDEV:0.02132,(SDEV:0.01465,SRAT:0.02113):0.40355):0.00000;
(SRAT:0.02154,SDEV:0.02154):0.00000;
(SDEV:0.02419,SRAT:0.03143,LCRE:0.67625):0.00000;
(SRAT:0.03559,SDEV:0.03559):0.00000;
(SRAT:0.17052,SDEV:0.17052):0.00000;
((((SPYO:0.04116,(SCAN:0.03866,SDYS:0.03541):0.00464):0.07824,(SDEV:0.04249,SRAT:0.04962):0.07688):0.00736,(((((SMIT:0.00653,SPSE:0.00774):0.00189,SPNE:0.01322):0.09591,((SANG:0.03487,SINT:0.04846):0.00694,SCON:0.04623):0.06701):0.02387,SSUI:0.12640):0.01597,SDOW:0.13737):0.01278):0.00274,((SSAL:0.01696,(STHE:0.01684,SVES:0.01609):0.00561):0.08932,(SLUT:0.03823,(SINF:0.02101,SEQU:0.01087):0.01753):0.06437):0.00668,(SPLU:0.09576,SENT:0.13663):0.00823):0.00000;
(SRAT:0.00805,SDEV:0.00805):0.00000;
(SDEV:0.03104,SRAT:0.03825,SDOW:0.47529):0.00000;
((((((SANG:0.02435,(SINT:0.00039,SCON:0.00043):0.02339):0.07054,(SMIT:0.07485,(SPSE:0.00000,SPNE:0.00000):0.10176):0.06948):0.02339,(SCAN:0.00578,(SDYS:0.00051,SPYO:0.00113):0.00322):0.20967):0.01784,(SDEV:0.03461,SRAT:0.02863):0.12145):0.00659,((LLAC:0.00000,LCRE:0.00000):0.30224,(((SINF:0.01544,SLUT:0.00843):0.01601,SEQU:0.03117):0.13352,((STHE:0.02570,(SSAL:0.00237,SVES:0.00607):0.01519):0.07920,SDOW:0.10798):0.06012):0.06280):0.03168):0.00303,SENT:0.21113,(SSUI:0.16293,SPLU:0.17149):0.00961):0.00000;
(SDEV:0.00000,SDEV:0.00000):0.00000;
(((SDEV:0.26378,((SENT:0.15595,((SCAN:0.07737,SPYO:0.08117):0.01255,SDYS:0.09949):0.07724):0.20368,(SDEV:0.17059,SPLU:0.16990):0.26904):0.08342):0.02806,SDEV:0.28512):0.08085,((SINT:0.00660,SCON:0.00862):0.12017,(SDEV:0.03986,SRAT:0.04085):0.09462):0.02540,(LCRE:0.03130,LLAC:0.02947):0.11713):0.00000;
((SINT:0.00275,SANG:0.00372):0.24238,(SDOW:0.23716,SDEV:0.42917):0.03463,SRAT:0.23180):0.00000;
((SDEV:0.03595,SRAT:0.02412):0.14179,SENT:0.22404,SANG:0.13261):0.00000;
(SDEV:0.00499,SRAT:0.01679,(SPLU:0.10811,(SPYO:0.00651,SDYS:0.00519):0.14639):0.08540):0.00000;
(SPLU:0.20644,(SPYO:0.06244,SDYS:0.05302):0.14135,(SDEV:0.08534,SRAT:0.08671):0.11900):0.00000;
(SRAT:0.03663,SDEV:0.03663):0.00000;
(SRAT:0.05494,SDEV:0.05494):0.00000;
(((((SANG:0.12004,SINT:0.13608):0.01533,(SPSE:0.01159,(SMIT:0.00649,SPNE:0.00671):0.00332):0.13549):0.07385,((SSUI:0.01046,SPLU:0.00578):0.18268,(SCAN:0.15305,(SDOW:0.12134,SRAT:0.11400):0.04702):0.03094):0.01833):0.01681,((((SENT:0.18608,((SDEV:0.02660,SRAT:0.02375):0.11255,(SINF:0.04945,SEQU:0.04755):0.08974):0.04274):0.00951,SSAL:0.21616):0.11365,((SSUI:0.08764,(SCON:0.01290,(SPNE:0.00194,SPSE:0.00223):0.01423):0.08881):0.10089,(SCAN:0.07669,SPYO:0.08253):0.12424):0.10904):0.02226,((LCRE:0.04967,LLAC:0.05161):0.19448,SANG:0.27587):0.07605):0.22531):0.00382,SANG:0.20107,(SEQU:0.06120,SLUT:0.06622):0.14114):0.00000;
(((LLAC:0.04542,LCRE:0.04677):0.35078,((SANG:0.04878,(SINT:0.01397,SCON:0.01451):0.03670):0.14486,SSUI:0.20163):0.00828):0.00374,(SDOW:0.26178,((SSAL:0.05938,(STHE:0.01888,SVES:0.04568):0.01422):0.16011,(((SDEV:0.04958,SRAT:0.05761):0.12760,((SCAN:0.07007,SDYS:0.07411):0.04533,SPYO:0.12910):0.09776):0.01021,(SEQU:0.09781,(SLUT:0.03873,SINF:0.03558):0.06182):0.11268):0.01621):0.00613):0.00435,SENT:0.23800):0.00000;
(SRAT:0.06923,SDEV:0.06923):0.00000;
((((SENT:0.22099,((SCAN:0.02338,SPYO:0.02814):0.03781,SDYS:0.05969):0.10717):0.04177,(SDEV:0.02215,SRAT:0.03703):0.11605):0.06474,SEQU:0.05763):0.01807,SLUT:0.02876,SINF:0.02925):0.00000;
(SDEV:0.16988,SRAT:0.12265,SDOW:0.16515):0.00000;
(SDEV:0.20360,SSUI:0.24339,SSUI:0.39199):0.00000;
(SRAT:0.11443,SDEV:0.11443):0.00000;
(((SDEV:0.17638,SRAT:0.18468):0.04803,SSAL:0.19861):0.03233,((SANG:0.02199,SINT:0.04217):0.07007,SCON:0.11317):0.08086,SDOW:0.45367):0.00000;
((((LLAC:0.02227,LCRE:0.01588):0.22420,(SDEV:0.02723,SRAT:0.02872):0.16974):0.07457,(SMIT:0.03446,(SPSE:0.00986,SPNE:0.00325):0.04022):0.10410):0.08187,SCON:0.03556,(SANG:0.00880,SINT:0.01561):0.02042):0.00000;
((SEQU:0.12784,(SDEV:0.02799,SRAT:0.03433):0.36770):0.07827,SINF:0.00965,SLUT:0.01279):0.00000;
((((SDEV:0.02524,SRAT:0.03162):0.07893,SENT:0.10946):0.14974,SSAL:0.07371):0.03092,(SINT:0.04163,SCON:0.02822):0.00943,SANG:0.02775):0.00000;
(((SMIT:0.01429,(SPSE:0.00057,SPNE:0.00264):0.00700):0.03455,((SDEV:0.00676,SRAT:0.00592):0.19675,(SCAN:0.00905,(SPYO:0.00641,SDYS:0.00458):0.00749):0.10799):0.07050):0.01935,SCON:0.01781,(SANG:0.00513,SINT:0.00485):0.01054):0.00000;
(SDEV:0.12728,SRAT:0.14162,SDOW:0.20815):0.00000;
((SDEV:0.03985,SRAT:0.04210):0.09135,(SINF:0.06762,(SLUT:0.05122,SEQU:0.05835):0.02711):0.06896,((SDOW:0.19453,((STHE:0.02733,(SSAL:0.01796,SVES:0.01267):0.01263):0.11131,(SANG:0.02792,SCON:0.03265):0.10853):0.03729):0.00851,(SSUI:0.13750,SENT:0.12682):0.01803):0.00435):0.00000;
(SDEV:0.36933,SPYO:0.19907,SPLU:0.18146):0.00000;
(SDEV:0.15674,SDEV:0.15674):0.00000;
(SRAT:0.11902,SDEV:0.11902):0.00000;
((SDEV:0.28561,SINF:0.33981):0.39854,LCRE:0.00555,LLAC:0.00479):0.00000;
(SDEV:0.33244,SPNE:0.00539,SPSE:0.01597):0.00000;
(SDEV:0.36621,SDEV:0.36621):0.00000;
(SDEV:0.05966,SRAT:0.06667,SINT:0.46403):0.00000;
(((STHE:0.01723,((SMIT:0.00285,SPSE:0.00000):0.00058,SPNE:0.00454):0.01197):0.03071,SSUI:0.04376):0.01118,((LCRE:0.01401,LLAC:0.00825):0.10761,SPLU:0.05483):0.01206,((((SINF:0.00197,SLUT:0.00261):0.00653,SEQU:0.00807):0.02298,(SDEV:0.00714,SRAT:0.00834):0.04880):0.01096,((SSAL:0.00000,SVES:0.00000):0.03451,SDOW:0.06634):0.04121):0.00714):0.00000;
(SDEV:0.10544,SRAT:0.10194,SDOW:0.48042):0.00000;
((((SDEV:0.23099,(SPLU:0.00000,SSUI:0.00000):0.41768):0.05788,((SMIT:0.03637,SPNE:0.02745):0.01404,SVES:0.05873):0.09486):0.05950,SDOW:0.09776):0.01883,SSUI:0.07030,SANG:0.08389):0.00000;
(SVES:0.26964,SDEV:0.26964):0.00000;
(SRAT:0.19658,SDEV:0.19658):0.00000;
(SDEV:0.04321,SDEV:0.04321):0.00000;
(SRAT:0.08487,SDEV:0.08487):0.00000;
((SDEV:0.20214,SRAT:0.23199):0.02621,SDOW:0.29441,SDOW:0.16666):0.00000;
(SRAT:0.05068,SDEV:0.05068):0.00000;
(SDEV:0.03100,SRAT:0.04573,SPLU:0.46688):0.00000;
(SANG:0.32927,SDEV:0.32927):0.00000;
(SRAT:0.13140,SDEV:0.13140):0.00000;
(((SENT:0.13830,SEQU:0.15074):0.01229,(((LLAC:0.12098,LCRE:0.11544):0.16569,((SSUI:0.17373,(SRAT:0.16774,SENT:0.15985):0.01876):0.02863,(SMIT:0.00783,(SPSE:0.00879,SPNE:0.00534):0.00545):0.16497):0.04852):0.25091,((SPLU:0.07075,SDYS:0.09166):0.08099,SENT:0.15364):0.07491):0.09979):0.01233,((((SANG:0.04040,(SINT:0.01108,SCON:0.01433):0.02131):0.04295,((SPSE:0.00593,(SMIT:0.00626,SPNE:0.00826):0.00134):0.09574,SSUI:0.15009):0.01986):0.02804,SDOW:0.14791):0.01885,((SSAL:0.01059,SVES:0.01095):0.09833,(SSUI:0.12937,(SDEV:0.08054,SRAT:0.08433):0.02852):0.00529):0.01209):0.00590,(SPLU:0.12628,((SCAN:0.00000,SPYO:0.00000):0.02275,SDYS:0.03564):0.06876):0.01490):0.00000;
((SSUI:0.11379,(((SCAN:0.00504,SDYS:0.01209):0.02411,SPYO:0.02744):0.02838,(SLUT:0.06126,(SINF:0.00815,SEQU:0.00045):0.01039):0.02623):0.01786):0.01351,((SPSE:0.00000,SPNE:0.00000):0.04340,SENT:0.03253):0.23263,LLAC:0.17567):0.00000;
((SPLU:0.04883,(SDYS:0.00000,SPYO:0.00000):0.04443):0.00800,((((LCRE:0.35079,(((SLUT:0.01266,SEQU:0.01122):0.03865,SPLU:0.06222):0.23854,LCRE:0.25836):0.10334):0.01052,((SPSE:0.00341,(SMIT:0.00108,SPNE:0.00151):0.00113):0.39642,((SSUI:0.09538,SPLU:0.07671):0.12903,(SPNE:0.09081,((SDEV:0.08735,(((SINF:0.00000,SLUT:0.00000):0.00685,SEQU:0.00610):0.05557,SRAT:0.05091):0.01552):0.00402,SMIT:0.08136):0.02523):0.07317):0.16107):0.02688):0.02070,(SCAN:0.08518,(SSUI:0.00978,SPLU:0.01307):0.07427):0.24794):0.29494,SENT:0.05748):0.00278,((SPSE:0.01874,(SMIT:0.00516,SPNE:0.00713):0.00756):0.01844,(SANG:0.00156,(SINT:0.00023,SCON:0.00245):0.00112):0.02575):0.02511):0.00000;
(((SSAL:0.03128,(STHE:0.00000,SVES:0.00000):0.00443):0.09634,((SDYS:0.04334,(SCAN:0.02660,SPYO:0.04569):0.04134):0.03864,((SINF:0.00000,SLUT:0.00000):0.06596,SEQU:0.05550):0.01525):0.05519):0.00636,SPLU:0.11294,(SSUI:0.17176,((LLAC:0.01111,LCRE:0.02069):0.32293,((SDOW:0.16247,SENT:0.16504):0.02203,(((SPSE:0.02627,(SMIT:0.00248,SPNE:0.04316):0.01947):0.08876,((SANG:0.06642,SINT:0.10858):0.02830,SCON:0.03955):0.01934):0.05491,(SRAT:0.07358,SDEV:0.08267):0.10830):0.06521):0.04068):0.02565):0.03696):0.00000;
((SPLU:0.12224,(SPYO:0.01910,SDYS:0.01344):0.15229):0.07942,SRAT:0.02187,SDEV:0.01666):0.00000;
(((((SINF:0.01167,SLUT:0.01474):0.03788,SEQU:0.04443):0.09233,(SCAN:0.07139,(SPYO:0.04785,SDYS:0.04566):0.02181):0.10397):0.00851,(SDOW:0.14345,(SDEV:0.02648,SRAT:0.02534):0.10816):0.00899):0.00407,(((LCRE:0.02853,LLAC:0.02812):0.32382,((((SPSE:0.01492,SPNE:0.01525):0.00412,SMIT:0.02331):0.16076,(SINT:0.04948,(SANG:0.04021,SCON:0.03742):0.00637):0.10001):0.02881,SSUI:0.16975):0.00745):0.01396,(SENT:0.16611,SPLU:0.16457):0.00992):0.00467,(SSAL:0.02179,(STHE:0.01892,SVES:0.01729):0.00897):0.14858):0.00000;
(((SSAL:0.00361,(STHE:0.00701,SVES:0.00125):0.01624):0.00599,((((SDOW:0.08367,(SENT:0.03601,((SCAN:0.00737,SPYO:0.01243):0.00267,SDYS:0.00395):0.04030):0.01392):0.01246,((LCRE:0.00629,LLAC:0.00295):0.14423,(((SINF:0.00222,SLUT:0.00117):0.00808,SEQU:0.00713):0.01417,(SDEV:0.01929,SRAT:0.02382):0.01891):0.05005):0.01667):0.00897,(SSUI:0.01698,SPLU:0.02033):0.06335):0.02025,(SINT:0.02381,(SANG:0.01200,SCON:0.01037):0.00525):0.03544):0.02523):0.01133,SPNE:0.01872,(SMIT:0.00229,SPSE:0.00184):0.00067):0.00000;
(((((SINF:0.01128,SLUT:0.00735):0.00881,SEQU:0.01639):0.03122,(SCAN:0.02807,(SPYO:0.00383,SDYS:0.00061):0.01811):0.03558):0.00285,(((STHE:0.01370,(SSAL:0.00622,SVES:0.00626):0.00720):0.03076,SPLU:0.05543):0.00536,(SDOW:0.06938,(SDEV:0.00799,SRAT:0.00223):0.05246):0.00677):0.00737):0.00070,((((SMIT:0.00833,(SPSE:0.00543,SPNE:0.00924):0.00167):0.03235,(SANG:0.01468,(SINT:0.00882,SCON:0.01580):0.03637):0.02134):0.01567,SSUI:0.06683):0.01336,SENT:0.08556):0.00164,(LCRE:0.01075,LLAC:0.00950):0.13979):0.00000;
((SPNE:0.04708,SPSE:0.03928):0.01150,SMIT:0.05860,((LLAC:0.05506,LCRE:0.03605):0.49159,SSUI:0.24387):0.14839):0.00000;
(SPNE:0.10182,SDEV:0.13268,SENT:0.11310):0.00000;
((((SINF:0.00334,(SLUT:0.00000,SEQU:0.00000):0.00301):0.06932,SRAT:0.03826):0.00714,(SPNE:0.09293,((SSUI:0.09900,SPLU:0.07305):0.08197,((SMIT:0.00134,SPNE:0.00300):0.00139,SPSE:0.00802):0.53039):0.06802):0.03359):0.00584,SDEV:0.05855,SMIT:0.04194):0.00000;
((SPSE:0.00337,SPNE:0.00346):0.00303,SENT:0.31789,SMIT:0.00564):0.00000;
(SPNE:0.01215,SPSE:0.05372,SMIT:0.01910):0.00000;
((SPSE:0.01363,SPNE:0.01021):0.00737,(SPLU:0.09622,SENT:0.09910):0.07892,SMIT:0.01621):0.00000;
(((SMIT:0.01033,SPNE:0.02100):0.06110,SINF:0.20382):0.03090,(SSAL:0.00682,SVES:0.00219):0.00318,STHE:0.00790):0.00000;
(SENT:0.02509,SPNE:0.02509):0.00000;
(SPNE:0.10004,SPSE:0.04559,SMIT:0.29600):0.00000;
(SPNE:0.35740,SENT:0.28184,SDEV:0.40710):0.00000;
((SSUI:0.00843,(SANG:0.05111,((((SCON:0.02680,(SCON:0.00023,SCAN:0.00001):0.02111):0.37883,(((SDYS:0.09860,SINF:0.07992):0.06774,SDOW:0.14992):0.07812,SCAN:0.25563):0.08768):0.18883,SENT:0.11458):0.02599,(SVES:0.00314,(SMIT:0.00387,SPNE:0.00417):0.00013):0.08904):0.03912):0.03988):0.00173,SDYS:0.00510,(SSUI:0.00486,SPLU:0.00719):0.00130):0.00000;
(((SLUT:0.05137,SEQU:0.02743):0.03093,((STHE:0.01358,(SSAL:0.00000,SVES:0.00000):0.00763):0.03462,((SMIT:0.00000,SPSE:0.00000):0.02510,SPNE:0.27229):0.03598):0.02227):0.01361,(SDEV:0.04122,SRAT:0.03339):0.02067,SDOW:0.06415):0.00000;
(SPNE:0.00137,SPSE:0.02820,SMIT:0.01481):0.00000;
(SPNE:0.00016,SDYS:0.24397,SPSE:0.00344):0.00000;
(SPNE:0.00924,SPSE:0.00680,SMIT:0.00202):0.00000;
(SPNE:0.47960,SCAN:0.11833,SDYS:0.12710):0.00000;
(SPNE:0.20397,SPSE:0.35201,SMIT:0.19461):0.00000;
((((((STHE:0.01857,(SSAL:0.01050,SVES:0.00332):0.01148):0.07306,SPLU:0.11727):0.03147,((SPYO:0.14302,(SCAN:0.06913,SDYS:0.08356):0.05034):0.01941,(SINF:0.08188,(SEQU:0.02491,SLUT:0.03559):0.04682):0.05657):0.00483):0.08518,((SRAT:0.04531,SDEV:0.05556):0.12413,(SDOW:0.18717,SDOW:0.22325):0.04788):0.00914):0.00640,(SMIT:0.02072,(SPSE:0.00296,SPNE:0.00807):0.02656):0.13454):0.00537,SSUI:0.15673,(SINT:0.03112,(SANG:0.02723,SCON:0.01231):0.01357):0.10891):0.00000;
(SENT:0.19903,SPNE:0.19903):0.00000;
(SPNE:0.02983,SMIT:0.02119,SDYS:0.72641):0.00000;
(SPNE:0.01221,(SMIT:0.01126,SSUI:0.36846):0.00483,SPSE:0.00476):0.00000;
((SPNE:0.03218,((((SCON:0.07022,SANG:0.04755):0.12192,SDEV:0.18381):0.03402,(SEQU:0.02223,SLUT:0.01934):0.20030):0.15275,SINT:0.10003):0.04530):0.01770,SPSE:0.03818,SMIT:0.02249):0.00000;
(SDYS:0.23560,SPNE:0.23560):0.00000;
(((SPNE:0.02370,(SINT:0.00663,SCON:0.00548):0.02304):0.05217,((SSUI:0.01880,SPLU:0.02138):0.06696,(SPNE:0.29814,SDEV:0.31394):0.32019):0.02208):0.08214,(SCAN:0.00299,SDYS:0.00231):0.00277,SPYO:0.00744):0.00000;
(SRAT:0.26433,SPNE:0.26433):0.00000;
(SPNE:0.04957,SPSE:0.02818,SMIT:0.23920):0.00000;
(SENT:0.18170,SDOW:0.21353,((((SSAL:0.30720,(STHE:0.00890,(SSAL:0.00969,SVES:0.01261):0.00765):0.08508):0.09930,((LLAC:0.01725,LCRE:0.02215):0.24619,((SRAT:0.03307,SDEV:0.03067):0.36351,((SINT:0.01895,(SCON:0.01092,SANG:0.01274):0.00635):0.28192,((SANG:0.18776,(SSUI:0.16318,SCAN:0.15373):0.04958):0.10446,((SMIT:0.07443,(SPNE:0.01575,SPSE:0.01138):0.06435):0.16245,((SPYO:0.15194,SSUI:0.13975):0.08213,(SENT:0.22265,((SEQU:0.02181,(SLUT:0.01629,SINF:0.01771):0.00647):0.16322,((SCAN:0.03259,(SPYO:0.03969,SDYS:0.02718):0.00727):0.13613,(SDOW:0.10508,(SDEV:0.03200,SRAT:0.02683):0.07436):0.08762):0.00311):0.01694):0.02211):0.00351):0.07432):0.01210):0.07242):0.05717):0.06259):0.00497,(SSUI:0.18241,(((SCAN:0.03725,SPYO:0.05397):0.00620,SDYS:0.04844):0.14070,((SDEV:0.01083,SRAT:0.01929):0.14971,((SINF:0.01373,SLUT:0.01448):0.01996,SEQU:0.03482):0.11485):0.01153):0.00250):0.01009):0.01001,(SPLU:0.17263,((SINT:0.02713,(SANG:0.01536,SCON:0.01180):0.00366):0.10284,((SMIT:0.00530,SPSE:0.00295):0.00240,SPNE:0.00913):0.11926):0.06094):0.00539):0.00514):0.00000;
((SPSE:0.00952,SPNE:0.00346):0.02868,(((SENT:0.23385,SANG:0.17395):0.04072,SSUI:0.13204):0.05143,SRAT:0.03968):0.02230,SSAL:0.03959):0.00000;
((SMIT:0.00156,SPNE:0.00926):0.01231,SPSE:0.00624,SVES:0.26329):0.00000;
(SPNE:0.02108,SPSE:0.03880,SMIT:0.05387):0.00000;
(((SSUI:0.06910,((LCRE:0.00647,LLAC:0.00937):0.29257,(((SANG:0.00798,SINT:0.01358):0.00331,SCON:0.01467):0.02677,(SMIT:0.01315,(SPSE:0.01986,SPNE:0.01421):0.00741):0.03228):0.04589):0.00999):0.02622,(SPLU:0.08381,(SENT:0.06753,(((SLUT:0.01335,(SINF:0.00480,SEQU:0.00778):0.00312):0.02376,(SCAN:0.00615,(SPYO:0.00774,SDYS:0.00303):0.00254):0.02627):0.00766,(SDEV:0.00742,SRAT:0.00517):0.03939):0.01105):0.00350):0.00659):0.00144,SDOW:0.09797,(SSAL:0.01242,(STHE:0.01420,SVES:0.00725):0.01260):0.06003):0.00000;
((SPNE:0.60010,SANG:0.06393):0.06329,SCON:0.00605,SINT:0.00705):0.00000;
(((LLAC:0.07207,LCRE:0.07267):0.23907,((SPNE:0.01294,SPSE:0.01054):0.10105,SMIT:0.10914):0.19605):0.00568,((SSAL:0.07020,STHE:0.05920):0.23031,((SPLU:0.26112,((SRAT:0.02174,SDEV:0.01406):0.18873,SDOW:0.20662):0.03431):0.00667,((((SINF:0.01518,SLUT:0.01927):0.03056,SEQU:0.04834):0.13583,(SPYO:0.12618,(SDYS:0.07280,SCAN:0.07611):0.04445):0.09515):0.01682,SENT:0.30097):0.02805):0.01725):0.01562,(SSUI:0.29660,(SINT:0.04878,(SCON:0.03933,SANG:0.03829):0.01031):0.18968):0.01056):0.00000;
(SENT:0.20480,SPNE:0.20480):0.00000;
(SPSE:0.03065,SPNE:0.03065):0.00000;
((SINT:0.00529,((((SPYO:0.03537,SDYS:0.03474):0.03267,SCAN:0.06681):0.21823,SPNE:0.19438):0.04001,SSUI:0.16974):0.12859):0.00147,SCON:0.00310,SANG:0.00304):0.00000;
(SRAT:0.34340,SPNE:0.34340):0.00000;
((((SANG:0.02207,SINT:0.02295):0.00567,SCON:0.02885):0.03776,((SPNE:0.00000,SPSE:0.00000):0.00832,SMIT:0.00422):0.07032):0.01290,((SINF:0.00795,(SLUT:0.00497,SEQU:0.00073):0.00343):0.06065,((((SPLU:0.09287,SENT:0.11040):0.02678,(SPYO:0.05319,(SCAN:0.02008,SDYS:0.02786):0.02141):0.05320):0.01259,(((LLAC:0.00245,LCRE:0.00120):0.18277,(STHE:0.02559,(SSAL:0.00121,SVES:0.00260):0.00687):0.05117):0.00413,SDOW:0.07917):0.01275):0.00581,(SDEV:0.01667,SRAT:0.00730):0.06259):0.00902):0.00713,SSUI:0.10157):0.00000;
(((SDOW:0.12208,(((SINF:0.05328,SLUT:0.04763):0.00761,SEQU:0.06219):0.04090,((SDEV:0.03475,SRAT:0.04690):0.07325,((SPYO:0.08666,(SCAN:0.05555,SDYS:0.04468):0.04164):0.06560,((LCRE:0.00677,LLAC:0.00452):0.18407,(((SPNE:0.01493,SPSE:0.01761):0.00369,SMIT:0.01316):0.14445,(SSUI:0.18053,((SANG:0.05318,SCON:0.04506):0.01085,SINT:0.08889):0.11249):0.01375):0.00815):0.01940):0.01367):0.00959):0.01583):0.00921,(SSAL:0.05328,(STHE:0.02528,SVES:0.03090):0.01664):0.09308):0.00663,SENT:0.12577,SPLU:0.08662):0.00000;
(SPSE:0.03143,SPNE:0.03143):0.00000;
(SPSE:0.14578,SPNE:0.14578):0.00000;
((((SENT:0.16239,((SMIT:0.01295,SPNE:0.01003):0.10226,((SANG:0.03395,SINT:0.01794):0.00119,SCON:0.02118):0.06952):0.04333):0.00280,(((SINF:0.01071,SLUT:0.01134):0.02224,SEQU:0.02791):0.07361,(SDEV:0.02633,SRAT:0.02892):0.06504):0.01234):0.01061,SDOW:0.10130):0.00452,SPLU:0.11950,(SSAL:0.02152,(STHE:0.01654,SVES:0.01458):0.00512):0.08976):0.00000;
(SINT:0.23487,SPNE:0.23487):0.00000;
(SPNE:0.11020,SPSE:0.09687,SMIT:0.07603):0.00000;
((SSUI:0.06873,((SANG:0.02058,(SINT:0.00637,SCON:0.00802):0.01942):0.03629,(SPSE:0.01049,(SMIT:0.00780,SPNE:0.00522):0.00048):0.04189):0.01765):0.00485,(SDOW:0.07982,((((LCRE:0.00979,LLAC:0.00983):0.12425,((SANG:0.05893,SCON:0.05486):0.08771,(SRAT:0.04443,SDEV:0.04235):0.09205):0.22358):0.04445,SENT:0.09553):0.00958,(SDEV:0.06913,SRAT:0.06275):0.02126):0.00621):0.00256,((STHE:0.01089,(SSAL:0.00487,SVES:0.01218):0.00684):0.05011,((SPLU:0.06123,((SINF:0.00605,SLUT:0.00635):0.00868,SEQU:0.01131):0.03731):0.00456,(SCAN:0.01778,(SPYO:0.01395,SDYS:0.00860):0.01019):0.03738):0.00814):0.00406):0.00000;
(SPNE:0.06279,SPNE:0.06279):0.00000;
(SDEV:0.29055,SPNE:0.29055):0.00000;
(((SPSE:0.02020,SPNE:0.01233):0.08448,SDYS:0.08863):0.00468,SCAN:0.07546,SENT:0.26107):0.00000;
(SPNE:0.11519,SPNE:0.11519):0.00000;
(SPNE:0.05154,SDYS:0.04247,(SVES:0.41268,STHE:0.10427):0.07757):0.00000;
(SANG:0.20208,SPSE:0.20208):0.00000;
((((SANG:0.04606,(SINT:0.02589,SCON:0.01485):0.05359):0.06451,(SPLU:0.39062,(SSUI:0.17309,SENT:0.18832):0.01891):0.09662):0.09826,SPSE:0.00932):0.00444,SPNE:0.00671,SMIT:0.00399):0.00000;
(SPSE:0.00000,SPYO:0.27543,SPNE:0.00000):0.00000;
(SDYS:0.26188,SPSE:0.26188):0.00000;
((((SSUI:0.27722,SPLU:0.20678):0.02232,SSUI:0.21584):0.05646,((SMIT:0.00978,(SPSE:0.00033,SPNE:0.00292):0.00971):0.29517,(SPLU:0.19762,SPSE:0.11176):0.06003):0.02898):0.02847,SMIT:0.15278,SSUI:0.15117):0.00000;
(SDOW:0.23428,SPSE:0.23428):0.00000;
(SPSE:0.20216,SENT:0.12636,SINF:0.12448):0.00000;
(SANG:0.11171,SPSE:0.11171):0.00000;
((SPNE:0.00720,SPSE:0.01299):0.10823,SCON:0.15218,((LLAC:0.11552,LCRE:0.08955):0.32416,SSUI:0.24075):0.11378):0.00000;
(SPSE:0.10227,SINF:0.14114,SINT:0.10686):0.00000;
(SDYS:0.30973,SPSE:0.30973):0.00000;
((SPSE:0.00885,SPNE:0.01472):0.38848,(SANG:0.06711,SPLU:0.05968):0.23168,SPSE:0.32729):0.00000;
(SPSE:0.14091,SENT:0.07661,SPLU:0.09134):0.00000;
(SPSE:0.01677,(SPNE:0.02911,(SSUI:0.32841,SINT:0.13088):0.10278):0.00149,SMIT:0.01921):0.00000;
((SENT:0.24213,SPSE:0.24704):0.03309,(SINF:0.11315,SPYO:0.13161):0.20918,(SPLU:0.19180,SANG:0.16844):0.13935):0.00000;
(SSUI:0.22989,SPSE:0.22989):0.00000;
((((((SCON:0.00000,SANG:0.00000):0.01299,SINT:0.01299):0.16700,(SDOW:0.35899,(SPLU:0.24378,(SRAT:0.02284,SDEV:0.04181):0.12480):0.02091):0.11545):0.05556,SPSE:0.21274):0.04052,SPSE:0.01617):0.00645,SPNE:0.01696,SMIT:0.02829):0.00000;
(((LLAC:0.08506,(LCRE:0.05866,(LLAC:0.07364,LCRE:0.07092):0.00618):0.00449):0.12381,(SPSE:0.03273,(SVES:0.01988,(STHE:0.01256,SANG:0.01438):0.00250):0.00924):0.13879):0.08836,((SDEV:0.02518,SRAT:0.02580):0.02840,(SMIT:0.04701,SDOW:0.03202):0.00457):0.00347,(SSUI:0.02946,SPLU:0.01857):0.02274):0.00000;
(SDOW:0.14650,SPSE:0.14650):0.00000;
(SPSE:0.03902,SPNE:0.06049,SPSE:0.02244):0.00000;
(SPNE:0.02736,SPSE:0.02736):0.00000;
(SVES:0.29239,SPSE:0.29239):0.00000;
(((SSUI:0.29772,(SPSE:0.33865,(SPNE:0.01988,SPSE:0.01776):0.29785):0.03710):0.00782,((((((SDOW:0.16593,SDEV:0.19456):0.02140,SRAT:0.18411):0.08893,(SDOW:0.25517,(SVES:0.07864,(SSAL:0.02544,STHE:0.02747):0.06135):0.17555):0.01134):0.02685,(SDEV:0.23591,SSAL:0.25783):0.03492):0.11164,(SPSE:0.00384,SPNE:0.00354):0.33200):0.00559,SEQU:0.35478):0.02972):0.04186,((SPLU:0.25571,(SDYS:0.22554,(SPYO:0.07399,SCAN:0.06932):0.15613):0.03276):0.01710,SENT:0.27263):0.00465,((SEQU:0.08601,(SLUT:0.01061,SINF:0.00273):0.08955):0.16512,(SRAT:0.02361,SDEV:0.02096):0.20869):0.01315):0.00000;
(SDEV:0.29924,SPSE:0.29924):0.00000;
(SPNE:0.16974,SPSE:0.16974):0.00000;
((SPSE:0.11545,SENT:0.25454):0.12764,(SSAL:0.01051,SVES:0.01465):0.00972,STHE:0.01672):0.00000;
(SENT:0.45663,SPSE:0.13384,SPSE:0.15851):0.00000;
(SMIT:0.22933,SPSE:0.22933):0.00000;
(SPNE:0.00859,SPSE:0.00859):0.00000;
(SPSE:0.00657,(SPNE:0.05685,SANG:0.22232):0.03278,SPSE:0.04494):0.00000;
((((LCRE:0.04728,LLAC:0.04455):0.25555,(SPSE:0.01130,SPNE:0.00951):0.12527):0.05741,SDOW:0.09374):0.03616,SRAT:0.02201,SDEV:0.03511):0.00000;
(SPNE:0.06395,SPSE:0.06395):0.00000;
(SPNE:0.00000,SPSE:0.00000):0.00000;
(((SPSE:0.03109,SPNE:0.02116):0.01622,SMIT:0.02205):0.16166,(SENT:0.18323,(((SEQU:0.05781,(SINF:0.01424,SLUT:0.01891):0.01803):0.11078,(((STHE:0.02415,(SSAL:0.01242,SVES:0.01504):0.00409):0.11078,SPLU:0.12312):0.03351,(SPYO:0.12404,(SCAN:0.07571,SDYS:0.07307):0.01019):0.09380):0.00879):0.01266,(SSUI:0.15695,SRAT:0.15599):0.02562):0.01403):0.00512,(SANG:0.06245,(SINT:0.05304,SCON:0.04152):0.03181):0.12079):0.00000;
(SENT:0.30504,(SPSE:0.27066,(SCON:0.03502,SINT:0.03113):0.24363):0.17656,SSUI:0.24406):0.00000;
(SPNE:0.02482,SPSE:0.02482):0.00000;
(SPNE:0.02013,SPSE:0.02013):0.00000;
(SANG:0.13043,SPSE:0.13043):0.00000;
(SPNE:0.00000,SPSE:0.00000):0.00000;
(SENT:0.04431,SPSE:0.04431):0.00000;
(SPSE:0.02966,SPSE:0.02966):0.00000;
((SINF:0.17069,((SPNE:0.00281,SPSE:0.00485):0.05084,SDYS:0.04275):0.32210):0.01833,SDEV:0.14203,SLUT:0.12891):0.00000;
(SPNE:0.02592,SPSE:0.02592):0.00000;
(SPNE:0.06042,SPSE:0.06042):0.00000;
(SPNE:0.02632,SPSE:0.02632):0.00000;
((SPSE:0.05106,SPSE:0.01674):0.02330,(SPSE:0.11310,SPSE:0.05357):0.01445,SPSE:0.21553):0.00000;
(SPNE:0.06241,SPSE:0.06241):0.00000;
(SPNE:0.00766,SPSE:0.00766):0.00000;
(SPNE:0.02509,SPSE:0.02509):0.00000;
(SPSE:0.03044,SPNE:0.27293,SMIT:0.05383):0.00000;
(SPNE:0.03355,SPSE:0.03355):0.00000;
((SPSE:0.28552,(SPNE:0.27519,SENT:0.24906):0.03878):0.02875,((SPSE:0.02859,SPNE:0.02380):0.33799,SPSE:0.27598):0.00099,SVES:0.41747):0.00000;
((SPSE:0.16111,(SPNE:0.12117,SPSE:0.13574):0.07895):0.04743,(SPNE:0.04647,SPSE:0.06123):0.02537,SMIT:0.10891):0.00000;
(SPNE:0.01008,SPSE:0.01008):0.00000;
(SSUI:0.15572,SPSE:0.15572):0.00000;
((SPSE:0.01317,(STHE:0.24741,(SANG:0.06597,(SINT:0.00411,SCON:0.00093):0.06175):0.08967):0.13228):0.00176,SPNE:0.01468,SMIT:0.01127):0.00000;
(SPNE:0.00000,SPSE:0.00000):0.00000;
(SINF:0.23284,SPSE:0.23284):0.00000;
(SPNE:0.00916,SPSE:0.00916):0.00000;
(SPNE:0.00744,SPSE:0.00744):0.00000;
((SENT:0.21062,SSUI:0.16423):0.01619,((SSAL:0.04019,STHE:0.04389):0.10068,(SCON:0.03741,SANG:0.03743):0.14160):0.02364,((LCRE:0.06422,LLAC:0.07271):0.20982,((SDYS:0.18697,(SEQU:0.07759,(SLUT:0.01775,SINF:0.01033):0.06304):0.10411):0.08679,SDOW:0.25937):0.04394):0.02615):0.00000;
((((SDYS:0.05569,SCAN:0.04979):0.12455,((SSUI:0.01937,SPLU:0.01096):0.11634,SENT:0.10979):0.03577):0.01280,(((((LLAC:0.07467,LCRE:0.07356):0.27223,((SEQU:0.08338,(SINF:0.05313,SLUT:0.05772):0.03100):0.16187,(SDEV:0.04620,SRAT:0.03981):0.21904):0.11472):0.13536,(LLAC:0.04351,LCRE:0.05016):0.25580):0.09875,(((STHE:0.00596,SSAL:0.00701):0.00652,SVES:0.01156):0.11288,(((SMIT:0.00223,SPSE:0.00547):0.00100,SPNE:0.00578):0.06692,(SINT:0.04776,(SANG:0.03346,SCON:0.03719):0.00414):0.03175):0.04020):0.07104):0.00699,SDOW:0.19261):0.02778):0.01228,(SRAT:0.05146,SDEV:0.04656):0.07617,(SLUT:0.00479,(SINF:0.00366,SLUT:0.00352):0.00172):0.13157):0.00000;
(SENT:0.07058,((SPYO:0.04809,(SCAN:0.01608,SDYS:0.00907):0.01745):0.03971,(((STHE:0.00222,(SSAL:0.00611,SVES:0.00785):0.00286):0.03856,((SINF:0.00000,SLUT:0.00000):0.00479,SEQU:0.00147):0.04187):0.00836,(SPLU:0.04622,SDOW:0.06642):0.00665):0.00660):0.00528,((SRAT:0.02151,SDEV:0.03613):0.04019,((LCRE:0.00270,LLAC:0.00493):0.19589,(SSUI:0.06025,((SPSE:0.00109,(SMIT:0.00000,SPNE:0.00000):0.00017):0.02269,((SANG:0.02019,SINT:0.02001):0.00334,SCON:0.01164):0.01472):0.05556):0.02126):0.00956):0.00391):0.00000;
(SENT:0.67169,(SCON:0.01092,SANG:0.02129):0.01174,SINT:0.03289):0.00000;
(SENT:0.40476,SRAT:0.10690,SDEV:0.13266):0.00000;
(SSUI:0.23077,SENT:0.23077):0.00000;
((LCRE:0.03497,LLAC:0.04032):0.19944,(SENT:0.15326,(((SPSE:0.00821,(SMIT:0.00171,SPNE:0.00124):0.00723):0.08474,(SANG:0.01140,(SINT:0.00968,SCON:0.01464):0.00780):0.07202):0.01192,((SPLU:0.07659,((SSAL:0.01852,(STHE:0.01839,SVES:0.00565):0.01409):0.08599,SDOW:0.05961):0.01479):0.00695,((SPYO:0.07026,(SCAN:0.03322,SDYS:0.02974):0.01616):0.04859,(((SINF:0.00701,SLUT:0.01029):0.01860,SEQU:0.02359):0.06654,(SDEV:0.01457,SRAT:0.02458):0.06159):0.00271):0.00723):0.00322):0.00267):0.00246,SSUI:0.08808):0.00000;
(SPSE:0.19469,SENT:0.19469):0.00000;
(SINT:0.31685,SENT:0.31685):0.00000;
((((SSAL:0.03626,SVES:0.02272):0.03760,((SANG:0.08907,(SENT:0.13342,(SEQU:0.19282,SENT:0.16413):0.02222):0.04282):0.04720,SINT:0.10908):0.05885):0.04322,SCON:0.01572):0.03388,SPNE:0.01304,SPSE:0.00001):0.00000;
((((SCAN:0.01643,(SPYO:0.01382,SDYS:0.01223):0.00342):0.04340,((SSUI:0.03787,SPLU:0.03467):0.02166,SENT:0.08784):0.00585):0.01350,((((STHE:0.00980,SSAL:0.00576):0.00115,SVES:0.01686):0.03958,SDOW:0.05864):0.00120,(((SINF:0.00323,SLUT:0.00502):0.00254,SEQU:0.00935):0.03542,(SDEV:0.02705,SRAT:0.02307):0.02881):0.00627):0.01034):0.00160,((((SMIT:0.00979,SPSE:0.00901):0.00177,SPNE:0.01473):0.01653,SINT:0.02119):0.01147,(SANG:0.01517,SCON:0.01222):0.02393):0.03114,(LCRE:0.00093,LLAC:0.00277):0.11486):0.00000;
(SSUI:0.15240,SPLU:0.15278,SENT:0.39891):0.00000;
(SENT:0.30752,SENT:0.30752):0.00000;
((SDOW:0.11904,((SSAL:0.00546,SVES:0.00664):0.10837,((LLAC:0.00758,LCRE:0.00855):0.25392,((SENT:0.09709,SPLU:0.10532):0.06678,(((SMIT:0.01292,(SPSE:0.00590,SPNE:0.00403):0.00717):0.03305,((SANG:0.00009,SINT:0.00036):0.00145,SCON:0.00079):0.06303):0.01584,SSUI:0.07551):0.07238):0.28584):0.09496):0.01141):0.02056,((SPYO:0.02679,(SCAN:0.01191,SDYS:0.00837):0.00903):0.05023,(SRAT:0.04276,SDEV:0.03783):0.02877):0.00560,((SEQU:0.00673,SINF:0.00524):0.00218,SLUT:0.01237):0.07666):0.00000;
(SENT:0.30216,(SSUI:0.24053,((SPNE:0.01865,(SPSE:0.00999,SMIT:0.00610):0.00956):0.17114,(SINT:0.04069,(SCON:0.01498,SANG:0.00984):0.01739):0.16234):0.07250):0.03949,(SDYS:0.27342,SPLU:0.24655):0.21457):0.00000;
(SENT:0.27701,(SSUI:0.30286,SPLU:0.29623):0.01087,(SPSE:0.02278,SMIT:0.02916):0.35510):0.00000;
(SENT:0.44911,SEQU:0.04913,SLUT:0.05877):0.00000;
((SENT:0.16302,SPLU:0.17635):0.15339,SPNE:0.04483,SPSE:0.06450):0.00000;
(SPLU:0.13011,((((STHE:0.02347,SSAL:0.00329):0.00185,SVES:0.00729):0.08120,SDOW:0.12996):0.01032,(((SCAN:0.02473,(SPYO:0.00127,SDYS:0.00962):0.01886):0.12469,((SINF:0.00638,SLUT:0.00222):0.01291,SEQU:0.01780):0.09215):0.01606,((((LLAC:0.03821,LCRE:0.05259):0.15143,((SMIT:0.01126,(SPSE:0.00323,SPNE:0.00411):0.00403):0.14268,(SINT:0.09772,(SANG:0.01855,SCON:0.02976):0.10210):0.04064):0.02556):0.01144,SSUI:0.15046):0.01789,SENT:0.18327):0.03345):0.01443):0.00925,(SDEV:0.06904,SRAT:0.08443):0.01160):0.00000;
((((LLAC:0.03701,LCRE:0.03965):0.21775,(((SMIT:0.01008,(SPSE:0.00255,SPNE:0.00505):0.00633):0.11936,(SINT:0.05591,(SCON:0.04110,SANG:0.02961):0.02076):0.03719):0.01748,SSUI:0.12016):0.00144):0.02240,SENT:0.10735):0.00858,(((((SINF:0.01574,SLUT:0.02319):0.01289,SEQU:0.02493):0.04137,((SSAL:0.01005,SVES:0.01112):0.00154,STHE:0.02220):0.05970):0.00782,SDOW:0.08487):0.00365,(((SCAN:0.02769,SPYO:0.03075):0.01363,SDYS:0.03886):0.06479,(SDEV:0.03521,SRAT:0.04319):0.05098):0.00289):0.00267,SPLU:0.09127):0.00000;
(SENT:0.42089,SPLU:0.30292,SPNE:0.37085):0.00000;
((((STHE:0.02088,(SSAL:0.00273,SVES:0.00837):0.00256):0.01209,((SMIT:0.01021,SPSE:0.01695):0.00291,SPNE:0.01241):0.00951):0.00819,((SDEV:0.05609,((LLAC:0.03701,LCRE:0.03700):0.15909,SDOW:0.06275):0.00858):0.00652,((SPYO:0.03925,(SCAN:0.04496,SDYS:0.06349):0.00814):0.00933,((SSUI:0.00861,SPLU:0.01691):0.05705,SENT:0.06151):0.00523):0.00818):0.01190):0.00303,((SINT:0.01005,SCON:0.00406):0.03416,SRAT:0.02885):0.00169,(SANG:0.00983,(SLUT:0.00564,(SINF:0.00431,SEQU:0.00448):0.00161):0.00542):0.01950):0.00000;
(SENT:0.01739,SENT:0.01739):0.00000;
((((SENT:0.21720,SDOW:0.20695):0.00966,((SSAL:0.05386,(STHE:0.02823,SVES:0.01909):0.03687):0.16788,(SPYO:0.14890,(SCAN:0.12934,SDYS:0.13797):0.01045):0.11195):0.02364):0.01265,(((SINF:0.03014,SLUT:0.01911):0.07936,SEQU:0.10713):0.06909,(SDEV:0.05261,SRAT:0.05662):0.15194):0.00564):0.00473,SPLU:0.18696,((LLAC:0.12612,LCRE:0.13040):0.16081,(SSUI:0.17029,((SMIT:0.03224,(SPSE:0.01928,SPNE:0.01335):0.01137):0.11040,(SINT:0.07835,(SANG:0.04671,SCON:0.04979):0.01658):0.07513):0.01871):0.02891):0.01295):0.00000;
(SENT:0.13525,(((SINF:0.01634,SLUT:0.01950):0.00479,SEQU:0.01973):0.07851,(SDEV:0.03648,SRAT:0.04075):0.07772):0.02210,((SPYO:0.04491,(SCAN:0.03479,SDYS:0.03152):0.01434):0.10522,((LCRE:0.01688,LLAC:0.02342):0.16393,((((SANG:0.00850,SINT:0.01516):0.00324,SCON:0.01380):0.07357,((STHE:0.01487,(SSAL:0.01010,SVES:0.01011):0.00362):0.07296,SSUI:0.08699):0.00999):0.06662,SDOW:0.15228):0.04004):0.02369):0.00390):0.00000;
(((SSUI:0.38354,(SPLU:0.34198,SENT:0.37391):0.00877):0.04952,(SDOW:0.27280,(SDEV:0.02851,SRAT:0.02212):0.21662):0.01121):0.00596,(((SLUT:0.05720,SEQU:0.06503):0.03892,SINF:0.09731):0.10116,(SPYO:0.13241,(SCAN:0.10596,SDYS:0.09562):0.01652):0.14252):0.02652,((SSAL:0.02611,SVES:0.02923):0.02664,STHE:0.05082):0.23470):0.00000;
(SCAN:0.26754,SENT:0.26754):0.00000;
(SDYS:0.27622,SENT:0.27622):0.00000;
(SDYS:0.30163,SENT:0.30163):0.00000;
((SENT:0.22977,(((((STHE:0.05645,SVES:0.06190):0.01331,SSAL:0.05608):0.14312,(SPLU:0.19749,(SCAN:0.06399,(SPYO:0.05448,SDYS:0.04692):0.02175):0.16056):0.01980):0.01755,(SRAT:0.11090,SDEV:0.10240):0.11263):0.02258,SDOW:0.27387):0.01346):0.01236,((SEQU:0.01727,(SLUT:0.01864,SINF:0.01653):0.00309):0.18390,SSUI:0.22070):0.09613,((SMIT:0.04117,(SPSE:0.02601,SPNE:0.03778):0.01054):0.16129,(SINT:0.08530,(SANG:0.04828,SCON:0.06029):0.03748):0.13141):0.06451):0.00000;
(SCAN:0.07706,SENT:0.07706):0.00000;
(SCAN:0.21830,SENT:0.21830):0.00000;
((SPLU:0.16241,SENT:0.15417):0.02739,((((SINF:0.00528,SLUT:0.00870):0.03311,SEQU:0.02750):0.05909,((STHE:0.02002,(SSAL:0.00709,SVES:0.00686):0.00363):0.10294,SDOW:0.08986):0.00772):0.02144,(SRAT:0.03976,SDEV:0.03658):0.10569):0.01221,(((LLAC:0.02988,LCRE:0.03994):0.33934,(SSUI:0.16987,((SMIT:0.00717,(SPSE:0.00512,SPNE:0.01972):0.00360):0.13760,(SANG:0.02016,(SINT:0.00338,SCON:0.00092):0.01212):0.10189):0.02135):0.02490):0.01482,(SPYO:0.05551,(SCAN:0.03752,SDYS:0.04599):0.01267):0.07194):0.00517):0.00000;
(SVES:0.04487,SPLU:0.04487):0.00000;
((SPNE:0.00000,SPLU:0.00000):0.00079,(SSUI:0.00078,SENT:0.00317):0.00554,SPSE:0.00000):0.00000;
(SPLU:0.00000,SSUI:0.00000,SVES:0.07317):0.00000;
(SPLU:0.00000,SDEV:0.34870,SENT:0.00000):0.00000;
(((SPLU:0.05423,SCAN:0.04440):0.39808,SDOW:0.21367):0.15792,(SPSE:0.00000,SPNE:0.00000):0.04013,SMIT:0.05307):0.00000;
(SCAN:0.08128,SPLU:0.08128):0.00000;
(((SCAN:0.00203,SENT:0.00248):0.12277,SPLU:0.14713):0.02778,SVES:0.17768,SANG:0.42349):0.00000;
(SANG:0.29448,SPLU:0.29448):0.00000;
((SDYS:0.06407,(SENT:0.15005,((SSAL:0.17954,SENT:0.22385):0.09462,SPLU:0.23536):0.22954):0.10143):0.01097,SCAN:0.03989,SPYO:0.04318):0.00000;
((SPLU:0.22287,(((SSAL:0.03597,(STHE:0.01777,SVES:0.02008):0.02196):0.16945,(SEQU:0.03208,(SLUT:0.01738,SINF:0.01459):0.02375):0.20046):0.06846,(SENT:0.22231,(SDYS:0.11917,(SPYO:0.03826,SCAN:0.04738):0.08872):0.12217):0.09337):0.02848):0.01888,SENT:0.21884,SSAL:0.20609):0.00000;
(SPLU:0.26037,((SENT:0.15243,SVES:0.15725):0.10850,SSUI:0.17297):0.10258,(SDYS:0.05837,SCAN:0.04774):0.19313):0.00000;
(SPLU:0.08415,SPLU:0.08415):0.00000;
(SPLU:0.01839,SPLU:0.01839):0.00000;
((((SENT:0.05974,((SPYO:0.07002,(SCAN:0.00493,SDYS:0.01456):0.03185):0.03445,SPLU:0.07398):0.01307):0.02951,(SDEV:0.01089,SRAT:0.01173):0.09538):0.03156,(SSUI:0.10834,((SPSE:0.00090,(SMIT:0.00000,SPNE:0.00151):0.00062):0.07230,(SCON:0.06117,(SANG:0.01544,SINT:0.03174):0.01113):0.05476):0.01101):0.05533):0.00554,SDOW:0.14139,((LCRE:0.05731,LLAC:0.05052):0.18027,(SSAL:0.02801,SVES:0.02339):0.11925):0.01365):0.00000;
((((LCRE:0.04316,LLAC:0.05043):0.18042,(SSUI:0.09165,((SANG:0.01406,(SINT:0.01353,SCON:0.01423):0.00320):0.07141,((SMIT:0.01059,SPSE:0.00704):0.00275,SPNE:0.01080):0.08291):0.00933):0.01607):0.01318,((SENT:0.10317,(SCAN:0.01651,SDYS:0.01479):0.08768):0.00468,SPLU:0.09257):0.00601):0.00285,(SDOW:0.14109,(SDEV:0.03640,SRAT:0.03229):0.06361):0.01278,(SSAL:0.03740,SVES:0.03661):0.11952):0.00000;
((SPLU:0.05930,((LCRE:0.00000,LLAC:0.00000):0.09378,SPLU:0.54882):0.01473):0.00564,((SSUI:0.05466,((SLUT:0.00686,(SINF:0.00056,SEQU:0.00074):0.00530):0.06007,(SENT:0.06760,(SCAN:0.00665,(SPYO:0.00707,SDYS:0.00379):0.00227):0.03207):0.00999):0.00461):0.00275,((SDEV:0.01037,SRAT:0.00821):0.05858,SDOW:0.04845):0.00716):0.00242,((SSAL:0.00847,(STHE:0.00834,SVES:0.00555):0.00520):0.03242,((SMIT:0.00093,(SPSE:0.00208,SPNE:0.00573):0.00081):0.01986,(SANG:0.00599,(SINT:0.00204,SCON:0.00274):0.00269):0.02019):0.01401):0.02315):0.00000;
(((SMIT:0.04139,(SPSE:0.00898,SPNE:0.01078):0.03770):0.05699,SPLU:0.10891):0.02973,SENT:0.14374,((LCRE:0.02068,LLAC:0.01899):0.12197,(SDOW:0.10674,SRAT:0.10881):0.04138):0.29806):0.00000;
((SDOW:0.05399,((SPLU:0.07031,(STHE:0.01185,(SSAL:0.00842,SVES:0.01253):0.00165):0.05746):0.01100,(SSUI:0.09089,(((SMIT:0.01606,(SPSE:0.01781,SPNE:0.00926):0.00650):0.06443,((SANG:0.01270,SINT:0.01529):0.00258,SCON:0.01190):0.05751):0.03196,(SENT:0.14077,(((LLAC:0.01535,LCRE:0.01068):0.13504,(((SANG:0.01561,(SINT:0.01346,SCON:0.01330):0.00696):0.06186,((SMIT:0.00750,SPSE:0.01544):0.00127,SPNE:0.01607):0.05713):0.03624,(SENT:0.09481,(SPLU:0.09152,((SDEV:0.01026,SRAT:0.01099):0.06679,(SDOW:0.06515,((STHE:0.02844,(SSAL:0.00149,SVES:0.00183):0.02106):0.04619,(((SINF:0.00147,SLUT:0.00419):0.00786,SEQU:0.00746):0.05847,(SDYS:0.03278,(SPYO:0.04293,SCAN:0.02985):0.00384):0.02237):0.00932):0.00760):0.00331):0.01217):0.01294):0.01865):0.02869):0.27649,(LCRE:0.00380,LLAC:0.00720):0.15075):0.01921):0.02292):0.00657):0.00648):0.00381):0.00060,(((SINF:0.00795,SLUT:0.01355):0.00609,SEQU:0.01060):0.04803,(SDEV:0.03205,SRAT:0.03325):0.03855):0.00363,(SPYO:0.02893,(SCAN:0.01813,SDYS:0.02178):0.00533):0.03803):0.00000;
((((LCRE:0.02929,LLAC:0.03552):0.16254,SDOW:0.12693):0.01335,((SDEV:0.06442,SRAT:0.06033):0.06597,(SPLU:0.12245,SENT:0.14399):0.01384):0.00976):0.00263,((SCAN:0.04620,(SPYO:0.02509,SDYS:0.02700):0.01851):0.08086,((SANG:0.04950,(SINT:0.02532,SCON:0.02430):0.03010):0.05557,((SMIT:0.00572,SPSE:0.00564):0.00229,SPNE:0.01209):0.08829):0.05876):0.00418,(((STHE:0.02612,(SSAL:0.01067,SVES:0.02203):0.00237):0.09281,SSUI:0.10557):0.00617,(SINF:0.03410,(SLUT:0.02477,SEQU:0.01550):0.01909):0.06551):0.00559):0.00000;
((SPLU:0.32772,(SENT:0.30417,(LLAC:0.10680,LCRE:0.12280):0.18125):0.02498):0.01509,((SDYS:0.16138,(SSAL:0.05713,(SVES:0.04521,STHE:0.03129):0.01770):0.09815):0.08864,((SINT:0.11093,(SANG:0.06934,SCON:0.07881):0.02970):0.08988,((SMIT:0.04819,SPSE:0.03863):0.06166,SPNE:0.09225):0.08685):0.08041):0.13659,LCRE:0.39094):0.00000;
((((SPYO:0.17176,(SDYS:0.16700,SCAN:0.14879):0.02360):0.14758,SPLU:0.31878):0.01504,(SDOW:0.34889,(((SDEV:0.07779,SRAT:0.07745):0.16826,((STHE:0.07713,(SVES:0.01387,SSAL:0.00978):0.05099):0.17940,((SINF:0.03121,SLUT:0.03063):0.07339,SEQU:0.11729):0.11842):0.04000):0.00462,SENT:0.28670):0.02559):0.00882):0.00845,SSUI:0.30232,(((SPSE:0.01667,SPNE:0.02260):0.02181,SMIT:0.03548):0.22322,(SANG:0.06754,(SINT:0.05826,SCON:0.04434):0.03526):0.20307):0.06787):0.00000;
(((SDYS:0.33621,(SPLU:0.16755,SDYS:0.14342):0.18692):0.17931,STHE:0.08896):0.02046,SVES:0.06374,SVES:0.03741):0.00000;
(((SPLU:0.25424,SCAN:0.45917):0.20848,SENT:0.15272):0.02507,SDYS:0.21416,SINT:0.25490):0.00000;
(((((STHE:0.02384,SSAL:0.01828):0.01916,SVES:0.03969):0.14262,(SEQU:0.07880,(SLUT:0.02969,SINF:0.03367):0.04660):0.10755):0.01768,((((SCAN:0.14192,(SPYO:0.03495,SDYS:0.02102):0.09638):0.10692,(LCRE:0.01466,LLAC:0.01357):0.23427):0.00266,SSUI:0.29038):0.00845,SPLU:0.22414):0.00785):0.00260,((SRAT:0.03666,SDEV:0.03512):0.20611,((SANG:0.01835,(SINT:0.00513,SCON:0.00850):0.01377):0.16171,(SDEV:0.04842,SRAT:0.04077):0.14125):0.01456):0.00807,SDOW:0.19899):0.00000;
(((SINF:0.02450,SLUT:0.01931):0.03895,SEQU:0.06218):0.10922,(SCAN:0.06500,SDYS:0.06681):0.10523,(((STHE:0.04035,(SSAL:0.01657,SVES:0.01472):0.02212):0.16803,((((LLAC:0.03784,LCRE:0.04179):0.34390,SSUI:0.20828):0.01131,SENT:0.20910):0.01123,SPLU:0.20228):0.01349):0.00692,(SDOW:0.18462,(SDEV:0.09964,SRAT:0.08819):0.06553):0.00523):0.00457):0.00000;
(SPLU:0.17893,(((STHE:0.01390,(SSAL:0.00000,SVES:0.00000):0.01943):0.10563,SDOW:0.10295):0.00570,(SDEV:0.06403,SRAT:0.05886):0.06835):0.00130,((((SPSE:0.01788,SPNE:0.03875):0.12273,((SINT:0.00678,SCON:0.00501):0.04885,SANG:0.03539):0.08245):0.06182,(((LLAC:0.05567,LCRE:0.05327):0.27305,SENT:0.29110):0.01535,SSUI:0.16203):0.01436):0.00996,((SINF:0.01476,(SLUT:0.00555,SEQU:0.00592):0.00787):0.10711,((SCAN:0.04267,SDYS:0.03624):0.02853,SPYO:0.11317):0.06252):0.01312):0.01092):0.00000;
((((SCAN:0.03200,SPYO:0.06477):0.00515,SDYS:0.03929):0.04744,((SEQU:0.02668,(SINF:0.01236,SLUT:0.02067):0.00892):0.04912,SPLU:0.07881):0.00954):0.00639,(SDOW:0.13700,((SSUI:0.11004,(((SMIT:0.00984,SPSE:0.00607):0.01024,SPNE:0.01324):0.06429,(SCON:0.04718,(SINT:0.05865,SANG:0.04465):0.01513):0.04623):0.01705):0.00676,(((LCRE:0.05108,LLAC:0.04055):0.22122,SENT:0.13744):0.01324,(SDEV:0.06966,SRAT:0.07779):0.06414):0.02014):0.00893):0.01021,(STHE:0.01447,(SSAL:0.00146,SVES:0.00778):0.01789):0.08562):0.00000;
(SENT:0.08778,SPLU:0.08778):0.00000;
(SPLU:0.27024,((((STHE:0.06689,(SSAL:0.04804,SVES:0.03727):0.01192):0.21548,SENT:0.26115):0.02963,((SPSE:0.04616,SMIT:0.06470):0.06050,SPNE:0.11910):0.17017):0.01609,(SPYO:0.25770,((SDEV:0.09521,SRAT:0.09133):0.12380,SDOW:0.25732):0.01611):0.00611):0.00456,(SEQU:0.02206,(SLUT:0.00100,SINF:0.00259):0.02787):0.17474):0.00000;
(SMIT:0.28353,SPLU:0.28353):0.00000;
((((SSAL:0.00761,(STHE:0.01398,SVES:0.00816):0.00378):0.06946,(((SINF:0.01170,SLUT:0.01910):0.01781,SEQU:0.02434):0.04756,SPLU:0.07365):0.00798):0.00713,(SDEV:0.05765,SRAT:0.05613):0.05048):0.00243,((LCRE:0.03193,LLAC:0.02314):0.14673,SDOW:0.10299):0.01221,((((((SMIT:0.00854,SPSE:0.00529):0.00515,SPNE:0.01405):0.09820,(SINT:0.06682,(SANG:0.05055,SCON:0.05605):0.01014):0.04311):0.00696,SSUI:0.11515):0.00700,SENT:0.13920):0.00908,(SPYO:0.07234,(SCAN:0.04365,SDYS:0.03754):0.01531):0.05467):0.00624):0.00000;
(SPLU:0.13125,(SDYS:0.01535,SCAN:0.00701):0.08992,SCON:0.06556):0.00000;
(((SDEV:0.01467,SRAT:0.01636):0.04712,((((SANG:0.03830,(SINT:0.03332,SCON:0.04342):0.00463):0.05068,(SPSE:0.00701,(SMIT:0.00000,SPNE:0.00118):0.00357):0.06872):0.00594,SSUI:0.13111):0.06736,(SPLU:0.14116,SENT:0.10825):0.00924):0.05011):0.00207,((STHE:0.03498,(SSAL:0.02232,SVES:0.01287):0.01269):0.01907,(SDOW:0.06382,((SINF:0.00911,SLUT:0.00787):0.01036,SEQU:0.01174):0.03576):0.00248):0.00738,(SCAN:0.02426,(SPYO:0.01530,SDYS:0.02984):0.01891):0.03168):0.00000;
((LLAC:0.01151,LCRE:0.00501):0.36352,(SENT:0.24150,(((SDEV:0.02949,SRAT:0.03590):0.15220,(SCAN:0.06911,(SPYO:0.06516,SDYS:0.03463):0.01387):0.13991):0.00822,((SDOW:0.15919,(SSAL:0.00896,(STHE:0.00318,SVES:0.00446):0.00305):0.13884):0.01697,((((SMIT:0.00199,SPSE:0.00345):0.00183,SPNE:0.01119):0.10982,((SCON:0.02772,SANG:0.02047):0.01053,SINT:0.04109):0.07258):0.04433,(SSUI:0.19672,((SINF:0.01861,SLUT:0.01361):0.02320,SEQU:0.02732):0.11833):0.01092):0.01204):0.01951):0.00928):0.00754,SPLU:0.29380):0.00000;
((LLAC:0.06493,LCRE:0.06830):0.33677,(SPLU:0.30040,SENT:0.29797):0.04489,((SPNE:0.06295,(SPSE:0.03981,SMIT:0.04633):0.03047):0.19926,((SANG:0.03654,SCON:0.03947):0.04913,SINT:0.08726):0.17717):0.07451):0.00000;
((SPLU:0.24966,SPLU:0.24026):0.03231,(SCAN:0.13067,SDYS:0.13328):0.16364,SPSE:0.41827):0.00000;
((SSAL:0.13625,(SSUI:0.27719,((SPLU:0.22084,SSUI:0.16582):0.09926,SENT:0.28366):0.06498):0.14680):0.08370,(SCON:0.05579,SANG:0.04376):0.00312,SINT:0.05893):0.00000;
(SPLU:0.51606,SEQU:0.15572,SPLU:0.19691):0.00000;
(SPLU:0.54065,LCRE:0.06970,LLAC:0.09638):0.00000;
(SPLU:0.15117,(SDEV:0.02321,SRAT:0.02449):0.15091,(SDYS:0.06087,SPYO:0.06952):0.15941):0.00000;
(((SENT:0.22242,((((LLAC:0.01805,LCRE:0.01265):0.21984,((SPSE:0.01044,(SPNE:0.01488,SMIT:0.00821):0.00272):0.12049,(SANG:0.02715,(SINT:0.00397,SCON:0.00199):0.02522):0.09933):0.03841):0.00998,SSUI:0.20966):0.01949,(SPLU:0.15533,((SINF:0.00979,SLUT:0.01240):0.00159,SEQU:0.00658):0.14653):0.04889):0.02505):0.02725,((SSAL:0.01510,(STHE:0.01033,SVES:0.01385):0.00550):0.15047,SDOW:0.15022):0.01207):0.00368,(SDEV:0.03433,SRAT:0.03238):0.10191,(SCAN:0.02017,(SPYO:0.01247,SDYS:0.01459):0.00660):0.11514):0.00000;
(SPLU:0.06571,SPLU:0.09886,SPLU:0.40114):0.00000;
(SSUI:0.22203,SPLU:0.22203):0.00000;
((SCAN:0.05086,((SPNE:0.19161,(SINT:0.02840,SCON:0.02774):0.16820):0.09404,(SPLU:0.12382,SSUI:0.10683):0.17363):0.25675):0.04320,SDYS:0.01453,SPYO:0.01497):0.00000;
(((((LCRE:0.10395,LLAC:0.10928):0.19292,((SMIT:0.03596,(SPNE:0.03703,SPSE:0.03109):0.01105):0.17978,((SINT:0.07114,SCON:0.06635):0.00831,SANG:0.07543):0.15227):0.03148):0.01706,SSUI:0.20672):0.00980,SPLU:0.23527):0.00306,(SENT:0.22088,((SSAL:0.05436,(STHE:0.03067,SVES:0.02263):0.02874):0.19658,(SDYS:0.09603,(SPYO:0.05951,SCAN:0.05014):0.03231):0.18771):0.00836):0.01128,((SRAT:0.07898,SDEV:0.06988):0.14303,(SDOW:0.22344,(SINF:0.09787,SEQU:0.09397):0.08528):0.01150):0.00705):0.00000;
(SPLU:0.36303,SRAT:0.22393,SSUI:0.35078):0.00000;
(SSUI:0.18052,SPLU:0.18052):0.00000;
((SPLU:0.32080,SENT:0.37985):0.00943,SENT:0.34486,((SCON:0.08482,(SINT:0.05357,SANG:0.05787):0.03398):0.25137,(LLAC:0.08090,LCRE:0.09071):0.26079):0.06908):0.00000;
(SDEV:0.28025,SPLU:0.28025):0.00000;
(SENT:0.29258,SPLU:0.29258):0.00000;
(SLUT:0.30235,SPLU:0.30235):0.00000;
(SSUI:0.07444,SPLU:0.07444):0.00000;
(SENT:0.29163,SPLU:0.29163):0.00000;
(SPLU:0.09365,SPLU:0.07141,SPLU:0.07466):0.00000;
(SPLU:0.16186,SPLU:0.16186):0.00000;
(SINT:0.36307,SPLU:0.36307):0.00000;
(SPLU:0.24714,((SCAN:0.09168,SDYS:0.07915):0.11405,(SDEV:0.05808,SRAT:0.05733):0.15994):0.04090,SDOW:0.18719):0.00000;
((((SCAN:0.00701,(SPYO:0.00465,SDYS:0.00496):0.00345):0.02454,SPLU:0.04719):0.01171,(((SINF:0.00507,SLUT:0.00612):0.00760,SEQU:0.00821):0.02827,(SDEV:0.02595,SRAT:0.02404):0.02125):0.01180):0.00223,((LLAC:0.01255,LCRE:0.01245):0.11796,((STHE:0.03635,(SSAL:0.01410,SVES:0.01910):0.00724):0.07349,SDOW:0.10124):0.01113):0.00488,((((SMIT:0.00385,SPSE:0.00780):0.00174,SPNE:0.00800):0.03448,(SANG:0.00775,(SINT:0.00645,SCON:0.00812):0.00270):0.02972):0.01199,SSUI:0.07303):0.00945):0.00000;
(SSUI:0.31269,(SENT:0.26409,SPLU:0.27130):0.07868,(LCRE:0.16101,LLAC:0.18923):0.09243):0.00000;
(SENT:0.28965,SPLU:0.28965):0.00000;
(SDYS:0.06569,SPLU:0.06569):0.00000;
(SANG:0.12586,SPLU:0.12586):0.00000;
(SDEV:0.08641,SPLU:0.08641):0.00000;
(SEQU:0.15382,SPLU:0.15382):0.00000;
(SPLU:0.31221,(SVES:0.01468,SSAL:0.01349):0.15618,SCON:0.16816):0.00000;
((((SPLU:0.14541,SDEV:0.13880):0.01984,(SENT:0.20764,(SSUI:0.21892,((STHE:0.04166,(SSAL:0.01141,SVES:0.01698):0.01054):0.10235,((SMIT:0.03793,SPSE:0.03978):0.06055,(SCON:0.02301,SANG:0.02452):0.10977):0.01260):0.02989):0.04381):0.01631):0.02276,(SDYS:0.05997,(SCAN:0.05209,SPYO:0.05068):0.01001):0.09803):0.00865,SDOW:0.12867,((SINF:0.01384,SLUT:0.01152):0.02177,SEQU:0.04094):0.09953):0.00000;
(SSUI:0.07912,SPLU:0.07912):0.00000;
(SENT:0.24771,(((SDOW:0.19685,SPLU:0.19766):0.03606,SPNE:0.19471):0.01787,((LLAC:0.07731,LCRE:0.07567):0.31303,(SPLU:0.11508,SSUI:0.08818):0.10330):0.01381):0.01057,SPLU:0.23055):0.00000;
(SPSE:0.15939,SSUI:0.15939):0.00000;
(((SRAT:0.00885,SDEV:0.01112):0.10467,((STHE:0.02611,(SSAL:0.00213,SVES:0.00062):0.00676):0.08624,((LLAC:0.02516,LCRE:0.02502):0.17427,((((SMIT:0.00523,SPSE:0.00364):0.00039,SPNE:0.00916):0.05992,(SANG:0.00609,(SINT:0.00000,SCON:0.00000):0.00897):0.06138):0.06568,SSUI:0.11704):0.01264):0.00852):0.02173):0.00751,(SDOW:0.07842,((SLUT:0.00850,SEQU:0.00670):0.00538,SINF:0.01984):0.05412):0.00217,(SENT:0.09945,(SPLU:0.08415,(SCAN:0.01943,(SPYO:0.00183,SDYS:0.00026):0.01256):0.04038):0.01524):0.01176):0.00000;
((SINT:0.01794,(((SPSE:0.05208,(SMIT:0.02468,SPNE:0.04489):0.01666):0.12336,(((LLAC:0.02497,LCRE:0.01822):0.29831,(SSUI:0.25770,(((SMIT:0.00713,SPSE:0.01556):0.00810,SPNE:0.02097):0.13733,(SANG:0.05224,(SINT:0.00928,SCON:0.00893):0.03039):0.10457):0.05164):0.08584):0.23378,(((SCAN:0.00008,SPYO:0.00116):0.00234,SDYS:0.00260):0.12063,SRAT:0.13225):0.03273):0.04584):0.03107,SSUI:0.10406):0.08181):0.01210,SCON:0.00000,SANG:0.00000):0.00000;
(SENT:0.25290,SSUI:0.25290):0.00000;
(((SLUT:0.01400,SEQU:0.00875):0.04450,(((SDEV:0.01381,SRAT:0.01176):0.03161,((((SMIT:0.00523,(SPSE:0.00000,SPNE:0.00000):0.00635):0.03203,(SANG:0.00000,(SINT:0.00000,SCON:0.00000):0.00000):0.03333):0.00749,SENT:0.07937):0.01322,(SPLU:0.02912,SSUI:0.02629):0.04674):0.01276):0.00677,(LCRE:0.00503,LLAC:0.00118):0.15692):0.01796):0.00559,SDOW:0.07927,(((STHE:0.01750,(SSAL:0.01012,SVES:0.00511):0.01045):0.01852,SINF:0.04425):0.04281,(SPYO:0.00530,(SCAN:0.00498,SDYS:0.00141):0.00107):0.04812):0.00609):0.00000;
((((SINT:0.03725,SCON:0.04702):0.00159,SANG:0.03493):0.11098,(SMIT:0.00018,(SPSE:0.00000,SPNE:0.00000):0.00264):0.16803):0.12225,(SSUI:0.26219,(((SINF:0.00593,SLUT:0.01569):0.03177,SEQU:0.03869):0.14594,(SPYO:0.03867,(SCAN:0.02710,SDYS:0.02877):0.01161):0.15747):0.03330):0.00387,(((STHE:0.07152,(SSAL:0.00449,SVES:0.00641):0.02601):0.14852,SDOW:0.16587):0.07219,(SPLU:0.27415,(SENT:0.23738,(SRAT:0.01069,SDEV:0.00355):0.16522):0.03199):0.01290):0.02682):0.00000;
(SEQU:0.27637,SSUI:0.27637):0.00000;
(SPLU:0.00295,SSUI:0.00295):0.00000;
(((SPLU:0.07502,(((LLAC:0.01110,LCRE:0.01298):0.24912,SENT:0.15761):0.01401,(SSUI:0.09305,((SMIT:0.00925,(SPSE:0.00342,SPNE:0.00658):0.00411):0.04836,((SCON:0.00193,SANG:0.00368):0.00313,SINT:0.00359):0.02953):0.06648):0.01698):0.00608):0.00384,((((SINF:0.00668,SLUT:0.00651):0.01750,SEQU:0.02318):0.04909,(SDEV:0.01934,SRAT:0.01126):0.05904):0.01179,(SPYO:0.03108,(SCAN:0.00276,SDYS:0.00274):0.02179):0.04096):0.00799):0.00371,SDOW:0.08716,(SSAL:0.01806,(STHE:0.04609,SVES:0.03225):0.00161):0.06130):0.00000;
((SENT:0.14379,(SSUI:0.10026,SDOW:0.11779):0.37069):0.03905,SINT:0.09430,SMIT:0.07945):0.00000;
(((SSUI:0.02617,((SINT:0.00431,(SANG:0.00349,SCON:0.01843):0.01743):0.01514,(SDOW:0.02985,(((SPSE:0.01484,(SMIT:0.00000,SPNE:0.00000):0.00638):0.07368,((SVES:0.33075,(LLAC:0.00000,LCRE:0.00000):0.14251):0.10127,((SENT:0.12862,((SINF:0.00000,SLUT:0.00000):0.00270,SEQU:0.00001):0.08374):0.01855,(SPLU:0.09108,(SCAN:0.03532,(SPYO:0.01047,SDYS:0.00548):0.00462):0.03462):0.02431):0.01144):0.03857):0.00743,(SDEV:0.01760,SRAT:0.00679):0.05673):0.00516):0.01516):0.01020):0.00653,SVES:0.00000):0.00000,SSAL:0.00000,STHE:0.00000):0.00000;
((((SSAL:0.01929,(STHE:0.01523,SVES:0.00742):0.01363):0.11327,(SPLU:0.11643,((((SINF:0.00612,SLUT:0.01001):0.00905,SEQU:0.01618):0.08170,((SCAN:0.06583,SPYO:0.06105):0.00786,SDYS:0.04704):0.04048):0.00822,(SDEV:0.00574,SRAT:0.00723):0.08080):0.00842):0.01469):0.00917,(((LLAC:0.05954,LCRE:0.04295):0.27831,(((SMIT:0.00658,SPSE:0.01075):0.00341,SPNE:0.01232):0.07866,(SANG:0.02318,(SINT:0.00838,SCON:0.01089):0.00925):0.09161):0.03214):0.02604,SSUI:0.15810):0.04996):0.00384,SENT:0.12912,SDOW:0.15706):0.00000;
(SENT:0.19866,SSUI:0.19866):0.00000;
(SSUI:0.36560,(SINT:0.02390,SCON:0.02773):0.04477,SANG:0.06325):0.00000;
(SSUI:0.17757,((SSAL:0.01330,SVES:0.01635):0.01415,STHE:0.02585):0.17694,(SENT:0.23272,((SLUT:0.02795,(SINF:0.01592,SEQU:0.02642):0.00769):0.13282,(SPLU:0.14096,(SPYO:0.02682,(SCAN:0.01777,SDYS:0.00695):0.01424):0.14222):0.02959):0.01890):0.01269):0.00000;
(((((SPLU:0.09821,SDOW:0.09480):0.01308,(SENT:0.15071,((SSAL:0.11159,(SINT:0.02813,(SANG:0.02273,SCON:0.02680):0.00930):0.05042):0.02278,(SSUI:0.12656,((SMIT:0.01618,(SPSE:0.00921,SPNE:0.00683):0.01656):0.13091,((LCRE:0.04040,LLAC:0.04386):0.25251,SSUI:0.43556):0.11953):0.01916):0.00733):0.00962):0.00908):0.00923,(SDEV:0.02283,SRAT:0.02983):0.05308):0.00991,(SCAN:0.02462,(SPYO:0.00562,SDYS:0.00252):0.01157):0.07911):0.00380,((SINF:0.00757,SLUT:0.00990):0.02037,SEQU:0.02327):0.04071,(STHE:0.02785,SVES:0.02461):0.04607):0.00000;
(((SANG:0.22463,(SSUI:0.02286,SPLU:0.02302):0.15047):0.15555,SDYS:0.09548):0.01518,SPYO:0.10958,SCAN:0.06724):0.00000;
((SSUI:0.18730,SPLU:0.17064):0.05120,((SANG:0.03345,(SINT:0.01401,SCON:0.01611):0.03555):0.09645,((SMIT:0.02001,SPNE:0.01799):0.00391,SPSE:0.01959):0.13931):0.05506,(((SSUI:0.39314,(LLAC:0.05534,LCRE:0.04887):0.23915):0.02665,SENT:0.30332):0.02513,((((SEQU:0.05035,(SLUT:0.04016,SINF:0.03803):0.02414):0.07467,(SRAT:0.05374,SDEV:0.06054):0.08175):0.04029,(SDYS:0.10728,(SPYO:0.07191,SCAN:0.06907):0.02633):0.13509):0.01747,((SSAL:0.02318,(STHE:0.02523,SVES:0.01841):0.00879):0.14883,SDOW:0.19140):0.03422):0.01268):0.00563):0.00000;
((SDYS:0.05023,((((LLAC:0.02605,LCRE:0.02414):0.20506,(SDOW:0.15796,SINF:0.15742):0.06548):0.17100,(LCRE:0.22361,(SINF:0.15512,SLUT:0.15870):0.07058):0.11430):0.15613,(SSUI:0.02597,SPLU:0.02508):0.15797):0.14440):0.01324,SPYO:0.03269,SCAN:0.03703):0.00000;
(SSUI:0.14133,(SENT:0.19228,SDEV:0.15681):0.04878,SPLU:0.10686):0.00000;
((((SMIT:0.08549,SPSE:0.08261):0.18234,(SSUI:0.17811,SPLU:0.17771):0.13887):0.11293,SCON:0.12311):0.03618,SINT:0.09330,SANG:0.09795):0.00000;
(SENT:0.27832,SSUI:0.27832):0.00000;
(SCAN:0.01852,SCON:0.01852):0.00000;
(SCON:0.00000,SCAN:0.00000,SCON:0.08594):0.00000;
(SCON:0.01549,SCON:0.01549):0.00000;
(SCAN:0.00943,SCON:0.00943):0.00000;
(SCAN:0.01400,SCON:0.01400):0.00000;
(((SPNE:0.28425,((((SLUT:0.00000,SEQU:0.00000):0.13366,(((SLUT:0.02258,SEQU:0.01989):0.07514,(SDEV:0.06389,SRAT:0.05433):0.02888):0.05091,(((SSAL:0.00584,SVES:0.00377):0.08236,SPSE:0.05610):0.04450,((SANG:0.00434,SINT:0.00522):0.06482,(SCON:0.00360,SANG:0.00404):0.06643):0.03850):0.02740):0.00487):0.13666,((((SPNE:0.12427,(SINT:0.03312,(SANG:0.01147,SCON:0.01545):0.03012):0.13379):0.04353,(SSUI:0.15751,(SCAN:0.00000,SPYO:0.00000):0.15971):0.07330):0.02007,(LLAC:0.01249,LCRE:0.01473):0.31632):0.02988,((SSUI:0.09290,(SPNE:0.10534,(SINT:0.01417,(SANG:0.00000,SCON:0.00000):0.01403):0.07099):0.00899):0.02632,(SPYO:0.02519,(SCAN:0.01154,SDYS:0.01132):0.01672):0.10507):0.18239):0.04848):0.07166,(SANG:0.11505,SEQU:0.07918):0.14543):0.01105):0.10529,SINT:0.11259):0.00754,(SDEV:0.00529,SRAT:0.00835):0.10304,((((SPSE:0.00305,(SMIT:0.00000,SPNE:0.00000):0.00457):0.01669,SANG:0.02125):0.02544,(SINF:0.00000,SLUT:0.00000):0.09627):0.04303,((((SSUI:0.00000,SPLU:0.00000):0.07501,SCAN:0.07442):0.01185,(SSUI:0.01835,SPYO:0.02331):0.06906):0.01449,SDOW:0.10918):0.00551):0.00241):0.00000;
(SCON:0.01738,SINT:0.10858,SANG:0.01482):0.00000;
((SPYO:0.00657,((SENT:0.04894,((((STHE:0.00745,(SSAL:0.00000,SVES:0.00000):0.01338):0.09189,SPLU:0.04092):0.01911,SDOW:0.05083):0.01727,((LLAC:0.00234,LCRE:0.00018):0.28810,(((SMIT:0.00000,(SPSE:0.00000,SPNE:0.00000):0.00000):0.03873,(SANG:0.00908,(SINT:0.00000,SCON:0.00000):0.00161):0.06972):0.04389,SSUI:0.15567):0.00554):0.05983):0.02941):0.01057,(SEQU:0.01420,((SINF:0.00000,SLUT:0.00000):0.00974,(SDEV:0.00611,SRAT:0.01494):0.01930):0.00700):0.01464):0.00927):0.00413,SDYS:0.00000,SCAN:0.00000):0.00000;
((SENT:0.12034,((LCRE:0.19270,((SMIT:0.00174,(SPSE:0.00000,SPNE:0.00000):0.01205):0.05055,(SANG:0.00000,(SINT:0.00000,SCON:0.00000):0.00000):0.03190):0.10852):0.01514,SSUI:0.10603):0.02431):0.00837,(SEQU:0.06264,(STHE:0.00000,(SSAL:0.00000,SVES:0.00000):0.00000):0.07517):0.04720,((SPYO:0.03734,(SCAN:0.00775,SDYS:0.01266):0.01379):0.01605,SDOW:0.07394):0.02831):0.00000;
((((SPSE:0.02258,(SPNE:0.01174,SMIT:0.02637):0.01024):0.17163,((SANG:0.07064,SCON:0.08639):0.01737,SINT:0.10575):0.10492):0.03357,(SSUI:0.20303,((SEQU:0.04898,(SLUT:0.01560,SINF:0.02188):0.02333):0.15679,(SDEV:0.09363,SRAT:0.10094):0.08100):0.02530):0.05024):0.02206,((SPLU:0.21029,SENT:0.25769):0.03775,SDOW:0.27462):0.02939,((SDYS:0.09208,(SCAN:0.08474,SPYO:0.08942):0.02925):0.14076,(SSAL:0.03038,(SVES:0.01872,STHE:0.02140):0.00520):0.20155):0.01149):0.00000;
(((SANG:0.00000,SCON:0.00000):0.01418,SSUI:0.13525):0.00055,SINT:0.00167,((SMIT:0.00000,SPSE:0.00000):0.00077,SPNE:0.01599):0.02338):0.00000;
((SDOW:0.22883,((SSAL:0.07982,(STHE:0.05831,SVES:0.02481):0.04013):0.14382,((LLAC:0.02118,LCRE:0.02332):0.22949,((((SMIT:0.03966,(SPSE:0.01556,SPNE:0.01198):0.02625):0.05784,(SINT:0.02867,(SANG:0.01039,SCON:0.01593):0.01262):0.06274):0.06783,SSUI:0.15346):0.18384,(((SEQU:0.10142,SINF:0.09764):0.07906,(SRAT:0.04083,SDEV:0.03554):0.13822):0.01559,(SDYS:0.08788,SCAN:0.07516):0.12664):0.15745):0.10654):0.01490):0.03828):0.00707,((((SINF:0.01499,SLUT:0.00954):0.02685,SEQU:0.03209):0.09613,(SPYO:0.06890,(SDYS:0.03242,SCAN:0.03292):0.02153):0.07426):0.04888,((SDEV:0.07830,SRAT:0.09737):0.08090,SENT:0.18357):0.00742):0.01072,SPLU:0.17827):0.00000;
((SINT:0.01772,SCON:0.02301):0.05689,(SDEV:0.04779,SRAT:0.04574):0.11913,SANG:0.09022):0.00000;
(((SCON:0.00870,SINT:0.00497):0.01555,SANG:0.02718):0.22774,(SCAN:0.04674,SDYS:0.05476):0.17590,((SSUI:0.12722,SENT:0.19555):0.07799,SINF:0.16065):0.04800):0.00000;
(SCON:0.00005,SINT:0.01185,SANG:0.08254):0.00000;
((SPLU:0.09714,(SENT:0.20505,(((SPNE:0.00708,(SMIT:0.00000,SPSE:0.00000):0.00187):0.10341,((SANG:0.01867,SINT:0.02421):0.03094,SCON:0.07203):0.01727):0.02695,((SSAL:0.01054,(STHE:0.00897,SVES:0.00430):0.00718):0.13366,(((LLAC:0.00000,LCRE:0.00000):0.20569,(SCAN:0.02420,(SPYO:0.01851,SDYS:0.02643):0.00846):0.09026):0.01391,SDOW:0.13581):0.01648):0.00548):0.03166):0.00905):0.00620,SSUI:0.08916,((SINF:0.01902,(SLUT:0.00599,SEQU:0.00537):0.01738):0.06837,(SDEV:0.05743,SRAT:0.02758):0.07803):0.01519):0.00000;
((((SSUI:0.02558,SPLU:0.00883):0.05662,((LCRE:0.01136,LLAC:0.00495):0.09858,((SPSE:0.02589,(SMIT:0.00099,SPNE:0.00382):0.03096):0.06702,(SANG:0.01383,(SINT:0.02351,SCON:0.02320):0.00238):0.04012):0.00643):0.00306):0.01052,(((STHE:0.04990,(SSAL:0.01713,SVES:0.01723):0.03086):0.09534,SDOW:0.09829):0.02168,(SDEV:0.02441,SRAT:0.00852):0.06484):0.01036):0.00556,((SINF:0.02323,(SLUT:0.01285,SEQU:0.01694):0.01550):0.02878,(SPYO:0.01889,(SCAN:0.01614,SDYS:0.02586):0.01346):0.02812):0.00431,SENT:0.06878):0.00000;
(SCON:0.03013,SINT:0.01974,SANG:0.22441):0.00000;
(SCON:0.06600,((SMIT:0.04862,SPSE:0.05976):0.51626,SINT:0.11121):0.04461,SANG:0.08260):0.00000;
(SPLU:0.21894,SCON:0.21894):0.00000;
((SINT:0.03654,SCON:0.03041):0.03595,(((STHE:0.02457,(SSAL:0.00503,SVES:0.00914):0.00155):0.05716,(SLUT:0.01847,(SINF:0.01548,SEQU:0.01148):0.00605):0.07516):0.01066,((SPSE:0.00628,(SMIT:0.00224,SPNE:0.01014):0.00612):0.07826,(((SSUI:0.01480,SPLU:0.01407):0.06411,SENT:0.13387):0.00979,((LCRE:0.01050,LLAC:0.00877):0.19619,((SPYO:0.01649,(SCAN:0.02016,SDYS:0.00911):0.00126):0.08886,(SDOW:0.11873,(SDEV:0.06161,SRAT:0.05439):0.01849):0.00635):0.00684):0.00783):0.01077):0.00798):0.00558,SANG:0.08812):0.00000;
((SCON:0.00357,SVES:0.00255):0.00852,STHE:0.01597,(SANG:0.34647,SDYS:0.33596):0.25471):0.00000;
((SCON:0.00409,SINT:0.00578):0.06688,SANG:0.06417,(SPLU:0.30666,((SEQU:0.06430,SINF:0.08039):0.20845,(SRAT:0.11318,SDEV:0.11089):0.15690):0.09398):0.18196):0.00000;
((SEQU:0.13001,(SSAL:0.06372,SCON:0.03087):0.11934):0.04787,(SDOW:0.17920,SDEV:0.16146):0.02772,(((SLUT:0.01995,SEQU:0.01783):0.02962,SINF:0.05371):0.34769,LLAC:0.25913):0.07249):0.00000;
(((SPLU:0.16759,SSUI:0.16747):0.27193,(SSUI:0.22439,((SCON:0.00818,SINT:0.01013):0.09184,SPNE:0.10143):0.12930):0.04561):0.22637,(SPYO:0.00678,SDYS:0.00257):0.02325,SCAN:0.03615):0.00000;
(SCON:0.00817,SINT:0.00388,((SPLU:0.08438,SSUI:0.06947):0.22173,SPNE:0.09294):0.16486):0.00000;
((SCAN:0.01916,(SPYO:0.01712,SDYS:0.01049):0.00239):0.02498,(((STHE:0.00478,(SSAL:0.00319,SVES:0.00007):0.00229):0.03136,SPLU:0.06065):0.00816,((LCRE:0.00566,LLAC:0.00416):0.12000,(SSUI:0.03727,((SMIT:0.00260,(SPSE:0.00154,SPNE:0.00246):0.00140):0.02369,(SANG:0.00364,(SINT:0.00859,SCON:0.00691):0.00234):0.03171):0.00657):0.00365):0.01399):0.00178,(((SINF:0.00487,(SLUT:0.01439,SEQU:0.00849):0.00022):0.01849,SDOW:0.03313):0.00237,(SDEV:0.01544,SRAT:0.01388):0.01852):0.00125):0.00000;
(SCON:0.01600,SINT:0.04792,SANG:0.03962):0.00000;
((((((SCON:0.02937,SINT:0.03285):0.00828,SANG:0.03515):0.11249,(SMIT:0.02549,(SPSE:0.01317,SPNE:0.01832):0.00553):0.15735):0.01620,(SSAL:0.02699,(STHE:0.01808,SVES:0.01257):0.01577):0.14603):0.05918,((LLAC:0.04187,LCRE:0.04075):0.38484,((SCAN:0.05389,SDYS:0.04410):0.01215,SPYO:0.05713):0.18922):0.02217):0.01015,(SDOW:0.18248,(SPLU:0.19201,(SRAT:0.17581,((SINF:0.02546,SLUT:0.02588):0.07799,SEQU:0.10823):0.05505):0.01495):0.01205):0.01385,SSUI:0.24666):0.00000;
(SPSE:0.03358,SMIT:0.03358):0.00000;
((((SCON:0.03045,SANG:0.01678):0.25844,(SEQU:0.11041,SLUT:0.11363):0.21663):0.02197,(SINF:0.20196,SMIT:0.22314):0.05096):0.01860,(SDYS:0.33068,(SDOW:0.23654,SDOW:0.25546):0.08046):0.01363,(SSAL:0.02467,STHE:0.03985):0.24087):0.00000;
(SMIT:0.02346,SPNE:0.03951,SPSE:0.03851):0.00000;
(SDOW:0.24068,SMIT:0.24068):0.00000;
((SPSE:0.01615,SMIT:0.03398):0.01494,SPNE:0.02603,(SANG:0.02694,(SINT:0.00949,SCON:0.01732):0.02014):0.36238):0.00000;
((SMIT:0.02139,SPSE:0.02487):0.38431,(SRAT:0.05898,SDEV:0.06074):0.04063,SDOW:0.13256):0.00000;
(SPSE:0.01944,SMIT:0.01944):0.00000;
(SMIT:0.33884,SPNE:0.19057,SPNE:0.13296):0.00000;
(SMIT:0.04924,SPNE:0.04007,SSUI:0.57723):0.00000;
(SPSE:0.00948,SMIT:0.00948):0.00000;
(SMIT:0.03819,SPSE:0.00873,SPNE:0.02614):0.00000;
(SPSE:0.05615,SMIT:0.05615):0.00000;
(SPLU:0.01450,SVES:0.01450):0.00000;
(SPLU:0.00000,SVES:0.00000):0.00000;
(SPLU:0.25885,SVES:0.25885):0.00000;
(SSAL:0.31300,SVES:0.31300):0.00000;
(SVES:0.22465,SENT:0.00172,SCAN:0.00172):0.00000;
((((SVES:0.03048,SINF:0.02949):0.01768,(SSUI:0.01647,SCAN:0.00954):0.03391):0.10838,(SVES:0.29591,(SPLU:0.25014,(SCAN:0.00525,SENT:0.00156):0.24300):0.05783):0.28589):0.01378,(SANG:0.09759,SSUI:0.11429):0.02969,(((SDYS:0.02644,SPLU:0.02653):0.15543,SMIT:0.16909):0.01591,SENT:0.17360):0.00290):0.00000;
(SPNE:0.00000,SVES:0.00000):0.00000;
((SSAL:0.00404,SVES:0.00549):0.00633,(SENT:0.25350,SPSE:0.08908):0.06024,STHE:0.01109):0.00000;
(((SRAT:0.01386,SDEV:0.00418):0.07896,(((((SINF:0.01770,SLUT:0.00950):0.01477,SEQU:0.01180):0.05735,(SPYO:0.01682,(SCAN:0.00686,SDYS:0.00952):0.00777):0.06342):0.01456,(STHE:0.01350,(SSAL:0.00273,SVES:0.00652):0.00644):0.06112):0.00446,SDOW:0.06899):0.00621):0.00209,((SANG:0.01420,(SINT:0.00678,SCON:0.01050):0.00632):0.06317,(SSUI:0.07044,(SMIT:0.00343,(SPSE:0.00240,SPNE:0.00702):0.00667):0.03939):0.01690):0.00879,((SPLU:0.10267,SENT:0.10070):0.00998,(LCRE:0.01481,LLAC:0.01564):0.16087):0.01670):0.00000;
((SSAL:0.00574,SVES:0.00252):0.00997,(SINF:0.07564,SDOW:0.05891):0.05335,STHE:0.02807):0.00000;
((((SENT:0.28363,(((SMIT:0.08498,(SPSE:0.00374,SPNE:0.00220):0.12492):0.04485,((SINT:0.00000,SCON:0.00000):0.02658,SANG:0.02362):0.14056):0.08872,SSUI:0.24535):0.04162):0.02660,((STHE:0.02320,SVES:0.01960):0.00877,SSAL:0.02614):0.22771):0.01852,SDOW:0.20014):0.02222,((SINF:0.02297,(SLUT:0.00466,SEQU:0.00305):0.01171):0.15714,((SPYO:0.04918,(SCAN:0.01276,SDYS:0.02226):0.00709):0.10271,(SDEV:0.00755,SRAT:0.00401):0.11232):0.01531):0.00108,SPLU:0.26039):0.00000;
(SVES:0.01353,SSAL:0.07001,STHE:0.01610):0.00000;
((SVES:0.24399,SCAN:0.43675):0.20246,SINF:0.04604,SDYS:0.05287):0.00000;
(((SRAT:0.12277,(((SINF:0.02275,SLUT:0.04142):0.01902,SEQU:0.04458):0.08409,(SCAN:0.02772,(SPYO:0.02035,SDYS:0.02387):0.00341):0.10301):0.00438):0.00785,((SSUI:0.14855,SPLU:0.16899):0.02524,(SDEV:0.16201,(((LLAC:0.02263,LCRE:0.02741):0.49155,SDOW:0.17496):0.00499,(STHE:0.03093,(SSAL:0.01717,SVES:0.01687):0.00723):0.13084):0.01271):0.00758):0.01207):0.00802,((SPSE:0.01446,(SMIT:0.01196,SPNE:0.00990):0.00192):0.07785,(SINT:0.03426,(SANG:0.00388,SCON:0.00542):0.02470):0.06862):0.06894,((LCRE:0.01215,LLAC:0.00798):0.16458,SENT:0.16163):0.00313):0.00000;
((((LCRE:0.00500,LLAC:0.01293):0.26411,((((SMIT:0.00000,SPSE:0.00000):0.00073,SPNE:0.00737):0.03102,((SANG:0.00734,SINT:0.00220):0.00372,SCON:0.00980):0.04137):0.04062,SSUI:0.08179):0.03204):0.02641,(((SINF:0.00068,SLUT:0.00068):0.01110,SEQU:0.00659):0.05426,(SCAN:0.01835,(SPYO:0.00527,SDYS:0.00695):0.01478):0.05843):0.00659):0.00607,(SDOW:0.07843,((SPLU:0.08246,SENT:0.07291):0.00247,(STHE:0.01430,(SSAL:0.00652,SVES:0.01330):0.01085):0.05321):0.02331):0.01251,(SDEV:0.01407,SRAT:0.01296):0.05728):0.00000;
(SDYS:0.28889,(((STHE:0.03582,SVES:0.03418):0.04551,SSAL:0.09693):0.21211,(SDOW:0.24130,SDOW:0.23989):0.18648):0.03510,(SEQU:0.12925,(SLUT:0.01865,SINF:0.02226):0.08589):0.17142):0.00000;
(SSAL:0.12782,SVES:0.12782):0.00000;
(SDOW:0.22703,SVES:0.22703):0.00000;
(((STHE:0.03460,(SSAL:0.01426,SVES:0.01491):0.01476):0.07927,SDOW:0.12527):0.01412,((SPLU:0.09936,((SINF:0.02356,SLUT:0.02568):0.01317,SEQU:0.02203):0.08601):0.01238,(SCAN:0.02273,(SPYO:0.00406,SDYS:0.00095):0.02027):0.10525):0.00661,((SMIT:0.02387,(SPNE:0.00000,SPSE:0.00000):0.02208):0.16132,SENT:0.20349):0.06266):0.00000;
((SANG:0.00897,((SVES:0.01259,(STHE:0.01298,SSAL:0.00592):0.00395):0.09747,((SMIT:0.01798,(SPSE:0.00572,SPNE:0.00871):0.01380):0.05938,(SENT:0.19621,(SPLU:0.11194,(SDYS:0.02421,(SCAN:0.01739,SPYO:0.02149):0.00674):0.11968):0.02076):0.07665):0.00935):0.05289):0.00573,SCON:0.00509,SINT:0.00705):0.00000;
((((STHE:0.02809,(SSAL:0.00120,SVES:0.00494):0.02080):0.07156,SDOW:0.13300):0.06379,SEQU:0.01312):0.01269,SLUT:0.01179,SINF:0.01085):0.00000;
(STHE:0.13176,SVES:0.13176):0.00000;
(((((SANG:0.16945,SENT:0.15600):0.01481,(SVES:0.10635,SPLU:0.10470):0.05719):0.14140,(((SPLU:0.16352,SSUI:0.17817):0.12549,(SPYO:0.17175,SEQU:0.18305):0.17969):0.01117,(SPSE:0.28917,SPYO:0.29412):0.04894):0.04902):0.22829,(SPSE:0.15446,(SENT:0.14746,(SENT:0.02095,SPLU:0.02148):0.11172):0.01840):0.05321):0.01804,(STHE:0.13400,SINF:0.12387):0.07164,SENT:0.21019):0.00000;
(SCON:0.02370,SVES:0.02370):0.00000;
(SVES:0.07963,SANG:0.03162,SMIT:0.03864):0.00000;
(((LLAC:0.01441,LCRE:0.01440):0.19876,(SRAT:0.02918,SDEV:0.02761):0.32961):0.15765,(SSAL:0.02396,SVES:0.02046):0.01580,(STHE:0.00415,SINF:0.00344):0.02898):0.00000;
((SENT:0.18028,(SPLU:0.23548,(((STHE:0.02533,SSAL:0.01510):0.00091,SVES:0.01934):0.17022,SDOW:0.14714):0.03663):0.01043):0.04377,(SSAL:0.20739,(((SPYO:0.07561,(SCAN:0.02187,SDYS:0.03570):0.03761):0.07038,(SDEV:0.03827,SRAT:0.04578):0.07748):0.01806,((SSUI:0.10383,((SINF:0.00798,SLUT:0.01011):0.01709,SEQU:0.01491):0.08383):0.01154,((SINT:0.01204,(SANG:0.00504,SCON:0.00818):0.01441):0.06082,(SMIT:0.01476,(SPSE:0.00109,SPNE:0.00000):0.00810):0.09277):0.01826):0.02380):0.01959):0.00439,(LLAC:0.14383,LCRE:0.15770):0.16392):0.00000;
(SVES:0.03416,SSAL:0.06893,STHE:0.05786):0.00000;
(((SVES:0.01978,SMIT:0.03325):0.28699,(SINF:0.00557,SLUT:0.00079):0.14197):0.13351,SPNE:0.01532,SPSE:0.01047):0.00000;
(SVES:0.01291,SPNE:0.00559,SPSE:0.00220):0.00000;
(SVES:0.36474,SCAN:0.18116,SPLU:0.22051):0.00000;
(SVES:0.01763,SSAL:0.02462,STHE:0.07506):0.00000;
(SENT:0.06932,(((((SCAN:0.01374,SDYS:0.01309):0.00401,SPYO:0.02244):0.10253,(SDOW:0.11655,((SINF:0.02914,SLUT:0.02394):0.05276,(SRAT:0.01883,SDEV:0.01942):0.05729):0.03043):0.00602):0.51156,(SMIT:0.01338,SPNE:0.01274):0.10706):0.04114,((SSAL:0.00141,(STHE:0.00282,SVES:0.00347):0.00069):0.08613,(((SINF:0.00721,SLUT:0.00703):0.00562,SEQU:0.00756):0.05580,(SDOW:0.05408,(SDEV:0.01002,SRAT:0.00887):0.06940):0.01407):0.00605):0.00790):0.00785,(SPLU:0.07557,(SCAN:0.04329,(SPYO:0.01828,SDYS:0.01555):0.02866):0.01312):0.00849):0.00000;
(SANG:0.36201,SVES:0.36201):0.00000;
((SLUT:0.02250,SINF:0.04983):0.15055,(SVES:0.08780,SVES:0.03681):0.17933,((SPYO:0.04901,SPYO:0.08044):0.08728,SDYS:0.12487):0.08441):0.00000;
(((SSAL:0.00799,(STHE:0.01115,SVES:0.00781):0.00096):0.07028,(SANG:0.01225,(SINT:0.00650,SCON:0.00556):0.01146):0.05082):0.03030,SSUI:0.09392,((((SPLU:0.07413,SDYS:0.08833):0.01051,SDOW:0.09826):0.01139,(SENT:0.11431,(((LLAC:0.04541,LCRE:0.04396):0.29446,(((SENT:0.29817,((SDYS:0.09824,SPYO:0.11337):0.14978,(SPLU:0.21666,(SSUI:0.20910,((SMIT:0.03180,(SPSE:0.01674,SPNE:0.02090):0.00744):0.15743,((SSAL:0.03972,(STHE:0.02351,SVES:0.02313):0.01579):0.13887,((SEQU:0.04962,(SINF:0.01322,SLUT:0.01002):0.03961):0.10915,((SDEV:0.05038,SRAT:0.05094):0.13184,(SDOW:0.15214,((SINT:0.03663,SCON:0.03566):0.02375,SANG:0.06170):0.08640):0.00858):0.00218):0.00721):0.01890):0.00694):0.00752):0.02415):0.02969):0.11641,(((LLAC:0.01755,LCRE:0.01625):0.24972,(((SANG:0.04036,(SINT:0.02212,SCON:0.02478):0.02158):0.11659,((SPLU:0.11231,(SENT:0.11441,((SCAN:0.04119,SDYS:0.04110):0.07134,((SINF:0.05048,SEQU:0.04625):0.05239,(((SPSE:0.02790,(SMIT:0.01587,SPNE:0.01897):0.01075):0.05224,((STHE:0.01707,SSAL:0.01566):0.00327,SVES:0.02348):0.05788):0.01167,(SDEV:0.01392,SRAT:0.01663):0.07868):0.01223):0.00425):0.00402):0.00494):0.00558,SDOW:0.12564):0.02637):0.01681,SSUI:0.17606):0.08038):0.07476,((SENT:0.16581,((SANG:0.02794,(SINT:0.00675,SCON:0.00803):0.01910):0.14004,SSUI:0.15285):0.01290):0.02087,((SCAN:0.05050,SDYS:0.05235):0.12853,SPLU:0.18339):0.00808):0.15290):0.09841):0.00930,((((SVES:0.01729,SSAL:0.01233):0.10243,SDEV:0.11813):0.09196,((SINF:0.00544,SLUT:0.00650):0.00731,SEQU:0.01433):0.20063):0.12555,((LLAC:0.01328,LCRE:0.01337):0.18573,(((SMIT:0.00428,SPSE:0.00534):0.00324,SPNE:0.01060):0.13927,(((SSUI:0.01578,SPLU:0.02092):0.06197,SENT:0.08208):0.03923,(SPYO:0.06330,(SDYS:0.03511,SCAN:0.03793):0.02838):0.05100):0.03410):0.04536):0.14360):0.00739):0.01907):0.01136,((SMIT:0.09900,(SANG:0.01754,(SINT:0.01112,SCON:0.01394):0.00480):0.07786):0.05090,(((STHE:0.01343,(SSAL:0.00752,SVES:0.00974):0.00616):0.06718,((SINF:0.00809,SLUT:0.00623):0.02012,SEQU:0.02367):0.05368):0.06351,((SDEV:0.02132,SRAT:0.02274):0.03676,SDOW:0.06491):0.09199):0.01030):0.14821):0.20359):0.00754):0.00582,((SDEV:0.02374,SRAT:0.02678):0.05938,((SINF:0.00226,SLUT:0.00189):0.03196,SEQU:0.03796):0.04958):0.00979):0.00324):0.00000;
(SVES:0.31188,SVES:0.31188):0.00000;
(SSAL:0.08420,SVES:0.08420):0.00000;
(SVES:0.09428,SSAL:0.05169,SSAL:0.37736):0.00000;
(STHE:0.12836,SVES:0.12836):0.00000;
(SCAN:0.03523,SCAN:0.03523):0.00000;
(SENT:0.18588,SCAN:0.18588):0.00000;
((SCAN:0.00000,SDYS:0.00000):0.28357,SPSE:0.38731,LLAC:0.37925):0.00000;
(((SSAL:0.07549,(STHE:0.04524,SVES:0.03632):0.04865):0.17247,(SCAN:0.09490,SDYS:0.08938):0.20764):0.01408,(SDOW:0.24687,(SRAT:0.08536,SDEV:0.07209):0.14913):0.01485,((LLAC:0.06227,LCRE:0.08749):0.27474,(SEQU:0.12190,(SLUT:0.03646,SINF:0.03684):0.13671):0.12741):0.02682):0.00000;
(SCAN:0.00069,SCON:0.00000,SCON:0.03956):0.00000;
(SDYS:0.32233,SCAN:0.32233):0.00000;
(SINT:0.16869,SCAN:0.16869):0.00000;
((SCAN:0.02702,SDYS:0.01573):0.04023,SPYO:0.02617,(SDEV:0.21830,SDOW:0.33687):0.17829):0.00000;
(SCAN:0.03035,SDYS:0.15338,SPYO:0.04361):0.00000;
(SPYO:0.09524,SCAN:0.09524):0.00000;
(SINT:0.27441,SCAN:0.27441):0.00000;
(SCAN:0.04886,SDYS:0.05944,SPYO:0.08738):0.00000;
((SSUI:0.15187,((LLAC:0.00793,LCRE:0.00827):0.16796,((((SINF:0.00214,SLUT:0.00258):0.08677,(SMIT:0.00376,SPNE:0.01651):0.08313):0.23006,(SCAN:0.07948,SDYS:0.08525):0.21199):0.25410,(SPSE:0.08254,(SANG:0.00397,(SINT:0.00005,SCON:0.01177):0.00412):0.08663):0.06949):0.01156):0.02620):0.01167,((STHE:0.01847,(SSAL:0.01083,SVES:0.00922):0.01073):0.07219,(SDEV:0.01111,SRAT:0.01335):0.08288):0.00531,((((SINF:0.00460,SLUT:0.00931):0.01554,SEQU:0.01777):0.05948,((SPLU:0.10647,SENT:0.14529):0.00927,(SCAN:0.02122,(SPYO:0.01651,SDYS:0.00748):0.00396):0.07655):0.00798):0.00849,SDOW:0.10911):0.00967):0.00000;
((((((SMIT:0.00364,SPNE:0.00455):0.01190,SVES:0.01064):0.29162,((SCAN:0.01175,SENT:0.00251):0.14219,SPLU:0.17482):0.10682):0.02912,SENT:0.25679):0.13880,SANG:0.05352):0.01928,SDYS:0.07541,(SSUI:0.02650,SPLU:0.04004):0.02492):0.00000;
(SCAN:0.07775,SDYS:0.10456,SPYO:0.10456):0.00000;
(((SENT:0.06077,SDOW:0.05775):0.00701,((LCRE:0.00524,LLAC:0.00875):0.14503,(((STHE:0.00429,(SSAL:0.00097,SVES:0.00182):0.00106):0.06376,((SINF:0.00287,SLUT:0.00875):0.00291,SEQU:0.00267):0.03680):0.00801,((SSUI:0.01150,SPLU:0.01907):0.01762,((SPYO:0.01378,SDYS:0.01268):0.01070,SCAN:0.02485):0.02969):0.01059):0.00414):0.01417):0.00285,(SDEV:0.02531,SRAT:0.01599):0.05608,(((SMIT:0.00077,SPSE:0.00386):0.00200,SPNE:0.00402):0.03910,(SANG:0.01204,(SINT:0.00301,SCON:0.00209):0.00789):0.03638):0.01940):0.00000;
(SDYS:0.03406,SCAN:0.03406):0.00000;
(SPYO:0.02592,SCAN:0.02592):0.00000;
((((SINF:0.01442,SLUT:0.00997):0.02008,SEQU:0.02581):0.09062,((SDYS:0.01038,SPYO:0.01763):0.00734,SCAN:0.02446):0.11760):0.04478,(((LLAC:0.01106,LCRE:0.00728):0.27658,(SSUI:0.19292,((SCON:0.02275,(SANG:0.00605,SINT:0.01086):0.01246):0.11493,(SMIT:0.01106,(SPSE:0.01582,SPNE:0.01098):0.00140):0.17026):0.02412):0.02081):0.00907,(SDEV:0.02264,SRAT:0.02166):0.17331):0.00835,(((SDOW:0.14028,((STHE:0.00940,SVES:0.01159):0.00616,SSAL:0.01866):0.09526):0.06141,SPLU:0.15666):0.02506,SENT:0.24354):0.00961):0.00000;
(SCAN:0.05987,SDYS:0.13275,SPYO:0.13933):0.00000;
(SCAN:0.21371,(SPYO:0.00215,SDYS:0.00174):0.29178,SPNE:0.31663):0.00000;
((SCAN:0.02212,(SPYO:0.00000,SDYS:0.00000):0.03330):0.09940,(((SSAL:0.03079,(STHE:0.02594,SVES:0.01265):0.01477):0.06392,(((SINF:0.01093,SLUT:0.01042):0.01066,SEQU:0.01628):0.05003,SDOW:0.07121):0.02257):0.00693,((((SPSE:0.01661,(SMIT:0.01262,SPNE:0.01246):0.00246):0.06536,SSUI:0.07149):0.01821,SENT:0.10921):0.00942,(((SANG:0.01202,SINT:0.01663):0.00592,SCON:0.01748):0.06570,(SDEV:0.04298,SRAT:0.04300):0.05948):0.01987):0.00573):0.00274,((LLAC:0.00706,LCRE:0.00946):0.32912,SPLU:0.11288):0.01327):0.00000;
((SSUI:0.01003,(((SVES:0.00000,(SMIT:0.00000,SPNE:0.00000):0.00000):0.07298,SENT:0.10877):0.02056,(SANG:0.04039,SCAN:0.05924):0.01749):0.03984):0.00292,(SPLU:0.00400,SDYS:0.00183):0.00140,SSUI:0.00260):0.00000;
(SPYO:0.01774,SCAN:0.01774):0.00000;
(SPYO:0.04316,SCAN:0.04316):0.00000;
((SPYO:0.05322,SCAN:0.05719):0.00542,SDYS:0.05162,(SANG:0.01337,(SINT:0.00700,SCON:0.00215):0.01384):0.11685):0.00000;
(SLUT:0.11572,SCAN:0.11572):0.00000;
(SCAN:0.29152,SDYS:0.29142,SCAN:0.35455):0.00000;
(SENT:0.07550,SCAN:0.07550):0.00000;
(SENT:0.22513,SCAN:0.22513):0.00000;
(SPYO:0.03644,SCAN:0.03644):0.00000;
(SPYO:0.32534,SCAN:0.32534):0.00000;
(SCAN:0.01738,SCON:0.01521,SDYS:0.59140):0.00000;
(SCAN:0.01347,SCON:0.02420,SCON:0.09145):0.00000;
(SCAN:0.03699,SCON:0.03527,SCON:0.09865):0.00000;
(SCAN:0.10736,SDYS:0.08679,SPYO:0.08780):0.00000;
(SCAN:0.11340,SDYS:0.08105,SPYO:0.04355):0.00000;
(SCAN:0.04534,SPYO:0.06720,SDYS:0.28335):0.00000;
(SCAN:0.03323,(SPYO:0.02817,SDYS:0.02471):0.01008,((LLAC:0.02490,LCRE:0.02069):0.11467,(LCRE:0.00435,LLAC:0.00442):0.09686):0.14293):0.00000;
((SCAN:0.03737,SDYS:0.03733):0.00707,SPYO:0.04142,(LCRE:0.02837,LLAC:0.01620):0.26975):0.00000;
(SDYS:0.00964,SCAN:0.00964):0.00000;
(SDYS:0.08912,SCAN:0.08912):0.00000;
((SINF:0.03994,(SLUT:0.02135,SEQU:0.00553):0.03538):0.03260,(SDEV:0.07344,(SINT:0.05221,SRAT:0.03974):0.01328):0.00567,((STHE:0.03492,(SSAL:0.01723,SVES:0.02256):0.00807):0.07101,(SDOW:0.16551,(SANG:0.02869,SCON:0.04108):0.17590):0.02080):0.01533):0.00000;
(SEQU:0.08966,SRAT:0.07134,SDEV:0.04675):0.00000;
((SINT:0.00307,((SPSE:0.00058,SPNE:0.00000):0.00678,(SMIT:0.01291,((SSAL:0.01828,(((((LCRE:0.00355,LLAC:0.00231):0.06966,(SDOW:0.12370,(LCRE:0.00205,LLAC:0.00028):0.08435):0.01667):0.01574,((SLUT:0.00804,SEQU:0.00537):0.02952,SDOW:0.01697):0.02119):0.04934,(((SSUI:0.03181,SENT:0.06335):0.00444,SPLU:0.02975):0.01205,(SCAN:0.00425,(SPYO:0.00240,SDYS:0.00576):0.00100):0.02831):0.00789):0.00362,(SVES:0.02534,(SDEV:0.00712,SRAT:0.00339):0.02638):0.00462):0.00934):0.00849,(STHE:0.01396,SINF:0.00811):0.01378):0.00837):0.00356):0.00304):0.00192,SCON:0.00115,SANG:0.00179):0.00000;
(SEQU:0.00459,SLUT:0.00318,SPLU:0.08587):0.00000;
((SEQU:0.01382,SLUT:0.01695):0.02320,SINF:0.03927,(SPYO:0.00659,SPNE:0.00449):0.46710):0.00000;
(SEQU:0.00538,SLUT:0.00600,((LLAC:0.04428,LCRE:0.05187):0.29917,(SSAL:0.05580,SVES:0.05286):0.20225):0.19551):0.00000;
((SEQU:0.01132,SLUT:0.01521):0.07256,SSAL:0.08070,(LLAC:0.01388,LCRE:0.02252):0.55540):0.00000;
((((((SLUT:0.00709,(SINF:0.00566,SEQU:0.00192):0.00200):0.01330,SRAT:0.01439):0.00846,SDOW:0.02701):0.00663,SDEV:0.05309):0.00701,(((STHE:0.02429,(SSAL:0.00759,SVES:0.00389):0.00538):0.00968,(SSUI:0.02461,SPLU:0.01903):0.01900):0.00965,(SENT:0.03108,(SCAN:0.02631,(SPYO:0.00000,SDYS:0.00000):0.04390):0.03496):0.01470):0.00604):0.00371,(SPNE:0.05167,(SINT:0.02588,(SANG:0.00904,SCON:0.01007):0.00651):0.02375):0.00819,(LCRE:0.00896,LLAC:0.01487):0.05916):0.00000;
(SPLU:0.07743,SEQU:0.07743):0.00000;
(((SANG:0.07424,(SINT:0.03720,SCON:0.01759):0.07894):0.05485,SEQU:0.17086):0.02247,(LCRE:0.24749,SPLU:0.25251):0.03597,SSUI:0.14928):0.00000;
(SEQU:0.11276,SINF:0.14245,SRAT:0.37466):0.00000;
(SEQU:0.35209,SINF:0.06149,SLUT:0.03554):0.00000;
(((SDYS:0.05635,(SPYO:0.05597,SCAN:0.04906):0.01861):0.07337,(SEQU:0.01312,(SINF:0.00798,SLUT:0.00795):0.00647):0.09200):0.00795,((((SSUI:0.11237,((SMIT:0.02299,(SPSE:0.00422,SPNE:0.00868):0.01733):0.05814,(SINT:0.01546,(SANG:0.01250,SCON:0.01309):0.00470):0.07209):0.06107):0.02099,(SPLU:0.15780,SENT:0.13096):0.01540):0.01069,(SDEV:0.02651,SRAT:0.03048):0.09635):0.00822,(STHE:0.01809,(SSAL:0.01402,SVES:0.01175):0.00530):0.11092):0.00595,SDOW:0.12223):0.00000;
(SLUT:0.02960,SEQU:0.02960):0.00000;
(SPLU:0.20067,SEQU:0.20067):0.00000;
(SPLU:0.15470,SEQU:0.15470):0.00000;
(SPLU:0.12351,SEQU:0.12351):0.00000;
(SDOW:0.19060,((SRAT:0.02330,SDEV:0.02209):0.11243,((SINF:0.00940,SLUT:0.01097):0.01298,SEQU:0.02250):0.10067):0.01148,((((LLAC:0.01590,LCRE:0.01651):0.23999,(((SPSE:0.00860,(SMIT:0.00439,SPNE:0.00295):0.00462):0.07947,(SANG:0.01621,(SCON:0.01379,SINT:0.01750):0.00598):0.07568):0.04402,SSUI:0.13948):0.02897):0.02955,SENT:0.17848):0.00514,(SPLU:0.16987,SDYS:0.16547):0.00722):0.00348):0.00000;
(SEQU:0.06256,SINF:0.05665,SSUI:0.31773):0.00000;
(((((SSUI:0.01492,SPLU:0.01800):0.00535,SENT:0.02256):0.00690,((STHE:0.00507,(SSAL:0.00270,SVES:0.00187):0.00080):0.01854,SDOW:0.03056):0.00076):0.00179,((SPYO:0.00846,(SCAN:0.00456,SDYS:0.00262):0.00099):0.01921,(SINF:0.00319,(SLUT:0.00041,SEQU:0.00122):0.00448):0.01496):0.00096):0.00057,(SDEV:0.01224,SRAT:0.01656):0.01590,((LCRE:0.00308,LLAC:0.00383):0.07051,((SMIT:0.00120,(SPSE:0.00021,SPNE:0.00078):0.00077):0.01582,(SANG:0.00484,(SINT:0.00836,SCON:0.00610):0.00370):0.01401):0.00944):0.00268):0.00000;
((((SANG:0.03414,(SINT:0.01077,SCON:0.01680):0.03900):0.05178,(SSUI:0.08224,SPLU:0.07546):0.01573):0.00428,((SINF:0.01574,SLUT:0.02187):0.00203,SEQU:0.01697):0.04942):0.00269,(SDOW:0.10584,((((LCRE:0.02434,LLAC:0.03151):0.14621,(SCAN:0.10541,SPYO:0.10807):0.11128):0.02663,(SPSE:0.01817,(SMIT:0.01398,SPNE:0.01895):0.00089):0.08024):0.01106,(SDEV:0.04118,SRAT:0.03505):0.04587):0.00639):0.00489,(STHE:0.01221,(SSAL:0.00809,SVES:0.01209):0.00329):0.04931):0.00000;
(SEQU:0.34005,LLAC:0.31197,SPLU:0.39375):0.00000;
(SEQU:0.00000,SLUT:0.01584,SINF:0.24356):0.00000;
((SEQU:0.08074,(SINF:0.01717,SLUT:0.01946):0.06807):0.13632,((SVES:0.02546,SSAL:0.02553):0.20265,SDEV:0.19841):0.04662,(LLAC:0.05208,LCRE:0.03933):0.43029):0.00000;
((SEQU:0.06750,(SINF:0.01926,SLUT:0.03244):0.04221):0.11690,((((SDYS:0.15727,(SPYO:0.14073,SCAN:0.11557):0.02184):0.18229,SDOW:0.30362):0.03401,((SSUI:0.23516,SENT:0.24791):0.04743,((LLAC:0.05727,LCRE:0.05825):0.25639,((SMIT:0.06326,(SPSE:0.01564,SPNE:0.01329):0.04091):0.13329,(SANG:0.05191,(SINT:0.01090,SCON:0.01313):0.04273):0.11762):0.04752):0.03516):0.01996):0.03152,(SPLU:0.19388,(SDEV:0.04163,SRAT:0.03764):0.15373):0.01200):0.00799,(SSAL:0.05329,(STHE:0.04010,SVES:0.04286):0.03618):0.13755):0.00000;
(((SEQU:0.05222,(SINF:0.01694,SLUT:0.01529):0.03970):0.12013,(SPYO:0.10373,(SDYS:0.06170,SCAN:0.07244):0.01815):0.11793):0.00351,((((SSUI:0.19591,SENT:0.17018):0.01210,(SPLU:0.15252,((SSAL:0.03984,(STHE:0.01508,SVES:0.01735):0.01457):0.09941,SDOW:0.16655):0.01239):0.01525):0.01083,(SDEV:0.11804,SRAT:0.11144):0.04479):0.00277,(((SMIT:0.02346,SPSE:0.00763):0.01843,SPNE:0.02140):0.14387,(SANG:0.05095,(SCON:0.02456,SINT:0.02041):0.05023):0.06754):0.04743):0.00839,(LLAC:0.04042,LCRE:0.04062):0.24690):0.00000;
(SEQU:0.17123,SLUT:0.01630,SINF:0.01409):0.00000;
((SENT:0.18438,((SINF:0.03009,SLUT:0.00006):0.03287,SEQU:0.02255):0.06751):0.01876,(SPYO:0.00000,SDYS:0.00000):0.01560,SCAN:0.00003):0.00000;
(SEQU:0.27692,SEQU:0.27692):0.00000;
(SEQU:0.43817,SEQU:0.22017,SLUT:0.17254):0.00000;
(((SPYO:0.08821,((SINF:0.00651,SLUT:0.00543):0.01808,SEQU:0.02678):0.05831):0.00291,((((((SCON:0.05868,(SANG:0.04060,SINT:0.04609):0.00703):0.12357,SDEV:0.16212):0.04323,(((SINT:0.00891,SCON:0.00696):0.02779,SANG:0.04688):0.08967,SSUI:0.15411):0.08627):0.04709,SPLU:0.16492):0.01658,(SCAN:0.07063,(((SMIT:0.00000,SPSE:0.00000):0.00278,SPNE:0.00326):0.06379,(SDOW:0.05699,(SANG:0.04052,(SDEV:0.01764,SRAT:0.01469):0.02720):0.00578):0.00904):0.02053):0.02654):0.02039,((SPYO:0.09723,((SCAN:0.00457,SCAN:0.00935):0.03280,(SDYS:0.01428,SDYS:0.01893):0.02143):0.02337):0.04459,(SDEV:0.07815,SRAT:0.09515):0.05448):0.00648):0.01462):0.00283,((SSUI:0.01421,SPLU:0.01641):0.09190,SENT:0.07420):0.01121,SSUI:0.07205):0.00000;
(((SSUI:0.05595,SENT:0.07286):0.01951,((SINF:0.04068,(SLUT:0.01400,SEQU:0.01400):0.01500):0.00686,SRAT:0.04642):0.03373):0.00573,(SPLU:0.10566,(SCAN:0.08707,SDEV:0.08698):0.00821):0.00125,((LLAC:0.00870,LCRE:0.01070):0.31330,((STHE:0.03201,(SSAL:0.00689,SVES:0.00809):0.00597):0.04803,((SPSE:0.01100,(SMIT:0.00760,SPNE:0.00822):0.00309):0.05757,(SANG:0.04668,(SINT:0.02977,SCON:0.03512):0.01082):0.02860):0.00282):0.03385):0.01280):0.00000;
(SEQU:0.04743,SLUT:0.04743):0.00000;
(SRAT:0.19407,SLUT:0.19407):0.00000;
((SINF:0.03377,SLUT:0.03423):0.05963,SEQU:0.14497,(SEQU:0.12265,(SLUT:0.07506,SINF:0.04368):0.07443):0.34594):0.00000;
(((((SINF:0.01269,SLUT:0.01353):0.05051,SEQU:0.04774):0.09049,(SDEV:0.05402,SRAT:0.06772):0.08820):0.02344,(((SCAN:0.07745,(SPYO:0.05578,SDYS:0.04834):0.02584):0.14481,((SENT:0.39095,LLAC:0.41091):0.01929,(SINT:0.05604,SANG:0.03953):0.15739):0.04984):0.01701,((SPLU:0.17922,SSUI:0.17365):0.01240,SENT:0.14565):0.01069):0.00819):0.00665,((STHE:0.06259,(SSAL:0.03362,SVES:0.02588):0.03180):0.07638,(SPNE:0.08782,SMIT:0.09275):0.03731):0.02491,(SANG:0.08470,(SINT:0.04277,SCON:0.05176):0.04946):0.10571):0.00000;
(SPLU:0.32316,SLUT:0.32316):0.00000;
(((LCRE:0.47055,SLUT:0.23943):0.19221,SDEV:0.07139):0.01671,SINT:0.03981,SPNE:0.04650):0.00000;
((SDEV:0.18389,(SRAT:0.17639,((SLUT:0.01044,SEQU:0.00551):0.02485,SINF:0.04751):0.14851):0.01963):0.01093,SSUI:0.23038,((SCAN:0.15909,(SPLU:0.06129,SSUI:0.06162):0.10229):0.24878,((SPNE:0.01158,SMIT:0.00907):0.20976,SPLU:0.25198):0.10454):0.09132):0.00000;
(SLUT:0.01409,SEQU:0.17485,SSAL:0.02479):0.00000;
(SINF:0.04032,SLUT:0.04032):0.00000;
((SLUT:0.00597,SLUT:0.00346):0.00098,(SLUT:0.00110,SLUT:0.00061):0.00223,(SINF:0.01050,(((SPLU:0.12513,(SANG:0.10961,SRAT:0.12162):0.00327):0.00667,((SDEV:0.09408,SPYO:0.15077):0.01205,(((SDYS:0.00146,SDYS:0.00111):0.16451,SLUT:0.15769):0.02431,((SPNE:0.08201,SMIT:0.11499):0.02084,SANG:0.08597):0.03319):0.02670):0.00021):0.11562,SLUT:0.01528):0.00266):0.00180):0.00000;
(SDOW:0.09847,SLUT:0.09847):0.00000;
((((SDOW:0.10371,((SINF:0.00983,SLUT:0.00685):0.02162,SEQU:0.02275):0.04633):0.00340,(((STHE:0.02125,SSAL:0.01144):0.00385,SVES:0.02204):0.05544,(((((SMIT:0.00655,SPSE:0.00204):0.00994,SPNE:0.01954):0.04583,(SINT:0.01456,(SANG:0.01046,SCON:0.01081):0.00200):0.05202):0.03103,SSUI:0.07011):0.00804,(LCRE:0.01336,LLAC:0.01351):0.18998):0.00750):0.00397):0.00959,(SDEV:0.01291,SRAT:0.01283):0.05897):0.00038,(SCAN:0.01403,(SPYO:0.00627,SDYS:0.01067):0.01565):0.07778,(SPLU:0.06421,SENT:0.07254):0.01105):0.00000;
(SLUT:0.03730,((((LCRE:0.01507,LLAC:0.01586):0.19860,(LLAC:0.01429,LCRE:0.02061):0.15052):0.25423,SDOW:0.08855):0.04840,SEQU:0.04173):0.01815,SINF:0.02597):0.00000;
(((SENT:0.20594,SSUI:0.21935):0.03670,(((SPSE:0.00307,SPNE:0.00821):0.03159,SMIT:0.03484):0.19895,(SLUT:0.05664,SEQU:0.06320):0.43592):0.02425):0.00826,((SCON:0.01995,SINT:0.02848):0.13317,SANG:0.15453):0.04957,SSAL:0.27058):0.00000;
(((SLUT:0.00324,SINF:0.00276):0.17800,SANG:0.11140):0.10355,(SVES:0.01816,SSAL:0.02373):0.00636,STHE:0.03489):0.00000;
((SPLU:0.06629,((SCAN:0.00851,(SPYO:0.00019,SDYS:0.00484):0.00344):0.02505,(SEQU:0.00446,(SINF:0.00576,SLUT:0.01492):0.00317):0.01269):0.00346):0.00894,(SENT:0.08295,((SSAL:0.00726,(STHE:0.02079,SVES:0.00605):0.00524):0.03359,(SDEV:0.00224,SRAT:0.00976):0.07216):0.00380):0.00198,SDOW:0.08734):0.00000;
(SLUT:0.04147,SEQU:0.24372,SINF:0.08220):0.00000;
(SLUT:0.02693,((SSAL:0.00439,SVES:0.00938):0.32302,SEQU:0.07429):0.07714,SINF:0.02694):0.00000;
(LLAC:0.20580,SLUT:0.20580):0.00000;
((SINF:0.10296,SLUT:0.00791):0.02545,SEQU:0.04122,SPLU:0.18837):0.00000;
(SEQU:0.08186,((SLUT:0.07246,SEQU:0.03714):0.08062,SPLU:0.12928):0.10318,(SINF:0.02695,SLUT:0.01710):0.05848):0.00000;
(SSUI:0.26570,SLUT:0.26570):0.00000;
(SLUT:0.17776,SLUT:0.17776):0.00000;
(SLUT:0.17582,SLUT:0.17582):0.00000;
(((((((SPSE:0.00000,SPNE:0.00000):0.06864,SENT:0.08922):0.04227,((LCRE:0.00890,LLAC:0.00809):0.13797,((((((SCAN:0.01531,(SPYO:0.00441,SDYS:0.00345):0.00290):0.30001,SLUT:0.20190):0.01863,SDEV:0.28773):0.05108,((SDEV:0.41675,(SEQU:0.05770,((SANG:0.00226,(SINT:0.00130,SCON:0.00151):0.00195):0.04535,(SDEV:0.00507,SRAT:0.00331):0.04270):0.01160):0.29593):0.03304,((((SPNE:0.04135,(SINT:0.00000,SCON:0.00000):0.03507):0.03362,(SCAN:0.01257,(SPYO:0.01056,SDYS:0.00969):0.00300):0.05193):0.01707,(SPLU:0.02088,SSUI:0.01854):0.05154):0.28654,((SANG:0.00842,(SINT:0.00083,SCON:0.00269):0.00992):0.10682,(((SMIT:0.01648,(SPSE:0.00000,SPNE:0.00000):0.01724):0.06264,(SSUI:0.05148,SENT:0.05405):0.03188):0.03676,(SPLU:0.08248,(SDYS:0.01510,SCAN:0.01069):0.06608):0.03376):0.01096):0.22916):0.01762):0.01667):0.02455,SPNE:0.29980):0.09798,(SDOW:0.06931,(SMIT:0.04853,(SVES:0.02348,SSAL:0.01683):0.03697):0.01845):0.11606):0.05112):0.02576):0.01988,(SDOW:0.01724,SRAT:0.01678):0.09801):0.00956,SDEV:0.06066):0.00893,(((STHE:0.01921,(SSAL:0.00371,SVES:0.00333):0.00377):0.07429,SANG:0.04939):0.00691,(SSUI:0.06322,(SPYO:0.01541,(SCAN:0.01265,SDYS:0.00839):0.00533):0.07771):0.01326):0.00591):0.00386,((SINF:0.00279,SLUT:0.00363):0.01590,SEQU:0.02008):0.03584,(SINT:0.01461,SCON:0.01499):0.04265):0.00000;
((SPLU:0.12977,((SDOW:0.13202,((STHE:0.02038,(SSAL:0.01458,SVES:0.01411):0.00100):0.10387,(SEQU:0.05095,(SINF:0.01029,SLUT:0.01354):0.04390):0.06328):0.01007):0.00304,(SRAT:0.07522,SDEV:0.06155):0.07225):0.00888):0.00585,(((LLAC:0.06826,LCRE:0.06743):0.18039,((SANG:0.04782,(SINT:0.00854,SCON:0.00954):0.03961):0.09931,(SMIT:0.00917,(SPSE:0.01085,SPNE:0.00769):0.00627):0.12735):0.02424):0.00863,(SSUI:0.16322,SDYS:0.19083):0.00892):0.00288,SENT:0.16255):0.00000;
(((SLUT:0.09713,SEQU:0.10455):0.15082,(SRAT:0.08679,SDEV:0.08759):0.18346):0.13369,SDOW:0.26332,(SEQU:0.14913,SLUT:0.16613):0.26306):0.00000;
(((SSAL:0.18265,SVES:0.18248):0.14125,((SINT:0.06981,(SCON:0.04398,SANG:0.04333):0.02374):0.22783,(SPNE:0.02314,(SPSE:0.02059,SMIT:0.02020):0.00353):0.29783):0.01611):0.02893,((SENT:0.34942,(((SDYS:0.03523,SPYO:0.03233):0.23011,SPLU:0.27191):0.03147,((SINF:0.02620,SLUT:0.02752):0.07126,SEQU:0.09932):0.21119):0.01381):0.00951,SDOW:0.33409):0.00804,(SRAT:0.12775,SDEV:0.12325):0.19130):0.00000;
(SVES:0.26370,SLUT:0.26370):0.00000;
(SINF:0.15849,SLUT:0.15849):0.00000;
(SINF:0.03321,SLUT:0.03321):0.00000;
(STHE:0.23885,SLUT:0.23885):0.00000;
(((LLAC:0.02777,LCRE:0.03253):0.26860,(SSUI:0.20788,SINT:0.21452):0.12004):0.24218,(((SCAN:0.01775,SPYO:0.01326):0.00894,SDYS:0.02207):0.12029,((SLUT:0.00183,SINF:0.00856):0.00849,SEQU:0.01796):0.14095):0.01454,(SPLU:0.13244,SENT:0.14896):0.02007):0.00000;
(SINF:0.01500,(((SCON:0.02019,SINT:0.01606):0.36281,SSAL:0.03905):0.02320,SVES:0.01936):0.02268,STHE:0.02055):0.00000;
(SDEV:0.31471,SINF:0.31471):0.00000;
(((LLAC:0.02562,LCRE:0.02353):0.29814,((SINF:0.02173,SLUT:0.02091):0.09082,SENT:0.15567):0.01276):0.00292,SPLU:0.13311,(SRAT:0.03310,SDEV:0.03071):0.10747):0.00000;
(SLUT:0.00920,SINF:0.00920):0.00000;
(SLUT:0.02039,SINF:0.02039):0.00000;
((SEQU:0.16251,(SCON:0.17745,(SENT:0.21001,(((SINT:0.22772,(SINF:0.04572,SEQU:0.04343):0.11515):0.01452,SSUI:0.22383):0.04165,(SINT:0.29043,((SSUI:0.18390,(SDYS:0.20379,(SCAN:0.12697,SPNE:0.13027):0.07527):0.01430):0.03689,(SDYS:0.21851,(SSUI:0.23264,(SPNE:0.19087,SCAN:0.19447):0.05364):0.00792):0.00219):0.06687):0.08073):0.05212):0.00904):0.02979):0.00933,SSUI:0.16286,SINF:0.12152):0.00000;
((SSUI:0.16695,(SENT:0.21030,(SCON:0.18945,(SSUI:0.15188,(SINF:0.03498,SEQU:0.03516):0.12118):0.06318):0.01126):0.04877):0.01138,SINF:0.12396,(SINF:0.06373,SEQU:0.03930):0.08548):0.00000;
(SEQU:0.05102,SINF:0.05102):0.00000;
(SEQU:0.01173,SINF:0.01173):0.00000;
(SINF:0.03570,SLUT:0.01933,STHE:0.08764):0.00000;
(SPLU:0.22381,SINF:0.22381):0.00000;
(SINF:0.00714,SEQU:0.01714,SLUT:0.01714):0.00000;
(SINF:0.03399,SEQU:0.10733,SLUT:0.00787):0.00000;
(SEQU:0.07404,SINF:0.07404):0.00000;
((SINF:0.09056,SEQU:0.14796):0.24130,SLUT:0.11018,SEQU:0.05903):0.00000;
(SEQU:0.08127,SINF:0.08127):0.00000;
(STHE:0.03530,((SPLU:0.24224,(SINF:0.03037,SLUT:0.02318):0.16956):0.11311,SDOW:0.21588):0.16666,(SSAL:0.04256,SVES:0.02626):0.02427):0.00000;
(SINF:0.00967,SEQU:0.02339,SLUT:0.00141):0.00000;
(SINF:0.02549,SEQU:0.11583,SLUT:0.06132):0.00000;
((SENT:0.28854,(((SANG:0.11327,(SINT:0.01172,SCON:0.00893):0.08769):0.20704,(SRAT:0.02176,SDEV:0.02207):0.27707):0.04513,(SINF:0.12527,SEQU:0.10857):0.25199):0.05035):0.02030,SPLU:0.23946,SSUI:0.23845):0.00000;
(SINF:0.08823,SEQU:0.06527,SCON:0.38075):0.00000;
(SLUT:0.08746,SINF:0.08746):0.00000;
(SINF:0.02143,SEQU:0.12864,SLUT:0.01788):0.00000;
(SEQU:0.00722,SINF:0.00722):0.00000;
(SEQU:0.31569,SINF:0.31569):0.00000;
(SPLU:0.28869,SINF:0.14786,(SDOW:0.06226,SDEV:0.06741):0.05203):0.00000;
((((SDEV:0.05553,SRAT:0.05636):0.12646,(((SINF:0.07198,SEQU:0.06051):0.11054,(SDYS:0.08443,SCAN:0.10329):0.14660):0.08405,SSUI:0.24800):0.05698):0.13784,SANG:0.06013):0.05261,SCON:0.02200,SINT:0.02913):0.00000;
(((SPLU:0.04095,((SENT:0.06519,((LCRE:0.00790,LLAC:0.00962):0.11538,((SDYS:0.01834,(SPYO:0.01512,SCAN:0.01471):0.00731):0.39515,(SINF:0.06492,SDOW:0.08439):0.15070):0.08592):0.04022):0.01218,(((SMIT:0.00295,(SPSE:0.00000,SPNE:0.00000):0.00475):0.03203,((SANG:0.00738,SINT:0.00805):0.00730,SCON:0.01499):0.01200):0.00824,(SSUI:0.04306,(SDEV:0.03186,SRAT:0.02808):0.01101):0.00175):0.00601):0.00843):0.00191,SDOW:0.03927):0.00221,(((SINF:0.00622,SLUT:0.01155):0.00488,SEQU:0.02545):0.01385,(SPYO:0.02833,(SCAN:0.00712,SDYS:0.01068):0.01464):0.00803):0.00167,(SSAL:0.00481,(STHE:0.00172,SVES:0.00066):0.00591):0.02872):0.00000;
(SDOW:0.24318,SINF:0.24318):0.00000;
((SSUI:0.26945,(SDOW:0.19992,SINF:0.22255):0.00720):0.00712,((SDEV:0.18805,SPLU:0.25370):0.00954,(SVES:0.09740,SSAL:0.09124):0.09469):0.02279,(((SPSE:0.05941,SPNE:0.06899):0.02560,SMIT:0.08697):0.17416,(SANG:0.13393,SINT:0.13113):0.10341):0.08195):0.00000;
(SINF:0.22467,(SLUT:0.38898,(SINF:0.23627,SDOW:0.22811):0.04632):0.01270,LCRE:0.26442):0.00000;
(SLUT:0.32017,SINF:0.32017):0.00000;
((SPNE:0.01302,(((SLUT:0.01466,SINF:0.03126):0.10891,SEQU:0.10528):0.20855,SINT:0.29418):0.33168):0.00754,SPSE:0.01298,SPSE:0.01655):0.00000;
(SINF:0.01189,SLUT:0.01279,SEQU:0.53849):0.00000;
(SINF:0.00526,SLUT:0.01388,SEQU:0.43465):0.00000;
((STHE:0.01003,((((SLUT:0.03197,SINF:0.02650):0.07023,SEQU:0.11424):0.15337,SDOW:0.17194):0.05722,((SPYO:0.02925,SDYS:0.02958):0.02529,SCAN:0.05631):0.15232):0.18486):0.00630,SVES:0.00582,SSAL:0.01050):0.00000;
((SDOW:0.21152,SINF:0.23597):0.01377,((SENT:0.19589,(SVES:0.22048,((SINT:0.04611,SCON:0.03650):0.03548,SANG:0.07862):0.13440):0.02225):0.02160,((LLAC:0.11776,LCRE:0.10153):0.14801,(SDEV:0.11993,SRAT:0.12017):0.11223):0.02652):0.02246,SPLU:0.23162):0.00000;
(SINF:0.09289,(SSAL:0.00000,SVES:0.00000):0.00084,STHE:0.00351):0.00000;
(SINF:0.01754,SLUT:0.01365,SEQU:0.55003):0.00000;
((SLUT:0.02919,SINF:0.01170):0.11934,SEQU:0.11119,SDEV:0.58018):0.00000;
(((SLUT:0.02229,SINF:0.01926):0.02377,SEQU:0.03933):0.27139,(SDOW:0.32483,(SSAL:0.06014,(STHE:0.04314,SVES:0.03015):0.02318):0.24050):0.00791,(SSUI:0.28455,((SINT:0.05510,(SCON:0.03874,SANG:0.04795):0.01086):0.15911,(SPSE:0.02363,(SPNE:0.02433,SMIT:0.02025):0.00780):0.20451):0.06984):0.01700):0.00000;
(SINF:0.13327,SEQU:0.08261,SSAL:0.32818):0.00000;
((SLUT:0.00000,SINF:0.00000):0.09276,SEQU:0.12654,SSUI:0.31008):0.00000;
((SLUT:0.03865,SINF:0.01212):0.09778,SEQU:0.07464,(SRAT:0.00759,SLUT:0.00575):0.48752):0.00000;
(((SPNE:0.44227,(SSAL:0.03339,SVES:0.03834):0.19430):0.09898,SLUT:0.12902):0.09491,(SPSE:0.02616,SPNE:0.02133):0.00250,SMIT:0.02422):0.00000;
((SLUT:0.01559,((SANG:0.00751,(SINT:0.00043,SCON:0.00044):0.00335):0.29239,(SSAL:0.01778,SVES:0.01044):0.18576):0.16227):0.00703,(SPSE:0.00499,SPNE:0.00161):0.00378,SMIT:0.01159):0.00000;
(SSAL:0.35849,(SSAL:0.31221,SSAL:0.22565):0.01936,SSAL:0.30235):0.00000;
(SSUI:0.30758,SSAL:0.30758):0.00000;
(SMIT:0.11847,SPNE:0.14221,(SSAL:0.03375,SVES:0.03468):0.37290):0.00000;
(SSAL:0.01386,SVES:0.01568,SCON:0.30745):0.00000;
(SVES:0.03171,SSAL:0.03171):0.00000;
(SENT:0.49627,SSAL:0.06777,SVES:0.06272):0.00000;
(SDEV:0.23062,((LLAC:0.02200,LCRE:0.01894):0.23199,((SMIT:0.02138,(SPSE:0.00527,SPNE:0.00453):0.02557):0.13383,((SANG:0.04003,SINT:0.03754):0.10971,((SSAL:0.02445,SVES:0.00869):0.00630,STHE:0.02649):0.14354):0.01380):0.08112):0.01047,(SENT:0.33727,(SDYS:0.00585,SPYO:0.00629):0.41940):0.00332):0.00000;
((STHE:0.33715,(SSAL:0.12064,SSAL:0.20678):0.03207):0.02375,(SVES:0.18834,SSAL:0.19445):0.07227,(LLAC:0.43840,((SSAL:0.04059,SVES:0.03955):0.01300,STHE:0.11812):0.31819):0.06498):0.00000;
(SDOW:0.19368,SSAL:0.19368):0.00000;
(SVES:0.02645,SSAL:0.02645):0.00000;
(SSAL:0.15066,(SDYS:0.04039,SENT:0.02947):0.17325,SENT:0.31876):0.00000;
((LLAC:0.30244,SSAL:0.41360):0.02871,(SENT:0.05076,SDYS:0.04711):0.19808,SENT:0.29595):0.00000;
(SINF:0.31003,SSAL:0.31003):0.00000;
(SPSE:0.11415,SSAL:0.11415):0.00000;
(SPSE:0.20339,SSAL:0.20339):0.00000;
((SCAN:0.14797,SSAL:0.61099):0.07693,SMIT:0.02313,SINT:0.01976):0.00000;
(SINF:0.14813,(SLUT:0.06438,SSAL:0.04388):0.11945,SEQU:0.21968):0.00000;
(SSAL:0.01628,SEQU:0.14860,SLUT:0.01649):0.00000;
(SRAT:0.31903,SSAL:0.31903):0.00000;
(STHE:0.29456,SSAL:0.29456):0.00000;
(((SCAN:0.06594,SDYS:0.07739):0.09894,(SPLU:0.17864,(SENT:0.25646,(SSUI:0.19651,SSAL:0.18005):0.15864):0.02022):0.02311):0.00314,(SDEV:0.05261,SRAT:0.06152):0.13410,SDOW:0.17529):0.00000;
(SINF:0.29849,SSAL:0.29849):0.00000;
(SSAL:0.65620,SMIT:0.01931,SPSE:0.01666):0.00000;
(SDOW:0.25148,SSAL:0.25148):0.00000;
((SPLU:0.07017,(STHE:0.01585,(SVES:0.00782,SSAL:0.00420):0.00783):0.06530):0.01759,((((LCRE:0.01032,LLAC:0.01298):0.15283,(((SMIT:0.00714,(SPSE:0.00384,SPNE:0.00193):0.00345):0.07277,((SANG:0.03078,SINT:0.03461):0.00865,SCON:0.04056):0.04313):0.02244,SSUI:0.14684):0.01568):0.01207,((((SINF:0.00182,SLUT:0.00203):0.00724,SEQU:0.01653):0.06809,(SPYO:0.04696,(SCAN:0.01270,SDYS:0.01591):0.02407):0.04622):0.01960,SDOW:0.09902):0.01250):0.00912,(SDEV:0.02788,SRAT:0.02764):0.06109):0.00499,SENT:0.09458):0.00000;
(STHE:0.00000,(SVES:0.00001,SINF:0.12772):0.00366,SSAL:0.00000):0.00000;
(((STHE:0.05806,(SSAL:0.01342,SVES:0.00981):0.03009):0.15449,((LLAC:0.01577,LCRE:0.01312):0.48553,SMIT:0.21101):0.02168):0.01645,((SRAT:0.09931,SDEV:0.13289):0.09440,LLAC:0.24500):0.02482,(SCON:0.02434,SINT:0.01369):0.16265):0.00000;
(((SRAT:0.07040,SDEV:0.07020):0.16560,((SVES:0.02521,(SSAL:0.00817,STHE:0.01866):0.00362):0.17433,SPLU:0.17111):0.03601):0.02341,((((SMIT:0.02190,(SPSE:0.00809,SPNE:0.00980):0.01835):0.14486,(SCON:0.04287,(SANG:0.00591,SINT:0.00292):0.03486):0.11454):0.03458,SSUI:0.21523):0.06409,SDOW:0.30623):0.04462,SDOW:0.23551):0.00000;
((((SDOW:0.09717,(SRAT:0.01933,SDEV:0.02322):0.06459):0.19392,(STHE:0.23747,(SENT:0.18646,SDOW:0.22029):0.01478):0.19328):0.12602,SENT:0.18853):0.01005,SDOW:0.20121,STHE:0.18730):0.00000;
(STHE:0.20994,SVES:0.12570,SSAL:0.21340):0.00000;
(SMIT:0.16339,STHE:0.16339):0.00000;
((STHE:0.04165,SVES:0.05358):0.03672,SSAL:0.02066,SPLU:0.37557):0.00000;
(((STHE:0.01289,(SSAL:0.00720,SVES:0.01199):0.00704):0.14674,((SPSE:0.00199,(SMIT:0.00000,SPNE:0.00000):0.00302):0.09423,(SINT:0.01727,(SANG:0.00420,SCON:0.00326):0.00746):0.07327):0.08854):0.02779,((SENT:0.17184,(SDEV:0.01877,SRAT:0.03283):0.04802):0.08060,((LLAC:0.00000,LCRE:0.00000):0.30434,SSUI:0.20723):0.04650):0.03790,(SPLU:0.16340,(SDOW:0.17744,((SINF:0.00000,(SLUT:0.00000,SEQU:0.00000):0.00000):0.05773,(SCAN:0.01867,(SPYO:0.01308,SDYS:0.00965):0.00537):0.08872):0.05082):0.04885):0.03481):0.00000;
(STHE:0.00000,(SVES:0.00746,SINF:0.11606):0.00229,SSAL:0.00109):0.00000;
(STHE:0.00000,(SVES:0.00523,SINF:0.03655):0.00001,SSAL:0.00000):0.00000;
((SSAL:0.00273,STHE:0.01134):0.10856,SPSE:0.11804,SVES:0.53908):0.00000;
(STHE:0.10127,SVES:0.01258,SSAL:0.01800):0.00000;
((((((SMIT:0.00300,SPSE:0.00476):0.00174,SPNE:0.00947):0.09421,(SANG:0.01900,(SINT:0.00416,SCON:0.00450):0.01713):0.06242):0.02189,SSUI:0.09774):0.01044,(((LLAC:0.00191,LCRE:0.00404):0.48129,(SEQU:0.03631,(SLUT:0.01335,SINF:0.00986):0.02935):0.16619):0.03034,((STHE:0.01048,SVES:0.00976):0.00948,SSAL:0.01231):0.13991):0.01855):0.02194,SDOW:0.13046,(SPLU:0.12467,((SPYO:0.07988,(SCAN:0.03320,SDYS:0.04369):0.01966):0.05353,(SDEV:0.01918,SRAT:0.01779):0.07715):0.00449):0.00223):0.00000;
((STHE:0.05024,SVES:0.05608):0.58275,SANG:0.03261,SCON:0.05150):0.00000;
(STHE:0.01256,(SPNE:0.34940,SLUT:0.00871):0.06558,SINF:0.00778):0.00000;
(((LCRE:0.01417,LLAC:0.00952):0.21157,(SVES:0.02087,(SSAL:0.00658,STHE:0.01631):0.01796):0.13181):0.01030,(SPLU:0.17171,(SENT:0.21624,(SDOW:0.12480,((SPYO:0.06652,(SDYS:0.02487,SCAN:0.01825):0.02927):0.11812,(((SINF:0.00014,SLUT:0.00153):0.00524,SEQU:0.00476):0.09070,(SDEV:0.01596,SRAT:0.02102):0.08431):0.03179):0.00400):0.01585):0.00559):0.00352,(((SPSE:0.00840,SPNE:0.00781):0.00363,SMIT:0.01257):0.15095,(((SANG:0.02632,SINT:0.02828):0.00907,SCON:0.05285):0.09571,SSUI:0.13009):0.01501):0.02151):0.00000;
(SVES:0.06103,STHE:0.06103):0.00000;
(((SDOW:0.18009,SPLU:0.15461):0.02615,((SSAL:0.02091,SVES:0.01551):0.00999,STHE:0.02678):0.14880):0.00420,(((SLUT:0.01637,(SINF:0.01640,SEQU:0.01215):0.00814):0.13938,((SCAN:0.01134,SPYO:0.01655):0.04135,SDYS:0.04410):0.09919):0.04930,(((LLAC:0.01361,LCRE:0.01364):0.32258,(SSUI:0.15749,(SDEV:0.05179,SRAT:0.04863):0.13583):0.12903):0.07442,SENT:0.24014):0.02960):0.00537,((SMIT:0.02031,(SPNE:0.01664,SPSE:0.01040):0.00406):0.12688,(SANG:0.04763,(SCON:0.00719,SINT:0.00299):0.04416):0.09004):0.05093):0.00000;
(SANG:0.18827,STHE:0.18827):0.00000;
((SEQU:0.04307,((LCRE:0.00946,LLAC:0.00680):0.11105,(STHE:0.20711,SMIT:0.18014):0.17278):0.07582):0.04104,SLUT:0.00419,SINF:0.00495):0.00000;
((STHE:0.05934,(SENT:0.20102,SDOW:0.20298):0.12632):0.02911,SVES:0.00928,SSAL:0.00124):0.00000;
(STHE:0.07552,SVES:0.01641,SSAL:0.02314):0.00000;
((((SPLU:0.18051,((STHE:0.04146,SVES:0.03027):0.01489,SSAL:0.06264):0.16905):0.01332,(SANG:0.14843,(SMIT:0.02797,(SPSE:0.01480,SPNE:0.01600):0.01825):0.08447):0.06208):0.00511,(((LLAC:0.00867,LCRE:0.00897):0.43923,SENT:0.25517):0.01674,((SCAN:0.06614,SDYS:0.05866):0.16046,SDOW:0.18238):0.01071):0.01418):0.00414,((SINF:0.01053,SLUT:0.00783):0.00713,SEQU:0.01503):0.19176,SSUI:0.18866):0.00000;
(STHE:0.05534,SVES:0.03748,SSAL:0.01907):0.00000;
(STHE:0.15107,(SENT:0.17468,SLUT:0.12308):0.01356,LCRE:0.21595):0.00000;
(STHE:0.03230,SVES:0.06329,SSAL:0.03781):0.00000;
((SENT:0.22070,((SMIT:0.31286,(SSUI:0.21660,(SDEV:0.20324,((SENT:0.13703,SPSE:0.12596):0.03178,SENT:0.20639):0.04131):0.05329):0.03030):0.02398,(SMIT:0.17910,STHE:0.18588):0.04415):0.01295):0.00420,SDYS:0.20965,(((SLUT:0.02693,SEQU:0.01697):0.00582,SINF:0.04041):0.21905,(SSAL:0.06955,SVES:0.08219):0.18867):0.03334):0.00000;
(STHE:0.02930,(SSAL:0.00973,SVES:0.01736):0.00901,(SEQU:0.02810,SINF:0.04115):0.29162):0.00000;
(((STHE:0.03241,(SSAL:0.01509,SVES:0.02136):0.00502):0.15727,(SSUI:0.20515,SPLU:0.27462):0.03000):0.13789,(SPSE:0.03446,SPNE:0.02322):0.00376,SMIT:0.02553):0.00000;
(SPYO:0.09451,(((LLAC:0.02089,LCRE:0.01401):0.28556,((STHE:0.03843,(SSAL:0.02094,SVES:0.02767):0.00943):0.15385,SDOW:0.18559):0.15709):0.11559,(((SINF:0.00156,SLUT:0.00681):0.03273,SEQU:0.02362):0.13644,(SRAT:0.03346,SDEV:0.03259):0.11635):0.03790):0.10613,(SCAN:0.04826,SDYS:0.03638):0.01678):0.00000;
(STHE:0.02590,SPNE:0.22684,SSAL:0.02758):0.00000;
(STHE:0.05023,SVES:0.00597,SSAL:0.02026):0.00000;
(STHE:0.08569,SVES:0.02758,SSAL:0.00007):0.00000;
(SVES:0.25171,STHE:0.25171):0.00000;
(STHE:0.01876,SVES:0.01781,SSAL:0.39063):0.00000;
(SINF:0.02141,STHE:0.02141):0.00000;
(SSAL:0.06924,STHE:0.06924):0.00000;
(STHE:0.01967,(SSAL:0.00422,SVES:0.00956):0.00437,SINF:0.49757):0.00000;
((((((SMIT:0.01619,(SPSE:0.00043,SPNE:0.00537):0.01714):0.02297,(SANG:0.00321,(SINT:0.00000,SCON:0.00000):0.00693):0.03427):0.08831,SSUI:0.15553):0.03409,((LCRE:0.01548,LLAC:0.01321):0.19714,((SSAL:0.00000,SVES:0.00000):0.01591,STHE:0.03597):0.10476):0.00702):0.01271,(SDEV:0.01269,SRAT:0.00889):0.07856):0.00943,(((SINF:0.01384,(SLUT:0.01604,SEQU:0.00379):0.01948):0.06118,(SCAN:0.00535,(SPYO:0.01535,SDYS:0.00184):0.00040):0.10027):0.01289,SDOW:0.12365):0.00584,(SPLU:0.11506,SENT:0.11767):0.01027):0.00000;
(STHE:0.08756,SVES:0.02912,SSAL:0.01828):0.00000;
(SSAL:0.08426,STHE:0.08426):0.00000;
(SVES:0.14958,STHE:0.14958):0.00000;
(SLUT:0.23693,STHE:0.23693):0.00000;
(STHE:0.07286,SVES:0.04044,SINT:0.33612):0.00000;
(((STHE:0.02845,(SSAL:0.01647,SVES:0.02429):0.00422):0.10642,SDEV:0.14473):0.00258,((SCAN:0.07913,SDYS:0.09773):0.11828,((LLAC:0.02638,LCRE:0.02883):0.20093,SRAT:0.14890):0.05733):0.01704,(((SINF:0.02351,SLUT:0.02239):0.05268,SEQU:0.06870):0.05477,SSUI:0.12792):0.01508):0.00000;
(STHE:0.03781,SVES:0.05695,SSAL:0.03578):0.00000;
(STHE:0.00146,STHE:0.00146):0.00000;
(((SDOW:0.12040,((SSUI:0.12474,((SANG:0.00226,(SINT:0.00003,SCON:0.00090):0.00285):0.04544,(SMIT:0.00929,(SPNE:0.00286,SPSE:0.00750):0.00707):0.05092):0.05523):0.02042,(LCRE:0.01366,LLAC:0.01231):0.15986):0.02825):0.00918,(((SLUT:0.00750,(SINF:0.00609,SEQU:0.00137):0.00090):0.04409,(SPYO:0.01189,(SCAN:0.00389,SDYS:0.00264):0.00350):0.04699):0.01232,(STHE:0.01082,(SSAL:0.00272,SVES:0.00335):0.00176):0.07672):0.01310):0.00266,(SDEV:0.00518,SRAT:0.00452):0.06614,(SPLU:0.08776,SENT:0.09868):0.00836):0.00000;
(STHE:0.01439,(SSAL:0.01838,SVES:0.01350):0.00362,SINF:0.36154):0.00000;
((STHE:0.01029,SINF:0.29605):0.00515,SVES:0.00875,SSAL:0.00516):0.00000;
(SVES:0.12615,STHE:0.12615):0.00000;
(LCRE:0.04009,LLAC:0.04009):0.00000;
((((SSAL:0.00771,(STHE:0.00943,SVES:0.00246):0.00889):0.02478,SDOW:0.03793):0.00362,((SLUT:0.00313,(SINF:0.00732,SEQU:0.00155):0.00057):0.02083,(LCRE:0.00121,LLAC:0.00562):0.11264):0.00239):0.00098,((SINT:0.01366,(SANG:0.01676,SCON:0.01725):0.00320):0.00361,(SDEV:0.01212,SRAT:0.01796):0.01435):0.00654,(((SPSE:0.00277,(SMIT:0.00000,SPNE:0.00000):0.00019):0.02345,(SSUI:0.01725,SPLU:0.00985):0.00615):0.00540,(SENT:0.01866,(SCAN:0.00448,(SPYO:0.00526,SDYS:0.00513):0.00194):0.01168):0.00451):0.00169):0.00000;
(((LCRE:0.00041,LLAC:0.00041):0.08768,(((STHE:0.00723,(SSAL:0.00216,SVES:0.00095):0.00209):0.01287,SDOW:0.02155):0.00594,SRAT:0.01517):0.00365):0.00173,SDEV:0.01320,(((SINF:0.00112,SLUT:0.00030):0.00384,SEQU:0.00239):0.01342,((SANG:0.00249,(SINT:0.00093,SCON:0.00020):0.00063):0.01403,(((SMIT:0.00009,SPSE:0.00019):0.00175,SPNE:0.00137):0.01137,(SENT:0.02393,((SSUI:0.01202,SPLU:0.00898):0.00634,(SCAN:0.00067,(SPYO:0.00083,SDYS:0.00115):0.00019):0.01281):0.00189):0.00280):0.00910):0.00220):0.00229):0.00000;
(((SSAL:0.00000,SVES:0.00000):0.00433,((((SPYO:0.02648,(SCAN:0.00488,SDYS:0.00477):0.00447):0.01131,(((SINF:0.00011,SLUT:0.00539):0.00120,SEQU:0.00018):0.00953,SDOW:0.01516):0.01607):0.00642,(SENT:0.03747,(((SANG:0.00400,(SINT:0.00031,SCON:0.00518):0.00699):0.03085,((SMIT:0.00028,(SPSE:0.00814,SPNE:0.00011):0.00110):0.00701,SSUI:0.02997):0.00483):0.01254,(LCRE:0.00788,LLAC:0.00186):0.22493):0.00651):0.00981):0.00098,(SDEV:0.00938,SRAT:0.01669):0.03336):0.00436):0.00116,SPLU:0.00821,STHE:0.02867):0.00000;
(((SPLU:0.00670,((STHE:0.00000,(SSAL:0.00000,SVES:0.00000):0.00000):0.02946,((SINF:0.00144,(SLUT:0.00748,SEQU:0.00036):0.00199):0.01685,((SENT:0.04282,((((SINT:0.00098,(SANG:0.00000,SCON:0.00000):0.00000):0.01160,(SPNE:0.01123,((SMIT:0.00044,SPSE:0.00054):0.00342,SSUI:0.01623):0.01480):0.01930):0.00675,(LCRE:0.00491,LLAC:0.00481):0.14218):0.01228,(SDEV:0.00694,SRAT:0.00087):0.03821):0.01712):0.00510,SDOW:0.04804):0.00414):0.00583):0.01004):0.00609,SDYS:0.00000):0.00000,SPYO:0.00000,SCAN:0.00000):0.00000;
((((((SPLU:0.05233,SENT:0.02964):0.00788,((((SMIT:0.00178,(SPSE:0.00000,SPNE:0.00109):0.00477):0.02712,(SANG:0.00770,(SINT:0.00681,SCON:0.00412):0.00381):0.00442):0.00359,SSUI:0.02962):0.04219,(LCRE:0.00402,LLAC:0.00016):0.23983):0.06487):0.00447,((SCAN:0.00218,(SPYO:0.00000,SDYS:0.00000):0.00000):0.02310,((SLUT:0.00570,(SINF:0.00180,SEQU:0.00259):0.00414):0.01656,(SDEV:0.00237,SRAT:0.00638):0.00847):0.00604):0.00283):0.00985,SDOW:0.01972):0.00761,SVES:0.00000):0.00000,SSAL:0.00000,STHE:0.00000):0.00000;
(((SSAL:0.01312,(STHE:0.02348,SVES:0.02665):0.00222):0.05525,(((((SMIT:0.00428,SPSE:0.00936):0.00162,SPNE:0.00553):0.01894,(SINT:0.02181,(SANG:0.01946,SCON:0.02207):0.00930):0.00655):0.03260,((SCAN:0.02037,(SPYO:0.01857,SDYS:0.01392):0.00435):0.07298,((LCRE:0.01117,LLAC:0.00917):0.13557,SRAT:0.05884):0.00852):0.00381):0.01329,(((SSUI:0.02372,SPLU:0.01455):0.03341,SENT:0.06600):0.01004,SDOW:0.07814):0.01160):0.00900):0.00539,SDEV:0.05705,((SINF:0.00750,SLUT:0.01149):0.00221,SEQU:0.00857):0.04330):0.00000;
((LLAC:0.27538,SVES:0.32100):0.37208,LCRE:0.03240,LLAC:0.03763):0.00000;
(((((STHE:0.01491,(SSAL:0.00395,SVES:0.01033):0.01190):0.00865,SPLU:0.03880):0.00667,(SINF:0.00275,(SLUT:0.00000,SEQU:0.00000):0.00084):0.03597):0.00668,((SENT:0.04723,((SANG:0.02710,(SINT:0.00711,SCON:0.00368):0.02331):0.02137,(LCRE:0.00000,LLAC:0.00000):0.19521):0.00416):0.00540,(SSUI:0.03007,(SDEV:0.00573,SRAT:0.01570):0.02628):0.01004):0.00354):0.00295,((SMIT:0.00710,(SPSE:0.00396,SPNE:0.00497):0.00359):0.02782,SDOW:0.05224):0.00476,((SCAN:0.01078,SPYO:0.02279):0.01348,SDYS:0.01482):0.03777):0.00000;
((((SANG:0.04151,SINT:0.04496):0.00460,SCON:0.05478):0.04718,((SSUI:0.09025,(SPLU:0.09546,(SPYO:0.07762,(SCAN:0.03724,SDYS:0.03785):0.01124):0.06533):0.00612):0.01131,(SENT:0.14978,((SMIT:0.03183,(SPSE:0.01560,SPNE:0.02921):0.01307):0.07308,(LLAC:0.01833,LCRE:0.01240):0.28129):0.00867):0.01502):0.00648):0.00347,(((SINF:0.01620,SLUT:0.01274):0.01532,SEQU:0.02120):0.06701,(SDEV:0.05228,SRAT:0.05699):0.05230):0.00738,(((STHE:0.00480,SSAL:0.00525):0.00454,SVES:0.01179):0.08875,SDOW:0.12056):0.00632):0.00000;
(LCRE:0.01619,LLAC:0.01619):0.00000;
(((SPYO:0.00172,(SCAN:0.00000,SDYS:0.00000):0.00553):0.02116,((SINT:0.00272,SCON:0.00782):0.01883,(((SSUI:0.00477,SPLU:0.01228):0.02498,SENT:0.02276):0.01043,(((SSAL:0.01579,(STHE:0.00498,SVES:0.00159):0.00650):0.01524,((SPSE:0.00798,(SMIT:0.00000,SPNE:0.00000):0.00122):0.01572,SANG:0.02965):0.00408):0.00943,(LCRE:0.00000,LLAC:0.00000):0.17651):0.00537):0.01185):0.00294):0.00243,(SDEV:0.01188,(SDOW:0.02940,SRAT:0.01290):0.00296):0.00711,((SINF:0.00913,SLUT:0.00404):0.00324,SEQU:0.00203):0.01525):0.00000;
(((SMIT:0.01832,SPSE:0.01874):0.11482,(SANG:0.02484,(SINT:0.00927,SCON:0.00922):0.01742):0.07178):0.02112,((SDOW:0.05381,(SDEV:0.02548,SRAT:0.01825):0.03338):0.07793,((SINF:0.02651,(SLUT:0.01766,SEQU:0.01956):0.00872):0.04709,(STHE:0.01853,(SSAL:0.00869,SVES:0.01462):0.00530):0.07715):0.04199):0.01330,((LCRE:0.00379,LLAC:0.00457):0.18946,((SMIT:0.01243,(SPSE:0.02014,SPNE:0.01399):0.00157):0.13090,(((SSUI:0.00293,SPLU:0.00145):0.07111,SENT:0.07630):0.01976,(SCAN:0.01746,(SPYO:0.00388,SDYS:0.00383):0.02381):0.06476):0.03970):0.03530):0.33050):0.00000;
(((((((((((((((STHE:0.01760,(SSAL:0.00000,SVES:0.00000):0.00003):0.00153,(SCAN:0.00000,(SPYO:0.00000,SDYS:0.00000):0.00000):0.00858):0.00660,((SSUI:0.00000,SENT:0.00000):0.00066,(LCRE:0.00000,LLAC:0.00000):0.08585):0.00775):0.00229,SRAT:0.00000):0.00000,SDOW:0.00000):0.00000,SDEV:0.00000):0.00000,SEQU:0.00000):0.00000,SLUT:0.00000):0.00000,SINF:0.00000):0.00000,SPLU:0.00000):0.00000,SCON:0.00000):0.00000,SINT:0.00000):0.00000,SANG:0.00000):0.00000,SPNE:0.00000):0.00000,SPSE:0.00000,SMIT:0.00000):0.00000;
(LCRE:0.05593,LLAC:0.05593):0.00000;
((SDOW:0.01428,((((SMIT:0.00739,(SPSE:0.00000,SPNE:0.00000):0.00211):0.00841,SSUI:0.03423):0.01439,((SINT:0.01004,(SANG:0.00000,SCON:0.00000):0.00178):0.01518,SENT:0.02855):0.00509):0.00191,(SPLU:0.08747,(LCRE:0.00059,LLAC:0.00645):0.04322):0.00322):0.00793):0.00214,((SSAL:0.00015,SVES:0.00696):0.00909,(((SINF:0.00236,SEQU:0.00000):0.00458,(SCAN:0.00000,(SPYO:0.00000,SDYS:0.00000):0.00000):0.00960):0.00158,(SDEV:0.00000,SRAT:0.00000):0.01721):0.00213):0.00144,(STHE:0.01579,SLUT:0.01238):0.00795):0.00000;
(((LLAC:0.00780,(LLAC:0.05030,((LCRE:0.00118,LLAC:0.01038):0.07203,((LCRE:0.07900,(((LLAC:0.00381,STHE:0.02428):0.00525,LLAC:0.03982):0.10913,LCRE:0.07520):0.25366):0.02648,(((SANG:0.01508,(SINT:0.00000,SCON:0.00000):0.08179):0.04284,((SSUI:0.01627,SINF:0.02087):0.05215,(SINF:0.02031,SLUT:0.02292):0.06503):0.03626):0.03811,(SPYO:0.01416,(SCAN:0.01112,SDYS:0.00317):0.00301):0.03872):0.02015):0.00934):0.04240):0.01169):0.01367,STHE:0.04687):0.00104,LLAC:0.00998,LCRE:0.00161):0.00000;
((LCRE:0.03861,LLAC:0.03194):0.19331,(((SSUI:0.16852,SPLU:0.19212):0.00862,((((SINF:0.00770,SLUT:0.01978):0.01435,SEQU:0.03030):0.10849,(SPYO:0.10284,(SCAN:0.03651,SDYS:0.03206):0.04259):0.07772):0.01306,(SDOW:0.12451,((SDEV:0.02168,SRAT:0.02284):0.10624,(SSAL:0.02318,(STHE:0.01428,SVES:0.02703):0.00960):0.12392):0.00530):0.02868):0.01151):0.00733,(SENT:0.21348,((SPSE:0.00014,SPNE:0.00165):0.05210,SMIT:0.06099):0.10676):0.02083):0.00456,(SANG:0.04202,(SINT:0.01560,SCON:0.01387):0.02453):0.10956):0.00000;
((SDOW:0.03136,(SPLU:0.05014,(((LLAC:0.00053,LCRE:0.00725):0.32183,SEQU:0.38239):0.11771,(LCRE:0.00353,LLAC:0.00195):0.09197):0.04907):0.01052):0.00921,((STHE:0.00000,(SSAL:0.00000,SVES:0.00000):0.00000):0.03182,(((SANG:0.01109,(SINT:0.00000,SCON:0.00000):0.00605):0.01104,SSUI:0.03828):0.00486,((SLUT:0.01319,(SINF:0.00571,SEQU:0.00001):0.00112):0.02163,(SDEV:0.00130,SRAT:0.00012):0.01252):0.00248):0.00156):0.00029,(((SMIT:0.00371,(SPSE:0.00000,SPNE:0.00000):0.00056):0.01986,SENT:0.03687):0.00864,((SCAN:0.01103,SPYO:0.02413):0.00901,SDYS:0.01712):0.03102):0.00987):0.00000;
(LCRE:0.03814,LLAC:0.03814):0.00000;
((SDOW:0.11163,((STHE:0.02208,(SSAL:0.00724,SVES:0.01437):0.00842):0.08348,(SENT:0.14093,(SPLU:0.11376,(((((SMIT:0.01435,SPSE:0.01295):0.00172,SPNE:0.01730):0.08243,(SANG:0.03712,(SINT:0.01966,SCON:0.01238):0.03295):0.07680):0.01555,SSUI:0.12373):0.01034,(LLAC:0.01691,LCRE:0.01580):0.18679):0.01142):0.00745):0.00757):0.00418):0.00226,((SDEV:0.02616,SRAT:0.03331):0.07143,((SINF:0.00716,SLUT:0.01100):0.00972,SEQU:0.01766):0.07094):0.00101,(SCAN:0.03611,(SPYO:0.01773,SDYS:0.01541):0.02073):0.07098):0.00000;
(LCRE:0.18076,LLAC:0.18076):0.00000;
(((SSUI:0.00793,SPLU:0.00725):0.03274,SENT:0.06303):0.02566,((((SMIT:0.01193,SPSE:0.00452):0.00122,SPNE:0.01752):0.06927,(SANG:0.03650,(SINT:0.04228,SCON:0.05357):0.00388):0.03593):0.00897,(LCRE:0.00654,LLAC:0.00434):0.22466):0.00922,((SDEV:0.04725,SDOW:0.06432):0.01318,((SCAN:0.00802,(SPYO:0.00517,SDYS:0.00377):0.00229):0.04205,((SSAL:0.02641,(STHE:0.02042,SVES:0.00778):0.01831):0.01906,((SINF:0.01304,(SLUT:0.00000,SEQU:0.00000):0.00978):0.01545,SRAT:0.04900):0.00721):0.00789):0.00602):0.00485):0.00000;
(LCRE:0.03481,LLAC:0.03481):0.00000;
((((((SMIT:0.00925,(SPSE:0.00151,SPNE:0.00370):0.00507):0.09227,(SINT:0.01994,(SANG:0.00528,SCON:0.00314):0.01213):0.06425):0.01405,SSUI:0.12504):0.00713,(SPLU:0.14165,(LLAC:0.02592,LCRE:0.02612):0.21031):0.02473):0.00946,(SDOW:0.11119,((STHE:0.02278,(SSAL:0.01581,SVES:0.01330):0.00450):0.06330,(SDEV:0.01167,SRAT:0.01123):0.06789):0.01385):0.00685):0.00455,((SCAN:0.02767,SPYO:0.01740):0.00514,SDYS:0.02695):0.07655,(SENT:0.10169,(SLUT:0.00865,(SINF:0.00275,SEQU:0.00504):0.00402):0.06792):0.00576):0.00000;
(SEQU:0.08444,SINF:0.08444):0.00000;
((SINF:0.08220,SEQU:0.08432):0.53725,SINF:0.07162,SEQU:0.07478):0.00000;
(SINF:0.00872,(SEQU:0.01567,(((LLAC:0.04427,LCRE:0.03702):0.10409,(SPNE:0.00311,SPSE:0.00331):0.10689):0.08987,(SDEV:0.06519,SRAT:0.07055):0.10727):0.09363):0.00952,SLUT:0.00420):0.00000;
((SLUT:0.01544,SINF:0.01816):0.01034,SEQU:0.03199,((SCAN:0.04203,(SPYO:0.08772,SDYS:0.03386):0.01352):0.25862,((SSAL:0.01843,(STHE:0.02643,SVES:0.01807):0.00391):0.20596,(SRAT:0.04023,SDEV:0.03529):0.13555):0.07029):0.12439):0.00000;
((SDYS:0.34665,((SINF:0.23498,(SPLU:0.05799,SANG:0.06297):0.18402):0.10487,LLAC:0.41521):0.02149):0.01042,LCRE:0.31470,((LCRE:0.29652,LLAC:0.30607):0.01228,SPSE:0.29670):0.01258):0.00000;
(SINF:0.15407,SEQU:0.19346,((SEQU:0.20691,SINF:0.18861):0.11565,SEQU:0.25007):0.05419):0.00000;
(((SPYO:0.07404,(SCAN:0.05709,SDYS:0.04386):0.01230):0.09899,((SLUT:0.02574,SINF:0.02174):0.00542,SEQU:0.02570):0.11680):0.00435,(((SDEV:0.03548,SRAT:0.02913):0.11717,(SENT:0.14487,SPLU:0.13600):0.01382):0.01003,(((LCRE:0.01383,LLAC:0.00985):0.17641,SSUI:0.13931):0.02373,((SANG:0.03099,(SINT:0.02313,SCON:0.01142):0.03048):0.11037,(SMIT:0.01995,(SPSE:0.00470,SPNE:0.00955):0.01329):0.11387):0.02990):0.02011):0.00454,(SDOW:0.17270,(STHE:0.04451,(SSAL:0.02438,SVES:0.02529):0.02837):0.10201):0.01099):0.00000;
(SINF:0.01129,SEQU:0.05677,SLUT:0.04060):0.00000;
(SINF:0.01788,SEQU:0.04496,SLUT:0.03212):0.00000;
((SDYS:0.35673,((SLUT:0.03656,SINF:0.02754):0.07698,SEQU:0.12154):0.15590):0.02117,SDOW:0.39415,SPSE:0.24173):0.00000;
(SLUT:0.00802,SINF:0.00802):0.00000;
(SLUT:0.02011,SINF:0.02011):0.00000;
(LLAC:0.11218,LCRE:0.15809,(SINF:0.20473,SLUT:0.21463):0.17973):0.00000;
(SINF:0.01568,SEQU:0.06983,SLUT:0.02675):0.00000;
(SINF:0.01515,SEQU:0.14100,SLUT:0.02318):0.00000;
(SDOW:0.26178,(((SSAL:0.00191,SVES:0.00173):0.03011,STHE:0.04550):0.29719,((SLUT:0.02453,SINF:0.01522):0.03604,SEQU:0.06892):0.17357):0.03165,(SRAT:0.04043,SDEV:0.03463):0.19306):0.00000;
(((SEQU:0.01104,(SLUT:0.00409,SINF:0.00611):0.01267):0.07368,(((SSAL:0.02076,(STHE:0.01573,SVES:0.00768):0.01348):0.08004,SDOW:0.12497):0.01089,(SDEV:0.01903,SRAT:0.01709):0.06571):0.00589):0.00437,(SPYO:0.07987,(SCAN:0.03434,SDYS:0.04393):0.01954):0.04301,(((SPSE:0.00188,(SMIT:0.00207,SPNE:0.00403):0.00117):0.04832,(SINT:0.02422,(SANG:0.01288,SCON:0.02149):0.00224):0.05842):0.03712,((LCRE:0.01134,LLAC:0.00955):0.29066,((SSUI:0.01102,SPLU:0.01410):0.11152,SENT:0.15511):0.01655):0.01953):0.01219):0.00000;
(SEQU:0.02070,SINF:0.02070):0.00000;
(SINF:0.31504,SPLU:0.03518,SENT:0.04890):0.00000;
(((LLAC:0.05834,LCRE:0.05378):0.30859,(((SLUT:0.02216,SINF:0.01699):0.06145,SEQU:0.06630):0.14099,(SRAT:0.08216,SDEV:0.10077):0.07603):0.04199):0.18211,(SSAL:0.02023,SVES:0.01984):0.01677,STHE:0.03758):0.00000;
(SDOW:0.10772,SINF:0.10772):0.00000;
(SEQU:0.03157,SINF:0.03157):0.00000;
((SSUI:0.18339,SINF:0.14801):0.04041,(SCON:0.37227,SENT:0.37081):0.08806,SEQU:0.26583):0.00000;
(SENT:0.26450,SDYS:0.04456,SPYO:0.02857):0.00000;
((SENT:0.34141,SDYS:0.20600):0.10298,SCAN:0.08968,SPYO:0.08474):0.00000;
((SDYS:0.11334,(SSUI:0.35823,SENT:0.19221):0.16101):0.02611,SCAN:0.09249,SPYO:0.11342):0.00000;
((SPLU:0.14437,SENT:0.19056):0.03869,SDOW:0.20667,((LLAC:0.08273,LCRE:0.07075):0.33838,SENT:0.32447):0.11559):0.00000;
((((((SINF:0.00581,SLUT:0.00369):0.00612,SEQU:0.01461):0.09382,(SPYO:0.04309,(SCAN:0.02396,SDYS:0.02527):0.02056):0.07089):0.01757,(SDEV:0.01698,SRAT:0.02079):0.10643):0.01442,(SPLU:0.15351,SENT:0.17256):0.00408):0.00381,(SSUI:0.12682,((SPSE:0.00217,(SMIT:0.00000,SPNE:0.00000):0.00208):0.10293,(SINT:0.03446,(SANG:0.02366,SCON:0.02741):0.00156):0.05851):0.03257):0.02434,((LCRE:0.00867,LLAC:0.00744):0.27632,((STHE:0.01172,(SSAL:0.00392,SVES:0.00297):0.00550):0.12170,SDOW:0.12506):0.01248):0.00449):0.00000;
((SCON:0.06525,SENT:0.40830):0.05392,SCON:0.01081,SANG:0.02436):0.00000;
(SENT:0.26866,SENT:0.26866):0.00000;
(((LLAC:0.02310,LCRE:0.02896):0.20291,(((SMIT:0.01858,SPSE:0.01075):0.00313,SPNE:0.01440):0.09406,SENT:0.13679):0.08499):0.02879,((SPYO:0.02837,SDYS:0.02057):0.02794,SCAN:0.04814):0.12918,((SDOW:0.15824,(STHE:0.02706,(SVES:0.01311,SSAL:0.00698):0.01280):0.14121):0.01503,((SDEV:0.01847,SRAT:0.02860):0.10137,((SINT:0.03203,SCON:0.03025):0.01079,SANG:0.02884):0.09873):0.02155):0.00918):0.00000;
(SENT:0.43931,SPYO:0.00994,SDYS:0.01456):0.00000;
(((SDOW:0.22190,(((SINT:0.01155,SCON:0.01165):0.07726,SANG:0.07885):0.12856,((SPNE:0.04696,(SPSE:0.03944,SMIT:0.04785):0.00577):0.18770,(SSUI:0.43564,SENT:0.22821):0.01847):0.01187):0.01743):0.00816,(SDYS:0.10072,(SPYO:0.04512,SCAN:0.03687):0.07559):0.13401):0.00578,((SEQU:0.09848,(SINF:0.02490,SLUT:0.02567):0.07457):0.06297,(SDEV:0.08155,SRAT:0.09706):0.07917):0.02190,(SPLU:0.17366,(SSAL:0.03246,(STHE:0.02300,SVES:0.03188):0.02111):0.14328):0.04505):0.00000;
(((SPLU:0.17887,SENT:0.15303):0.09791,(SSUI:0.18897,SENT:0.15225):0.03257):0.17319,(SRAT:0.05972,SDEV:0.07404):0.00986,SINT:0.06691):0.00000;
(SENT:0.36108,(LLAC:0.08387,LCRE:0.08238):0.19264,(LCRE:0.05616,LLAC:0.06303):0.26034):0.00000;
((((STHE:0.16177,(SANG:0.09874,SINT:0.09829):0.07329):0.16372,SPLU:0.32519):0.02567,SENT:0.29124):0.01102,(SPYO:0.15851,(SCAN:0.08903,SDYS:0.08940):0.07855):0.12133,(SSUI:0.22241,(SCON:0.11261,(SVES:0.01261,SSAL:0.01477):0.10175):0.13682):0.02964):0.00000;
(((SPYO:0.48840,((SANG:0.01319,SINT:0.01403):0.04476,STHE:0.06451):0.18765):0.04409,SENT:0.21304):0.02714,SDYS:0.18479,SCAN:0.17657):0.00000;
((SSUI:0.07637,SENT:0.07775):0.00325,(((((SSAL:0.00499,(STHE:0.02223,SVES:0.01329):0.00212):0.04072,SPLU:0.05504):0.01402,((SCAN:0.02057,SPYO:0.02206):0.00401,SDYS:0.02043):0.03674):0.00727,((SLUT:0.01709,(SINF:0.01036,SEQU:0.00829):0.00161):0.02582,SDOW:0.05342):0.01465):0.01661,(SDEV:0.02551,SRAT:0.03828):0.09819):0.01260,((LCRE:0.00000,LLAC:0.00000):0.19132,((SPSE:0.00323,(SMIT:0.00046,SPNE:0.00490):0.00124):0.03206,(SANG:0.03015,(SINT:0.00000,SCON:0.00000):0.02590):0.03443):0.05740):0.00912):0.00000;
((SENT:0.25020,SPYO:0.34871):0.24282,(SPYO:0.03659,SDYS:0.02032):0.05668,SCAN:0.07364):0.00000;
(SSAL:0.13891,SENT:0.13891):0.00000;
(SENT:0.34127,SENT:0.34127):0.00000;
((((SMIT:0.01050,(SPSE:0.00222,SPNE:0.00389):0.03302):0.06116,SDEV:0.07436):0.02683,(SSUI:0.43228,SENT:0.11203):0.06359):0.00551,((SPYO:0.01629,(SCAN:0.02222,SDYS:0.01568):0.01140):0.04296,SRAT:0.07862):0.01693,(SSUI:0.09935,(SSAL:0.06968,SPLU:0.06825):0.01843):0.00657):0.00000;
((SENT:0.31114,(SPLU:0.29905,(SDEV:0.19856,SRAT:0.19257):0.05730):0.01288):0.00960,(SDYS:0.03938,SCAN:0.04275):0.29991,((SMIT:0.11496,(SPNE:0.00264,SPSE:0.00307):0.10218):0.22470,SSUI:0.26378):0.14025):0.00000;
(LLAC:0.02879,LCRE:0.01105,SENT:0.52282):0.00000;
(((SSAL:0.12844,(SSAL:0.01785,SVES:0.02849):0.09724):0.06165,SENT:0.39405):0.01786,((SINT:0.03444,SCON:0.03220):0.04191,SANG:0.06292):0.09483,SPLU:0.17265):0.00000;
((((((((SMIT:0.00231,(SPSE:0.00038,SPNE:0.00097):0.00085):0.03112,((SANG:0.00627,SINT:0.00911):0.00080,SCON:0.00463):0.03587):0.02795,SSUI:0.09658):0.02078,(LCRE:0.00106,LLAC:0.00161):0.16624):0.01910,(SANG:0.10730,SPLU:0.09116):0.13602):0.04277,SENT:0.10557):0.01158,(SDOW:0.05998,(SDEV:0.02111,SRAT:0.01291):0.03663):0.01094):0.00471,((STHE:0.01195,(SSAL:0.00110,SVES:0.00158):0.00368):0.05347,(((SINF:0.00536,SLUT:0.00488):0.00179,SEQU:0.00445):0.02929,(SPYO:0.03804,(SCAN:0.02181,SDYS:0.01435):0.00531):0.01734):0.00639):0.00994,SPLU:0.06042):0.00000;
((SINT:0.35011,SENT:0.24149):0.01801,((SMIT:0.18737,SPLU:0.17240):0.02887,SDYS:0.18708):0.01357,SPLU:0.26676):0.00000;
((SINT:0.22221,(SENT:0.30083,((SVES:0.29798,(STHE:0.00862,SVES:0.01747):0.16072):0.04793,((SDYS:0.00188,SPLU:0.00041):0.30392,(SCAN:0.25888,SENT:0.23250):0.07528):0.06010):0.04097):0.01496):0.01302,(SPLU:0.11867,SDYS:0.11112):0.06662,(SMIT:0.15842,(SPSE:0.24544,SPNE:0.09430):0.02344):0.02850):0.00000;
((SENT:0.27041,SCAN:0.40040):0.03636,SPSE:0.27542,SSUI:0.30519):0.00000;
(SMIT:0.18318,SENT:0.18318):0.00000;
(SENT:0.01382,SENT:0.01382):0.00000;
((((SMIT:0.00565,(SPSE:0.00199,SPNE:0.00760):0.00202):0.02706,(SANG:0.01387,(SINT:0.00474,SCON:0.00362):0.00513):0.04591):0.01191,((SPLU:0.06222,((LCRE:0.01398,LLAC:0.01390):0.10932,SENT:0.09004):0.01014):0.00217,SSUI:0.05484):0.01527):0.00689,(((SSAL:0.01525,(STHE:0.01049,SVES:0.01816):0.01158):0.02746,(SDEV:0.01601,SRAT:0.02109):0.03361):0.00868,(((SINF:0.00949,SLUT:0.00972):0.01503,SEQU:0.02787):0.02758,(SCAN:0.00589,(SPYO:0.00000,SDYS:0.00000):0.00514):0.03824):0.01721):0.00128,SDOW:0.04567):0.00000;
((((SINT:0.01646,(SANG:0.00603,SCON:0.00760):0.00792):0.02913,((SMIT:0.02552,(SPSE:0.00352,SPNE:0.00654):0.02698):0.03996,((LCRE:0.02036,LLAC:0.01509):0.16418,SENT:0.08976):0.00973):0.00429):0.01017,(SSUI:0.06729,((SSAL:0.00779,(STHE:0.01446,SVES:0.00450):0.00433):0.03354,(SDEV:0.01058,SRAT:0.01459):0.03084):0.00513):0.00116):0.00331,((((SINF:0.00343,SLUT:0.00335):0.00921,SEQU:0.01452):0.02743,(SCAN:0.01159,(SPYO:0.00389,SDYS:0.00143):0.00807):0.02683):0.00497,SDOW:0.05663):0.00171,SPLU:0.06078):0.00000;
(SENT:0.31240,SENT:0.36072,SCON:0.40642):0.00000;
(SPNE:0.23520,SENT:0.23520):0.00000;
((((SENT:0.08867,SSUI:0.06717):0.04054,SSAL:0.10522):0.08762,SDYS:0.49723):0.07917,(SANG:0.10624,(SDOW:0.14067,SPSE:0.12715):0.02495):0.02020,((SINF:0.08113,SLUT:0.03401):0.05499,SEQU:0.09894):0.06131):0.00000;
((SCAN:0.02255,SENT:0.50989):0.03883,SCON:0.01938,SCON:0.00660):0.00000;
((SENT:0.07348,((((STHE:0.01137,(SSAL:0.00173,SVES:0.00926):0.00235):0.02958,((SINF:0.00479,SLUT:0.01177):0.00441,SEQU:0.00627):0.04371):0.00854,((SCAN:0.01678,SPYO:0.01160):0.00058,SDYS:0.01707):0.04185):0.00506,(SDEV:0.03969,SRAT:0.03046):0.04275):0.00494):0.00097,((SSUI:0.00967,SPLU:0.00877):0.05063,SDOW:0.06080):0.01149,((LCRE:0.01900,LLAC:0.02293):0.18751,((SPSE:0.01980,(SMIT:0.00752,SPNE:0.00838):0.00227):0.04941,(SANG:0.02979,(SINT:0.02901,SCON:0.01910):0.00909):0.03413):0.01609):0.00792):0.00000;
(SENT:0.52084,(SDYS:0.08418,SCAN:0.07144):0.03918,SPYO:0.15359):0.00000;
(SENT:0.33971,SPLU:0.23534,SSUI:0.28155):0.00000;
((SENT:0.04037,((SVES:0.06516,SDOW:0.06929):0.00446,(SDEV:0.01343,SRAT:0.00870):0.05176):0.00960):0.00399,SSUI:0.06895,(((SMIT:0.00601,SPSE:0.00777):0.00275,SPNE:0.00931):0.04241,(SINT:0.02416,(SANG:0.01090,SCON:0.01994):0.00913):0.02952):0.01936):0.00000;
((((SMIT:0.00506,(SPSE:0.00403,SPNE:0.00312):0.00864):0.04133,(SANG:0.03534,(SINT:0.00996,SCON:0.00891):0.02847):0.01496):0.01906,((LCRE:0.00606,LLAC:0.00116):0.21872,((SPLU:0.08416,((SCAN:0.02004,SPYO:0.02379):0.00431,SDYS:0.01766):0.03251):0.00589,(SDOW:0.07063,((STHE:0.00000,(SSAL:0.00000,SVES:0.00000):0.00000):0.06111,(SSUI:0.04872,SENT:0.07303):0.01408):0.00581):0.02436):0.00881):0.00708):0.00225,(SDEV:0.02010,SRAT:0.04195):0.03694,((SINF:0.01065,SLUT:0.00935):0.01456,SEQU:0.03020):0.02928):0.00000;
(SPLU:0.14985,SENT:0.14985):0.00000;
(SDYS:0.20631,SENT:0.20631):0.00000;
(SDYS:0.19882,SENT:0.19882):0.00000;
(SDYS:0.25648,SENT:0.25648):0.00000;
(SDYS:0.17275,SENT:0.17275):0.00000;
(SDYS:0.20648,SENT:0.20648):0.00000;
(SDYS:0.25971,SENT:0.25971):0.00000;
(SDYS:0.21692,SENT:0.21692):0.00000;
(SPLU:0.12034,SENT:0.12034):0.00000;
(SPLU:0.11186,SENT:0.11186):0.00000;
(SANG:0.17770,SENT:0.17770):0.00000;
(SANG:0.10854,SENT:0.10854):0.00000;
(SENT:0.15438,SENT:0.22715,SANG:0.23946):0.00000;
(SANG:0.16131,SENT:0.16131):0.00000;
(SPYO:0.30138,SENT:0.30138):0.00000;
(SDYS:0.09165,SENT:0.09165):0.00000;
(SDYS:0.09091,SENT:0.09091):0.00000;
((SENT:0.16896,(SPSE:0.13847,(SENT:0.09190,SPLU:0.10273):0.05298):0.04347):0.02340,SENT:0.20389,(SINF:0.11705,STHE:0.20757):0.07525):0.00000;
(SSAL:0.28675,SENT:0.28675):0.00000;
(SENT:0.23552,(SENT:0.09352,SDYS:0.08763):0.13434,SSAL:0.22982):0.00000;
(SDYS:0.14838,SENT:0.62057,SENT:0.13767):0.00000;
((SSAL:0.28981,SENT:0.43507):0.06443,SDYS:0.17278,SENT:0.19013):0.00000;
((LLAC:0.39156,(SENT:0.24488,SINF:0.38381):0.06332):0.18388,(SDYS:0.10626,SENT:0.11352):0.02535,SSAL:0.16078):0.00000;
((SENT:0.30918,SDYS:0.36144):0.25448,(SDYS:0.01676,SCAN:0.02958):0.00435,SCAN:0.03284):0.00000;
(((((SINF:0.01251,SLUT:0.01118):0.00561,SEQU:0.00996):0.10503,(SPYO:0.04488,(SCAN:0.02543,SDYS:0.02405):0.01303):0.04679):0.01304,(SDOW:0.12532,(((LLAC:0.01672,LCRE:0.01629):0.26512,(SSAL:0.02135,(STHE:0.00910,SVES:0.01155):0.01038):0.13594):0.01543,((((SMIT:0.01179,(SPSE:0.00498,SPNE:0.00326):0.00539):0.14380,(SANG:0.02538,(SINT:0.02534,SCON:0.01387):0.01282):0.06907):0.07008,SSUI:0.16184):0.01522,SENT:0.20854):0.00556):0.01084):0.01040):0.00238,(SDEV:0.02673,SRAT:0.02958):0.05836,SPLU:0.12463):0.00000;
(SINT:0.13926,SENT:0.13926):0.00000;
(SENT:0.36150,SINT:0.21436,SMIT:0.23670):0.00000;
(LLAC:0.01187,LCRE:0.00743,SENT:0.62396):0.00000;
((((SEQU:0.08745,(SLUT:0.01769,SSAL:0.01833):0.07907):0.20682,(SSUI:0.21158,(SANG:0.05576,SINT:0.07280):0.15080):0.07635):0.09473,SENT:0.20694):0.01407,SPLU:0.17698,SSAL:0.14628):0.00000;
(SENT:0.22418,SPLU:0.26019,SSAL:0.20514):0.00000;
((SPNE:0.41705,SENT:0.28267):0.23891,(SCON:0.02049,SINT:0.00714):0.04978,SANG:0.05092):0.00000;
(SENT:0.28957,SANG:0.02723,SCON:0.03030):0.00000;
(SENT:0.33402,SCON:0.00799,SANG:0.01462):0.00000;
